data_1tiu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tiu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.14 153.95 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 1.0 109.721 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -128.9 -3.8 5.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 1.0 111.048 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t 53.14 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 1.0 110.183 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -85.52 -26.58 26.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.316 -0.865 . . . . 1.0 109.995 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 105.33 40.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 1.0 110.079 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.84 178.55 5.7 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.604 1.318 . . . . 1.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 14.2 mt -73.77 -157.81 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 1.0 110.156 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -155.9 134.22 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 1.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.65 140.87 26.7 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.671 -1.372 . . . . 1.0 109.671 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.7 152.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 1.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -96.13 169.19 10.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 1.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 17' ' ' GLU . 11.6 p -159.35 146.16 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 1.0 110.299 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -88.35 125.87 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 1.0 109.725 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 63' ' ' CYS . 6.4 p -46.84 93.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.413 -0.805 . . . . 1.0 111.712 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 155.64 -36.4 0.63 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.055 -1.218 . . . . 1.0 110.055 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' CG ' HG21 ' A' ' 13' ' ' VAL . 3.6 pt-20 -85.73 -148.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.826 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.475 HG22 ' CE1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -136.75 137.24 39.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 1.0 110.472 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -85.36 -176.5 6.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 1.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.481 ' CD2' HG12 ' A' ' 59' ' ' ILE . 8.0 m80 -160.7 108.5 1.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.954 -1.091 . . . . 1.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 91.6 m-85 -114.81 120.87 41.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.789 . . . . 1.0 109.369 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -109.8 155.18 21.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 1.0 110.925 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.4 tt -161.37 119.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.767 . . . . 1.0 109.833 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -101.08 131.88 46.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 1.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' CD1' ' NE2' ' A' ' 56' ' ' HIS . 22.0 mt -87.63 179.56 6.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.86 . . . . 1.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.7 p -85.26 -22.05 28.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.0 109.98 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -121.45 135.83 25.39 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 1.0 109.978 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.52 -178.32 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.537 1.283 . . . . 1.0 110.459 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.68 67.48 0.98 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 1.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.52 159.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 1.0 110.307 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.2 148.35 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 1.0 109.963 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.76 -134.02 2.34 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -167.54 140.44 3.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -1.117 . . . . 1.0 110.18 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 58' ' ' LEU . 33.9 m95 -102.93 170.73 7.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 1.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -173.62 170.29 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.486 -0.759 . . . . 1.0 109.942 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.25 -131.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 1.0 109.469 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.6 -25.03 2.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.7 -1.25 . . . . 1.0 110.399 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.64 40.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -128.48 107.63 19.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.199 -1.177 . . . . 1.0 110.046 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.08 112.36 3.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.487 1.256 . . . . 1.0 110.637 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pp -106.7 -146.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 1.0 109.89 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.66 128.12 36.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.05 -1.031 . . . . 1.0 110.39 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.28 111.32 1.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.873 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -177.3 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.386 -0.821 . . . . 1.0 110.244 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -72.19 -74.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.441 1.232 . . . . 1.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD2' ' CE ' ' A' ' 67' ' ' MET . 27.9 t70 -133.19 58.63 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 1.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 t -162.71 142.3 9.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.905 . . . . 1.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -144.5 87.98 1.9 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.284 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.0 mt -87.81 131.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.132 -0.98 . . . . 1.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 tt -134.95 146.36 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 1.0 110.318 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.0 146.7 19.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 110.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.68 9.01 11.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.739 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.49 -21.24 30.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.474 -1.051 . . . . 1.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 -23.22 20.6 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.172 -1.193 . . . . 1.0 109.718 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 56' ' ' HIS . 38.8 tttt -164.56 163.49 21.89 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.423 -0.798 . . . . 1.0 109.498 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.446 ' NE2' ' CD1' ' A' ' 25' ' ' LEU . 51.6 m-70 -113.19 121.63 45.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 1.0 110.04 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.19 141.62 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 1.0 110.345 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 34' ' ' TRP . 21.6 tp -115.57 148.93 39.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.345 -0.847 . . . . 1.0 110.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG12 ' CD2' ' A' ' 20' ' ' HIS . 58.4 mt -146.01 116.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 1.0 109.719 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' CD1' HD22 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -117.44 107.27 14.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 1.0 110.587 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CE1' HG22 ' A' ' 18' ' ' THR . 67.5 m-70 -69.7 -172.14 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 1.0 110.328 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.8 p-10 -13.94 80.85 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.025 1.12 . . . . 1.0 114.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 80.7 m -74.42 148.07 41.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.25 171.0 9.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 1.0 111.541 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -23.93 2.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.715 -0.615 . . . . 1.0 110.748 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.32 -123.87 0.06 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.98 -1.648 . . . . 1.0 108.98 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.441 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 1.7 mtt 43.53 28.02 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.895 . . . . 1.0 111.287 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.51 52.52 2.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.297 -0.877 . . . . 1.0 110.365 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.75 -141.84 5.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.416 -1.474 . . . . 1.0 109.416 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -130.99 143.33 50.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -1.154 . . . . 1.0 110.258 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.7 t -79.71 99.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 1.0 109.856 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -103.11 128.02 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 1.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 64.4 t80 -104.63 154.82 19.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 109.707 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.61 146.85 51.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 1.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.21 -142.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 1.0 110.04 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.94 -70.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.274 -0.891 . . . . 1.0 110.702 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -146.42 21.21 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 1.0 110.106 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -111.8 167.1 10.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 1.0 110.157 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.61 115.79 2.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.939 . . . . 1.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 66.9 p -96.96 177.84 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.286 -0.884 . . . . 1.0 109.696 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.29 97.15 0.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.033 -1.042 . . . . 1.0 110.696 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -97.09 -175.98 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 1.0 109.691 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -100.14 138.33 37.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.047 . . . . 1.0 110.242 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -131.6 120.74 23.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 1.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -134.35 136.63 43.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 1.0 110.101 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 59.5 t -94.57 148.15 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.251 -0.906 . . . . 1.0 110.052 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' N ' HG11 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -122.46 141.53 51.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 1.0 110.192 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -105.06 -157.84 0.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 tp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.261 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.321 0.581 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 27' ' ' GLU . 5.1 tt -106.41 157.87 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 1.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.77 -148.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 1.0 110.041 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.11 129.89 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.64 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 -57.61 3.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.954 . . . . 1.0 109.652 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.09 100.68 15.79 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.661 -0.65 . . . . 1.0 110.345 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.92 -179.33 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.649 1.341 . . . . 1.0 110.441 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' CB ' ' CB ' ' A' ' 82' ' ' ALA . 22.6 mt -76.71 159.34 30.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.055 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -125.96 15.92 7.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.105 -0.997 . . . . 1.0 110.731 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.32 157.69 0.15 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 21' ' ' PHE . 10.2 p -160.07 170.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.523 -0.986 . . . . 1.0 109.714 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.56 166.08 14.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 1.0 110.531 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.18 147.7 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.422 -0.799 . . . . 1.0 110.496 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -97.04 27.73 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 1.0 109.4 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.419 ' CG2' ' CG1' ' A' ' 86' ' ' VAL . 75.4 t 57.39 87.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.55 0.691 . . . . 1.0 110.721 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.48 -30.2 2.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.35 -138.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.304 -1.115 . . . . 1.0 109.386 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.417 ' CG2' ' ND1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -149.64 132.21 15.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 1.0 110.232 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.451 ' O ' ' CD2' ' A' ' 20' ' ' HIS . . . -85.26 165.22 17.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.827 . . . . 1.0 110.037 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 34.4 m170 -144.14 80.52 1.65 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 1.0 110.764 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.483 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 67.3 m-85 -79.77 152.99 29.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 1.0 109.442 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -136.24 158.86 43.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 1.0 110.941 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.428 HG23 ' CZ2' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -168.06 127.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.503 -0.748 . . . . 1.0 109.765 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.37 150.12 24.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -0.925 . . . . 1.0 110.55 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.18 1.1 3.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 1.0 111.569 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 2' ' ' ILE . 6.3 p 41.16 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.6 -0.688 . . . . 1.0 111.721 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' HG3' ' CG2' ' A' ' 2' ' ' ILE . 1.4 mm-40 -136.44 119.74 12.21 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.9 -1.125 . . . . 1.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.75 161.11 44.71 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.501 1.264 . . . . 1.0 110.122 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.78 86.77 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.205 -0.935 . . . . 1.0 110.328 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -168.37 144.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 1.0 109.902 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.42 -175.95 3.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 1.0 110.608 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.0 -164.8 35.03 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -157.32 158.22 35.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -1.144 . . . . 1.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 22.5 m95 -115.49 166.55 11.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.0 110.451 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -162.19 142.8 10.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 1.0 109.758 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 mt -64.16 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 1.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -49.47 -25.46 2.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.635 -1.291 . . . . 1.0 110.056 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 160.79 40.2 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.484 -1.446 . . . . 1.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 7.4 mm-40 -118.8 121.58 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 1.0 110.174 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.73 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.449 1.236 . . . . 1.0 110.744 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -173.99 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 1.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -150.93 -178.06 6.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 1.0 110.274 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.19 106.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 1.0 110.255 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 164.37 24.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 1.0 110.167 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.48 -17.52 30.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.656 1.345 . . . . 1.0 110.613 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -83.45 -26.16 30.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 1.0 110.125 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -118.76 119.79 35.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.0 110.074 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.13 88.84 2.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.966 . . . . 1.0 110.409 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.97 106.96 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 1.0 109.867 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.2 tp -131.28 118.33 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 1.0 110.191 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.37 169.25 21.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 1.0 110.133 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -117.08 -134.51 0.34 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.281 -0.887 . . . . 1.0 109.126 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.68 -19.81 4.8 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.679 -1.248 . . . . 1.0 110.096 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -21.81 22.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 1.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -153.79 173.12 16.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.184 -0.947 . . . . 1.0 110.545 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -133.25 127.62 34.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.352 -0.842 . . . . 1.0 109.787 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.87 135.79 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 1.0 110.715 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -112.89 147.96 35.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.495 -0.753 . . . . 1.0 110.144 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 59' ' ' ILE . 87.8 mt -138.73 82.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0 109.882 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.2 161.71 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 1.0 110.467 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.5 m-70 -126.89 -169.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.486 -0.759 . . . . 1.0 109.503 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.495 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 42.2 p30 -13.64 80.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 61' ' ' HIS . 80.5 m -78.98 175.12 10.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 1.0 109.501 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 86' ' ' VAL . 1.2 mt-30 -138.58 -163.89 1.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.047 -1.033 . . . . 1.0 110.567 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.32 8.56 4.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 1.0 111.476 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.93 -22.91 19.23 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.064 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.469 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 37.7 mtt -86.69 34.93 0.66 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.067 -1.255 . . . . 1.0 110.799 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 34.9 0.93 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 1.0 110.134 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.35 -124.83 4.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.57 147.17 46.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -1.121 . . . . 1.0 110.393 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 70.7 t -89.05 107.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.316 -0.865 . . . . 1.0 109.884 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 p -108.03 110.6 22.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 1.0 110.663 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 22.7 t80 -91.03 146.87 23.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 1.0 109.823 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -131.54 104.55 7.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.037 -1.04 . . . . 1.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -123.62 124.94 43.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 1.0 109.763 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.84 -90.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 1.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 6.2 p30 -129.66 -38.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.807 -1.183 . . . . 1.0 110.378 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.09 159.76 16.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 1.0 110.516 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -156.63 126.92 6.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 1.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 8' ' ' LEU . 75.5 p -92.52 -179.14 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.32 88.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.432 ' CB ' ' CB ' ' A' ' 8' ' ' LEU . . . -91.67 -170.18 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 1.0 110.307 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -119.91 111.59 18.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 1.0 110.363 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.0 tp -102.15 145.43 29.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 1.0 110.087 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.64 107.92 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.299 -0.875 . . . . 1.0 110.207 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 46.3 t -80.9 147.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.118 -0.989 . . . . 1.0 110.405 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -115.45 168.37 10.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 110.165 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -101.95 155.46 18.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.241 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.205 0.526 . . . . 1.0 110.176 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.14 140.94 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.34 156.63 17.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 1.0 109.971 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.78 167.28 2.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.116 -0.99 . . . . 1.0 110.018 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -123.69 -30.72 3.55 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.482 0.658 . . . . 1.0 110.033 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -146.96 122.39 5.37 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 1.0 110.029 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.55 -176.49 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.535 1.282 . . . . 1.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 18.3 mt -82.46 -164.62 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.21 -0.931 . . . . 1.0 110.777 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.13 139.78 26.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.404 -0.81 . . . . 1.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.6 150.29 34.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.429 -1.468 . . . . 1.0 109.429 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -158.56 169.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 1.0 110.332 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -122.29 165.05 16.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 1.0 110.499 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.94 127.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.238 -0.914 . . . . 1.0 110.104 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.55 47.57 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.217 -0.927 . . . . 1.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t 48.77 71.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.683 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.65 -22.52 1.04 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -78.99 -122.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -1.157 . . . . 1.0 109.232 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -161.17 157.85 26.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.705 -1.247 . . . . 1.0 110.492 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . . . -108.64 172.52 6.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.393 -0.817 . . . . 1.0 108.883 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.471 ' CE1' HD13 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -157.72 122.87 4.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.112 . . . . 1.0 111.249 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 73.6 m-85 -140.32 132.82 28.61 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.16 155.5 41.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.937 -1.102 . . . . 1.0 111.155 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -167.8 122.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.607 -0.683 . . . . 1.0 109.752 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.24 130.35 54.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 1.0 110.491 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 55.6 mt -91.33 -174.2 3.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.822 . . . . 1.0 109.871 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -99.03 -57.37 2.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.0 109.963 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.99 144.01 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 1.0 109.852 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 -169.5 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.628 1.331 . . . . 1.0 110.567 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t0 55.26 80.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 1.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.4 t -131.28 154.09 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 1.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -124.53 43.53 2.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.92 . . . . 1.0 110.452 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.74 171.36 55.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 12.4 tm0? -145.07 165.26 28.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -1.112 . . . . 1.0 109.902 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 34.2 m95 -108.52 163.84 12.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 1.0 110.819 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -159.59 157.11 29.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.413 -0.804 . . . . 1.0 110.102 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.31 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 1.0 109.805 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -47.34 -25.92 1.13 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.856 -1.152 . . . . 1.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 150.64 39.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -136.41 136.47 22.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 O-C-N 121.126 -1.22 . . . . 1.0 109.132 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.42 114.48 3.94 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.468 1.246 . . . . 1.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.77 -139.58 0.2 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 1.0 109.926 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 p -138.69 136.85 36.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.119 . . . . 1.0 110.013 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.79 98.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 1.0 110.088 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -88.69 169.12 14.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 1.0 110.184 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.06 -16.72 28.71 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.731 1.385 . . . . 1.0 110.513 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -98.37 -21.27 16.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 1.0 110.376 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.27 136.32 33.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 1.0 110.181 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.63 136.42 54.49 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 1.0 109.626 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.7 mt -139.39 76.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 1.0 109.761 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.4 144.32 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 1.0 110.038 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.76 137.53 8.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 1.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 26.6 8.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 1.0 109.872 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 -92.39 1.77 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -15.79 30.55 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.631 -0.923 . . . . 1.0 110.547 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -121.63 130.72 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 1.0 110.588 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.461 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 29.3 m-70 -118.16 131.13 56.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.0 110.085 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.97 136.42 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 1.0 110.226 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 59' ' ' ILE . 16.2 tp -125.17 139.96 53.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 1.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.471 HD13 ' CE1' ' A' ' 20' ' ' HIS . 33.9 mm -140.61 115.43 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 1.0 109.331 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 19' ' ' ALA . 9.0 mt -112.82 108.46 17.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 1.0 110.846 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 25.0 m-70 -75.44 -159.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 1.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 54.0 t30 -14.13 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' HIS . 91.7 m -86.29 -176.27 5.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.6 -0.688 . . . . 1.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.444 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -149.96 -164.22 1.97 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 1.0 110.202 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.58 13.43 0.62 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.071 . . . . 1.0 112.404 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.36 -30.97 10.04 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.448 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 36.9 mtt -86.72 39.23 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -1.121 . . . . 1.0 110.565 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -90.69 79.77 6.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.181 -0.949 . . . . 1.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.64 -120.76 0.59 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.63 140.1 31.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 1.0 110.415 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.69 102.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 1.0 109.853 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 p -102.83 128.69 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 1.0 110.365 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 53.9 t80 -105.57 142.04 36.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.0 109.622 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 127.64 32.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.038 . . . . 1.0 110.647 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.49 -147.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 1.0 109.746 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.43 -73.53 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.932 -1.105 . . . . 1.0 110.081 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -130.12 -1.21 4.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 1.0 110.794 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.22 156.11 23.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.927 -1.108 . . . . 1.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.07 125.88 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.927 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.419 ' CB ' HD13 ' A' ' 8' ' ' LEU . 2.6 p -126.17 178.34 5.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 1.0 109.729 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.55 106.69 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 1.0 110.592 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 8' ' ' LEU . . . -100.01 -170.44 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 1.0 109.716 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.14 109.18 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.025 . . . . 1.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 tp -108.01 147.01 31.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 1.0 110.036 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 105.09 3.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 110.136 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 38.3 t -80.5 133.35 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.186 -0.946 . . . . 1.0 110.149 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -98.44 146.26 25.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.06 149.05 48.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 1.0 110.168 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.235 -179.819 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.179 0.514 . . . . 1.0 110.157 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 1.2 pt -110.15 133.03 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 1.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.6 162.82 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 1.0 110.271 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 1.3 p -74.59 124.98 33.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.236 -0.915 . . . . 1.0 110.002 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.21 -34.6 23.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.736 0.779 . . . . 1.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -126.17 109.36 24.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.76 -0.587 . . . . 1.0 110.137 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.0 174.81 10.7 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.578 1.304 . . . . 1.0 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 10.1 mt -87.01 -174.08 4.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0 109.535 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.7 m-85 -145.34 131.4 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 1.0 110.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.35 152.55 14.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 21' ' ' PHE . 7.7 p -158.78 142.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -1.074 . . . . 1.0 110.39 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.31 155.0 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 1.0 109.599 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.07 170.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.025 -1.047 . . . . 1.0 110.931 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -102.13 135.6 43.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.46 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.909 -1.119 . . . . 1.0 111.048 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 147.15 -41.97 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -161.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -1.068 . . . . 1.0 110.107 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.415 HG23 ' ND1' ' A' ' 61' ' ' HIS . 4.8 p -120.98 163.57 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 1.0 110.851 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.65 172.56 7.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.529 -0.732 . . . . 1.0 109.268 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.476 ' CD2' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -155.41 124.43 6.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 1.0 111.178 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 11' ' ' VAL . 60.4 m-85 -134.36 118.44 17.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.523 -0.736 . . . . 1.0 109.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.51 157.11 17.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.052 -1.03 . . . . 1.0 111.034 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.481 HG23 ' CZ2' ' A' ' 34' ' ' TRP . 5.6 tt -168.43 120.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 1.0 109.801 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.69 148.6 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 1.0 110.274 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.467 HD13 ' CD2' ' A' ' 56' ' ' HIS . 28.3 mt -103.84 -154.36 0.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 1.0 109.767 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 31.1 t -116.44 -76.05 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 1.0 109.931 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.66 137.42 20.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.0 109.789 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.31 136.76 27.17 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.578 1.304 . . . . 1.0 110.53 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -164.01 -61.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 110.091 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.82 148.38 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 1.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -75.61 -164.02 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.29 179.38 25.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -131.53 149.35 52.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -1.18 . . . . 1.0 109.944 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.514 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 26.8 m95 -104.91 154.21 20.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 1.0 110.776 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 6.9 pttt -147.66 162.28 39.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 1.0 109.514 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.99 -84.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 1.0 110.115 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 21.16 5.78 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.513 -0.742 . . . . 1.0 110.053 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 107.85 -14.7 37.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 1.0 109.633 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -82.94 134.76 46.07 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.175 -1.191 . . . . 1.0 110.044 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.92 114.25 3.99 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.695 1.366 . . . . 1.0 110.615 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.12 -141.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.836 . . . . 1.0 109.461 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.0 t -158.92 163.45 36.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.742 -1.224 . . . . 1.0 110.252 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.91 106.5 0.31 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 m -116.59 159.44 40.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 1.0 110.17 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -4.8 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.672 1.354 . . . . 1.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.19 -22.76 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.983 -1.073 . . . . 1.0 110.28 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -101.76 122.81 44.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 1.0 110.377 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.49 144.54 44.2 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.147 -0.971 . . . . 1.0 109.233 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.44 85.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 1.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -87.38 120.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 1.0 109.911 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 19.6 pt-20 -146.02 147.52 31.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 1.0 110.505 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.56 23.44 5.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.732 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -74.58 2.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -18.12 24.1 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.736 -0.861 . . . . 1.0 110.823 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.66 43.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.034 -1.041 . . . . 1.0 110.816 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.467 ' CD2' HD13 ' A' ' 25' ' ' LEU . 67.5 m-70 -143.06 103.35 4.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 1.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.87 136.83 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 1.0 110.502 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.438 HD23 ' CE3' ' A' ' 34' ' ' TRP . 34.3 tp -117.35 130.72 56.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.311 -0.868 . . . . 1.0 110.387 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.476 HG12 ' CD2' ' A' ' 20' ' ' HIS . 21.1 mt -132.18 100.81 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 1.0 109.636 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.72 116.16 31.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 1.0 110.922 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 62' ' ' ASN . 43.9 m-70 -77.59 -166.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 1.0 109.945 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 61' ' ' HIS . 54.0 t30 -15.45 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 61.4 m -73.71 143.92 45.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.503 -0.748 . . . . 1.0 109.496 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 173.51 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.0 110.825 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -9.52 46.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.774 . . . . 1.0 110.904 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.14 -10.61 82.35 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.944 -1.122 . . . . 1.0 110.342 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.461 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 6.2 mtt -84.37 38.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.888 -1.36 . . . . 1.0 111.458 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -91.43 40.0 1.02 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.019 -1.051 . . . . 1.0 109.918 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.33 -128.31 4.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -135.13 -170.66 2.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -1.083 . . . . 1.0 110.468 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.61 78.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 p -86.78 125.21 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 1.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.23 143.83 32.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 1.0 110.124 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -133.72 127.12 32.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 1.0 110.125 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -159.78 118.58 2.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.0 110.5 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.62 -89.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 1.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 75' ' ' ALA . 41.6 t30 -128.03 -35.77 2.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.893 -1.129 . . . . 1.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 150.32 11.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 1.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 125.96 6.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 1.0 110.24 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 m -125.5 174.51 8.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 1.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.4 94.21 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 1.0 110.193 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -90.84 -172.88 3.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 1.0 110.29 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -123.26 139.23 54.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.72 127.42 17.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 1.0 110.386 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -134.7 132.95 39.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 1.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 35.2 t -91.66 126.07 44.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.268 -0.895 . . . . 1.0 110.19 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 160.36 14.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 1.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.32 -176.74 3.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.0 110.177 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.993 -1.004 . . . . 1.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.459 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.338 0.59 . . . . 1.0 110.111 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' A' ' 2' ' ' ILE . 6.9 tt -170.25 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 1.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.27 179.54 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 1.0 111.044 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.2 t 48.56 85.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.439 0.638 . . . . 1.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.4 -29.26 13.23 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -129.46 114.85 18.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.73 165.88 21.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.443 1.233 . . . . 1.0 111.586 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 3.9 mt -65.53 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.752 -0.592 . . . . 1.0 110.721 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 10' ' ' GLY . 86.0 t80 -144.74 159.92 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 1.0 109.994 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 9' ' ' TYR . . . -95.48 141.66 15.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.511 -1.435 . . . . 1.0 109.511 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.88 166.46 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -1.222 . . . . 1.0 110.408 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -122.02 166.13 14.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.0 110.299 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 86' ' ' VAL . 15.8 m -152.65 157.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.171 -0.956 . . . . 1.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.42 33.73 5.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.497 -0.752 . . . . 1.0 109.011 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t 61.75 73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.701 0.762 . . . . 1.0 109.895 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 152.54 -23.11 0.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.24 164.96 22.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -1.119 . . . . 1.0 110.096 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.5 m -112.26 105.95 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.289 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -79.54 171.46 15.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 1.0 109.839 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 59' ' ' ILE . 13.1 m80 -144.99 120.5 10.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.0 110.734 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD1' HD22 ' A' ' 58' ' ' LEU . 77.0 m-85 -114.11 111.43 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.843 . . . . 1.0 109.365 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.92 165.66 11.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.148 -0.97 . . . . 1.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -170.04 119.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 1.0 109.802 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.34 124.49 43.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 1.0 110.206 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 26.0 mt -86.94 -150.64 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.195 -0.941 . . . . 1.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.67 -47.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.972 . . . . 1.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.73 150.19 37.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 1.0 110.608 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.11 -165.66 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.597 1.314 . . . . 1.0 110.335 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 t70 49.92 81.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.276 -0.89 . . . . 1.0 110.544 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.7 t -138.87 148.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 1.0 110.154 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -140.63 40.74 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 1.0 110.331 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.45 -150.3 0.04 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -166.31 -179.8 5.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -1.095 . . . . 1.0 109.674 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.402 ' CZ3' HD21 ' A' ' 58' ' ' LEU . 57.9 m95 -117.65 131.06 56.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.982 -1.074 . . . . 1.0 110.628 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 2.7 ttpt -124.03 133.82 53.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.505 -0.747 . . . . 1.0 109.978 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.46 -130.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 1.0 109.815 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -28.84 3.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.592 -1.317 . . . . 1.0 110.708 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 154.47 39.46 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.961 -1.255 . . . . 1.0 109.961 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 1.1 pt20 -150.39 150.42 28.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.106 -1.232 . . . . 1.0 110.014 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.45 113.35 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.601 1.316 . . . . 1.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.34 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.46 -0.775 . . . . 1.0 109.877 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.41 14.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 1.0 112.119 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -162.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.709 -1.245 . . . . 1.0 109.817 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.73 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.22 -0.925 . . . . 1.0 110.384 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.19 -42.87 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.525 1.276 . . . . 1.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -23.83 51.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 1.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.84 121.77 42.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 110.308 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.1 144.13 39.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 1.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -134.04 119.26 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 1.0 109.825 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 tp -130.07 109.26 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.283 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.08 147.65 50.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 1.0 110.397 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.02 20.98 17.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 1.0 110.185 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 -90.5 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -59.39 -16.0 20.26 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.662 -0.905 . . . . 1.0 110.836 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -125.28 168.12 13.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 94.8 m-70 -149.99 126.87 11.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -124.08 142.2 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 1.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.473 HD22 ' CD1' ' A' ' 21' ' ' PHE . 24.6 tp -118.48 145.44 45.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.104 -0.997 . . . . 1.0 110.409 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 20' ' ' HIS . 56.6 mt -141.2 92.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 1.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.47 115.21 28.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.0 110.621 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 62' ' ' ASN . 31.6 m-70 -83.04 -165.04 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 1.0 109.702 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 50.2 t30 -16.57 82.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.762 1.023 . . . . 1.0 113.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' HIS . 71.9 m -69.95 -175.54 0.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.429 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 2.9 mt-30 -138.31 -168.23 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 1.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mp -84.81 69.1 10.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 1.0 110.264 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.84 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.19 -15.32 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -1.168 . . . . 1.0 111.622 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -43.57 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.417 -0.802 . . . . 1.0 110.929 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 174.11 -127.35 1.31 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -139.82 146.4 39.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 1.0 110.456 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.6 t -94.39 87.66 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.343 -0.848 . . . . 1.0 109.957 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -87.91 110.11 20.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 1.0 110.426 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -71.48 154.2 41.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 1.0 110.072 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 139.46 52.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 1.0 110.1 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -160.72 -148.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 1.0 109.744 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -77.5 126.95 31.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 1.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 18.1 p30 34.05 31.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 76' ' ' ALA . . . -152.26 158.32 42.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 1.0 110.791 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 115.07 2.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 1.0 110.003 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 m -72.62 -172.75 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 1.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.44 97.43 0.25 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 1.0 110.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -100.46 -164.53 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 1.0 110.406 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -132.13 137.43 47.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 1.0 109.598 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 21' ' ' PHE . 65.0 tp -154.35 143.29 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 1.0 110.531 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -145.17 127.65 16.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.431 -0.793 . . . . 1.0 110.082 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 16.9 t -92.54 142.64 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.366 -0.834 . . . . 1.0 109.732 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 130.05 22.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.999 . . . . 1.0 110.492 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.34 174.08 8.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 1.0 109.99 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 pt -100.64 161.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 1.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.82 -162.17 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.39 120.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 1.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -93.59 -44.98 7.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.249 -0.907 . . . . 1.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.9 tttt -108.87 109.34 61.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 1.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.1 173.8 13.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.434 1.229 . . . . 1.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD13 ' CB ' ' A' ' 80' ' ' SER . 42.3 mt -75.34 169.38 18.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 1.0 110.162 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -137.06 153.02 50.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 1.0 110.177 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.33 136.53 20.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.056 -1.217 . . . . 1.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.4 t -136.86 154.85 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -1.111 . . . . 1.0 110.03 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -107.73 155.2 20.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.184 -0.947 . . . . 1.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.1 134.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 1.0 110.083 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.21 39.85 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.24 -0.912 . . . . 1.0 110.378 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t 52.09 88.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 1.0 110.306 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.31 -29.38 2.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.349 -1.5 . . . . 1.0 109.349 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.92 -124.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.182 . . . . 1.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -160.27 114.48 2.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.698 -1.251 . . . . 1.0 111.002 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.77 148.19 31.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.938 . . . . 1.0 108.808 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -128.33 128.92 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.169 . . . . 1.0 111.469 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -134.1 112.12 10.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.549 -0.719 . . . . 1.0 109.404 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.51 165.8 11.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 1.0 111.066 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -170.45 137.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.4 164.55 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.978 . . . . 1.0 110.97 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.487 HD12 ' CD2' ' A' ' 56' ' ' HIS . 71.3 mt -124.3 -148.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 1.0 109.81 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.49 -67.74 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 1.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -97.26 155.55 37.26 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 1.0 110.171 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.25 -167.41 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.707 1.372 . . . . 1.0 110.515 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 53.55 67.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.848 . . . . 1.0 110.432 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.79 170.51 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 1.0 110.349 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -143.43 165.95 26.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.1 -171.7 36.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.18 156.83 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -1.088 . . . . 1.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD2' HD13 ' A' ' 58' ' ' LEU . 45.4 m95 -108.8 139.12 44.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 1.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 39' ' ' GLN . 2.9 ttpt -132.99 125.19 29.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.532 -0.73 . . . . 1.0 109.215 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 HD23 ' HG2' ' A' ' 67' ' ' MET . 1.1 mp -64.45 -132.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.135 -0.978 . . . . 1.0 109.596 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -26.08 3.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.644 -1.285 . . . . 1.0 109.572 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.81 38.71 0.02 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.781 -1.328 . . . . 1.0 109.781 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 1.3 mm-40 -131.25 104.01 15.09 Favored Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.141 -1.211 . . . . 1.0 109.997 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.73 101.74 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.673 1.354 . . . . 1.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 42' ' ' THR . 2.1 pp -84.71 -151.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 1.0 110.466 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.469 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 14.9 p -135.0 133.91 39.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 1.0 110.087 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.31 113.7 24.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 1.0 110.274 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -176.69 -60.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 1.0 110.399 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.3 Cg_endo -72.05 -57.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.348 1.183 . . . . 1.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -133.8 69.28 1.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.0 110.565 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -157.2 134.78 10.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 1.0 110.029 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 86.65 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.0 110.338 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -105.11 98.21 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 1.0 110.158 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 50' ' ' ILE . 50.7 mm -97.23 112.2 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.0 110.088 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -130.61 157.81 41.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 1.0 110.531 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.65 27.16 9.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 1.0 109.762 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.42 -87.72 1.41 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -55.88 -19.83 13.37 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.677 -0.896 . . . . 1.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 155.38 33.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 1.0 110.749 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.487 ' CD2' HD12 ' A' ' 25' ' ' LEU . 87.0 m-70 -138.65 102.77 4.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 1.0 109.845 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -109.33 137.22 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 1.0 110.535 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 34' ' ' TRP . 3.2 tt -114.35 133.05 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 1.0 110.224 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 58' ' ' LEU . 22.7 mt -136.22 80.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.377 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.94 125.4 35.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 1.0 110.524 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.3 m-70 -83.33 -160.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 1.0 109.716 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 61' ' ' HIS . 37.5 t30 -14.56 82.12 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' HIS . 68.0 m -75.46 -178.27 3.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.506 -0.746 . . . . 1.0 109.954 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 5.4 tp-100 -117.08 169.66 9.26 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.168 -0.958 . . . . 1.0 109.143 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.467 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.2 mp -72.79 4.22 4.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.822 -1.174 . . . . 1.0 112.139 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.7 -27.11 15.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.464 ' HG2' HD23 ' A' ' 36' ' ' LEU . 4.3 mtt -50.55 -23.21 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -1.043 . . . . 1.0 111.016 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 p -48.52 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.163 -0.961 . . . . 1.0 110.503 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.31 -126.4 0.97 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.072 -1.611 . . . . 1.0 109.072 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -135.35 136.14 41.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.137 . . . . 1.0 110.175 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.427 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 52.3 t -91.45 87.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 1.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -91.85 111.64 23.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 1.0 110.863 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 19.6 t80 -86.78 133.53 33.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 1.0 109.375 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -110.55 70.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.986 . . . . 1.0 110.755 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -94.38 112.32 24.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 1.0 109.784 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.4 -159.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 1.0 109.988 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 26.1 p30 -62.65 -16.89 59.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 1.0 110.455 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' N ' ' OD1' ' A' ' 77' ' ' ASN . . . -69.84 158.58 35.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 1.0 110.217 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -159.69 116.77 2.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.137 -0.977 . . . . 1.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.439 ' CB ' HD13 ' A' ' 8' ' ' LEU . 4.6 p -105.34 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 1.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.55 101.73 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 1.0 110.556 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' CB ' ' CB ' ' A' ' 8' ' ' LEU . . . -100.23 -164.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 1.0 110.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.38 147.28 52.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 1.0 109.944 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.11 145.5 31.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 1.0 110.515 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 9.2 ptpt -138.2 105.86 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 1.0 109.71 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 99.2 t -89.49 117.71 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.245 -0.91 . . . . 1.0 110.501 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -116.78 146.63 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 1.0 110.203 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -64.69 -171.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 1.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.314 0.578 . . . . 1.0 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 tt -144.39 162.6 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.927 . . . . 1.0 110.109 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.59 166.95 21.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.0 110.006 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -80.04 -165.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.087 -1.008 . . . . 1.0 109.691 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -127.74 -54.26 1.32 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 1.0 110.113 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -126.57 112.36 22.93 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.593 -0.692 . . . . 1.0 110.095 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.92 178.11 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.645 1.34 . . . . 1.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 10.1 mt -75.4 173.89 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 1.0 110.168 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.9 m-85 -134.67 12.53 3.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.142 -0.974 . . . . 1.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.09 150.32 1.84 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.879 -1.288 . . . . 1.0 109.879 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 77.3 t -145.35 161.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -1.11 . . . . 1.0 110.022 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -125.88 149.72 48.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.0 110.387 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.6 135.01 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 1.0 109.915 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.47 58.62 3.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.281 -0.887 . . . . 1.0 110.788 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t 46.08 81.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 1.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 139.57 -31.63 2.3 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.746 -1.742 . . . . 1.0 108.746 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -66.17 -158.36 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.494 -1.004 . . . . 1.0 109.502 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -142.74 108.87 5.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 1.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.05 132.72 36.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 1.0 109.505 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.9 110.09 18.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 1.0 111.107 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -101.25 134.71 43.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 1.0 109.324 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -130.08 162.79 27.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.934 -1.104 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 80' ' ' SER . 1.1 tt -170.77 125.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.0 109.806 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.73 145.2 25.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 1.0 110.225 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -111.23 155.14 23.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 1.0 109.996 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.54 -58.0 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -88.29 141.38 30.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 1.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.03 104.56 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.653 1.344 . . . . 1.0 110.153 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -119.85 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.112 -0.992 . . . . 1.0 109.201 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -176.61 43.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 1.0 110.027 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -152.57 143.63 23.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 1.0 110.27 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.0 146.36 5.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 1.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -129.71 146.72 51.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -1.183 . . . . 1.0 110.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 27.9 m95 -112.5 173.22 6.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.967 . . . . 1.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 3.3 ptpt -171.2 152.55 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.521 -0.737 . . . . 1.0 109.596 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 67' ' ' MET . 3.5 mt -66.35 -94.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 1.0 109.813 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.58 21.84 5.95 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.124 -0.985 . . . . 1.0 109.946 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' CA ' ' HG3' ' A' ' 35' ' ' LYS . . . 117.2 -0.27 19.07 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -92.35 109.13 36.06 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.27 . . . . 1.0 110.27 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.01 104.77 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.572 1.301 . . . . 1.0 110.43 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.85 -168.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 1.0 110.606 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -109.12 175.01 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 1.0 110.275 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 109.65 11.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 1.0 110.372 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -122.22 170.56 7.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 1.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.41 -24.23 19.56 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.627 1.33 . . . . 1.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.31 -40.31 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 1.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.49 127.74 35.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 1.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -119.36 144.1 47.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.914 . . . . 1.0 109.573 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.25 90.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 1.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.0 tp -113.02 147.48 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 1.0 110.187 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -159.67 149.48 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.199 -0.938 . . . . 1.0 110.197 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.32 22.75 11.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 1.0 110.173 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.63 -85.02 1.07 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -6.82 31.85 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.656 -0.908 . . . . 1.0 111.031 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.24 107.62 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.865 -1.147 . . . . 1.0 110.623 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -87.32 133.59 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.231 -0.918 . . . . 1.0 109.992 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.1 mt -132.71 134.84 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.058 -1.027 . . . . 1.0 110.534 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.511 ' CD2' ' CE3' ' A' ' 34' ' ' TRP . 27.2 tp -117.16 150.96 37.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 1.0 110.083 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.412 HG23 ' NE2' ' A' ' 61' ' ' HIS . 24.9 mm -143.43 99.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 1.0 109.945 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -105.69 116.57 32.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.0 110.08 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 62' ' ' ASN . 42.2 m-70 -85.99 -164.03 0.97 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.877 . . . . 1.0 110.278 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 66.8 t30 -14.71 81.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.808 1.04 . . . . 1.0 113.808 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 64.3 m -73.92 142.58 45.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.506 -0.746 . . . . 1.0 109.562 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.31 -175.71 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 1.0 110.787 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 tp -79.59 5.26 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 1.0 111.127 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.01 -29.3 6.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 2.8 mtt -49.99 -23.57 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -1.13 . . . . 1.0 110.648 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -47.06 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.51 -0.744 . . . . 1.0 110.406 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.98 -121.6 0.59 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.96 174.29 10.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -1.076 . . . . 1.0 110.585 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.61 89.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -0.795 . . . . 1.0 109.742 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -97.9 125.16 42.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 1.0 110.609 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 46.9 t80 -113.75 157.85 21.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.447 -0.783 . . . . 1.0 109.632 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -143.48 136.73 27.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 1.0 110.683 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -160.5 120.62 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 1.0 109.454 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.64 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -0.872 . . . . 1.0 109.799 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.3 m-20 -128.92 -15.31 4.32 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 1.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.48 157.91 8.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.0 110.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -158.1 93.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 1.0 109.776 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 49.5 p -101.73 172.06 7.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.912 . . . . 1.0 110.72 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.17 91.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -0.809 . . . . 1.0 109.816 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -94.02 -171.05 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 1.0 110.593 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.81 133.38 55.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 1.0 110.244 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.02 136.88 47.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 1.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -135.27 131.54 36.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 1.0 109.973 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 93.6 t -100.58 153.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 1.0 109.852 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -144.32 130.2 19.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 1.0 110.505 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.96 173.3 8.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 1.0 110.302 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.066 179.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.428 ' HB3' ' ND2' ' A' ' 77' ' ' ASN . 2.0 mp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.273 0.559 . . . . 1.0 110.184 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.424 ' CD1' ' HB1' ' A' ' 76' ' ' ALA . 48.3 mt -90.01 148.38 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 1.0 109.75 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.432 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.02 -5.61 6.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 1.0 111.211 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 46.1 t 60.16 136.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.344 -0.848 . . . . 1.0 110.959 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -116.85 -37.02 3.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 1.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -119.0 109.0 39.86 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.765 -0.584 . . . . 1.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.05 172.72 14.13 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.604 1.318 . . . . 1.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 80' ' ' SER . 51.4 mt -73.3 170.0 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 1.0 110.348 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.55 113.1 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 1.0 110.066 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.9 153.34 4.32 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.424 ' CG1' ' CZ ' ' A' ' 21' ' ' PHE . 9.0 p -153.43 158.76 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.382 -1.069 . . . . 1.0 110.176 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -112.18 160.49 17.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 1.0 110.406 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 86' ' ' VAL . 9.6 m -147.83 172.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 1.0 110.592 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.53 30.35 4.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t 58.34 70.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.716 0.769 . . . . 1.0 109.95 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.45 -21.49 1.06 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' O ' ' CG2' ' A' ' 18' ' ' THR . 58.7 mm-40 -76.31 -121.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 1.0 109.705 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 17' ' ' GLU . 1.2 p -160.27 171.12 19.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.845 -1.16 . . . . 1.0 110.452 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.3 158.37 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.417 -0.802 . . . . 1.0 109.548 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -146.63 92.35 2.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 1.0 110.946 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.424 ' CZ ' ' CG1' ' A' ' 11' ' ' VAL . 87.4 m-85 -106.65 112.39 25.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.181 -0.949 . . . . 1.0 109.713 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -121.77 157.4 31.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.997 . . . . 1.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -163.84 122.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.0 109.792 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.62 138.23 33.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 1.0 110.262 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -109.0 170.16 8.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 1.0 109.848 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -11.08 42.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 1.0 110.67 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -123.82 124.98 26.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.0 110.167 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.83 171.2 18.73 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.417 1.219 . . . . 1.0 110.645 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 50.72 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 1.0 110.584 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.26 179.96 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 1.0 110.062 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -127.39 41.26 3.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 1.0 110.382 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 74' ' ' GLN . . . -86.32 174.26 46.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.762 -1.335 . . . . 1.0 109.762 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.07 155.59 32.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -1.13 . . . . 1.0 110.148 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.75 135.56 33.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.047 -1.033 . . . . 1.0 110.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -138.69 126.39 22.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.382 -0.824 . . . . 1.0 109.424 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.62 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.171 -0.956 . . . . 1.0 109.274 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -25.04 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.48 -1.388 . . . . 1.0 109.51 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.74 38.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -128.39 136.4 29.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.238 . . . . 1.0 110.294 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.98 121.03 6.33 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.534 1.281 . . . . 1.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 42' ' ' THR . 2.2 pp -83.29 -149.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 1.0 110.026 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.47 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 2.9 p -157.74 120.89 3.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.949 . . . . 1.0 109.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.2 97.67 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 1.0 110.518 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.464 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER 176.03 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.274 -0.891 . . . . 1.0 110.424 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.2 Cg_endo -72.02 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.579 1.305 . . . . 1.0 111.196 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -113.84 57.78 0.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.924 -1.11 . . . . 1.0 110.729 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.2 t -152.28 126.79 9.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 1.0 110.169 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -111.44 52.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 1.0 110.393 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -87.68 124.48 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 1.0 109.985 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 tt -121.42 128.06 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.238 -0.914 . . . . 1.0 110.136 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.02 137.68 14.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.92 . . . . 1.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.89 17.51 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 1.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.48 -24.13 26.98 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -90.56 -20.32 22.75 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.391 -1.064 . . . . 1.0 110.108 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.38 127.89 2.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.33 -0.856 . . . . 1.0 110.287 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.5 m-70 -96.61 120.6 37.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 1.0 110.03 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.15 140.07 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 110.217 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.76 130.77 49.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.0 110.207 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.6 mt -135.41 87.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 1.0 109.394 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.87 119.08 34.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 1.0 110.729 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.8 m-70 -80.08 -161.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 1.0 109.423 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.484 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.7 p30 -14.38 80.97 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.927 1.084 . . . . 1.0 113.927 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 80.7 m -70.22 -169.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.573 -0.704 . . . . 1.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.69 -163.68 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 1.0 110.435 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 9.2 mp -82.38 34.21 0.42 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.105 -0.997 . . . . 1.0 111.472 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.82 -29.82 2.98 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.655 -1.778 . . . . 1.0 108.655 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.444 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 53.6 mtp -88.02 36.22 0.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.991 . . . . 1.0 110.228 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -90.26 58.83 4.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 1.0 109.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -154.83 -125.81 0.99 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.54 151.19 52.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.438 -1.037 . . . . 1.0 110.483 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.13 84.26 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 1.0 109.924 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.6 p -88.28 119.87 29.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -103.23 143.34 32.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' O ' ' CA ' ' A' ' 32' ' ' GLY . 24.3 mt-30 -130.41 137.18 49.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -164.33 105.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 1.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB1' ' CD1' ' A' ' 2' ' ' ILE . . . 56.47 -89.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 1.0 110.31 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 1' ' ' LEU . 1.8 t30 -114.78 -27.18 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.956 -1.09 . . . . 1.0 110.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.401 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -50.04 141.91 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 1.0 110.714 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 75.62 1.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 1.0 109.967 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.418 ' CB ' HD13 ' A' ' 8' ' ' LEU . 61.4 p -90.98 176.96 6.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.953 . . . . 1.0 110.146 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.03 93.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.0 110.15 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.99 -171.29 3.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 1.0 110.069 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.12 105.61 8.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 1.0 109.932 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD23 ' CZ ' ' A' ' 21' ' ' PHE . 42.5 tp -112.66 124.53 52.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 1.0 110.577 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -127.76 134.72 49.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 1.0 109.807 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 84.3 t -100.19 135.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 109.934 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -122.95 134.17 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.0 110.306 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -76.29 169.03 18.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 1.0 110.072 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.291 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.286 0.565 . . . . 1.0 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.9 pt -118.77 174.16 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.857 . . . . 1.0 110.136 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -122.52 -166.18 1.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 110.499 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 78' ' ' ALA . 63.6 t -116.31 122.09 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 1.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.74 -41.72 26.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 1.0 108.733 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -117.77 101.75 51.9 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.823 -0.548 . . . . 1.0 109.855 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.15 174.35 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.599 1.315 . . . . 1.0 110.74 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 17.7 mt -75.3 176.38 7.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 1.0 110.015 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 28.0 m-85 -135.18 125.0 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.0 110.234 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 142.69 40.78 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.56 164.03 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -1.073 . . . . 1.0 109.851 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -124.82 152.78 43.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 1.0 110.438 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.424 HG21 ' N ' ' A' ' 14' ' ' PHE . 11.3 p -142.12 149.02 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.82 . . . . 1.0 110.138 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.426 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.87 47.96 1.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 1.0 110.475 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 14' ' ' PHE . 7.7 p 37.02 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.733 0.778 . . . . 1.0 111.72 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 159.01 -25.42 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.05 -1.62 . . . . 1.0 109.05 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.47 -112.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -1.098 . . . . 1.0 109.013 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.18 151.17 17.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.592 -1.317 . . . . 1.0 110.826 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CD2' ' A' ' 20' ' ' HIS . . . -107.2 160.94 15.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 1.0 109.076 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -153.81 97.91 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.0 111.105 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 88.0 m-85 -111.73 108.14 17.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.544 -0.723 . . . . 1.0 109.324 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 155.17 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.324 -0.86 . . . . 1.0 110.509 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' OG ' ' A' ' 80' ' ' SER . 7.2 tt -164.81 139.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.444 -0.785 . . . . 1.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -120.45 143.38 48.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.975 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.2 mt -108.03 -156.71 0.59 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 1.0 110.179 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 -68.37 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 1.0 110.388 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.76 130.1 23.27 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 1.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -78.14 154.53 29.03 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.408 1.215 . . . . 1.0 110.166 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.22 -61.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 1.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.16 166.12 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 1.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -70.81 -164.85 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.841 . . . . 1.0 110.411 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.4 -150.58 5.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.606 -1.398 . . . . 1.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.25 135.27 3.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.373 -1.075 . . . . 1.0 110.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.508 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 27.9 m95 -101.95 149.01 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 1.0 110.608 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.463 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 19.1 ttpt -141.54 123.14 15.09 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.35 -0.843 . . . . 1.0 109.592 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.44 -131.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 1.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.52 -25.16 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.411 -1.43 . . . . 1.0 109.619 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.42 38.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.698 -1.361 . . . . 1.0 109.698 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 7.9 mm-40 -126.68 109.03 22.79 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.162 -1.199 . . . . 1.0 110.147 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.08 83.83 1.58 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.62 1.326 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.09 -163.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 1.0 110.678 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.1 148.39 50.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 1.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.28 107.48 18.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 1.0 110.231 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -179.32 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.269 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.87 -50.82 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.59 1.31 . . . . 1.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.0 -54.72 1.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -0.985 . . . . 1.0 110.823 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.416 ' CB ' HD22 ' A' ' 60' ' ' LEU . 36.8 t -69.5 150.04 47.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 1.0 110.443 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.15 65.0 1.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.875 . . . . 1.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.431 HD11 ' CD1' ' A' ' 58' ' ' LEU . 6.1 tp -84.56 140.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 1.0 110.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.7 mt -128.84 120.96 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.084 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.25 141.79 43.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 1.0 110.273 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.85 27.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.222 -0.924 . . . . 1.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.82 -23.92 30.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -90.38 71.8 7.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -1.018 . . . . 1.0 108.93 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 24' ' ' GLU . 5.4 mmtt 54.79 170.83 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.889 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 89.9 m-70 -114.69 144.92 42.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.982 -1.074 . . . . 1.0 110.763 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.406 ' N ' HD11 ' A' ' 57' ' ' ILE . 4.6 mp -140.47 115.06 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.842 . . . . 1.0 109.799 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.478 HD23 ' CE3' ' A' ' 34' ' ' TRP . 44.8 tp -99.19 132.03 44.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 1.0 110.862 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.413 HG12 ' CD2' ' A' ' 20' ' ' HIS . 98.6 mt -133.33 93.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.474 -0.766 . . . . 1.0 109.456 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD22 ' CB ' ' A' ' 47' ' ' CYS . 2.6 mt -95.51 105.05 16.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 1.0 110.93 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 68.1 m-70 -69.85 -169.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 1.0 109.475 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 40.5 p-10 -14.87 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.867 1.062 . . . . 1.0 113.867 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 61' ' ' HIS . 61.2 m -70.62 -156.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.639 -0.663 . . . . 1.0 109.429 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.43 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -151.43 -169.97 3.52 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.967 -1.083 . . . . 1.0 110.815 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 38.51 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -0.784 . . . . 1.0 111.517 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.55 -15.02 2.5 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.803 -1.189 . . . . 1.0 110.293 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.436 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -87.42 37.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.718 -1.46 . . . . 1.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.22 40.27 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 1.0 110.139 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 -125.11 2.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -136.93 152.33 50.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -1.042 . . . . 1.0 110.294 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.34 88.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.908 . . . . 1.0 109.84 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.5 p -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 1.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -96.39 146.27 24.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 1.0 109.95 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -152.58 126.6 9.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 1.0 110.379 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 76' ' ' ALA . . . -132.66 16.06 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.11 -0.994 . . . . 1.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . 169.15 -81.97 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.363 -0.835 . . . . 1.0 109.601 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -127.2 -39.03 1.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 1.0 109.535 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' HB3' ' CG2' ' A' ' 4' ' ' VAL . . . -69.29 119.38 13.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.831 . . . . 1.0 110.016 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -123.29 95.81 4.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 1.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.3 m -73.35 -179.24 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 1.0 110.182 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.39 104.75 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 1.0 110.576 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.28 -176.64 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 1.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.37 121.15 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 1.0 109.838 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -125.2 133.98 52.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 1.0 110.545 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -130.88 130.42 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 1.0 109.511 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 92.0 t -91.64 145.48 7.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.181 -0.949 . . . . 1.0 110.447 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -135.47 141.37 45.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.418 -0.801 . . . . 1.0 109.921 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.98 -167.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 1.0 110.336 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.327 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.18 0.514 . . . . 1.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.6 mm -123.32 166.83 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 1.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.6 -154.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 1.0 110.344 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 27.7 t -125.17 127.49 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 1.0 109.958 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.39 -46.17 6.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 1.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 107.87 61.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.705 -0.622 . . . . 1.0 110.063 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.17 173.73 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.563 1.297 . . . . 1.0 110.799 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.39 173.89 10.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 1.0 110.45 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -138.59 122.55 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 1.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.0 146.66 47.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.791 -1.323 . . . . 1.0 109.791 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 12' ' ' GLU . 74.3 t -144.23 162.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 1.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' N ' HG11 ' A' ' 11' ' ' VAL . 3.2 mt-10 -108.41 154.8 21.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 17' ' ' GLU . 2.7 p -151.08 130.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.0 110.013 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.55 38.06 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 1.0 110.337 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.432 HG21 ' CG1' ' A' ' 86' ' ' VAL . 47.3 t 55.82 99.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.374 -0.829 . . . . 1.0 110.684 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 131.83 -40.8 1.58 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' CG ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -69.69 -136.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 1.0 109.062 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.3 m -154.42 120.65 5.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.795 -1.191 . . . . 1.0 110.763 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -79.13 152.81 30.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.48 ' CD2' HG12 ' A' ' 59' ' ' ILE . 10.0 m80 -138.07 133.34 33.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.907 -1.12 . . . . 1.0 111.561 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.436 ' CD2' HD21 ' A' ' 58' ' ' LEU . 75.0 m-85 -125.7 135.47 52.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -125.43 154.65 41.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.0 111.574 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -168.15 135.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.64 . . . . 1.0 109.438 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -125.98 142.97 51.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 1.0 110.618 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.03 -164.16 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.352 -0.842 . . . . 1.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -108.47 -42.85 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 1.0 109.981 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -132.13 132.56 23.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 1.0 110.045 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 143.41 35.49 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.362 1.19 . . . . 1.0 110.441 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -168.71 -54.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 1.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.52 157.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.06 174.4 10.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 1.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.33 -177.41 14.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.597 -1.401 . . . . 1.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.11 151.63 40.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.091 . . . . 1.0 110.107 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.51 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 30.7 m95 -110.46 147.06 34.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 1.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 ttpp -133.38 119.56 19.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.426 -0.796 . . . . 1.0 109.525 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -63.66 -135.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.395 -0.816 . . . . 1.0 108.816 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -49.8 -24.63 2.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.243 -1.535 . . . . 1.0 109.759 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 153.8 42.6 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -129.82 122.33 20.44 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.434 -1.039 . . . . 1.0 110.097 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.1 88.58 0.95 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.461 1.243 . . . . 1.0 110.386 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 42' ' ' THR . 4.4 pp -72.22 -160.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 1.0 110.691 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.496 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -170.32 -176.82 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.582 -0.699 . . . . 1.0 109.794 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 102.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.0 109.976 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.41 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -127.75 177.04 2.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 1.0 110.493 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 48.3 Cg_endo -73.87 -20.7 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.698 1.368 . . . . 1.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -98.18 -39.99 8.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 1.0 110.387 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.1 158.34 18.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.22 -0.925 . . . . 1.0 110.275 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -148.14 67.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 1.0 110.247 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -85.09 128.67 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -0.793 . . . . 1.0 110.536 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.0 128.9 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 1.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.13 151.24 32.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 1.0 110.367 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -130.6 20.98 5.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 1.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.92 -61.97 3.34 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -12.79 61.88 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.614 -0.933 . . . . 1.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.89 148.5 29.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.978 -1.076 . . . . 1.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -128.02 107.66 10.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.32 148.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 1.0 110.55 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 21' ' ' PHE . 19.7 tp -133.48 121.79 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.353 -0.842 . . . . 1.0 110.188 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 20' ' ' HIS . 40.6 mt -122.9 126.17 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 1.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.441 ' CD2' ' CE ' ' A' ' 67' ' ' MET . 0.2 OUTLIER -129.35 103.0 6.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 1.0 110.372 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 79.6 m-70 -70.16 -163.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.25 -0.906 . . . . 1.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.481 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 29.2 t-20 -13.53 81.44 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' HIS . 78.5 m -83.15 -159.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.0 109.253 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.431 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 3.1 mt-30 -142.82 -170.47 3.24 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.204 -0.935 . . . . 1.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.59 9.19 6.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.3 -29.26 10.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 1.0 109.39 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.441 ' CE ' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.29 -23.3 1.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.328 -1.101 . . . . 1.0 111.429 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -46.49 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.148 -0.97 . . . . 1.0 110.621 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.86 -121.29 0.63 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.253 -1.539 . . . . 1.0 109.253 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -155.3 145.74 22.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -1.12 . . . . 1.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' A' ' 21' ' ' PHE . 67.8 t -98.11 93.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 1.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -96.03 101.44 13.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.0 110.441 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 32.1 t80 -73.61 154.24 39.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 1.0 109.557 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 106.52 7.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.063 -1.023 . . . . 1.0 110.688 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.58 118.22 9.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 1.0 109.682 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.56 -153.99 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 1.0 109.865 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -74.29 -10.45 59.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 1.0 110.504 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 4' ' ' VAL . . . -83.62 153.63 24.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.944 -1.098 . . . . 1.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -159.59 145.89 16.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 1.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 76.8 p -125.87 178.1 5.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.0 110.089 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.8 103.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 1.0 110.204 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.21 -174.59 2.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 1.0 110.339 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.88 129.6 36.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 1.0 110.004 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 19' ' ' ALA . 1.1 tt -135.8 145.62 46.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 1.0 110.469 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 136.33 46.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 1.0 109.802 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 61.3 t -103.7 151.16 6.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.249 -0.907 . . . . 1.0 110.446 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.66 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 1.0 110.201 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -93.42 145.59 24.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.358 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.105 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.252 0.549 . . . . 1.0 110.201 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.8 pt -102.15 158.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 110.198 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.68 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 1.0 110.19 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.97 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -86.48 -34.45 20.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -131.01 112.47 15.93 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.13 171.4 11.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.647 1.34 . . . . 1.0 111.455 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.442 ' CB ' ' HB1' ' A' ' 82' ' ' ALA . 67.7 mt -59.95 -167.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.562 0.696 . . . . 1.0 110.913 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 10' ' ' GLY . 20.9 t80 -134.4 158.64 43.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 1.0 110.001 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -99.13 133.49 11.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -152.81 164.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -1.144 . . . . 1.0 110.256 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.69 172.31 7.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.92 . . . . 1.0 110.58 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 m -155.25 134.69 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 1.0 110.5 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -92.9 34.68 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 1.0 109.775 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 14.5 t 61.73 73.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.462 -0.773 . . . . 1.0 110.439 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.41 -25.34 1.09 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.866 -1.693 . . . . 1.0 108.866 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 -163.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.35 -1.088 . . . . 1.0 109.531 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 m -144.32 113.03 6.66 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.2 -0.938 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.29 161.8 26.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 1.0 109.638 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.426 ' NE2' HG22 ' A' ' 57' ' ' ILE . 12.7 t-160 -139.29 88.31 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.002 . . . . 1.0 110.691 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD1' HD21 ' A' ' 58' ' ' LEU . 81.0 m-85 -84.03 162.12 20.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 1.0 109.594 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -153.65 162.49 41.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.046 . . . . 1.0 110.678 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' CD1' ' OG ' ' A' ' 80' ' ' SER . 4.7 tt -169.23 135.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.448 -0.782 . . . . 1.0 109.921 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.88 136.45 49.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.111 -0.993 . . . . 1.0 110.057 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 35.1 mt -101.7 -151.19 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.958 . . . . 1.0 109.879 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.3 p -117.31 -46.72 2.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 1.0 109.989 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.1 140.8 21.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 1.0 110.064 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.17 178.91 6.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.558 1.294 . . . . 1.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 t70 54.59 92.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 1.0 110.732 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.4 p -156.84 154.51 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 1.0 109.874 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 49.1 p-80 -108.74 121.16 44.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 1.0 110.657 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.81 156.18 26.88 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.41 ' C ' ' CD1' ' A' ' 34' ' ' TRP . 14.2 mm-40 -124.41 177.81 5.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -1.232 . . . . 1.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 58' ' ' LEU . 37.4 m95 -136.43 139.04 42.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.451 -0.78 . . . . 1.0 110.682 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 6.7 tttp -157.11 -109.99 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.211 -0.931 . . . . 1.0 109.614 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.441 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -157.89 -160.11 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.929 -1.107 . . . . 1.0 109.005 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.833 -1.167 . . . . 1.0 109.632 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.75 -114.19 0.01 OUTLIER Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 2.0 mm-40 -136.33 176.59 2.7 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 107.475 -1.306 . . . . 1.0 107.475 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.06 116.42 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.678 1.357 . . . . 1.0 110.878 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -95.29 -167.75 1.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.81 -1.181 . . . . 1.0 110.716 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.438 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.5 p -116.09 162.33 17.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.0 110.218 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.46 120.46 16.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.91 . . . . 1.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.487 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.4 t -173.29 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 1.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -67.87 -89.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.33 1.174 . . . . 1.0 111.146 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.29 70.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 1.0 110.322 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.83 129.6 11.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 1.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.18 94.76 4.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 1.0 109.878 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.2 89.31 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 1.0 110.664 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 8.3 tt -89.17 119.65 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.868 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.68 145.5 47.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.99 . . . . 1.0 110.599 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.29 23.24 14.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 1.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.57 -89.25 1.23 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -49.15 -23.81 1.43 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.878 . . . . 1.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -137.5 157.35 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.983 -1.073 . . . . 1.0 110.237 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.514 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 87.1 m-70 -118.1 138.06 52.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.532 -0.73 . . . . 1.0 109.486 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.426 HG22 ' NE2' ' A' ' 20' ' ' HIS . 57.7 mt -140.33 128.46 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.037 -1.039 . . . . 1.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.502 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 9.9 tp -103.99 149.9 24.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 1.0 110.421 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.425 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 64.9 mt -140.0 82.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.795 . . . . 1.0 109.372 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' ' HE3' ' A' ' 67' ' ' MET . 5.1 mt -84.19 115.37 22.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 1.0 110.729 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 62' ' ' ASN . 60.8 m-70 -87.74 -165.84 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 1.0 109.624 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.474 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.5 p-10 -14.27 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 85.2 m -74.86 -155.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.639 -0.663 . . . . 1.0 109.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.429 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 15.6 mt-30 -159.47 -165.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 1.0 110.613 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.39 39.84 0.8 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 1.0 111.237 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.98 -37.83 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.981 -1.647 . . . . 1.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 69' ' ' GLY . 50.3 mtt -63.15 -13.36 36.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.365 -1.079 . . . . 1.0 110.778 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.77 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.297 -0.877 . . . . 1.0 110.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 170.75 -113.57 0.5 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.933 -1.667 . . . . 1.0 108.933 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.81 136.4 24.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.48 -1.012 . . . . 1.0 110.468 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.28 144.07 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 1.0 108.963 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 p -136.42 126.56 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.48 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 59.1 t80 -105.66 147.11 28.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.695 . . . . 1.0 109.131 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -137.91 152.5 49.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 1.0 110.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.46 -149.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 1.0 109.939 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.03 -76.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 1.0 110.24 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -123.73 17.01 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 1.0 110.301 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.76 137.92 42.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 1.0 110.658 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 14.9 ptmt -154.16 101.53 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.515 -0.741 . . . . 1.0 109.637 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.41 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 13.4 m -105.15 -176.04 2.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 1.0 110.535 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.08 97.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 1.0 110.197 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 8' ' ' LEU . . . -95.55 -168.07 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 1.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -122.14 143.97 49.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 1.0 110.178 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -150.69 119.75 6.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 1.0 110.395 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -117.33 125.98 51.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 1.0 109.852 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 41.5 t -90.77 112.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.347 -0.845 . . . . 1.0 110.058 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.33 144.98 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 1.0 110.381 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.15 -177.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 1.0 110.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.258 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.226 0.536 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mm -95.37 146.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 1.0 109.756 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 4' ' ' VAL . 1.1 tp10 -129.85 -5.16 4.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 1.0 111.194 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 3' ' ' GLU . 47.5 t 56.72 108.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 1.0 110.308 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -78.18 -51.49 10.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.054 -1.029 . . . . 1.0 109.884 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -122.91 108.48 32.66 Favored Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 120.073 -0.651 . . . . 1.0 110.277 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.42 -175.8 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.572 1.301 . . . . 1.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 80' ' ' SER . 7.0 mt -71.0 -161.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 1.0 110.67 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 30.7 p90 -160.4 133.85 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.7 149.01 33.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.39 168.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -1.104 . . . . 1.0 110.195 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.69 158.92 21.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 1.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.82 171.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 1.0 110.342 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.71 135.56 54.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 1.0 109.446 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 11.7 p -50.8 112.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 1.0 110.572 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 122.22 -48.67 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.825 -1.71 . . . . 1.0 108.825 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -165.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -1.018 . . . . 1.0 109.924 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -121.42 148.29 44.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 1.0 110.449 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.2 174.97 6.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 1.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -158.97 110.94 2.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 1.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -116.49 156.59 26.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.56 160.53 41.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.03 . . . . 1.0 110.45 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tt -170.56 124.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 1.0 109.848 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.73 132.71 36.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 1.0 110.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HG ' ' CD2' ' A' ' 56' ' ' HIS . 2.5 mm? -119.97 -177.35 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 1.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 t -132.1 20.53 4.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 1.0 110.122 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.22 156.37 66.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 1.0 110.197 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.72 -20.76 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.683 1.359 . . . . 1.0 110.38 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.62 -132.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 1.0 109.392 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.87 167.27 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.632 -1.293 . . . . 1.0 110.102 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -175.53 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 1.0 110.277 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.85 -177.46 33.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.42 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.25 167.77 25.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -1.078 . . . . 1.0 110.092 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.503 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 26.9 m95 -99.82 167.06 10.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 1.0 110.496 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -171.4 153.43 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 1.0 109.91 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.22 -131.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.09 -1.006 . . . . 1.0 109.894 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -48.1 -25.36 1.42 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.666 -1.271 . . . . 1.0 110.638 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 154.06 39.3 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.645 -1.382 . . . . 1.0 109.645 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -131.87 117.21 16.08 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.164 -1.198 . . . . 1.0 109.442 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.88 94.07 1.01 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.649 1.342 . . . . 1.0 109.959 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -179.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 42' ' ' THR . 90.7 m -136.56 23.53 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.772 . . . . 1.0 110.094 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.56 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 1.0 110.397 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -174.4 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 1.0 110.91 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 45.0 Cg_endo -70.6 -14.11 33.14 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.304 1.16 . . . . 1.0 111.115 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 47' ' ' CYS . 2.6 p30 -113.05 -24.53 9.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.017 . . . . 1.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.41 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 53.4 t -122.7 128.8 51.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.114 -0.991 . . . . 1.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -118.45 140.04 50.48 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.189 -0.944 . . . . 1.0 109.664 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.1 mt -139.61 108.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.486 -0.759 . . . . 1.0 109.801 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -128.02 128.01 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 1.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.78 138.66 16.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 1.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -122.54 18.88 10.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 1.0 110.775 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -42.54 2.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.955 -1.258 . . . . 1.0 109.955 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -62.31 -29.69 70.62 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.571 -0.958 . . . . 1.0 110.044 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 146.5 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.33 -0.856 . . . . 1.0 110.283 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.466 ' CD2' ' HG ' ' A' ' 25' ' ' LEU . 86.0 m-70 -105.72 119.65 39.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 1.0 110.01 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.55 137.55 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.209 -0.932 . . . . 1.0 110.383 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.5 tp -120.63 136.98 54.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.393 -0.817 . . . . 1.0 110.186 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 59' ' ' ILE . 58.2 mt -141.73 100.7 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.25 170.93 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 1.0 110.499 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.4 m-70 -126.52 -168.31 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.421 -0.8 . . . . 1.0 109.665 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -14.78 81.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.815 1.042 . . . . 1.0 113.815 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' HIS . 62.7 m -78.63 165.47 23.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.694 -0.629 . . . . 1.0 109.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.453 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 3.9 tp-100 -105.27 167.16 9.91 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.112 -0.992 . . . . 1.0 109.234 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -66.58 0.51 2.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.95 -1.094 . . . . 1.0 112.5 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.77 -21.42 33.88 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.431 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -50.99 -20.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -1.131 . . . . 1.0 111.523 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 m -44.42 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.305 -0.872 . . . . 1.0 110.736 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.78 -119.15 0.49 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.79 130.57 10.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.017 . . . . 1.0 110.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 25.4 t -85.33 93.36 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 1.0 109.144 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 13.4 m -101.5 150.76 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.059 . . . . 1.0 110.934 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 64.2 t80 -118.12 138.04 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.517 -0.739 . . . . 1.0 109.692 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -121.35 151.59 39.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 1.0 110.5 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.8 -153.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 1.0 110.068 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -67.37 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.973 . . . . 1.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -130.25 18.76 5.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 1.0 110.152 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -99.04 149.89 22.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 110.132 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -159.71 74.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 1.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.436 ' CB ' HD13 ' A' ' 8' ' ' LEU . 83.5 p -82.95 168.45 17.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' SER . . . -169.82 96.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.1 -174.22 3.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 1.0 110.08 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -125.49 107.54 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 1.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.42 138.89 43.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 1.0 110.567 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -131.11 140.45 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.815 . . . . 1.0 109.945 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 97.6 t -97.41 116.33 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.912 . . . . 1.0 110.195 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -93.85 130.67 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 110.491 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -68.23 179.03 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 1.0 110.039 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.232 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.267 0.556 . . . . 1.0 110.345 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.26 -170.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 1.0 110.272 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -135.95 -165.58 1.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.0 110.231 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.14 125.5 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 1.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -86.79 -48.0 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 1.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.79 107.27 44.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.65 -0.656 . . . . 1.0 109.886 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.76 176.83 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.679 1.357 . . . . 1.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.415 ' CD1' ' OG ' ' A' ' 80' ' ' SER . 80.9 mt -60.16 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 1.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 88.4 t80 -152.36 163.31 39.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 1.0 109.549 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -87.45 145.92 19.86 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.842 -1.303 . . . . 1.0 109.842 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -153.8 164.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.0 110.241 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.26 163.48 18.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 1.0 110.34 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 p -155.65 132.61 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 1.0 109.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CA ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -87.32 76.08 9.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 1.0 110.959 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t 59.36 97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.841 0.829 . . . . 1.0 112.049 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 63' ' ' CYS . . . 46.12 23.34 1.12 Allowed Glycine 0 N--CA 1.495 2.592 0 O-C-N 121.943 -0.473 . . . . 1.0 113.217 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HG3' ' CA ' ' A' ' 14' ' ' PHE . 1.8 mm-40 -62.49 -75.17 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.714 1.757 . . . . 1.0 107.653 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.483 ' CG2' ' CE1' ' A' ' 61' ' ' HIS . 63.3 m -162.02 151.38 15.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.783 -0.573 . . . . 1.0 109.672 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.31 163.11 16.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 1.0 109.624 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -155.89 81.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.934 -1.104 . . . . 1.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 71.9 m-85 -102.36 115.49 30.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -0.901 . . . . 1.0 109.591 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.16 157.34 20.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 1.0 111.111 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.1 tt -167.09 120.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -87.16 129.81 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 1.0 110.727 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -96.74 -171.99 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.814 . . . . 1.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -105.45 -83.82 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 1.0 110.398 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 121.89 67.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.0 110.216 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.26 111.87 3.39 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.41 1.216 . . . . 1.0 110.078 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.91 -64.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 1.0 110.444 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.44 157.6 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 1.0 110.335 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -107.58 -175.56 2.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 1.0 109.91 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.97 -159.33 9.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.471 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -156.8 171.05 21.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -1.081 . . . . 1.0 109.882 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.483 ' CG ' HD13 ' A' ' 58' ' ' LEU . 56.2 m95 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.038 -1.039 . . . . 1.0 110.648 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' CD ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -157.23 126.08 5.81 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.37 -133.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 1.0 108.873 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -24.76 6.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.328 -1.483 . . . . 1.0 109.355 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 162.64 40.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.441 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -115.72 101.74 54.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.265 -1.138 . . . . 1.0 110.299 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.73 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.889 1.468 . . . . 1.0 110.324 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -164.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 1.0 110.677 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -162.08 172.12 16.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 1.0 110.225 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.0 125.38 34.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 1.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -174.88 -59.93 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 1.0 110.343 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -71.13 -87.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.447 1.235 . . . . 1.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -142.15 52.88 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.877 -1.139 . . . . 1.0 110.487 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.04 138.07 31.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.202 -0.936 . . . . 1.0 110.167 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 4.2 tt0 -123.65 53.49 1.36 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.105 -0.997 . . . . 1.0 110.002 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.8 114.98 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.87 -1.144 . . . . 1.0 109.908 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.0 99.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 1.0 110.238 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -124.85 141.87 51.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.95 . . . . 1.0 110.277 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.85 14.48 2.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.12 -30.3 6.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.388 -1.085 . . . . 1.0 110.388 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -90.9 -16.24 28.49 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.309 -1.113 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.88 114.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.161 -0.962 . . . . 1.0 110.383 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -95.1 111.63 23.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.843 . . . . 1.0 110.187 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.7 mm -120.7 147.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 1.0 110.07 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD13 ' CG ' ' A' ' 34' ' ' TRP . 4.5 tt -123.9 130.51 52.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 1.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -133.46 103.1 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.43 127.34 46.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.006 -1.059 . . . . 1.0 111.722 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.483 ' CE1' ' CG2' ' A' ' 18' ' ' THR . 12.8 m-70 -103.7 28.1 6.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.846 0.832 . . . . 1.0 108.82 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -108.53 -4.58 17.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.596 -0.69 . . . . 1.0 111.319 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.457 ' N ' ' HA2' ' A' ' 16' ' ' GLY . 76.8 m -43.04 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.274 -0.891 . . . . 1.0 111.395 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 63' ' ' CYS . 18.8 mt-30 -161.24 -166.78 1.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 1.0 110.213 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -3.44 18.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 1.0 111.152 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.85 -36.25 5.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.435 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -48.57 -23.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 1.0 111.548 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 p -46.34 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.933 . . . . 1.0 110.762 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -175.21 -125.67 0.88 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -139.76 142.94 36.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 1.0 110.513 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.529 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 55.2 t -94.51 105.2 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.634 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -107.77 108.09 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 1.0 110.625 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 24.4 t80 -81.07 145.01 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 1.0 109.586 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -121.2 111.01 16.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 1.0 110.593 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.57 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.528 -0.732 . . . . 1.0 109.502 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.93 -162.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 1.0 109.596 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -62.85 -19.49 64.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.0 110.163 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.7 145.36 47.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 1.0 110.398 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -153.57 133.37 13.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 1.0 110.094 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.415 ' OG ' ' CD1' ' A' ' 8' ' ' LEU . 69.8 p -112.16 178.35 4.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.947 . . . . 1.0 110.171 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.14 79.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 1.0 110.511 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.64 -178.74 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.985 . . . . 1.0 110.194 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -114.09 136.74 52.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 1.0 110.25 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.7 tp -136.55 134.25 37.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.0 110.233 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -131.92 125.88 32.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 1.0 109.744 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 51.4 t -90.92 112.29 24.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.304 -0.872 . . . . 1.0 109.949 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -75.75 172.38 12.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 1.0 110.519 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -86.73 176.47 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 1.0 110.226 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.108 179.8 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 pt -143.46 150.67 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.176 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.69 -172.66 2.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 1.0 110.301 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.0 111.53 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.27 -38.98 19.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.449 -0.945 . . . . 1.0 108.449 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -122.5 106.44 35.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.66 173.46 9.94 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.617 1.325 . . . . 1.0 111.032 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.77 -160.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.515 -0.741 . . . . 1.0 109.981 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -148.66 114.05 5.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0 109.835 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 132.3 38.55 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -154.14 161.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -1.179 . . . . 1.0 110.586 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -107.49 169.63 8.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.0 109.96 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.35 172.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 1.0 110.49 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.68 137.46 49.54 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.461 -0.774 . . . . 1.0 108.948 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 88' ' ' GLU . 93.2 t -46.11 111.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.415 -0.803 . . . . 1.0 111.403 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 127.24 -47.33 1.03 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.37 -1.076 . . . . 1.0 109.965 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -130.17 139.93 50.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 110.569 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.16 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 1.0 109.744 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -130.64 100.68 5.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 1.0 110.755 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 51.8 m-85 -104.41 154.38 19.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 1.0 109.743 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -140.92 157.61 45.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.002 -1.061 . . . . 1.0 110.611 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -169.48 139.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.446 -0.784 . . . . 1.0 110.154 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.13 132.27 54.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.334 -0.854 . . . . 1.0 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -94.37 -152.57 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 1.0 110.097 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -109.16 -37.77 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -0.834 . . . . 1.0 110.149 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.07 148.28 59.77 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 1.0 110.171 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.62 -167.9 0.45 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.677 1.357 . . . . 1.0 110.797 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.53 46.49 22.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 1.0 110.364 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.58 102.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 1.0 110.349 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -91.99 137.55 32.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.268 -0.895 . . . . 1.0 110.18 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.57 172.98 21.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -122.38 163.55 19.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 1.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 28.1 m95 -114.05 149.16 35.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 1.0 110.293 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 1.1 ttpt -139.47 131.33 27.63 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.318 -0.864 . . . . 1.0 109.939 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 67' ' ' MET . 44.7 mt -61.46 -112.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.142 -0.974 . . . . 1.0 109.304 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -85.97 12.62 8.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.448 -1.408 . . . . 1.0 110.264 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 131.19 -1.77 5.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -97.57 112.09 60.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.91 -1.347 . . . . 1.0 109.96 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.3 109.04 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.525 1.276 . . . . 1.0 110.543 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 169.42 17.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.288 -0.882 . . . . 1.0 110.534 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -143.52 24.13 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 1.0 109.742 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.02 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.832 . . . . 1.0 110.753 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.58 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 1.0 109.74 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.6 Cg_endo -70.54 -19.3 32.59 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.584 1.307 . . . . 1.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.89 -58.75 1.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.948 . . . . 1.0 109.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.26 152.13 44.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 1.0 109.95 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.57 86.51 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 1.0 110.409 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.68 128.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 1.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.05 122.47 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 1.0 110.591 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -142.55 162.25 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.0 109.72 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.55 16.76 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.02 -1.05 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.38 -29.86 7.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.984 -1.246 . . . . 1.0 109.984 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -74.12 -28.39 61.32 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.308 -1.113 . . . . 1.0 109.767 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.19 -173.66 1.32 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.376 -0.827 . . . . 1.0 110.063 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 81.1 m-70 -139.41 118.27 12.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.91 130.47 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 1.0 110.167 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.515 ' CD1' ' CE3' ' A' ' 34' ' ' TRP . 3.0 tt -105.88 136.34 45.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.833 . . . . 1.0 110.349 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -134.2 73.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 1.0 109.565 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.06 151.12 43.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 1.0 110.533 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 56.9 m-70 -113.99 -172.42 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.0 109.6 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.485 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 63.4 t-20 -14.52 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 61' ' ' HIS . 99.8 m -78.4 172.71 13.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.609 -0.682 . . . . 1.0 109.291 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.48 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 49.4 tp60 -115.0 167.28 10.94 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.023 -1.048 . . . . 1.0 109.128 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.48 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 14.0 tp -63.86 -5.96 5.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.033 -1.042 . . . . 1.0 112.308 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.66 -12.53 82.76 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 120.674 -1.266 . . . . 1.0 110.445 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.465 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 23.1 mtt -86.06 41.95 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.374 . . . . 1.0 110.93 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -90.83 45.02 1.22 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 1.0 110.004 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.1 -125.32 3.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 8.6 pt-20 -144.59 151.89 39.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -1.057 . . . . 1.0 110.336 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -90.33 90.48 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 1.0 109.964 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 p -94.52 99.94 12.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.836 . . . . 1.0 110.287 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 31.4 t80 -73.28 167.86 20.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.968 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.99 107.31 1.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 1.0 110.258 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 73' ' ' PHE . . . -139.74 122.92 16.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 1.0 109.99 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.89 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 1.0 110.387 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' ALA . 24.3 t30 -128.54 -31.04 2.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.047 -1.033 . . . . 1.0 110.589 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.47 127.68 33.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 1.0 110.511 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 124.03 15.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 1.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.411 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.9 m -112.62 -174.22 2.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 1.0 110.486 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.05 102.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 1.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 70' ' ' GLU . . . -99.98 -172.67 2.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.905 . . . . 1.0 109.903 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -114.51 137.23 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.108 -0.995 . . . . 1.0 110.238 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -140.63 124.02 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 1.0 110.607 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -126.54 133.71 51.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 1.0 109.52 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 43.4 t -91.79 149.83 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.14 -0.975 . . . . 1.0 110.377 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.66 104.78 4.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 1.0 110.029 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 15' ' ' VAL . 13.6 pt-20 -73.45 -156.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 1.0 110.461 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.932 -1.032 . . . . 1.0 110.081 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.356 0.598 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 2' ' ' ILE . 47.4 mm -112.87 137.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.312 -0.868 . . . . 1.0 110.485 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -171.36 2.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.348 -0.845 . . . . 1.0 110.063 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.5 t -119.13 119.38 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 1.0 110.1 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -82.64 -49.64 9.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.208 -0.932 . . . . 1.0 109.626 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -119.14 107.91 41.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 1.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.41 -175.86 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.491 1.258 . . . . 1.0 110.482 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 81' ' ' ALA . 6.6 mt -79.2 -172.65 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 1.0 110.494 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.35 136.48 33.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 1.0 110.125 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.89 149.91 36.84 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.439 HG11 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -160.11 154.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.161 . . . . 1.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.05 162.4 17.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 1.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.35 137.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 1.0 109.818 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.404 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.32 55.65 3.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.379 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 15' ' ' VAL . 5.9 p 36.55 76.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 CA-C-O 121.776 0.798 . . . . 1.0 111.95 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 158.13 -30.43 0.48 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.764 -1.735 . . . . 1.0 108.764 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.8 -161.94 0.19 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -1.027 . . . . 1.0 109.699 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 20.7 m -126.07 112.73 16.2 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.323 -0.951 . . . . 1.0 110.743 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.32 33.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 1.0 109.36 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -126.63 119.35 26.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.945 -1.097 . . . . 1.0 110.744 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -117.21 123.48 46.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -0.883 . . . . 1.0 109.804 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.58 153.15 25.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.017 . . . . 1.0 110.167 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -166.83 120.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 1.0 109.495 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.38 148.34 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 1.0 110.403 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 56' ' ' HIS . 42.9 mt -106.56 -150.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 1.0 109.854 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -116.09 -40.96 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 1.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.13 135.95 12.97 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 1.0 110.179 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.57 153.96 49.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.481 1.253 . . . . 1.0 110.391 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.75 -64.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.0 110.301 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.38 -164.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 1.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -115.21 143.79 44.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 1.0 110.132 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.38 -166.22 22.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.45 -1.46 . . . . 1.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.64 154.35 36.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -1.182 . . . . 1.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.492 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 30.8 m95 -102.01 147.35 26.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -141.84 132.49 25.52 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.359 -0.838 . . . . 1.0 109.328 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.413 HD23 ' HG2' ' A' ' 67' ' ' MET . 5.5 mt -64.7 -136.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.062 -1.023 . . . . 1.0 109.004 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -25.11 7.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.443 -1.41 . . . . 1.0 109.315 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.35 42.73 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.82 33.03 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.372 -1.076 . . . . 1.0 109.765 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.79 85.24 1.35 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.721 1.38 . . . . 1.0 110.197 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -69.36 -172.97 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.243 -0.911 . . . . 1.0 110.224 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.4 p -136.39 -170.65 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.93 109.64 14.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 110.149 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -120.29 166.39 15.39 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 1.0 110.141 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.6 -23.16 20.1 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.599 1.315 . . . . 1.0 110.486 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.39 -25.6 23.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 1.0 110.218 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.35 127.22 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.914 . . . . 1.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.18 147.46 44.18 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 1.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.9 mt -140.33 95.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 1.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -99.54 98.68 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 1.0 109.726 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.27 162.82 25.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 1.0 110.599 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.1 23.62 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 1.0 109.96 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 -86.24 1.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -50.08 -23.77 2.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.75 -0.853 . . . . 1.0 110.747 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -134.74 160.48 38.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 1.0 110.655 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.456 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.0 m-70 -143.34 105.42 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -104.83 144.49 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 1.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.473 HD21 ' CZ3' ' A' ' 34' ' ' TRP . 15.7 tp -128.87 136.18 50.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.0 110.272 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG21 ' CG2' ' A' ' 18' ' ' THR . 4.3 mt -132.58 93.9 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 1.0 109.8 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 103.89 14.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 1.0 110.531 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' C ' ' A' ' 62' ' ' ASN . 67.1 m-70 -69.44 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 1.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 61' ' ' HIS . 3.1 m120 -12.18 79.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 113.85 1.056 . . . . 1.0 113.85 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.7 m -71.63 145.44 48.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.781 . . . . 1.0 109.092 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -99.18 172.92 7.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 1.0 110.902 -179.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HA ' HG13 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -70.23 -4.63 22.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.639 -0.663 . . . . 1.0 111.136 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.73 -11.91 76.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.793 -1.194 . . . . 1.0 110.336 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.467 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -85.95 43.26 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.905 -1.35 . . . . 1.0 110.615 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 40.73 1.04 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 1.0 109.75 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.9 2.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.886 -1.285 . . . . 1.0 109.886 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.44 152.17 44.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.403 -1.057 . . . . 1.0 110.539 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 83.6 t -92.99 87.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 1.0 109.475 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.0 p -94.52 112.23 23.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 1.0 110.894 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 46.8 t80 -91.26 137.97 31.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 1.0 109.398 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -120.13 138.26 53.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 1.0 111.087 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.56 47.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.72 . . . . 1.0 109.356 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 62.22 132.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.782 . . . . 1.0 110.425 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.23 24.07 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 1.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.21 139.03 16.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.025 . . . . 1.0 109.972 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.96 68.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 1.0 110.8 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.417 ' OG ' ' CD1' ' A' ' 8' ' ' LEU . 71.1 p -54.65 171.88 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.981 -1.074 . . . . 1.0 109.554 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -165.88 104.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.035 -1.04 . . . . 1.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.57 -167.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 1.0 109.828 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -128.19 137.45 52.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 1.0 109.787 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.439 ' CD2' HG11 ' A' ' 11' ' ' VAL . 1.9 tm? -139.27 116.31 10.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.043 -1.036 . . . . 1.0 111.146 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -111.12 132.82 53.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.416 -0.803 . . . . 1.0 109.39 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 28.0 t -103.9 111.09 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.228 -0.92 . . . . 1.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -99.58 129.9 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.72 -176.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 1.0 110.374 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.321 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.279 0.561 . . . . 1.0 110.12 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 26' ' ' SER . 37.6 mm -101.93 140.31 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.128 -0.983 . . . . 1.0 110.073 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . 50.3 mt-10 -123.84 -178.6 4.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 1.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.2 t -105.4 115.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.804 . . . . 1.0 109.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -75.95 -39.76 55.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -124.95 106.92 28.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.65 176.57 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.565 1.297 . . . . 1.0 110.705 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 4.1 mt -72.05 172.22 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 1.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 20.6 m-85 -129.25 3.71 5.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.137 -0.977 . . . . 1.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 82' ' ' ALA . . . 70.43 153.52 1.04 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.95 134.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.114 . . . . 1.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -109.07 150.64 27.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.0 110.068 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 14' ' ' PHE . 1.1 p -160.55 -158.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.454 -0.779 . . . . 1.0 109.782 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.478 ' N ' HG12 ' A' ' 13' ' ' VAL . 5.8 m-85 -107.33 -154.51 0.53 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -120.16 121.76 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.85 -1.156 . . . . 1.0 110.763 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.34 -48.95 0.94 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HG3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.14 -147.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -1.109 . . . . 1.0 110.617 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.458 HG21 ' CG ' ' A' ' 61' ' ' HIS . 4.6 p -128.81 161.06 30.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 110.996 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.68 170.13 8.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.69 . . . . 1.0 109.477 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 93.38 2.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.013 . . . . 1.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.427 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 81.9 m-85 -94.67 162.63 13.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.51 -0.744 . . . . 1.0 109.552 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -140.67 153.98 46.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.945 -1.097 . . . . 1.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 80' ' ' SER . 3.6 tt -170.55 138.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.598 -0.689 . . . . 1.0 109.814 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 30.1 tt0 -96.43 170.41 9.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 1.0 110.559 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD12 ' CD2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -159.17 175.03 13.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.522 -0.736 . . . . 1.0 109.889 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB2' HD11 ' A' ' 2' ' ' ILE . 9.7 m -93.31 -44.16 8.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.083 -1.011 . . . . 1.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.82 150.79 53.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.95 . . . . 1.0 110.132 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.85 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.732 1.386 . . . . 1.0 110.652 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.65 76.65 9.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 1.0 110.218 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' CG1' ' NE2' ' A' ' 56' ' ' HIS . 7.4 p -95.17 143.73 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.29 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 31' ' ' HIS . 25.9 p80 -76.32 117.79 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.875 . . . . 1.0 110.231 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.92 -166.14 10.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.346 -1.502 . . . . 1.0 109.346 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.71 128.03 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -1.2 . . . . 1.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 28.2 m95 -94.7 154.66 17.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 1.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 4.4 ptmt -152.07 156.08 39.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 1.0 109.968 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.424 HD23 ' CE ' ' A' ' 67' ' ' MET . 5.4 mt -65.16 -133.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.903 . . . . 1.0 109.354 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -52.15 -23.31 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.474 -1.391 . . . . 1.0 110.126 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 159.52 39.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.385 -1.486 . . . . 1.0 109.385 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -119.33 109.15 39.04 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.235 -1.156 . . . . 1.0 109.607 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.21 111.56 3.34 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.586 1.308 . . . . 1.0 110.037 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.84 -144.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 1.0 110.153 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -143.96 150.9 39.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.986 -1.071 . . . . 1.0 110.319 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.84 113.31 20.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 1.0 110.136 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -177.91 -59.71 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 1.0 110.372 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -69.73 -69.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.493 1.26 . . . . 1.0 111.305 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -132.68 64.24 1.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.935 -1.103 . . . . 1.0 110.494 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.9 t -169.05 139.93 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 1.0 110.348 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.5 85.52 2.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 1.0 110.21 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 58' ' ' LEU . 28.6 mt -80.3 130.2 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 1.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.416 HG23 ' CD1' ' A' ' 59' ' ' ILE . 7.4 tt -142.97 102.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 1.0 109.848 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.57 159.27 19.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 1.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -113.44 20.84 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.395 -0.816 . . . . 1.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.84 -101.58 2.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.834 -1.307 . . . . 1.0 109.834 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -50.75 -21.76 1.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.417 -1.049 . . . . 1.0 110.673 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 1.5 mmtt -134.11 173.78 11.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 1.0 110.493 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.494 ' CD2' HD12 ' A' ' 25' ' ' LEU . 19.5 m-70 -126.34 135.95 52.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.0 109.736 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.3 mt -137.16 127.89 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.0 110.882 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 32.6 tp -103.25 149.12 25.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.0 109.963 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.416 ' CD1' HG23 ' A' ' 50' ' ' ILE . 55.1 mt -145.2 82.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.149 -0.969 . . . . 1.0 109.523 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.83 -179.82 5.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 1.0 110.775 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' C ' ' A' ' 62' ' ' ASN . 65.8 m-70 -137.5 -162.4 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.57 -0.706 . . . . 1.0 109.103 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 61' ' ' HIS . 1.7 t-20 -14.25 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 113.415 0.895 . . . . 1.0 113.415 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 61' ' ' HIS . 73.5 m -71.03 163.49 27.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.682 -0.636 . . . . 1.0 110.142 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 4.5 tp-100 -121.51 168.68 11.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.444 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 8.3 tp -76.52 17.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.849 -1.157 . . . . 1.0 112.124 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 -25.54 6.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.026 -1.63 . . . . 1.0 109.026 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 69' ' ' GLY . 54.1 mtp -54.59 -18.58 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -1.116 . . . . 1.0 110.722 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -42.22 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.634 -0.666 . . . . 1.0 110.95 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -176.81 -116.74 0.48 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.336 -1.506 . . . . 1.0 109.336 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.72 130.39 10.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.6 t -79.1 100.4 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 1.0 109.168 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -99.34 116.55 31.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.0 110.947 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 31.5 t80 -87.54 146.4 25.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 1.0 108.959 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 105.3 8.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.959 -1.088 . . . . 1.0 111.055 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 73' ' ' PHE . . . -139.45 121.48 15.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.595 -0.691 . . . . 1.0 109.369 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.32 -153.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 1.0 109.738 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -72.02 -10.51 59.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 110.719 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 3' ' ' GLU . . . -80.13 155.5 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.042 . . . . 1.0 110.525 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -159.9 95.51 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 110.013 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.433 ' CB ' HD13 ' A' ' 23' ' ' ILE . 36.8 m -85.51 167.54 15.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 1.0 110.293 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 72' ' ' SER . . . -169.89 106.22 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 1.0 110.894 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HB2' ' CA ' ' A' ' 10' ' ' GLY . . . -100.42 -161.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.989 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -115.66 148.56 39.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.955 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -140.82 132.44 27.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 1.0 110.518 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -132.6 131.2 41.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 1.0 109.825 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.44 151.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.309 -0.87 . . . . 1.0 110.124 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -148.34 144.8 27.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 1.0 110.382 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -73.51 146.16 45.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 1.0 110.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.233 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.239 0.543 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.97 118.17 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 1.0 110.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.68 179.0 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.936 . . . . 1.0 110.355 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.58 106.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 1.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.87 -36.86 84.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.273 -0.892 . . . . 1.0 109.281 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 106.31 27.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.421 -0.799 . . . . 1.0 109.804 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.79 172.82 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.587 1.309 . . . . 1.0 110.864 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 10.6 mt -82.05 177.73 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.765 . . . . 1.0 109.56 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -136.25 6.65 3.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.941 -1.099 . . . . 1.0 111.483 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.41 144.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 1.0 109.997 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG23 ' CE1' ' A' ' 21' ' ' PHE . 5.8 m -141.36 -175.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -1.165 . . . . 1.0 110.14 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.43 158.16 45.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.194 -0.941 . . . . 1.0 110.322 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 17' ' ' GLU . 2.9 p -153.87 134.37 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.348 -0.845 . . . . 1.0 109.837 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -92.09 55.19 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 1.0 110.546 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t 48.44 89.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.87 . . . . 1.0 110.808 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.44 -33.99 3.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.044 -1.622 . . . . 1.0 109.044 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' CB ' HG22 ' A' ' 13' ' ' VAL . 2.2 mt-10 -67.34 -162.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.351 -1.088 . . . . 1.0 109.552 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 m -135.64 119.59 17.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.135 -0.978 . . . . 1.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.97 165.25 23.67 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.348 -0.845 . . . . 1.0 109.077 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -147.13 115.57 6.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.923 -1.111 . . . . 1.0 110.883 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 71.9 m-85 -113.82 130.8 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.0 109.758 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -115.06 151.61 33.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 1.0 110.649 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 13.1 tt -170.87 154.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.447 -0.783 . . . . 1.0 109.73 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.3 160.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 1.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' CD2' ' CD2' ' A' ' 56' ' ' HIS . 2.4 mm? -112.98 -168.76 1.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 1.0 109.898 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -99.55 -45.32 5.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 1.0 110.129 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.28 153.97 38.05 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 1.0 110.117 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.35 -166.02 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.717 1.377 . . . . 1.0 110.485 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.82 54.68 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 1.0 110.398 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.04 117.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 1.0 110.413 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -98.75 144.7 27.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 1.0 110.025 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -151.13 171.89 30.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.763 -1.335 . . . . 1.0 109.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -139.08 179.22 6.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.384 -1.068 . . . . 1.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.508 ' CE3' ' CD1' ' A' ' 58' ' ' LEU . 59.8 m95 -123.69 133.41 53.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 1.0 110.701 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.428 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -129.08 111.47 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.786 . . . . 1.0 110.711 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.44 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 1.0 108.725 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -92.27 9.05 35.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 1.0 109.497 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 127.79 -1.23 6.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.09 -1.204 . . . . 1.0 110.09 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -96.7 137.61 21.42 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.251 . . . . 1.0 109.913 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.97 106.05 2.18 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.613 1.323 . . . . 1.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.02 3.37 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 110.573 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 m -70.55 -35.48 73.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.07 . . . . 1.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.74 44.59 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 1.0 110.548 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -115.82 158.96 40.83 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.346 -0.847 . . . . 1.0 110.231 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.53 -12.87 27.34 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.759 1.4 . . . . 1.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.54 -17.81 15.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.0 110.518 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.4 131.84 35.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 1.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -133.15 77.41 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 1.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.403 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 1.1 pp -96.83 105.32 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 1.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.8 111.54 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 1.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -132.83 161.46 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 1.0 110.094 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.27 33.23 5.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 1.0 110.183 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 56' ' ' HIS . . . 86.38 -91.11 1.7 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -48.24 -24.31 1.14 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.648 -0.913 . . . . 1.0 110.769 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.16 165.76 17.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 1.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.496 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 m-70 -148.52 114.07 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 57' ' ' ILE . 55.3 mt -116.4 136.11 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 1.0 110.291 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.508 ' CD1' ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -115.57 133.94 55.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.26 -0.9 . . . . 1.0 110.295 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.26 83.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 1.0 109.631 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' HD23 ' A' ' 58' ' ' LEU . 4.6 mt -86.69 116.01 24.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 1.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 62' ' ' ASN . 86.9 m-70 -79.06 -169.65 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 1.0 110.452 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 20.4 p-10 -14.95 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.0 m -71.11 178.53 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.69 . . . . 1.0 109.482 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 10.4 tp60 -111.28 158.82 18.55 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.092 -1.005 . . . . 1.0 109.102 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.544 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.1 mp -46.89 -25.29 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.0 111.074 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.72 -119.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.466 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 3.3 mtt 42.13 30.73 0.2 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.715 -0.874 . . . . 1.0 111.487 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.21 53.0 2.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 1.0 110.098 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.39 -126.46 2.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.57 154.07 36.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 1.0 110.374 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 74.5 t -89.28 86.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.328 -0.858 . . . . 1.0 110.031 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 97.2 p -94.25 109.62 21.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 1.0 110.231 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CZ ' ' HA3' ' A' ' 32' ' ' GLY . 42.5 t80 -78.54 157.44 28.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 1.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -146.1 146.0 30.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 1.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -169.45 -146.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 1.0 110.113 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.8 -69.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 1.0 110.634 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -142.98 33.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 1.0 110.249 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.81 120.43 34.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 1.0 110.054 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.18 88.45 2.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 1.0 110.237 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.416 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 25.7 m -82.36 174.73 10.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.994 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.65 97.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 1.0 110.381 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -97.41 -163.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.0 109.995 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 129.04 53.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 1.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 126.52 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.0 110.299 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 137.82 46.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 1.0 109.902 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 42.5 t -100.21 108.22 22.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 1.0 110.133 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -86.6 107.54 18.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 1.0 110.219 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.27 -152.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 1.0 110.281 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.97 -1.014 . . . . 1.0 110.653 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.169 0.509 . . . . 1.0 110.281 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.5 mt -131.53 151.13 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 1.0 110.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -91.63 9.54 31.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 1.0 111.155 -179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 17.3 t 62.06 145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.41 -0.806 . . . . 1.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.79 -41.2 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 1.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -116.79 107.88 45.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.609 -0.682 . . . . 1.0 109.899 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.07 176.65 6.72 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 1.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD13 ' N ' ' A' ' 81' ' ' ALA . 12.4 mt -70.25 171.23 10.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.417 -0.802 . . . . 1.0 110.49 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.5 m-85 -129.72 169.23 15.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 1.0 110.074 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 155.52 31.9 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.202 -1.159 . . . . 1.0 110.202 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -159.55 155.23 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 1.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.1 157.11 30.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.983 . . . . 1.0 110.784 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 p -157.87 142.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 1.0 110.078 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.41 46.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 1.0 110.472 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 88' ' ' GLU . 11.3 t 61.42 142.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 1.0 110.175 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 87.8 -56.21 4.39 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.51 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -1.162 . . . . 1.0 109.926 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.17 150.33 36.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 1.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.1 168.94 10.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 1.0 109.654 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -147.58 97.04 2.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 1.0 110.78 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.495 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 90.8 m-85 -106.07 115.94 31.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 1.0 109.535 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -107.49 151.71 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.042 . . . . 1.0 110.985 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 80' ' ' SER . 1.4 tt -159.29 123.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -0.767 . . . . 1.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -87.3 142.05 28.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 1.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.21 19.6 17.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 1.0 110.412 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.81 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.663 -0.648 . . . . 1.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.67 138.73 27.98 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.302 -0.874 . . . . 1.0 110.068 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.62 109.75 2.97 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.584 1.307 . . . . 1.0 110.452 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -174.71 -45.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 1.0 110.346 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 75' ' ' ALA . 94.3 t -53.27 163.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 1.0 110.48 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -178.11 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 1.0 110.104 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -119.94 -132.42 4.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.89 179.17 7.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -1.11 . . . . 1.0 110.378 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.524 ' NE1' ' CE1' ' A' ' 73' ' ' PHE . 27.5 m95 -127.25 148.44 50.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.103 -0.998 . . . . 1.0 111.622 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -154.35 -114.78 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.389 -0.82 . . . . 1.0 109.128 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 2.7 mp -157.15 -158.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.925 -1.109 . . . . 1.0 108.775 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -22.44 8.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.777 -1.202 . . . . 1.0 109.425 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.09 -113.83 0.01 OUTLIER Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 1.3 mt-30 -134.72 178.43 1.77 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' ' CG ' ' A' ' 33' ' ' GLN . 50.6 Cg_endo -89.29 113.07 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.443 1.233 . . . . 1.0 111.281 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -98.04 -168.27 1.64 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.672 -1.268 . . . . 1.0 110.211 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.434 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.6 t -113.24 161.91 16.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 1.0 110.086 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.02 123.32 20.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.263 -0.898 . . . . 1.0 109.491 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -175.8 -59.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 1.0 110.96 -179.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 40.2 Cg_endo -67.72 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.412 1.217 . . . . 1.0 111.296 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.11 69.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.14 . . . . 1.0 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 136.88 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 1.0 110.394 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.43 78.61 1.68 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 1.0 109.732 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.444 HG13 ' CD1' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -91.89 136.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 1.0 110.233 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.1 pt -135.32 106.95 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.442 -0.786 . . . . 1.0 109.955 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.7 141.21 34.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 1.0 110.352 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.69 17.9 14.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 1.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 -26.61 16.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.79 -27.03 40.39 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.449 -1.03 . . . . 1.0 109.582 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.01 122.89 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.542 -0.724 . . . . 1.0 109.701 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.54 103.69 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 1.0 109.995 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.75 137.6 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 1.0 110.548 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.478 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 29.3 tp -109.69 142.68 40.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 1.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -138.44 82.73 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 1.0 110.29 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' CD1' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.64 167.02 22.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 1.0 110.181 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 35.5 m-70 -129.75 -163.72 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 1.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -13.4 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 61' ' ' HIS . 69.6 m -87.61 -173.33 4.28 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.51 -0.744 . . . . 1.0 109.024 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.445 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -167.01 -160.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 1.0 110.098 -179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.48 81.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.865 0.84 . . . . 1.0 109.904 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.62 -40.67 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.604 -1.798 . . . . 1.0 108.604 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.439 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 31.0 mtt -87.06 39.95 0.89 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -1.121 . . . . 1.0 110.549 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -91.31 27.4 1.94 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 1.0 110.173 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.49 -109.74 2.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.229 -1.549 . . . . 1.0 109.229 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -146.56 139.58 25.49 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.538 -0.978 . . . . 1.0 110.522 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 26.2 t -78.99 128.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 p -123.97 127.58 48.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.0 111.285 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.524 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 51.1 t80 -104.63 137.11 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 1.0 109.439 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -130.72 144.17 51.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 1.0 109.939 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' A' ' 30' ' ' VAL . . . -159.12 -148.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.805 . . . . 1.0 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.26 51.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 1.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -154.46 30.28 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 1.0 109.931 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.2 108.78 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.024 -1.047 . . . . 1.0 110.164 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.901 . . . . 1.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.437 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 6.5 p -102.39 175.57 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 1.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -169.76 103.12 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.123 -0.986 . . . . 1.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.63 -176.14 3.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 1.0 109.752 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -108.1 134.66 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 1.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.08 141.61 48.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.409 -0.807 . . . . 1.0 109.858 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -139.22 125.93 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.0 110.062 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 64' ' ' GLN . 40.6 t -96.9 132.8 40.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.901 . . . . 1.0 109.921 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -124.23 119.51 29.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 1.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' HG22 ' A' ' 15' ' ' VAL . 12.4 pt-20 -63.19 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.935 . . . . 1.0 110.193 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.035 -0.983 . . . . 1.0 110.182 179.864 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.437 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 2.7 mp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.201 0.524 . . . . 1.0 110.278 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -171.11 126.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 1.0 109.85 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 2' ' ' ILE . 15.9 mt-10 -152.72 -77.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 1.0 110.784 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 HG23 ' OG ' ' A' ' 80' ' ' SER . 46.2 t -47.15 107.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 1.0 111.281 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 2.8 mm-40 -96.23 -26.1 15.55 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.431 -0.793 . . . . 1.0 109.039 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -135.49 119.39 13.03 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.4 168.12 18.78 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.537 1.283 . . . . 1.0 111.763 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.406 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 7.8 mt -82.4 161.33 22.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.631 -0.668 . . . . 1.0 109.923 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -115.2 168.12 10.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 1.0 110.189 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.63 124.65 7.91 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.67 179.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 1.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -135.04 161.32 35.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 1.0 110.667 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 p -160.7 129.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 1.0 109.957 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 57.3 4.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.951 . . . . 1.0 110.361 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t 48.66 91.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.174 -0.954 . . . . 1.0 110.531 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 132.36 -34.92 2.43 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -67.45 -163.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -1.07 . . . . 1.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.9 m -136.74 115.4 12.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 1.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -79.55 149.85 31.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.206 -0.934 . . . . 1.0 109.517 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -127.04 137.33 53.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 1.0 110.746 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 62.1 m-85 -133.38 115.45 14.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 1.0 109.797 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.3 154.76 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 1.0 110.731 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tt -170.32 122.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 1.0 109.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -88.01 171.62 10.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 1.0 110.217 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -150.08 128.36 12.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.817 . . . . 1.0 110.097 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.6 t -67.19 -49.36 64.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 1.0 110.724 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.97 136.32 44.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 1.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.19 -159.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.605 1.318 . . . . 1.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.47 118.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.963 . . . . 1.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 17.8 m -103.22 119.35 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.383 -0.823 . . . . 1.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.09 19.92 2.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 1.0 110.312 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.38 -150.04 23.41 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.12 165.72 2.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -1.04 . . . . 1.0 109.907 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.533 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 27.8 m95 -104.55 150.6 24.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 1.0 110.374 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 2.3 ttpt -149.3 122.99 9.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 1.0 109.328 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.78 -132.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 1.0 108.824 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -52.46 -24.04 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.427 -1.421 . . . . 1.0 109.436 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.18 41.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -122.27 116.85 29.55 Favored Pre-proline 0 N--CA 1.484 1.273 0 O-C-N 121.271 -1.135 . . . . 1.0 109.213 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.82 99.86 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.562 1.296 . . . . 1.0 110.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 42' ' ' THR . 3.8 pp -70.95 -157.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 1.0 110.421 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.49 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -166.68 170.07 12.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 1.0 109.755 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.17 105.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 1.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.43 175.04 3.07 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 1.0 110.287 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.44 -24.62 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.676 1.356 . . . . 1.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -79.04 -11.56 60.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 1.0 110.631 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -124.53 167.45 14.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 1.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 84.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 1.0 110.009 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -102.1 131.99 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 1.0 110.268 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.9 tt -147.95 135.54 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.0 110.214 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' OE2' ' CG2' ' A' ' 30' ' ' VAL . 5.1 pt-20 -133.78 176.74 8.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 1.0 110.512 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -136.01 23.11 3.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 1.0 109.977 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.35 -88.65 1.4 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -5.21 27.33 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.623 -0.928 . . . . 1.0 111.077 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -132.65 164.78 25.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.846 -1.159 . . . . 1.0 110.572 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CD2' HD12 ' A' ' 25' ' ' LEU . 27.7 m-70 -142.36 127.59 18.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 1.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.63 137.08 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.922 . . . . 1.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.517 ' CD2' ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -126.15 144.29 50.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 1.0 110.591 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.3 mt -139.58 115.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 1.0 109.59 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mt -111.09 97.09 6.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.077 -1.014 . . . . 1.0 110.72 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 62' ' ' ASN . 62.7 m-70 -69.87 -166.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.007 . . . . 1.0 109.841 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 61' ' ' HIS . 45.0 p-10 -16.11 82.48 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.197 0.814 . . . . 1.0 113.197 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 70.1 m -77.4 -168.14 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.634 -0.666 . . . . 1.0 110.159 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -129.02 170.8 13.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.484 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 9.1 tp -78.67 25.1 0.27 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 1.0 111.95 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.68 -23.14 5.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.432 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 33.1 mtt -61.3 -12.98 15.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -1.139 . . . . 1.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -43.3 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.416 -0.802 . . . . 1.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.59 -119.14 0.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.371 -1.492 . . . . 1.0 109.371 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.31 149.63 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -1.062 . . . . 1.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 ' CE1' ' A' ' 21' ' ' PHE . 78.9 t -89.11 83.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.0 109.54 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -86.02 103.31 14.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 1.0 110.806 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -98.15 151.64 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 1.0 109.23 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -156.43 129.69 8.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.967 -1.083 . . . . 1.0 111.393 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.08 22.72 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.707 0.765 . . . . 1.0 109.269 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.17 -160.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.544 -0.909 . . . . 1.0 108.544 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 12.2 p30 -64.46 -22.8 67.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.923 -1.11 . . . . 1.0 109.741 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.88 169.15 18.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.0 110.216 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.55 102.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.0 110.447 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.404 ' OG ' HG23 ' A' ' 4' ' ' VAL . 71.1 m -75.41 170.08 16.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 1.0 109.954 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.46 111.44 0.57 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.135 -0.978 . . . . 1.0 110.541 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -100.16 -173.71 2.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 1.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -119.07 106.89 12.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 1.0 110.144 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.88 127.66 55.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.969 . . . . 1.0 110.282 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 3.1 pttp -130.88 113.62 14.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 1.0 110.291 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 61.5 t -87.58 104.04 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.224 -0.923 . . . . 1.0 110.233 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 154.54 22.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.99 -153.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 1.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.311 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.46 ' O ' ' CG ' ' A' ' 1' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.641 0.734 . . . . 1.0 110.528 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pt -117.08 178.88 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.054 -1.029 . . . . 1.0 110.194 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.77 -151.09 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.269 -0.894 . . . . 1.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 78' ' ' ALA . 87.2 t -130.66 123.57 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.125 -0.984 . . . . 1.0 110.216 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -86.41 -57.18 3.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 1.0 109.326 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 102.96 48.6 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.657 -0.652 . . . . 1.0 109.896 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.93 174.51 10.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.627 1.33 . . . . 1.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.402 HD13 ' CB ' ' A' ' 80' ' ' SER . 97.6 mt -75.42 174.78 9.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.0 110.355 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -142.94 150.3 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 1.0 109.883 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.98 140.3 28.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.93 170.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 1.0 109.77 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -138.29 158.35 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.963 -1.086 . . . . 1.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -160.87 138.64 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 1.0 110.393 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.55 51.22 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 1.0 109.865 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 86' ' ' VAL . 23.1 t 51.83 72.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.815 0.817 . . . . 1.0 110.423 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 157.05 -28.57 0.52 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.564 -1.814 . . . . 1.0 108.564 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -73.96 -160.93 0.1 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.979 . . . . 1.0 109.579 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -135.28 116.46 14.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.927 . . . . 1.0 110.521 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.11 163.19 25.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 1.0 109.01 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -148.8 124.63 10.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.942 -1.098 . . . . 1.0 111.078 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 71' ' ' VAL . 64.6 m-85 -132.18 109.9 10.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.0 109.282 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -115.85 159.4 21.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0 110.515 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 tt -170.83 123.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -0.764 . . . . 1.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -100.44 157.13 16.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 1.0 110.179 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 56' ' ' HIS . 35.4 mt -114.8 -150.01 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.0 109.922 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.43 -70.23 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 1.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.61 143.49 33.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.08 -174.08 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 1.0 110.555 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 53.07 85.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 1.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.47 174.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 1.0 110.256 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -128.81 130.04 46.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 1.0 109.878 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.68 175.12 23.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.963 -1.255 . . . . 1.0 109.963 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -156.17 151.64 26.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -1.053 . . . . 1.0 109.793 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 32.3 m95 -106.92 155.48 19.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 1.0 110.481 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 12.9 ttpt -143.26 112.73 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.335 -0.853 . . . . 1.0 109.61 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.434 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 1.2 mp -66.37 -123.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 1.0 109.744 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -48.79 -25.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.477 -1.389 . . . . 1.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 148.97 39.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.436 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -136.88 136.91 21.94 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.047 -1.267 . . . . 1.0 109.95 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.22 91.01 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.65 1.342 . . . . 1.0 110.557 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.46 -170.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 1.0 110.552 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 172.07 13.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.86 . . . . 1.0 109.965 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 104.14 5.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 1.0 110.17 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.13 176.11 2.26 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 1.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.74 -19.43 27.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.669 1.352 . . . . 1.0 110.372 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -102.3 -20.21 14.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 110.187 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 72.2 m -93.66 131.44 38.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 1.0 110.039 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 1.8 tt0 -104.98 46.16 0.93 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.262 -0.899 . . . . 1.0 109.801 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 tt -79.59 80.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.935 -1.103 . . . . 1.0 109.901 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.16 145.63 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 1.0 110.224 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.94 120.1 18.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.212 -0.93 . . . . 1.0 110.341 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.76 19.59 12.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 1.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.32 -95.29 1.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -21.23 1.32 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.671 -0.9 . . . . 1.0 111.101 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -134.07 136.31 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.916 -1.115 . . . . 1.0 111.046 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.438 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.7 m-70 -121.62 116.44 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 1.0 109.687 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.02 130.08 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 1.0 110.745 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.5 tp -117.13 131.61 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 1.0 109.982 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 96.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 1.0 109.957 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.2 144.99 28.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 1.0 110.507 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' C ' ' A' ' 62' ' ' ASN . 58.2 m-70 -111.24 -163.46 0.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 1.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.496 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 17.6 p-10 -14.49 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' HIS . 75.3 m -80.78 -159.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.694 -0.629 . . . . 1.0 109.645 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.431 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -158.02 -160.78 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.237 -0.914 . . . . 1.0 109.944 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.35 33.22 0.4 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.875 -1.141 . . . . 1.0 111.719 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.48 4.1 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 1.0 108.645 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.465 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 34.6 mtt -87.62 37.17 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.567 -0.961 . . . . 1.0 110.46 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 51.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 1.0 109.922 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.58 1.91 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -146.38 148.11 31.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 1.0 110.272 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 77.3 t -89.94 91.37 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 1.0 109.862 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.9 p -96.89 103.23 15.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 1.0 110.533 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -88.24 156.88 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 1.0 109.775 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.11 144.93 26.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.05 -1.031 . . . . 1.0 110.656 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.61 -147.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 1.0 109.887 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.83 -62.63 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.005 -1.06 . . . . 1.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.93 24.41 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.418 -0.801 . . . . 1.0 109.926 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -106.75 137.8 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 1.0 110.294 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.61 62.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 1.0 110.252 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.402 ' CB ' HD13 ' A' ' 8' ' ' LEU . 8.5 p -74.97 173.6 10.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 1.0 110.376 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.64 98.86 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.55 4.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.0 110.203 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -126.45 104.73 8.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 1.0 109.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.8 tp -109.36 146.79 33.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 1.0 110.483 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -149.79 112.0 4.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 1.0 109.777 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 42.3 t -79.41 111.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.064 -1.022 . . . . 1.0 110.079 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.53 108.5 20.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 1.0 110.246 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -75.22 149.06 39.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 1.0 110.092 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.199 -179.868 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.289 0.566 . . . . 1.0 110.206 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 2' ' ' ILE . 69.0 mt -110.61 153.9 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 1.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.09 178.92 4.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.108 -0.995 . . . . 1.0 110.388 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.7 t -116.84 115.14 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 1.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -87.99 -51.29 5.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 1.0 109.608 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -114.0 105.27 54.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.702 -0.624 . . . . 1.0 110.428 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.4 178.03 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.619 1.326 . . . . 1.0 110.707 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 81' ' ' ALA . 7.5 mt -78.34 -170.73 2.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.842 . . . . 1.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 35.1 p90 -152.2 130.5 12.04 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 1.0 109.904 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.51 150.61 30.17 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 12' ' ' GLU . 48.1 t -149.13 167.97 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.484 -1.01 . . . . 1.0 109.826 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 45.6 mt-10 -125.87 154.99 41.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 1.0 110.368 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 17' ' ' GLU . 3.6 p -154.01 147.95 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 1.0 109.948 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -98.14 47.09 1.0 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.0 111.012 -179.347 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG21 ' CG1' ' A' ' 86' ' ' VAL . 61.1 t 48.79 95.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.219 -0.926 . . . . 1.0 110.717 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.61 -38.15 1.82 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.644 -1.782 . . . . 1.0 108.644 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' CB ' HG22 ' A' ' 13' ' ' VAL . 3.2 mt-10 -69.7 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.484 -1.009 . . . . 1.0 109.179 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.405 ' CG2' HG21 ' A' ' 59' ' ' ILE . 19.6 m -134.27 122.16 22.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.94 -1.1 . . . . 1.0 110.954 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.58 157.7 27.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 1.0 108.859 178.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -139.84 131.16 26.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.838 -1.164 . . . . 1.0 111.051 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.98 126.39 41.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 1.0 109.721 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.87 154.72 32.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.971 . . . . 1.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -170.33 140.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 1.0 110.008 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.27 162.73 17.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 45.1 mt -124.97 -154.93 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 109.815 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.81 -30.12 5.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.132 -0.98 . . . . 1.0 110.04 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -127.77 121.95 22.28 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.0 109.847 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.27 116.86 4.87 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.47 1.247 . . . . 1.0 110.611 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.2 -1.87 7.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 1.0 110.64 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.1 t 55.7 64.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.048 -1.033 . . . . 1.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -168.8 135.4 1.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 1.0 110.223 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.94 168.16 24.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 11.4 tt0 -156.32 159.83 39.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.181 -1.188 . . . . 1.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 23.7 m95 -119.89 163.08 18.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 1.0 110.345 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -164.82 150.16 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 110.348 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.9 mt -68.32 -128.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.0 109.204 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -50.25 -24.64 3.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.604 -1.31 . . . . 1.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.71 41.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -126.07 109.79 24.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.329 -1.1 . . . . 1.0 110.054 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.84 89.47 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.597 1.314 . . . . 1.0 110.503 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.75 -172.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 1.0 110.634 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.8 m -136.69 156.85 47.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 1.0 110.094 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -78.64 115.21 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 1.0 110.184 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -170.16 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 111.116 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 44.2 Cg_endo -70.83 -90.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.27 1.142 . . . . 1.0 110.837 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -125.23 40.33 3.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.774 -1.204 . . . . 1.0 110.43 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 27.8 t -107.92 146.92 31.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 1.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -141.63 74.38 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 1.0 110.077 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.1 tt -91.09 128.94 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 1.0 110.481 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.0 118.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 1.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 170.2 16.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 1.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.88 19.94 2.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 1.0 110.216 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.56 -76.91 1.55 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -18.39 18.49 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.662 -0.905 . . . . 1.0 110.684 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.45 126.57 13.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 1.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 70.5 m-70 -103.19 115.12 29.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.797 . . . . 1.0 109.725 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 mt -118.26 144.32 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.004 . . . . 1.0 110.477 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.493 ' CD2' ' CE3' ' A' ' 34' ' ' TRP . 46.6 tp -132.92 132.56 42.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 1.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 18' ' ' THR . 51.6 mt -132.38 118.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 1.0 110.037 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -119.87 106.71 12.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 1.0 110.529 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 83.9 m-70 -72.48 -170.86 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 1.0 109.965 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.0 p-10 -15.02 81.74 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 61' ' ' HIS . 72.8 m -70.92 -158.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.52 -0.738 . . . . 1.0 109.611 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -138.37 174.48 10.5 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.153 -0.967 . . . . 1.0 108.595 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.485 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 4.5 tp -78.37 30.07 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.98 -1.075 . . . . 1.0 112.037 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.79 -11.43 10.25 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.434 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 8.5 mtt -85.17 42.85 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 1.0 110.822 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -89.93 62.09 5.53 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.071 -1.018 . . . . 1.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.89 -119.59 1.37 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.796 -1.322 . . . . 1.0 109.796 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.85 156.59 43.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -1.007 . . . . 1.0 110.571 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.94 82.04 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.45 -0.781 . . . . 1.0 109.557 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -89.34 129.85 35.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 1.0 110.45 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.507 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 21.5 t80 -98.31 145.81 26.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.478 -0.764 . . . . 1.0 109.679 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -120.66 100.9 7.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 1.0 110.426 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.03 89.33 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.902 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.46 -153.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 1.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -53.35 -24.9 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.0 110.346 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.25 134.22 39.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 1.0 110.191 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.22 149.64 30.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 1.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -138.6 174.91 10.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.95 . . . . 1.0 110.18 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 72' ' ' SER . . . -163.64 104.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 1.0 110.302 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.48 -160.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 1.0 110.078 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.59 115.98 9.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.959 . . . . 1.0 110.014 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.68 128.95 49.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 111.029 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -125.91 136.72 53.37 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.322 -0.861 . . . . 1.0 109.665 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 32.1 t -92.64 140.5 16.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 1.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -124.59 128.34 48.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.09 140.67 37.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 1.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.219 0.533 . . . . 1.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 3' ' ' GLU . 2.8 tp -157.26 151.69 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -79.98 -147.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 1.0 110.188 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.65 136.68 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 1.0 110.113 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -86.98 -49.49 7.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.423 -0.798 . . . . 1.0 109.646 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 106.26 51.69 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 1.0 110.337 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -71.74 174.12 11.6 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.556 1.293 . . . . 1.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 15.5 mt -72.83 178.12 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 1.0 109.789 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.1 m-85 -142.24 132.91 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 1.0 110.073 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.24 141.85 48.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.1 t -141.09 156.84 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -1.086 . . . . 1.0 109.653 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -111.48 150.09 30.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 1.0 110.422 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.01 165.37 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 1.0 110.542 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.411 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.91 32.85 5.79 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.525 -0.735 . . . . 1.0 109.222 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 10.9 t 64.92 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.69 0.757 . . . . 1.0 110.188 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.471 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 142.87 -25.44 2.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.139 -1.584 . . . . 1.0 109.139 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -1.093 . . . . 1.0 109.947 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -136.85 110.19 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 1.0 110.425 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.32 142.65 35.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 1.0 109.688 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -119.73 105.69 11.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 1.0 110.627 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.45 ' CD2' HD21 ' A' ' 58' ' ' LEU . 62.6 m-85 -96.03 124.95 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 1.0 109.385 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -114.56 152.36 31.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.026 -1.046 . . . . 1.0 110.99 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -167.6 117.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.681 . . . . 1.0 109.547 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.15 165.31 11.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 110.866 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 40.5 mt -129.08 -144.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 1.0 109.494 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -130.91 -47.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -100.79 160.0 28.0 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.936 . . . . 1.0 110.696 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.99 124.23 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.728 1.383 . . . . 1.0 110.381 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.19 101.07 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 1.0 110.093 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.21 60.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.0 110.151 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 28.1 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 1.0 109.992 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.23 176.17 28.94 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -158.74 139.96 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -1.101 . . . . 1.0 109.772 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.49 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 31.6 m95 -95.52 164.94 12.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 1.0 110.841 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -165.01 160.37 18.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 179.481 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.418 HD12 ' HG2' ' A' ' 67' ' ' MET . 0.2 OUTLIER -65.08 -141.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.062 . . . . 1.0 108.838 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.8 -28.16 0.6 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.508 -1.37 . . . . 1.0 110.385 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 164.18 39.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.436 ' HG3' ' CD2' ' A' ' 41' ' ' LEU . 26.4 tt0 -123.32 95.91 44.83 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.37 -1.076 . . . . 1.0 108.515 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.72 77.23 3.76 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.693 1.365 . . . . 1.0 111.455 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD2' ' HG3' ' A' ' 39' ' ' GLN . 4.2 pp -171.76 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.198 -0.938 . . . . 1.0 110.625 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.9 m -69.86 -19.69 63.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.933 -1.104 . . . . 1.0 110.299 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.34 100.43 11.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.481 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -179.56 -59.02 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 1.0 110.375 179.78 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.9 Cg_endo -74.58 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.44 1.232 . . . . 1.0 110.445 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 30.12 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 1.0 110.16 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.8 t -129.13 155.62 45.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 1.0 110.2 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 80.98 1.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 1.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 15.5 tt -82.31 117.28 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 1.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.59 94.54 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 1.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.22 163.05 15.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 1.0 110.359 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.67 26.33 5.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 1.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.21 -96.41 2.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -21.68 2.54 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.635 -0.921 . . . . 1.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -122.05 149.58 43.33 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.022 -1.049 . . . . 1.0 110.173 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.497 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 61.6 m-70 -128.29 113.57 15.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 1.0 109.83 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.5 mm -124.08 151.26 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 1.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 21' ' ' PHE . 6.5 tp -136.11 136.86 40.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.797 . . . . 1.0 109.989 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.41 93.53 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 1.0 110.276 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 21' ' ' PHE . 7.0 mt -89.74 118.43 29.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.903 . . . . 1.0 110.242 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.7 m-70 -89.66 -167.83 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 1.0 110.289 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 43.0 t30 -15.35 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' HIS . 57.1 m -75.88 140.1 42.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.586 -0.696 . . . . 1.0 109.397 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -89.08 -177.39 5.43 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.218 -0.926 . . . . 1.0 110.455 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -1.65 14.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 1.0 111.528 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.35 -17.57 60.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.99 -1.244 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.463 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 1.5 mtt -84.73 42.07 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.281 . . . . 1.0 111.243 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -90.96 41.13 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 1.0 110.035 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.18 -139.5 5.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.99 157.95 34.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 1.0 110.509 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.11 98.54 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 1.0 109.71 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -96.76 141.1 30.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 1.0 110.76 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 35.9 t80 -121.77 143.44 49.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -0.829 . . . . 1.0 109.54 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -120.06 114.72 22.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 1.0 110.545 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.456 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -145.94 132.08 19.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 1.0 109.62 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.57 -150.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 1.0 109.765 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -90.35 45.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.973 . . . . 1.0 109.929 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.02 167.05 31.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 1.0 110.33 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.66 135.96 8.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 1.0 110.299 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.442 ' CB ' HD13 ' A' ' 8' ' ' LEU . 4.7 p -101.79 176.11 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -165.58 109.83 0.85 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.992 . . . . 1.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.08 179.88 4.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 1.0 109.816 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -114.12 107.94 16.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 1.0 110.089 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 tp -108.76 138.92 44.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 1.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -142.03 136.04 29.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 1.0 109.97 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 45.2 t -101.28 135.07 39.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.268 -0.895 . . . . 1.0 110.245 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.33 120.33 18.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -84.91 170.16 13.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 1.0 110.037 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.209 179.92 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.312 0.577 . . . . 1.0 110.262 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.45 -175.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 1.0 110.007 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 2.4 pm0 -147.83 -159.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 1.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 HG23 ' OG ' ' A' ' 80' ' ' SER . 75.1 t -116.92 107.47 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 1.0 110.306 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -74.96 -34.47 62.05 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 1.0 109.175 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -131.15 107.82 14.97 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.519 -0.738 . . . . 1.0 109.482 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.98 175.28 8.5 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.546 1.287 . . . . 1.0 110.99 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 13.7 mt -71.37 -177.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 1.0 109.771 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -122.57 -14.15 7.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.084 -1.01 . . . . 1.0 111.39 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.87 118.66 0.01 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.911 -1.275 . . . . 1.0 109.911 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.5 -176.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.782 -1.423 . . . . 1.0 110.93 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.5 173.01 10.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 1.0 109.592 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 m -149.86 -176.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.088 . . . . 1.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.39 25.22 6.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.147 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t 61.91 85.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.575 -0.703 . . . . 1.0 110.759 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.55 -25.17 3.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.191 -1.163 . . . . 1.0 110.191 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.03 -144.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -1.203 . . . . 1.0 110.269 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 29.9 m -149.82 111.56 4.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 1.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.74 165.66 22.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 1.0 109.96 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -143.3 110.16 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 1.0 110.772 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.45 125.02 53.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -0.807 . . . . 1.0 109.593 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.16 157.13 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 1.0 111.335 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 9.3 tt -166.32 129.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 1.0 109.556 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -108.63 138.2 45.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 1.0 110.681 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.4 mt -94.01 173.36 7.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 1.0 109.751 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -74.29 -61.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.0 . . . . 1.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -117.77 131.04 24.3 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.029 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.13 126.2 9.73 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.513 1.27 . . . . 1.0 110.236 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.63 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.3 t -97.34 148.19 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 1.0 110.065 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -86.53 -166.47 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.0 110.17 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.84 162.11 35.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 1.0 109.613 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.49 171.65 11.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -1.126 . . . . 1.0 109.98 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.523 ' CE3' ' CD1' ' A' ' 58' ' ' LEU . 28.8 m95 -111.87 176.37 5.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.106 -0.996 . . . . 1.0 110.589 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 5.6 ttmt -165.38 126.14 1.91 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.388 -0.82 . . . . 1.0 108.812 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.77 -131.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.0 109.112 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -51.65 -24.51 5.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.337 -1.477 . . . . 1.0 109.698 179.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.38 41.64 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.08 -1.608 . . . . 1.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -122.5 111.84 31.39 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 1.0 110.555 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.76 96.59 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.679 1.357 . . . . 1.0 109.651 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 42' ' ' THR . 3.1 pp -70.05 -153.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 1.0 110.526 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -152.72 -166.04 2.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 1.0 110.027 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.67 107.03 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 1.0 110.047 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -147.67 168.82 10.4 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 1.0 110.235 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.05 -19.11 26.89 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.543 1.286 . . . . 1.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -23.54 59.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 1.0 110.344 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.5 t -141.36 125.64 17.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 1.0 110.413 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.17 135.1 54.02 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.251 -0.905 . . . . 1.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -130.93 95.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.38 -0.825 . . . . 1.0 110.023 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.96 94.03 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 1.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -139.57 147.57 41.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 1.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -146.21 19.37 1.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 1.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.77 -23.55 30.27 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -90.07 -20.93 22.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.264 -1.139 . . . . 1.0 109.989 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.3 144.7 3.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.294 -0.879 . . . . 1.0 110.128 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 69.1 m-70 -110.94 118.85 37.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 1.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.53 128.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.34 -0.85 . . . . 1.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.523 ' CD1' ' CE3' ' A' ' 34' ' ' TRP . 4.3 tt -116.23 133.21 56.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 1.0 110.56 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 59' ' ' ILE . 41.0 mm -133.55 86.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.59 103.37 15.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 1.0 110.758 -179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.2 m-70 -69.69 -156.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 1.0 109.304 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 59.7 t-20 -14.77 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 61' ' ' HIS . 76.7 m -71.78 171.02 12.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.714 -0.616 . . . . 1.0 110.419 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 1.2 tp60 -110.07 163.57 13.46 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.361 -0.837 . . . . 1.0 108.905 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.549 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -75.39 5.08 6.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.868 -1.145 . . . . 1.0 111.739 -179.467 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.25 -20.24 28.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.447 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 12.0 mtt -55.3 -17.41 4.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 1.0 111.167 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -43.91 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 1.0 110.789 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.97 -121.35 0.63 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.92 135.5 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -1.066 . . . . 1.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.1 101.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 1.0 109.843 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -103.56 128.76 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 1.0 110.361 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -108.58 148.2 30.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.0 109.792 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 137.09 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 1.0 110.55 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.58 99.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.93 -89.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 1.0 110.38 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -119.18 32.38 6.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.968 -1.082 . . . . 1.0 110.281 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.01 133.85 55.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 1.0 110.195 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 68.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 1.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.404 ' OG ' HG23 ' A' ' 4' ' ' VAL . 46.8 m -77.94 166.9 22.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.0 109.987 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.31 104.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 1.0 110.509 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -100.35 -170.67 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.08 123.44 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 1.0 109.848 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 tp -124.66 138.26 54.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 1.0 110.699 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -140.09 130.56 25.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.404 -0.81 . . . . 1.0 109.604 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 52.9 t -99.85 118.01 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 1.0 110.366 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 3.3 ttpt -97.99 140.57 32.14 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.32 -0.862 . . . . 1.0 109.665 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.94 -156.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 1.0 109.999 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.884 -1.055 . . . . 1.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.232 0.539 . . . . 1.0 110.308 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 43.9 pt -121.16 178.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 1.0 110.198 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -108.27 -166.97 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.937 . . . . 1.0 110.271 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 78' ' ' ALA . 89.0 t -121.21 124.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 1.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.83 -31.83 31.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 1.0 110.289 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.2 113.82 6.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 1.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.77 -176.69 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.58 1.305 . . . . 1.0 110.25 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.416 ' CD1' ' O ' ' A' ' 71' ' ' VAL . 19.1 mt -73.38 -154.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 1.0 110.396 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -155.98 116.32 3.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 1.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.25 133.46 45.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.16 152.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.302 -1.116 . . . . 1.0 110.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -94.03 175.35 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 1.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.14 174.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 1.0 110.737 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.8 136.6 53.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 1.0 109.582 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 63' ' ' CYS . 6.4 p -60.07 91.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 1.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 140.66 -37.8 1.64 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.017 -1.633 . . . . 1.0 109.017 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -71.99 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 1.0 109.684 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.411 ' CG2' HG21 ' A' ' 59' ' ' ILE . 85.9 m -160.65 150.32 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 1.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.22 176.99 5.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 1.0 109.197 179.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -160.5 112.29 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.0 111.664 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 47.1 m-85 -117.48 127.25 53.82 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 178.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -115.84 151.62 34.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 1.0 111.147 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 56' ' ' HIS . 1.2 tt -164.26 139.02 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.578 -0.701 . . . . 1.0 109.546 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.46 154.04 33.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 1.0 110.355 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.77 -152.88 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 1.0 110.048 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.09 -35.02 3.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 1.0 109.65 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.07 160.96 42.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.85 134.54 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.659 1.347 . . . . 1.0 110.446 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -171.58 113.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 110.241 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.82 54.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 1.0 110.088 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -131.53 45.87 2.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 1.0 110.052 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.02 164.18 12.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.044 -1.223 . . . . 1.0 110.044 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.01 169.94 16.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -1.055 . . . . 1.0 109.851 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 42.8 m95 -122.56 138.72 54.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 1.0 110.793 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 1.3 ttmt -121.62 143.27 49.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.527 -0.733 . . . . 1.0 110.287 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.96 -93.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 1.0 109.705 179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -14.72 62.06 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.097 -1.002 . . . . 1.0 110.083 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 138.16 -10.14 3.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.978 -1.249 . . . . 1.0 109.978 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.99 159.81 28.6 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.065 -1.256 . . . . 1.0 109.605 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.25 79.17 3.02 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.751 1.395 . . . . 1.0 110.561 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pp -127.6 -15.79 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.349 -0.844 . . . . 1.0 110.891 -179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -69.45 -16.9 63.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 1.0 110.54 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.11 112.63 21.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 1.0 110.26 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.98 170.74 7.43 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.925 . . . . 1.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.38 5.1 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.621 1.327 . . . . 1.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.89 -11.78 11.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.844 -1.16 . . . . 1.0 110.904 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.1 -169.59 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 1.0 110.386 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -144.35 76.39 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.0 110.269 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -95.9 128.34 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 1.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.21 133.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 1.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -142.37 137.62 30.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.986 -1.071 . . . . 1.0 110.508 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.62 21.9 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 1.0 110.202 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.05 -64.0 2.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.749 -1.34 . . . . 1.0 109.749 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.58 31.86 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.727 -0.867 . . . . 1.0 110.795 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -153.01 115.72 4.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.41 ' HB2' HG21 ' A' ' 23' ' ' ILE . 91.8 m-70 -110.0 117.92 35.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 1.0 109.836 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 57' ' ' ILE . 41.9 mm -121.31 157.81 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 1.0 110.237 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 39.2 tp -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 1.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 HG21 ' CG2' ' A' ' 18' ' ' THR . 5.0 mt -129.02 111.57 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 1.0 109.589 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' ' HE2' ' A' ' 67' ' ' MET . 5.1 mt -110.46 103.26 11.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.049 . . . . 1.0 110.679 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 62' ' ' ASN . 80.6 m-70 -72.13 -162.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 1.0 110.374 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 39.7 t-20 -12.86 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.555 1.317 . . . . 1.0 114.555 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 73.8 m -86.08 -158.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.441 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -158.67 -173.67 4.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.798 -1.189 . . . . 1.0 110.907 179.654 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.21 -18.53 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 1.0 111.465 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.74 -130.32 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.783 -1.727 . . . . 1.0 108.783 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 1.3 mtt 39.42 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.981 -0.717 . . . . 1.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 m -91.17 37.64 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.068 -1.02 . . . . 1.0 110.176 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.21 -122.46 3.57 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.491 -1.444 . . . . 1.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -150.09 162.94 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -1.113 . . . . 1.0 110.555 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' A' ' 21' ' ' PHE . 70.1 t -104.69 87.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 1.0 109.808 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 p -92.45 107.97 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.938 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -79.14 158.77 27.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.685 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.52 109.96 3.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 1.0 110.61 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.38 -146.09 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 1.0 109.625 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.12 43.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -0.991 . . . . 1.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 2' ' ' ILE . 49.3 t30 -163.11 30.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 1.0 110.004 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -113.03 74.27 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 1.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -86.59 86.1 7.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.864 . . . . 1.0 110.431 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -81.73 -179.22 7.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -0.945 . . . . 1.0 110.117 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.49 89.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 1.0 110.383 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.36 -177.52 3.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 1.0 110.123 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -110.49 138.76 46.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.69 130.35 36.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 1.0 110.32 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -143.75 147.26 33.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 1.0 109.687 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 25.4 t -105.82 158.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.059 -1.026 . . . . 1.0 110.736 -179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -130.69 146.11 52.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 1.0 109.664 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -81.98 -160.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.0 110.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.961 -1.018 . . . . 1.0 110.269 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.14 153.95 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 1.0 109.721 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -128.9 -3.8 5.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 1.0 111.048 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t 53.14 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 1.0 110.183 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -85.52 -26.58 26.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.316 -0.865 . . . . 1.0 109.995 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 105.33 40.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 1.0 110.079 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.84 178.55 5.7 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.604 1.318 . . . . 1.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 14.2 mt -73.77 -157.81 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 1.0 110.156 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -155.9 134.22 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 1.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.65 140.87 26.7 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.671 -1.372 . . . . 1.0 109.671 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.7 152.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 1.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -96.13 169.19 10.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 1.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 17' ' ' GLU . 11.6 p -159.35 146.16 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 1.0 110.299 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -88.35 125.87 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 1.0 109.725 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 63' ' ' CYS . 6.4 p -46.84 93.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.413 -0.805 . . . . 1.0 111.712 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 155.64 -36.4 0.63 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.055 -1.218 . . . . 1.0 110.055 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' CG ' HG21 ' A' ' 13' ' ' VAL . 3.6 pt-20 -85.73 -148.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.826 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.475 HG22 ' CE1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -136.75 137.24 39.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 1.0 110.472 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -85.36 -176.5 6.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 1.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.481 ' CD2' HG12 ' A' ' 59' ' ' ILE . 8.0 m80 -160.7 108.5 1.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.954 -1.091 . . . . 1.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 91.6 m-85 -114.81 120.87 41.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.789 . . . . 1.0 109.369 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -109.8 155.18 21.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 1.0 110.925 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.4 tt -161.37 119.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.767 . . . . 1.0 109.833 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -101.08 131.88 46.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 1.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.446 ' CD1' ' NE2' ' A' ' 56' ' ' HIS . 22.0 mt -87.63 179.56 6.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.86 . . . . 1.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.7 p -85.26 -22.05 28.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.0 109.98 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -121.45 135.83 25.39 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 1.0 109.978 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.52 -178.32 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.537 1.283 . . . . 1.0 110.459 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.68 67.48 0.98 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 1.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.52 159.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 1.0 110.307 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.2 148.35 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 1.0 109.963 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.76 -134.02 2.34 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -167.54 140.44 3.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -1.117 . . . . 1.0 110.18 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 58' ' ' LEU . 33.9 m95 -102.93 170.73 7.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 1.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -173.62 170.29 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.486 -0.759 . . . . 1.0 109.942 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.25 -131.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 1.0 109.469 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.6 -25.03 2.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.7 -1.25 . . . . 1.0 110.399 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.64 40.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -128.48 107.63 19.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.199 -1.177 . . . . 1.0 110.046 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.08 112.36 3.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.487 1.256 . . . . 1.0 110.637 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pp -106.7 -146.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 1.0 109.89 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.66 128.12 36.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.05 -1.031 . . . . 1.0 110.39 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.28 111.32 1.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.873 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -177.3 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.386 -0.821 . . . . 1.0 110.244 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -72.19 -74.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.441 1.232 . . . . 1.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD2' ' CE ' ' A' ' 67' ' ' MET . 27.9 t70 -133.19 58.63 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 1.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 t -162.71 142.3 9.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.905 . . . . 1.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -144.5 87.98 1.9 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.284 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.0 mt -87.81 131.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.132 -0.98 . . . . 1.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 tt -134.95 146.36 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 1.0 110.318 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.0 146.7 19.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 110.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.68 9.01 11.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.739 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.49 -21.24 30.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.474 -1.051 . . . . 1.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 -23.22 20.6 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.172 -1.193 . . . . 1.0 109.718 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 56' ' ' HIS . 38.8 tttt -164.56 163.49 21.89 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.423 -0.798 . . . . 1.0 109.498 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.446 ' NE2' ' CD1' ' A' ' 25' ' ' LEU . 51.6 m-70 -113.19 121.63 45.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 1.0 110.04 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.19 141.62 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 1.0 110.345 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 34' ' ' TRP . 21.6 tp -115.57 148.93 39.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.345 -0.847 . . . . 1.0 110.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG12 ' CD2' ' A' ' 20' ' ' HIS . 58.4 mt -146.01 116.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 1.0 109.719 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' CD1' HD22 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -117.44 107.27 14.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 1.0 110.587 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CE1' HG22 ' A' ' 18' ' ' THR . 67.5 m-70 -69.7 -172.14 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 1.0 110.328 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.8 p-10 -13.94 80.85 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.025 1.12 . . . . 1.0 114.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 80.7 m -74.42 148.07 41.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.25 171.0 9.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 1.0 111.541 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -23.93 2.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.715 -0.615 . . . . 1.0 110.748 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.32 -123.87 0.06 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.98 -1.648 . . . . 1.0 108.98 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.441 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 1.7 mtt 43.53 28.02 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.895 . . . . 1.0 111.287 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.51 52.52 2.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.297 -0.877 . . . . 1.0 110.365 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.75 -141.84 5.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.416 -1.474 . . . . 1.0 109.416 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -130.99 143.33 50.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -1.154 . . . . 1.0 110.258 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.7 t -79.71 99.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 1.0 109.856 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -103.11 128.02 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 1.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 64.4 t80 -104.63 154.82 19.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 109.707 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.61 146.85 51.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 1.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.21 -142.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 1.0 110.04 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.94 -70.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.274 -0.891 . . . . 1.0 110.702 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -146.42 21.21 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 1.0 110.106 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -111.8 167.1 10.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 1.0 110.157 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.61 115.79 2.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.939 . . . . 1.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 66.9 p -96.96 177.84 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.286 -0.884 . . . . 1.0 109.696 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.29 97.15 0.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.033 -1.042 . . . . 1.0 110.696 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -97.09 -175.98 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 1.0 109.691 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -100.14 138.33 37.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.047 . . . . 1.0 110.242 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -131.6 120.74 23.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 1.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -134.35 136.63 43.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 1.0 110.101 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 59.5 t -94.57 148.15 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.251 -0.906 . . . . 1.0 110.052 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' N ' HG11 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -122.46 141.53 51.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 1.0 110.192 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -105.06 -157.84 0.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 tp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.261 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.321 0.581 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 27' ' ' GLU . 5.1 tt -106.41 157.87 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 1.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.77 -148.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 1.0 110.041 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.11 129.89 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.64 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 -57.61 3.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.954 . . . . 1.0 109.652 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.09 100.68 15.79 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.661 -0.65 . . . . 1.0 110.345 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.92 -179.33 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.649 1.341 . . . . 1.0 110.441 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' CB ' ' CB ' ' A' ' 82' ' ' ALA . 22.6 mt -76.71 159.34 30.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.055 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -125.96 15.92 7.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.105 -0.997 . . . . 1.0 110.731 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.32 157.69 0.15 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 21' ' ' PHE . 10.2 p -160.07 170.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.523 -0.986 . . . . 1.0 109.714 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.56 166.08 14.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 1.0 110.531 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.18 147.7 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.422 -0.799 . . . . 1.0 110.496 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -97.04 27.73 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 1.0 109.4 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.419 ' CG2' ' CG1' ' A' ' 86' ' ' VAL . 75.4 t 57.39 87.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.55 0.691 . . . . 1.0 110.721 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.48 -30.2 2.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.35 -138.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.304 -1.115 . . . . 1.0 109.386 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.417 ' CG2' ' ND1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -149.64 132.21 15.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 1.0 110.232 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.451 ' O ' ' CD2' ' A' ' 20' ' ' HIS . . . -85.26 165.22 17.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.827 . . . . 1.0 110.037 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 34.4 m170 -144.14 80.52 1.65 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 1.0 110.764 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.483 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 67.3 m-85 -79.77 152.99 29.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 1.0 109.442 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -136.24 158.86 43.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 1.0 110.941 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.428 HG23 ' CZ2' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -168.06 127.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.503 -0.748 . . . . 1.0 109.765 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.37 150.12 24.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -0.925 . . . . 1.0 110.55 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.18 1.1 3.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 1.0 111.569 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 2' ' ' ILE . 6.3 p 41.16 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.6 -0.688 . . . . 1.0 111.721 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' HG3' ' CG2' ' A' ' 2' ' ' ILE . 1.4 mm-40 -136.44 119.74 12.21 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.9 -1.125 . . . . 1.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.75 161.11 44.71 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.501 1.264 . . . . 1.0 110.122 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.78 86.77 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.205 -0.935 . . . . 1.0 110.328 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -168.37 144.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 1.0 109.902 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.42 -175.95 3.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 1.0 110.608 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.0 -164.8 35.03 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -157.32 158.22 35.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -1.144 . . . . 1.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 22.5 m95 -115.49 166.55 11.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.0 110.451 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -162.19 142.8 10.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 1.0 109.758 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 mt -64.16 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 1.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -49.47 -25.46 2.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.635 -1.291 . . . . 1.0 110.056 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 160.79 40.2 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.484 -1.446 . . . . 1.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 7.4 mm-40 -118.8 121.58 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 1.0 110.174 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.73 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.449 1.236 . . . . 1.0 110.744 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -173.99 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 1.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -150.93 -178.06 6.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 1.0 110.274 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.19 106.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 1.0 110.255 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 164.37 24.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 1.0 110.167 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.48 -17.52 30.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.656 1.345 . . . . 1.0 110.613 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -83.45 -26.16 30.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 1.0 110.125 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -118.76 119.79 35.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.0 110.074 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.13 88.84 2.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.966 . . . . 1.0 110.409 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.97 106.96 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 1.0 109.867 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.2 tp -131.28 118.33 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 1.0 110.191 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.37 169.25 21.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 1.0 110.133 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -117.08 -134.51 0.34 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.281 -0.887 . . . . 1.0 109.126 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.68 -19.81 4.8 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.679 -1.248 . . . . 1.0 110.096 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -21.81 22.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 1.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -153.79 173.12 16.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.184 -0.947 . . . . 1.0 110.545 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -133.25 127.62 34.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.352 -0.842 . . . . 1.0 109.787 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.87 135.79 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 1.0 110.715 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -112.89 147.96 35.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.495 -0.753 . . . . 1.0 110.144 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 59' ' ' ILE . 87.8 mt -138.73 82.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0 109.882 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.2 161.71 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 1.0 110.467 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.5 m-70 -126.89 -169.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.486 -0.759 . . . . 1.0 109.503 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.495 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 42.2 p30 -13.64 80.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 61' ' ' HIS . 80.5 m -78.98 175.12 10.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 1.0 109.501 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 86' ' ' VAL . 1.2 mt-30 -138.58 -163.89 1.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.047 -1.033 . . . . 1.0 110.567 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.32 8.56 4.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 1.0 111.476 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.93 -22.91 19.23 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.064 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.469 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 37.7 mtt -86.69 34.93 0.66 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.067 -1.255 . . . . 1.0 110.799 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 34.9 0.93 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 1.0 110.134 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.35 -124.83 4.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.57 147.17 46.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -1.121 . . . . 1.0 110.393 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 70.7 t -89.05 107.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.316 -0.865 . . . . 1.0 109.884 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 p -108.03 110.6 22.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 1.0 110.663 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 22.7 t80 -91.03 146.87 23.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 1.0 109.823 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -131.54 104.55 7.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.037 -1.04 . . . . 1.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -123.62 124.94 43.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 1.0 109.763 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.84 -90.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 1.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 6.2 p30 -129.66 -38.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.807 -1.183 . . . . 1.0 110.378 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.09 159.76 16.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 1.0 110.516 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -156.63 126.92 6.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 1.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 8' ' ' LEU . 75.5 p -92.52 -179.14 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.32 88.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.432 ' CB ' ' CB ' ' A' ' 8' ' ' LEU . . . -91.67 -170.18 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 1.0 110.307 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -119.91 111.59 18.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 1.0 110.363 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.0 tp -102.15 145.43 29.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 1.0 110.087 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.64 107.92 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.299 -0.875 . . . . 1.0 110.207 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 46.3 t -80.9 147.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.118 -0.989 . . . . 1.0 110.405 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -115.45 168.37 10.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 110.165 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -101.95 155.46 18.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.241 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.205 0.526 . . . . 1.0 110.176 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.14 140.94 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.34 156.63 17.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 1.0 109.971 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.78 167.28 2.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.116 -0.99 . . . . 1.0 110.018 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -123.69 -30.72 3.55 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.482 0.658 . . . . 1.0 110.033 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -146.96 122.39 5.37 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 1.0 110.029 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.55 -176.49 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.535 1.282 . . . . 1.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 18.3 mt -82.46 -164.62 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.21 -0.931 . . . . 1.0 110.777 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.13 139.78 26.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.404 -0.81 . . . . 1.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.6 150.29 34.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.429 -1.468 . . . . 1.0 109.429 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -158.56 169.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 1.0 110.332 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -122.29 165.05 16.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 1.0 110.499 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.94 127.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.238 -0.914 . . . . 1.0 110.104 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.55 47.57 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.217 -0.927 . . . . 1.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t 48.77 71.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.683 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.65 -22.52 1.04 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -78.99 -122.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -1.157 . . . . 1.0 109.232 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -161.17 157.85 26.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.705 -1.247 . . . . 1.0 110.492 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . . . -108.64 172.52 6.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.393 -0.817 . . . . 1.0 108.883 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.471 ' CE1' HD13 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -157.72 122.87 4.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.112 . . . . 1.0 111.249 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 73.6 m-85 -140.32 132.82 28.61 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.16 155.5 41.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.937 -1.102 . . . . 1.0 111.155 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -167.8 122.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.607 -0.683 . . . . 1.0 109.752 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.24 130.35 54.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 1.0 110.491 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 55.6 mt -91.33 -174.2 3.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.822 . . . . 1.0 109.871 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -99.03 -57.37 2.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.0 109.963 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.99 144.01 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 1.0 109.852 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 -169.5 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.628 1.331 . . . . 1.0 110.567 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t0 55.26 80.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 1.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.4 t -131.28 154.09 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 1.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -124.53 43.53 2.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.92 . . . . 1.0 110.452 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.74 171.36 55.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 12.4 tm0? -145.07 165.26 28.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -1.112 . . . . 1.0 109.902 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 34.2 m95 -108.52 163.84 12.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 1.0 110.819 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -159.59 157.11 29.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.413 -0.804 . . . . 1.0 110.102 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.31 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 1.0 109.805 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -47.34 -25.92 1.13 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.856 -1.152 . . . . 1.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 150.64 39.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -136.41 136.47 22.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 O-C-N 121.126 -1.22 . . . . 1.0 109.132 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.42 114.48 3.94 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.468 1.246 . . . . 1.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.77 -139.58 0.2 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 1.0 109.926 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 p -138.69 136.85 36.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.119 . . . . 1.0 110.013 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.79 98.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 1.0 110.088 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -88.69 169.12 14.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 1.0 110.184 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.06 -16.72 28.71 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.731 1.385 . . . . 1.0 110.513 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -98.37 -21.27 16.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 1.0 110.376 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.27 136.32 33.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 1.0 110.181 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.63 136.42 54.49 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 1.0 109.626 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.7 mt -139.39 76.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 1.0 109.761 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.4 144.32 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 1.0 110.038 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.76 137.53 8.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 1.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 26.6 8.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 1.0 109.872 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 -92.39 1.77 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -15.79 30.55 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.631 -0.923 . . . . 1.0 110.547 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -121.63 130.72 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 1.0 110.588 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.461 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 29.3 m-70 -118.16 131.13 56.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.0 110.085 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.97 136.42 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 1.0 110.226 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 59' ' ' ILE . 16.2 tp -125.17 139.96 53.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 1.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.471 HD13 ' CE1' ' A' ' 20' ' ' HIS . 33.9 mm -140.61 115.43 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 1.0 109.331 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 19' ' ' ALA . 9.0 mt -112.82 108.46 17.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 1.0 110.846 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 25.0 m-70 -75.44 -159.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 1.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 54.0 t30 -14.13 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' HIS . 91.7 m -86.29 -176.27 5.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.6 -0.688 . . . . 1.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.444 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -149.96 -164.22 1.97 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 1.0 110.202 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.58 13.43 0.62 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.071 . . . . 1.0 112.404 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.36 -30.97 10.04 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.448 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 36.9 mtt -86.72 39.23 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -1.121 . . . . 1.0 110.565 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -90.69 79.77 6.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.181 -0.949 . . . . 1.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.64 -120.76 0.59 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.63 140.1 31.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 1.0 110.415 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.69 102.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 1.0 109.853 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 p -102.83 128.69 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 1.0 110.365 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 53.9 t80 -105.57 142.04 36.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.0 109.622 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 127.64 32.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.038 . . . . 1.0 110.647 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.49 -147.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 1.0 109.746 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.43 -73.53 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.932 -1.105 . . . . 1.0 110.081 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -130.12 -1.21 4.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 1.0 110.794 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.22 156.11 23.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.927 -1.108 . . . . 1.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.07 125.88 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.927 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.419 ' CB ' HD13 ' A' ' 8' ' ' LEU . 2.6 p -126.17 178.34 5.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 1.0 109.729 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.55 106.69 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 1.0 110.592 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 8' ' ' LEU . . . -100.01 -170.44 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 1.0 109.716 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.14 109.18 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.025 . . . . 1.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 tp -108.01 147.01 31.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 1.0 110.036 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 105.09 3.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 110.136 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 38.3 t -80.5 133.35 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.186 -0.946 . . . . 1.0 110.149 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -98.44 146.26 25.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.06 149.05 48.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 1.0 110.168 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.235 -179.819 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.179 0.514 . . . . 1.0 110.157 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 1.2 pt -110.15 133.03 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 1.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.6 162.82 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 1.0 110.271 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 1.3 p -74.59 124.98 33.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.236 -0.915 . . . . 1.0 110.002 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.21 -34.6 23.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.736 0.779 . . . . 1.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -126.17 109.36 24.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.76 -0.587 . . . . 1.0 110.137 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.0 174.81 10.7 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.578 1.304 . . . . 1.0 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 10.1 mt -87.01 -174.08 4.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0 109.535 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.7 m-85 -145.34 131.4 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 1.0 110.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.35 152.55 14.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 21' ' ' PHE . 7.7 p -158.78 142.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -1.074 . . . . 1.0 110.39 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.31 155.0 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 1.0 109.599 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.07 170.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.025 -1.047 . . . . 1.0 110.931 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -102.13 135.6 43.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.46 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.909 -1.119 . . . . 1.0 111.048 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 147.15 -41.97 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -161.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -1.068 . . . . 1.0 110.107 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.415 HG23 ' ND1' ' A' ' 61' ' ' HIS . 4.8 p -120.98 163.57 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 1.0 110.851 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.65 172.56 7.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.529 -0.732 . . . . 1.0 109.268 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.476 ' CD2' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -155.41 124.43 6.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 1.0 111.178 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 11' ' ' VAL . 60.4 m-85 -134.36 118.44 17.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.523 -0.736 . . . . 1.0 109.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.51 157.11 17.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.052 -1.03 . . . . 1.0 111.034 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.481 HG23 ' CZ2' ' A' ' 34' ' ' TRP . 5.6 tt -168.43 120.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 1.0 109.801 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.69 148.6 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 1.0 110.274 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD13 ' CD2' ' A' ' 56' ' ' HIS . 28.3 mt -103.84 -154.36 0.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 1.0 109.767 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 31.1 t -116.44 -76.05 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 1.0 109.931 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.66 137.42 20.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.0 109.789 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.31 136.76 27.17 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.578 1.304 . . . . 1.0 110.53 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -164.01 -61.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 110.091 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.82 148.38 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 1.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -75.61 -164.02 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.29 179.38 25.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -131.53 149.35 52.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -1.18 . . . . 1.0 109.944 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.514 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 26.8 m95 -104.91 154.21 20.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 1.0 110.776 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 6.9 pttt -147.66 162.28 39.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 1.0 109.514 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.99 -84.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 1.0 110.115 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 21.16 5.78 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.513 -0.742 . . . . 1.0 110.053 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 107.85 -14.7 37.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 1.0 109.633 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -82.94 134.76 46.07 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.175 -1.191 . . . . 1.0 110.044 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.92 114.25 3.99 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.695 1.366 . . . . 1.0 110.615 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.12 -141.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.836 . . . . 1.0 109.461 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.0 t -158.92 163.45 36.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.742 -1.224 . . . . 1.0 110.252 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.91 106.5 0.31 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 m -116.59 159.44 40.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 1.0 110.17 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -4.8 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.672 1.354 . . . . 1.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.19 -22.76 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.983 -1.073 . . . . 1.0 110.28 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -101.76 122.81 44.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 1.0 110.377 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.49 144.54 44.2 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.147 -0.971 . . . . 1.0 109.233 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.44 85.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 1.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -87.38 120.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 1.0 109.911 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 19.6 pt-20 -146.02 147.52 31.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 1.0 110.505 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.56 23.44 5.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.732 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -74.58 2.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -18.12 24.1 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.736 -0.861 . . . . 1.0 110.823 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.66 43.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.034 -1.041 . . . . 1.0 110.816 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.467 ' CD2' HD13 ' A' ' 25' ' ' LEU . 67.5 m-70 -143.06 103.35 4.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 1.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.87 136.83 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 1.0 110.502 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.438 HD23 ' CE3' ' A' ' 34' ' ' TRP . 34.3 tp -117.35 130.72 56.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.311 -0.868 . . . . 1.0 110.387 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.476 HG12 ' CD2' ' A' ' 20' ' ' HIS . 21.1 mt -132.18 100.81 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 1.0 109.636 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.72 116.16 31.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 1.0 110.922 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 62' ' ' ASN . 43.9 m-70 -77.59 -166.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 1.0 109.945 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 61' ' ' HIS . 54.0 t30 -15.45 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 61.4 m -73.71 143.92 45.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.503 -0.748 . . . . 1.0 109.496 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.13 173.51 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.0 110.825 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -9.52 46.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.774 . . . . 1.0 110.904 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.14 -10.61 82.35 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.944 -1.122 . . . . 1.0 110.342 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.461 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 6.2 mtt -84.37 38.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.888 -1.36 . . . . 1.0 111.458 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -91.43 40.0 1.02 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.019 -1.051 . . . . 1.0 109.918 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.33 -128.31 4.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -135.13 -170.66 2.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -1.083 . . . . 1.0 110.468 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.61 78.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 p -86.78 125.21 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 1.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.23 143.83 32.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 1.0 110.124 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -133.72 127.12 32.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 1.0 110.125 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -159.78 118.58 2.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.0 110.5 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.62 -89.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 1.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 75' ' ' ALA . 41.6 t30 -128.03 -35.77 2.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.893 -1.129 . . . . 1.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 150.32 11.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 1.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 125.96 6.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 1.0 110.24 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 m -125.5 174.51 8.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 1.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.4 94.21 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 1.0 110.193 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -90.84 -172.88 3.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 1.0 110.29 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -123.26 139.23 54.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.72 127.42 17.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 1.0 110.386 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -134.7 132.95 39.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 1.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 35.2 t -91.66 126.07 44.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.268 -0.895 . . . . 1.0 110.19 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 160.36 14.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 1.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.32 -176.74 3.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.0 110.177 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.993 -1.004 . . . . 1.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.459 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.338 0.59 . . . . 1.0 110.111 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' A' ' 2' ' ' ILE . 6.9 tt -170.25 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 1.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.27 179.54 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 1.0 111.044 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.2 t 48.56 85.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.439 0.638 . . . . 1.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.4 -29.26 13.23 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -129.46 114.85 18.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.73 165.88 21.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.443 1.233 . . . . 1.0 111.586 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 3.9 mt -65.53 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.752 -0.592 . . . . 1.0 110.721 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 10' ' ' GLY . 86.0 t80 -144.74 159.92 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 1.0 109.994 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 9' ' ' TYR . . . -95.48 141.66 15.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.511 -1.435 . . . . 1.0 109.511 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.88 166.46 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -1.222 . . . . 1.0 110.408 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -122.02 166.13 14.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.0 110.299 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 86' ' ' VAL . 15.8 m -152.65 157.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.171 -0.956 . . . . 1.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.42 33.73 5.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.497 -0.752 . . . . 1.0 109.011 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t 61.75 73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.701 0.762 . . . . 1.0 109.895 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 152.54 -23.11 0.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.24 164.96 22.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -1.119 . . . . 1.0 110.096 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.5 m -112.26 105.95 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.289 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -79.54 171.46 15.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 1.0 109.839 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 59' ' ' ILE . 13.1 m80 -144.99 120.5 10.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.0 110.734 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD1' HD22 ' A' ' 58' ' ' LEU . 77.0 m-85 -114.11 111.43 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.843 . . . . 1.0 109.365 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.92 165.66 11.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.148 -0.97 . . . . 1.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -170.04 119.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 1.0 109.802 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.34 124.49 43.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 1.0 110.206 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 26.0 mt -86.94 -150.64 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.195 -0.941 . . . . 1.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.67 -47.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.972 . . . . 1.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.73 150.19 37.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 1.0 110.608 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.11 -165.66 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.597 1.314 . . . . 1.0 110.335 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 t70 49.92 81.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.276 -0.89 . . . . 1.0 110.544 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.7 t -138.87 148.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 1.0 110.154 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -140.63 40.74 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 1.0 110.331 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.45 -150.3 0.04 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -166.31 -179.8 5.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -1.095 . . . . 1.0 109.674 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.402 ' CZ3' HD21 ' A' ' 58' ' ' LEU . 57.9 m95 -117.65 131.06 56.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.982 -1.074 . . . . 1.0 110.628 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 2.7 ttpt -124.03 133.82 53.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.505 -0.747 . . . . 1.0 109.978 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.46 -130.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 1.0 109.815 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -28.84 3.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.592 -1.317 . . . . 1.0 110.708 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 154.47 39.46 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.961 -1.255 . . . . 1.0 109.961 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 1.1 pt20 -150.39 150.42 28.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.106 -1.232 . . . . 1.0 110.014 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.45 113.35 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.601 1.316 . . . . 1.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.34 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.46 -0.775 . . . . 1.0 109.877 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.41 14.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 1.0 112.119 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -162.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.709 -1.245 . . . . 1.0 109.817 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.73 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.22 -0.925 . . . . 1.0 110.384 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.19 -42.87 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.525 1.276 . . . . 1.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -23.83 51.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 1.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.84 121.77 42.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 110.308 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.1 144.13 39.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 1.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -134.04 119.26 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 1.0 109.825 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 tp -130.07 109.26 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.283 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.08 147.65 50.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 1.0 110.397 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.02 20.98 17.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 1.0 110.185 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 -90.5 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -59.39 -16.0 20.26 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.662 -0.905 . . . . 1.0 110.836 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -125.28 168.12 13.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 94.8 m-70 -149.99 126.87 11.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -124.08 142.2 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 1.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.473 HD22 ' CD1' ' A' ' 21' ' ' PHE . 24.6 tp -118.48 145.44 45.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.104 -0.997 . . . . 1.0 110.409 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 20' ' ' HIS . 56.6 mt -141.2 92.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 1.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.47 115.21 28.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.0 110.621 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 62' ' ' ASN . 31.6 m-70 -83.04 -165.04 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 1.0 109.702 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 50.2 t30 -16.57 82.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.762 1.023 . . . . 1.0 113.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' HIS . 71.9 m -69.95 -175.54 0.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.429 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 2.9 mt-30 -138.31 -168.23 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 1.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mp -84.81 69.1 10.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 1.0 110.264 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.84 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.19 -15.32 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -1.168 . . . . 1.0 111.622 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -43.57 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.417 -0.802 . . . . 1.0 110.929 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 174.11 -127.35 1.31 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -139.82 146.4 39.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 1.0 110.456 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.6 t -94.39 87.66 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.343 -0.848 . . . . 1.0 109.957 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -87.91 110.11 20.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 1.0 110.426 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -71.48 154.2 41.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 1.0 110.072 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 139.46 52.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 1.0 110.1 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -160.72 -148.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 1.0 109.744 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -77.5 126.95 31.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 1.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 18.1 p30 34.05 31.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 76' ' ' ALA . . . -152.26 158.32 42.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 1.0 110.791 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 115.07 2.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 1.0 110.003 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 m -72.62 -172.75 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 1.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.44 97.43 0.25 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 1.0 110.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -100.46 -164.53 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 1.0 110.406 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -132.13 137.43 47.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 1.0 109.598 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 21' ' ' PHE . 65.0 tp -154.35 143.29 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 1.0 110.531 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -145.17 127.65 16.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.431 -0.793 . . . . 1.0 110.082 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 16.9 t -92.54 142.64 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.366 -0.834 . . . . 1.0 109.732 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 130.05 22.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.999 . . . . 1.0 110.492 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.34 174.08 8.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 1.0 109.99 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 pt -100.64 161.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 1.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.82 -162.17 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.39 120.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 1.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -93.59 -44.98 7.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.249 -0.907 . . . . 1.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.9 tttt -108.87 109.34 61.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 1.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.1 173.8 13.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.434 1.229 . . . . 1.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD13 ' CB ' ' A' ' 80' ' ' SER . 42.3 mt -75.34 169.38 18.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 1.0 110.162 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -137.06 153.02 50.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 1.0 110.177 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.33 136.53 20.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.056 -1.217 . . . . 1.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.4 t -136.86 154.85 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -1.111 . . . . 1.0 110.03 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -107.73 155.2 20.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.184 -0.947 . . . . 1.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.1 134.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 1.0 110.083 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.21 39.85 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.24 -0.912 . . . . 1.0 110.378 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t 52.09 88.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 1.0 110.306 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.31 -29.38 2.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.349 -1.5 . . . . 1.0 109.349 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.92 -124.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.182 . . . . 1.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -160.27 114.48 2.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.698 -1.251 . . . . 1.0 111.002 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.77 148.19 31.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.938 . . . . 1.0 108.808 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -128.33 128.92 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.169 . . . . 1.0 111.469 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -134.1 112.12 10.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.549 -0.719 . . . . 1.0 109.404 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.51 165.8 11.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 1.0 111.066 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -170.45 137.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.4 164.55 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.978 . . . . 1.0 110.97 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.487 HD12 ' CD2' ' A' ' 56' ' ' HIS . 71.3 mt -124.3 -148.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 1.0 109.81 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.49 -67.74 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 1.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -97.26 155.55 37.26 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 1.0 110.171 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.25 -167.41 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.707 1.372 . . . . 1.0 110.515 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 53.55 67.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.848 . . . . 1.0 110.432 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.79 170.51 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 1.0 110.349 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -143.43 165.95 26.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.1 -171.7 36.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.18 156.83 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -1.088 . . . . 1.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD2' HD13 ' A' ' 58' ' ' LEU . 45.4 m95 -108.8 139.12 44.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 1.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 39' ' ' GLN . 2.9 ttpt -132.99 125.19 29.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.532 -0.73 . . . . 1.0 109.215 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 HD23 ' HG2' ' A' ' 67' ' ' MET . 1.1 mp -64.45 -132.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.135 -0.978 . . . . 1.0 109.596 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -26.08 3.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.644 -1.285 . . . . 1.0 109.572 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.81 38.71 0.02 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.781 -1.328 . . . . 1.0 109.781 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 1.3 mm-40 -131.25 104.01 15.09 Favored Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.141 -1.211 . . . . 1.0 109.997 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.73 101.74 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.673 1.354 . . . . 1.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 42' ' ' THR . 2.1 pp -84.71 -151.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 1.0 110.466 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.469 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 14.9 p -135.0 133.91 39.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 1.0 110.087 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.31 113.7 24.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 1.0 110.274 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -176.69 -60.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 1.0 110.399 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.3 Cg_endo -72.05 -57.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.348 1.183 . . . . 1.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -133.8 69.28 1.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.0 110.565 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -157.2 134.78 10.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 1.0 110.029 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 86.65 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.0 110.338 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -105.11 98.21 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 1.0 110.158 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 50' ' ' ILE . 50.7 mm -97.23 112.2 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.0 110.088 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -130.61 157.81 41.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 1.0 110.531 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.65 27.16 9.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 1.0 109.762 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.42 -87.72 1.41 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -55.88 -19.83 13.37 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.677 -0.896 . . . . 1.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 155.38 33.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 1.0 110.749 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.487 ' CD2' HD12 ' A' ' 25' ' ' LEU . 87.0 m-70 -138.65 102.77 4.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 1.0 109.845 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -109.33 137.22 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 1.0 110.535 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 34' ' ' TRP . 3.2 tt -114.35 133.05 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 1.0 110.224 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 58' ' ' LEU . 22.7 mt -136.22 80.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.377 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.94 125.4 35.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 1.0 110.524 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.3 m-70 -83.33 -160.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 1.0 109.716 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 61' ' ' HIS . 37.5 t30 -14.56 82.12 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' HIS . 68.0 m -75.46 -178.27 3.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.506 -0.746 . . . . 1.0 109.954 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 5.4 tp-100 -117.08 169.66 9.26 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.168 -0.958 . . . . 1.0 109.143 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.467 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.2 mp -72.79 4.22 4.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.822 -1.174 . . . . 1.0 112.139 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.7 -27.11 15.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.464 ' HG2' HD23 ' A' ' 36' ' ' LEU . 4.3 mtt -50.55 -23.21 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -1.043 . . . . 1.0 111.016 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 p -48.52 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.163 -0.961 . . . . 1.0 110.503 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.31 -126.4 0.97 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.072 -1.611 . . . . 1.0 109.072 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -135.35 136.14 41.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.137 . . . . 1.0 110.175 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.427 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 52.3 t -91.45 87.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 1.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -91.85 111.64 23.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 1.0 110.863 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 19.6 t80 -86.78 133.53 33.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 1.0 109.375 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -110.55 70.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.986 . . . . 1.0 110.755 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -94.38 112.32 24.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 1.0 109.784 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.4 -159.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 1.0 109.988 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 26.1 p30 -62.65 -16.89 59.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 1.0 110.455 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' N ' ' OD1' ' A' ' 77' ' ' ASN . . . -69.84 158.58 35.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 1.0 110.217 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -159.69 116.77 2.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.137 -0.977 . . . . 1.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.439 ' CB ' HD13 ' A' ' 8' ' ' LEU . 4.6 p -105.34 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 1.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.55 101.73 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 1.0 110.556 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' CB ' ' CB ' ' A' ' 8' ' ' LEU . . . -100.23 -164.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 1.0 110.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.38 147.28 52.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 1.0 109.944 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.11 145.5 31.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 1.0 110.515 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 9.2 ptpt -138.2 105.86 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 1.0 109.71 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 99.2 t -89.49 117.71 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.245 -0.91 . . . . 1.0 110.501 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -116.78 146.63 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 1.0 110.203 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -64.69 -171.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 1.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.314 0.578 . . . . 1.0 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 tt -144.39 162.6 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.927 . . . . 1.0 110.109 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.59 166.95 21.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.0 110.006 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -80.04 -165.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.087 -1.008 . . . . 1.0 109.691 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -127.74 -54.26 1.32 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 1.0 110.113 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -126.57 112.36 22.93 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.593 -0.692 . . . . 1.0 110.095 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.92 178.11 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.645 1.34 . . . . 1.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 10.1 mt -75.4 173.89 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 1.0 110.168 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.9 m-85 -134.67 12.53 3.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.142 -0.974 . . . . 1.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.09 150.32 1.84 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.879 -1.288 . . . . 1.0 109.879 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 77.3 t -145.35 161.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -1.11 . . . . 1.0 110.022 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -125.88 149.72 48.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.0 110.387 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.6 135.01 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 1.0 109.915 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.47 58.62 3.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.281 -0.887 . . . . 1.0 110.788 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t 46.08 81.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 1.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 139.57 -31.63 2.3 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.746 -1.742 . . . . 1.0 108.746 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -66.17 -158.36 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.494 -1.004 . . . . 1.0 109.502 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -142.74 108.87 5.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 1.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.05 132.72 36.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 1.0 109.505 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.9 110.09 18.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 1.0 111.107 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -101.25 134.71 43.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 1.0 109.324 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -130.08 162.79 27.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.934 -1.104 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 80' ' ' SER . 1.1 tt -170.77 125.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.0 109.806 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.73 145.2 25.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 1.0 110.225 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -111.23 155.14 23.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 1.0 109.996 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.54 -58.0 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -88.29 141.38 30.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 1.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.03 104.56 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.653 1.344 . . . . 1.0 110.153 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -119.85 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.112 -0.992 . . . . 1.0 109.201 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -176.61 43.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 1.0 110.027 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -152.57 143.63 23.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 1.0 110.27 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.0 146.36 5.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 1.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -129.71 146.72 51.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -1.183 . . . . 1.0 110.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 27.9 m95 -112.5 173.22 6.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.967 . . . . 1.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 3.3 ptpt -171.2 152.55 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.521 -0.737 . . . . 1.0 109.596 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 67' ' ' MET . 3.5 mt -66.35 -94.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 1.0 109.813 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.58 21.84 5.95 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.124 -0.985 . . . . 1.0 109.946 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' CA ' ' HG3' ' A' ' 35' ' ' LYS . . . 117.2 -0.27 19.07 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -92.35 109.13 36.06 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.27 . . . . 1.0 110.27 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.01 104.77 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.572 1.301 . . . . 1.0 110.43 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.85 -168.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 1.0 110.606 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -109.12 175.01 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 1.0 110.275 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 109.65 11.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 1.0 110.372 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -122.22 170.56 7.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 1.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.41 -24.23 19.56 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.627 1.33 . . . . 1.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.31 -40.31 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 1.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.49 127.74 35.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 1.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -119.36 144.1 47.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.914 . . . . 1.0 109.573 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.25 90.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 1.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.0 tp -113.02 147.48 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 1.0 110.187 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -159.67 149.48 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.199 -0.938 . . . . 1.0 110.197 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.32 22.75 11.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 1.0 110.173 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.63 -85.02 1.07 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -6.82 31.85 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.656 -0.908 . . . . 1.0 111.031 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.24 107.62 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.865 -1.147 . . . . 1.0 110.623 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -87.32 133.59 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.231 -0.918 . . . . 1.0 109.992 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.1 mt -132.71 134.84 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.058 -1.027 . . . . 1.0 110.534 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.511 ' CD2' ' CE3' ' A' ' 34' ' ' TRP . 27.2 tp -117.16 150.96 37.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 1.0 110.083 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.412 HG23 ' NE2' ' A' ' 61' ' ' HIS . 24.9 mm -143.43 99.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 1.0 109.945 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -105.69 116.57 32.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.0 110.08 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 62' ' ' ASN . 42.2 m-70 -85.99 -164.03 0.97 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.877 . . . . 1.0 110.278 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 66.8 t30 -14.71 81.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.808 1.04 . . . . 1.0 113.808 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 64.3 m -73.92 142.58 45.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.506 -0.746 . . . . 1.0 109.562 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.31 -175.71 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 1.0 110.787 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 tp -79.59 5.26 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 1.0 111.127 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.01 -29.3 6.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 2.8 mtt -49.99 -23.57 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -1.13 . . . . 1.0 110.648 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -47.06 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.51 -0.744 . . . . 1.0 110.406 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.98 -121.6 0.59 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.96 174.29 10.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -1.076 . . . . 1.0 110.585 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.61 89.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -0.795 . . . . 1.0 109.742 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -97.9 125.16 42.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 1.0 110.609 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 46.9 t80 -113.75 157.85 21.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.447 -0.783 . . . . 1.0 109.632 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -143.48 136.73 27.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 1.0 110.683 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -160.5 120.62 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 1.0 109.454 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.64 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -0.872 . . . . 1.0 109.799 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.3 m-20 -128.92 -15.31 4.32 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 1.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.48 157.91 8.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.0 110.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -158.1 93.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 1.0 109.776 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 49.5 p -101.73 172.06 7.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.912 . . . . 1.0 110.72 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.17 91.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -0.809 . . . . 1.0 109.816 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -94.02 -171.05 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 1.0 110.593 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.81 133.38 55.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 1.0 110.244 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.02 136.88 47.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 1.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -135.27 131.54 36.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 1.0 109.973 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 93.6 t -100.58 153.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 1.0 109.852 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -144.32 130.2 19.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 1.0 110.505 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.96 173.3 8.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 1.0 110.302 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.066 179.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.428 ' HB3' ' ND2' ' A' ' 77' ' ' ASN . 2.0 mp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.273 0.559 . . . . 1.0 110.184 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.424 ' CD1' ' HB1' ' A' ' 76' ' ' ALA . 48.3 mt -90.01 148.38 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 1.0 109.75 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.02 -5.61 6.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 1.0 111.211 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 46.1 t 60.16 136.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.344 -0.848 . . . . 1.0 110.959 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -116.85 -37.02 3.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 1.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -119.0 109.0 39.86 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.765 -0.584 . . . . 1.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.05 172.72 14.13 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.604 1.318 . . . . 1.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 80' ' ' SER . 51.4 mt -73.3 170.0 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 1.0 110.348 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.55 113.1 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 1.0 110.066 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.9 153.34 4.32 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' CG1' ' CZ ' ' A' ' 21' ' ' PHE . 9.0 p -153.43 158.76 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.382 -1.069 . . . . 1.0 110.176 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -112.18 160.49 17.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 1.0 110.406 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 86' ' ' VAL . 9.6 m -147.83 172.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 1.0 110.592 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.53 30.35 4.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t 58.34 70.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.716 0.769 . . . . 1.0 109.95 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.45 -21.49 1.06 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' O ' ' CG2' ' A' ' 18' ' ' THR . 58.7 mm-40 -76.31 -121.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 1.0 109.705 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 17' ' ' GLU . 1.2 p -160.27 171.12 19.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.845 -1.16 . . . . 1.0 110.452 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.3 158.37 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.417 -0.802 . . . . 1.0 109.548 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -146.63 92.35 2.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 1.0 110.946 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.424 ' CZ ' ' CG1' ' A' ' 11' ' ' VAL . 87.4 m-85 -106.65 112.39 25.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.181 -0.949 . . . . 1.0 109.713 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -121.77 157.4 31.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.997 . . . . 1.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -163.84 122.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.0 109.792 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.62 138.23 33.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 1.0 110.262 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -109.0 170.16 8.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 1.0 109.848 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -11.08 42.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 1.0 110.67 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -123.82 124.98 26.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.0 110.167 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.83 171.2 18.73 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.417 1.219 . . . . 1.0 110.645 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 50.72 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 1.0 110.584 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.26 179.96 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 1.0 110.062 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -127.39 41.26 3.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 1.0 110.382 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 74' ' ' GLN . . . -86.32 174.26 46.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.762 -1.335 . . . . 1.0 109.762 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.07 155.59 32.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -1.13 . . . . 1.0 110.148 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.75 135.56 33.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.047 -1.033 . . . . 1.0 110.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -138.69 126.39 22.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.382 -0.824 . . . . 1.0 109.424 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.62 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.171 -0.956 . . . . 1.0 109.274 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -25.04 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.48 -1.388 . . . . 1.0 109.51 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.74 38.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -128.39 136.4 29.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.238 . . . . 1.0 110.294 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.98 121.03 6.33 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.534 1.281 . . . . 1.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 42' ' ' THR . 2.2 pp -83.29 -149.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 1.0 110.026 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.47 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 2.9 p -157.74 120.89 3.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.949 . . . . 1.0 109.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.2 97.67 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 1.0 110.518 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.464 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER 176.03 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.274 -0.891 . . . . 1.0 110.424 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.2 Cg_endo -72.02 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.579 1.305 . . . . 1.0 111.196 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -113.84 57.78 0.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.924 -1.11 . . . . 1.0 110.729 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.2 t -152.28 126.79 9.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 1.0 110.169 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -111.44 52.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 1.0 110.393 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -87.68 124.48 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 1.0 109.985 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 tt -121.42 128.06 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.238 -0.914 . . . . 1.0 110.136 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.02 137.68 14.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.92 . . . . 1.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.89 17.51 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 1.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.48 -24.13 26.98 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -90.56 -20.32 22.75 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.391 -1.064 . . . . 1.0 110.108 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.38 127.89 2.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.33 -0.856 . . . . 1.0 110.287 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 84.5 m-70 -96.61 120.6 37.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 1.0 110.03 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.15 140.07 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 110.217 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.76 130.77 49.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.0 110.207 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.6 mt -135.41 87.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 1.0 109.394 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.87 119.08 34.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 1.0 110.729 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.8 m-70 -80.08 -161.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 1.0 109.423 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.7 p30 -14.38 80.97 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.927 1.084 . . . . 1.0 113.927 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 80.7 m -70.22 -169.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.573 -0.704 . . . . 1.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.69 -163.68 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 1.0 110.435 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 9.2 mp -82.38 34.21 0.42 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.105 -0.997 . . . . 1.0 111.472 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.82 -29.82 2.98 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.655 -1.778 . . . . 1.0 108.655 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.444 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 53.6 mtp -88.02 36.22 0.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.991 . . . . 1.0 110.228 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -90.26 58.83 4.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 1.0 109.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -154.83 -125.81 0.99 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.54 151.19 52.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.438 -1.037 . . . . 1.0 110.483 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.13 84.26 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 1.0 109.924 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.6 p -88.28 119.87 29.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -103.23 143.34 32.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' O ' ' CA ' ' A' ' 32' ' ' GLY . 24.3 mt-30 -130.41 137.18 49.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -164.33 105.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 1.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB1' ' CD1' ' A' ' 2' ' ' ILE . . . 56.47 -89.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 1.0 110.31 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 1' ' ' LEU . 1.8 t30 -114.78 -27.18 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.956 -1.09 . . . . 1.0 110.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.401 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -50.04 141.91 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 1.0 110.714 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 75.62 1.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 1.0 109.967 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.418 ' CB ' HD13 ' A' ' 8' ' ' LEU . 61.4 p -90.98 176.96 6.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.953 . . . . 1.0 110.146 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.03 93.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.0 110.15 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.99 -171.29 3.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 1.0 110.069 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.12 105.61 8.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 1.0 109.932 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 HD23 ' CZ ' ' A' ' 21' ' ' PHE . 42.5 tp -112.66 124.53 52.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 1.0 110.577 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -127.76 134.72 49.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 1.0 109.807 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 84.3 t -100.19 135.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 109.934 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -122.95 134.17 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.0 110.306 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -76.29 169.03 18.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 1.0 110.072 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.291 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.286 0.565 . . . . 1.0 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.9 pt -118.77 174.16 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.857 . . . . 1.0 110.136 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -122.52 -166.18 1.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 110.499 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 78' ' ' ALA . 63.6 t -116.31 122.09 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 1.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.74 -41.72 26.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 1.0 108.733 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -117.77 101.75 51.9 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.823 -0.548 . . . . 1.0 109.855 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.15 174.35 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.599 1.315 . . . . 1.0 110.74 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 17.7 mt -75.3 176.38 7.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 1.0 110.015 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 28.0 m-85 -135.18 125.0 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.0 110.234 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 142.69 40.78 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.56 164.03 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -1.073 . . . . 1.0 109.851 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -124.82 152.78 43.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 1.0 110.438 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG21 ' N ' ' A' ' 14' ' ' PHE . 11.3 p -142.12 149.02 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.82 . . . . 1.0 110.138 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.426 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.87 47.96 1.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 1.0 110.475 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 14' ' ' PHE . 7.7 p 37.02 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.733 0.778 . . . . 1.0 111.72 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 159.01 -25.42 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.05 -1.62 . . . . 1.0 109.05 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.47 -112.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -1.098 . . . . 1.0 109.013 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.18 151.17 17.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.592 -1.317 . . . . 1.0 110.826 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CD2' ' A' ' 20' ' ' HIS . . . -107.2 160.94 15.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 1.0 109.076 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -153.81 97.91 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.0 111.105 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 88.0 m-85 -111.73 108.14 17.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.544 -0.723 . . . . 1.0 109.324 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 155.17 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.324 -0.86 . . . . 1.0 110.509 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' OG ' ' A' ' 80' ' ' SER . 7.2 tt -164.81 139.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.444 -0.785 . . . . 1.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -120.45 143.38 48.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.975 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.2 mt -108.03 -156.71 0.59 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 1.0 110.179 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 -68.37 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 1.0 110.388 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.76 130.1 23.27 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 1.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -78.14 154.53 29.03 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.408 1.215 . . . . 1.0 110.166 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.22 -61.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 1.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.16 166.12 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 1.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -70.81 -164.85 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.841 . . . . 1.0 110.411 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.4 -150.58 5.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.606 -1.398 . . . . 1.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.25 135.27 3.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.373 -1.075 . . . . 1.0 110.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.508 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 27.9 m95 -101.95 149.01 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 1.0 110.608 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.463 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 19.1 ttpt -141.54 123.14 15.09 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.35 -0.843 . . . . 1.0 109.592 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.44 -131.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 1.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.52 -25.16 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.411 -1.43 . . . . 1.0 109.619 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.42 38.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.698 -1.361 . . . . 1.0 109.698 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 7.9 mm-40 -126.68 109.03 22.79 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.162 -1.199 . . . . 1.0 110.147 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.08 83.83 1.58 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.62 1.326 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.09 -163.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 1.0 110.678 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.1 148.39 50.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 1.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.28 107.48 18.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 1.0 110.231 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -179.32 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.269 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.87 -50.82 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.59 1.31 . . . . 1.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.0 -54.72 1.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -0.985 . . . . 1.0 110.823 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.416 ' CB ' HD22 ' A' ' 60' ' ' LEU . 36.8 t -69.5 150.04 47.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 1.0 110.443 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.15 65.0 1.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.875 . . . . 1.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.431 HD11 ' CD1' ' A' ' 58' ' ' LEU . 6.1 tp -84.56 140.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 1.0 110.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.7 mt -128.84 120.96 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.084 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.25 141.79 43.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 1.0 110.273 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.85 27.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.222 -0.924 . . . . 1.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.82 -23.92 30.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -90.38 71.8 7.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -1.018 . . . . 1.0 108.93 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 24' ' ' GLU . 5.4 mmtt 54.79 170.83 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.889 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 89.9 m-70 -114.69 144.92 42.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.982 -1.074 . . . . 1.0 110.763 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' N ' HD11 ' A' ' 57' ' ' ILE . 4.6 mp -140.47 115.06 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.842 . . . . 1.0 109.799 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.478 HD23 ' CE3' ' A' ' 34' ' ' TRP . 44.8 tp -99.19 132.03 44.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 1.0 110.862 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.413 HG12 ' CD2' ' A' ' 20' ' ' HIS . 98.6 mt -133.33 93.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.474 -0.766 . . . . 1.0 109.456 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD22 ' CB ' ' A' ' 47' ' ' CYS . 2.6 mt -95.51 105.05 16.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 1.0 110.93 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 68.1 m-70 -69.85 -169.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 1.0 109.475 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 40.5 p-10 -14.87 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.867 1.062 . . . . 1.0 113.867 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 61' ' ' HIS . 61.2 m -70.62 -156.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.639 -0.663 . . . . 1.0 109.429 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.43 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -151.43 -169.97 3.52 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.967 -1.083 . . . . 1.0 110.815 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 38.51 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -0.784 . . . . 1.0 111.517 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.55 -15.02 2.5 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.803 -1.189 . . . . 1.0 110.293 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.436 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -87.42 37.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.718 -1.46 . . . . 1.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.22 40.27 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 1.0 110.139 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 -125.11 2.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -136.93 152.33 50.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -1.042 . . . . 1.0 110.294 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.34 88.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.908 . . . . 1.0 109.84 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.5 p -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 1.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -96.39 146.27 24.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 1.0 109.95 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -152.58 126.6 9.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 1.0 110.379 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 76' ' ' ALA . . . -132.66 16.06 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.11 -0.994 . . . . 1.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . 169.15 -81.97 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.363 -0.835 . . . . 1.0 109.601 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -127.2 -39.03 1.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 1.0 109.535 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' HB3' ' CG2' ' A' ' 4' ' ' VAL . . . -69.29 119.38 13.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.831 . . . . 1.0 110.016 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -123.29 95.81 4.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 1.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.3 m -73.35 -179.24 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 1.0 110.182 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.39 104.75 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 1.0 110.576 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.28 -176.64 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 1.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.37 121.15 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 1.0 109.838 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -125.2 133.98 52.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 1.0 110.545 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -130.88 130.42 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 1.0 109.511 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 92.0 t -91.64 145.48 7.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.181 -0.949 . . . . 1.0 110.447 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -135.47 141.37 45.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.418 -0.801 . . . . 1.0 109.921 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.98 -167.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 1.0 110.336 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.327 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.18 0.514 . . . . 1.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.6 mm -123.32 166.83 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 1.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.6 -154.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 1.0 110.344 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 27.7 t -125.17 127.49 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 1.0 109.958 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.39 -46.17 6.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 1.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 107.87 61.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.705 -0.622 . . . . 1.0 110.063 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.17 173.73 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.563 1.297 . . . . 1.0 110.799 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.39 173.89 10.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 1.0 110.45 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -138.59 122.55 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 1.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.0 146.66 47.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.791 -1.323 . . . . 1.0 109.791 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 12' ' ' GLU . 74.3 t -144.23 162.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 1.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' N ' HG11 ' A' ' 11' ' ' VAL . 3.2 mt-10 -108.41 154.8 21.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 17' ' ' GLU . 2.7 p -151.08 130.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.0 110.013 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.55 38.06 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 1.0 110.337 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.432 HG21 ' CG1' ' A' ' 86' ' ' VAL . 47.3 t 55.82 99.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.374 -0.829 . . . . 1.0 110.684 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 131.83 -40.8 1.58 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' CG ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -69.69 -136.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 1.0 109.062 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.3 m -154.42 120.65 5.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.795 -1.191 . . . . 1.0 110.763 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -79.13 152.81 30.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.48 ' CD2' HG12 ' A' ' 59' ' ' ILE . 10.0 m80 -138.07 133.34 33.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.907 -1.12 . . . . 1.0 111.561 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.436 ' CD2' HD21 ' A' ' 58' ' ' LEU . 75.0 m-85 -125.7 135.47 52.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -125.43 154.65 41.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.0 111.574 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -168.15 135.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.64 . . . . 1.0 109.438 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -125.98 142.97 51.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 1.0 110.618 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.03 -164.16 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.352 -0.842 . . . . 1.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -108.47 -42.85 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 1.0 109.981 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -132.13 132.56 23.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 1.0 110.045 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 143.41 35.49 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.362 1.19 . . . . 1.0 110.441 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -168.71 -54.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 1.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.52 157.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.06 174.4 10.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 1.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.33 -177.41 14.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.597 -1.401 . . . . 1.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.11 151.63 40.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.091 . . . . 1.0 110.107 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.51 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 30.7 m95 -110.46 147.06 34.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 1.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 ttpp -133.38 119.56 19.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.426 -0.796 . . . . 1.0 109.525 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -63.66 -135.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.395 -0.816 . . . . 1.0 108.816 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -49.8 -24.63 2.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.243 -1.535 . . . . 1.0 109.759 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 153.8 42.6 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -129.82 122.33 20.44 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.434 -1.039 . . . . 1.0 110.097 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.1 88.58 0.95 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.461 1.243 . . . . 1.0 110.386 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 42' ' ' THR . 4.4 pp -72.22 -160.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 1.0 110.691 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.496 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -170.32 -176.82 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.582 -0.699 . . . . 1.0 109.794 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 102.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.0 109.976 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.41 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -127.75 177.04 2.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 1.0 110.493 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 48.3 Cg_endo -73.87 -20.7 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.698 1.368 . . . . 1.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -98.18 -39.99 8.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 1.0 110.387 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.1 158.34 18.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.22 -0.925 . . . . 1.0 110.275 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -148.14 67.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 1.0 110.247 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -85.09 128.67 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -0.793 . . . . 1.0 110.536 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.0 128.9 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 1.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.13 151.24 32.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 1.0 110.367 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -130.6 20.98 5.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 1.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.92 -61.97 3.34 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -12.79 61.88 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.614 -0.933 . . . . 1.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.89 148.5 29.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.978 -1.076 . . . . 1.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -128.02 107.66 10.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.32 148.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 1.0 110.55 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 21' ' ' PHE . 19.7 tp -133.48 121.79 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.353 -0.842 . . . . 1.0 110.188 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 20' ' ' HIS . 40.6 mt -122.9 126.17 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 1.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.441 ' CD2' ' CE ' ' A' ' 67' ' ' MET . 0.2 OUTLIER -129.35 103.0 6.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 1.0 110.372 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 79.6 m-70 -70.16 -163.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.25 -0.906 . . . . 1.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 29.2 t-20 -13.53 81.44 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' HIS . 78.5 m -83.15 -159.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.0 109.253 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.431 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 3.1 mt-30 -142.82 -170.47 3.24 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.204 -0.935 . . . . 1.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.59 9.19 6.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.3 -29.26 10.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 1.0 109.39 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.441 ' CE ' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.29 -23.3 1.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.328 -1.101 . . . . 1.0 111.429 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -46.49 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.148 -0.97 . . . . 1.0 110.621 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.86 -121.29 0.63 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.253 -1.539 . . . . 1.0 109.253 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -155.3 145.74 22.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -1.12 . . . . 1.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' A' ' 21' ' ' PHE . 67.8 t -98.11 93.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 1.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -96.03 101.44 13.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.0 110.441 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 32.1 t80 -73.61 154.24 39.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 1.0 109.557 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 106.52 7.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.063 -1.023 . . . . 1.0 110.688 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.58 118.22 9.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 1.0 109.682 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.56 -153.99 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 1.0 109.865 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -74.29 -10.45 59.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 1.0 110.504 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 4' ' ' VAL . . . -83.62 153.63 24.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.944 -1.098 . . . . 1.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -159.59 145.89 16.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 1.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 76.8 p -125.87 178.1 5.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.0 110.089 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.8 103.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 1.0 110.204 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.21 -174.59 2.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 1.0 110.339 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.88 129.6 36.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 1.0 110.004 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 19' ' ' ALA . 1.1 tt -135.8 145.62 46.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 1.0 110.469 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 136.33 46.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 1.0 109.802 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 61.3 t -103.7 151.16 6.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.249 -0.907 . . . . 1.0 110.446 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.66 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 1.0 110.201 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -93.42 145.59 24.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.358 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.105 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.252 0.549 . . . . 1.0 110.201 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.8 pt -102.15 158.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 110.198 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.68 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 1.0 110.19 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.97 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -86.48 -34.45 20.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -131.01 112.47 15.93 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.13 171.4 11.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.647 1.34 . . . . 1.0 111.455 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' CB ' ' HB1' ' A' ' 82' ' ' ALA . 67.7 mt -59.95 -167.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.562 0.696 . . . . 1.0 110.913 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 10' ' ' GLY . 20.9 t80 -134.4 158.64 43.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 1.0 110.001 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -99.13 133.49 11.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -152.81 164.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -1.144 . . . . 1.0 110.256 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.69 172.31 7.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.92 . . . . 1.0 110.58 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 m -155.25 134.69 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 1.0 110.5 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -92.9 34.68 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 1.0 109.775 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 14.5 t 61.73 73.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.462 -0.773 . . . . 1.0 110.439 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.41 -25.34 1.09 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.866 -1.693 . . . . 1.0 108.866 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 -163.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.35 -1.088 . . . . 1.0 109.531 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 m -144.32 113.03 6.66 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.2 -0.938 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.29 161.8 26.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 1.0 109.638 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.426 ' NE2' HG22 ' A' ' 57' ' ' ILE . 12.7 t-160 -139.29 88.31 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.002 . . . . 1.0 110.691 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD1' HD21 ' A' ' 58' ' ' LEU . 81.0 m-85 -84.03 162.12 20.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 1.0 109.594 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -153.65 162.49 41.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.046 . . . . 1.0 110.678 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' CD1' ' OG ' ' A' ' 80' ' ' SER . 4.7 tt -169.23 135.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.448 -0.782 . . . . 1.0 109.921 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.88 136.45 49.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.111 -0.993 . . . . 1.0 110.057 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 35.1 mt -101.7 -151.19 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.958 . . . . 1.0 109.879 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.3 p -117.31 -46.72 2.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 1.0 109.989 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.1 140.8 21.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 1.0 110.064 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.17 178.91 6.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.558 1.294 . . . . 1.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 t70 54.59 92.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 1.0 110.732 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.4 p -156.84 154.51 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 1.0 109.874 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 49.1 p-80 -108.74 121.16 44.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 1.0 110.657 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.81 156.18 26.88 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' C ' ' CD1' ' A' ' 34' ' ' TRP . 14.2 mm-40 -124.41 177.81 5.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -1.232 . . . . 1.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 58' ' ' LEU . 37.4 m95 -136.43 139.04 42.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.451 -0.78 . . . . 1.0 110.682 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 6.7 tttp -157.11 -109.99 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.211 -0.931 . . . . 1.0 109.614 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.441 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -157.89 -160.11 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.929 -1.107 . . . . 1.0 109.005 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.833 -1.167 . . . . 1.0 109.632 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.75 -114.19 0.01 OUTLIER Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 2.0 mm-40 -136.33 176.59 2.7 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 107.475 -1.306 . . . . 1.0 107.475 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.06 116.42 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.678 1.357 . . . . 1.0 110.878 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -95.29 -167.75 1.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.81 -1.181 . . . . 1.0 110.716 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.438 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.5 p -116.09 162.33 17.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.0 110.218 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.46 120.46 16.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.91 . . . . 1.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.487 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.4 t -173.29 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 1.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -67.87 -89.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.33 1.174 . . . . 1.0 111.146 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.29 70.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 1.0 110.322 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.83 129.6 11.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 1.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.18 94.76 4.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 1.0 109.878 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.2 89.31 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 1.0 110.664 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 8.3 tt -89.17 119.65 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.868 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.68 145.5 47.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.99 . . . . 1.0 110.599 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.29 23.24 14.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 1.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.57 -89.25 1.23 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -49.15 -23.81 1.43 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.878 . . . . 1.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -137.5 157.35 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.983 -1.073 . . . . 1.0 110.237 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.514 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 87.1 m-70 -118.1 138.06 52.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.532 -0.73 . . . . 1.0 109.486 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.426 HG22 ' NE2' ' A' ' 20' ' ' HIS . 57.7 mt -140.33 128.46 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.037 -1.039 . . . . 1.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.502 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 9.9 tp -103.99 149.9 24.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 1.0 110.421 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.425 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 64.9 mt -140.0 82.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.795 . . . . 1.0 109.372 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' ' HE3' ' A' ' 67' ' ' MET . 5.1 mt -84.19 115.37 22.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 1.0 110.729 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 62' ' ' ASN . 60.8 m-70 -87.74 -165.84 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 1.0 109.624 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.474 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.5 p-10 -14.27 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 85.2 m -74.86 -155.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.639 -0.663 . . . . 1.0 109.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.429 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 15.6 mt-30 -159.47 -165.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 1.0 110.613 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.39 39.84 0.8 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 1.0 111.237 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.98 -37.83 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.981 -1.647 . . . . 1.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 69' ' ' GLY . 50.3 mtt -63.15 -13.36 36.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.365 -1.079 . . . . 1.0 110.778 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.77 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.297 -0.877 . . . . 1.0 110.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 170.75 -113.57 0.5 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.933 -1.667 . . . . 1.0 108.933 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.81 136.4 24.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.48 -1.012 . . . . 1.0 110.468 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.28 144.07 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 1.0 108.963 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 p -136.42 126.56 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.48 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 59.1 t80 -105.66 147.11 28.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.695 . . . . 1.0 109.131 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -137.91 152.5 49.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 1.0 110.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.46 -149.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 1.0 109.939 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.03 -76.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 1.0 110.24 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -123.73 17.01 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 1.0 110.301 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.76 137.92 42.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 1.0 110.658 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 14.9 ptmt -154.16 101.53 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.515 -0.741 . . . . 1.0 109.637 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.41 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 13.4 m -105.15 -176.04 2.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 1.0 110.535 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.08 97.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 1.0 110.197 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 8' ' ' LEU . . . -95.55 -168.07 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 1.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -122.14 143.97 49.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 1.0 110.178 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -150.69 119.75 6.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 1.0 110.395 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -117.33 125.98 51.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 1.0 109.852 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 41.5 t -90.77 112.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.347 -0.845 . . . . 1.0 110.058 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.33 144.98 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 1.0 110.381 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.15 -177.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 1.0 110.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.258 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.226 0.536 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mm -95.37 146.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 1.0 109.756 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 4' ' ' VAL . 1.1 tp10 -129.85 -5.16 4.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 1.0 111.194 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 3' ' ' GLU . 47.5 t 56.72 108.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 1.0 110.308 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -78.18 -51.49 10.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.054 -1.029 . . . . 1.0 109.884 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -122.91 108.48 32.66 Favored Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 120.073 -0.651 . . . . 1.0 110.277 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.42 -175.8 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.572 1.301 . . . . 1.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 80' ' ' SER . 7.0 mt -71.0 -161.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 1.0 110.67 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 30.7 p90 -160.4 133.85 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.7 149.01 33.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.39 168.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -1.104 . . . . 1.0 110.195 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.69 158.92 21.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 1.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.82 171.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 1.0 110.342 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.71 135.56 54.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 1.0 109.446 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 11.7 p -50.8 112.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 1.0 110.572 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 122.22 -48.67 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.825 -1.71 . . . . 1.0 108.825 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -165.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -1.018 . . . . 1.0 109.924 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -121.42 148.29 44.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 1.0 110.449 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.2 174.97 6.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 1.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -158.97 110.94 2.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 1.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -116.49 156.59 26.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.56 160.53 41.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.03 . . . . 1.0 110.45 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tt -170.56 124.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 1.0 109.848 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.73 132.71 36.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 1.0 110.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HG ' ' CD2' ' A' ' 56' ' ' HIS . 2.5 mm? -119.97 -177.35 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 1.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 t -132.1 20.53 4.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 1.0 110.122 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.22 156.37 66.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 1.0 110.197 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.72 -20.76 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.683 1.359 . . . . 1.0 110.38 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.62 -132.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 1.0 109.392 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.87 167.27 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.632 -1.293 . . . . 1.0 110.102 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -175.53 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 1.0 110.277 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.85 -177.46 33.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.42 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.25 167.77 25.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -1.078 . . . . 1.0 110.092 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.503 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 26.9 m95 -99.82 167.06 10.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 1.0 110.496 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -171.4 153.43 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 1.0 109.91 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.22 -131.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.09 -1.006 . . . . 1.0 109.894 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -48.1 -25.36 1.42 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.666 -1.271 . . . . 1.0 110.638 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 154.06 39.3 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.645 -1.382 . . . . 1.0 109.645 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -131.87 117.21 16.08 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.164 -1.198 . . . . 1.0 109.442 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.88 94.07 1.01 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.649 1.342 . . . . 1.0 109.959 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -179.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 42' ' ' THR . 90.7 m -136.56 23.53 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.772 . . . . 1.0 110.094 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.56 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 1.0 110.397 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -174.4 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 1.0 110.91 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 45.0 Cg_endo -70.6 -14.11 33.14 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.304 1.16 . . . . 1.0 111.115 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 47' ' ' CYS . 2.6 p30 -113.05 -24.53 9.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.017 . . . . 1.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.41 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 53.4 t -122.7 128.8 51.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.114 -0.991 . . . . 1.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -118.45 140.04 50.48 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.189 -0.944 . . . . 1.0 109.664 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.1 mt -139.61 108.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.486 -0.759 . . . . 1.0 109.801 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -128.02 128.01 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 1.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.78 138.66 16.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 1.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -122.54 18.88 10.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 1.0 110.775 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -42.54 2.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.955 -1.258 . . . . 1.0 109.955 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -62.31 -29.69 70.62 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.571 -0.958 . . . . 1.0 110.044 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 146.5 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.33 -0.856 . . . . 1.0 110.283 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.466 ' CD2' ' HG ' ' A' ' 25' ' ' LEU . 86.0 m-70 -105.72 119.65 39.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 1.0 110.01 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.55 137.55 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.209 -0.932 . . . . 1.0 110.383 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.5 tp -120.63 136.98 54.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.393 -0.817 . . . . 1.0 110.186 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 59' ' ' ILE . 58.2 mt -141.73 100.7 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.25 170.93 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 1.0 110.499 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.4 m-70 -126.52 -168.31 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.421 -0.8 . . . . 1.0 109.665 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -14.78 81.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.815 1.042 . . . . 1.0 113.815 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' HIS . 62.7 m -78.63 165.47 23.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.694 -0.629 . . . . 1.0 109.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.453 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 3.9 tp-100 -105.27 167.16 9.91 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.112 -0.992 . . . . 1.0 109.234 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -66.58 0.51 2.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.95 -1.094 . . . . 1.0 112.5 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.77 -21.42 33.88 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.431 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -50.99 -20.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -1.131 . . . . 1.0 111.523 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 m -44.42 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.305 -0.872 . . . . 1.0 110.736 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.78 -119.15 0.49 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.79 130.57 10.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.017 . . . . 1.0 110.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 25.4 t -85.33 93.36 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 1.0 109.144 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 13.4 m -101.5 150.76 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.059 . . . . 1.0 110.934 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 64.2 t80 -118.12 138.04 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.517 -0.739 . . . . 1.0 109.692 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -121.35 151.59 39.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 1.0 110.5 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.8 -153.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 1.0 110.068 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -67.37 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.973 . . . . 1.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -130.25 18.76 5.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 1.0 110.152 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -99.04 149.89 22.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 110.132 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -159.71 74.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 1.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.436 ' CB ' HD13 ' A' ' 8' ' ' LEU . 83.5 p -82.95 168.45 17.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' SER . . . -169.82 96.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.1 -174.22 3.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 1.0 110.08 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -125.49 107.54 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 1.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.42 138.89 43.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 1.0 110.567 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -131.11 140.45 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.815 . . . . 1.0 109.945 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 97.6 t -97.41 116.33 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.912 . . . . 1.0 110.195 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -93.85 130.67 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 110.491 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -68.23 179.03 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 1.0 110.039 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.232 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.267 0.556 . . . . 1.0 110.345 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.26 -170.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 1.0 110.272 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -135.95 -165.58 1.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.0 110.231 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.14 125.5 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 1.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -86.79 -48.0 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 1.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.79 107.27 44.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.65 -0.656 . . . . 1.0 109.886 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.76 176.83 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.679 1.357 . . . . 1.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' CD1' ' OG ' ' A' ' 80' ' ' SER . 80.9 mt -60.16 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 1.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 88.4 t80 -152.36 163.31 39.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 1.0 109.549 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -87.45 145.92 19.86 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.842 -1.303 . . . . 1.0 109.842 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -153.8 164.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.0 110.241 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.26 163.48 18.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 1.0 110.34 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 p -155.65 132.61 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 1.0 109.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CA ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -87.32 76.08 9.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 1.0 110.959 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t 59.36 97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.841 0.829 . . . . 1.0 112.049 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 63' ' ' CYS . . . 46.12 23.34 1.12 Allowed Glycine 0 N--CA 1.495 2.592 0 O-C-N 121.943 -0.473 . . . . 1.0 113.217 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HG3' ' CA ' ' A' ' 14' ' ' PHE . 1.8 mm-40 -62.49 -75.17 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.714 1.757 . . . . 1.0 107.653 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.483 ' CG2' ' CE1' ' A' ' 61' ' ' HIS . 63.3 m -162.02 151.38 15.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.783 -0.573 . . . . 1.0 109.672 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.31 163.11 16.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 1.0 109.624 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -155.89 81.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.934 -1.104 . . . . 1.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 71.9 m-85 -102.36 115.49 30.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -0.901 . . . . 1.0 109.591 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.16 157.34 20.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 1.0 111.111 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.1 tt -167.09 120.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -87.16 129.81 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 1.0 110.727 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -96.74 -171.99 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.814 . . . . 1.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -105.45 -83.82 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 1.0 110.398 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 121.89 67.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.0 110.216 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.26 111.87 3.39 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.41 1.216 . . . . 1.0 110.078 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.91 -64.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 1.0 110.444 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.44 157.6 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 1.0 110.335 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -107.58 -175.56 2.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 1.0 109.91 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.97 -159.33 9.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.471 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -156.8 171.05 21.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -1.081 . . . . 1.0 109.882 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.483 ' CG ' HD13 ' A' ' 58' ' ' LEU . 56.2 m95 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.038 -1.039 . . . . 1.0 110.648 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' CD ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -157.23 126.08 5.81 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.37 -133.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 1.0 108.873 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -24.76 6.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.328 -1.483 . . . . 1.0 109.355 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 162.64 40.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.441 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -115.72 101.74 54.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.265 -1.138 . . . . 1.0 110.299 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.73 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.889 1.468 . . . . 1.0 110.324 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -164.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 1.0 110.677 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -162.08 172.12 16.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 1.0 110.225 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.0 125.38 34.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 1.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -174.88 -59.93 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 1.0 110.343 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -71.13 -87.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.447 1.235 . . . . 1.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -142.15 52.88 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.877 -1.139 . . . . 1.0 110.487 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.04 138.07 31.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.202 -0.936 . . . . 1.0 110.167 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 4.2 tt0 -123.65 53.49 1.36 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.105 -0.997 . . . . 1.0 110.002 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.8 114.98 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.87 -1.144 . . . . 1.0 109.908 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.0 99.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 1.0 110.238 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -124.85 141.87 51.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.95 . . . . 1.0 110.277 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.85 14.48 2.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.12 -30.3 6.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.388 -1.085 . . . . 1.0 110.388 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -90.9 -16.24 28.49 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.309 -1.113 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.88 114.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.161 -0.962 . . . . 1.0 110.383 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -95.1 111.63 23.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.843 . . . . 1.0 110.187 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.7 mm -120.7 147.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 1.0 110.07 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD13 ' CG ' ' A' ' 34' ' ' TRP . 4.5 tt -123.9 130.51 52.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 1.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -133.46 103.1 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.43 127.34 46.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.006 -1.059 . . . . 1.0 111.722 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.483 ' CE1' ' CG2' ' A' ' 18' ' ' THR . 12.8 m-70 -103.7 28.1 6.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.846 0.832 . . . . 1.0 108.82 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -108.53 -4.58 17.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.596 -0.69 . . . . 1.0 111.319 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.457 ' N ' ' HA2' ' A' ' 16' ' ' GLY . 76.8 m -43.04 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.274 -0.891 . . . . 1.0 111.395 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 63' ' ' CYS . 18.8 mt-30 -161.24 -166.78 1.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 1.0 110.213 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -3.44 18.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 1.0 111.152 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.85 -36.25 5.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.435 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -48.57 -23.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 1.0 111.548 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 p -46.34 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.933 . . . . 1.0 110.762 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -175.21 -125.67 0.88 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -139.76 142.94 36.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 1.0 110.513 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.529 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 55.2 t -94.51 105.2 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.634 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -107.77 108.09 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 1.0 110.625 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 24.4 t80 -81.07 145.01 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 1.0 109.586 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -121.2 111.01 16.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 1.0 110.593 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.57 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.528 -0.732 . . . . 1.0 109.502 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.93 -162.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 1.0 109.596 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -62.85 -19.49 64.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.0 110.163 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.7 145.36 47.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 1.0 110.398 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -153.57 133.37 13.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 1.0 110.094 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.415 ' OG ' ' CD1' ' A' ' 8' ' ' LEU . 69.8 p -112.16 178.35 4.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.947 . . . . 1.0 110.171 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.14 79.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 1.0 110.511 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.64 -178.74 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.985 . . . . 1.0 110.194 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -114.09 136.74 52.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 1.0 110.25 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.7 tp -136.55 134.25 37.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.0 110.233 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -131.92 125.88 32.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 1.0 109.744 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 51.4 t -90.92 112.29 24.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.304 -0.872 . . . . 1.0 109.949 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -75.75 172.38 12.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 1.0 110.519 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -86.73 176.47 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 1.0 110.226 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.108 179.8 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 pt -143.46 150.67 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.176 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.69 -172.66 2.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 1.0 110.301 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.0 111.53 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.27 -38.98 19.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.449 -0.945 . . . . 1.0 108.449 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -122.5 106.44 35.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.66 173.46 9.94 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.617 1.325 . . . . 1.0 111.032 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.77 -160.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.515 -0.741 . . . . 1.0 109.981 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -148.66 114.05 5.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0 109.835 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 132.3 38.55 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -154.14 161.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -1.179 . . . . 1.0 110.586 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -107.49 169.63 8.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.0 109.96 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.35 172.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 1.0 110.49 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.68 137.46 49.54 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.461 -0.774 . . . . 1.0 108.948 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 88' ' ' GLU . 93.2 t -46.11 111.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.415 -0.803 . . . . 1.0 111.403 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 127.24 -47.33 1.03 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.37 -1.076 . . . . 1.0 109.965 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -130.17 139.93 50.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 110.569 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.16 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 1.0 109.744 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -130.64 100.68 5.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 1.0 110.755 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 51.8 m-85 -104.41 154.38 19.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 1.0 109.743 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -140.92 157.61 45.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.002 -1.061 . . . . 1.0 110.611 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -169.48 139.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.446 -0.784 . . . . 1.0 110.154 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.13 132.27 54.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.334 -0.854 . . . . 1.0 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -94.37 -152.57 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 1.0 110.097 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -109.16 -37.77 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -0.834 . . . . 1.0 110.149 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.07 148.28 59.77 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 1.0 110.171 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.62 -167.9 0.45 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.677 1.357 . . . . 1.0 110.797 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.53 46.49 22.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 1.0 110.364 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.58 102.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 1.0 110.349 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -91.99 137.55 32.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.268 -0.895 . . . . 1.0 110.18 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.57 172.98 21.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -122.38 163.55 19.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 1.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 28.1 m95 -114.05 149.16 35.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 1.0 110.293 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 1.1 ttpt -139.47 131.33 27.63 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.318 -0.864 . . . . 1.0 109.939 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 67' ' ' MET . 44.7 mt -61.46 -112.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.142 -0.974 . . . . 1.0 109.304 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -85.97 12.62 8.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.448 -1.408 . . . . 1.0 110.264 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 131.19 -1.77 5.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -97.57 112.09 60.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.91 -1.347 . . . . 1.0 109.96 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.3 109.04 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.525 1.276 . . . . 1.0 110.543 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 169.42 17.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.288 -0.882 . . . . 1.0 110.534 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -143.52 24.13 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 1.0 109.742 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.02 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.832 . . . . 1.0 110.753 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.58 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 1.0 109.74 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.6 Cg_endo -70.54 -19.3 32.59 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.584 1.307 . . . . 1.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.89 -58.75 1.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.948 . . . . 1.0 109.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.26 152.13 44.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 1.0 109.95 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.57 86.51 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 1.0 110.409 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.68 128.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 1.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.05 122.47 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 1.0 110.591 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -142.55 162.25 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.0 109.72 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.55 16.76 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.02 -1.05 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.38 -29.86 7.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.984 -1.246 . . . . 1.0 109.984 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -74.12 -28.39 61.32 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.308 -1.113 . . . . 1.0 109.767 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.19 -173.66 1.32 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.376 -0.827 . . . . 1.0 110.063 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 81.1 m-70 -139.41 118.27 12.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.91 130.47 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 1.0 110.167 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.515 ' CD1' ' CE3' ' A' ' 34' ' ' TRP . 3.0 tt -105.88 136.34 45.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.833 . . . . 1.0 110.349 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -134.2 73.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 1.0 109.565 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.06 151.12 43.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 1.0 110.533 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 56.9 m-70 -113.99 -172.42 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.0 109.6 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.485 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 63.4 t-20 -14.52 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 61' ' ' HIS . 99.8 m -78.4 172.71 13.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.609 -0.682 . . . . 1.0 109.291 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.48 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 49.4 tp60 -115.0 167.28 10.94 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.023 -1.048 . . . . 1.0 109.128 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.48 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 14.0 tp -63.86 -5.96 5.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.033 -1.042 . . . . 1.0 112.308 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.66 -12.53 82.76 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 120.674 -1.266 . . . . 1.0 110.445 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.465 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 23.1 mtt -86.06 41.95 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.374 . . . . 1.0 110.93 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -90.83 45.02 1.22 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 1.0 110.004 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.1 -125.32 3.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 8.6 pt-20 -144.59 151.89 39.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -1.057 . . . . 1.0 110.336 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -90.33 90.48 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 1.0 109.964 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 p -94.52 99.94 12.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.836 . . . . 1.0 110.287 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 31.4 t80 -73.28 167.86 20.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.968 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.99 107.31 1.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 1.0 110.258 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 73' ' ' PHE . . . -139.74 122.92 16.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 1.0 109.99 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.89 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 1.0 110.387 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' ALA . 24.3 t30 -128.54 -31.04 2.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.047 -1.033 . . . . 1.0 110.589 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.47 127.68 33.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 1.0 110.511 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 124.03 15.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 1.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.411 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.9 m -112.62 -174.22 2.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 1.0 110.486 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.05 102.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 1.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 70' ' ' GLU . . . -99.98 -172.67 2.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.905 . . . . 1.0 109.903 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -114.51 137.23 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.108 -0.995 . . . . 1.0 110.238 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -140.63 124.02 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 1.0 110.607 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -126.54 133.71 51.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 1.0 109.52 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 43.4 t -91.79 149.83 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.14 -0.975 . . . . 1.0 110.377 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.66 104.78 4.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 1.0 110.029 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 15' ' ' VAL . 13.6 pt-20 -73.45 -156.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 1.0 110.461 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.932 -1.032 . . . . 1.0 110.081 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.356 0.598 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 2' ' ' ILE . 47.4 mm -112.87 137.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.312 -0.868 . . . . 1.0 110.485 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -171.36 2.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.348 -0.845 . . . . 1.0 110.063 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.5 t -119.13 119.38 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 1.0 110.1 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -82.64 -49.64 9.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.208 -0.932 . . . . 1.0 109.626 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -119.14 107.91 41.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 1.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.41 -175.86 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.491 1.258 . . . . 1.0 110.482 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 81' ' ' ALA . 6.6 mt -79.2 -172.65 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 1.0 110.494 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.35 136.48 33.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 1.0 110.125 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.89 149.91 36.84 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.439 HG11 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -160.11 154.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.161 . . . . 1.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.05 162.4 17.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 1.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.35 137.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 1.0 109.818 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.404 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.32 55.65 3.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.379 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 15' ' ' VAL . 5.9 p 36.55 76.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 CA-C-O 121.776 0.798 . . . . 1.0 111.95 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 158.13 -30.43 0.48 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.764 -1.735 . . . . 1.0 108.764 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.8 -161.94 0.19 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -1.027 . . . . 1.0 109.699 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 20.7 m -126.07 112.73 16.2 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.323 -0.951 . . . . 1.0 110.743 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.32 33.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 1.0 109.36 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -126.63 119.35 26.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.945 -1.097 . . . . 1.0 110.744 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -117.21 123.48 46.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -0.883 . . . . 1.0 109.804 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.58 153.15 25.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.017 . . . . 1.0 110.167 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -166.83 120.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 1.0 109.495 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.38 148.34 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 1.0 110.403 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 56' ' ' HIS . 42.9 mt -106.56 -150.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 1.0 109.854 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -116.09 -40.96 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 1.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.13 135.95 12.97 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 1.0 110.179 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.57 153.96 49.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.481 1.253 . . . . 1.0 110.391 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.75 -64.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.0 110.301 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.38 -164.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 1.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -115.21 143.79 44.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 1.0 110.132 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.38 -166.22 22.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.45 -1.46 . . . . 1.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.64 154.35 36.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -1.182 . . . . 1.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.492 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 30.8 m95 -102.01 147.35 26.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -141.84 132.49 25.52 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.359 -0.838 . . . . 1.0 109.328 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.413 HD23 ' HG2' ' A' ' 67' ' ' MET . 5.5 mt -64.7 -136.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.062 -1.023 . . . . 1.0 109.004 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -25.11 7.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.443 -1.41 . . . . 1.0 109.315 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.35 42.73 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.82 33.03 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.372 -1.076 . . . . 1.0 109.765 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.79 85.24 1.35 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.721 1.38 . . . . 1.0 110.197 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -69.36 -172.97 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.243 -0.911 . . . . 1.0 110.224 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.4 p -136.39 -170.65 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.93 109.64 14.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 110.149 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -120.29 166.39 15.39 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 1.0 110.141 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.6 -23.16 20.1 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.599 1.315 . . . . 1.0 110.486 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.39 -25.6 23.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 1.0 110.218 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.35 127.22 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.914 . . . . 1.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.18 147.46 44.18 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 1.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.9 mt -140.33 95.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 1.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -99.54 98.68 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 1.0 109.726 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.27 162.82 25.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 1.0 110.599 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.1 23.62 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 1.0 109.96 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 -86.24 1.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -50.08 -23.77 2.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.75 -0.853 . . . . 1.0 110.747 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -134.74 160.48 38.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 1.0 110.655 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.456 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.0 m-70 -143.34 105.42 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -104.83 144.49 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 1.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.473 HD21 ' CZ3' ' A' ' 34' ' ' TRP . 15.7 tp -128.87 136.18 50.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.0 110.272 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG21 ' CG2' ' A' ' 18' ' ' THR . 4.3 mt -132.58 93.9 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 1.0 109.8 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 103.89 14.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 1.0 110.531 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' C ' ' A' ' 62' ' ' ASN . 67.1 m-70 -69.44 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 1.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 61' ' ' HIS . 3.1 m120 -12.18 79.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 113.85 1.056 . . . . 1.0 113.85 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.7 m -71.63 145.44 48.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.781 . . . . 1.0 109.092 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -99.18 172.92 7.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 1.0 110.902 -179.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HA ' HG13 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -70.23 -4.63 22.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.639 -0.663 . . . . 1.0 111.136 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.73 -11.91 76.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.793 -1.194 . . . . 1.0 110.336 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.467 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -85.95 43.26 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.905 -1.35 . . . . 1.0 110.615 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 40.73 1.04 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 1.0 109.75 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.9 2.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.886 -1.285 . . . . 1.0 109.886 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.44 152.17 44.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.403 -1.057 . . . . 1.0 110.539 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 83.6 t -92.99 87.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 1.0 109.475 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.0 p -94.52 112.23 23.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 1.0 110.894 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 46.8 t80 -91.26 137.97 31.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 1.0 109.398 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -120.13 138.26 53.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 1.0 111.087 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.56 47.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.72 . . . . 1.0 109.356 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 62.22 132.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.782 . . . . 1.0 110.425 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.23 24.07 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 1.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.21 139.03 16.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.025 . . . . 1.0 109.972 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.96 68.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 1.0 110.8 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.417 ' OG ' ' CD1' ' A' ' 8' ' ' LEU . 71.1 p -54.65 171.88 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.981 -1.074 . . . . 1.0 109.554 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -165.88 104.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.035 -1.04 . . . . 1.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.57 -167.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 1.0 109.828 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -128.19 137.45 52.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 1.0 109.787 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.439 ' CD2' HG11 ' A' ' 11' ' ' VAL . 1.9 tm? -139.27 116.31 10.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.043 -1.036 . . . . 1.0 111.146 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -111.12 132.82 53.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.416 -0.803 . . . . 1.0 109.39 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 28.0 t -103.9 111.09 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.228 -0.92 . . . . 1.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -99.58 129.9 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.72 -176.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 1.0 110.374 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.321 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.279 0.561 . . . . 1.0 110.12 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 26' ' ' SER . 37.6 mm -101.93 140.31 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.128 -0.983 . . . . 1.0 110.073 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . 50.3 mt-10 -123.84 -178.6 4.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 1.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.2 t -105.4 115.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.804 . . . . 1.0 109.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -75.95 -39.76 55.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -124.95 106.92 28.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.65 176.57 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.565 1.297 . . . . 1.0 110.705 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 4.1 mt -72.05 172.22 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 1.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 20.6 m-85 -129.25 3.71 5.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.137 -0.977 . . . . 1.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 82' ' ' ALA . . . 70.43 153.52 1.04 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.95 134.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.114 . . . . 1.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -109.07 150.64 27.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.0 110.068 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 14' ' ' PHE . 1.1 p -160.55 -158.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.454 -0.779 . . . . 1.0 109.782 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.478 ' N ' HG12 ' A' ' 13' ' ' VAL . 5.8 m-85 -107.33 -154.51 0.53 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -120.16 121.76 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.85 -1.156 . . . . 1.0 110.763 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.34 -48.95 0.94 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HG3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.14 -147.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -1.109 . . . . 1.0 110.617 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.458 HG21 ' CG ' ' A' ' 61' ' ' HIS . 4.6 p -128.81 161.06 30.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 110.996 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.68 170.13 8.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.69 . . . . 1.0 109.477 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 93.38 2.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.013 . . . . 1.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.427 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 81.9 m-85 -94.67 162.63 13.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.51 -0.744 . . . . 1.0 109.552 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -140.67 153.98 46.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.945 -1.097 . . . . 1.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 80' ' ' SER . 3.6 tt -170.55 138.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.598 -0.689 . . . . 1.0 109.814 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 30.1 tt0 -96.43 170.41 9.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 1.0 110.559 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD12 ' CD2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -159.17 175.03 13.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.522 -0.736 . . . . 1.0 109.889 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB2' HD11 ' A' ' 2' ' ' ILE . 9.7 m -93.31 -44.16 8.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.083 -1.011 . . . . 1.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.82 150.79 53.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.95 . . . . 1.0 110.132 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.85 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.732 1.386 . . . . 1.0 110.652 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.65 76.65 9.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 1.0 110.218 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' CG1' ' NE2' ' A' ' 56' ' ' HIS . 7.4 p -95.17 143.73 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.29 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 31' ' ' HIS . 25.9 p80 -76.32 117.79 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.875 . . . . 1.0 110.231 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.92 -166.14 10.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.346 -1.502 . . . . 1.0 109.346 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.71 128.03 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -1.2 . . . . 1.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 28.2 m95 -94.7 154.66 17.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 1.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 4.4 ptmt -152.07 156.08 39.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 1.0 109.968 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.424 HD23 ' CE ' ' A' ' 67' ' ' MET . 5.4 mt -65.16 -133.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.903 . . . . 1.0 109.354 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -52.15 -23.31 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.474 -1.391 . . . . 1.0 110.126 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 159.52 39.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.385 -1.486 . . . . 1.0 109.385 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -119.33 109.15 39.04 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.235 -1.156 . . . . 1.0 109.607 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.21 111.56 3.34 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.586 1.308 . . . . 1.0 110.037 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.84 -144.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 1.0 110.153 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -143.96 150.9 39.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.986 -1.071 . . . . 1.0 110.319 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.84 113.31 20.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 1.0 110.136 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -177.91 -59.71 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 1.0 110.372 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -69.73 -69.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.493 1.26 . . . . 1.0 111.305 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -132.68 64.24 1.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.935 -1.103 . . . . 1.0 110.494 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.9 t -169.05 139.93 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 1.0 110.348 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.5 85.52 2.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 1.0 110.21 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 58' ' ' LEU . 28.6 mt -80.3 130.2 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 1.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.416 HG23 ' CD1' ' A' ' 59' ' ' ILE . 7.4 tt -142.97 102.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 1.0 109.848 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.57 159.27 19.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 1.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -113.44 20.84 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.395 -0.816 . . . . 1.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.84 -101.58 2.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.834 -1.307 . . . . 1.0 109.834 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -50.75 -21.76 1.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.417 -1.049 . . . . 1.0 110.673 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 1.5 mmtt -134.11 173.78 11.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 1.0 110.493 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.494 ' CD2' HD12 ' A' ' 25' ' ' LEU . 19.5 m-70 -126.34 135.95 52.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.0 109.736 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.3 mt -137.16 127.89 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.0 110.882 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 32.6 tp -103.25 149.12 25.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.0 109.963 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.416 ' CD1' HG23 ' A' ' 50' ' ' ILE . 55.1 mt -145.2 82.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.149 -0.969 . . . . 1.0 109.523 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.83 -179.82 5.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 1.0 110.775 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' C ' ' A' ' 62' ' ' ASN . 65.8 m-70 -137.5 -162.4 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.57 -0.706 . . . . 1.0 109.103 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 61' ' ' HIS . 1.7 t-20 -14.25 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 113.415 0.895 . . . . 1.0 113.415 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 61' ' ' HIS . 73.5 m -71.03 163.49 27.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.682 -0.636 . . . . 1.0 110.142 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 4.5 tp-100 -121.51 168.68 11.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.444 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 8.3 tp -76.52 17.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.849 -1.157 . . . . 1.0 112.124 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 -25.54 6.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.026 -1.63 . . . . 1.0 109.026 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 69' ' ' GLY . 54.1 mtp -54.59 -18.58 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -1.116 . . . . 1.0 110.722 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -42.22 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.634 -0.666 . . . . 1.0 110.95 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -176.81 -116.74 0.48 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.336 -1.506 . . . . 1.0 109.336 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.72 130.39 10.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.6 t -79.1 100.4 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 1.0 109.168 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -99.34 116.55 31.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.0 110.947 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 31.5 t80 -87.54 146.4 25.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 1.0 108.959 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 105.3 8.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.959 -1.088 . . . . 1.0 111.055 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 73' ' ' PHE . . . -139.45 121.48 15.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.595 -0.691 . . . . 1.0 109.369 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.32 -153.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 1.0 109.738 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -72.02 -10.51 59.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 110.719 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 3' ' ' GLU . . . -80.13 155.5 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.042 . . . . 1.0 110.525 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -159.9 95.51 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 110.013 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.433 ' CB ' HD13 ' A' ' 23' ' ' ILE . 36.8 m -85.51 167.54 15.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 1.0 110.293 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 72' ' ' SER . . . -169.89 106.22 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 1.0 110.894 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HB2' ' CA ' ' A' ' 10' ' ' GLY . . . -100.42 -161.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.989 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -115.66 148.56 39.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.955 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -140.82 132.44 27.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 1.0 110.518 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -132.6 131.2 41.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 1.0 109.825 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.44 151.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.309 -0.87 . . . . 1.0 110.124 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -148.34 144.8 27.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 1.0 110.382 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -73.51 146.16 45.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 1.0 110.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.233 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.239 0.543 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.97 118.17 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 1.0 110.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.68 179.0 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.936 . . . . 1.0 110.355 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.58 106.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 1.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.87 -36.86 84.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.273 -0.892 . . . . 1.0 109.281 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 106.31 27.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.421 -0.799 . . . . 1.0 109.804 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.79 172.82 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.587 1.309 . . . . 1.0 110.864 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 10.6 mt -82.05 177.73 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.765 . . . . 1.0 109.56 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -136.25 6.65 3.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.941 -1.099 . . . . 1.0 111.483 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.41 144.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 1.0 109.997 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG23 ' CE1' ' A' ' 21' ' ' PHE . 5.8 m -141.36 -175.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -1.165 . . . . 1.0 110.14 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.43 158.16 45.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.194 -0.941 . . . . 1.0 110.322 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 17' ' ' GLU . 2.9 p -153.87 134.37 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.348 -0.845 . . . . 1.0 109.837 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -92.09 55.19 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 1.0 110.546 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t 48.44 89.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.87 . . . . 1.0 110.808 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.44 -33.99 3.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.044 -1.622 . . . . 1.0 109.044 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' CB ' HG22 ' A' ' 13' ' ' VAL . 2.2 mt-10 -67.34 -162.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.351 -1.088 . . . . 1.0 109.552 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 m -135.64 119.59 17.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.135 -0.978 . . . . 1.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.97 165.25 23.67 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.348 -0.845 . . . . 1.0 109.077 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -147.13 115.57 6.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.923 -1.111 . . . . 1.0 110.883 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 71.9 m-85 -113.82 130.8 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.0 109.758 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -115.06 151.61 33.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 1.0 110.649 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 13.1 tt -170.87 154.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.447 -0.783 . . . . 1.0 109.73 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.3 160.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 1.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' CD2' ' CD2' ' A' ' 56' ' ' HIS . 2.4 mm? -112.98 -168.76 1.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 1.0 109.898 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -99.55 -45.32 5.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 1.0 110.129 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.28 153.97 38.05 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 1.0 110.117 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.35 -166.02 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.717 1.377 . . . . 1.0 110.485 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.82 54.68 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 1.0 110.398 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.04 117.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 1.0 110.413 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -98.75 144.7 27.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 1.0 110.025 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -151.13 171.89 30.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.763 -1.335 . . . . 1.0 109.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -139.08 179.22 6.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.384 -1.068 . . . . 1.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.508 ' CE3' ' CD1' ' A' ' 58' ' ' LEU . 59.8 m95 -123.69 133.41 53.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 1.0 110.701 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -129.08 111.47 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.786 . . . . 1.0 110.711 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.44 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 1.0 108.725 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -92.27 9.05 35.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 1.0 109.497 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 127.79 -1.23 6.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.09 -1.204 . . . . 1.0 110.09 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -96.7 137.61 21.42 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.251 . . . . 1.0 109.913 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.97 106.05 2.18 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.613 1.323 . . . . 1.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.02 3.37 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 110.573 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 m -70.55 -35.48 73.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.07 . . . . 1.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.74 44.59 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 1.0 110.548 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -115.82 158.96 40.83 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.346 -0.847 . . . . 1.0 110.231 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.53 -12.87 27.34 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.759 1.4 . . . . 1.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.54 -17.81 15.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.0 110.518 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.4 131.84 35.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 1.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -133.15 77.41 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 1.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.403 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 1.1 pp -96.83 105.32 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 1.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.8 111.54 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 1.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -132.83 161.46 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 1.0 110.094 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.27 33.23 5.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 1.0 110.183 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 56' ' ' HIS . . . 86.38 -91.11 1.7 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -48.24 -24.31 1.14 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.648 -0.913 . . . . 1.0 110.769 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.16 165.76 17.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 1.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.496 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 m-70 -148.52 114.07 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 57' ' ' ILE . 55.3 mt -116.4 136.11 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 1.0 110.291 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.508 ' CD1' ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -115.57 133.94 55.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.26 -0.9 . . . . 1.0 110.295 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.26 83.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 1.0 109.631 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' HD23 ' A' ' 58' ' ' LEU . 4.6 mt -86.69 116.01 24.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 1.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 62' ' ' ASN . 86.9 m-70 -79.06 -169.65 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 1.0 110.452 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 20.4 p-10 -14.95 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.0 m -71.11 178.53 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.69 . . . . 1.0 109.482 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 10.4 tp60 -111.28 158.82 18.55 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.092 -1.005 . . . . 1.0 109.102 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.544 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.1 mp -46.89 -25.29 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.0 111.074 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.72 -119.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.466 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 3.3 mtt 42.13 30.73 0.2 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.715 -0.874 . . . . 1.0 111.487 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.21 53.0 2.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 1.0 110.098 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.39 -126.46 2.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.57 154.07 36.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 1.0 110.374 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 74.5 t -89.28 86.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.328 -0.858 . . . . 1.0 110.031 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 97.2 p -94.25 109.62 21.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 1.0 110.231 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CZ ' ' HA3' ' A' ' 32' ' ' GLY . 42.5 t80 -78.54 157.44 28.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 1.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -146.1 146.0 30.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 1.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -169.45 -146.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 1.0 110.113 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.8 -69.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 1.0 110.634 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -142.98 33.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 1.0 110.249 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.81 120.43 34.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 1.0 110.054 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.18 88.45 2.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 1.0 110.237 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.416 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 25.7 m -82.36 174.73 10.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.994 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.65 97.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 1.0 110.381 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -97.41 -163.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.0 109.995 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 129.04 53.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 1.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 126.52 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.0 110.299 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 137.82 46.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 1.0 109.902 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 42.5 t -100.21 108.22 22.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 1.0 110.133 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -86.6 107.54 18.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 1.0 110.219 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.27 -152.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 1.0 110.281 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.97 -1.014 . . . . 1.0 110.653 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.169 0.509 . . . . 1.0 110.281 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.5 mt -131.53 151.13 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 1.0 110.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -91.63 9.54 31.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 1.0 111.155 -179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 17.3 t 62.06 145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.41 -0.806 . . . . 1.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.79 -41.2 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 1.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -116.79 107.88 45.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.609 -0.682 . . . . 1.0 109.899 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.07 176.65 6.72 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 1.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD13 ' N ' ' A' ' 81' ' ' ALA . 12.4 mt -70.25 171.23 10.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.417 -0.802 . . . . 1.0 110.49 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.5 m-85 -129.72 169.23 15.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 1.0 110.074 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 155.52 31.9 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.202 -1.159 . . . . 1.0 110.202 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -159.55 155.23 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 1.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.1 157.11 30.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.983 . . . . 1.0 110.784 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 p -157.87 142.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 1.0 110.078 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.41 46.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 1.0 110.472 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 88' ' ' GLU . 11.3 t 61.42 142.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 1.0 110.175 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 87.8 -56.21 4.39 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.51 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -1.162 . . . . 1.0 109.926 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.17 150.33 36.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 1.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.1 168.94 10.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 1.0 109.654 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -147.58 97.04 2.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 1.0 110.78 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.495 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 90.8 m-85 -106.07 115.94 31.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 1.0 109.535 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -107.49 151.71 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.042 . . . . 1.0 110.985 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 80' ' ' SER . 1.4 tt -159.29 123.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -0.767 . . . . 1.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -87.3 142.05 28.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 1.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.21 19.6 17.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 1.0 110.412 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.81 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.663 -0.648 . . . . 1.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.67 138.73 27.98 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.302 -0.874 . . . . 1.0 110.068 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.62 109.75 2.97 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.584 1.307 . . . . 1.0 110.452 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -174.71 -45.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 1.0 110.346 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 75' ' ' ALA . 94.3 t -53.27 163.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 1.0 110.48 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -178.11 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 1.0 110.104 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -119.94 -132.42 4.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.89 179.17 7.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -1.11 . . . . 1.0 110.378 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.524 ' NE1' ' CE1' ' A' ' 73' ' ' PHE . 27.5 m95 -127.25 148.44 50.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.103 -0.998 . . . . 1.0 111.622 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -154.35 -114.78 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.389 -0.82 . . . . 1.0 109.128 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 2.7 mp -157.15 -158.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.925 -1.109 . . . . 1.0 108.775 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -22.44 8.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.777 -1.202 . . . . 1.0 109.425 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.09 -113.83 0.01 OUTLIER Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 1.3 mt-30 -134.72 178.43 1.77 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' ' CG ' ' A' ' 33' ' ' GLN . 50.6 Cg_endo -89.29 113.07 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.443 1.233 . . . . 1.0 111.281 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -98.04 -168.27 1.64 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.672 -1.268 . . . . 1.0 110.211 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.434 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.6 t -113.24 161.91 16.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 1.0 110.086 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.02 123.32 20.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.263 -0.898 . . . . 1.0 109.491 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -175.8 -59.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 1.0 110.96 -179.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 40.2 Cg_endo -67.72 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.412 1.217 . . . . 1.0 111.296 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.11 69.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.14 . . . . 1.0 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 136.88 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 1.0 110.394 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.43 78.61 1.68 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 1.0 109.732 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.444 HG13 ' CD1' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -91.89 136.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 1.0 110.233 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.1 pt -135.32 106.95 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.442 -0.786 . . . . 1.0 109.955 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.7 141.21 34.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 1.0 110.352 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.69 17.9 14.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 1.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 -26.61 16.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.79 -27.03 40.39 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.449 -1.03 . . . . 1.0 109.582 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.01 122.89 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.542 -0.724 . . . . 1.0 109.701 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.54 103.69 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 1.0 109.995 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.75 137.6 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 1.0 110.548 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.478 ' HB2' ' CE3' ' A' ' 34' ' ' TRP . 29.3 tp -109.69 142.68 40.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 1.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -138.44 82.73 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 1.0 110.29 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' CD1' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.64 167.02 22.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 1.0 110.181 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 35.5 m-70 -129.75 -163.72 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 1.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -13.4 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 61' ' ' HIS . 69.6 m -87.61 -173.33 4.28 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.51 -0.744 . . . . 1.0 109.024 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.445 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -167.01 -160.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 1.0 110.098 -179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.48 81.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.865 0.84 . . . . 1.0 109.904 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.62 -40.67 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.604 -1.798 . . . . 1.0 108.604 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.439 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 31.0 mtt -87.06 39.95 0.89 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -1.121 . . . . 1.0 110.549 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -91.31 27.4 1.94 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 1.0 110.173 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.49 -109.74 2.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.229 -1.549 . . . . 1.0 109.229 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -146.56 139.58 25.49 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.538 -0.978 . . . . 1.0 110.522 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' CZ ' ' A' ' 21' ' ' PHE . 26.2 t -78.99 128.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 p -123.97 127.58 48.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.0 111.285 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.524 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 51.1 t80 -104.63 137.11 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 1.0 109.439 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -130.72 144.17 51.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 1.0 109.939 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' A' ' 30' ' ' VAL . . . -159.12 -148.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.805 . . . . 1.0 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.26 51.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 1.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -154.46 30.28 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 1.0 109.931 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.2 108.78 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.024 -1.047 . . . . 1.0 110.164 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.901 . . . . 1.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.437 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 6.5 p -102.39 175.57 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 1.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -169.76 103.12 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.123 -0.986 . . . . 1.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.63 -176.14 3.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 1.0 109.752 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -108.1 134.66 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 1.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.08 141.61 48.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.409 -0.807 . . . . 1.0 109.858 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -139.22 125.93 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.0 110.062 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 64' ' ' GLN . 40.6 t -96.9 132.8 40.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.901 . . . . 1.0 109.921 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -124.23 119.51 29.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 1.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' HG22 ' A' ' 15' ' ' VAL . 12.4 pt-20 -63.19 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.935 . . . . 1.0 110.193 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.035 -0.983 . . . . 1.0 110.182 179.864 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.437 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 2.7 mp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.201 0.524 . . . . 1.0 110.278 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -171.11 126.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 1.0 109.85 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 2' ' ' ILE . 15.9 mt-10 -152.72 -77.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 1.0 110.784 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 HG23 ' OG ' ' A' ' 80' ' ' SER . 46.2 t -47.15 107.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 1.0 111.281 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 2.8 mm-40 -96.23 -26.1 15.55 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.431 -0.793 . . . . 1.0 109.039 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -135.49 119.39 13.03 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.4 168.12 18.78 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.537 1.283 . . . . 1.0 111.763 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.406 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 7.8 mt -82.4 161.33 22.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.631 -0.668 . . . . 1.0 109.923 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -115.2 168.12 10.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 1.0 110.189 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.63 124.65 7.91 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.67 179.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 1.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -135.04 161.32 35.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 1.0 110.667 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 p -160.7 129.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 1.0 109.957 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 57.3 4.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.951 . . . . 1.0 110.361 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t 48.66 91.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.174 -0.954 . . . . 1.0 110.531 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 132.36 -34.92 2.43 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -67.45 -163.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -1.07 . . . . 1.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.9 m -136.74 115.4 12.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 1.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -79.55 149.85 31.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.206 -0.934 . . . . 1.0 109.517 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -127.04 137.33 53.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 1.0 110.746 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 62.1 m-85 -133.38 115.45 14.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 1.0 109.797 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.3 154.76 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 1.0 110.731 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tt -170.32 122.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 1.0 109.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -88.01 171.62 10.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 1.0 110.217 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -150.08 128.36 12.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.817 . . . . 1.0 110.097 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.6 t -67.19 -49.36 64.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 1.0 110.724 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.97 136.32 44.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 1.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.19 -159.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.605 1.318 . . . . 1.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.47 118.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.963 . . . . 1.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 17.8 m -103.22 119.35 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.383 -0.823 . . . . 1.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.09 19.92 2.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 1.0 110.312 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.38 -150.04 23.41 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.12 165.72 2.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -1.04 . . . . 1.0 109.907 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.533 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 27.8 m95 -104.55 150.6 24.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 1.0 110.374 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 2.3 ttpt -149.3 122.99 9.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 1.0 109.328 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.78 -132.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 1.0 108.824 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -52.46 -24.04 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.427 -1.421 . . . . 1.0 109.436 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.18 41.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -122.27 116.85 29.55 Favored Pre-proline 0 N--CA 1.484 1.273 0 O-C-N 121.271 -1.135 . . . . 1.0 109.213 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.82 99.86 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.562 1.296 . . . . 1.0 110.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 42' ' ' THR . 3.8 pp -70.95 -157.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 1.0 110.421 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.49 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -166.68 170.07 12.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 1.0 109.755 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.17 105.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 1.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.43 175.04 3.07 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 1.0 110.287 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.44 -24.62 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.676 1.356 . . . . 1.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -79.04 -11.56 60.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 1.0 110.631 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -124.53 167.45 14.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 1.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 84.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 1.0 110.009 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -102.1 131.99 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 1.0 110.268 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.9 tt -147.95 135.54 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.0 110.214 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' OE2' ' CG2' ' A' ' 30' ' ' VAL . 5.1 pt-20 -133.78 176.74 8.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 1.0 110.512 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -136.01 23.11 3.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 1.0 109.977 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.35 -88.65 1.4 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -5.21 27.33 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.623 -0.928 . . . . 1.0 111.077 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -132.65 164.78 25.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.846 -1.159 . . . . 1.0 110.572 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CD2' HD12 ' A' ' 25' ' ' LEU . 27.7 m-70 -142.36 127.59 18.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 1.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.63 137.08 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.922 . . . . 1.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.517 ' CD2' ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -126.15 144.29 50.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 1.0 110.591 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.3 mt -139.58 115.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 1.0 109.59 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mt -111.09 97.09 6.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.077 -1.014 . . . . 1.0 110.72 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 62' ' ' ASN . 62.7 m-70 -69.87 -166.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.007 . . . . 1.0 109.841 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 61' ' ' HIS . 45.0 p-10 -16.11 82.48 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.197 0.814 . . . . 1.0 113.197 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 70.1 m -77.4 -168.14 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.634 -0.666 . . . . 1.0 110.159 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -129.02 170.8 13.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 9.1 tp -78.67 25.1 0.27 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 1.0 111.95 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.68 -23.14 5.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.432 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 33.1 mtt -61.3 -12.98 15.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -1.139 . . . . 1.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -43.3 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.416 -0.802 . . . . 1.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.59 -119.14 0.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.371 -1.492 . . . . 1.0 109.371 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.31 149.63 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -1.062 . . . . 1.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 ' CE1' ' A' ' 21' ' ' PHE . 78.9 t -89.11 83.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.0 109.54 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -86.02 103.31 14.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 1.0 110.806 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -98.15 151.64 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 1.0 109.23 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -156.43 129.69 8.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.967 -1.083 . . . . 1.0 111.393 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.08 22.72 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.707 0.765 . . . . 1.0 109.269 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.17 -160.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.544 -0.909 . . . . 1.0 108.544 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 12.2 p30 -64.46 -22.8 67.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.923 -1.11 . . . . 1.0 109.741 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.88 169.15 18.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.0 110.216 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.55 102.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.0 110.447 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.404 ' OG ' HG23 ' A' ' 4' ' ' VAL . 71.1 m -75.41 170.08 16.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 1.0 109.954 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.46 111.44 0.57 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.135 -0.978 . . . . 1.0 110.541 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -100.16 -173.71 2.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 1.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -119.07 106.89 12.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 1.0 110.144 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.88 127.66 55.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.969 . . . . 1.0 110.282 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 3.1 pttp -130.88 113.62 14.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 1.0 110.291 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 61.5 t -87.58 104.04 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.224 -0.923 . . . . 1.0 110.233 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 154.54 22.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.99 -153.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 1.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.311 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.46 ' O ' ' CG ' ' A' ' 1' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.641 0.734 . . . . 1.0 110.528 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pt -117.08 178.88 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.054 -1.029 . . . . 1.0 110.194 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.77 -151.09 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.269 -0.894 . . . . 1.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 78' ' ' ALA . 87.2 t -130.66 123.57 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.125 -0.984 . . . . 1.0 110.216 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -86.41 -57.18 3.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 1.0 109.326 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 102.96 48.6 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.657 -0.652 . . . . 1.0 109.896 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.93 174.51 10.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.627 1.33 . . . . 1.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.402 HD13 ' CB ' ' A' ' 80' ' ' SER . 97.6 mt -75.42 174.78 9.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.0 110.355 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -142.94 150.3 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 1.0 109.883 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.98 140.3 28.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.93 170.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 1.0 109.77 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -138.29 158.35 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.963 -1.086 . . . . 1.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -160.87 138.64 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 1.0 110.393 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.55 51.22 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 1.0 109.865 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 86' ' ' VAL . 23.1 t 51.83 72.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.815 0.817 . . . . 1.0 110.423 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 157.05 -28.57 0.52 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.564 -1.814 . . . . 1.0 108.564 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -73.96 -160.93 0.1 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.979 . . . . 1.0 109.579 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -135.28 116.46 14.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.927 . . . . 1.0 110.521 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.11 163.19 25.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 1.0 109.01 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -148.8 124.63 10.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.942 -1.098 . . . . 1.0 111.078 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 71' ' ' VAL . 64.6 m-85 -132.18 109.9 10.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.0 109.282 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -115.85 159.4 21.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0 110.515 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 tt -170.83 123.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -0.764 . . . . 1.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -100.44 157.13 16.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 1.0 110.179 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 56' ' ' HIS . 35.4 mt -114.8 -150.01 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.0 109.922 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.43 -70.23 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 1.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.61 143.49 33.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.08 -174.08 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 1.0 110.555 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 53.07 85.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 1.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.47 174.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 1.0 110.256 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -128.81 130.04 46.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 1.0 109.878 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.68 175.12 23.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.963 -1.255 . . . . 1.0 109.963 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -156.17 151.64 26.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -1.053 . . . . 1.0 109.793 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 32.3 m95 -106.92 155.48 19.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 1.0 110.481 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 12.9 ttpt -143.26 112.73 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.335 -0.853 . . . . 1.0 109.61 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 1.2 mp -66.37 -123.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 1.0 109.744 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -48.79 -25.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.477 -1.389 . . . . 1.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 148.97 39.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.436 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -136.88 136.91 21.94 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.047 -1.267 . . . . 1.0 109.95 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.22 91.01 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.65 1.342 . . . . 1.0 110.557 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.46 -170.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 1.0 110.552 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 172.07 13.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.86 . . . . 1.0 109.965 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 104.14 5.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 1.0 110.17 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.13 176.11 2.26 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 1.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.74 -19.43 27.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.669 1.352 . . . . 1.0 110.372 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -102.3 -20.21 14.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 110.187 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 72.2 m -93.66 131.44 38.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 1.0 110.039 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 1.8 tt0 -104.98 46.16 0.93 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.262 -0.899 . . . . 1.0 109.801 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 tt -79.59 80.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.935 -1.103 . . . . 1.0 109.901 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.16 145.63 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 1.0 110.224 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.94 120.1 18.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.212 -0.93 . . . . 1.0 110.341 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.76 19.59 12.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 1.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.32 -95.29 1.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -21.23 1.32 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.671 -0.9 . . . . 1.0 111.101 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -134.07 136.31 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.916 -1.115 . . . . 1.0 111.046 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.438 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.7 m-70 -121.62 116.44 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 1.0 109.687 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.02 130.08 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 1.0 110.745 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.5 tp -117.13 131.61 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 1.0 109.982 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.72 96.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 1.0 109.957 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.2 144.99 28.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 1.0 110.507 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' C ' ' A' ' 62' ' ' ASN . 58.2 m-70 -111.24 -163.46 0.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 1.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.496 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 17.6 p-10 -14.49 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' HIS . 75.3 m -80.78 -159.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.694 -0.629 . . . . 1.0 109.645 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.431 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -158.02 -160.78 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.237 -0.914 . . . . 1.0 109.944 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.35 33.22 0.4 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.875 -1.141 . . . . 1.0 111.719 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.48 4.1 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 1.0 108.645 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.465 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 34.6 mtt -87.62 37.17 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.567 -0.961 . . . . 1.0 110.46 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 51.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 1.0 109.922 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.58 1.91 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -146.38 148.11 31.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 1.0 110.272 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 77.3 t -89.94 91.37 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 1.0 109.862 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.9 p -96.89 103.23 15.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 1.0 110.533 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -88.24 156.88 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 1.0 109.775 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.11 144.93 26.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.05 -1.031 . . . . 1.0 110.656 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.61 -147.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 1.0 109.887 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.83 -62.63 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.005 -1.06 . . . . 1.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.93 24.41 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.418 -0.801 . . . . 1.0 109.926 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -106.75 137.8 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 1.0 110.294 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.61 62.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 1.0 110.252 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.402 ' CB ' HD13 ' A' ' 8' ' ' LEU . 8.5 p -74.97 173.6 10.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 1.0 110.376 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.64 98.86 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.55 4.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.0 110.203 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -126.45 104.73 8.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 1.0 109.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.8 tp -109.36 146.79 33.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 1.0 110.483 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -149.79 112.0 4.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 1.0 109.777 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 42.3 t -79.41 111.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.064 -1.022 . . . . 1.0 110.079 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.53 108.5 20.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 1.0 110.246 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -75.22 149.06 39.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 1.0 110.092 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.199 -179.868 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.289 0.566 . . . . 1.0 110.206 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 2' ' ' ILE . 69.0 mt -110.61 153.9 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 1.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.09 178.92 4.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.108 -0.995 . . . . 1.0 110.388 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.7 t -116.84 115.14 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 1.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -87.99 -51.29 5.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 1.0 109.608 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -114.0 105.27 54.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.702 -0.624 . . . . 1.0 110.428 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.4 178.03 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.619 1.326 . . . . 1.0 110.707 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 81' ' ' ALA . 7.5 mt -78.34 -170.73 2.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.842 . . . . 1.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 35.1 p90 -152.2 130.5 12.04 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 1.0 109.904 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.51 150.61 30.17 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 12' ' ' GLU . 48.1 t -149.13 167.97 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.484 -1.01 . . . . 1.0 109.826 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 45.6 mt-10 -125.87 154.99 41.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 1.0 110.368 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 17' ' ' GLU . 3.6 p -154.01 147.95 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 1.0 109.948 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -98.14 47.09 1.0 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.0 111.012 -179.347 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG21 ' CG1' ' A' ' 86' ' ' VAL . 61.1 t 48.79 95.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.219 -0.926 . . . . 1.0 110.717 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.61 -38.15 1.82 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.644 -1.782 . . . . 1.0 108.644 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' CB ' HG22 ' A' ' 13' ' ' VAL . 3.2 mt-10 -69.7 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.484 -1.009 . . . . 1.0 109.179 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.405 ' CG2' HG21 ' A' ' 59' ' ' ILE . 19.6 m -134.27 122.16 22.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.94 -1.1 . . . . 1.0 110.954 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.58 157.7 27.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 1.0 108.859 178.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -139.84 131.16 26.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.838 -1.164 . . . . 1.0 111.051 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.98 126.39 41.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 1.0 109.721 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.87 154.72 32.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.971 . . . . 1.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -170.33 140.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 1.0 110.008 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.27 162.73 17.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 45.1 mt -124.97 -154.93 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 109.815 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.81 -30.12 5.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.132 -0.98 . . . . 1.0 110.04 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -127.77 121.95 22.28 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.0 109.847 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.27 116.86 4.87 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.47 1.247 . . . . 1.0 110.611 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.2 -1.87 7.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 1.0 110.64 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.1 t 55.7 64.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.048 -1.033 . . . . 1.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -168.8 135.4 1.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 1.0 110.223 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.94 168.16 24.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 11.4 tt0 -156.32 159.83 39.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.181 -1.188 . . . . 1.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 23.7 m95 -119.89 163.08 18.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 1.0 110.345 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -164.82 150.16 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 110.348 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.9 mt -68.32 -128.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.0 109.204 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -50.25 -24.64 3.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.604 -1.31 . . . . 1.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.71 41.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -126.07 109.79 24.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.329 -1.1 . . . . 1.0 110.054 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.84 89.47 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.597 1.314 . . . . 1.0 110.503 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.75 -172.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 1.0 110.634 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.8 m -136.69 156.85 47.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 1.0 110.094 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -78.64 115.21 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 1.0 110.184 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -170.16 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 111.116 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 44.2 Cg_endo -70.83 -90.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.27 1.142 . . . . 1.0 110.837 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -125.23 40.33 3.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.774 -1.204 . . . . 1.0 110.43 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 27.8 t -107.92 146.92 31.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 1.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -141.63 74.38 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 1.0 110.077 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.1 tt -91.09 128.94 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 1.0 110.481 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.0 118.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 1.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 170.2 16.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 1.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.88 19.94 2.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 1.0 110.216 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.56 -76.91 1.55 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -18.39 18.49 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.662 -0.905 . . . . 1.0 110.684 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.45 126.57 13.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 1.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 70.5 m-70 -103.19 115.12 29.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.797 . . . . 1.0 109.725 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 mt -118.26 144.32 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.004 . . . . 1.0 110.477 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.493 ' CD2' ' CE3' ' A' ' 34' ' ' TRP . 46.6 tp -132.92 132.56 42.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 1.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 18' ' ' THR . 51.6 mt -132.38 118.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 1.0 110.037 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -119.87 106.71 12.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 1.0 110.529 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 83.9 m-70 -72.48 -170.86 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 1.0 109.965 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.0 p-10 -15.02 81.74 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 61' ' ' HIS . 72.8 m -70.92 -158.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.52 -0.738 . . . . 1.0 109.611 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -138.37 174.48 10.5 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.153 -0.967 . . . . 1.0 108.595 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.485 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 4.5 tp -78.37 30.07 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.98 -1.075 . . . . 1.0 112.037 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.79 -11.43 10.25 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.434 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 8.5 mtt -85.17 42.85 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 1.0 110.822 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -89.93 62.09 5.53 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.071 -1.018 . . . . 1.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.89 -119.59 1.37 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.796 -1.322 . . . . 1.0 109.796 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.85 156.59 43.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -1.007 . . . . 1.0 110.571 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.94 82.04 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.45 -0.781 . . . . 1.0 109.557 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -89.34 129.85 35.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 1.0 110.45 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.507 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 21.5 t80 -98.31 145.81 26.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.478 -0.764 . . . . 1.0 109.679 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -120.66 100.9 7.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 1.0 110.426 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.03 89.33 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.902 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.46 -153.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 1.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -53.35 -24.9 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.0 110.346 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.25 134.22 39.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 1.0 110.191 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.22 149.64 30.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 1.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -138.6 174.91 10.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.95 . . . . 1.0 110.18 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 72' ' ' SER . . . -163.64 104.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 1.0 110.302 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.48 -160.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 1.0 110.078 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.59 115.98 9.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.959 . . . . 1.0 110.014 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.68 128.95 49.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 111.029 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -125.91 136.72 53.37 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.322 -0.861 . . . . 1.0 109.665 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 32.1 t -92.64 140.5 16.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 1.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -124.59 128.34 48.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.09 140.67 37.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 1.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.219 0.533 . . . . 1.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 3' ' ' GLU . 2.8 tp -157.26 151.69 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -79.98 -147.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 1.0 110.188 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.65 136.68 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 1.0 110.113 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -86.98 -49.49 7.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.423 -0.798 . . . . 1.0 109.646 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 106.26 51.69 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 1.0 110.337 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -71.74 174.12 11.6 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.556 1.293 . . . . 1.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 15.5 mt -72.83 178.12 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 1.0 109.789 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.1 m-85 -142.24 132.91 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 1.0 110.073 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.24 141.85 48.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.1 t -141.09 156.84 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -1.086 . . . . 1.0 109.653 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -111.48 150.09 30.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 1.0 110.422 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.01 165.37 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 1.0 110.542 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.411 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.91 32.85 5.79 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.525 -0.735 . . . . 1.0 109.222 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 10.9 t 64.92 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.69 0.757 . . . . 1.0 110.188 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.471 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 142.87 -25.44 2.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.139 -1.584 . . . . 1.0 109.139 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -1.093 . . . . 1.0 109.947 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -136.85 110.19 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 1.0 110.425 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.32 142.65 35.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 1.0 109.688 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -119.73 105.69 11.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 1.0 110.627 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' CD2' HD21 ' A' ' 58' ' ' LEU . 62.6 m-85 -96.03 124.95 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 1.0 109.385 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -114.56 152.36 31.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.026 -1.046 . . . . 1.0 110.99 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -167.6 117.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.681 . . . . 1.0 109.547 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.15 165.31 11.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 110.866 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' CD1' ' CD2' ' A' ' 56' ' ' HIS . 40.5 mt -129.08 -144.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 1.0 109.494 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -130.91 -47.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -100.79 160.0 28.0 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.936 . . . . 1.0 110.696 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.99 124.23 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.728 1.383 . . . . 1.0 110.381 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.19 101.07 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 1.0 110.093 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.21 60.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.0 110.151 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 28.1 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 1.0 109.992 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.23 176.17 28.94 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -158.74 139.96 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -1.101 . . . . 1.0 109.772 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.49 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 31.6 m95 -95.52 164.94 12.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 1.0 110.841 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -165.01 160.37 18.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 179.481 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.418 HD12 ' HG2' ' A' ' 67' ' ' MET . 0.2 OUTLIER -65.08 -141.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.062 . . . . 1.0 108.838 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.8 -28.16 0.6 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.508 -1.37 . . . . 1.0 110.385 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 164.18 39.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.436 ' HG3' ' CD2' ' A' ' 41' ' ' LEU . 26.4 tt0 -123.32 95.91 44.83 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.37 -1.076 . . . . 1.0 108.515 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.72 77.23 3.76 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.693 1.365 . . . . 1.0 111.455 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD2' ' HG3' ' A' ' 39' ' ' GLN . 4.2 pp -171.76 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.198 -0.938 . . . . 1.0 110.625 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.9 m -69.86 -19.69 63.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.933 -1.104 . . . . 1.0 110.299 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.34 100.43 11.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.481 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -179.56 -59.02 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 1.0 110.375 179.78 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.9 Cg_endo -74.58 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.44 1.232 . . . . 1.0 110.445 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 30.12 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 1.0 110.16 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.8 t -129.13 155.62 45.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 1.0 110.2 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 80.98 1.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 1.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 15.5 tt -82.31 117.28 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 1.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.59 94.54 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 1.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.22 163.05 15.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 1.0 110.359 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.67 26.33 5.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 1.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.21 -96.41 2.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -21.68 2.54 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.635 -0.921 . . . . 1.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -122.05 149.58 43.33 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.022 -1.049 . . . . 1.0 110.173 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.497 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 61.6 m-70 -128.29 113.57 15.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 1.0 109.83 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.5 mm -124.08 151.26 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 1.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 21' ' ' PHE . 6.5 tp -136.11 136.86 40.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.797 . . . . 1.0 109.989 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.41 93.53 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 1.0 110.276 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 21' ' ' PHE . 7.0 mt -89.74 118.43 29.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.903 . . . . 1.0 110.242 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.7 m-70 -89.66 -167.83 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 1.0 110.289 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 43.0 t30 -15.35 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' HIS . 57.1 m -75.88 140.1 42.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.586 -0.696 . . . . 1.0 109.397 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -89.08 -177.39 5.43 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.218 -0.926 . . . . 1.0 110.455 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -1.65 14.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 1.0 111.528 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.35 -17.57 60.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.99 -1.244 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.463 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 1.5 mtt -84.73 42.07 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.281 . . . . 1.0 111.243 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -90.96 41.13 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 1.0 110.035 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.18 -139.5 5.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.99 157.95 34.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 1.0 110.509 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.11 98.54 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 1.0 109.71 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -96.76 141.1 30.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 1.0 110.76 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 35.9 t80 -121.77 143.44 49.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -0.829 . . . . 1.0 109.54 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -120.06 114.72 22.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 1.0 110.545 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.456 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -145.94 132.08 19.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 1.0 109.62 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.57 -150.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 1.0 109.765 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -90.35 45.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.973 . . . . 1.0 109.929 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.02 167.05 31.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 1.0 110.33 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.66 135.96 8.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 1.0 110.299 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.442 ' CB ' HD13 ' A' ' 8' ' ' LEU . 4.7 p -101.79 176.11 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -165.58 109.83 0.85 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.992 . . . . 1.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.08 179.88 4.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 1.0 109.816 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -114.12 107.94 16.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 1.0 110.089 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 tp -108.76 138.92 44.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 1.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -142.03 136.04 29.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 1.0 109.97 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 45.2 t -101.28 135.07 39.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.268 -0.895 . . . . 1.0 110.245 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.33 120.33 18.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -84.91 170.16 13.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 1.0 110.037 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.209 179.92 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.312 0.577 . . . . 1.0 110.262 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.45 -175.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 1.0 110.007 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 2.4 pm0 -147.83 -159.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 1.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 HG23 ' OG ' ' A' ' 80' ' ' SER . 75.1 t -116.92 107.47 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 1.0 110.306 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -74.96 -34.47 62.05 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 1.0 109.175 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -131.15 107.82 14.97 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.519 -0.738 . . . . 1.0 109.482 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.98 175.28 8.5 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.546 1.287 . . . . 1.0 110.99 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 13.7 mt -71.37 -177.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 1.0 109.771 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -122.57 -14.15 7.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.084 -1.01 . . . . 1.0 111.39 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.87 118.66 0.01 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.911 -1.275 . . . . 1.0 109.911 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.5 -176.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.782 -1.423 . . . . 1.0 110.93 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.5 173.01 10.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 1.0 109.592 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 m -149.86 -176.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.088 . . . . 1.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.39 25.22 6.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.147 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t 61.91 85.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.575 -0.703 . . . . 1.0 110.759 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.55 -25.17 3.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.191 -1.163 . . . . 1.0 110.191 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.03 -144.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -1.203 . . . . 1.0 110.269 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 29.9 m -149.82 111.56 4.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 1.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.74 165.66 22.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 1.0 109.96 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -143.3 110.16 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 1.0 110.772 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.45 125.02 53.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -0.807 . . . . 1.0 109.593 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.16 157.13 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 1.0 111.335 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 56' ' ' HIS . 9.3 tt -166.32 129.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 1.0 109.556 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -108.63 138.2 45.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 1.0 110.681 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.4 mt -94.01 173.36 7.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 1.0 109.751 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -74.29 -61.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.0 . . . . 1.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -117.77 131.04 24.3 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.029 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.13 126.2 9.73 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.513 1.27 . . . . 1.0 110.236 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.63 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.3 t -97.34 148.19 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 1.0 110.065 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -86.53 -166.47 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.0 110.17 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.84 162.11 35.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 1.0 109.613 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.49 171.65 11.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -1.126 . . . . 1.0 109.98 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.523 ' CE3' ' CD1' ' A' ' 58' ' ' LEU . 28.8 m95 -111.87 176.37 5.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.106 -0.996 . . . . 1.0 110.589 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 5.6 ttmt -165.38 126.14 1.91 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.388 -0.82 . . . . 1.0 108.812 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.77 -131.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.0 109.112 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -51.65 -24.51 5.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.337 -1.477 . . . . 1.0 109.698 179.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.38 41.64 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.08 -1.608 . . . . 1.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -122.5 111.84 31.39 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 1.0 110.555 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.76 96.59 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.679 1.357 . . . . 1.0 109.651 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 42' ' ' THR . 3.1 pp -70.05 -153.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 1.0 110.526 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -152.72 -166.04 2.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 1.0 110.027 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.67 107.03 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 1.0 110.047 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -147.67 168.82 10.4 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 1.0 110.235 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.05 -19.11 26.89 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.543 1.286 . . . . 1.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -23.54 59.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 1.0 110.344 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.5 t -141.36 125.64 17.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 1.0 110.413 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.17 135.1 54.02 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.251 -0.905 . . . . 1.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -130.93 95.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.38 -0.825 . . . . 1.0 110.023 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.96 94.03 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 1.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -139.57 147.57 41.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 1.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -146.21 19.37 1.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 1.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.77 -23.55 30.27 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -90.07 -20.93 22.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.264 -1.139 . . . . 1.0 109.989 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.3 144.7 3.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.294 -0.879 . . . . 1.0 110.128 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 69.1 m-70 -110.94 118.85 37.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 1.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.53 128.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.34 -0.85 . . . . 1.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.523 ' CD1' ' CE3' ' A' ' 34' ' ' TRP . 4.3 tt -116.23 133.21 56.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 1.0 110.56 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 59' ' ' ILE . 41.0 mm -133.55 86.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.59 103.37 15.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 1.0 110.758 -179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.2 m-70 -69.69 -156.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 1.0 109.304 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 59.7 t-20 -14.77 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 61' ' ' HIS . 76.7 m -71.78 171.02 12.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.714 -0.616 . . . . 1.0 110.419 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 1.2 tp60 -110.07 163.57 13.46 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.361 -0.837 . . . . 1.0 108.905 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.549 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -75.39 5.08 6.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.868 -1.145 . . . . 1.0 111.739 -179.467 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.25 -20.24 28.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.447 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 12.0 mtt -55.3 -17.41 4.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 1.0 111.167 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -43.91 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 1.0 110.789 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.97 -121.35 0.63 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.92 135.5 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -1.066 . . . . 1.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.1 101.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 1.0 109.843 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -103.56 128.76 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 1.0 110.361 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -108.58 148.2 30.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.0 109.792 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 137.09 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 1.0 110.55 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.58 99.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.93 -89.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 1.0 110.38 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -119.18 32.38 6.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.968 -1.082 . . . . 1.0 110.281 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.01 133.85 55.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 1.0 110.195 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 68.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 1.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.404 ' OG ' HG23 ' A' ' 4' ' ' VAL . 46.8 m -77.94 166.9 22.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.0 109.987 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.31 104.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 1.0 110.509 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 8' ' ' LEU . . . -100.35 -170.67 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.08 123.44 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 1.0 109.848 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 tp -124.66 138.26 54.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 1.0 110.699 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -140.09 130.56 25.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.404 -0.81 . . . . 1.0 109.604 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 52.9 t -99.85 118.01 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 1.0 110.366 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 3.3 ttpt -97.99 140.57 32.14 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.32 -0.862 . . . . 1.0 109.665 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.94 -156.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 1.0 109.999 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.884 -1.055 . . . . 1.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.232 0.539 . . . . 1.0 110.308 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 43.9 pt -121.16 178.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 1.0 110.198 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -108.27 -166.97 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.937 . . . . 1.0 110.271 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 78' ' ' ALA . 89.0 t -121.21 124.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 1.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.83 -31.83 31.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 1.0 110.289 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.2 113.82 6.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 1.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.77 -176.69 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.58 1.305 . . . . 1.0 110.25 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' CD1' ' O ' ' A' ' 71' ' ' VAL . 19.1 mt -73.38 -154.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 1.0 110.396 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -155.98 116.32 3.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 1.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.25 133.46 45.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.16 152.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.302 -1.116 . . . . 1.0 110.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -94.03 175.35 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 1.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.14 174.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 1.0 110.737 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.8 136.6 53.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 1.0 109.582 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 63' ' ' CYS . 6.4 p -60.07 91.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 1.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 140.66 -37.8 1.64 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.017 -1.633 . . . . 1.0 109.017 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -71.99 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 1.0 109.684 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.411 ' CG2' HG21 ' A' ' 59' ' ' ILE . 85.9 m -160.65 150.32 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 1.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.22 176.99 5.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 1.0 109.197 179.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -160.5 112.29 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.0 111.664 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 47.1 m-85 -117.48 127.25 53.82 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 178.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -115.84 151.62 34.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 1.0 111.147 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 56' ' ' HIS . 1.2 tt -164.26 139.02 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.578 -0.701 . . . . 1.0 109.546 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.46 154.04 33.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 1.0 110.355 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.77 -152.88 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 1.0 110.048 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.09 -35.02 3.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 1.0 109.65 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.07 160.96 42.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.85 134.54 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.659 1.347 . . . . 1.0 110.446 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -171.58 113.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 110.241 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.82 54.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 1.0 110.088 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -131.53 45.87 2.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 1.0 110.052 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.02 164.18 12.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.044 -1.223 . . . . 1.0 110.044 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.01 169.94 16.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -1.055 . . . . 1.0 109.851 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 42.8 m95 -122.56 138.72 54.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 1.0 110.793 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 1.3 ttmt -121.62 143.27 49.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.527 -0.733 . . . . 1.0 110.287 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.96 -93.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 1.0 109.705 179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -14.72 62.06 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.097 -1.002 . . . . 1.0 110.083 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 138.16 -10.14 3.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.978 -1.249 . . . . 1.0 109.978 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.99 159.81 28.6 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.065 -1.256 . . . . 1.0 109.605 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.25 79.17 3.02 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.751 1.395 . . . . 1.0 110.561 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pp -127.6 -15.79 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.349 -0.844 . . . . 1.0 110.891 -179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -69.45 -16.9 63.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 1.0 110.54 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.11 112.63 21.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 1.0 110.26 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.98 170.74 7.43 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.925 . . . . 1.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.38 5.1 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.621 1.327 . . . . 1.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.89 -11.78 11.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.844 -1.16 . . . . 1.0 110.904 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.1 -169.59 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 1.0 110.386 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -144.35 76.39 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.0 110.269 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -95.9 128.34 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 1.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.21 133.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 1.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -142.37 137.62 30.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.986 -1.071 . . . . 1.0 110.508 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.62 21.9 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 1.0 110.202 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.05 -64.0 2.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.749 -1.34 . . . . 1.0 109.749 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.58 31.86 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.727 -0.867 . . . . 1.0 110.795 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -153.01 115.72 4.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.41 ' HB2' HG21 ' A' ' 23' ' ' ILE . 91.8 m-70 -110.0 117.92 35.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 1.0 109.836 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 57' ' ' ILE . 41.9 mm -121.31 157.81 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 1.0 110.237 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 39.2 tp -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 1.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 HG21 ' CG2' ' A' ' 18' ' ' THR . 5.0 mt -129.02 111.57 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 1.0 109.589 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' ' HE2' ' A' ' 67' ' ' MET . 5.1 mt -110.46 103.26 11.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.049 . . . . 1.0 110.679 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 62' ' ' ASN . 80.6 m-70 -72.13 -162.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 1.0 110.374 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 39.7 t-20 -12.86 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.555 1.317 . . . . 1.0 114.555 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 73.8 m -86.08 -158.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.441 ' O ' ' CG1' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -158.67 -173.67 4.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.798 -1.189 . . . . 1.0 110.907 179.654 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.21 -18.53 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 1.0 111.465 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.74 -130.32 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.783 -1.727 . . . . 1.0 108.783 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 1.3 mtt 39.42 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.981 -0.717 . . . . 1.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 m -91.17 37.64 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.068 -1.02 . . . . 1.0 110.176 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.21 -122.46 3.57 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.491 -1.444 . . . . 1.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -150.09 162.94 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -1.113 . . . . 1.0 110.555 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' A' ' 21' ' ' PHE . 70.1 t -104.69 87.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 1.0 109.808 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 p -92.45 107.97 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.938 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -79.14 158.77 27.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.685 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.52 109.96 3.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 1.0 110.61 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.38 -146.09 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 1.0 109.625 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.12 43.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -0.991 . . . . 1.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 2' ' ' ILE . 49.3 t30 -163.11 30.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 1.0 110.004 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -113.03 74.27 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 1.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -86.59 86.1 7.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.864 . . . . 1.0 110.431 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -81.73 -179.22 7.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -0.945 . . . . 1.0 110.117 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.49 89.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 1.0 110.383 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.36 -177.52 3.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 1.0 110.123 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -110.49 138.76 46.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.69 130.35 36.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 1.0 110.32 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -143.75 147.26 33.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 1.0 109.687 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 67' ' ' MET . 25.4 t -105.82 158.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.059 -1.026 . . . . 1.0 110.736 -179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -130.69 146.11 52.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 1.0 109.664 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -81.98 -160.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.0 110.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.961 -1.018 . . . . 1.0 110.269 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.14 153.95 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 1.0 109.721 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -128.9 -3.8 5.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 1.0 111.048 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 85.5 t 53.14 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 1.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -85.52 -26.58 26.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.316 -0.865 . . . . 1.0 109.995 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 105.33 40.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 1.0 110.079 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.84 178.55 5.7 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.604 1.318 . . . . 1.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.919 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 14.2 mt -73.77 -157.81 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 1.0 110.156 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -155.9 134.22 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 1.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.65 140.87 26.7 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.671 -1.372 . . . . 1.0 109.671 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.7 152.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 1.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -96.13 169.19 10.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 1.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' CD ' ' A' ' 17' ' ' GLU . 11.6 p -159.35 146.16 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 1.0 110.299 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -88.35 125.87 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 1.0 109.725 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -46.84 93.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.413 -0.805 . . . . 1.0 111.712 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 155.64 -36.4 0.63 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.055 -1.218 . . . . 1.0 110.055 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.594 ' CD ' HG23 ' A' ' 13' ' ' VAL . 3.6 pt-20 -85.73 -148.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.826 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.485 HG21 ' CE1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -136.75 137.24 39.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 1.0 110.472 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -85.36 -176.5 6.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 1.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.494 ' CD2' HG12 ' A' ' 59' ' ' ILE . 8.0 m80 -160.7 108.5 1.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.954 -1.091 . . . . 1.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CD1' HD23 ' A' ' 58' ' ' LEU . 91.6 m-85 -114.81 120.87 41.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.789 . . . . 1.0 109.369 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -109.8 155.18 21.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 1.0 110.925 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.589 ' O ' HG23 ' A' ' 23' ' ' ILE . 11.4 tt -161.37 119.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.767 . . . . 1.0 109.833 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -101.08 131.88 46.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 1.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 56' ' ' HIS . 22.0 mt -87.63 179.56 6.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.86 . . . . 1.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.7 p -85.26 -22.05 28.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.0 109.98 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -121.45 135.83 25.39 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 1.0 109.978 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.1 Cg_endo -75.52 -178.32 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.537 1.283 . . . . 1.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.68 67.48 0.98 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 1.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 28' ' ' PRO . 98.1 t -142.52 159.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 1.0 110.307 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -142.2 148.35 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 1.0 109.963 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.76 -134.02 2.34 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -167.54 140.44 3.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -1.117 . . . . 1.0 110.18 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.736 ' CE3' HD22 ' A' ' 58' ' ' LEU . 33.9 m95 -102.93 170.73 7.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 1.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -173.62 170.29 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.486 -0.759 . . . . 1.0 109.942 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.25 -131.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 1.0 109.469 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -49.6 -25.03 2.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.7 -1.25 . . . . 1.0 110.399 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.64 40.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -128.48 107.63 19.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.199 -1.177 . . . . 1.0 110.046 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.08 112.36 3.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.487 1.256 . . . . 1.0 110.637 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 42' ' ' THR . 1.3 pp -106.7 -146.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 1.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.705 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -132.66 128.12 36.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.05 -1.031 . . . . 1.0 110.39 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.28 111.32 1.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.873 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -177.3 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.386 -0.821 . . . . 1.0 110.244 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -72.19 -74.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.441 1.232 . . . . 1.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD2' ' CE ' ' A' ' 67' ' ' MET . 27.9 t70 -133.19 58.63 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 1.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 t -162.71 142.3 9.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.905 . . . . 1.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -144.5 87.98 1.9 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.284 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.0 mt -87.81 131.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.132 -0.98 . . . . 1.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 tt -134.95 146.36 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 1.0 110.318 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.0 146.7 19.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 110.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.68 9.01 11.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.739 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.49 -21.24 30.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.474 -1.051 . . . . 1.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 -23.22 20.6 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.172 -1.193 . . . . 1.0 109.718 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 56' ' ' HIS . 38.8 tttt -164.56 163.49 21.89 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.423 -0.798 . . . . 1.0 109.498 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.692 ' CD2' HD11 ' A' ' 25' ' ' LEU . 51.6 m-70 -113.19 121.63 45.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 1.0 110.04 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.19 141.62 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 1.0 110.345 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.736 HD22 ' CE3' ' A' ' 34' ' ' TRP . 21.6 tp -115.57 148.93 39.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.345 -0.847 . . . . 1.0 110.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 20' ' ' HIS . 58.4 mt -146.01 116.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 1.0 109.719 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -117.44 107.27 14.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 1.0 110.587 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.485 ' CE1' HG21 ' A' ' 18' ' ' THR . 67.5 m-70 -69.7 -172.14 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 1.0 110.328 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.8 p-10 -13.94 80.85 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.025 1.12 . . . . 1.0 114.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.837 ' O ' HG23 ' A' ' 15' ' ' VAL . 80.7 m -74.42 148.07 41.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.712 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -92.25 171.0 9.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 1.0 111.541 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -23.93 2.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.715 -0.615 . . . . 1.0 110.748 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.32 -123.87 0.06 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.98 -1.648 . . . . 1.0 108.98 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.655 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.7 mtt 43.53 28.02 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.895 . . . . 1.0 111.287 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.51 52.52 2.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.297 -0.877 . . . . 1.0 110.365 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.75 -141.84 5.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.416 -1.474 . . . . 1.0 109.416 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 37' ' ' LYS . 1.7 pt-20 -130.99 143.33 50.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -1.154 . . . . 1.0 110.258 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.597 HG23 ' HB2' ' A' ' 84' ' ' LEU . 45.7 t -79.71 99.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 1.0 109.856 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -103.11 128.02 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 1.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 64.4 t80 -104.63 154.82 19.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 109.707 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.61 146.85 51.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 1.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.21 -142.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 1.0 110.04 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.94 -70.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.274 -0.891 . . . . 1.0 110.702 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -146.42 21.21 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 1.0 110.106 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -111.8 167.1 10.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 1.0 110.157 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.61 115.79 2.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.939 . . . . 1.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 66.9 p -96.96 177.84 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.286 -0.884 . . . . 1.0 109.696 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.29 97.15 0.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.033 -1.042 . . . . 1.0 110.696 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.09 -175.98 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 1.0 109.691 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -100.14 138.33 37.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.047 . . . . 1.0 110.242 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' A' ' 71' ' ' VAL . 21.6 tp -131.6 120.74 23.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 1.0 110.249 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -134.35 136.63 43.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 1.0 110.101 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 64' ' ' GLN . 59.5 t -94.57 148.15 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.251 -0.906 . . . . 1.0 110.052 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.46 141.53 51.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 1.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -105.06 -157.84 0.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 tp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.261 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.321 0.581 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.666 HG21 ' HG3' ' A' ' 27' ' ' GLU . 5.1 tt -106.41 157.87 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 1.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.802 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.3 mt-10 -82.77 -148.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 1.0 110.041 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.03 HG23 ' HB1' ' A' ' 78' ' ' ALA . 61.2 t -129.11 129.89 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.64 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 -57.61 3.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.954 . . . . 1.0 109.652 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.09 100.68 15.79 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.661 -0.65 . . . . 1.0 110.345 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.92 -179.33 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.649 1.341 . . . . 1.0 110.441 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.928 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 22.6 mt -76.71 159.34 30.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.055 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -125.96 15.92 7.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.105 -0.997 . . . . 1.0 110.731 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 63.32 157.69 0.15 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.2 p -160.07 170.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.523 -0.986 . . . . 1.0 109.714 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -120.56 166.08 14.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 1.0 110.531 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 12' ' ' GLU . 18.7 m -151.18 147.7 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.422 -0.799 . . . . 1.0 110.496 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.415 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -97.04 27.73 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 1.0 109.4 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 63' ' ' CYS . 75.4 t 57.39 87.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.55 0.691 . . . . 1.0 110.721 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.48 -30.2 2.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.35 -138.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.304 -1.115 . . . . 1.0 109.386 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 ' CG2' ' ND1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -149.64 132.21 15.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 1.0 110.232 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -85.26 165.22 17.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.827 . . . . 1.0 110.037 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -144.14 80.52 1.65 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 1.0 110.764 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 67.3 m-85 -79.77 152.99 29.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 1.0 109.442 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' HD23 ' A' ' 8' ' ' LEU . 12.1 mt-10 -136.24 158.86 43.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 1.0 110.941 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.5 OUTLIER -168.06 127.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.503 -0.748 . . . . 1.0 109.765 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -103.37 150.12 24.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -0.925 . . . . 1.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' HD2' ' A' ' 56' ' ' HIS . 3.3 mp -134.18 1.1 3.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 1.0 111.569 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.464 ' OG ' HD11 ' A' ' 2' ' ' ILE . 6.3 p 41.16 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.6 -0.688 . . . . 1.0 111.721 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HG3' HG21 ' A' ' 2' ' ' ILE . 1.4 mm-40 -136.44 119.74 12.21 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.9 -1.125 . . . . 1.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 45.9 Cg_endo -72.75 161.11 44.71 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.501 1.264 . . . . 1.0 110.122 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.78 86.77 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.205 -0.935 . . . . 1.0 110.328 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -168.37 144.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 1.0 109.902 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -126.42 -175.95 3.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 1.0 110.608 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.0 -164.8 35.03 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -157.32 158.22 35.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -1.144 . . . . 1.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 22.5 m95 -115.49 166.55 11.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.0 110.451 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -162.19 142.8 10.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 1.0 109.758 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 mt -64.16 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 1.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -49.47 -25.46 2.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.635 -1.291 . . . . 1.0 110.056 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.499 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 160.79 40.2 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.484 -1.446 . . . . 1.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 7.4 mm-40 -118.8 121.58 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 1.0 110.174 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.73 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.449 1.236 . . . . 1.0 110.744 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -173.99 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 1.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 43' ' ' ALA . 1.6 m -150.93 -178.06 6.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 1.0 110.274 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' H ' HG22 ' A' ' 42' ' ' THR . . . -65.19 106.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 1.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 164.37 24.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 1.0 110.167 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.48 -17.52 30.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.656 1.345 . . . . 1.0 110.613 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -83.45 -26.16 30.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 1.0 110.125 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -118.76 119.79 35.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.0 110.074 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -107.13 88.84 2.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.966 . . . . 1.0 110.409 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.417 HG12 HD11 ' A' ' 58' ' ' LEU . 97.3 mt -86.97 106.96 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 1.0 109.867 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 50' ' ' ILE . 6.2 tp -131.28 118.33 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 1.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' HIS . 1.5 pt-20 -149.37 169.25 21.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 1.0 110.133 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -117.08 -134.51 0.34 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.281 -0.887 . . . . 1.0 109.126 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -117.68 -19.81 4.8 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.679 -1.248 . . . . 1.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -21.81 22.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 1.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -153.79 173.12 16.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.184 -0.947 . . . . 1.0 110.545 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.797 ' HD2' HD13 ' A' ' 25' ' ' LEU . 57.5 m-70 -133.25 127.62 34.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.352 -0.842 . . . . 1.0 109.787 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.87 135.79 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 1.0 110.715 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.527 HD22 ' CE3' ' A' ' 34' ' ' TRP . 23.8 tp -112.89 147.96 35.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.495 -0.753 . . . . 1.0 110.144 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 87.8 mt -138.73 82.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0 109.882 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -73.2 161.71 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 1.0 110.467 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.5 m-70 -126.89 -169.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.486 -0.759 . . . . 1.0 109.503 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.514 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 42.2 p30 -13.64 80.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.778 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.5 m -78.98 175.12 10.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 1.0 109.501 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG11 ' A' ' 86' ' ' VAL . 1.2 mt-30 -138.58 -163.89 1.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.047 -1.033 . . . . 1.0 110.567 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.32 8.56 4.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 1.0 111.476 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.93 -22.91 19.23 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.064 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.479 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 37.7 mtt -86.69 34.93 0.66 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.067 -1.255 . . . . 1.0 110.799 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 34.9 0.93 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 1.0 110.134 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.35 -124.83 4.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.57 147.17 46.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -1.121 . . . . 1.0 110.393 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 70.7 t -89.05 107.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.316 -0.865 . . . . 1.0 109.884 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 p -108.03 110.6 22.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 1.0 110.663 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 22.7 t80 -91.03 146.87 23.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 1.0 109.823 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -131.54 104.55 7.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.037 -1.04 . . . . 1.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -123.62 124.94 43.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 1.0 109.763 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.84 -90.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 1.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 5.5 p-10 -129.66 -38.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.807 -1.183 . . . . 1.0 110.378 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 1.03 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -63.09 159.76 16.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 1.0 110.516 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -156.63 126.92 6.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 1.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.58 ' OG ' HD11 ' A' ' 8' ' ' LEU . 75.5 p -92.52 -179.14 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.32 88.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -91.67 -170.18 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 1.0 110.307 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -119.91 111.59 18.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 1.0 110.363 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.692 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 66.0 tp -102.15 145.43 29.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 1.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.64 107.92 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.299 -0.875 . . . . 1.0 110.207 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 64' ' ' GLN . 46.3 t -80.9 147.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.118 -0.989 . . . . 1.0 110.405 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -115.45 168.37 10.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 110.165 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -101.95 155.46 18.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.241 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.205 0.526 . . . . 1.0 110.176 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.14 140.94 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.34 156.63 17.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 1.0 109.971 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.78 167.28 2.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.116 -0.99 . . . . 1.0 110.018 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -123.69 -30.72 3.55 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.482 0.658 . . . . 1.0 110.033 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -146.96 122.39 5.37 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 1.0 110.029 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.55 -176.49 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.535 1.282 . . . . 1.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.616 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 18.3 mt -82.46 -164.62 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.21 -0.931 . . . . 1.0 110.777 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.13 139.78 26.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.404 -0.81 . . . . 1.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.6 150.29 34.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.429 -1.468 . . . . 1.0 109.429 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.4 p -158.56 169.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 1.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 11' ' ' VAL . 3.0 mt-10 -122.29 165.05 16.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 1.0 110.499 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.5 p -158.94 127.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.238 -0.914 . . . . 1.0 110.104 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.55 47.57 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.217 -0.927 . . . . 1.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 63' ' ' CYS . 21.8 t 48.77 71.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.683 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.65 -22.52 1.04 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 13' ' ' VAL . 53.4 mm-40 -78.99 -122.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -1.157 . . . . 1.0 109.232 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -161.17 157.85 26.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.705 -1.247 . . . . 1.0 110.492 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -108.64 172.52 6.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.393 -0.817 . . . . 1.0 108.883 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.72 122.87 4.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.112 . . . . 1.0 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 58' ' ' LEU . 73.6 m-85 -140.32 132.82 28.61 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.16 155.5 41.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.937 -1.102 . . . . 1.0 111.155 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -167.8 122.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.607 -0.683 . . . . 1.0 109.752 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.24 130.35 54.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 1.0 110.491 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 56' ' ' HIS . 55.6 mt -91.33 -174.2 3.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.822 . . . . 1.0 109.871 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -99.03 -57.37 2.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.0 109.963 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.99 144.01 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 1.0 109.852 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 -169.5 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.628 1.331 . . . . 1.0 110.567 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t0 55.26 80.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 1.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 32' ' ' GLY . 75.4 t -131.28 154.09 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 1.0 109.899 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -124.53 43.53 2.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.92 . . . . 1.0 110.452 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 30' ' ' VAL . . . -77.74 171.36 55.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 12.4 tm0? -145.07 165.26 28.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -1.112 . . . . 1.0 109.902 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.931 ' CE3' HD22 ' A' ' 58' ' ' LEU . 34.2 m95 -108.52 163.84 12.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 1.0 110.819 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.581 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -159.59 157.11 29.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.413 -0.804 . . . . 1.0 110.102 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.42 HD22 ' HG2' ' A' ' 67' ' ' MET . 51.6 mt -68.31 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 1.0 109.805 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -47.34 -25.92 1.13 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.856 -1.152 . . . . 1.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 150.64 39.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 11.2 tt0 -136.41 136.47 22.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 O-C-N 121.126 -1.22 . . . . 1.0 109.132 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.42 114.48 3.94 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.468 1.246 . . . . 1.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 42' ' ' THR . 0.7 OUTLIER -92.77 -139.58 0.2 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 1.0 109.926 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.452 ' H ' HD12 ' A' ' 41' ' ' LEU . 1.2 p -138.69 136.85 36.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.119 . . . . 1.0 110.013 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.79 98.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 1.0 110.088 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -88.69 169.12 14.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 1.0 110.184 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.06 -16.72 28.71 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.731 1.385 . . . . 1.0 110.513 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -98.37 -21.27 16.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 1.0 110.376 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.27 136.32 33.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 1.0 110.181 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.63 136.42 54.49 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 1.0 109.626 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 49' ' ' ILE . 95.7 mt -139.39 76.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 1.0 109.761 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' ILE . 41.9 pt -85.4 144.32 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 1.0 110.038 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.76 137.53 8.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 1.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 26.6 8.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 1.0 109.872 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 -92.39 1.77 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -15.79 30.55 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.631 -0.923 . . . . 1.0 110.547 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -121.63 130.72 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 1.0 110.588 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.778 ' HB2' HG23 ' A' ' 23' ' ' ILE . 29.3 m-70 -118.16 131.13 56.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.0 110.085 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.97 136.42 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 1.0 110.226 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.931 HD22 ' CE3' ' A' ' 34' ' ' TRP . 16.2 tp -125.17 139.96 53.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 1.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 58' ' ' LEU . 33.9 mm -140.61 115.43 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 1.0 109.331 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 9.0 mt -112.82 108.46 17.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 1.0 110.846 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 30.1 m80 -75.44 -159.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 1.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 54.0 t30 -14.13 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.815 ' O ' HG13 ' A' ' 15' ' ' VAL . 91.7 m -86.29 -176.27 5.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.6 -0.688 . . . . 1.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.646 ' C ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -149.96 -164.22 1.97 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 1.0 110.202 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.58 13.43 0.62 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.071 . . . . 1.0 112.404 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.36 -30.97 10.04 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.46 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 36.9 mtt -86.72 39.23 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -1.121 . . . . 1.0 110.565 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -90.69 79.77 6.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.181 -0.949 . . . . 1.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.64 -120.76 0.59 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.63 140.1 31.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 1.0 110.415 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.527 ' O ' HD13 ' A' ' 8' ' ' LEU . 70.5 t -84.69 102.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 1.0 109.853 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 p -102.83 128.69 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 1.0 110.365 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 53.9 t80 -105.57 142.04 36.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.0 109.622 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 127.64 32.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.038 . . . . 1.0 110.647 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.49 -147.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 1.0 109.746 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.43 -73.53 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.932 -1.105 . . . . 1.0 110.081 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -130.12 -1.21 4.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 1.0 110.794 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.22 156.11 23.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.927 -1.108 . . . . 1.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.07 125.88 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.927 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 2.6 p -126.17 178.34 5.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 1.0 109.729 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.55 106.69 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.01 -170.44 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 1.0 109.716 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.14 109.18 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.025 . . . . 1.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 67' ' ' MET . 58.2 tp -108.01 147.01 31.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 1.0 110.036 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 105.09 3.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 110.136 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.646 HG11 ' C ' ' A' ' 64' ' ' GLN . 38.3 t -80.5 133.35 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.186 -0.946 . . . . 1.0 110.149 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -98.44 146.26 25.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.06 149.05 48.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 1.0 110.168 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.235 -179.819 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.179 0.514 . . . . 1.0 110.157 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 1.2 pt -110.15 133.03 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 1.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.6 162.82 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 1.0 110.271 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.695 HG21 ' OG ' ' A' ' 80' ' ' SER . 1.3 p -74.59 124.98 33.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.236 -0.915 . . . . 1.0 110.002 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.21 -34.6 23.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.736 0.779 . . . . 1.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -126.17 109.36 24.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.76 -0.587 . . . . 1.0 110.137 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.0 174.81 10.7 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.578 1.304 . . . . 1.0 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.954 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -87.01 -174.08 4.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0 109.535 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.7 m-85 -145.34 131.4 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 1.0 110.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.35 152.55 14.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.78 142.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -1.074 . . . . 1.0 110.39 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.31 155.0 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 1.0 109.599 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.07 170.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.025 -1.047 . . . . 1.0 110.931 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' N ' HG22 ' A' ' 13' ' ' VAL . 1.7 m-85 -102.13 135.6 43.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.6 p -49.46 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.909 -1.119 . . . . 1.0 111.048 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 147.15 -41.97 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -161.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -1.068 . . . . 1.0 110.107 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 p -120.98 163.57 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 1.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 21' ' ' PHE . . . -120.65 172.56 7.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.529 -0.732 . . . . 1.0 109.268 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.41 124.43 6.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 1.0 111.178 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.707 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 60.4 m-85 -134.36 118.44 17.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.523 -0.736 . . . . 1.0 109.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.51 157.11 17.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.052 -1.03 . . . . 1.0 111.034 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 56' ' ' HIS . 5.6 tt -168.43 120.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 1.0 109.801 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.69 148.6 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 1.0 110.274 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.3 mt -103.84 -154.36 0.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 1.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 31.1 t -116.44 -76.05 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 1.0 109.931 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.66 137.42 20.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.0 109.789 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.31 136.76 27.17 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.578 1.304 . . . . 1.0 110.53 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -164.01 -61.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 110.091 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.82 148.38 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 1.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.61 -164.02 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.29 179.38 25.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -131.53 149.35 52.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -1.18 . . . . 1.0 109.944 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.783 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.8 m95 -104.91 154.21 20.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 1.0 110.776 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 6.9 pttt -147.66 162.28 39.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 1.0 109.514 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 67' ' ' MET . 2.1 mt -81.99 -84.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 1.0 110.115 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 21.16 5.78 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.513 -0.742 . . . . 1.0 110.053 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 107.85 -14.7 37.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 1.0 109.633 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.4 mt-30 -82.94 134.76 46.07 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.175 -1.191 . . . . 1.0 110.044 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.92 114.25 3.99 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.695 1.366 . . . . 1.0 110.615 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 42' ' ' THR . 1.1 pp -73.12 -141.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.836 . . . . 1.0 109.461 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.0 t -158.92 163.45 36.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.742 -1.224 . . . . 1.0 110.252 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.91 106.5 0.31 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 m -116.59 159.44 40.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 1.0 110.17 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -4.8 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.672 1.354 . . . . 1.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.19 -22.76 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.983 -1.073 . . . . 1.0 110.28 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.494 ' SG ' HD21 ' A' ' 60' ' ' LEU . 48.2 t -101.76 122.81 44.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 1.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.49 144.54 44.2 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.147 -0.971 . . . . 1.0 109.233 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.44 85.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 1.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -87.38 120.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 1.0 109.911 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 19.6 pt-20 -146.02 147.52 31.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 1.0 110.505 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.56 23.44 5.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.732 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -74.58 2.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -18.12 24.1 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.736 -0.861 . . . . 1.0 110.823 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.66 43.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.034 -1.041 . . . . 1.0 110.816 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.693 ' HB2' HG23 ' A' ' 23' ' ' ILE . 67.5 m-70 -143.06 103.35 4.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 1.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.87 136.83 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 1.0 110.502 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD22 ' CE3' ' A' ' 34' ' ' TRP . 34.3 tp -117.35 130.72 56.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.311 -0.868 . . . . 1.0 110.387 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.18 100.81 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 1.0 109.636 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mt -103.72 116.16 31.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 1.0 110.922 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 62' ' ' ASN . 43.9 m-70 -77.59 -166.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 1.0 109.945 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 61' ' ' HIS . 54.0 t30 -15.45 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.66 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.4 m -73.71 143.92 45.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.503 -0.748 . . . . 1.0 109.496 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -79.13 173.51 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.0 110.825 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -9.52 46.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.774 . . . . 1.0 110.904 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.14 -10.61 82.35 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.944 -1.122 . . . . 1.0 110.342 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.666 ' HB2' HG21 ' A' ' 86' ' ' VAL . 6.2 mtt -84.37 38.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.888 -1.36 . . . . 1.0 111.458 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -91.43 40.0 1.02 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.019 -1.051 . . . . 1.0 109.918 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.33 -128.31 4.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 83' ' ' ASN . 1.9 mp0 -135.13 -170.66 2.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -1.083 . . . . 1.0 110.468 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 78.1 t -128.61 78.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 110.072 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' A' ' 35' ' ' LYS . 17.1 p -86.78 125.21 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 1.0 110.15 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 23' ' ' ILE . 57.2 t80 -103.23 143.83 32.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 1.0 110.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -133.72 127.12 32.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 1.0 110.125 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -159.78 118.58 2.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.0 110.5 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.62 -89.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 1.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 75' ' ' ALA . 9.1 t-20 -128.03 -35.77 2.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.893 -1.129 . . . . 1.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 150.32 11.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 1.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 125.96 6.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 1.0 110.24 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.695 ' OG ' HG21 ' A' ' 4' ' ' VAL . 23.1 m -125.5 174.51 8.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 1.0 110.38 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.4 94.21 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 1.0 110.193 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -90.84 -172.88 3.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 1.0 110.29 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 17.8 m-20 -123.26 139.23 54.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.707 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 60.7 tp -143.72 127.42 17.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 1.0 110.386 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -134.7 132.95 39.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 1.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 67' ' ' MET . 35.2 t -91.66 126.07 44.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.268 -0.895 . . . . 1.0 110.19 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 160.36 14.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 1.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.32 -176.74 3.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.0 110.177 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.993 -1.004 . . . . 1.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.338 0.59 . . . . 1.0 110.111 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 2' ' ' ILE . 6.9 tt -170.25 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 1.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.439 ' OE2' ' HB1' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -150.27 179.54 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 1.0 111.044 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' VAL . 54.2 t 48.56 85.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.439 0.638 . . . . 1.0 111.078 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 6.4 mm-40 -98.4 -29.26 13.23 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 23' ' ' ILE . 7.0 tmtt? -129.46 114.85 18.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.73 165.88 21.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.443 1.233 . . . . 1.0 111.586 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.985 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 3.9 mt -65.53 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.752 -0.592 . . . . 1.0 110.721 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 10' ' ' GLY . 86.0 t80 -144.74 159.92 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 1.0 109.994 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 9' ' ' TYR . . . -95.48 141.66 15.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.511 -1.435 . . . . 1.0 109.511 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 84' ' ' LEU . 10.4 p -149.88 166.46 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -1.222 . . . . 1.0 110.408 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' VAL . 80.1 mt-10 -122.02 166.13 14.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.0 110.299 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.504 HG23 ' HA ' ' A' ' 86' ' ' VAL . 15.8 m -152.65 157.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.171 -0.956 . . . . 1.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -117.42 33.73 5.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.497 -0.752 . . . . 1.0 109.011 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 18.5 t 61.75 73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.701 0.762 . . . . 1.0 109.895 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 152.54 -23.11 0.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.24 164.96 22.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -1.119 . . . . 1.0 110.096 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.5 m -112.26 105.95 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.289 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.54 171.46 15.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 1.0 109.839 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CD2' HG12 ' A' ' 59' ' ' ILE . 13.1 m80 -144.99 120.5 10.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.0 110.734 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.72 ' CD1' HD23 ' A' ' 58' ' ' LEU . 77.0 m-85 -114.11 111.43 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.843 . . . . 1.0 109.365 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.92 165.66 11.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.148 -0.97 . . . . 1.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -170.04 119.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 1.0 109.802 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.34 124.49 43.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 1.0 110.206 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' A' ' 56' ' ' HIS . 26.0 mt -86.94 -150.64 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.195 -0.941 . . . . 1.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.411 ' HB3' HG12 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -126.67 -47.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.972 . . . . 1.0 110.211 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.73 150.19 37.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 1.0 110.608 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.11 -165.66 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.597 1.314 . . . . 1.0 110.335 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 t70 49.92 81.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.276 -0.89 . . . . 1.0 110.544 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.7 t -138.87 148.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 1.0 110.154 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -140.63 40.74 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 1.0 110.331 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.45 -150.3 0.04 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -166.31 -179.8 5.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -1.095 . . . . 1.0 109.674 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.55 ' CE3' HD22 ' A' ' 58' ' ' LEU . 57.9 m95 -117.65 131.06 56.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.982 -1.074 . . . . 1.0 110.628 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 2.7 ttpt -124.03 133.82 53.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.505 -0.747 . . . . 1.0 109.978 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.46 -130.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 1.0 109.815 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -28.84 3.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.592 -1.317 . . . . 1.0 110.708 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 154.47 39.46 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.961 -1.255 . . . . 1.0 109.961 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 1.1 pt20 -150.39 150.42 28.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.106 -1.232 . . . . 1.0 110.014 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.45 113.35 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.601 1.316 . . . . 1.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -70.34 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.46 -0.775 . . . . 1.0 109.877 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.523 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -168.41 14.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 1.0 112.119 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -75.76 -162.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.709 -1.245 . . . . 1.0 109.817 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.73 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.22 -0.925 . . . . 1.0 110.384 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.19 -42.87 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.525 1.276 . . . . 1.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -23.83 51.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 1.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.84 121.77 42.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 110.308 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.1 144.13 39.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 1.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -134.04 119.26 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 1.0 109.825 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.64 HG23 ' HB ' ' A' ' 57' ' ' ILE . 7.0 tp -130.07 109.26 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.08 147.65 50.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 1.0 110.397 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.02 20.98 17.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 1.0 110.185 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 -90.5 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -59.39 -16.0 20.26 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.662 -0.905 . . . . 1.0 110.836 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -125.28 168.12 13.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 25' ' ' LEU . 94.8 m-70 -149.99 126.87 11.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.64 ' HB ' HG23 ' A' ' 50' ' ' ILE . 57.6 mt -124.08 142.2 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 1.0 109.981 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.72 HD23 ' CD1' ' A' ' 21' ' ' PHE . 24.6 tp -118.48 145.44 45.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.104 -0.997 . . . . 1.0 110.409 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 20' ' ' HIS . 56.6 mt -141.2 92.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 1.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' THR . 16.3 mt -98.47 115.21 28.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 62' ' ' ASN . 31.6 m-70 -83.04 -165.04 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 1.0 109.702 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 50.2 t30 -16.57 82.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.762 1.023 . . . . 1.0 113.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' HIS . 71.9 m -69.95 -175.54 0.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.809 ' O ' HG11 ' A' ' 86' ' ' VAL . 2.9 mt-30 -138.31 -168.23 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 1.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mp -84.81 69.1 10.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 1.0 110.264 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.84 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.6 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.19 -15.32 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -1.168 . . . . 1.0 111.622 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -43.57 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.417 -0.802 . . . . 1.0 110.929 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 174.11 -127.35 1.31 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -139.82 146.4 39.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 1.0 110.456 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' HD13 ' A' ' 8' ' ' LEU . 69.6 t -94.39 87.66 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.343 -0.848 . . . . 1.0 109.957 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -87.91 110.11 20.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 1.0 110.426 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 27.8 t80 -71.48 154.2 41.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 1.0 110.072 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 139.46 52.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 1.0 110.1 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB1' ' OE2' ' A' ' 3' ' ' GLU . . . -160.72 -148.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 1.0 109.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' O ' ' ND2' ' A' ' 77' ' ' ASN . . . -77.5 126.95 31.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 1.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER 34.05 31.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 76' ' ' ALA . . . -152.26 158.32 42.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 1.0 110.791 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -160.54 115.07 2.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 1.0 110.003 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 7.3 m -72.62 -172.75 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 1.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.44 97.43 0.25 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 1.0 110.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.985 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.46 -164.53 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 1.0 110.406 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.42 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 61.0 t-20 -132.13 137.43 47.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 1.0 109.598 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.689 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 65.0 tp -154.35 143.29 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 1.0 110.531 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -145.17 127.65 16.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.431 -0.793 . . . . 1.0 110.082 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.809 HG11 ' O ' ' A' ' 64' ' ' GLN . 16.9 t -92.54 142.64 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.366 -0.834 . . . . 1.0 109.732 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -141.4 130.05 22.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.999 . . . . 1.0 110.492 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.34 174.08 8.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 1.0 109.99 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 pt -100.64 161.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 1.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.82 -162.17 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.819 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 93.8 t -126.39 120.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 1.0 110.345 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -93.59 -44.98 7.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.249 -0.907 . . . . 1.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.9 tttt -108.87 109.34 61.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 1.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.1 173.8 13.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.434 1.229 . . . . 1.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.925 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 42.3 mt -75.34 169.38 18.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 1.0 110.162 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -137.06 153.02 50.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 1.0 110.177 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.33 136.53 20.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.056 -1.217 . . . . 1.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.4 t -136.86 154.85 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -1.111 . . . . 1.0 110.03 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -107.73 155.2 20.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.184 -0.947 . . . . 1.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 86' ' ' VAL . 5.5 p -152.1 134.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 1.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.21 39.85 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.24 -0.912 . . . . 1.0 110.378 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 87' ' ' LYS . 89.2 t 52.09 88.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 1.0 110.306 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.31 -29.38 2.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.349 -1.5 . . . . 1.0 109.349 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.92 -124.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.182 . . . . 1.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -160.27 114.48 2.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.698 -1.251 . . . . 1.0 111.002 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.77 148.19 31.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.938 . . . . 1.0 108.808 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -128.33 128.92 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.169 . . . . 1.0 111.469 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.702 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 99.5 m-85 -134.1 112.12 10.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.549 -0.719 . . . . 1.0 109.404 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.51 165.8 11.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 1.0 111.066 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -170.45 137.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.4 164.55 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.978 . . . . 1.0 110.97 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.671 HD12 HG21 ' A' ' 30' ' ' VAL . 71.3 mt -124.3 -148.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 1.0 109.81 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.49 -67.74 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 1.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -97.26 155.55 37.26 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 1.0 110.171 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -75.25 -167.41 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.707 1.372 . . . . 1.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 53.55 67.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.848 . . . . 1.0 110.432 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 25' ' ' LEU . 29.5 m -142.79 170.51 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 1.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -143.43 165.95 26.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.1 -171.7 36.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.18 156.83 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -1.088 . . . . 1.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.894 ' CE3' HD12 ' A' ' 58' ' ' LEU . 45.4 m95 -108.8 139.12 44.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 1.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 39' ' ' GLN . 2.9 ttpt -132.99 125.19 29.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.532 -0.73 . . . . 1.0 109.215 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.409 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 mp -64.45 -132.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.135 -0.978 . . . . 1.0 109.596 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -26.08 3.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.644 -1.285 . . . . 1.0 109.572 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 156.81 38.71 0.02 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.781 -1.328 . . . . 1.0 109.781 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 1.3 mm-40 -131.25 104.01 15.09 Favored Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.141 -1.211 . . . . 1.0 109.997 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.73 101.74 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.673 1.354 . . . . 1.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 42' ' ' THR . 2.1 pp -84.71 -151.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 1.0 110.466 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 41' ' ' LEU . 14.9 p -135.0 133.91 39.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 1.0 110.087 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.31 113.7 24.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 1.0 110.274 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -176.69 -60.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 1.0 110.399 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.3 Cg_endo -72.05 -57.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.348 1.183 . . . . 1.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -133.8 69.28 1.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.0 110.565 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -157.2 134.78 10.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 1.0 110.029 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -127.32 86.65 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.0 110.338 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -105.11 98.21 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 1.0 110.158 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.23 112.2 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -130.61 157.81 41.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 1.0 110.531 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.65 27.16 9.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 1.0 109.762 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.42 -87.72 1.41 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -55.88 -19.83 13.37 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.677 -0.896 . . . . 1.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 155.38 33.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 1.0 110.749 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.0 m-70 -138.65 102.77 4.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 1.0 109.845 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -109.33 137.22 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 1.0 110.535 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.894 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.2 tt -114.35 133.05 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 1.0 110.224 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.747 ' N ' HD23 ' A' ' 58' ' ' LEU . 22.7 mt -136.22 80.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.377 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.94 125.4 35.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 1.0 110.524 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.3 m-70 -83.33 -160.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 1.0 109.716 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 61' ' ' HIS . 37.5 t30 -14.56 82.12 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' HIS . 68.0 m -75.46 -178.27 3.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.506 -0.746 . . . . 1.0 109.954 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG11 ' A' ' 86' ' ' VAL . 44.5 tp60 -117.08 169.66 9.26 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.168 -0.958 . . . . 1.0 109.143 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 88' ' ' GLU . 2.2 mp -72.79 4.22 4.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.822 -1.174 . . . . 1.0 112.139 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.7 -27.11 15.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.776 ' HB2' HG21 ' A' ' 86' ' ' VAL . 4.3 mtt -50.55 -23.21 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -1.043 . . . . 1.0 111.016 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 p -48.52 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.163 -0.961 . . . . 1.0 110.503 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.31 -126.4 0.97 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.072 -1.611 . . . . 1.0 109.072 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -135.35 136.14 41.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.137 . . . . 1.0 110.175 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 8' ' ' LEU . 52.3 t -91.45 87.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 1.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -91.85 111.64 23.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 1.0 110.863 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.889 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 19.6 t80 -86.78 133.53 33.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 1.0 109.375 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -110.55 70.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.986 . . . . 1.0 110.755 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.889 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -94.38 112.32 24.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 1.0 109.784 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.4 -159.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 1.0 109.988 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 26.1 p30 -62.65 -16.89 59.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 1.0 110.455 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.819 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -69.84 158.58 35.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 1.0 110.217 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -159.69 116.77 2.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.137 -0.977 . . . . 1.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 4.6 p -105.34 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 1.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.55 101.73 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 1.0 110.556 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.23 -164.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 1.0 110.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.38 147.28 52.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 1.0 109.944 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.702 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 52.9 tp -145.11 145.5 31.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 1.0 110.515 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 9.2 ptpt -138.2 105.86 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 1.0 109.71 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 67' ' ' MET . 99.2 t -89.49 117.71 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.245 -0.91 . . . . 1.0 110.501 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.6 mtpt -116.78 146.63 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 1.0 110.203 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.488 ' HG3' HD11 ' A' ' 65' ' ' LEU . 19.4 mt-10 -64.69 -171.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 1.0 110.256 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.314 0.578 . . . . 1.0 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 tt -144.39 162.6 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.927 . . . . 1.0 110.109 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.59 166.95 21.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.0 110.006 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 23' ' ' ILE . 2.0 p -80.04 -165.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.087 -1.008 . . . . 1.0 109.691 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 4' ' ' VAL . 50.0 mm-40 -127.74 -54.26 1.32 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 1.0 110.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -126.57 112.36 22.93 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.593 -0.692 . . . . 1.0 110.095 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.92 178.11 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.645 1.34 . . . . 1.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -75.4 173.89 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 1.0 110.168 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.9 m-85 -134.67 12.53 3.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.142 -0.974 . . . . 1.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 74.09 150.32 1.84 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.879 -1.288 . . . . 1.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 19' ' ' ALA . 77.3 t -145.35 161.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -1.11 . . . . 1.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 11' ' ' VAL . 62.8 mt-10 -125.88 149.72 48.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.0 110.387 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.855 HG23 ' CB ' ' A' ' 17' ' ' GLU . 3.1 p -155.6 135.01 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 1.0 109.915 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.47 58.62 3.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.281 -0.887 . . . . 1.0 110.788 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.4 t 46.08 81.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 1.0 110.925 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 139.57 -31.63 2.3 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.746 -1.742 . . . . 1.0 108.746 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.855 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.7 mt-10 -66.17 -158.36 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.494 -1.004 . . . . 1.0 109.502 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -142.74 108.87 5.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 1.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' HG11 ' A' ' 11' ' ' VAL . . . -79.05 132.72 36.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 1.0 109.505 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.9 110.09 18.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 1.0 111.107 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 85.6 m-85 -101.25 134.71 43.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 1.0 109.324 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -130.08 162.79 27.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.934 -1.104 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.672 HD11 HG21 ' A' ' 4' ' ' VAL . 1.1 tt -170.77 125.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.0 109.806 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -90.73 145.2 25.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 1.0 110.225 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.579 HD22 ' C ' ' A' ' 24' ' ' GLU . 4.2 mm? -111.23 155.14 23.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 1.0 109.996 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.54 -58.0 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -88.29 141.38 30.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 1.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.03 104.56 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.653 1.344 . . . . 1.0 110.153 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -119.85 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.112 -0.992 . . . . 1.0 109.201 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 30' ' ' VAL . 8.7 p -176.61 43.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 1.0 110.027 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -152.57 143.63 23.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 1.0 110.27 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.0 146.36 5.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 1.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -129.71 146.72 51.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -1.183 . . . . 1.0 110.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 1.038 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -112.5 173.22 6.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.967 . . . . 1.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 3.3 ptpt -171.2 152.55 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.521 -0.737 . . . . 1.0 109.596 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 67' ' ' MET . 3.5 mt -66.35 -94.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 1.0 109.813 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.58 21.84 5.95 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.124 -0.985 . . . . 1.0 109.946 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 35' ' ' LYS . . . 117.2 -0.27 19.07 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -92.35 109.13 36.06 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.27 . . . . 1.0 110.27 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.01 104.77 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.572 1.301 . . . . 1.0 110.43 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -71.85 -168.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 1.0 110.606 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' THR . 5.6 t -109.12 175.01 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 1.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 109.65 11.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 1.0 110.372 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -122.22 170.56 7.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 1.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.41 -24.23 19.56 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.627 1.33 . . . . 1.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.31 -40.31 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 1.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.49 127.74 35.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 1.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -119.36 144.1 47.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.914 . . . . 1.0 109.573 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.25 90.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 1.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.0 tp -113.02 147.48 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 1.0 110.187 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -159.67 149.48 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.199 -0.938 . . . . 1.0 110.197 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.32 22.75 11.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 1.0 110.173 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.63 -85.02 1.07 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -6.82 31.85 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.656 -0.908 . . . . 1.0 111.031 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.24 107.62 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.865 -1.147 . . . . 1.0 110.623 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.458 ' HB2' HG23 ' A' ' 23' ' ' ILE . 23.7 m80 -87.32 133.59 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.231 -0.918 . . . . 1.0 109.992 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.1 mt -132.71 134.84 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.058 -1.027 . . . . 1.0 110.534 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.038 HD22 ' CE3' ' A' ' 34' ' ' TRP . 27.2 tp -117.16 150.96 37.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 1.0 110.083 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 59' ' ' ILE . 24.9 mm -143.43 99.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 1.0 109.945 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -105.69 116.57 32.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.0 110.08 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 62' ' ' ASN . 42.2 m-70 -85.99 -164.03 0.97 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.877 . . . . 1.0 110.278 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 66.8 t30 -14.71 81.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.808 1.04 . . . . 1.0 113.808 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 64.3 m -73.92 142.58 45.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.506 -0.746 . . . . 1.0 109.562 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.881 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.31 -175.71 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 1.0 110.787 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 65' ' ' LEU . 17.8 tp -79.59 5.26 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 1.0 111.127 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.01 -29.3 6.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.884 ' HB2' HG21 ' A' ' 86' ' ' VAL . 2.8 mtt -49.99 -23.57 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -1.13 . . . . 1.0 110.648 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -47.06 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.51 -0.744 . . . . 1.0 110.406 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.98 -121.6 0.59 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.96 174.29 10.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -1.076 . . . . 1.0 110.585 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 76.9 t -127.61 89.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -0.795 . . . . 1.0 109.742 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -97.9 125.16 42.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 1.0 110.609 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 46.9 t80 -113.75 157.85 21.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.447 -0.783 . . . . 1.0 109.632 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -143.48 136.73 27.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 1.0 110.683 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -160.5 120.62 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 1.0 109.454 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.64 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -0.872 . . . . 1.0 109.799 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.3 m-20 -128.92 -15.31 4.32 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 1.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.48 157.91 8.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.0 110.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -158.1 93.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 1.0 109.776 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 49.5 p -101.73 172.06 7.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.912 . . . . 1.0 110.72 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.17 91.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -0.809 . . . . 1.0 109.816 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -94.02 -171.05 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 1.0 110.593 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.81 133.38 55.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 1.0 110.244 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 11' ' ' VAL . 64.7 tp -132.02 136.88 47.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 1.0 110.218 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -135.27 131.54 36.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 1.0 109.973 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' MET . 93.6 t -100.58 153.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 1.0 109.852 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.0 mtpp -144.32 130.2 19.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 1.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.471 ' HG3' HD13 ' A' ' 65' ' ' LEU . 6.2 mt-10 -71.96 173.3 8.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 1.0 110.302 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 89' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.066 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 77' ' ' ASN . 2.0 mp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.273 0.559 . . . . 1.0 110.184 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.929 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.3 mt -90.01 148.38 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 1.0 109.75 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.02 -5.61 6.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 1.0 111.211 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 46.1 t 60.16 136.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.344 -0.848 . . . . 1.0 110.959 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -116.85 -37.02 3.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 1.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -119.0 109.0 39.86 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.765 -0.584 . . . . 1.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.05 172.72 14.13 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.604 1.318 . . . . 1.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.808 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 51.4 mt -73.3 170.0 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 1.0 110.348 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.55 113.1 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 1.0 110.066 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.9 153.34 4.32 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.508 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 9.0 p -153.43 158.76 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.382 -1.069 . . . . 1.0 110.176 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -112.18 160.49 17.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 1.0 110.406 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 86' ' ' VAL . 9.6 m -147.83 172.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 1.0 110.592 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -129.53 30.35 4.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 63' ' ' CYS . 40.9 t 58.34 70.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.716 0.769 . . . . 1.0 109.95 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.45 -21.49 1.06 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 18' ' ' THR . 58.7 mm-40 -76.31 -121.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 1.0 109.705 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.2 p -160.27 171.12 19.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.845 -1.16 . . . . 1.0 110.452 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.683 ' HB1' ' HE1' ' A' ' 21' ' ' PHE . . . -136.3 158.37 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.417 -0.802 . . . . 1.0 109.548 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 56.3 m80 -146.63 92.35 2.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 1.0 110.946 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.683 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 87.4 m-85 -106.65 112.39 25.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.181 -0.949 . . . . 1.0 109.713 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -121.77 157.4 31.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.997 . . . . 1.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -163.84 122.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.0 109.792 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.62 138.23 33.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 1.0 110.262 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD11 ' CD2' ' A' ' 56' ' ' HIS . 33.9 mt -109.0 170.16 8.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 1.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -11.08 42.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 1.0 110.67 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -123.82 124.98 26.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.0 110.167 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.83 171.2 18.73 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.417 1.219 . . . . 1.0 110.645 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 50.72 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 1.0 110.584 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.26 179.96 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 1.0 110.062 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -127.39 41.26 3.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 1.0 110.382 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 75' ' ' ALA . . . -86.32 174.26 46.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.762 -1.335 . . . . 1.0 109.762 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.07 155.59 32.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -1.13 . . . . 1.0 110.148 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' CE3' HD12 ' A' ' 58' ' ' LEU . 77.0 m95 -86.75 135.56 33.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.047 -1.033 . . . . 1.0 110.475 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -138.69 126.39 22.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.382 -0.824 . . . . 1.0 109.424 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 67' ' ' MET . 1.3 mt -63.62 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.171 -0.956 . . . . 1.0 109.274 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -25.04 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.48 -1.388 . . . . 1.0 109.51 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.74 38.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -128.39 136.4 29.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.238 . . . . 1.0 110.294 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.98 121.03 6.33 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.534 1.281 . . . . 1.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 42' ' ' THR . 2.2 pp -83.29 -149.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 1.0 110.026 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.851 ' N ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -157.74 120.89 3.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.949 . . . . 1.0 109.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -88.2 97.67 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 1.0 110.518 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.464 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER 176.03 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.274 -0.891 . . . . 1.0 110.424 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.2 Cg_endo -72.02 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.579 1.305 . . . . 1.0 111.196 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -113.84 57.78 0.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.924 -1.11 . . . . 1.0 110.729 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 11.2 t -152.28 126.79 9.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 1.0 110.169 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 1.5 mt-10 -111.44 52.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 1.0 110.393 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.634 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.68 124.48 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 1.0 109.985 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.634 ' N ' HD13 ' A' ' 49' ' ' ILE . 3.8 tt -121.42 128.06 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.238 -0.914 . . . . 1.0 110.136 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.02 137.68 14.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.92 . . . . 1.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.89 17.51 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 1.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.48 -24.13 26.98 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -90.56 -20.32 22.75 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.391 -1.064 . . . . 1.0 110.108 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -164.38 127.89 2.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.33 -0.856 . . . . 1.0 110.287 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 23' ' ' ILE . 84.5 m-70 -96.61 120.6 37.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 1.0 110.03 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 55' ' ' LYS . 3.3 mp -130.15 140.07 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 110.217 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.705 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -127.76 130.77 49.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 58' ' ' LEU . 81.6 mt -135.41 87.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 1.0 109.394 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.721 HD13 ' CE ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -96.87 119.08 34.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 1.0 110.729 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.8 m-70 -80.08 -161.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 1.0 109.423 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -14.38 80.97 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.927 1.084 . . . . 1.0 113.927 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.445 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.7 m -70.22 -169.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.573 -0.704 . . . . 1.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.777 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.69 -163.68 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 1.0 110.435 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 88' ' ' GLU . 9.2 mp -82.38 34.21 0.42 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.105 -0.997 . . . . 1.0 111.472 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.82 -29.82 2.98 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.655 -1.778 . . . . 1.0 108.655 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 60' ' ' LEU . 53.6 mtp -88.02 36.22 0.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.991 . . . . 1.0 110.228 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -90.26 58.83 4.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 1.0 109.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -154.83 -125.81 0.99 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.54 151.19 52.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.438 -1.037 . . . . 1.0 110.483 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' LEU . 60.2 t -95.13 84.26 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 1.0 109.924 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.6 p -88.28 119.87 29.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -103.23 143.34 32.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' O ' ' CA ' ' A' ' 32' ' ' GLY . 24.3 mt-30 -130.41 137.18 49.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . . . -164.33 105.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 1.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.929 ' HB3' HD12 ' A' ' 2' ' ' ILE . . . 56.47 -89.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 1.0 110.31 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 1' ' ' LEU . 1.8 t30 -114.78 -27.18 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.956 -1.09 . . . . 1.0 110.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.04 141.91 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 1.0 110.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 75.62 1.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 1.0 109.967 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.438 ' OG ' HD11 ' A' ' 8' ' ' LEU . 61.4 p -90.98 176.96 6.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.953 . . . . 1.0 110.146 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.03 93.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.0 110.15 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.808 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -89.99 -171.29 3.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 1.0 110.069 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.12 105.61 8.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 1.0 109.932 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.608 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 42.5 tp -112.66 124.53 52.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 1.0 110.577 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -127.76 134.72 49.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 1.0 109.807 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.777 HG11 ' O ' ' A' ' 64' ' ' GLN . 84.3 t -100.19 135.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 109.934 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -122.95 134.17 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.0 110.306 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 65' ' ' LEU . 21.8 mt-10 -76.29 169.03 18.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 1.0 110.072 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.291 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.286 0.565 . . . . 1.0 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 16.9 pt -118.77 174.16 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.857 . . . . 1.0 110.136 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -122.52 -166.18 1.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 110.499 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.005 HG23 ' HB1' ' A' ' 78' ' ' ALA . 63.6 t -116.31 122.09 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 1.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.74 -41.72 26.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 1.0 108.733 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 2.3 mtmt -117.77 101.75 51.9 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.823 -0.548 . . . . 1.0 109.855 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.15 174.35 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.599 1.315 . . . . 1.0 110.74 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.874 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 17.7 mt -75.3 176.38 7.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 1.0 110.015 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 28.0 m-85 -135.18 125.0 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.0 110.234 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 142.69 40.78 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.558 ' O ' HD12 ' A' ' 84' ' ' LEU . 7.7 p -153.56 164.03 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -1.073 . . . . 1.0 109.851 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 11' ' ' VAL . 31.3 mt-10 -124.82 152.78 43.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 1.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 17' ' ' GLU . 11.3 p -142.12 149.02 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.82 . . . . 1.0 110.138 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -88.87 47.96 1.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 1.0 110.475 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.7 p 37.02 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.733 0.778 . . . . 1.0 111.72 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 159.01 -25.42 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.05 -1.62 . . . . 1.0 109.05 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.6 mm-40 -76.47 -112.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -1.098 . . . . 1.0 109.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -161.18 151.17 17.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.592 -1.317 . . . . 1.0 110.826 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -107.2 160.94 15.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 1.0 109.076 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.81 97.91 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.0 111.105 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.759 ' CD2' HD23 ' A' ' 58' ' ' LEU . 88.0 m-85 -111.73 108.14 17.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.544 -0.723 . . . . 1.0 109.324 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 155.17 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.324 -0.86 . . . . 1.0 110.509 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.738 HD11 ' OG ' ' A' ' 80' ' ' SER . 7.2 tt -164.81 139.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.444 -0.785 . . . . 1.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -120.45 143.38 48.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.975 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.2 mt -108.03 -156.71 0.59 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 1.0 110.179 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -108.1 -68.37 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 1.0 110.388 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.76 130.1 23.27 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 1.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -78.14 154.53 29.03 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.408 1.215 . . . . 1.0 110.166 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.22 -61.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 1.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.16 166.12 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 1.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 p80 -70.81 -164.85 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.841 . . . . 1.0 110.411 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.4 -150.58 5.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.606 -1.398 . . . . 1.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.25 135.27 3.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.373 -1.075 . . . . 1.0 110.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.877 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -101.95 149.01 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 1.0 110.608 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 19.1 ttpt -141.54 123.14 15.09 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.35 -0.843 . . . . 1.0 109.592 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.44 -131.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 1.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.52 -25.16 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.411 -1.43 . . . . 1.0 109.619 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.42 38.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.698 -1.361 . . . . 1.0 109.698 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 7.9 mm-40 -126.68 109.03 22.79 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.162 -1.199 . . . . 1.0 110.147 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.08 83.83 1.58 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.62 1.326 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.09 -163.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 1.0 110.678 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.1 148.39 50.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 1.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.857 ' HB2' HG22 ' A' ' 49' ' ' ILE . . . -88.28 107.48 18.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 1.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -179.32 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.269 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.87 -50.82 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.59 1.31 . . . . 1.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.0 -54.72 1.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -0.985 . . . . 1.0 110.823 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HA ' HD23 ' A' ' 60' ' ' LEU . 36.8 t -69.5 150.04 47.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 1.0 110.443 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.15 65.0 1.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.875 . . . . 1.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.857 HG22 ' HB2' ' A' ' 43' ' ' ALA . 6.1 tp -84.56 140.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 1.0 110.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.7 mt -128.84 120.96 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.084 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -136.25 141.79 43.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 1.0 110.273 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.85 27.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.222 -0.924 . . . . 1.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.82 -23.92 30.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -90.38 71.8 7.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -1.018 . . . . 1.0 108.93 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 24' ' ' GLU . 5.4 mmtt 54.79 170.83 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.889 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 89.9 m-70 -114.69 144.92 42.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.982 -1.074 . . . . 1.0 110.763 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -140.47 115.06 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.842 . . . . 1.0 109.799 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.877 HD22 ' CE3' ' A' ' 34' ' ' TRP . 44.8 tp -99.19 132.03 44.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 1.0 110.862 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.6 mt -133.33 93.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.474 -0.766 . . . . 1.0 109.456 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 2.6 mt -95.51 105.05 16.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 1.0 110.93 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 68.1 m-70 -69.85 -169.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 1.0 109.475 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 40.5 p-10 -14.87 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.867 1.062 . . . . 1.0 113.867 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.2 m -70.62 -156.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.639 -0.663 . . . . 1.0 109.429 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.783 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -151.43 -169.97 3.52 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.967 -1.083 . . . . 1.0 110.815 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 38.51 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -0.784 . . . . 1.0 111.517 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.55 -15.02 2.5 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.803 -1.189 . . . . 1.0 110.293 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -87.42 37.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.718 -1.46 . . . . 1.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.22 40.27 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 1.0 110.139 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 -125.11 2.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -136.93 152.33 50.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -1.042 . . . . 1.0 110.294 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 71.1 t -94.34 88.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.908 . . . . 1.0 109.84 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.5 p -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 1.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 41.0 t80 -96.39 146.27 24.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 1.0 109.95 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -152.58 126.6 9.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 1.0 110.379 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -132.66 16.06 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.11 -0.994 . . . . 1.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 169.15 -81.97 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.363 -0.835 . . . . 1.0 109.601 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -127.2 -39.03 1.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 1.0 109.535 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 1.005 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -69.29 119.38 13.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.831 . . . . 1.0 110.016 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 1.4 mtpt -123.29 95.81 4.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 1.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.738 ' OG ' HD11 ' A' ' 23' ' ' ILE . 14.3 m -73.35 -179.24 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 1.0 110.182 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.39 104.75 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 1.0 110.576 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.28 -176.64 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 1.0 110.108 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.37 121.15 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 1.0 109.838 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.668 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 56.4 tp -125.2 133.98 52.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 1.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -130.88 130.42 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 1.0 109.511 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 64' ' ' GLN . 92.0 t -91.64 145.48 7.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.181 -0.949 . . . . 1.0 110.447 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -135.47 141.37 45.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.418 -0.801 . . . . 1.0 109.921 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.98 -167.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 1.0 110.336 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.593 HD12 ' HE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.18 0.514 . . . . 1.0 110.217 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.6 mm -123.32 166.83 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 1.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.6 -154.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 1.0 110.344 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.991 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 27.7 t -125.17 127.49 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 1.0 109.958 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.39 -46.17 6.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 1.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.23 107.87 61.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.705 -0.622 . . . . 1.0 110.063 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.17 173.73 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.563 1.297 . . . . 1.0 110.799 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 49.6 mt -75.39 173.89 10.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 1.0 110.45 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -138.59 122.55 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 1.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.0 146.66 47.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.791 -1.323 . . . . 1.0 109.791 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 12' ' ' GLU . 74.3 t -144.23 162.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 1.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 11' ' ' VAL . 3.2 mt-10 -108.41 154.8 21.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 ' CG ' ' A' ' 17' ' ' GLU . 2.7 p -151.08 130.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.0 110.013 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.55 38.06 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 1.0 110.337 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.571 ' H ' HG22 ' A' ' 13' ' ' VAL . 47.3 t 55.82 99.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.374 -0.829 . . . . 1.0 110.684 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.435 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 131.83 -40.8 1.58 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.988 ' CG ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -69.69 -136.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 1.0 109.062 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.3 m -154.42 120.65 5.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.795 -1.191 . . . . 1.0 110.763 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 152.81 30.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 59' ' ' ILE . 10.0 m80 -138.07 133.34 33.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.907 -1.12 . . . . 1.0 111.561 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.837 ' CE1' HG21 ' A' ' 71' ' ' VAL . 75.0 m-85 -125.7 135.47 52.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -125.43 154.65 41.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.0 111.574 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -168.15 135.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.64 . . . . 1.0 109.438 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -125.98 142.97 51.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 1.0 110.618 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.03 -164.16 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.352 -0.842 . . . . 1.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.492 ' HB2' HG23 ' A' ' 2' ' ' ILE . 19.8 m -108.47 -42.85 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 1.0 109.981 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -132.13 132.56 23.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 1.0 110.045 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 143.41 35.49 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.362 1.19 . . . . 1.0 110.441 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -168.71 -54.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 1.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.52 157.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.06 174.4 10.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 1.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.33 -177.41 14.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.597 -1.401 . . . . 1.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.11 151.63 40.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.091 . . . . 1.0 110.107 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.683 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.7 m95 -110.46 147.06 34.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 1.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.451 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 ttpp -133.38 119.56 19.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.426 -0.796 . . . . 1.0 109.525 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -63.66 -135.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.395 -0.816 . . . . 1.0 108.816 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -49.8 -24.63 2.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.243 -1.535 . . . . 1.0 109.759 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 153.8 42.6 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -129.82 122.33 20.44 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.434 -1.039 . . . . 1.0 110.097 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.1 88.58 0.95 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.461 1.243 . . . . 1.0 110.386 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 42' ' ' THR . 4.4 pp -72.22 -160.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 1.0 110.691 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.834 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -170.32 -176.82 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.582 -0.699 . . . . 1.0 109.794 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 102.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.0 109.976 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -127.75 177.04 2.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 1.0 110.493 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 48.3 Cg_endo -73.87 -20.7 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.698 1.368 . . . . 1.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -98.18 -39.99 8.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 1.0 110.387 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.673 ' SG ' HD21 ' A' ' 60' ' ' LEU . 1.3 m -88.1 158.34 18.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.22 -0.925 . . . . 1.0 110.275 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -148.14 67.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 1.0 110.247 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.9 tt -85.09 128.67 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -0.793 . . . . 1.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.0 128.9 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 1.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.13 151.24 32.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 1.0 110.367 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -130.6 20.98 5.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 1.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.92 -61.97 3.34 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -12.79 61.88 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.614 -0.933 . . . . 1.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.89 148.5 29.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.978 -1.076 . . . . 1.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.731 ' HB2' HG23 ' A' ' 23' ' ' ILE . 62.4 m-70 -128.02 107.66 10.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 109.967 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.32 148.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 1.0 110.55 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.689 HD23 ' CD2' ' A' ' 21' ' ' PHE . 19.7 tp -133.48 121.79 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.353 -0.842 . . . . 1.0 110.188 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 20' ' ' HIS . 40.6 mt -122.9 126.17 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 1.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.941 HD22 ' CE ' ' A' ' 67' ' ' MET . 0.2 OUTLIER -129.35 103.0 6.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 1.0 110.372 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 79.6 m-70 -70.16 -163.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.25 -0.906 . . . . 1.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 29.2 t-20 -13.53 81.44 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 15' ' ' VAL . 78.5 m -83.15 -159.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.0 109.253 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.802 ' O ' HG11 ' A' ' 86' ' ' VAL . 3.1 mt-30 -142.82 -170.47 3.24 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.204 -0.935 . . . . 1.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.59 9.19 6.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.3 -29.26 10.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 1.0 109.39 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.941 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.29 -23.3 1.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.328 -1.101 . . . . 1.0 111.429 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -46.49 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.148 -0.97 . . . . 1.0 110.621 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.86 -121.29 0.63 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.253 -1.539 . . . . 1.0 109.253 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -155.3 145.74 22.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -1.12 . . . . 1.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.837 HG21 ' CE1' ' A' ' 21' ' ' PHE . 67.8 t -98.11 93.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 1.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' SER . 86.4 p -96.03 101.44 13.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.0 110.441 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 32.1 t80 -73.61 154.24 39.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 1.0 109.557 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 106.52 7.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.063 -1.023 . . . . 1.0 110.688 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -143.58 118.22 9.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 1.0 109.682 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.56 -153.99 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 1.0 109.865 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -10.45 59.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 1.0 110.504 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.991 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -83.62 153.63 24.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.944 -1.098 . . . . 1.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -159.59 145.89 16.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 1.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 76.8 p -125.87 178.1 5.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.8 103.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 1.0 110.204 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.21 -174.59 2.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 1.0 110.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.88 129.6 36.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 1.0 110.004 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 1.1 tt -135.8 145.62 46.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 1.0 110.469 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 136.33 46.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 1.0 109.802 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.802 HG11 ' O ' ' A' ' 64' ' ' GLN . 61.3 t -103.7 151.16 6.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.249 -0.907 . . . . 1.0 110.446 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.66 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 1.0 110.201 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -93.42 145.59 24.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.358 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.105 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.252 0.549 . . . . 1.0 110.201 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.503 HG22 ' OG ' ' A' ' 26' ' ' SER . 25.8 pt -102.15 158.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 110.198 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.68 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 1.0 110.19 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.97 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -86.48 -34.45 20.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -131.01 112.47 15.93 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.13 171.4 11.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.647 1.34 . . . . 1.0 111.455 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.904 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 67.7 mt -59.95 -167.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.562 0.696 . . . . 1.0 110.913 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 10' ' ' GLY . 20.9 t80 -134.4 158.64 43.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 1.0 110.001 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -99.13 133.49 11.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.697 ' O ' HD12 ' A' ' 84' ' ' LEU . 8.6 p -152.81 164.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -1.144 . . . . 1.0 110.256 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' VAL . 4.6 pt-20 -118.69 172.31 7.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.92 . . . . 1.0 110.58 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG23 HG13 ' A' ' 86' ' ' VAL . 13.1 m -155.25 134.69 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 1.0 110.5 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.9 34.68 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 1.0 109.775 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 14.5 t 61.73 73.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.462 -0.773 . . . . 1.0 110.439 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.41 -25.34 1.09 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.866 -1.693 . . . . 1.0 108.866 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 -163.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.35 -1.088 . . . . 1.0 109.531 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 m -144.32 113.03 6.66 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.2 -0.938 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.29 161.8 26.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 1.0 109.638 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -139.29 88.31 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.002 . . . . 1.0 110.691 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.874 ' CD1' HD23 ' A' ' 58' ' ' LEU . 81.0 m-85 -84.03 162.12 20.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 1.0 109.594 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -153.65 162.49 41.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.046 . . . . 1.0 110.678 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 56' ' ' HIS . 4.7 tt -169.23 135.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.448 -0.782 . . . . 1.0 109.921 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.88 136.45 49.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.111 -0.993 . . . . 1.0 110.057 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.1 mt -101.7 -151.19 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.958 . . . . 1.0 109.879 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 2' ' ' ILE . 24.3 p -117.31 -46.72 2.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 1.0 109.989 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.1 140.8 21.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 1.0 110.064 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.17 178.91 6.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.558 1.294 . . . . 1.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 t70 54.59 92.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 1.0 110.732 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.4 p -156.84 154.51 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 1.0 109.874 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 49.1 p-80 -108.74 121.16 44.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 1.0 110.657 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.81 156.18 26.88 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.41 ' C ' ' CD1' ' A' ' 34' ' ' TRP . 14.2 mm-40 -124.41 177.81 5.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -1.232 . . . . 1.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.658 ' CB ' HD13 ' A' ' 58' ' ' LEU . 37.4 m95 -136.43 139.04 42.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.451 -0.78 . . . . 1.0 110.682 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 6.7 tttp -157.11 -109.99 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.211 -0.931 . . . . 1.0 109.614 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -157.89 -160.11 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.929 -1.107 . . . . 1.0 109.005 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.833 -1.167 . . . . 1.0 109.632 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.75 -114.19 0.01 OUTLIER Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 2.0 mm-40 -136.33 176.59 2.7 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 107.475 -1.306 . . . . 1.0 107.475 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HD2' ' OE1' ' A' ' 39' ' ' GLN . 50.5 Cg_endo -86.06 116.42 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.678 1.357 . . . . 1.0 110.878 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -95.29 -167.75 1.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.81 -1.181 . . . . 1.0 110.716 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.5 p -116.09 162.33 17.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.0 110.218 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.46 120.46 16.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.91 . . . . 1.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.487 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.4 t -173.29 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 1.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -67.87 -89.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.33 1.174 . . . . 1.0 111.146 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.29 70.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 1.0 110.322 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.83 129.6 11.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 1.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.18 94.76 4.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 1.0 109.878 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.2 89.31 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 1.0 110.664 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.59 ' O ' HG23 ' A' ' 50' ' ' ILE . 8.3 tt -89.17 119.65 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.868 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.68 145.5 47.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.99 . . . . 1.0 110.599 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.29 23.24 14.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 1.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.57 -89.25 1.23 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -49.15 -23.81 1.43 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.878 . . . . 1.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -137.5 157.35 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.983 -1.073 . . . . 1.0 110.237 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.741 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.1 m-70 -118.1 138.06 52.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.532 -0.73 . . . . 1.0 109.486 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -140.33 128.46 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.037 -1.039 . . . . 1.0 110.783 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.874 HD23 ' CD1' ' A' ' 21' ' ' PHE . 9.9 tp -103.99 149.9 24.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 1.0 110.421 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 64.9 mt -140.0 82.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.795 . . . . 1.0 109.372 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 60' ' ' LEU . 5.1 mt -84.19 115.37 22.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 1.0 110.729 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 62' ' ' ASN . 60.8 m-70 -87.74 -165.84 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 1.0 109.624 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 7.5 p-10 -14.27 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 85.2 m -74.86 -155.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.639 -0.663 . . . . 1.0 109.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.723 ' O ' HG11 ' A' ' 86' ' ' VAL . 15.6 mt-30 -159.47 -165.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 1.0 110.613 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.39 39.84 0.8 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 1.0 111.237 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.98 -37.83 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.981 -1.647 . . . . 1.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.463 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 50.3 mtt -63.15 -13.36 36.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.365 -1.079 . . . . 1.0 110.778 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.77 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.297 -0.877 . . . . 1.0 110.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 170.75 -113.57 0.5 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.933 -1.667 . . . . 1.0 108.933 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.81 136.4 24.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.48 -1.012 . . . . 1.0 110.468 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.1 t -79.28 144.07 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 1.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 p -136.42 126.56 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.48 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 59.1 t80 -105.66 147.11 28.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.695 . . . . 1.0 109.131 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -137.91 152.5 49.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 1.0 110.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.46 -149.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 1.0 109.939 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.03 -76.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 1.0 110.24 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -123.73 17.01 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 1.0 110.301 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.76 137.92 42.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 1.0 110.658 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 14.9 ptmt -154.16 101.53 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.515 -0.741 . . . . 1.0 109.637 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.41 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 13.4 m -105.15 -176.04 2.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 1.0 110.535 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -167.08 97.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 1.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.55 -168.07 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 1.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -122.14 143.97 49.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 1.0 110.178 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 11' ' ' VAL . 57.1 tp -150.69 119.75 6.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 1.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -117.33 125.98 51.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 1.0 109.852 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.723 HG11 ' O ' ' A' ' 64' ' ' GLN . 41.5 t -90.77 112.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.347 -0.845 . . . . 1.0 110.058 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.33 144.98 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 1.0 110.381 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.15 -177.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 1.0 110.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 89' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.226 0.536 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 77' ' ' ASN . 44.1 mm -95.37 146.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 1.0 109.756 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 1.1 tp10 -129.85 -5.16 4.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 1.0 111.194 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 47.5 t 56.72 108.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 1.0 110.308 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -78.18 -51.49 10.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.054 -1.029 . . . . 1.0 109.884 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -122.91 108.48 32.66 Favored Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 120.073 -0.651 . . . . 1.0 110.277 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.42 -175.8 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.572 1.301 . . . . 1.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 7.0 mt -71.0 -161.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 1.0 110.67 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 9' ' ' TYR . 30.7 p90 -160.4 133.85 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.7 149.01 33.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 7.3 p -155.39 168.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -1.104 . . . . 1.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 44.8 mt-10 -114.69 158.92 21.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 1.0 110.28 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 14' ' ' PHE . 8.8 p -155.82 171.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 1.0 110.342 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.71 135.56 54.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 1.0 109.446 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 11.7 p -50.8 112.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 1.0 110.572 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 122.22 -48.67 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.825 -1.71 . . . . 1.0 108.825 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -165.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -1.018 . . . . 1.0 109.924 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 60' ' ' LEU . 1.1 p -121.42 148.29 44.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 1.0 110.449 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.2 174.97 6.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 1.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -158.97 110.94 2.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 1.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.816 ' CD1' HD23 ' A' ' 58' ' ' LEU . 96.2 m-85 -116.49 156.59 26.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.56 160.53 41.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.03 . . . . 1.0 110.45 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 23' ' ' ILE . 9.3 tt -170.56 124.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 1.0 109.848 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.535 ' O ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -79.73 132.71 36.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 1.0 110.107 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 24' ' ' GLU . 2.5 mm? -119.97 -177.35 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 1.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 t -132.1 20.53 4.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 1.0 110.122 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.22 156.37 66.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 1.0 110.197 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.72 -20.76 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.683 1.359 . . . . 1.0 110.38 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.62 -132.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 1.0 109.392 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.87 167.27 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.632 -1.293 . . . . 1.0 110.102 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -175.53 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 1.0 110.277 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -97.85 -177.46 33.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.42 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.25 167.77 25.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -1.078 . . . . 1.0 110.092 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.754 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.9 m95 -99.82 167.06 10.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 1.0 110.496 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -171.4 153.43 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 1.0 109.91 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 67' ' ' MET . 4.0 mt -67.22 -131.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.09 -1.006 . . . . 1.0 109.894 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -48.1 -25.36 1.42 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.666 -1.271 . . . . 1.0 110.638 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 154.06 39.3 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.645 -1.382 . . . . 1.0 109.645 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -131.87 117.21 16.08 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.164 -1.198 . . . . 1.0 109.442 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.88 94.07 1.01 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.649 1.342 . . . . 1.0 109.959 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -179.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 42' ' ' THR . 90.7 m -136.56 23.53 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.772 . . . . 1.0 110.094 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.56 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 1.0 110.397 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -174.4 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 1.0 110.91 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 45.0 Cg_endo -70.6 -14.11 33.14 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.304 1.16 . . . . 1.0 111.115 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 47' ' ' CYS . 2.6 p30 -113.05 -24.53 9.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.017 . . . . 1.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.41 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 53.4 t -122.7 128.8 51.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.114 -0.991 . . . . 1.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -118.45 140.04 50.48 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.189 -0.944 . . . . 1.0 109.664 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.562 HG22 ' OE2' ' A' ' 51' ' ' GLU . 97.1 mt -139.61 108.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.486 -0.759 . . . . 1.0 109.801 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 50' ' ' ILE . 8.9 tp -128.02 128.01 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 1.0 110.494 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -154.78 138.66 16.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 1.0 109.894 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -122.54 18.88 10.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 1.0 110.775 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -42.54 2.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.955 -1.258 . . . . 1.0 109.955 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -62.31 -29.69 70.62 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.571 -0.958 . . . . 1.0 110.044 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 146.5 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.33 -0.856 . . . . 1.0 110.283 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' ' HG ' ' A' ' 25' ' ' LEU . 86.0 m-70 -105.72 119.65 39.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 1.0 110.01 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.55 137.55 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.209 -0.932 . . . . 1.0 110.383 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 ' CD1' ' A' ' 21' ' ' PHE . 15.5 tp -120.63 136.98 54.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.393 -0.817 . . . . 1.0 110.186 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.2 mt -141.73 100.7 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 18' ' ' THR . 0.3 OUTLIER -98.25 170.93 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 1.0 110.499 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.4 m-70 -126.52 -168.31 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.421 -0.8 . . . . 1.0 109.665 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 61' ' ' HIS . 15.2 p-10 -14.78 81.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.815 1.042 . . . . 1.0 113.815 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 15' ' ' VAL . 62.7 m -78.63 165.47 23.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.694 -0.629 . . . . 1.0 109.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' VAL . 38.3 tp60 -105.27 167.16 9.91 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.112 -0.992 . . . . 1.0 109.234 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.434 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -66.58 0.51 2.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.95 -1.094 . . . . 1.0 112.5 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.77 -21.42 33.88 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -50.99 -20.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -1.131 . . . . 1.0 111.523 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 m -44.42 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.305 -0.872 . . . . 1.0 110.736 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.78 -119.15 0.49 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.79 130.57 10.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.017 . . . . 1.0 110.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 8' ' ' LEU . 25.4 t -85.33 93.36 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 1.0 109.144 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -101.5 150.76 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.059 . . . . 1.0 110.934 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 64.2 t80 -118.12 138.04 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.517 -0.739 . . . . 1.0 109.692 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 10.3 pt20 -121.35 151.59 39.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 1.0 110.5 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . . . -167.8 -153.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 1.0 110.068 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -67.37 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.973 . . . . 1.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 57.2 t30 -130.25 18.76 5.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 1.0 110.152 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . . . -99.04 149.89 22.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -159.71 74.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 1.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.493 ' OG ' HD11 ' A' ' 8' ' ' LEU . 83.5 p -82.95 168.45 17.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.82 96.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.1 -174.22 3.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 1.0 110.08 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -125.49 107.54 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 1.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD22 ' HZ ' ' A' ' 21' ' ' PHE . 55.7 tp -108.42 138.89 43.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 1.0 110.567 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -131.11 140.45 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.815 . . . . 1.0 109.945 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 67' ' ' MET . 97.6 t -97.41 116.33 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.912 . . . . 1.0 110.195 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -93.85 130.67 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 110.491 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -68.23 179.03 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 1.0 110.039 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.232 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.267 0.556 . . . . 1.0 110.345 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 27' ' ' GLU . 6.1 pt -88.26 -170.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 1.0 110.272 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -135.95 -165.58 1.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.0 110.231 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.634 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 99.4 t -126.14 125.5 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 1.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -86.79 -48.0 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 1.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -117.79 107.27 44.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.65 -0.656 . . . . 1.0 109.886 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.76 176.83 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.679 1.357 . . . . 1.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.742 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 80.9 mt -60.16 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 1.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 88.4 t80 -152.36 163.31 39.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 1.0 109.549 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -87.45 145.92 19.86 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.842 -1.303 . . . . 1.0 109.842 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG22 ' N ' ' A' ' 12' ' ' GLU . 8.2 p -153.8 164.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.0 110.241 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 11' ' ' VAL . 36.9 mt-10 -121.26 163.48 18.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 1.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.2 p -155.65 132.61 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 1.0 109.931 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CA ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -87.32 76.08 9.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 1.0 110.959 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 32.8 t 59.36 97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.841 0.829 . . . . 1.0 112.049 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' ' N ' ' A' ' 63' ' ' CYS . . . 46.12 23.34 1.12 Allowed Glycine 0 N--CA 1.495 2.592 0 O-C-N 121.943 -0.473 . . . . 1.0 113.217 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HG3' ' CA ' ' A' ' 14' ' ' PHE . 1.8 mm-40 -62.49 -75.17 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.714 1.757 . . . . 1.0 107.653 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.701 HG23 ' CE1' ' A' ' 61' ' ' HIS . 63.3 m -162.02 151.38 15.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.783 -0.573 . . . . 1.0 109.672 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 60' ' ' LEU . . . -117.31 163.11 16.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 1.0 109.624 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -155.89 81.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.934 -1.104 . . . . 1.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -102.36 115.49 30.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -0.901 . . . . 1.0 109.591 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -112.16 157.34 20.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 1.0 111.111 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 23' ' ' ILE . 12.1 tt -167.09 120.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 1.0 109.488 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 2.7 tt0 -87.16 129.81 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 1.0 110.727 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -96.74 -171.99 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.814 . . . . 1.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -105.45 -83.82 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 1.0 110.398 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' HG21 ' A' ' 2' ' ' ILE . 55.6 mt-10 -90.78 121.89 67.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.0 110.216 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.26 111.87 3.39 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.41 1.216 . . . . 1.0 110.078 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.91 -64.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 1.0 110.444 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.44 157.6 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 1.0 110.335 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -107.58 -175.56 2.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 1.0 109.91 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.97 -159.33 9.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.471 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -156.8 171.05 21.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -1.081 . . . . 1.0 109.882 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.874 ' CD2' HD12 ' A' ' 58' ' ' LEU . 56.2 m95 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.038 -1.039 . . . . 1.0 110.648 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' CD ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -157.23 126.08 5.81 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.37 -133.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 1.0 108.873 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -24.76 6.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.328 -1.483 . . . . 1.0 109.355 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 162.64 40.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -115.72 101.74 54.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.265 -1.138 . . . . 1.0 110.299 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.73 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.889 1.468 . . . . 1.0 110.324 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 42' ' ' THR . 0.2 OUTLIER -78.82 -164.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 1.0 110.677 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -162.08 172.12 16.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 1.0 110.225 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.0 125.38 34.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 1.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -174.88 -59.93 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 1.0 110.343 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -71.13 -87.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.447 1.235 . . . . 1.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -142.15 52.88 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.877 -1.139 . . . . 1.0 110.487 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.04 138.07 31.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.202 -0.936 . . . . 1.0 110.167 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 4.2 tt0 -123.65 53.49 1.36 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.105 -0.997 . . . . 1.0 110.002 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.8 114.98 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.87 -1.144 . . . . 1.0 109.908 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.0 99.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 1.0 110.238 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 18.8 pt-20 -124.85 141.87 51.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.95 . . . . 1.0 110.277 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.85 14.48 2.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.12 -30.3 6.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.388 -1.085 . . . . 1.0 110.388 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -90.9 -16.24 28.49 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.309 -1.113 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.88 114.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.161 -0.962 . . . . 1.0 110.383 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.626 ' CD2' ' HB2' ' A' ' 51' ' ' GLU . 52.8 m80 -95.1 111.63 23.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.843 . . . . 1.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 22' ' ' GLU . 28.7 mm -120.7 147.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 1.0 110.07 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.874 HD12 ' CD2' ' A' ' 34' ' ' TRP . 4.5 tt -123.9 130.51 52.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 1.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.786 ' N ' HD23 ' A' ' 58' ' ' LEU . 25.1 mt -133.46 103.1 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.659 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -125.43 127.34 46.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.006 -1.059 . . . . 1.0 111.722 -178.625 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.701 ' CE1' HG23 ' A' ' 18' ' ' THR . 12.8 m-70 -103.7 28.1 6.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.846 0.832 . . . . 1.0 108.82 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.624 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 m-20 -108.53 -4.58 17.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.596 -0.69 . . . . 1.0 111.319 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 76.8 m -43.04 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.274 -0.891 . . . . 1.0 111.395 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.66 ' C ' HG11 ' A' ' 86' ' ' VAL . 18.8 mt-30 -161.24 -166.78 1.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 1.0 110.213 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -3.44 18.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 1.0 111.152 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.85 -36.25 5.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.797 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -48.57 -23.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 1.0 111.548 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 p -46.34 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.933 . . . . 1.0 110.762 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -175.21 -125.67 0.88 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -139.76 142.94 36.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 1.0 110.513 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 55.2 t -94.51 105.2 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.634 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -107.77 108.09 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 1.0 110.625 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 24.4 t80 -81.07 145.01 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 1.0 109.586 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -121.2 111.01 16.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 1.0 110.593 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -147.26 109.57 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.528 -0.732 . . . . 1.0 109.502 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 57.93 -162.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 1.0 109.596 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -62.85 -19.49 64.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.0 110.163 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -72.7 145.36 47.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 1.0 110.398 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -153.57 133.37 13.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 1.0 110.094 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.562 ' OG ' HD11 ' A' ' 8' ' ' LEU . 69.8 p -112.16 178.35 4.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.947 . . . . 1.0 110.171 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.14 79.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 1.0 110.511 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -82.64 -178.74 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.985 . . . . 1.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -114.09 136.74 52.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 1.0 110.25 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 25.7 tp -136.55 134.25 37.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -131.92 125.88 32.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 1.0 109.744 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 67' ' ' MET . 51.4 t -90.92 112.29 24.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.304 -0.872 . . . . 1.0 109.949 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -75.75 172.38 12.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 1.0 110.519 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -86.73 176.47 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 1.0 110.226 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.108 179.8 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.611 HD13 HG11 ' A' ' 30' ' ' VAL . 20.7 pt -143.46 150.67 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.69 -172.66 2.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 1.0 110.301 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.0 111.53 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.27 -38.98 19.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.449 -0.945 . . . . 1.0 108.449 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -122.5 106.44 35.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.66 173.46 9.94 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.617 1.325 . . . . 1.0 111.032 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.825 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 12.8 mt -73.77 -160.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.515 -0.741 . . . . 1.0 109.981 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -148.66 114.05 5.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0 109.835 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 83' ' ' ASN . . . -64.4 132.3 38.55 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.6 p -154.14 161.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -1.179 . . . . 1.0 110.586 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' VAL . 2.4 pt-20 -107.49 169.63 8.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.0 109.96 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.35 172.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 1.0 110.49 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -111.68 137.46 49.54 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.461 -0.774 . . . . 1.0 108.948 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 63' ' ' CYS . 93.2 t -46.11 111.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.415 -0.803 . . . . 1.0 111.403 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 127.24 -47.33 1.03 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.37 -1.076 . . . . 1.0 109.965 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -130.17 139.93 50.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 110.569 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.16 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 1.0 109.744 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -130.64 100.68 5.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 1.0 110.755 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 51.8 m-85 -104.41 154.38 19.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 1.0 109.743 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 8' ' ' LEU . 44.3 mt-10 -140.92 157.61 45.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.002 -1.061 . . . . 1.0 110.611 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -169.48 139.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.446 -0.784 . . . . 1.0 110.154 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.13 132.27 54.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.334 -0.854 . . . . 1.0 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 2' ' ' ILE . 18.4 mt -94.37 -152.57 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 1.0 110.097 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -109.16 -37.77 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -0.834 . . . . 1.0 110.149 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.07 148.28 59.77 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 1.0 110.171 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.6 Cg_endo -74.62 -167.9 0.45 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.677 1.357 . . . . 1.0 110.797 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.53 46.49 22.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 1.0 110.364 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 28' ' ' PRO . 58.9 t -137.58 102.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 1.0 110.349 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -91.99 137.55 32.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.268 -0.895 . . . . 1.0 110.18 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.57 172.98 21.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -122.38 163.55 19.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 1.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.1 m95 -114.05 149.16 35.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 1.0 110.293 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 1.1 ttpt -139.47 131.33 27.63 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.318 -0.864 . . . . 1.0 109.939 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.7 mt -61.46 -112.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.142 -0.974 . . . . 1.0 109.304 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -85.97 12.62 8.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.448 -1.408 . . . . 1.0 110.264 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 131.19 -1.77 5.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -97.57 112.09 60.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.91 -1.347 . . . . 1.0 109.96 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.3 109.04 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.525 1.276 . . . . 1.0 110.543 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 169.42 17.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.288 -0.882 . . . . 1.0 110.534 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -143.52 24.13 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 1.0 109.742 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.02 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.832 . . . . 1.0 110.753 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.58 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 1.0 109.74 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.6 Cg_endo -70.54 -19.3 32.59 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.584 1.307 . . . . 1.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.89 -58.75 1.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.948 . . . . 1.0 109.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.26 152.13 44.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 1.0 109.95 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 3.1 mm-40 -133.57 86.51 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 1.0 110.409 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.68 128.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 1.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.05 122.47 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 1.0 110.591 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -142.55 162.25 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.0 109.72 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.55 16.76 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.02 -1.05 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.38 -29.86 7.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.984 -1.246 . . . . 1.0 109.984 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -74.12 -28.39 61.32 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.308 -1.113 . . . . 1.0 109.767 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.19 -173.66 1.32 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.376 -0.827 . . . . 1.0 110.063 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.659 ' HB2' HG23 ' A' ' 23' ' ' ILE . 81.1 m-70 -139.41 118.27 12.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.91 130.47 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 1.0 110.167 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.981 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.0 tt -105.88 136.34 45.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.833 . . . . 1.0 110.349 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.792 ' N ' HD23 ' A' ' 58' ' ' LEU . 69.8 mt -134.2 73.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 1.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 18' ' ' THR . 2.0 mt -72.06 151.12 43.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 1.0 110.533 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.537 ' HA ' HG22 ' A' ' 18' ' ' THR . 56.9 m-70 -113.99 -172.42 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.0 109.6 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 63.4 t-20 -14.52 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 61' ' ' HIS . 99.8 m -78.4 172.71 13.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.609 -0.682 . . . . 1.0 109.291 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' O ' HG21 ' A' ' 86' ' ' VAL . 49.4 tp60 -115.0 167.28 10.94 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.023 -1.048 . . . . 1.0 109.128 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 14.0 tp -63.86 -5.96 5.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.033 -1.042 . . . . 1.0 112.308 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.66 -12.53 82.76 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 120.674 -1.266 . . . . 1.0 110.445 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.521 ' HB2' HG21 ' A' ' 86' ' ' VAL . 23.1 mtt -86.06 41.95 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.374 . . . . 1.0 110.93 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -90.83 45.02 1.22 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 1.0 110.004 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.1 -125.32 3.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 8.6 pt-20 -144.59 151.89 39.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -1.057 . . . . 1.0 110.336 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.411 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 73.2 t -90.33 90.48 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 1.0 109.964 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 p -94.52 99.94 12.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.836 . . . . 1.0 110.287 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -73.28 167.86 20.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.968 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.99 107.31 1.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 1.0 110.258 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -139.74 122.92 16.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 1.0 109.99 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 2' ' ' ILE . . . 54.89 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 1.0 110.387 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' ALA . 24.3 t30 -128.54 -31.04 2.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.047 -1.033 . . . . 1.0 110.589 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.47 127.68 33.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 1.0 110.511 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 124.03 15.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 1.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.411 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.9 m -112.62 -174.22 2.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 1.0 110.486 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.05 102.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 1.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -99.98 -172.67 2.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.905 . . . . 1.0 109.903 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 19.6 t-20 -114.51 137.23 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.108 -0.995 . . . . 1.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -140.63 124.02 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 1.0 110.607 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -126.54 133.71 51.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 1.0 109.52 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 64' ' ' GLN . 43.4 t -91.79 149.83 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.14 -0.975 . . . . 1.0 110.377 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.66 104.78 4.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 1.0 110.029 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.45 -156.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 1.0 110.461 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.932 -1.032 . . . . 1.0 110.081 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.356 0.598 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.716 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.4 mm -112.87 137.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.312 -0.868 . . . . 1.0 110.485 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -171.36 2.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.348 -0.845 . . . . 1.0 110.063 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.5 t -119.13 119.38 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 1.0 110.1 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -82.64 -49.64 9.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.208 -0.932 . . . . 1.0 109.626 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 5.5 mmtt -119.14 107.91 41.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 1.0 109.913 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.41 -175.86 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.491 1.258 . . . . 1.0 110.482 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 6.6 mt -79.2 -172.65 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 1.0 110.494 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.35 136.48 33.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 1.0 110.125 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.89 149.91 36.84 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -160.11 154.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.161 . . . . 1.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.05 162.4 17.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 1.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.7 p -160.35 137.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 1.0 109.818 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.32 55.65 3.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.379 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 63' ' ' CYS . 5.9 p 36.55 76.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 CA-C-O 121.776 0.798 . . . . 1.0 111.95 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 158.13 -30.43 0.48 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.764 -1.735 . . . . 1.0 108.764 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.3 mt-10 -75.8 -161.94 0.19 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -1.027 . . . . 1.0 109.699 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 20.7 m -126.07 112.73 16.2 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.323 -0.951 . . . . 1.0 110.743 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.32 33.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 1.0 109.36 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -126.63 119.35 26.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.945 -1.097 . . . . 1.0 110.744 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.709 ' CD2' HD23 ' A' ' 58' ' ' LEU . 82.9 m-85 -117.21 123.48 46.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -0.883 . . . . 1.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.58 153.15 25.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.017 . . . . 1.0 110.167 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.587 HD13 ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -166.83 120.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 1.0 109.495 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -107.38 148.34 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 1.0 110.403 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 56' ' ' HIS . 42.9 mt -106.56 -150.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 1.0 109.854 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.716 ' HB2' HG23 ' A' ' 2' ' ' ILE . 68.7 m -116.09 -40.96 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 1.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.13 135.95 12.97 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 1.0 110.179 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.57 153.96 49.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.481 1.253 . . . . 1.0 110.391 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.75 -64.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.0 110.301 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.38 -164.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 1.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -115.21 143.79 44.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 1.0 110.132 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.38 -166.22 22.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.45 -1.46 . . . . 1.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.64 154.35 36.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -1.182 . . . . 1.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.898 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.8 m95 -102.01 147.35 26.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -141.84 132.49 25.52 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.359 -0.838 . . . . 1.0 109.328 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.466 HD21 ' SD ' ' A' ' 67' ' ' MET . 5.5 mt -64.7 -136.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.062 -1.023 . . . . 1.0 109.004 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -25.11 7.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.443 -1.41 . . . . 1.0 109.315 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.35 42.73 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.82 33.03 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.372 -1.076 . . . . 1.0 109.765 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.79 85.24 1.35 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.721 1.38 . . . . 1.0 110.197 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -69.36 -172.97 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.243 -0.911 . . . . 1.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.4 p -136.39 -170.65 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.93 109.64 14.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 110.149 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 1.2 m -120.29 166.39 15.39 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 1.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 46.7 Cg_endo -72.6 -23.16 20.1 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.599 1.315 . . . . 1.0 110.486 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.39 -25.6 23.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 1.0 110.218 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.35 127.22 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.914 . . . . 1.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.18 147.46 44.18 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 1.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.9 mt -140.33 95.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 1.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -99.54 98.68 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 1.0 109.726 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.27 162.82 25.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 1.0 110.599 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.1 23.62 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 1.0 109.96 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 -86.24 1.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -50.08 -23.77 2.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.75 -0.853 . . . . 1.0 110.747 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -134.74 160.48 38.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 1.0 110.655 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.591 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.0 m-70 -143.34 105.42 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -104.83 144.49 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 1.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.898 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -128.87 136.18 50.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.0 110.272 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.58 93.9 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 1.0 109.8 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.56 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -103.09 103.89 14.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 1.0 110.531 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' C ' ' A' ' 62' ' ' ASN . 67.1 m-70 -69.44 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 1.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 61' ' ' HIS . 3.1 m120 -12.18 79.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 113.85 1.056 . . . . 1.0 113.85 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.813 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.7 m -71.63 145.44 48.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.781 . . . . 1.0 109.092 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.796 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -99.18 172.92 7.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 1.0 110.902 -179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -4.63 22.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.639 -0.663 . . . . 1.0 111.136 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.73 -11.91 76.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.793 -1.194 . . . . 1.0 110.336 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 86' ' ' VAL . 9.0 mtt -85.95 43.26 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.905 -1.35 . . . . 1.0 110.615 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 40.73 1.04 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 1.0 109.75 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.9 2.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.886 -1.285 . . . . 1.0 109.886 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.44 152.17 44.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.403 -1.057 . . . . 1.0 110.539 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 83.6 t -92.99 87.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 1.0 109.475 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.0 p -94.52 112.23 23.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 1.0 110.894 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 46.8 t80 -91.26 137.97 31.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 1.0 109.398 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -120.13 138.26 53.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 1.0 111.087 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -155.56 47.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.72 . . . . 1.0 109.356 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 62.22 132.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.782 . . . . 1.0 110.425 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 45.23 24.07 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 1.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.21 139.03 16.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.025 . . . . 1.0 109.972 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -155.96 68.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 1.0 110.8 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 8' ' ' LEU . 71.1 p -54.65 171.88 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.981 -1.074 . . . . 1.0 109.554 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.88 104.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.035 -1.04 . . . . 1.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -98.57 -167.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 1.0 109.828 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -128.19 137.45 52.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 1.0 109.787 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 84' ' ' LEU . 1.9 tm? -139.27 116.31 10.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.043 -1.036 . . . . 1.0 111.146 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.486 ' N ' HD13 ' A' ' 84' ' ' LEU . 11.7 mttt -111.12 132.82 53.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.416 -0.803 . . . . 1.0 109.39 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 64' ' ' GLN . 28.0 t -103.9 111.09 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.228 -0.92 . . . . 1.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -99.58 129.9 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.72 -176.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 1.0 110.374 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.321 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.279 0.561 . . . . 1.0 110.12 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 26' ' ' SER . 37.6 mm -101.93 140.31 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.128 -0.983 . . . . 1.0 110.073 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.3 mt-10 -123.84 -178.6 4.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 1.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.917 HG23 ' HB1' ' A' ' 78' ' ' ALA . 74.2 t -105.4 115.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.804 . . . . 1.0 109.93 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -75.95 -39.76 55.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 5.6 mptt -124.95 106.92 28.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.65 176.57 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.565 1.297 . . . . 1.0 110.705 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 4.1 mt -72.05 172.22 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 1.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 20.6 m-85 -129.25 3.71 5.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.137 -0.977 . . . . 1.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.702 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 70.43 153.52 1.04 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 11' ' ' VAL . 7.1 p -156.95 134.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.114 . . . . 1.0 110.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -109.07 150.64 27.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.0 110.068 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 14' ' ' PHE . 1.1 p -160.55 -158.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.454 -0.779 . . . . 1.0 109.782 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.635 ' N ' HG13 ' A' ' 13' ' ' VAL . 5.8 m-85 -107.33 -154.51 0.53 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 63' ' ' CYS . 81.6 t -120.16 121.76 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.85 -1.156 . . . . 1.0 110.763 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.34 -48.95 0.94 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -65.14 -147.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -1.109 . . . . 1.0 110.617 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CG ' ' A' ' 61' ' ' HIS . 4.6 p -128.81 161.06 30.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 110.996 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -105.68 170.13 8.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.69 . . . . 1.0 109.477 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 93.38 2.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.013 . . . . 1.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 81.9 m-85 -94.67 162.63 13.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.51 -0.744 . . . . 1.0 109.552 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 8' ' ' LEU . 4.2 mp0 -140.67 153.98 46.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.945 -1.097 . . . . 1.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' OG ' ' A' ' 80' ' ' SER . 3.6 tt -170.55 138.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.598 -0.689 . . . . 1.0 109.814 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.538 ' C ' HD12 ' A' ' 25' ' ' LEU . 30.1 tt0 -96.43 170.41 9.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 1.0 110.559 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.934 HD13 ' CD2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -159.17 175.03 13.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.522 -0.736 . . . . 1.0 109.889 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 2' ' ' ILE . 9.7 m -93.31 -44.16 8.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.083 -1.011 . . . . 1.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.82 150.79 53.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.95 . . . . 1.0 110.132 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.85 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.732 1.386 . . . . 1.0 110.652 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.65 76.65 9.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 1.0 110.218 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.456 HG11 HD22 ' A' ' 25' ' ' LEU . 7.4 p -95.17 143.73 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.29 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 31' ' ' HIS . 25.9 p80 -76.32 117.79 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.875 . . . . 1.0 110.231 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.92 -166.14 10.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.346 -1.502 . . . . 1.0 109.346 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.71 128.03 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -1.2 . . . . 1.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.758 ' CE3' HD22 ' A' ' 58' ' ' LEU . 28.2 m95 -94.7 154.66 17.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 1.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 4.4 ptmt -152.07 156.08 39.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 1.0 109.968 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.504 HD21 ' HE3' ' A' ' 67' ' ' MET . 5.4 mt -65.16 -133.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.903 . . . . 1.0 109.354 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -52.15 -23.31 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.474 -1.391 . . . . 1.0 110.126 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 159.52 39.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.385 -1.486 . . . . 1.0 109.385 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -119.33 109.15 39.04 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.235 -1.156 . . . . 1.0 109.607 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.21 111.56 3.34 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.586 1.308 . . . . 1.0 110.037 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 42' ' ' THR . 1.0 OUTLIER -114.84 -144.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 1.0 110.153 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 41' ' ' LEU . 4.2 m -143.96 150.9 39.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.986 -1.071 . . . . 1.0 110.319 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 49' ' ' ILE . . . -83.84 113.31 20.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 1.0 110.136 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -177.91 -59.71 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 1.0 110.372 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -69.73 -69.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.493 1.26 . . . . 1.0 111.305 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -132.68 64.24 1.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.935 -1.103 . . . . 1.0 110.494 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.43 ' HA ' HD23 ' A' ' 60' ' ' LEU . 8.9 t -169.05 139.93 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 1.0 110.348 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -135.5 85.52 2.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 1.0 110.21 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 43' ' ' ALA . 28.6 mt -80.3 130.2 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 1.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 59' ' ' ILE . 7.4 tt -142.97 102.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 1.0 109.848 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.57 159.27 19.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 1.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -113.44 20.84 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.395 -0.816 . . . . 1.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.84 -101.58 2.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.834 -1.307 . . . . 1.0 109.834 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -50.75 -21.76 1.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.417 -1.049 . . . . 1.0 110.673 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 1.5 mmtt -134.11 173.78 11.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 1.0 110.493 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.934 ' CD2' HD13 ' A' ' 25' ' ' LEU . 19.5 m-70 -126.34 135.95 52.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.0 109.736 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.3 mt -137.16 127.89 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.0 110.882 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.758 HD22 ' CE3' ' A' ' 34' ' ' TRP . 32.6 tp -103.25 149.12 25.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.0 109.963 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 HG21 ' A' ' 50' ' ' ILE . 55.1 mt -145.2 82.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.149 -0.969 . . . . 1.0 109.523 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HE1' ' A' ' 67' ' ' MET . 1.2 mt -76.83 -179.82 5.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 1.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' C ' ' A' ' 62' ' ' ASN . 65.8 m-70 -137.5 -162.4 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.57 -0.706 . . . . 1.0 109.103 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 61' ' ' HIS . 1.7 t-20 -14.25 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 113.415 0.895 . . . . 1.0 113.415 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.899 ' O ' HG13 ' A' ' 15' ' ' VAL . 73.5 m -71.03 163.49 27.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.682 -0.636 . . . . 1.0 110.142 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 39.3 tp60 -121.51 168.68 11.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.428 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 8.3 tp -76.52 17.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.849 -1.157 . . . . 1.0 112.124 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 -25.54 6.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.026 -1.63 . . . . 1.0 109.026 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.614 ' HE1' HD13 ' A' ' 60' ' ' LEU . 54.1 mtp -54.59 -18.58 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -1.116 . . . . 1.0 110.722 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -42.22 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.634 -0.666 . . . . 1.0 110.95 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -176.81 -116.74 0.48 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.336 -1.506 . . . . 1.0 109.336 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.72 130.39 10.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 27.6 t -79.1 100.4 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 1.0 109.168 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -99.34 116.55 31.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.0 110.947 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 31.5 t80 -87.54 146.4 25.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 1.0 108.959 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 105.3 8.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.959 -1.088 . . . . 1.0 111.055 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -139.45 121.48 15.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.595 -0.691 . . . . 1.0 109.369 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.32 -153.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 1.0 109.738 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -72.02 -10.51 59.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 110.719 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB2' ' HA ' ' A' ' 3' ' ' GLU . . . -80.13 155.5 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.042 . . . . 1.0 110.525 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -159.9 95.51 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 110.013 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 23' ' ' ILE . 36.8 m -85.51 167.54 15.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 1.0 110.293 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.415 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.89 106.22 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 1.0 110.894 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.841 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.42 -161.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.989 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -115.66 148.56 39.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.955 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.66 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 55.3 tp -140.82 132.44 27.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 1.0 110.518 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -132.6 131.2 41.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 1.0 109.825 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.607 ' CG1' HG22 ' A' ' 15' ' ' VAL . 61.1 t -108.44 151.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.309 -0.87 . . . . 1.0 110.124 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.3 mttt -148.34 144.8 27.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 1.0 110.382 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -73.51 146.16 45.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 1.0 110.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.233 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.239 0.543 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.97 118.17 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 1.0 110.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.68 179.0 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.936 . . . . 1.0 110.355 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 78' ' ' ALA . 61.9 t -88.58 106.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 1.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.87 -36.86 84.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.273 -0.892 . . . . 1.0 109.281 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 106.31 27.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.421 -0.799 . . . . 1.0 109.804 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.79 172.82 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.587 1.309 . . . . 1.0 110.864 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.6 mt -82.05 177.73 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.765 . . . . 1.0 109.56 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -136.25 6.65 3.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.941 -1.099 . . . . 1.0 111.483 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 62.41 144.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 1.0 109.997 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 5.8 m -141.36 -175.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -1.165 . . . . 1.0 110.14 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.43 158.16 45.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.194 -0.941 . . . . 1.0 110.322 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.473 HG23 ' CB ' ' A' ' 17' ' ' GLU . 2.9 p -153.87 134.37 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.348 -0.845 . . . . 1.0 109.837 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -92.09 55.19 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 1.0 110.546 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t 48.44 89.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.87 . . . . 1.0 110.808 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.44 -33.99 3.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.044 -1.622 . . . . 1.0 109.044 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.2 mt-10 -67.34 -162.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.351 -1.088 . . . . 1.0 109.552 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 m -135.64 119.59 17.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.135 -0.978 . . . . 1.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.97 165.25 23.67 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.348 -0.845 . . . . 1.0 109.077 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -147.13 115.57 6.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.923 -1.111 . . . . 1.0 110.883 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -113.82 130.8 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.0 109.758 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . 24.4 mp0 -115.06 151.61 33.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 1.0 110.649 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 56' ' ' HIS . 13.1 tt -170.87 154.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.447 -0.783 . . . . 1.0 109.73 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.488 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -151.3 160.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 1.0 110.311 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 25' ' ' LEU . 2.4 mm? -112.98 -168.76 1.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 1.0 109.898 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -99.55 -45.32 5.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 1.0 110.129 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.28 153.97 38.05 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 1.0 110.117 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.683 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.3 Cg_endo -78.35 -166.02 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.717 1.377 . . . . 1.0 110.485 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.82 54.68 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 1.0 110.398 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' PRO . 60.7 t -134.04 117.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 1.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -98.75 144.7 27.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 1.0 110.025 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -151.13 171.89 30.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.763 -1.335 . . . . 1.0 109.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -139.08 179.22 6.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.384 -1.068 . . . . 1.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 1.018 ' CE3' HD12 ' A' ' 58' ' ' LEU . 59.8 m95 -123.69 133.41 53.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 1.0 110.701 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -129.08 111.47 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.786 . . . . 1.0 110.711 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.806 HD12 HD22 ' A' ' 41' ' ' LEU . 6.6 mt -57.44 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 1.0 108.725 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -92.27 9.05 35.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 1.0 109.497 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 127.79 -1.23 6.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.09 -1.204 . . . . 1.0 110.09 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.6 mm-40 -96.7 137.61 21.42 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.251 . . . . 1.0 109.913 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.97 106.05 2.18 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.613 1.323 . . . . 1.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.806 HD22 HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -108.02 3.37 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 110.573 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 m -70.55 -35.48 73.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.07 . . . . 1.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.74 44.59 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 1.0 110.548 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -115.82 158.96 40.83 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.346 -0.847 . . . . 1.0 110.231 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.53 -12.87 27.34 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.759 1.4 . . . . 1.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.54 -17.81 15.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.0 110.518 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.4 131.84 35.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 1.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -133.15 77.41 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 1.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 58' ' ' LEU . 1.1 pp -96.83 105.32 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 1.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.8 111.54 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 1.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -132.83 161.46 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 1.0 110.094 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.27 33.23 5.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 1.0 110.183 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 56' ' ' HIS . . . 86.38 -91.11 1.7 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -48.24 -24.31 1.14 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.648 -0.913 . . . . 1.0 110.769 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -124.16 165.76 17.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 1.0 110.175 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 23' ' ' ILE . 94.1 m-70 -148.52 114.07 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 55' ' ' LYS . 55.3 mt -116.4 136.11 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 1.0 110.291 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.018 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -115.57 133.94 55.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.26 -0.9 . . . . 1.0 110.295 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.81 ' N ' HD23 ' A' ' 58' ' ' LEU . 5.6 mt -138.26 83.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 1.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 41' ' ' LEU . 4.6 mt -86.69 116.01 24.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 1.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 62' ' ' ASN . 86.9 m-70 -79.06 -169.65 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 1.0 110.452 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 61' ' ' HIS . 20.4 p-10 -14.95 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.0 m -71.11 178.53 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.69 . . . . 1.0 109.482 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.586 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.4 tp60 -111.28 158.82 18.55 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.092 -1.005 . . . . 1.0 109.102 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.1 mp -46.89 -25.29 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.0 111.074 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.72 -119.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.787 ' HB2' HG21 ' A' ' 86' ' ' VAL . 3.3 mtt 42.13 30.73 0.2 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.715 -0.874 . . . . 1.0 111.487 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.21 53.0 2.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 1.0 110.098 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.39 -126.46 2.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.57 154.07 36.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 1.0 110.374 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.907 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 74.5 t -89.28 86.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.328 -0.858 . . . . 1.0 110.031 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' SER . 97.2 p -94.25 109.62 21.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 1.0 110.231 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CZ ' ' HA3' ' A' ' 32' ' ' GLY . 42.5 t80 -78.54 157.44 28.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 1.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -146.1 146.0 30.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 1.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -169.45 -146.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 1.0 110.113 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.8 -69.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 1.0 110.634 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -142.98 33.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 1.0 110.249 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -121.81 120.43 34.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 1.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.18 88.45 2.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 1.0 110.237 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 23' ' ' ILE . 25.7 m -82.36 174.73 10.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.994 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.65 97.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 1.0 110.381 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.41 -163.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.0 109.995 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 129.04 53.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 1.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -127.57 126.52 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.0 110.299 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 137.82 46.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 1.0 109.902 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.787 HG21 ' HB2' ' A' ' 67' ' ' MET . 42.5 t -100.21 108.22 22.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 1.0 110.133 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -86.6 107.54 18.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 1.0 110.219 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.702 ' C ' HD13 ' A' ' 89' ' ' LEU . 1.2 pp20? -62.27 -152.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 1.0 110.281 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.821 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.97 -1.014 . . . . 1.0 110.653 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.169 0.509 . . . . 1.0 110.281 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 25' ' ' LEU . 69.5 mt -131.53 151.13 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 1.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -91.63 9.54 31.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 1.0 111.155 -179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.681 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t 62.06 145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.41 -0.806 . . . . 1.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.79 -41.2 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 1.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -116.79 107.88 45.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.609 -0.682 . . . . 1.0 109.899 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.07 176.65 6.72 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 1.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 12.4 mt -70.25 171.23 10.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.417 -0.802 . . . . 1.0 110.49 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.5 m-85 -129.72 169.23 15.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 1.0 110.074 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 155.52 31.9 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.202 -1.159 . . . . 1.0 110.202 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -159.55 155.23 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 1.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.1 157.11 30.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.983 . . . . 1.0 110.784 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 17' ' ' GLU . 6.8 p -157.87 142.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 1.0 110.078 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -97.41 46.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 1.0 110.472 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 63' ' ' CYS . 11.3 t 61.42 142.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 1.0 110.175 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 87.8 -56.21 4.39 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' CB ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -53.51 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -1.162 . . . . 1.0 109.926 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -115.17 150.33 36.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 1.0 110.367 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' CE2' ' A' ' 21' ' ' PHE . . . -95.1 168.94 10.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 1.0 109.654 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -147.58 97.04 2.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 1.0 110.78 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.97 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 90.8 m-85 -106.07 115.94 31.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 1.0 109.535 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -107.49 151.71 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.042 . . . . 1.0 110.985 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 23' ' ' ILE . 1.4 tt -159.29 123.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -0.767 . . . . 1.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.5 tt0 -87.3 142.05 28.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 1.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.761 ' O ' HD13 ' A' ' 2' ' ' ILE . 4.2 mm? -112.21 19.6 17.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 1.0 110.412 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.81 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.663 -0.648 . . . . 1.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.67 138.73 27.98 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.302 -0.874 . . . . 1.0 110.068 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.62 109.75 2.97 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.584 1.307 . . . . 1.0 110.452 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -174.71 -45.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 1.0 110.346 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG23 HD12 ' A' ' 2' ' ' ILE . 94.3 t -53.27 163.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 1.0 110.48 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.45 ' N ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -178.11 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 1.0 110.104 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -119.94 -132.42 4.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.433 ' CG ' ' HB2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.89 179.17 7.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -1.11 . . . . 1.0 110.378 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.713 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.5 m95 -127.25 148.44 50.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.103 -0.998 . . . . 1.0 111.622 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.74 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -154.35 -114.78 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.389 -0.82 . . . . 1.0 109.128 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.74 HD12 ' C ' ' A' ' 35' ' ' LYS . 2.7 mp -157.15 -158.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.925 -1.109 . . . . 1.0 108.775 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -22.44 8.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.777 -1.202 . . . . 1.0 109.425 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.09 -113.83 0.01 OUTLIER Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 1.3 mt-30 -134.72 178.43 1.77 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HB2' ' CG ' ' A' ' 33' ' ' GLN . 50.6 Cg_endo -89.29 113.07 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.443 1.233 . . . . 1.0 111.281 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -98.04 -168.27 1.64 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.672 -1.268 . . . . 1.0 110.211 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.6 t -113.24 161.91 16.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 1.0 110.086 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.02 123.32 20.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.263 -0.898 . . . . 1.0 109.491 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -175.8 -59.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 1.0 110.96 -179.543 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 40.2 Cg_endo -67.72 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.412 1.217 . . . . 1.0 111.296 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.11 69.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.14 . . . . 1.0 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 136.88 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 1.0 110.394 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.43 78.61 1.68 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 1.0 109.732 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.89 136.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 1.0 110.233 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 49' ' ' ILE . 1.1 pt -135.32 106.95 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.442 -0.786 . . . . 1.0 109.955 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.7 141.21 34.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 1.0 110.352 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.69 17.9 14.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 1.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 -26.61 16.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.79 -27.03 40.39 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.449 -1.03 . . . . 1.0 109.582 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.01 122.89 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.542 -0.724 . . . . 1.0 109.701 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -86.54 103.69 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 1.0 109.995 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.75 137.6 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 1.0 110.548 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.754 ' O ' HD13 ' A' ' 59' ' ' ILE . 29.3 tp -109.69 142.68 40.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 1.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.754 HD13 ' O ' ' A' ' 58' ' ' LEU . 38.0 mm -138.44 82.73 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 1.0 110.29 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.695 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.64 167.02 22.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 1.0 110.181 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 35.5 m-70 -129.75 -163.72 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 1.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -13.4 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.883 ' O ' HG13 ' A' ' 15' ' ' VAL . 69.6 m -87.61 -173.33 4.28 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.51 -0.744 . . . . 1.0 109.024 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.748 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -167.01 -160.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 1.0 110.098 -179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.48 81.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.865 0.84 . . . . 1.0 109.904 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.62 -40.67 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.604 -1.798 . . . . 1.0 108.604 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.481 ' HB3' HD23 ' A' ' 84' ' ' LEU . 31.0 mtt -87.06 39.95 0.89 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -1.121 . . . . 1.0 110.549 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -91.31 27.4 1.94 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 1.0 110.173 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.49 -109.74 2.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.229 -1.549 . . . . 1.0 109.229 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.1 pt-20 -146.56 139.58 25.49 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.538 -0.978 . . . . 1.0 110.522 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.97 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 26.2 t -78.99 128.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 p -123.97 127.58 48.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.0 111.285 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.524 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 51.1 t80 -104.63 137.11 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 1.0 109.439 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -130.72 144.17 51.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 1.0 109.939 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' CG1' ' A' ' 30' ' ' VAL . . . -159.12 -148.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.805 . . . . 1.0 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.26 51.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 1.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -154.46 30.28 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 1.0 109.931 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 25' ' ' LEU . . . -114.2 108.78 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.024 -1.047 . . . . 1.0 110.164 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.901 . . . . 1.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 6.5 p -102.39 175.57 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 1.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.76 103.12 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.123 -0.986 . . . . 1.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.63 -176.14 3.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 1.0 109.752 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -108.1 134.66 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 1.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.697 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 44.3 tp -133.08 141.61 48.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.409 -0.807 . . . . 1.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -139.22 125.93 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.0 110.062 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.748 HG11 ' O ' ' A' ' 64' ' ' GLN . 40.6 t -96.9 132.8 40.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.901 . . . . 1.0 109.921 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -124.23 119.51 29.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 1.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.19 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.935 . . . . 1.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 3.9 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.035 -0.983 . . . . 1.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.201 0.524 . . . . 1.0 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.674 HD13 ' N ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -171.11 126.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 1.0 109.85 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.674 ' N ' HD13 ' A' ' 2' ' ' ILE . 15.9 mt-10 -152.72 -77.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 1.0 110.784 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 23' ' ' ILE . 46.2 t -47.15 107.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 1.0 111.281 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 2.8 mm-40 -96.23 -26.1 15.55 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.431 -0.793 . . . . 1.0 109.039 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -135.49 119.39 13.03 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.4 168.12 18.78 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.537 1.283 . . . . 1.0 111.763 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.899 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.8 mt -82.4 161.33 22.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.631 -0.668 . . . . 1.0 109.923 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.809 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 2.5 m-85 -115.2 168.12 10.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 1.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.63 124.65 7.91 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.67 179.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 1.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -135.04 161.32 35.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 1.0 110.667 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 17' ' ' GLU . 5.0 p -160.7 129.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 1.0 109.957 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 57.3 4.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.951 . . . . 1.0 110.361 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 87' ' ' LYS . 42.1 t 48.66 91.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.174 -0.954 . . . . 1.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 132.36 -34.92 2.43 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.825 ' CB ' HG23 ' A' ' 13' ' ' VAL . 3.3 mt-10 -67.45 -163.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -1.07 . . . . 1.0 109.656 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.9 m -136.74 115.4 12.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 1.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.55 149.85 31.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.206 -0.934 . . . . 1.0 109.517 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -127.04 137.33 53.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 1.0 110.746 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.969 ' CE1' HG21 ' A' ' 71' ' ' VAL . 62.1 m-85 -133.38 115.45 14.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 1.0 109.797 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.3 154.76 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 1.0 110.731 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 4' ' ' VAL . 9.3 tt -170.32 122.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 1.0 109.911 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.533 ' C ' HD12 ' A' ' 25' ' ' LEU . 21.2 tt0 -88.01 171.62 10.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 1.0 110.217 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD13 ' ND1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -150.08 128.36 12.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.817 . . . . 1.0 110.097 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.6 t -67.19 -49.36 64.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 1.0 110.724 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.97 136.32 44.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 1.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.19 -159.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.605 1.318 . . . . 1.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.47 118.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.963 . . . . 1.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.814 HG21 ' OE2' ' A' ' 51' ' ' GLU . 17.8 m -103.22 119.35 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.383 -0.823 . . . . 1.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.09 19.92 2.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 1.0 110.312 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.38 -150.04 23.41 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.12 165.72 2.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -1.04 . . . . 1.0 109.907 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 1.06 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.8 m95 -104.55 150.6 24.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 1.0 110.374 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 2.3 ttpt -149.3 122.99 9.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 1.0 109.328 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' A' ' 67' ' ' MET . 11.2 mt -64.78 -132.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 1.0 108.824 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -52.46 -24.04 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.427 -1.421 . . . . 1.0 109.436 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.18 41.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -122.27 116.85 29.55 Favored Pre-proline 0 N--CA 1.484 1.273 0 O-C-N 121.271 -1.135 . . . . 1.0 109.213 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.82 99.86 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.562 1.296 . . . . 1.0 110.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 42' ' ' THR . 3.8 pp -70.95 -157.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 1.0 110.421 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.861 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -166.68 170.07 12.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 1.0 109.755 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.17 105.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 1.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.43 175.04 3.07 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 1.0 110.287 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.44 -24.62 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.676 1.356 . . . . 1.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -79.04 -11.56 60.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 1.0 110.631 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -124.53 167.45 14.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 1.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 84.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 1.0 110.009 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -102.1 131.99 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 1.0 110.268 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.797 ' N ' HD13 ' A' ' 49' ' ' ILE . 6.9 tt -147.95 135.54 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.0 110.214 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.814 ' OE2' HG21 ' A' ' 30' ' ' VAL . 5.1 pt-20 -133.78 176.74 8.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 1.0 110.512 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -136.01 23.11 3.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 1.0 109.977 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.35 -88.65 1.4 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -5.21 27.33 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.623 -0.928 . . . . 1.0 111.077 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -132.65 164.78 25.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.846 -1.159 . . . . 1.0 110.572 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.629 ' ND1' HD13 ' A' ' 25' ' ' LEU . 20.2 m80 -142.36 127.59 18.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 1.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.63 137.08 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.922 . . . . 1.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.06 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -126.15 144.29 50.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 1.0 110.591 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.3 mt -139.58 115.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 1.0 109.59 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mt -111.09 97.09 6.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.077 -1.014 . . . . 1.0 110.72 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 62' ' ' ASN . 62.7 m-70 -69.87 -166.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.007 . . . . 1.0 109.841 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 61' ' ' HIS . 45.0 p-10 -16.11 82.48 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.197 0.814 . . . . 1.0 113.197 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 70.1 m -77.4 -168.14 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.634 -0.666 . . . . 1.0 110.159 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.682 ' O ' HG11 ' A' ' 86' ' ' VAL . 14.6 tp60 -129.02 170.8 13.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 86' ' ' VAL . 9.1 tp -78.67 25.1 0.27 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 1.0 111.95 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.68 -23.14 5.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.527 ' HB2' HG21 ' A' ' 86' ' ' VAL . 33.1 mtt -61.3 -12.98 15.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -1.139 . . . . 1.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -43.3 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.416 -0.802 . . . . 1.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.59 -119.14 0.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.371 -1.492 . . . . 1.0 109.371 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.31 149.63 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -1.062 . . . . 1.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 21' ' ' PHE . 78.9 t -89.11 83.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.0 109.54 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -86.02 103.31 14.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 1.0 110.806 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 23' ' ' ILE . 85.9 t80 -98.15 151.64 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 1.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -156.43 129.69 8.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.967 -1.083 . . . . 1.0 111.393 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -139.08 22.72 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.707 0.765 . . . . 1.0 109.269 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 178.17 -160.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.544 -0.909 . . . . 1.0 108.544 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.46 -22.8 67.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.923 -1.11 . . . . 1.0 109.741 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.88 169.15 18.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.0 110.216 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.55 102.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.0 110.447 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.428 ' OG ' HG11 ' A' ' 4' ' ' VAL . 71.1 m -75.41 170.08 16.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 1.0 109.954 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -168.46 111.44 0.57 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.135 -0.978 . . . . 1.0 110.541 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.16 -173.71 2.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 1.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -119.07 106.89 12.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 1.0 110.144 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.624 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 65.2 tp -110.88 127.66 55.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.969 . . . . 1.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 3.1 pttp -130.88 113.62 14.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 1.0 110.291 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.709 ' O ' HD12 ' A' ' 65' ' ' LEU . 61.5 t -87.58 104.04 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.224 -0.923 . . . . 1.0 110.233 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.42 154.54 22.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.0 110.128 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.99 -153.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 1.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.311 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 1' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.641 0.734 . . . . 1.0 110.528 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 2.3 pt -117.08 178.88 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.054 -1.029 . . . . 1.0 110.194 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.77 -151.09 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.269 -0.894 . . . . 1.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 87.2 t -130.66 123.57 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.125 -0.984 . . . . 1.0 110.216 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -86.41 -57.18 3.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 1.0 109.326 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 102.96 48.6 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.657 -0.652 . . . . 1.0 109.896 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.93 174.51 10.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.627 1.33 . . . . 1.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 97.6 mt -75.42 174.78 9.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.0 110.355 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -142.94 150.3 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 1.0 109.883 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.98 140.3 28.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 12' ' ' GLU . 44.0 t -138.93 170.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 1.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 11' ' ' VAL . 10.0 pt-20 -138.29 158.35 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.963 -1.086 . . . . 1.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.931 HG23 ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -160.87 138.64 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 1.0 110.393 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.55 51.22 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 1.0 109.865 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 63' ' ' CYS . 23.1 t 51.83 72.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.815 0.817 . . . . 1.0 110.423 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 157.05 -28.57 0.52 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.564 -1.814 . . . . 1.0 108.564 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -73.96 -160.93 0.1 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.979 . . . . 1.0 109.579 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 58.2 m -135.28 116.46 14.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.927 . . . . 1.0 110.521 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.11 163.19 25.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 1.0 109.01 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -148.8 124.63 10.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.942 -1.098 . . . . 1.0 111.078 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 8' ' ' LEU . 64.6 m-85 -132.18 109.9 10.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.0 109.282 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -115.85 159.4 21.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0 110.515 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 23' ' ' ILE . 3.1 tt -170.83 123.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -0.764 . . . . 1.0 110.193 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -100.44 157.13 16.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 1.0 110.179 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.4 mt -114.8 -150.01 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.0 109.922 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -111.43 -70.23 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 1.0 110.119 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.61 143.49 33.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . 47.6 Cg_endo -74.08 -174.08 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 1.0 110.555 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' C ' HG13 ' A' ' 30' ' ' VAL . 9.3 t70 53.07 85.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 1.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 25' ' ' LEU . 30.7 m -148.47 174.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 1.0 110.256 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -128.81 130.04 46.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 1.0 109.878 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.68 175.12 23.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.963 -1.255 . . . . 1.0 109.963 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -156.17 151.64 26.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -1.053 . . . . 1.0 109.793 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 32.3 m95 -106.92 155.48 19.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 1.0 110.481 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 12.9 ttpt -143.26 112.73 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.335 -0.853 . . . . 1.0 109.61 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 41' ' ' LEU . 1.2 mp -66.37 -123.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 1.0 109.744 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -48.79 -25.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.477 -1.389 . . . . 1.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 148.97 39.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.45 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -136.88 136.91 21.94 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.047 -1.267 . . . . 1.0 109.95 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.22 91.01 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.65 1.342 . . . . 1.0 110.557 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 36' ' ' LEU . 1.4 pt? -69.46 -170.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 1.0 110.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 172.07 13.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.86 . . . . 1.0 109.965 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 104.14 5.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 1.0 110.17 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.407 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.13 176.11 2.26 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 1.0 110.161 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.74 -19.43 27.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.669 1.352 . . . . 1.0 110.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -102.3 -20.21 14.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 110.187 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 72.2 m -93.66 131.44 38.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 1.0 110.039 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 1.8 tt0 -104.98 46.16 0.93 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.262 -0.899 . . . . 1.0 109.801 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 49' ' ' ILE . 8.4 tt -79.59 80.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.935 -1.103 . . . . 1.0 109.901 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.16 145.63 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 1.0 110.224 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.94 120.1 18.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.212 -0.93 . . . . 1.0 110.341 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.76 19.59 12.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 1.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.32 -95.29 1.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -50.33 -21.23 1.32 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.671 -0.9 . . . . 1.0 111.101 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -134.07 136.31 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.916 -1.115 . . . . 1.0 111.046 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.7 m-70 -121.62 116.44 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 1.0 109.687 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.02 130.08 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 1.0 110.745 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' CE3' ' A' ' 34' ' ' TRP . 47.5 tp -117.13 131.61 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 1.0 109.982 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 96.5 mt -135.72 96.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 1.0 109.957 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 18' ' ' THR . 0.8 OUTLIER -100.2 144.99 28.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 1.0 110.507 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' C ' ' A' ' 62' ' ' ASN . 58.2 m-70 -111.24 -163.46 0.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 1.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 17.6 p-10 -14.49 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.866 ' O ' HG13 ' A' ' 15' ' ' VAL . 75.3 m -80.78 -159.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.694 -0.629 . . . . 1.0 109.645 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.664 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -158.02 -160.78 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.237 -0.914 . . . . 1.0 109.944 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.35 33.22 0.4 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.875 -1.141 . . . . 1.0 111.719 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.48 4.1 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 1.0 108.645 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.585 ' HG2' HD22 ' A' ' 36' ' ' LEU . 34.6 mtt -87.62 37.17 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.567 -0.961 . . . . 1.0 110.46 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 51.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 1.0 109.922 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.58 1.91 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -146.38 148.11 31.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 1.0 110.272 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 77.3 t -89.94 91.37 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 1.0 109.862 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.9 p -96.89 103.23 15.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 1.0 110.533 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -88.24 156.88 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 1.0 109.775 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG3' ' HG2' ' A' ' 79' ' ' LYS . 2.1 mt-30 -149.11 144.93 26.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.05 -1.031 . . . . 1.0 110.656 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.61 -147.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 1.0 109.887 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.83 -62.63 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.005 -1.06 . . . . 1.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.93 24.41 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.418 -0.801 . . . . 1.0 109.926 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.75 137.8 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 1.0 110.294 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HG2' ' HG3' ' A' ' 74' ' ' GLN . 5.1 mtmt -144.61 62.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 1.0 110.252 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -74.97 173.6 10.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 1.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.64 98.86 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -86.55 -173.55 4.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -126.45 104.73 8.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 1.0 109.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 56.8 tp -109.36 146.79 33.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 1.0 110.483 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -149.79 112.0 4.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 1.0 109.777 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' O ' ' A' ' 64' ' ' GLN . 42.3 t -79.41 111.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.064 -1.022 . . . . 1.0 110.079 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.53 108.5 20.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 1.0 110.246 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.567 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.7 mt-10 -75.22 149.06 39.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 1.0 110.092 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.6 tt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.199 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.289 0.566 . . . . 1.0 110.206 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.61 153.9 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 1.0 110.106 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.09 178.92 4.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.108 -0.995 . . . . 1.0 110.388 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.7 t -116.84 115.14 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 1.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -87.99 -51.29 5.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 1.0 109.608 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -114.0 105.27 54.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.702 -0.624 . . . . 1.0 110.428 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.4 178.03 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.619 1.326 . . . . 1.0 110.707 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.75 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.5 mt -78.34 -170.73 2.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.842 . . . . 1.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 9' ' ' TYR . 35.1 p90 -152.2 130.5 12.04 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 1.0 109.904 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.51 150.61 30.17 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLU . 48.1 t -149.13 167.97 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.484 -1.01 . . . . 1.0 109.826 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 45.6 mt-10 -125.87 154.99 41.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 1.0 110.368 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.6 p -154.01 147.95 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 1.0 109.948 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -98.14 47.09 1.0 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.0 111.012 -179.347 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.1 t 48.79 95.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.219 -0.926 . . . . 1.0 110.717 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' A' ' 62' ' ' ASN . . . 135.61 -38.15 1.82 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.644 -1.782 . . . . 1.0 108.644 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.595 ' HB2' HG23 ' A' ' 13' ' ' VAL . 3.2 mt-10 -69.7 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.484 -1.009 . . . . 1.0 109.179 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -134.27 122.16 22.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.94 -1.1 . . . . 1.0 110.954 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.58 157.7 27.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 1.0 108.859 178.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -139.84 131.16 26.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.838 -1.164 . . . . 1.0 111.051 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 47.2 m-85 -127.98 126.39 41.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 1.0 109.721 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.87 154.72 32.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.971 . . . . 1.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.8 tt -170.33 140.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 1.0 110.008 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -118.27 162.73 17.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.0 110.251 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.752 HD11 ' CD2' ' A' ' 56' ' ' HIS . 45.1 mt -124.97 -154.93 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 109.815 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.81 -30.12 5.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.132 -0.98 . . . . 1.0 110.04 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -127.77 121.95 22.28 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.0 109.847 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.27 116.86 4.87 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.47 1.247 . . . . 1.0 110.611 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.2 -1.87 7.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 1.0 110.64 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.1 t 55.7 64.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.048 -1.033 . . . . 1.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -168.8 135.4 1.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 1.0 110.223 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.94 168.16 24.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 11.4 tt0 -156.32 159.83 39.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.181 -1.188 . . . . 1.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.911 ' CE3' HD22 ' A' ' 58' ' ' LEU . 23.7 m95 -119.89 163.08 18.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 1.0 110.345 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -164.82 150.16 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 110.348 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.9 mt -68.32 -128.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.0 109.204 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -50.25 -24.64 3.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.604 -1.31 . . . . 1.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.71 41.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 1.1 mm100 -126.07 109.79 24.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.329 -1.1 . . . . 1.0 110.054 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 39' ' ' GLN . 42.3 Cg_endo -68.84 89.47 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.597 1.314 . . . . 1.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 pt? -69.75 -172.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 1.0 110.634 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.8 m -136.69 156.85 47.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 1.0 110.094 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -78.64 115.21 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 1.0 110.184 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -170.16 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 111.116 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 44.2 Cg_endo -70.83 -90.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.27 1.142 . . . . 1.0 110.837 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -125.23 40.33 3.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.774 -1.204 . . . . 1.0 110.43 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 27.8 t -107.92 146.92 31.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 1.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -141.63 74.38 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 1.0 110.077 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' ILE . 14.1 tt -91.09 128.94 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 1.0 110.481 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.0 118.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 1.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 170.2 16.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 1.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.88 19.94 2.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 1.0 110.216 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.56 -76.91 1.55 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -18.39 18.49 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.662 -0.905 . . . . 1.0 110.684 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.45 126.57 13.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 1.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.752 ' CD2' HD11 ' A' ' 25' ' ' LEU . 70.5 m-70 -103.19 115.12 29.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.797 . . . . 1.0 109.725 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 mt -118.26 144.32 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.004 . . . . 1.0 110.477 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.911 HD22 ' CE3' ' A' ' 34' ' ' TRP . 46.6 tp -132.92 132.56 42.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 1.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mt -132.38 118.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 1.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -119.87 106.71 12.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 1.0 110.529 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 83.9 m-70 -72.48 -170.86 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 1.0 109.965 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.0 p-10 -15.02 81.74 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 61' ' ' HIS . 72.8 m -70.92 -158.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.52 -0.738 . . . . 1.0 109.611 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.705 ' O ' HG21 ' A' ' 86' ' ' VAL . 1.1 tp60 -138.37 174.48 10.5 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.153 -0.967 . . . . 1.0 108.595 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 4.5 tp -78.37 30.07 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.98 -1.075 . . . . 1.0 112.037 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.79 -11.43 10.25 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.437 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 8.5 mtt -85.17 42.85 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 1.0 110.822 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -89.93 62.09 5.53 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.071 -1.018 . . . . 1.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.89 -119.59 1.37 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.796 -1.322 . . . . 1.0 109.796 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 2.2 pt-20 -145.85 156.59 43.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -1.007 . . . . 1.0 110.571 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.81 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 25.0 t -101.94 82.04 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.45 -0.781 . . . . 1.0 109.557 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.34 129.85 35.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 1.0 110.45 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.507 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 21.5 t80 -98.31 145.81 26.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.478 -0.764 . . . . 1.0 109.679 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -120.66 100.9 7.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 1.0 110.426 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -131.03 89.33 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.46 -153.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 1.0 110.341 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -53.35 -24.9 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.0 110.346 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.25 134.22 39.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 1.0 110.191 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.22 149.64 30.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 1.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.578 ' OG ' HD11 ' A' ' 8' ' ' LEU . 70.2 p -138.6 174.91 10.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.95 . . . . 1.0 110.18 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -163.64 104.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 1.0 110.302 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -95.48 -160.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 1.0 110.078 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.59 115.98 9.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.959 . . . . 1.0 110.014 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -124.68 128.95 49.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.516 ' N ' HD13 ' A' ' 84' ' ' LEU . 2.1 tttp -125.91 136.72 53.37 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.322 -0.861 . . . . 1.0 109.665 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 64' ' ' GLN . 32.1 t -92.64 140.5 16.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 1.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -124.59 128.34 48.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.09 140.67 37.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 1.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.219 0.533 . . . . 1.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 3' ' ' GLU . 2.8 tp -157.26 151.69 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -79.98 -147.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 1.0 110.188 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 HD11 ' A' ' 23' ' ' ILE . 58.8 t -134.65 136.68 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 1.0 110.113 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -86.98 -49.49 7.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.423 -0.798 . . . . 1.0 109.646 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 106.26 51.69 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 1.0 110.337 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -71.74 174.12 11.6 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.556 1.293 . . . . 1.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.818 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 15.5 mt -72.83 178.12 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 1.0 109.789 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.1 m-85 -142.24 132.91 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 1.0 110.073 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.24 141.85 48.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.1 t -141.09 156.84 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -1.086 . . . . 1.0 109.653 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -111.48 150.09 30.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 1.0 110.422 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.01 165.37 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 1.0 110.542 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.91 32.85 5.79 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.525 -0.735 . . . . 1.0 109.222 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 88' ' ' GLU . 10.9 t 64.92 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.69 0.757 . . . . 1.0 110.188 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 142.87 -25.44 2.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.139 -1.584 . . . . 1.0 109.139 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -1.093 . . . . 1.0 109.947 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 95.7 m -136.85 110.19 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 1.0 110.425 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.32 142.65 35.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 1.0 109.688 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -119.73 105.69 11.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 1.0 110.627 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CD2' HD23 ' A' ' 58' ' ' LEU . 62.6 m-85 -96.03 124.95 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 1.0 109.385 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -114.56 152.36 31.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.026 -1.046 . . . . 1.0 110.99 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.811 HD11 HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -167.6 117.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.681 . . . . 1.0 109.547 179.655 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -109.15 165.31 11.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 110.866 -179.331 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' CD2' ' A' ' 56' ' ' HIS . 40.5 mt -129.08 -144.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 1.0 109.494 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -130.91 -47.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -100.79 160.0 28.0 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.936 . . . . 1.0 110.696 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.99 124.23 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.728 1.383 . . . . 1.0 110.381 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.19 101.07 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 1.0 110.093 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 30' ' ' VAL . 9.9 p -97.21 60.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 28.1 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 1.0 109.992 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.23 176.17 28.94 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -158.74 139.96 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -1.101 . . . . 1.0 109.772 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.633 ' CE3' HD22 ' A' ' 58' ' ' LEU . 31.6 m95 -95.52 164.94 12.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 1.0 110.841 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -165.01 160.37 18.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 179.481 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.2 OUTLIER -65.08 -141.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.062 . . . . 1.0 108.838 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.8 -28.16 0.6 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.508 -1.37 . . . . 1.0 110.385 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 164.18 39.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.134 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.532 ' HG3' HD21 ' A' ' 41' ' ' LEU . 4.1 tt0 -123.32 95.91 44.83 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.37 -1.076 . . . . 1.0 108.515 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.72 77.23 3.76 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.693 1.365 . . . . 1.0 111.455 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 42' ' ' THR . 4.2 pp -171.76 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.198 -0.938 . . . . 1.0 110.625 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 65.9 m -69.86 -19.69 63.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.933 -1.104 . . . . 1.0 110.299 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.34 100.43 11.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.493 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -179.56 -59.02 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 1.0 110.375 179.78 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 43.9 Cg_endo -74.58 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.44 1.232 . . . . 1.0 110.445 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 30.12 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 1.0 110.16 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 44' ' ' SER . 52.8 t -129.13 155.62 45.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 1.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 80.98 1.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 1.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' ILE . 15.5 tt -82.31 117.28 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 1.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.59 94.54 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 1.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.22 163.05 15.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 1.0 110.359 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.67 26.33 5.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 1.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.21 -96.41 2.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -21.68 2.54 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.635 -0.921 . . . . 1.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -122.05 149.58 43.33 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.022 -1.049 . . . . 1.0 110.173 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.796 ' HB2' HG23 ' A' ' 23' ' ' ILE . 61.6 m-70 -128.29 113.57 15.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 1.0 109.83 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.5 mm -124.08 151.26 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 1.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 21' ' ' PHE . 6.5 tp -136.11 136.86 40.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.797 . . . . 1.0 109.989 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 58' ' ' LEU . 43.9 mm -126.41 93.53 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 1.0 110.276 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 18' ' ' THR . 7.0 mt -89.74 118.43 29.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.903 . . . . 1.0 110.242 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.7 m-70 -89.66 -167.83 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 1.0 110.289 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.465 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 43.0 t30 -15.35 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' HIS . 57.1 m -75.88 140.1 42.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.586 -0.696 . . . . 1.0 109.397 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.79 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -89.08 -177.39 5.43 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.218 -0.926 . . . . 1.0 110.455 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 86' ' ' VAL . 0.3 OUTLIER -71.8 -1.65 14.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 1.0 111.528 -179.73 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.35 -17.57 60.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.99 -1.244 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.617 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.5 mtt -84.73 42.07 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.281 . . . . 1.0 111.243 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -90.96 41.13 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 1.0 110.035 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.18 -139.5 5.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.99 157.95 34.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 1.0 110.509 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 41.9 t -101.11 98.54 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 1.0 109.71 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -96.76 141.1 30.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 1.0 110.76 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 35.9 t80 -121.77 143.44 49.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -0.829 . . . . 1.0 109.54 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -120.06 114.72 22.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 1.0 110.545 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -145.94 132.08 19.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 1.0 109.62 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.57 -150.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 1.0 109.765 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -90.35 45.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.973 . . . . 1.0 109.929 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.02 167.05 31.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 1.0 110.33 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.66 135.96 8.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 1.0 110.299 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.464 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 p -101.79 176.11 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.489 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.58 109.83 0.85 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.992 . . . . 1.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.08 179.88 4.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 1.0 109.816 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -114.12 107.94 16.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 1.0 110.089 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.506 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 50.4 tp -108.76 138.92 44.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 1.0 110.35 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -142.03 136.04 29.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 1.0 109.97 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 64' ' ' GLN . 45.2 t -101.28 135.07 39.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.268 -0.895 . . . . 1.0 110.245 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.33 120.33 18.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 15' ' ' VAL . 21.9 mt-10 -84.91 170.16 13.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 1.0 110.037 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.209 179.92 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 1' ' ' LEU . 5.0 tt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.312 0.577 . . . . 1.0 110.262 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.45 -175.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 1.0 110.007 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 2.4 pm0 -147.83 -159.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 1.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.92 107.47 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 1.0 110.306 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -74.96 -34.47 62.05 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 1.0 109.175 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -131.15 107.82 14.97 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.519 -0.738 . . . . 1.0 109.482 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.98 175.28 8.5 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.546 1.287 . . . . 1.0 110.99 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.924 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.7 mt -71.37 -177.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 1.0 109.771 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -122.57 -14.15 7.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.084 -1.01 . . . . 1.0 111.39 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 60.87 118.66 0.01 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.911 -1.275 . . . . 1.0 109.911 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.76 ' O ' HD12 ' A' ' 84' ' ' LEU . 34.4 m -136.5 -176.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.782 -1.423 . . . . 1.0 110.93 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 13' ' ' VAL . 9.2 pt-20 -127.5 173.01 10.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 1.0 109.592 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.646 HG12 ' OE2' ' A' ' 17' ' ' GLU . 25.7 m -149.86 -176.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.088 . . . . 1.0 111.11 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.39 25.22 6.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.147 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 13.4 t 61.91 85.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.575 -0.703 . . . . 1.0 110.759 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.55 -25.17 3.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.191 -1.163 . . . . 1.0 110.191 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.646 ' OE2' HG12 ' A' ' 13' ' ' VAL . 2.0 pt-20 -76.03 -144.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -1.203 . . . . 1.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.9 m -149.82 111.56 4.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 1.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.74 165.66 22.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 1.0 109.96 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -143.3 110.16 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 1.0 110.772 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 95.2 m-85 -112.45 125.02 53.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -0.807 . . . . 1.0 109.593 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.16 157.13 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 1.0 111.335 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.3 tt -166.32 129.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 1.0 109.556 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -108.63 138.2 45.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 1.0 110.681 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.574 HD11 ' NE2' ' A' ' 56' ' ' HIS . 66.4 mt -94.01 173.36 7.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 1.0 109.751 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -74.29 -61.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.0 . . . . 1.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -117.77 131.04 24.3 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.029 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.13 126.2 9.73 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.513 1.27 . . . . 1.0 110.236 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.63 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.3 t -97.34 148.19 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 1.0 110.065 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -86.53 -166.47 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.0 110.17 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.84 162.11 35.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 1.0 109.613 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.49 171.65 11.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -1.126 . . . . 1.0 109.98 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.893 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.8 m95 -111.87 176.37 5.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.106 -0.996 . . . . 1.0 110.589 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 5.6 ttmt -165.38 126.14 1.91 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.388 -0.82 . . . . 1.0 108.812 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.77 -131.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.0 109.112 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -51.65 -24.51 5.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.337 -1.477 . . . . 1.0 109.698 179.307 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.38 41.64 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.08 -1.608 . . . . 1.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -122.5 111.84 31.39 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 1.0 110.555 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.76 96.59 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.679 1.357 . . . . 1.0 109.651 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 42' ' ' THR . 3.1 pp -70.05 -153.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 1.0 110.526 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.887 ' N ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -152.72 -166.04 2.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 1.0 110.027 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.67 107.03 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 1.0 110.047 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 6.0 p -147.67 168.82 10.4 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 1.0 110.235 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 44.5 Cg_endo -72.05 -19.11 26.89 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.543 1.286 . . . . 1.0 110.475 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -23.54 59.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 1.0 110.344 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.5 t -141.36 125.64 17.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 1.0 110.413 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.17 135.1 54.02 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.251 -0.905 . . . . 1.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' HG2' ' A' ' 51' ' ' GLU . 3.5 mt -130.93 95.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.38 -0.825 . . . . 1.0 110.023 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.96 94.03 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 1.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' HG22 ' A' ' 49' ' ' ILE . 4.5 pt-20 -139.57 147.57 41.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 1.0 110.261 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -146.21 19.37 1.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 1.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.77 -23.55 30.27 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -90.07 -20.93 22.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.264 -1.139 . . . . 1.0 109.989 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.3 144.7 3.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.294 -0.879 . . . . 1.0 110.128 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.574 ' NE2' HD11 ' A' ' 25' ' ' LEU . 69.1 m-70 -110.94 118.85 37.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 1.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.53 128.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.34 -0.85 . . . . 1.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 34' ' ' TRP . 4.3 tt -116.23 133.21 56.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 1.0 110.56 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.751 ' N ' HD23 ' A' ' 58' ' ' LEU . 41.0 mm -133.55 86.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.59 103.37 15.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 1.0 110.758 -179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.2 m-70 -69.69 -156.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 1.0 109.304 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 59.7 t-20 -14.77 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 61' ' ' HIS . 76.7 m -71.78 171.02 12.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.714 -0.616 . . . . 1.0 110.419 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 2.9 tp-100 -110.07 163.57 13.46 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.361 -0.837 . . . . 1.0 108.905 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.549 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -75.39 5.08 6.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.868 -1.145 . . . . 1.0 111.739 -179.467 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.25 -20.24 28.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.559 ' HB2' HG21 ' A' ' 86' ' ' VAL . 12.0 mtt -55.3 -17.41 4.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 1.0 111.167 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -43.91 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 1.0 110.789 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.97 -121.35 0.63 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.92 135.5 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -1.066 . . . . 1.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.1 101.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 1.0 109.843 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -103.56 128.76 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 1.0 110.361 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -108.58 148.2 30.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.0 109.792 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 2.6 pt20 -136.33 137.09 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 1.0 110.55 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -165.58 99.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 56.93 -89.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 1.0 110.38 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 7.3 m-20 -119.18 32.38 6.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.968 -1.082 . . . . 1.0 110.281 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 74' ' ' GLN . . . -118.01 133.85 55.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 1.0 110.195 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 68.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 1.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.8 m -77.94 166.9 22.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.0 109.987 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.31 104.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 1.0 110.509 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.924 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.35 -170.67 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.08 123.44 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 1.0 109.848 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.779 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 57.5 tp -124.66 138.26 54.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 1.0 110.699 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -140.09 130.56 25.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.404 -0.81 . . . . 1.0 109.604 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 67' ' ' MET . 52.9 t -99.85 118.01 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 1.0 110.366 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 3.3 ttpt -97.99 140.57 32.14 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.32 -0.862 . . . . 1.0 109.665 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.94 -156.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 1.0 109.999 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.884 -1.055 . . . . 1.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.232 0.539 . . . . 1.0 110.308 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 26' ' ' SER . 43.9 pt -121.16 178.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 1.0 110.198 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -108.27 -166.97 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.937 . . . . 1.0 110.271 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG2' ' HA ' ' A' ' 78' ' ' ALA . 89.0 t -121.21 124.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 1.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.83 -31.83 31.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 1.0 110.289 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.2 113.82 6.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 1.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.77 -176.69 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.58 1.305 . . . . 1.0 110.25 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 19.1 mt -73.38 -154.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 1.0 110.396 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -155.98 116.32 3.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 1.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.25 133.46 45.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.16 152.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.302 -1.116 . . . . 1.0 110.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -94.03 175.35 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 1.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 14' ' ' PHE . 6.8 p -154.14 174.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 1.0 110.737 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -117.8 136.6 53.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 1.0 109.582 179.284 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.989 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -60.07 91.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 1.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 140.66 -37.8 1.64 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.017 -1.633 . . . . 1.0 109.017 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -71.99 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 1.0 109.684 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.9 m -160.65 150.32 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 1.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.22 176.99 5.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 1.0 109.197 179.349 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -160.5 112.29 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.0 111.664 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.863 ' CE2' HG21 ' A' ' 71' ' ' VAL . 47.1 m-85 -117.48 127.25 53.82 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 178.319 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -115.84 151.62 34.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 1.0 111.147 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 56' ' ' HIS . 1.2 tt -164.26 139.02 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.578 -0.701 . . . . 1.0 109.546 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 25' ' ' LEU . 1.3 mp0 -118.46 154.04 33.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 1.0 110.355 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 56' ' ' HIS . 24.7 mt -116.77 -152.88 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 1.0 110.048 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -121.09 -35.02 3.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 1.0 109.65 179.596 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.07 160.96 42.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.85 134.54 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.659 1.347 . . . . 1.0 110.446 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -171.58 113.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 110.241 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.82 54.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 1.0 110.088 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -131.53 45.87 2.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 1.0 110.052 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.02 164.18 12.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.044 -1.223 . . . . 1.0 110.044 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.01 169.94 16.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -1.055 . . . . 1.0 109.851 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.806 ' CE3' HD22 ' A' ' 58' ' ' LEU . 42.8 m95 -122.56 138.72 54.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 1.0 110.793 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 1.3 ttmt -121.62 143.27 49.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.527 -0.733 . . . . 1.0 110.287 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 41' ' ' LEU . 7.6 mt -93.96 -93.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 1.0 109.705 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -14.72 62.06 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.097 -1.002 . . . . 1.0 110.083 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 138.16 -10.14 3.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.978 -1.249 . . . . 1.0 109.978 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.99 159.81 28.6 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.065 -1.256 . . . . 1.0 109.605 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.25 79.17 3.02 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.751 1.395 . . . . 1.0 110.561 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 36' ' ' LEU . 1.5 pp -127.6 -15.79 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.349 -0.844 . . . . 1.0 110.891 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -69.45 -16.9 63.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 1.0 110.54 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.11 112.63 21.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 1.0 110.26 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.98 170.74 7.43 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.925 . . . . 1.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.38 5.1 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.621 1.327 . . . . 1.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.89 -11.78 11.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.844 -1.16 . . . . 1.0 110.904 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.1 -169.59 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 1.0 110.386 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -144.35 76.39 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.0 110.269 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -95.9 128.34 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 1.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.0 pt -133.21 133.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 1.0 109.916 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -142.37 137.62 30.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.986 -1.071 . . . . 1.0 110.508 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.62 21.9 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 1.0 110.202 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.05 -64.0 2.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.749 -1.34 . . . . 1.0 109.749 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.58 31.86 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.727 -0.867 . . . . 1.0 110.795 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -153.01 115.72 4.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 25' ' ' LEU . 91.8 m-70 -110.0 117.92 35.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 1.0 109.836 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 56' ' ' HIS . 41.9 mm -121.31 157.81 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 1.0 110.237 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.806 HD22 ' CE3' ' A' ' 34' ' ' TRP . 39.2 tp -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 1.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.02 111.57 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 1.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.742 HD13 ' CE ' ' A' ' 67' ' ' MET . 5.1 mt -110.46 103.26 11.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.049 . . . . 1.0 110.679 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 62' ' ' ASN . 80.6 m-70 -72.13 -162.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 1.0 110.374 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.512 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 39.7 t-20 -12.86 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.555 1.317 . . . . 1.0 114.555 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.989 ' O ' HG23 ' A' ' 15' ' ' VAL . 73.8 m -86.08 -158.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.711 ' O ' HG11 ' A' ' 86' ' ' VAL . 1.4 pm0 -158.67 -173.67 4.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.798 -1.189 . . . . 1.0 110.907 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.21 -18.53 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 1.0 111.465 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.74 -130.32 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.783 -1.727 . . . . 1.0 108.783 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.742 ' CE ' HD13 ' A' ' 60' ' ' LEU . 1.3 mtt 39.42 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.981 -0.717 . . . . 1.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 68' ' ' THR . 19.4 m -91.17 37.64 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.068 -1.02 . . . . 1.0 110.176 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.21 -122.46 3.57 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.491 -1.444 . . . . 1.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -150.09 162.94 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -1.113 . . . . 1.0 110.555 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.863 HG21 ' CE2' ' A' ' 21' ' ' PHE . 70.1 t -104.69 87.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 1.0 109.808 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 p -92.45 107.97 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.938 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 34.1 t80 -79.14 158.77 27.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.685 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.52 109.96 3.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 1.0 110.61 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.38 -146.09 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 1.0 109.625 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.12 43.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -0.991 . . . . 1.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 2' ' ' ILE . 49.3 t30 -163.11 30.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 1.0 110.004 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -113.03 74.27 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 1.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -86.59 86.1 7.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.864 . . . . 1.0 110.431 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.647 ' OG ' HD11 ' A' ' 8' ' ' LEU . 77.5 p -81.73 -179.22 7.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -0.945 . . . . 1.0 110.117 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.49 89.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 1.0 110.383 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -98.36 -177.52 3.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 1.0 110.123 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -110.49 138.76 46.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' SD ' ' A' ' 67' ' ' MET . 44.3 tp -134.69 130.35 36.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 1.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -143.75 147.26 33.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 1.0 109.687 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.711 HG11 ' O ' ' A' ' 64' ' ' GLN . 25.4 t -105.82 158.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.059 -1.026 . . . . 1.0 110.736 -179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -130.69 146.11 52.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 1.0 109.664 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -81.98 -160.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.0 110.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.961 -1.018 . . . . 1.0 110.269 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.14 153.95 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 1.0 109.721 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -128.9 -3.8 5.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 1.0 111.048 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 85.5 t 53.14 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 1.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -85.52 -26.58 26.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.316 -0.865 . . . . 1.0 109.995 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 105.33 40.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 1.0 110.079 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.84 178.55 5.7 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.604 1.318 . . . . 1.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.919 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 14.2 mt -73.77 -157.81 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 1.0 110.156 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -155.9 134.22 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 1.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.65 140.87 26.7 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.671 -1.372 . . . . 1.0 109.671 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.7 152.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 1.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -96.13 169.19 10.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 1.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' CD ' ' A' ' 17' ' ' GLU . 11.6 p -159.35 146.16 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 1.0 110.299 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -88.35 125.87 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 1.0 109.725 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -46.84 93.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.413 -0.805 . . . . 1.0 111.712 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 155.64 -36.4 0.63 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.055 -1.218 . . . . 1.0 110.055 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' CD ' HG23 ' A' ' 13' ' ' VAL . 3.6 pt-20 -85.73 -148.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.826 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.485 HG21 ' CE1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -136.75 137.24 39.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 1.0 110.472 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -85.36 -176.5 6.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 1.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.494 ' CD2' HG12 ' A' ' 59' ' ' ILE . 8.0 m80 -160.7 108.5 1.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.954 -1.091 . . . . 1.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CD1' HD23 ' A' ' 58' ' ' LEU . 91.6 m-85 -114.81 120.87 41.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.789 . . . . 1.0 109.369 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -109.8 155.18 21.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 1.0 110.925 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.589 ' O ' HG23 ' A' ' 23' ' ' ILE . 11.4 tt -161.37 119.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.767 . . . . 1.0 109.833 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -101.08 131.88 46.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 1.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 56' ' ' HIS . 22.0 mt -87.63 179.56 6.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.86 . . . . 1.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.7 p -85.26 -22.05 28.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.0 109.98 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -121.45 135.83 25.39 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 1.0 109.978 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.1 Cg_endo -75.52 -178.32 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.537 1.283 . . . . 1.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.68 67.48 0.98 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 1.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 28' ' ' PRO . 98.1 t -142.52 159.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 1.0 110.307 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -142.2 148.35 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 1.0 109.963 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.76 -134.02 2.34 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -167.54 140.44 3.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -1.117 . . . . 1.0 110.18 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.736 ' CE3' HD22 ' A' ' 58' ' ' LEU . 33.9 m95 -102.93 170.73 7.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 1.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -173.62 170.29 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.486 -0.759 . . . . 1.0 109.942 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.25 -131.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 1.0 109.469 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -49.6 -25.03 2.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.7 -1.25 . . . . 1.0 110.399 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.64 40.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -128.48 107.63 19.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.199 -1.177 . . . . 1.0 110.046 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.08 112.36 3.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.487 1.256 . . . . 1.0 110.637 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 42' ' ' THR . 1.3 pp -106.7 -146.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 1.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.705 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -132.66 128.12 36.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.05 -1.031 . . . . 1.0 110.39 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.28 111.32 1.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.873 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -177.3 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.386 -0.821 . . . . 1.0 110.244 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -72.19 -74.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.441 1.232 . . . . 1.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD2' ' CE ' ' A' ' 67' ' ' MET . 27.9 t70 -133.19 58.63 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 1.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 t -162.71 142.3 9.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.905 . . . . 1.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -144.5 87.98 1.9 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.284 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.0 mt -87.81 131.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.132 -0.98 . . . . 1.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 tt -134.95 146.36 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 1.0 110.318 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.0 146.7 19.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 110.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.68 9.01 11.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.739 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.49 -21.24 30.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.474 -1.051 . . . . 1.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 -23.22 20.6 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.172 -1.193 . . . . 1.0 109.718 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 56' ' ' HIS . 38.8 tttt -164.56 163.49 21.89 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.423 -0.798 . . . . 1.0 109.498 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.692 ' CD2' HD11 ' A' ' 25' ' ' LEU . 51.6 m-70 -113.19 121.63 45.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 1.0 110.04 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.19 141.62 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 1.0 110.345 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.736 HD22 ' CE3' ' A' ' 34' ' ' TRP . 21.6 tp -115.57 148.93 39.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.345 -0.847 . . . . 1.0 110.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 20' ' ' HIS . 58.4 mt -146.01 116.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 1.0 109.719 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -117.44 107.27 14.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 1.0 110.587 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' CE1' HG21 ' A' ' 18' ' ' THR . 67.5 m-70 -69.7 -172.14 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 1.0 110.328 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.8 p-10 -13.94 80.85 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.025 1.12 . . . . 1.0 114.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.837 ' O ' HG23 ' A' ' 15' ' ' VAL . 80.7 m -74.42 148.07 41.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -92.25 171.0 9.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 1.0 111.541 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -23.93 2.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.715 -0.615 . . . . 1.0 110.748 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.32 -123.87 0.06 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.98 -1.648 . . . . 1.0 108.98 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.655 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.7 mtt 43.53 28.02 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.895 . . . . 1.0 111.287 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.51 52.52 2.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.297 -0.877 . . . . 1.0 110.365 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.75 -141.84 5.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.416 -1.474 . . . . 1.0 109.416 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 37' ' ' LYS . 1.7 pt-20 -130.99 143.33 50.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -1.154 . . . . 1.0 110.258 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.597 HG23 ' HB2' ' A' ' 84' ' ' LEU . 45.7 t -79.71 99.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 1.0 109.856 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -103.11 128.02 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 1.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 64.4 t80 -104.63 154.82 19.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 109.707 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.61 146.85 51.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 1.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.21 -142.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 1.0 110.04 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.94 -70.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.274 -0.891 . . . . 1.0 110.702 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -146.42 21.21 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 1.0 110.106 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -111.8 167.1 10.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 1.0 110.157 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.61 115.79 2.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.939 . . . . 1.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 66.9 p -96.96 177.84 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.286 -0.884 . . . . 1.0 109.696 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.29 97.15 0.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.033 -1.042 . . . . 1.0 110.696 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.09 -175.98 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 1.0 109.691 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -100.14 138.33 37.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.047 . . . . 1.0 110.242 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' A' ' 71' ' ' VAL . 21.6 tp -131.6 120.74 23.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 1.0 110.249 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -134.35 136.63 43.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 1.0 110.101 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 64' ' ' GLN . 59.5 t -94.57 148.15 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.251 -0.906 . . . . 1.0 110.052 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.46 141.53 51.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 1.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -105.06 -157.84 0.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 tp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.261 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.321 0.581 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.666 HG21 ' HG3' ' A' ' 27' ' ' GLU . 5.1 tt -106.41 157.87 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 1.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.802 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.3 mt-10 -82.77 -148.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 1.0 110.041 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.03 HG23 ' HB1' ' A' ' 78' ' ' ALA . 61.2 t -129.11 129.89 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.64 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 -57.61 3.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.954 . . . . 1.0 109.652 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.09 100.68 15.79 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.661 -0.65 . . . . 1.0 110.345 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.92 -179.33 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.649 1.341 . . . . 1.0 110.441 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.928 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 22.6 mt -76.71 159.34 30.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.055 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -125.96 15.92 7.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.105 -0.997 . . . . 1.0 110.731 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 63.32 157.69 0.15 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.2 p -160.07 170.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.523 -0.986 . . . . 1.0 109.714 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -120.56 166.08 14.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 1.0 110.531 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 12' ' ' GLU . 18.7 m -151.18 147.7 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.422 -0.799 . . . . 1.0 110.496 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.415 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -97.04 27.73 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 1.0 109.4 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 63' ' ' CYS . 75.4 t 57.39 87.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.55 0.691 . . . . 1.0 110.721 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.48 -30.2 2.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.35 -138.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.304 -1.115 . . . . 1.0 109.386 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 ' CG2' ' ND1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -149.64 132.21 15.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 1.0 110.232 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -85.26 165.22 17.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.827 . . . . 1.0 110.037 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -144.14 80.52 1.65 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 1.0 110.764 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 67.3 m-85 -79.77 152.99 29.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 1.0 109.442 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' HD23 ' A' ' 8' ' ' LEU . 12.1 mt-10 -136.24 158.86 43.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 1.0 110.941 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.5 OUTLIER -168.06 127.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.503 -0.748 . . . . 1.0 109.765 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -103.37 150.12 24.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -0.925 . . . . 1.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' HD2' ' A' ' 56' ' ' HIS . 3.3 mp -134.18 1.1 3.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 1.0 111.569 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.464 ' OG ' HD11 ' A' ' 2' ' ' ILE . 6.3 p 41.16 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.6 -0.688 . . . . 1.0 111.721 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HG3' HG21 ' A' ' 2' ' ' ILE . 1.4 mm-40 -136.44 119.74 12.21 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.9 -1.125 . . . . 1.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 45.9 Cg_endo -72.75 161.11 44.71 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.501 1.264 . . . . 1.0 110.122 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.78 86.77 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.205 -0.935 . . . . 1.0 110.328 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -168.37 144.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 1.0 109.902 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -126.42 -175.95 3.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 1.0 110.608 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.0 -164.8 35.03 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -157.32 158.22 35.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -1.144 . . . . 1.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 22.5 m95 -115.49 166.55 11.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.0 110.451 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -162.19 142.8 10.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 1.0 109.758 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 mt -64.16 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 1.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -49.47 -25.46 2.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.635 -1.291 . . . . 1.0 110.056 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.499 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 160.79 40.2 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.484 -1.446 . . . . 1.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 7.4 mm-40 -118.8 121.58 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 1.0 110.174 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.73 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.449 1.236 . . . . 1.0 110.744 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -173.99 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 1.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 43' ' ' ALA . 1.6 m -150.93 -178.06 6.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 1.0 110.274 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' H ' HG22 ' A' ' 42' ' ' THR . . . -65.19 106.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 1.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 164.37 24.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 1.0 110.167 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.48 -17.52 30.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.656 1.345 . . . . 1.0 110.613 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -83.45 -26.16 30.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 1.0 110.125 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -118.76 119.79 35.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.0 110.074 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -107.13 88.84 2.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.966 . . . . 1.0 110.409 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.417 HG12 HD11 ' A' ' 58' ' ' LEU . 97.3 mt -86.97 106.96 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 1.0 109.867 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 50' ' ' ILE . 6.2 tp -131.28 118.33 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 1.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' HIS . 1.5 pt-20 -149.37 169.25 21.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 1.0 110.133 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -117.08 -134.51 0.34 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.281 -0.887 . . . . 1.0 109.126 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -117.68 -19.81 4.8 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.679 -1.248 . . . . 1.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -21.81 22.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 1.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -153.79 173.12 16.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.184 -0.947 . . . . 1.0 110.545 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.797 ' HD2' HD13 ' A' ' 25' ' ' LEU . 57.5 m-70 -133.25 127.62 34.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.352 -0.842 . . . . 1.0 109.787 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.87 135.79 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 1.0 110.715 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.527 HD22 ' CE3' ' A' ' 34' ' ' TRP . 23.8 tp -112.89 147.96 35.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.495 -0.753 . . . . 1.0 110.144 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 87.8 mt -138.73 82.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0 109.882 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -73.2 161.71 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 1.0 110.467 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.5 m-70 -126.89 -169.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.486 -0.759 . . . . 1.0 109.503 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.514 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 42.2 p30 -13.64 80.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.778 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.5 m -78.98 175.12 10.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 1.0 109.501 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG11 ' A' ' 86' ' ' VAL . 1.2 mt-30 -138.58 -163.89 1.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.047 -1.033 . . . . 1.0 110.567 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.32 8.56 4.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 1.0 111.476 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.93 -22.91 19.23 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.064 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.479 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 37.7 mtt -86.69 34.93 0.66 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.067 -1.255 . . . . 1.0 110.799 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 34.9 0.93 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 1.0 110.134 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.35 -124.83 4.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.57 147.17 46.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -1.121 . . . . 1.0 110.393 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 70.7 t -89.05 107.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.316 -0.865 . . . . 1.0 109.884 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 p -108.03 110.6 22.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 1.0 110.663 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 22.7 t80 -91.03 146.87 23.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 1.0 109.823 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -131.54 104.55 7.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.037 -1.04 . . . . 1.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -123.62 124.94 43.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 1.0 109.763 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.84 -90.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 1.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 5.5 p-10 -129.66 -38.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.807 -1.183 . . . . 1.0 110.378 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 1.03 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -63.09 159.76 16.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 1.0 110.516 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -156.63 126.92 6.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 1.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.58 ' OG ' HD11 ' A' ' 8' ' ' LEU . 75.5 p -92.52 -179.14 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.32 88.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -91.67 -170.18 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 1.0 110.307 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -119.91 111.59 18.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 1.0 110.363 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.692 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 66.0 tp -102.15 145.43 29.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 1.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.64 107.92 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.299 -0.875 . . . . 1.0 110.207 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 64' ' ' GLN . 46.3 t -80.9 147.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.118 -0.989 . . . . 1.0 110.405 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -115.45 168.37 10.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 110.165 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -101.95 155.46 18.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.241 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.205 0.526 . . . . 1.0 110.176 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.14 140.94 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.34 156.63 17.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 1.0 109.971 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.78 167.28 2.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.116 -0.99 . . . . 1.0 110.018 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -123.69 -30.72 3.55 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.482 0.658 . . . . 1.0 110.033 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -146.96 122.39 5.37 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 1.0 110.029 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.55 -176.49 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.535 1.282 . . . . 1.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 18.3 mt -82.46 -164.62 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.21 -0.931 . . . . 1.0 110.777 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.13 139.78 26.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.404 -0.81 . . . . 1.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.6 150.29 34.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.429 -1.468 . . . . 1.0 109.429 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.4 p -158.56 169.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 1.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 11' ' ' VAL . 3.0 mt-10 -122.29 165.05 16.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 1.0 110.499 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.5 p -158.94 127.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.238 -0.914 . . . . 1.0 110.104 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.55 47.57 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.217 -0.927 . . . . 1.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 63' ' ' CYS . 21.8 t 48.77 71.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.683 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.65 -22.52 1.04 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 13' ' ' VAL . 53.4 mm-40 -78.99 -122.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -1.157 . . . . 1.0 109.232 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -161.17 157.85 26.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.705 -1.247 . . . . 1.0 110.492 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -108.64 172.52 6.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.393 -0.817 . . . . 1.0 108.883 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.72 122.87 4.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.112 . . . . 1.0 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 58' ' ' LEU . 73.6 m-85 -140.32 132.82 28.61 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.16 155.5 41.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.937 -1.102 . . . . 1.0 111.155 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -167.8 122.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.607 -0.683 . . . . 1.0 109.752 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.24 130.35 54.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 1.0 110.491 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 56' ' ' HIS . 55.6 mt -91.33 -174.2 3.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.822 . . . . 1.0 109.871 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -99.03 -57.37 2.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.0 109.963 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.99 144.01 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 1.0 109.852 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 -169.5 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.628 1.331 . . . . 1.0 110.567 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t0 55.26 80.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 1.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 32' ' ' GLY . 75.4 t -131.28 154.09 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 1.0 109.899 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -124.53 43.53 2.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.92 . . . . 1.0 110.452 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 30' ' ' VAL . . . -77.74 171.36 55.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 12.4 tm0? -145.07 165.26 28.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -1.112 . . . . 1.0 109.902 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.931 ' CE3' HD22 ' A' ' 58' ' ' LEU . 34.2 m95 -108.52 163.84 12.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 1.0 110.819 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.581 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -159.59 157.11 29.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.413 -0.804 . . . . 1.0 110.102 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.42 HD22 ' HG2' ' A' ' 67' ' ' MET . 51.6 mt -68.31 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 1.0 109.805 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -47.34 -25.92 1.13 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.856 -1.152 . . . . 1.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 150.64 39.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 11.2 tt0 -136.41 136.47 22.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 O-C-N 121.126 -1.22 . . . . 1.0 109.132 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.42 114.48 3.94 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.468 1.246 . . . . 1.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 42' ' ' THR . 0.7 OUTLIER -92.77 -139.58 0.2 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 1.0 109.926 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.452 ' H ' HD12 ' A' ' 41' ' ' LEU . 1.2 p -138.69 136.85 36.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.119 . . . . 1.0 110.013 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.79 98.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 1.0 110.088 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -88.69 169.12 14.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 1.0 110.184 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.06 -16.72 28.71 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.731 1.385 . . . . 1.0 110.513 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -98.37 -21.27 16.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 1.0 110.376 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.27 136.32 33.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 1.0 110.181 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.63 136.42 54.49 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 1.0 109.626 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 49' ' ' ILE . 95.7 mt -139.39 76.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 1.0 109.761 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' ILE . 41.9 pt -85.4 144.32 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 1.0 110.038 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.76 137.53 8.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 1.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 26.6 8.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 1.0 109.872 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 -92.39 1.77 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -15.79 30.55 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.631 -0.923 . . . . 1.0 110.547 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -121.63 130.72 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 1.0 110.588 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.778 ' HB2' HG23 ' A' ' 23' ' ' ILE . 29.3 m-70 -118.16 131.13 56.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.0 110.085 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.97 136.42 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 1.0 110.226 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.931 HD22 ' CE3' ' A' ' 34' ' ' TRP . 16.2 tp -125.17 139.96 53.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 1.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 58' ' ' LEU . 33.9 mm -140.61 115.43 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 1.0 109.331 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 9.0 mt -112.82 108.46 17.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 1.0 110.846 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 30.1 m80 -75.44 -159.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 1.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 54.0 t30 -14.13 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.815 ' O ' HG13 ' A' ' 15' ' ' VAL . 91.7 m -86.29 -176.27 5.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.6 -0.688 . . . . 1.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.646 ' C ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -149.96 -164.22 1.97 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 1.0 110.202 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.58 13.43 0.62 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.071 . . . . 1.0 112.404 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.36 -30.97 10.04 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.46 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 36.9 mtt -86.72 39.23 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -1.121 . . . . 1.0 110.565 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -90.69 79.77 6.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.181 -0.949 . . . . 1.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.64 -120.76 0.59 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.63 140.1 31.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 1.0 110.415 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.527 ' O ' HD13 ' A' ' 8' ' ' LEU . 70.5 t -84.69 102.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 1.0 109.853 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 p -102.83 128.69 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 1.0 110.365 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 53.9 t80 -105.57 142.04 36.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.0 109.622 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 127.64 32.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.038 . . . . 1.0 110.647 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.49 -147.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 1.0 109.746 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.43 -73.53 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.932 -1.105 . . . . 1.0 110.081 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -130.12 -1.21 4.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 1.0 110.794 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.22 156.11 23.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.927 -1.108 . . . . 1.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.07 125.88 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.927 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 2.6 p -126.17 178.34 5.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 1.0 109.729 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.55 106.69 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.01 -170.44 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 1.0 109.716 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.14 109.18 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.025 . . . . 1.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 67' ' ' MET . 58.2 tp -108.01 147.01 31.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 1.0 110.036 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 105.09 3.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 110.136 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.646 HG11 ' C ' ' A' ' 64' ' ' GLN . 38.3 t -80.5 133.35 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.186 -0.946 . . . . 1.0 110.149 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -98.44 146.26 25.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.06 149.05 48.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 1.0 110.168 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.235 -179.819 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.179 0.514 . . . . 1.0 110.157 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 1.2 pt -110.15 133.03 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 1.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.6 162.82 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 1.0 110.271 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.695 HG21 ' OG ' ' A' ' 80' ' ' SER . 1.3 p -74.59 124.98 33.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.236 -0.915 . . . . 1.0 110.002 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.21 -34.6 23.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.736 0.779 . . . . 1.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -126.17 109.36 24.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.76 -0.587 . . . . 1.0 110.137 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.0 174.81 10.7 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.578 1.304 . . . . 1.0 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.954 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -87.01 -174.08 4.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0 109.535 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.7 m-85 -145.34 131.4 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 1.0 110.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.35 152.55 14.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.78 142.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -1.074 . . . . 1.0 110.39 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.31 155.0 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 1.0 109.599 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.07 170.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.025 -1.047 . . . . 1.0 110.931 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' N ' HG22 ' A' ' 13' ' ' VAL . 1.7 m-85 -102.13 135.6 43.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.6 p -49.46 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.909 -1.119 . . . . 1.0 111.048 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 147.15 -41.97 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -161.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -1.068 . . . . 1.0 110.107 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 p -120.98 163.57 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 1.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 21' ' ' PHE . . . -120.65 172.56 7.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.529 -0.732 . . . . 1.0 109.268 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.41 124.43 6.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 1.0 111.178 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.707 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 60.4 m-85 -134.36 118.44 17.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.523 -0.736 . . . . 1.0 109.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.51 157.11 17.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.052 -1.03 . . . . 1.0 111.034 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 56' ' ' HIS . 5.6 tt -168.43 120.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 1.0 109.801 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.69 148.6 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 1.0 110.274 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.3 mt -103.84 -154.36 0.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 1.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 31.1 t -116.44 -76.05 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 1.0 109.931 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.66 137.42 20.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.0 109.789 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.31 136.76 27.17 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.578 1.304 . . . . 1.0 110.53 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -164.01 -61.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 110.091 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.82 148.38 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 1.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.61 -164.02 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.29 179.38 25.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -131.53 149.35 52.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -1.18 . . . . 1.0 109.944 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.783 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.8 m95 -104.91 154.21 20.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 1.0 110.776 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 6.9 pttt -147.66 162.28 39.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 1.0 109.514 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 67' ' ' MET . 2.1 mt -81.99 -84.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 1.0 110.115 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 21.16 5.78 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.513 -0.742 . . . . 1.0 110.053 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 107.85 -14.7 37.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 1.0 109.633 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.4 mt-30 -82.94 134.76 46.07 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.175 -1.191 . . . . 1.0 110.044 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.92 114.25 3.99 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.695 1.366 . . . . 1.0 110.615 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 42' ' ' THR . 1.1 pp -73.12 -141.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.836 . . . . 1.0 109.461 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.0 t -158.92 163.45 36.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.742 -1.224 . . . . 1.0 110.252 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.91 106.5 0.31 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 m -116.59 159.44 40.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 1.0 110.17 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -4.8 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.672 1.354 . . . . 1.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.19 -22.76 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.983 -1.073 . . . . 1.0 110.28 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.494 ' SG ' HD21 ' A' ' 60' ' ' LEU . 48.2 t -101.76 122.81 44.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 1.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.49 144.54 44.2 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.147 -0.971 . . . . 1.0 109.233 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.44 85.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 1.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -87.38 120.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 1.0 109.911 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 19.6 pt-20 -146.02 147.52 31.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 1.0 110.505 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.56 23.44 5.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.732 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -74.58 2.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -18.12 24.1 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.736 -0.861 . . . . 1.0 110.823 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.66 43.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.034 -1.041 . . . . 1.0 110.816 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.693 ' HB2' HG23 ' A' ' 23' ' ' ILE . 67.5 m-70 -143.06 103.35 4.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 1.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.87 136.83 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 1.0 110.502 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD22 ' CE3' ' A' ' 34' ' ' TRP . 34.3 tp -117.35 130.72 56.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.311 -0.868 . . . . 1.0 110.387 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.18 100.81 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 1.0 109.636 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mt -103.72 116.16 31.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 1.0 110.922 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 62' ' ' ASN . 43.9 m-70 -77.59 -166.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 1.0 109.945 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 61' ' ' HIS . 54.0 t30 -15.45 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.66 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.4 m -73.71 143.92 45.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.503 -0.748 . . . . 1.0 109.496 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -79.13 173.51 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.0 110.825 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -9.52 46.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.774 . . . . 1.0 110.904 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.14 -10.61 82.35 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.944 -1.122 . . . . 1.0 110.342 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.666 ' HB2' HG21 ' A' ' 86' ' ' VAL . 6.2 mtt -84.37 38.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.888 -1.36 . . . . 1.0 111.458 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -91.43 40.0 1.02 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.019 -1.051 . . . . 1.0 109.918 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.33 -128.31 4.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 83' ' ' ASN . 1.9 mp0 -135.13 -170.66 2.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -1.083 . . . . 1.0 110.468 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 78.1 t -128.61 78.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 110.072 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' A' ' 35' ' ' LYS . 17.1 p -86.78 125.21 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 1.0 110.15 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 23' ' ' ILE . 57.2 t80 -103.23 143.83 32.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 1.0 110.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -133.72 127.12 32.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 1.0 110.125 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -159.78 118.58 2.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.0 110.5 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.62 -89.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 1.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 75' ' ' ALA . 9.1 t-20 -128.03 -35.77 2.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.893 -1.129 . . . . 1.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 150.32 11.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 1.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 125.96 6.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 1.0 110.24 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.695 ' OG ' HG21 ' A' ' 4' ' ' VAL . 23.1 m -125.5 174.51 8.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 1.0 110.38 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.4 94.21 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 1.0 110.193 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -90.84 -172.88 3.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 1.0 110.29 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 17.8 m-20 -123.26 139.23 54.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.707 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 60.7 tp -143.72 127.42 17.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 1.0 110.386 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -134.7 132.95 39.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 1.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 67' ' ' MET . 35.2 t -91.66 126.07 44.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.268 -0.895 . . . . 1.0 110.19 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 160.36 14.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 1.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.32 -176.74 3.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.0 110.177 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.993 -1.004 . . . . 1.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.338 0.59 . . . . 1.0 110.111 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 2' ' ' ILE . 6.9 tt -170.25 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 1.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' OE2' ' HB1' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -150.27 179.54 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 1.0 111.044 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' VAL . 54.2 t 48.56 85.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.439 0.638 . . . . 1.0 111.078 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 6.4 mm-40 -98.4 -29.26 13.23 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 23' ' ' ILE . 7.0 tmtt? -129.46 114.85 18.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.73 165.88 21.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.443 1.233 . . . . 1.0 111.586 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.985 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 3.9 mt -65.53 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.752 -0.592 . . . . 1.0 110.721 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 10' ' ' GLY . 86.0 t80 -144.74 159.92 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 1.0 109.994 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 9' ' ' TYR . . . -95.48 141.66 15.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.511 -1.435 . . . . 1.0 109.511 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 84' ' ' LEU . 10.4 p -149.88 166.46 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -1.222 . . . . 1.0 110.408 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' VAL . 80.1 mt-10 -122.02 166.13 14.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.0 110.299 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.504 HG23 ' HA ' ' A' ' 86' ' ' VAL . 15.8 m -152.65 157.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.171 -0.956 . . . . 1.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -117.42 33.73 5.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.497 -0.752 . . . . 1.0 109.011 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 18.5 t 61.75 73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.701 0.762 . . . . 1.0 109.895 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 152.54 -23.11 0.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.24 164.96 22.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -1.119 . . . . 1.0 110.096 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.5 m -112.26 105.95 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.289 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.54 171.46 15.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 1.0 109.839 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CD2' HG12 ' A' ' 59' ' ' ILE . 13.1 m80 -144.99 120.5 10.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.0 110.734 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.72 ' CD1' HD23 ' A' ' 58' ' ' LEU . 77.0 m-85 -114.11 111.43 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.843 . . . . 1.0 109.365 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.92 165.66 11.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.148 -0.97 . . . . 1.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -170.04 119.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 1.0 109.802 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.34 124.49 43.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 1.0 110.206 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' A' ' 56' ' ' HIS . 26.0 mt -86.94 -150.64 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.195 -0.941 . . . . 1.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.411 ' HB3' HG12 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -126.67 -47.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.972 . . . . 1.0 110.211 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.73 150.19 37.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 1.0 110.608 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.11 -165.66 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.597 1.314 . . . . 1.0 110.335 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 t70 49.92 81.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.276 -0.89 . . . . 1.0 110.544 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.7 t -138.87 148.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 1.0 110.154 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -140.63 40.74 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 1.0 110.331 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.45 -150.3 0.04 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -166.31 -179.8 5.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -1.095 . . . . 1.0 109.674 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.55 ' CE3' HD22 ' A' ' 58' ' ' LEU . 57.9 m95 -117.65 131.06 56.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.982 -1.074 . . . . 1.0 110.628 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 2.7 ttpt -124.03 133.82 53.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.505 -0.747 . . . . 1.0 109.978 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.46 -130.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 1.0 109.815 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -28.84 3.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.592 -1.317 . . . . 1.0 110.708 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 154.47 39.46 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.961 -1.255 . . . . 1.0 109.961 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 1.1 pt20 -150.39 150.42 28.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.106 -1.232 . . . . 1.0 110.014 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.45 113.35 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.601 1.316 . . . . 1.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -70.34 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.46 -0.775 . . . . 1.0 109.877 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.523 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -168.41 14.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 1.0 112.119 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -75.76 -162.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.709 -1.245 . . . . 1.0 109.817 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.73 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.22 -0.925 . . . . 1.0 110.384 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.19 -42.87 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.525 1.276 . . . . 1.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -23.83 51.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 1.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.84 121.77 42.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 110.308 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.1 144.13 39.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 1.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -134.04 119.26 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 1.0 109.825 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.64 HG23 ' HB ' ' A' ' 57' ' ' ILE . 7.0 tp -130.07 109.26 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.08 147.65 50.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 1.0 110.397 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.02 20.98 17.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 1.0 110.185 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 -90.5 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -59.39 -16.0 20.26 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.662 -0.905 . . . . 1.0 110.836 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -125.28 168.12 13.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 25' ' ' LEU . 94.8 m-70 -149.99 126.87 11.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.64 ' HB ' HG23 ' A' ' 50' ' ' ILE . 57.6 mt -124.08 142.2 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 1.0 109.981 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.72 HD23 ' CD1' ' A' ' 21' ' ' PHE . 24.6 tp -118.48 145.44 45.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.104 -0.997 . . . . 1.0 110.409 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 20' ' ' HIS . 56.6 mt -141.2 92.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 1.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' THR . 16.3 mt -98.47 115.21 28.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 62' ' ' ASN . 31.6 m-70 -83.04 -165.04 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 1.0 109.702 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 50.2 t30 -16.57 82.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.762 1.023 . . . . 1.0 113.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' HIS . 71.9 m -69.95 -175.54 0.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.809 ' O ' HG11 ' A' ' 86' ' ' VAL . 2.9 mt-30 -138.31 -168.23 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 1.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mp -84.81 69.1 10.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 1.0 110.264 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.84 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.6 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.19 -15.32 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -1.168 . . . . 1.0 111.622 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -43.57 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.417 -0.802 . . . . 1.0 110.929 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 174.11 -127.35 1.31 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -139.82 146.4 39.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 1.0 110.456 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' HD13 ' A' ' 8' ' ' LEU . 69.6 t -94.39 87.66 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.343 -0.848 . . . . 1.0 109.957 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -87.91 110.11 20.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 1.0 110.426 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 27.8 t80 -71.48 154.2 41.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 1.0 110.072 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 139.46 52.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 1.0 110.1 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB1' ' OE2' ' A' ' 3' ' ' GLU . . . -160.72 -148.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 1.0 109.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' O ' ' ND2' ' A' ' 77' ' ' ASN . . . -77.5 126.95 31.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 1.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER 34.05 31.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 76' ' ' ALA . . . -152.26 158.32 42.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 1.0 110.791 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -160.54 115.07 2.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 1.0 110.003 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 7.3 m -72.62 -172.75 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 1.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.44 97.43 0.25 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 1.0 110.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.985 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.46 -164.53 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 1.0 110.406 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.42 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 61.0 t-20 -132.13 137.43 47.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 1.0 109.598 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.689 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 65.0 tp -154.35 143.29 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 1.0 110.531 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -145.17 127.65 16.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.431 -0.793 . . . . 1.0 110.082 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.809 HG11 ' O ' ' A' ' 64' ' ' GLN . 16.9 t -92.54 142.64 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.366 -0.834 . . . . 1.0 109.732 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -141.4 130.05 22.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.999 . . . . 1.0 110.492 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.34 174.08 8.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 1.0 109.99 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 pt -100.64 161.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 1.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.82 -162.17 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.819 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 93.8 t -126.39 120.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 1.0 110.345 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -93.59 -44.98 7.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.249 -0.907 . . . . 1.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.9 tttt -108.87 109.34 61.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 1.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.1 173.8 13.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.434 1.229 . . . . 1.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.925 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 42.3 mt -75.34 169.38 18.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 1.0 110.162 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -137.06 153.02 50.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 1.0 110.177 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.33 136.53 20.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.056 -1.217 . . . . 1.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.4 t -136.86 154.85 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -1.111 . . . . 1.0 110.03 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -107.73 155.2 20.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.184 -0.947 . . . . 1.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 86' ' ' VAL . 5.5 p -152.1 134.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 1.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.21 39.85 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.24 -0.912 . . . . 1.0 110.378 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 87' ' ' LYS . 89.2 t 52.09 88.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 1.0 110.306 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.31 -29.38 2.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.349 -1.5 . . . . 1.0 109.349 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.92 -124.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.182 . . . . 1.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -160.27 114.48 2.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.698 -1.251 . . . . 1.0 111.002 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.77 148.19 31.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.938 . . . . 1.0 108.808 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -128.33 128.92 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.169 . . . . 1.0 111.469 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.702 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 99.5 m-85 -134.1 112.12 10.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.549 -0.719 . . . . 1.0 109.404 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.51 165.8 11.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 1.0 111.066 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -170.45 137.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.4 164.55 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.978 . . . . 1.0 110.97 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.671 HD12 HG21 ' A' ' 30' ' ' VAL . 71.3 mt -124.3 -148.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 1.0 109.81 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.49 -67.74 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 1.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -97.26 155.55 37.26 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 1.0 110.171 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -75.25 -167.41 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.707 1.372 . . . . 1.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 53.55 67.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.848 . . . . 1.0 110.432 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 25' ' ' LEU . 29.5 m -142.79 170.51 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 1.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -143.43 165.95 26.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.1 -171.7 36.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.18 156.83 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -1.088 . . . . 1.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.894 ' CE3' HD12 ' A' ' 58' ' ' LEU . 45.4 m95 -108.8 139.12 44.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 1.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 39' ' ' GLN . 2.9 ttpt -132.99 125.19 29.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.532 -0.73 . . . . 1.0 109.215 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.409 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 mp -64.45 -132.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.135 -0.978 . . . . 1.0 109.596 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -26.08 3.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.644 -1.285 . . . . 1.0 109.572 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 156.81 38.71 0.02 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.781 -1.328 . . . . 1.0 109.781 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 1.3 mm-40 -131.25 104.01 15.09 Favored Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.141 -1.211 . . . . 1.0 109.997 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.73 101.74 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.673 1.354 . . . . 1.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 42' ' ' THR . 2.1 pp -84.71 -151.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 1.0 110.466 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 41' ' ' LEU . 14.9 p -135.0 133.91 39.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 1.0 110.087 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.31 113.7 24.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 1.0 110.274 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -176.69 -60.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 1.0 110.399 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.3 Cg_endo -72.05 -57.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.348 1.183 . . . . 1.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -133.8 69.28 1.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.0 110.565 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -157.2 134.78 10.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 1.0 110.029 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -127.32 86.65 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.0 110.338 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -105.11 98.21 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 1.0 110.158 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.23 112.2 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -130.61 157.81 41.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 1.0 110.531 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.65 27.16 9.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 1.0 109.762 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.42 -87.72 1.41 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -55.88 -19.83 13.37 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.677 -0.896 . . . . 1.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 155.38 33.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 1.0 110.749 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.0 m-70 -138.65 102.77 4.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 1.0 109.845 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -109.33 137.22 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 1.0 110.535 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.894 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.2 tt -114.35 133.05 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 1.0 110.224 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.747 ' N ' HD23 ' A' ' 58' ' ' LEU . 22.7 mt -136.22 80.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.377 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.94 125.4 35.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 1.0 110.524 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.3 m-70 -83.33 -160.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 1.0 109.716 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 61' ' ' HIS . 37.5 t30 -14.56 82.12 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' HIS . 68.0 m -75.46 -178.27 3.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.506 -0.746 . . . . 1.0 109.954 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG11 ' A' ' 86' ' ' VAL . 44.5 tp60 -117.08 169.66 9.26 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.168 -0.958 . . . . 1.0 109.143 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 88' ' ' GLU . 2.2 mp -72.79 4.22 4.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.822 -1.174 . . . . 1.0 112.139 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.7 -27.11 15.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.776 ' HB2' HG21 ' A' ' 86' ' ' VAL . 4.3 mtt -50.55 -23.21 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -1.043 . . . . 1.0 111.016 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 p -48.52 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.163 -0.961 . . . . 1.0 110.503 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.31 -126.4 0.97 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.072 -1.611 . . . . 1.0 109.072 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -135.35 136.14 41.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.137 . . . . 1.0 110.175 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 8' ' ' LEU . 52.3 t -91.45 87.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 1.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -91.85 111.64 23.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 1.0 110.863 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.889 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 19.6 t80 -86.78 133.53 33.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 1.0 109.375 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -110.55 70.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.986 . . . . 1.0 110.755 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.889 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -94.38 112.32 24.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 1.0 109.784 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.4 -159.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 1.0 109.988 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 26.1 p30 -62.65 -16.89 59.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 1.0 110.455 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.819 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -69.84 158.58 35.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 1.0 110.217 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -159.69 116.77 2.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.137 -0.977 . . . . 1.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 4.6 p -105.34 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 1.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.55 101.73 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 1.0 110.556 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.23 -164.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 1.0 110.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.38 147.28 52.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 1.0 109.944 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 52.9 tp -145.11 145.5 31.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 1.0 110.515 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 9.2 ptpt -138.2 105.86 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 1.0 109.71 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 67' ' ' MET . 99.2 t -89.49 117.71 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.245 -0.91 . . . . 1.0 110.501 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.6 mtpt -116.78 146.63 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 1.0 110.203 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.488 ' HG3' HD11 ' A' ' 65' ' ' LEU . 19.4 mt-10 -64.69 -171.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 1.0 110.256 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.314 0.578 . . . . 1.0 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 tt -144.39 162.6 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.927 . . . . 1.0 110.109 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.59 166.95 21.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.0 110.006 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 23' ' ' ILE . 2.0 p -80.04 -165.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.087 -1.008 . . . . 1.0 109.691 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 4' ' ' VAL . 50.0 mm-40 -127.74 -54.26 1.32 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 1.0 110.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -126.57 112.36 22.93 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.593 -0.692 . . . . 1.0 110.095 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.92 178.11 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.645 1.34 . . . . 1.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -75.4 173.89 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 1.0 110.168 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.9 m-85 -134.67 12.53 3.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.142 -0.974 . . . . 1.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 74.09 150.32 1.84 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.879 -1.288 . . . . 1.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 19' ' ' ALA . 77.3 t -145.35 161.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -1.11 . . . . 1.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 11' ' ' VAL . 62.8 mt-10 -125.88 149.72 48.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.0 110.387 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.855 HG23 ' CB ' ' A' ' 17' ' ' GLU . 3.1 p -155.6 135.01 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 1.0 109.915 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.47 58.62 3.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.281 -0.887 . . . . 1.0 110.788 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.4 t 46.08 81.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 1.0 110.925 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 139.57 -31.63 2.3 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.746 -1.742 . . . . 1.0 108.746 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.855 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.7 mt-10 -66.17 -158.36 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.494 -1.004 . . . . 1.0 109.502 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -142.74 108.87 5.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 1.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' HG11 ' A' ' 11' ' ' VAL . . . -79.05 132.72 36.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 1.0 109.505 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.9 110.09 18.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 1.0 111.107 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 85.6 m-85 -101.25 134.71 43.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 1.0 109.324 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -130.08 162.79 27.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.934 -1.104 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.672 HD11 HG21 ' A' ' 4' ' ' VAL . 1.1 tt -170.77 125.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.0 109.806 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -90.73 145.2 25.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 1.0 110.225 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD22 ' C ' ' A' ' 24' ' ' GLU . 4.2 mm? -111.23 155.14 23.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 1.0 109.996 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.54 -58.0 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -88.29 141.38 30.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 1.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.03 104.56 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.653 1.344 . . . . 1.0 110.153 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -119.85 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.112 -0.992 . . . . 1.0 109.201 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 30' ' ' VAL . 8.7 p -176.61 43.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 1.0 110.027 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -152.57 143.63 23.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 1.0 110.27 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.0 146.36 5.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 1.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -129.71 146.72 51.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -1.183 . . . . 1.0 110.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 1.038 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -112.5 173.22 6.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.967 . . . . 1.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 3.3 ptpt -171.2 152.55 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.521 -0.737 . . . . 1.0 109.596 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 67' ' ' MET . 3.5 mt -66.35 -94.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 1.0 109.813 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.58 21.84 5.95 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.124 -0.985 . . . . 1.0 109.946 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 35' ' ' LYS . . . 117.2 -0.27 19.07 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -92.35 109.13 36.06 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.27 . . . . 1.0 110.27 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.01 104.77 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.572 1.301 . . . . 1.0 110.43 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -71.85 -168.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 1.0 110.606 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' THR . 5.6 t -109.12 175.01 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 1.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 109.65 11.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 1.0 110.372 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -122.22 170.56 7.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 1.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.41 -24.23 19.56 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.627 1.33 . . . . 1.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.31 -40.31 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 1.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.49 127.74 35.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 1.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -119.36 144.1 47.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.914 . . . . 1.0 109.573 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.25 90.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 1.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.0 tp -113.02 147.48 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 1.0 110.187 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -159.67 149.48 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.199 -0.938 . . . . 1.0 110.197 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.32 22.75 11.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 1.0 110.173 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.63 -85.02 1.07 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -6.82 31.85 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.656 -0.908 . . . . 1.0 111.031 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.24 107.62 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.865 -1.147 . . . . 1.0 110.623 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.458 ' HB2' HG23 ' A' ' 23' ' ' ILE . 23.7 m80 -87.32 133.59 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.231 -0.918 . . . . 1.0 109.992 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.1 mt -132.71 134.84 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.058 -1.027 . . . . 1.0 110.534 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.038 HD22 ' CE3' ' A' ' 34' ' ' TRP . 27.2 tp -117.16 150.96 37.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 1.0 110.083 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 59' ' ' ILE . 24.9 mm -143.43 99.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 1.0 109.945 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -105.69 116.57 32.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.0 110.08 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 62' ' ' ASN . 42.2 m-70 -85.99 -164.03 0.97 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.877 . . . . 1.0 110.278 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 66.8 t30 -14.71 81.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.808 1.04 . . . . 1.0 113.808 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 64.3 m -73.92 142.58 45.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.506 -0.746 . . . . 1.0 109.562 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.881 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.31 -175.71 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 1.0 110.787 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 65' ' ' LEU . 17.8 tp -79.59 5.26 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 1.0 111.127 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.01 -29.3 6.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.884 ' HB2' HG21 ' A' ' 86' ' ' VAL . 2.8 mtt -49.99 -23.57 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -1.13 . . . . 1.0 110.648 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -47.06 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.51 -0.744 . . . . 1.0 110.406 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.98 -121.6 0.59 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.96 174.29 10.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -1.076 . . . . 1.0 110.585 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 76.9 t -127.61 89.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -0.795 . . . . 1.0 109.742 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -97.9 125.16 42.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 1.0 110.609 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 46.9 t80 -113.75 157.85 21.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.447 -0.783 . . . . 1.0 109.632 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -143.48 136.73 27.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 1.0 110.683 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -160.5 120.62 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 1.0 109.454 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.64 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -0.872 . . . . 1.0 109.799 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.3 m-20 -128.92 -15.31 4.32 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 1.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.48 157.91 8.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.0 110.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -158.1 93.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 1.0 109.776 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 49.5 p -101.73 172.06 7.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.912 . . . . 1.0 110.72 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.17 91.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -0.809 . . . . 1.0 109.816 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -94.02 -171.05 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 1.0 110.593 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.81 133.38 55.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 1.0 110.244 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 11' ' ' VAL . 64.7 tp -132.02 136.88 47.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 1.0 110.218 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -135.27 131.54 36.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 1.0 109.973 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' MET . 93.6 t -100.58 153.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 1.0 109.852 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.0 mtpp -144.32 130.2 19.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 1.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.471 ' HG3' HD13 ' A' ' 65' ' ' LEU . 6.2 mt-10 -71.96 173.3 8.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 1.0 110.302 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 89' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.066 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 77' ' ' ASN . 2.0 mp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.273 0.559 . . . . 1.0 110.184 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.929 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.3 mt -90.01 148.38 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 1.0 109.75 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.02 -5.61 6.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 1.0 111.211 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 46.1 t 60.16 136.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.344 -0.848 . . . . 1.0 110.959 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -116.85 -37.02 3.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 1.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -119.0 109.0 39.86 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.765 -0.584 . . . . 1.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.05 172.72 14.13 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.604 1.318 . . . . 1.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.808 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 51.4 mt -73.3 170.0 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 1.0 110.348 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.55 113.1 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 1.0 110.066 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.9 153.34 4.32 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.508 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 9.0 p -153.43 158.76 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.382 -1.069 . . . . 1.0 110.176 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -112.18 160.49 17.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 1.0 110.406 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 86' ' ' VAL . 9.6 m -147.83 172.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 1.0 110.592 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -129.53 30.35 4.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 63' ' ' CYS . 40.9 t 58.34 70.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.716 0.769 . . . . 1.0 109.95 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.45 -21.49 1.06 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 18' ' ' THR . 58.7 mm-40 -76.31 -121.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 1.0 109.705 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.2 p -160.27 171.12 19.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.845 -1.16 . . . . 1.0 110.452 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.683 ' HB1' ' HE1' ' A' ' 21' ' ' PHE . . . -136.3 158.37 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.417 -0.802 . . . . 1.0 109.548 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 56.3 m80 -146.63 92.35 2.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 1.0 110.946 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.683 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 87.4 m-85 -106.65 112.39 25.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.181 -0.949 . . . . 1.0 109.713 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -121.77 157.4 31.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.997 . . . . 1.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -163.84 122.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.0 109.792 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.62 138.23 33.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 1.0 110.262 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD11 ' CD2' ' A' ' 56' ' ' HIS . 33.9 mt -109.0 170.16 8.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 1.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -11.08 42.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 1.0 110.67 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -123.82 124.98 26.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.0 110.167 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.83 171.2 18.73 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.417 1.219 . . . . 1.0 110.645 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 50.72 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 1.0 110.584 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.26 179.96 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 1.0 110.062 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -127.39 41.26 3.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 1.0 110.382 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 75' ' ' ALA . . . -86.32 174.26 46.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.762 -1.335 . . . . 1.0 109.762 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.07 155.59 32.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -1.13 . . . . 1.0 110.148 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' CE3' HD12 ' A' ' 58' ' ' LEU . 77.0 m95 -86.75 135.56 33.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.047 -1.033 . . . . 1.0 110.475 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -138.69 126.39 22.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.382 -0.824 . . . . 1.0 109.424 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 67' ' ' MET . 1.3 mt -63.62 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.171 -0.956 . . . . 1.0 109.274 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -25.04 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.48 -1.388 . . . . 1.0 109.51 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.74 38.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -128.39 136.4 29.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.238 . . . . 1.0 110.294 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.98 121.03 6.33 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.534 1.281 . . . . 1.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 42' ' ' THR . 2.2 pp -83.29 -149.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 1.0 110.026 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.851 ' N ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -157.74 120.89 3.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.949 . . . . 1.0 109.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -88.2 97.67 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 1.0 110.518 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.464 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER 176.03 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.274 -0.891 . . . . 1.0 110.424 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.2 Cg_endo -72.02 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.579 1.305 . . . . 1.0 111.196 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -113.84 57.78 0.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.924 -1.11 . . . . 1.0 110.729 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 11.2 t -152.28 126.79 9.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 1.0 110.169 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 1.5 mt-10 -111.44 52.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 1.0 110.393 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.634 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.68 124.48 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 1.0 109.985 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.634 ' N ' HD13 ' A' ' 49' ' ' ILE . 3.8 tt -121.42 128.06 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.238 -0.914 . . . . 1.0 110.136 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.02 137.68 14.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.92 . . . . 1.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.89 17.51 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 1.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.48 -24.13 26.98 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -90.56 -20.32 22.75 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.391 -1.064 . . . . 1.0 110.108 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -164.38 127.89 2.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.33 -0.856 . . . . 1.0 110.287 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 23' ' ' ILE . 84.5 m-70 -96.61 120.6 37.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 1.0 110.03 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 55' ' ' LYS . 3.3 mp -130.15 140.07 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 110.217 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.705 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -127.76 130.77 49.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 58' ' ' LEU . 81.6 mt -135.41 87.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 1.0 109.394 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.721 HD13 ' CE ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -96.87 119.08 34.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 1.0 110.729 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.8 m-70 -80.08 -161.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 1.0 109.423 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -14.38 80.97 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.927 1.084 . . . . 1.0 113.927 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.7 m -70.22 -169.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.573 -0.704 . . . . 1.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.777 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.69 -163.68 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 1.0 110.435 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 88' ' ' GLU . 9.2 mp -82.38 34.21 0.42 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.105 -0.997 . . . . 1.0 111.472 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.82 -29.82 2.98 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.655 -1.778 . . . . 1.0 108.655 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 60' ' ' LEU . 53.6 mtp -88.02 36.22 0.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.991 . . . . 1.0 110.228 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -90.26 58.83 4.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 1.0 109.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -154.83 -125.81 0.99 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.54 151.19 52.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.438 -1.037 . . . . 1.0 110.483 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' LEU . 60.2 t -95.13 84.26 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 1.0 109.924 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.6 p -88.28 119.87 29.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -103.23 143.34 32.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' O ' ' CA ' ' A' ' 32' ' ' GLY . 24.3 mt-30 -130.41 137.18 49.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . . . -164.33 105.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 1.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.929 ' HB3' HD12 ' A' ' 2' ' ' ILE . . . 56.47 -89.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 1.0 110.31 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 1' ' ' LEU . 1.8 t30 -114.78 -27.18 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.956 -1.09 . . . . 1.0 110.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.04 141.91 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 1.0 110.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 75.62 1.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 1.0 109.967 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.438 ' OG ' HD11 ' A' ' 8' ' ' LEU . 61.4 p -90.98 176.96 6.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.953 . . . . 1.0 110.146 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.03 93.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.0 110.15 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.808 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -89.99 -171.29 3.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 1.0 110.069 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.12 105.61 8.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 1.0 109.932 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.608 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 42.5 tp -112.66 124.53 52.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 1.0 110.577 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -127.76 134.72 49.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 1.0 109.807 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.777 HG11 ' O ' ' A' ' 64' ' ' GLN . 84.3 t -100.19 135.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 109.934 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -122.95 134.17 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.0 110.306 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 65' ' ' LEU . 21.8 mt-10 -76.29 169.03 18.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 1.0 110.072 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.291 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.286 0.565 . . . . 1.0 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 16.9 pt -118.77 174.16 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.857 . . . . 1.0 110.136 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -122.52 -166.18 1.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 110.499 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.005 HG23 ' HB1' ' A' ' 78' ' ' ALA . 63.6 t -116.31 122.09 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 1.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.74 -41.72 26.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 1.0 108.733 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 2.3 mtmt -117.77 101.75 51.9 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.823 -0.548 . . . . 1.0 109.855 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.15 174.35 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.599 1.315 . . . . 1.0 110.74 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.874 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 17.7 mt -75.3 176.38 7.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 1.0 110.015 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 28.0 m-85 -135.18 125.0 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.0 110.234 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 142.69 40.78 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.558 ' O ' HD12 ' A' ' 84' ' ' LEU . 7.7 p -153.56 164.03 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -1.073 . . . . 1.0 109.851 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 11' ' ' VAL . 31.3 mt-10 -124.82 152.78 43.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 1.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 17' ' ' GLU . 11.3 p -142.12 149.02 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.82 . . . . 1.0 110.138 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -88.87 47.96 1.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 1.0 110.475 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.7 p 37.02 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.733 0.778 . . . . 1.0 111.72 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 159.01 -25.42 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.05 -1.62 . . . . 1.0 109.05 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.6 mm-40 -76.47 -112.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -1.098 . . . . 1.0 109.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -161.18 151.17 17.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.592 -1.317 . . . . 1.0 110.826 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -107.2 160.94 15.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 1.0 109.076 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.81 97.91 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.0 111.105 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.759 ' CD2' HD23 ' A' ' 58' ' ' LEU . 88.0 m-85 -111.73 108.14 17.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.544 -0.723 . . . . 1.0 109.324 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 155.17 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.324 -0.86 . . . . 1.0 110.509 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.738 HD11 ' OG ' ' A' ' 80' ' ' SER . 7.2 tt -164.81 139.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.444 -0.785 . . . . 1.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -120.45 143.38 48.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.975 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.2 mt -108.03 -156.71 0.59 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 1.0 110.179 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -108.1 -68.37 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 1.0 110.388 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.76 130.1 23.27 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 1.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -78.14 154.53 29.03 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.408 1.215 . . . . 1.0 110.166 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.22 -61.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 1.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.16 166.12 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 1.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 p80 -70.81 -164.85 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.841 . . . . 1.0 110.411 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.4 -150.58 5.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.606 -1.398 . . . . 1.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.25 135.27 3.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.373 -1.075 . . . . 1.0 110.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.877 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -101.95 149.01 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 1.0 110.608 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 19.1 ttpt -141.54 123.14 15.09 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.35 -0.843 . . . . 1.0 109.592 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.44 -131.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 1.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.52 -25.16 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.411 -1.43 . . . . 1.0 109.619 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.42 38.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.698 -1.361 . . . . 1.0 109.698 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 7.9 mm-40 -126.68 109.03 22.79 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.162 -1.199 . . . . 1.0 110.147 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.08 83.83 1.58 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.62 1.326 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.09 -163.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 1.0 110.678 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.1 148.39 50.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 1.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.857 ' HB2' HG22 ' A' ' 49' ' ' ILE . . . -88.28 107.48 18.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 1.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -179.32 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.269 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.87 -50.82 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.59 1.31 . . . . 1.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.0 -54.72 1.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -0.985 . . . . 1.0 110.823 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HA ' HD23 ' A' ' 60' ' ' LEU . 36.8 t -69.5 150.04 47.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 1.0 110.443 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.15 65.0 1.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.875 . . . . 1.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.857 HG22 ' HB2' ' A' ' 43' ' ' ALA . 6.1 tp -84.56 140.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 1.0 110.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.7 mt -128.84 120.96 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.084 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -136.25 141.79 43.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 1.0 110.273 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.85 27.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.222 -0.924 . . . . 1.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.82 -23.92 30.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -90.38 71.8 7.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -1.018 . . . . 1.0 108.93 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 24' ' ' GLU . 5.4 mmtt 54.79 170.83 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.889 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 89.9 m-70 -114.69 144.92 42.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.982 -1.074 . . . . 1.0 110.763 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -140.47 115.06 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.842 . . . . 1.0 109.799 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.877 HD22 ' CE3' ' A' ' 34' ' ' TRP . 44.8 tp -99.19 132.03 44.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 1.0 110.862 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.6 mt -133.33 93.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.474 -0.766 . . . . 1.0 109.456 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 2.6 mt -95.51 105.05 16.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 1.0 110.93 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 68.1 m-70 -69.85 -169.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 1.0 109.475 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 40.5 p-10 -14.87 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.867 1.062 . . . . 1.0 113.867 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.2 m -70.62 -156.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.639 -0.663 . . . . 1.0 109.429 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.783 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -151.43 -169.97 3.52 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.967 -1.083 . . . . 1.0 110.815 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 38.51 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -0.784 . . . . 1.0 111.517 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.55 -15.02 2.5 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.803 -1.189 . . . . 1.0 110.293 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -87.42 37.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.718 -1.46 . . . . 1.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.22 40.27 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 1.0 110.139 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 -125.11 2.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -136.93 152.33 50.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -1.042 . . . . 1.0 110.294 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 71.1 t -94.34 88.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.908 . . . . 1.0 109.84 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.5 p -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 1.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 41.0 t80 -96.39 146.27 24.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 1.0 109.95 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -152.58 126.6 9.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 1.0 110.379 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -132.66 16.06 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.11 -0.994 . . . . 1.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 169.15 -81.97 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.363 -0.835 . . . . 1.0 109.601 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -127.2 -39.03 1.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 1.0 109.535 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 1.005 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -69.29 119.38 13.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.831 . . . . 1.0 110.016 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 1.4 mtpt -123.29 95.81 4.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 1.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.738 ' OG ' HD11 ' A' ' 23' ' ' ILE . 14.3 m -73.35 -179.24 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 1.0 110.182 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.39 104.75 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 1.0 110.576 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.28 -176.64 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 1.0 110.108 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.37 121.15 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 1.0 109.838 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.668 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 56.4 tp -125.2 133.98 52.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 1.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -130.88 130.42 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 1.0 109.511 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 64' ' ' GLN . 92.0 t -91.64 145.48 7.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.181 -0.949 . . . . 1.0 110.447 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -135.47 141.37 45.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.418 -0.801 . . . . 1.0 109.921 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.98 -167.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 1.0 110.336 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.593 HD12 ' HE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.18 0.514 . . . . 1.0 110.217 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.6 mm -123.32 166.83 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 1.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.6 -154.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 1.0 110.344 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.991 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 27.7 t -125.17 127.49 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 1.0 109.958 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.39 -46.17 6.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 1.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.23 107.87 61.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.705 -0.622 . . . . 1.0 110.063 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.17 173.73 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.563 1.297 . . . . 1.0 110.799 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 49.6 mt -75.39 173.89 10.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 1.0 110.45 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -138.59 122.55 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 1.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.0 146.66 47.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.791 -1.323 . . . . 1.0 109.791 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 12' ' ' GLU . 74.3 t -144.23 162.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 1.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 11' ' ' VAL . 3.2 mt-10 -108.41 154.8 21.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 ' CG ' ' A' ' 17' ' ' GLU . 2.7 p -151.08 130.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.0 110.013 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.55 38.06 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 1.0 110.337 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.571 ' H ' HG22 ' A' ' 13' ' ' VAL . 47.3 t 55.82 99.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.374 -0.829 . . . . 1.0 110.684 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.435 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 131.83 -40.8 1.58 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.988 ' CG ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -69.69 -136.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 1.0 109.062 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.3 m -154.42 120.65 5.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.795 -1.191 . . . . 1.0 110.763 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 152.81 30.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 59' ' ' ILE . 10.0 m80 -138.07 133.34 33.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.907 -1.12 . . . . 1.0 111.561 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.837 ' CE1' HG21 ' A' ' 71' ' ' VAL . 75.0 m-85 -125.7 135.47 52.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -125.43 154.65 41.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.0 111.574 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -168.15 135.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.64 . . . . 1.0 109.438 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -125.98 142.97 51.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 1.0 110.618 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.03 -164.16 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.352 -0.842 . . . . 1.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.492 ' HB2' HG23 ' A' ' 2' ' ' ILE . 19.8 m -108.47 -42.85 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 1.0 109.981 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -132.13 132.56 23.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 1.0 110.045 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 143.41 35.49 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.362 1.19 . . . . 1.0 110.441 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -168.71 -54.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 1.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.52 157.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.06 174.4 10.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 1.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.33 -177.41 14.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.597 -1.401 . . . . 1.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.11 151.63 40.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.091 . . . . 1.0 110.107 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.683 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.7 m95 -110.46 147.06 34.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 1.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 ttpp -133.38 119.56 19.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.426 -0.796 . . . . 1.0 109.525 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -63.66 -135.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.395 -0.816 . . . . 1.0 108.816 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -49.8 -24.63 2.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.243 -1.535 . . . . 1.0 109.759 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 153.8 42.6 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -129.82 122.33 20.44 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.434 -1.039 . . . . 1.0 110.097 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.1 88.58 0.95 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.461 1.243 . . . . 1.0 110.386 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 42' ' ' THR . 4.4 pp -72.22 -160.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 1.0 110.691 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.834 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -170.32 -176.82 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.582 -0.699 . . . . 1.0 109.794 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 102.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.0 109.976 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -127.75 177.04 2.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 1.0 110.493 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 48.3 Cg_endo -73.87 -20.7 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.698 1.368 . . . . 1.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -98.18 -39.99 8.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 1.0 110.387 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.673 ' SG ' HD21 ' A' ' 60' ' ' LEU . 1.3 m -88.1 158.34 18.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.22 -0.925 . . . . 1.0 110.275 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -148.14 67.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 1.0 110.247 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.9 tt -85.09 128.67 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -0.793 . . . . 1.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.0 128.9 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 1.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.13 151.24 32.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 1.0 110.367 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -130.6 20.98 5.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 1.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.92 -61.97 3.34 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -12.79 61.88 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.614 -0.933 . . . . 1.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.89 148.5 29.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.978 -1.076 . . . . 1.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.731 ' HB2' HG23 ' A' ' 23' ' ' ILE . 62.4 m-70 -128.02 107.66 10.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 109.967 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.32 148.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 1.0 110.55 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.689 HD23 ' CD2' ' A' ' 21' ' ' PHE . 19.7 tp -133.48 121.79 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.353 -0.842 . . . . 1.0 110.188 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 20' ' ' HIS . 40.6 mt -122.9 126.17 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 1.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.941 HD22 ' CE ' ' A' ' 67' ' ' MET . 0.2 OUTLIER -129.35 103.0 6.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 1.0 110.372 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 79.6 m-70 -70.16 -163.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.25 -0.906 . . . . 1.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 29.2 t-20 -13.53 81.44 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 15' ' ' VAL . 78.5 m -83.15 -159.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.0 109.253 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.802 ' O ' HG11 ' A' ' 86' ' ' VAL . 3.1 mt-30 -142.82 -170.47 3.24 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.204 -0.935 . . . . 1.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.59 9.19 6.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.3 -29.26 10.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 1.0 109.39 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.941 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.29 -23.3 1.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.328 -1.101 . . . . 1.0 111.429 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -46.49 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.148 -0.97 . . . . 1.0 110.621 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.86 -121.29 0.63 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.253 -1.539 . . . . 1.0 109.253 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -155.3 145.74 22.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -1.12 . . . . 1.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.837 HG21 ' CE1' ' A' ' 21' ' ' PHE . 67.8 t -98.11 93.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 1.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' SER . 86.4 p -96.03 101.44 13.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.0 110.441 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 32.1 t80 -73.61 154.24 39.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 1.0 109.557 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 106.52 7.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.063 -1.023 . . . . 1.0 110.688 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -143.58 118.22 9.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 1.0 109.682 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.56 -153.99 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 1.0 109.865 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -10.45 59.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 1.0 110.504 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.991 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -83.62 153.63 24.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.944 -1.098 . . . . 1.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -159.59 145.89 16.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 1.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 76.8 p -125.87 178.1 5.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.8 103.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 1.0 110.204 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.21 -174.59 2.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 1.0 110.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.88 129.6 36.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 1.0 110.004 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 1.1 tt -135.8 145.62 46.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 1.0 110.469 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 136.33 46.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 1.0 109.802 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.802 HG11 ' O ' ' A' ' 64' ' ' GLN . 61.3 t -103.7 151.16 6.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.249 -0.907 . . . . 1.0 110.446 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.66 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 1.0 110.201 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -93.42 145.59 24.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.358 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.105 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.252 0.549 . . . . 1.0 110.201 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.503 HG22 ' OG ' ' A' ' 26' ' ' SER . 25.8 pt -102.15 158.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 110.198 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.68 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 1.0 110.19 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.97 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -86.48 -34.45 20.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -131.01 112.47 15.93 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.13 171.4 11.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.647 1.34 . . . . 1.0 111.455 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.904 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 67.7 mt -59.95 -167.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.562 0.696 . . . . 1.0 110.913 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 10' ' ' GLY . 20.9 t80 -134.4 158.64 43.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 1.0 110.001 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -99.13 133.49 11.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.697 ' O ' HD12 ' A' ' 84' ' ' LEU . 8.6 p -152.81 164.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -1.144 . . . . 1.0 110.256 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' VAL . 4.6 pt-20 -118.69 172.31 7.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.92 . . . . 1.0 110.58 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG23 HG13 ' A' ' 86' ' ' VAL . 13.1 m -155.25 134.69 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 1.0 110.5 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.9 34.68 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 1.0 109.775 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 14.5 t 61.73 73.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.462 -0.773 . . . . 1.0 110.439 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.41 -25.34 1.09 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.866 -1.693 . . . . 1.0 108.866 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 -163.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.35 -1.088 . . . . 1.0 109.531 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 m -144.32 113.03 6.66 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.2 -0.938 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.29 161.8 26.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 1.0 109.638 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -139.29 88.31 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.002 . . . . 1.0 110.691 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.874 ' CD1' HD23 ' A' ' 58' ' ' LEU . 81.0 m-85 -84.03 162.12 20.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 1.0 109.594 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -153.65 162.49 41.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.046 . . . . 1.0 110.678 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 56' ' ' HIS . 4.7 tt -169.23 135.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.448 -0.782 . . . . 1.0 109.921 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.88 136.45 49.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.111 -0.993 . . . . 1.0 110.057 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.1 mt -101.7 -151.19 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.958 . . . . 1.0 109.879 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 2' ' ' ILE . 24.3 p -117.31 -46.72 2.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 1.0 109.989 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.1 140.8 21.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 1.0 110.064 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.17 178.91 6.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.558 1.294 . . . . 1.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 t70 54.59 92.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 1.0 110.732 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.4 p -156.84 154.51 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 1.0 109.874 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 49.1 p-80 -108.74 121.16 44.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 1.0 110.657 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.81 156.18 26.88 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' C ' ' CD1' ' A' ' 34' ' ' TRP . 14.2 mm-40 -124.41 177.81 5.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -1.232 . . . . 1.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.658 ' CB ' HD13 ' A' ' 58' ' ' LEU . 37.4 m95 -136.43 139.04 42.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.451 -0.78 . . . . 1.0 110.682 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 6.7 tttp -157.11 -109.99 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.211 -0.931 . . . . 1.0 109.614 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -157.89 -160.11 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.929 -1.107 . . . . 1.0 109.005 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.833 -1.167 . . . . 1.0 109.632 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.75 -114.19 0.01 OUTLIER Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 2.0 mm-40 -136.33 176.59 2.7 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 107.475 -1.306 . . . . 1.0 107.475 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HD2' ' OE1' ' A' ' 39' ' ' GLN . 50.5 Cg_endo -86.06 116.42 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.678 1.357 . . . . 1.0 110.878 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -95.29 -167.75 1.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.81 -1.181 . . . . 1.0 110.716 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.5 p -116.09 162.33 17.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.0 110.218 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.46 120.46 16.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.91 . . . . 1.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.487 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.4 t -173.29 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 1.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -67.87 -89.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.33 1.174 . . . . 1.0 111.146 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.29 70.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 1.0 110.322 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.83 129.6 11.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 1.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.18 94.76 4.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 1.0 109.878 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.2 89.31 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 1.0 110.664 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.59 ' O ' HG23 ' A' ' 50' ' ' ILE . 8.3 tt -89.17 119.65 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.868 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.68 145.5 47.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.99 . . . . 1.0 110.599 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.29 23.24 14.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 1.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.57 -89.25 1.23 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -49.15 -23.81 1.43 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.878 . . . . 1.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -137.5 157.35 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.983 -1.073 . . . . 1.0 110.237 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.741 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.1 m-70 -118.1 138.06 52.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.532 -0.73 . . . . 1.0 109.486 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -140.33 128.46 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.037 -1.039 . . . . 1.0 110.783 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.874 HD23 ' CD1' ' A' ' 21' ' ' PHE . 9.9 tp -103.99 149.9 24.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 1.0 110.421 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 64.9 mt -140.0 82.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.795 . . . . 1.0 109.372 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 60' ' ' LEU . 5.1 mt -84.19 115.37 22.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 1.0 110.729 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 62' ' ' ASN . 60.8 m-70 -87.74 -165.84 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 1.0 109.624 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 7.5 p-10 -14.27 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 85.2 m -74.86 -155.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.639 -0.663 . . . . 1.0 109.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.723 ' O ' HG11 ' A' ' 86' ' ' VAL . 15.6 mt-30 -159.47 -165.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 1.0 110.613 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.39 39.84 0.8 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 1.0 111.237 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.98 -37.83 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.981 -1.647 . . . . 1.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.463 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 50.3 mtt -63.15 -13.36 36.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.365 -1.079 . . . . 1.0 110.778 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.77 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.297 -0.877 . . . . 1.0 110.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 170.75 -113.57 0.5 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.933 -1.667 . . . . 1.0 108.933 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.81 136.4 24.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.48 -1.012 . . . . 1.0 110.468 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.1 t -79.28 144.07 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 1.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 p -136.42 126.56 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.48 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 59.1 t80 -105.66 147.11 28.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.695 . . . . 1.0 109.131 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -137.91 152.5 49.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 1.0 110.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.46 -149.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 1.0 109.939 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.03 -76.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 1.0 110.24 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -123.73 17.01 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 1.0 110.301 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.76 137.92 42.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 1.0 110.658 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 14.9 ptmt -154.16 101.53 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.515 -0.741 . . . . 1.0 109.637 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.41 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 13.4 m -105.15 -176.04 2.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 1.0 110.535 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -167.08 97.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 1.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.55 -168.07 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 1.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -122.14 143.97 49.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 1.0 110.178 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 11' ' ' VAL . 57.1 tp -150.69 119.75 6.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 1.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -117.33 125.98 51.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 1.0 109.852 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.723 HG11 ' O ' ' A' ' 64' ' ' GLN . 41.5 t -90.77 112.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.347 -0.845 . . . . 1.0 110.058 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.33 144.98 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 1.0 110.381 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.15 -177.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 1.0 110.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 89' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.226 0.536 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 77' ' ' ASN . 44.1 mm -95.37 146.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 1.0 109.756 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 1.1 tp10 -129.85 -5.16 4.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 1.0 111.194 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 47.5 t 56.72 108.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 1.0 110.308 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -78.18 -51.49 10.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.054 -1.029 . . . . 1.0 109.884 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -122.91 108.48 32.66 Favored Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 120.073 -0.651 . . . . 1.0 110.277 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.42 -175.8 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.572 1.301 . . . . 1.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 7.0 mt -71.0 -161.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 1.0 110.67 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 9' ' ' TYR . 30.7 p90 -160.4 133.85 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.7 149.01 33.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 7.3 p -155.39 168.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -1.104 . . . . 1.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 44.8 mt-10 -114.69 158.92 21.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 1.0 110.28 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 14' ' ' PHE . 8.8 p -155.82 171.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 1.0 110.342 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.71 135.56 54.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 1.0 109.446 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 11.7 p -50.8 112.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 1.0 110.572 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 122.22 -48.67 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.825 -1.71 . . . . 1.0 108.825 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -165.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -1.018 . . . . 1.0 109.924 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 60' ' ' LEU . 1.1 p -121.42 148.29 44.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 1.0 110.449 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.2 174.97 6.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 1.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -158.97 110.94 2.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 1.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.816 ' CD1' HD23 ' A' ' 58' ' ' LEU . 96.2 m-85 -116.49 156.59 26.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.56 160.53 41.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.03 . . . . 1.0 110.45 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 23' ' ' ILE . 9.3 tt -170.56 124.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 1.0 109.848 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.535 ' O ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -79.73 132.71 36.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 1.0 110.107 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 24' ' ' GLU . 2.5 mm? -119.97 -177.35 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 1.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 t -132.1 20.53 4.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 1.0 110.122 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.22 156.37 66.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 1.0 110.197 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.72 -20.76 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.683 1.359 . . . . 1.0 110.38 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.62 -132.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 1.0 109.392 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.87 167.27 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.632 -1.293 . . . . 1.0 110.102 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -175.53 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 1.0 110.277 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -97.85 -177.46 33.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.42 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.25 167.77 25.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -1.078 . . . . 1.0 110.092 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.754 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.9 m95 -99.82 167.06 10.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 1.0 110.496 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -171.4 153.43 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 1.0 109.91 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 67' ' ' MET . 4.0 mt -67.22 -131.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.09 -1.006 . . . . 1.0 109.894 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -48.1 -25.36 1.42 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.666 -1.271 . . . . 1.0 110.638 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 154.06 39.3 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.645 -1.382 . . . . 1.0 109.645 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -131.87 117.21 16.08 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.164 -1.198 . . . . 1.0 109.442 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.88 94.07 1.01 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.649 1.342 . . . . 1.0 109.959 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -179.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 42' ' ' THR . 90.7 m -136.56 23.53 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.772 . . . . 1.0 110.094 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.56 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 1.0 110.397 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -174.4 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 1.0 110.91 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 45.0 Cg_endo -70.6 -14.11 33.14 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.304 1.16 . . . . 1.0 111.115 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 47' ' ' CYS . 2.6 p30 -113.05 -24.53 9.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.017 . . . . 1.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.41 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 53.4 t -122.7 128.8 51.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.114 -0.991 . . . . 1.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -118.45 140.04 50.48 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.189 -0.944 . . . . 1.0 109.664 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.562 HG22 ' OE2' ' A' ' 51' ' ' GLU . 97.1 mt -139.61 108.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.486 -0.759 . . . . 1.0 109.801 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 50' ' ' ILE . 8.9 tp -128.02 128.01 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 1.0 110.494 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -154.78 138.66 16.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 1.0 109.894 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -122.54 18.88 10.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 1.0 110.775 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -42.54 2.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.955 -1.258 . . . . 1.0 109.955 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -62.31 -29.69 70.62 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.571 -0.958 . . . . 1.0 110.044 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 146.5 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.33 -0.856 . . . . 1.0 110.283 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' ' HG ' ' A' ' 25' ' ' LEU . 86.0 m-70 -105.72 119.65 39.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 1.0 110.01 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.55 137.55 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.209 -0.932 . . . . 1.0 110.383 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 ' CD1' ' A' ' 21' ' ' PHE . 15.5 tp -120.63 136.98 54.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.393 -0.817 . . . . 1.0 110.186 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.2 mt -141.73 100.7 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 18' ' ' THR . 0.3 OUTLIER -98.25 170.93 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 1.0 110.499 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.4 m-70 -126.52 -168.31 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.421 -0.8 . . . . 1.0 109.665 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 61' ' ' HIS . 15.2 p-10 -14.78 81.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.815 1.042 . . . . 1.0 113.815 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 15' ' ' VAL . 62.7 m -78.63 165.47 23.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.694 -0.629 . . . . 1.0 109.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' VAL . 38.3 tp60 -105.27 167.16 9.91 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.112 -0.992 . . . . 1.0 109.234 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.434 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -66.58 0.51 2.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.95 -1.094 . . . . 1.0 112.5 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.77 -21.42 33.88 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -50.99 -20.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -1.131 . . . . 1.0 111.523 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 m -44.42 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.305 -0.872 . . . . 1.0 110.736 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.78 -119.15 0.49 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.79 130.57 10.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.017 . . . . 1.0 110.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 8' ' ' LEU . 25.4 t -85.33 93.36 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 1.0 109.144 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -101.5 150.76 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.059 . . . . 1.0 110.934 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 64.2 t80 -118.12 138.04 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.517 -0.739 . . . . 1.0 109.692 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 10.3 pt20 -121.35 151.59 39.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 1.0 110.5 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . . . -167.8 -153.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 1.0 110.068 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -67.37 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.973 . . . . 1.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 57.2 t30 -130.25 18.76 5.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 1.0 110.152 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . . . -99.04 149.89 22.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -159.71 74.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 1.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.493 ' OG ' HD11 ' A' ' 8' ' ' LEU . 83.5 p -82.95 168.45 17.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.82 96.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.1 -174.22 3.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 1.0 110.08 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -125.49 107.54 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 1.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD22 ' HZ ' ' A' ' 21' ' ' PHE . 55.7 tp -108.42 138.89 43.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 1.0 110.567 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -131.11 140.45 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.815 . . . . 1.0 109.945 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 67' ' ' MET . 97.6 t -97.41 116.33 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.912 . . . . 1.0 110.195 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -93.85 130.67 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 110.491 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -68.23 179.03 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 1.0 110.039 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.232 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.267 0.556 . . . . 1.0 110.345 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 27' ' ' GLU . 6.1 pt -88.26 -170.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 1.0 110.272 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -135.95 -165.58 1.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.0 110.231 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.634 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 99.4 t -126.14 125.5 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 1.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -86.79 -48.0 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 1.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -117.79 107.27 44.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.65 -0.656 . . . . 1.0 109.886 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.76 176.83 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.679 1.357 . . . . 1.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.742 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 80.9 mt -60.16 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 1.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 88.4 t80 -152.36 163.31 39.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 1.0 109.549 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -87.45 145.92 19.86 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.842 -1.303 . . . . 1.0 109.842 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG22 ' N ' ' A' ' 12' ' ' GLU . 8.2 p -153.8 164.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.0 110.241 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 11' ' ' VAL . 36.9 mt-10 -121.26 163.48 18.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 1.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.2 p -155.65 132.61 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 1.0 109.931 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CA ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -87.32 76.08 9.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 1.0 110.959 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 32.8 t 59.36 97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.841 0.829 . . . . 1.0 112.049 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' ' N ' ' A' ' 63' ' ' CYS . . . 46.12 23.34 1.12 Allowed Glycine 0 N--CA 1.495 2.592 0 O-C-N 121.943 -0.473 . . . . 1.0 113.217 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HG3' ' CA ' ' A' ' 14' ' ' PHE . 1.8 mm-40 -62.49 -75.17 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.714 1.757 . . . . 1.0 107.653 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.701 HG23 ' CE1' ' A' ' 61' ' ' HIS . 63.3 m -162.02 151.38 15.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.783 -0.573 . . . . 1.0 109.672 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 60' ' ' LEU . . . -117.31 163.11 16.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 1.0 109.624 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -155.89 81.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.934 -1.104 . . . . 1.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -102.36 115.49 30.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -0.901 . . . . 1.0 109.591 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -112.16 157.34 20.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 1.0 111.111 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 23' ' ' ILE . 12.1 tt -167.09 120.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 1.0 109.488 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 2.7 tt0 -87.16 129.81 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 1.0 110.727 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -96.74 -171.99 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.814 . . . . 1.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -105.45 -83.82 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 1.0 110.398 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' HG21 ' A' ' 2' ' ' ILE . 55.6 mt-10 -90.78 121.89 67.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.0 110.216 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.26 111.87 3.39 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.41 1.216 . . . . 1.0 110.078 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.91 -64.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 1.0 110.444 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.44 157.6 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 1.0 110.335 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -107.58 -175.56 2.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 1.0 109.91 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.97 -159.33 9.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.471 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -156.8 171.05 21.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -1.081 . . . . 1.0 109.882 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.874 ' CD2' HD12 ' A' ' 58' ' ' LEU . 56.2 m95 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.038 -1.039 . . . . 1.0 110.648 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' CD ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -157.23 126.08 5.81 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.37 -133.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 1.0 108.873 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -24.76 6.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.328 -1.483 . . . . 1.0 109.355 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 162.64 40.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -115.72 101.74 54.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.265 -1.138 . . . . 1.0 110.299 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.73 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.889 1.468 . . . . 1.0 110.324 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 42' ' ' THR . 0.2 OUTLIER -78.82 -164.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 1.0 110.677 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -162.08 172.12 16.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 1.0 110.225 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.0 125.38 34.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 1.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -174.88 -59.93 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 1.0 110.343 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -71.13 -87.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.447 1.235 . . . . 1.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -142.15 52.88 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.877 -1.139 . . . . 1.0 110.487 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.04 138.07 31.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.202 -0.936 . . . . 1.0 110.167 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 4.2 tt0 -123.65 53.49 1.36 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.105 -0.997 . . . . 1.0 110.002 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.8 114.98 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.87 -1.144 . . . . 1.0 109.908 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.0 99.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 1.0 110.238 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 18.8 pt-20 -124.85 141.87 51.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.95 . . . . 1.0 110.277 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.85 14.48 2.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.12 -30.3 6.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.388 -1.085 . . . . 1.0 110.388 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -90.9 -16.24 28.49 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.309 -1.113 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.88 114.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.161 -0.962 . . . . 1.0 110.383 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.626 ' CD2' ' HB2' ' A' ' 51' ' ' GLU . 52.8 m80 -95.1 111.63 23.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.843 . . . . 1.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 22' ' ' GLU . 28.7 mm -120.7 147.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 1.0 110.07 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.874 HD12 ' CD2' ' A' ' 34' ' ' TRP . 4.5 tt -123.9 130.51 52.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 1.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.786 ' N ' HD23 ' A' ' 58' ' ' LEU . 25.1 mt -133.46 103.1 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.659 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -125.43 127.34 46.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.006 -1.059 . . . . 1.0 111.722 -178.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.701 ' CE1' HG23 ' A' ' 18' ' ' THR . 12.8 m-70 -103.7 28.1 6.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.846 0.832 . . . . 1.0 108.82 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.624 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 m-20 -108.53 -4.58 17.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.596 -0.69 . . . . 1.0 111.319 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 76.8 m -43.04 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.274 -0.891 . . . . 1.0 111.395 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.66 ' C ' HG11 ' A' ' 86' ' ' VAL . 18.8 mt-30 -161.24 -166.78 1.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 1.0 110.213 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -3.44 18.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 1.0 111.152 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.85 -36.25 5.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.797 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -48.57 -23.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 1.0 111.548 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 p -46.34 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.933 . . . . 1.0 110.762 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -175.21 -125.67 0.88 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -139.76 142.94 36.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 1.0 110.513 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 55.2 t -94.51 105.2 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.634 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -107.77 108.09 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 1.0 110.625 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 24.4 t80 -81.07 145.01 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 1.0 109.586 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -121.2 111.01 16.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 1.0 110.593 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -147.26 109.57 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.528 -0.732 . . . . 1.0 109.502 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 57.93 -162.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 1.0 109.596 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -62.85 -19.49 64.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.0 110.163 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -72.7 145.36 47.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 1.0 110.398 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -153.57 133.37 13.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 1.0 110.094 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.562 ' OG ' HD11 ' A' ' 8' ' ' LEU . 69.8 p -112.16 178.35 4.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.947 . . . . 1.0 110.171 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.14 79.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 1.0 110.511 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -82.64 -178.74 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.985 . . . . 1.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -114.09 136.74 52.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 1.0 110.25 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 25.7 tp -136.55 134.25 37.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -131.92 125.88 32.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 1.0 109.744 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 67' ' ' MET . 51.4 t -90.92 112.29 24.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.304 -0.872 . . . . 1.0 109.949 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -75.75 172.38 12.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 1.0 110.519 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -86.73 176.47 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 1.0 110.226 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.108 179.8 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.611 HD13 HG11 ' A' ' 30' ' ' VAL . 20.7 pt -143.46 150.67 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.69 -172.66 2.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 1.0 110.301 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.0 111.53 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.27 -38.98 19.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.449 -0.945 . . . . 1.0 108.449 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -122.5 106.44 35.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.66 173.46 9.94 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.617 1.325 . . . . 1.0 111.032 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.825 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 12.8 mt -73.77 -160.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.515 -0.741 . . . . 1.0 109.981 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -148.66 114.05 5.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0 109.835 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 83' ' ' ASN . . . -64.4 132.3 38.55 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.6 p -154.14 161.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -1.179 . . . . 1.0 110.586 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' VAL . 2.4 pt-20 -107.49 169.63 8.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.0 109.96 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.35 172.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 1.0 110.49 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -111.68 137.46 49.54 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.461 -0.774 . . . . 1.0 108.948 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 63' ' ' CYS . 93.2 t -46.11 111.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.415 -0.803 . . . . 1.0 111.403 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 127.24 -47.33 1.03 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.37 -1.076 . . . . 1.0 109.965 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -130.17 139.93 50.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 110.569 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.16 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 1.0 109.744 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -130.64 100.68 5.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 1.0 110.755 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 51.8 m-85 -104.41 154.38 19.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 1.0 109.743 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 8' ' ' LEU . 44.3 mt-10 -140.92 157.61 45.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.002 -1.061 . . . . 1.0 110.611 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -169.48 139.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.446 -0.784 . . . . 1.0 110.154 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.13 132.27 54.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.334 -0.854 . . . . 1.0 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 2' ' ' ILE . 18.4 mt -94.37 -152.57 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 1.0 110.097 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -109.16 -37.77 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -0.834 . . . . 1.0 110.149 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.07 148.28 59.77 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 1.0 110.171 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.6 Cg_endo -74.62 -167.9 0.45 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.677 1.357 . . . . 1.0 110.797 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.53 46.49 22.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 1.0 110.364 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 28' ' ' PRO . 58.9 t -137.58 102.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 1.0 110.349 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -91.99 137.55 32.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.268 -0.895 . . . . 1.0 110.18 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.57 172.98 21.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -122.38 163.55 19.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 1.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.1 m95 -114.05 149.16 35.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 1.0 110.293 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 1.1 ttpt -139.47 131.33 27.63 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.318 -0.864 . . . . 1.0 109.939 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.7 mt -61.46 -112.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.142 -0.974 . . . . 1.0 109.304 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -85.97 12.62 8.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.448 -1.408 . . . . 1.0 110.264 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 131.19 -1.77 5.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -97.57 112.09 60.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.91 -1.347 . . . . 1.0 109.96 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.3 109.04 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.525 1.276 . . . . 1.0 110.543 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 169.42 17.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.288 -0.882 . . . . 1.0 110.534 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -143.52 24.13 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 1.0 109.742 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.02 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.832 . . . . 1.0 110.753 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.58 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 1.0 109.74 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.6 Cg_endo -70.54 -19.3 32.59 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.584 1.307 . . . . 1.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.89 -58.75 1.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.948 . . . . 1.0 109.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.26 152.13 44.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 1.0 109.95 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 3.1 mm-40 -133.57 86.51 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 1.0 110.409 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.68 128.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 1.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.05 122.47 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 1.0 110.591 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -142.55 162.25 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.0 109.72 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.55 16.76 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.02 -1.05 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.38 -29.86 7.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.984 -1.246 . . . . 1.0 109.984 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -74.12 -28.39 61.32 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.308 -1.113 . . . . 1.0 109.767 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.19 -173.66 1.32 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.376 -0.827 . . . . 1.0 110.063 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.659 ' HB2' HG23 ' A' ' 23' ' ' ILE . 81.1 m-70 -139.41 118.27 12.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.91 130.47 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 1.0 110.167 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.981 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.0 tt -105.88 136.34 45.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.833 . . . . 1.0 110.349 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.792 ' N ' HD23 ' A' ' 58' ' ' LEU . 69.8 mt -134.2 73.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 1.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 18' ' ' THR . 2.0 mt -72.06 151.12 43.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 1.0 110.533 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.537 ' HA ' HG22 ' A' ' 18' ' ' THR . 56.9 m-70 -113.99 -172.42 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.0 109.6 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 63.4 t-20 -14.52 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 61' ' ' HIS . 99.8 m -78.4 172.71 13.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.609 -0.682 . . . . 1.0 109.291 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' O ' HG21 ' A' ' 86' ' ' VAL . 49.4 tp60 -115.0 167.28 10.94 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.023 -1.048 . . . . 1.0 109.128 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 14.0 tp -63.86 -5.96 5.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.033 -1.042 . . . . 1.0 112.308 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.66 -12.53 82.76 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 120.674 -1.266 . . . . 1.0 110.445 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.521 ' HB2' HG21 ' A' ' 86' ' ' VAL . 23.1 mtt -86.06 41.95 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.374 . . . . 1.0 110.93 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -90.83 45.02 1.22 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 1.0 110.004 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.1 -125.32 3.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 8.6 pt-20 -144.59 151.89 39.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -1.057 . . . . 1.0 110.336 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 73.2 t -90.33 90.48 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 1.0 109.964 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 p -94.52 99.94 12.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.836 . . . . 1.0 110.287 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -73.28 167.86 20.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.968 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.99 107.31 1.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 1.0 110.258 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -139.74 122.92 16.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 1.0 109.99 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 2' ' ' ILE . . . 54.89 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 1.0 110.387 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' ALA . 24.3 t30 -128.54 -31.04 2.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.047 -1.033 . . . . 1.0 110.589 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.47 127.68 33.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 1.0 110.511 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 124.03 15.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 1.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.411 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.9 m -112.62 -174.22 2.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 1.0 110.486 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.05 102.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 1.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -99.98 -172.67 2.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.905 . . . . 1.0 109.903 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 19.6 t-20 -114.51 137.23 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.108 -0.995 . . . . 1.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -140.63 124.02 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 1.0 110.607 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -126.54 133.71 51.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 1.0 109.52 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 64' ' ' GLN . 43.4 t -91.79 149.83 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.14 -0.975 . . . . 1.0 110.377 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.66 104.78 4.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 1.0 110.029 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.45 -156.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 1.0 110.461 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.932 -1.032 . . . . 1.0 110.081 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.356 0.598 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.716 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.4 mm -112.87 137.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.312 -0.868 . . . . 1.0 110.485 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -171.36 2.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.348 -0.845 . . . . 1.0 110.063 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.5 t -119.13 119.38 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 1.0 110.1 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -82.64 -49.64 9.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.208 -0.932 . . . . 1.0 109.626 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 5.5 mmtt -119.14 107.91 41.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 1.0 109.913 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.41 -175.86 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.491 1.258 . . . . 1.0 110.482 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 6.6 mt -79.2 -172.65 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 1.0 110.494 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.35 136.48 33.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 1.0 110.125 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.89 149.91 36.84 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -160.11 154.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.161 . . . . 1.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.05 162.4 17.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 1.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.7 p -160.35 137.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 1.0 109.818 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.32 55.65 3.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.379 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 63' ' ' CYS . 5.9 p 36.55 76.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 CA-C-O 121.776 0.798 . . . . 1.0 111.95 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 158.13 -30.43 0.48 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.764 -1.735 . . . . 1.0 108.764 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.3 mt-10 -75.8 -161.94 0.19 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -1.027 . . . . 1.0 109.699 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 20.7 m -126.07 112.73 16.2 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.323 -0.951 . . . . 1.0 110.743 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.32 33.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 1.0 109.36 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -126.63 119.35 26.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.945 -1.097 . . . . 1.0 110.744 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.709 ' CD2' HD23 ' A' ' 58' ' ' LEU . 82.9 m-85 -117.21 123.48 46.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -0.883 . . . . 1.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.58 153.15 25.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.017 . . . . 1.0 110.167 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.587 HD13 ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -166.83 120.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 1.0 109.495 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -107.38 148.34 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 1.0 110.403 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 56' ' ' HIS . 42.9 mt -106.56 -150.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 1.0 109.854 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.716 ' HB2' HG23 ' A' ' 2' ' ' ILE . 68.7 m -116.09 -40.96 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 1.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.13 135.95 12.97 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 1.0 110.179 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.57 153.96 49.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.481 1.253 . . . . 1.0 110.391 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.75 -64.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.0 110.301 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.38 -164.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 1.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -115.21 143.79 44.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 1.0 110.132 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.38 -166.22 22.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.45 -1.46 . . . . 1.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.64 154.35 36.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -1.182 . . . . 1.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.898 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.8 m95 -102.01 147.35 26.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -141.84 132.49 25.52 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.359 -0.838 . . . . 1.0 109.328 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.466 HD21 ' SD ' ' A' ' 67' ' ' MET . 5.5 mt -64.7 -136.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.062 -1.023 . . . . 1.0 109.004 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -25.11 7.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.443 -1.41 . . . . 1.0 109.315 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.35 42.73 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.82 33.03 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.372 -1.076 . . . . 1.0 109.765 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.79 85.24 1.35 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.721 1.38 . . . . 1.0 110.197 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -69.36 -172.97 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.243 -0.911 . . . . 1.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.4 p -136.39 -170.65 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.93 109.64 14.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 110.149 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 1.2 m -120.29 166.39 15.39 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 1.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 46.7 Cg_endo -72.6 -23.16 20.1 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.599 1.315 . . . . 1.0 110.486 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.39 -25.6 23.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 1.0 110.218 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.35 127.22 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.914 . . . . 1.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.18 147.46 44.18 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 1.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.9 mt -140.33 95.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 1.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -99.54 98.68 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 1.0 109.726 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.27 162.82 25.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 1.0 110.599 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.1 23.62 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 1.0 109.96 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 -86.24 1.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -50.08 -23.77 2.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.75 -0.853 . . . . 1.0 110.747 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -134.74 160.48 38.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 1.0 110.655 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.591 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.0 m-70 -143.34 105.42 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -104.83 144.49 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 1.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.898 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -128.87 136.18 50.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.0 110.272 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.58 93.9 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 1.0 109.8 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.56 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -103.09 103.89 14.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 1.0 110.531 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' C ' ' A' ' 62' ' ' ASN . 67.1 m-70 -69.44 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 1.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 61' ' ' HIS . 3.1 m120 -12.18 79.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 113.85 1.056 . . . . 1.0 113.85 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.813 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.7 m -71.63 145.44 48.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.781 . . . . 1.0 109.092 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.796 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -99.18 172.92 7.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 1.0 110.902 -179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -4.63 22.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.639 -0.663 . . . . 1.0 111.136 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.73 -11.91 76.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.793 -1.194 . . . . 1.0 110.336 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 86' ' ' VAL . 9.0 mtt -85.95 43.26 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.905 -1.35 . . . . 1.0 110.615 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 40.73 1.04 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 1.0 109.75 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.9 2.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.886 -1.285 . . . . 1.0 109.886 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.44 152.17 44.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.403 -1.057 . . . . 1.0 110.539 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 83.6 t -92.99 87.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 1.0 109.475 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.0 p -94.52 112.23 23.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 1.0 110.894 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 46.8 t80 -91.26 137.97 31.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 1.0 109.398 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -120.13 138.26 53.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 1.0 111.087 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -155.56 47.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.72 . . . . 1.0 109.356 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 62.22 132.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.782 . . . . 1.0 110.425 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 45.23 24.07 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 1.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.21 139.03 16.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.025 . . . . 1.0 109.972 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -155.96 68.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 1.0 110.8 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 8' ' ' LEU . 71.1 p -54.65 171.88 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.981 -1.074 . . . . 1.0 109.554 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.88 104.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.035 -1.04 . . . . 1.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -98.57 -167.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 1.0 109.828 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -128.19 137.45 52.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 1.0 109.787 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 84' ' ' LEU . 1.9 tm? -139.27 116.31 10.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.043 -1.036 . . . . 1.0 111.146 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.486 ' N ' HD13 ' A' ' 84' ' ' LEU . 11.7 mttt -111.12 132.82 53.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.416 -0.803 . . . . 1.0 109.39 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 64' ' ' GLN . 28.0 t -103.9 111.09 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.228 -0.92 . . . . 1.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -99.58 129.9 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.72 -176.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 1.0 110.374 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.321 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.279 0.561 . . . . 1.0 110.12 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 26' ' ' SER . 37.6 mm -101.93 140.31 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.128 -0.983 . . . . 1.0 110.073 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.3 mt-10 -123.84 -178.6 4.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 1.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.917 HG23 ' HB1' ' A' ' 78' ' ' ALA . 74.2 t -105.4 115.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.804 . . . . 1.0 109.93 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -75.95 -39.76 55.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 5.6 mptt -124.95 106.92 28.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.65 176.57 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.565 1.297 . . . . 1.0 110.705 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 4.1 mt -72.05 172.22 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 1.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 20.6 m-85 -129.25 3.71 5.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.137 -0.977 . . . . 1.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.702 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 70.43 153.52 1.04 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 11' ' ' VAL . 7.1 p -156.95 134.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.114 . . . . 1.0 110.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -109.07 150.64 27.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.0 110.068 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 14' ' ' PHE . 1.1 p -160.55 -158.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.454 -0.779 . . . . 1.0 109.782 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.635 ' N ' HG13 ' A' ' 13' ' ' VAL . 5.8 m-85 -107.33 -154.51 0.53 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 63' ' ' CYS . 81.6 t -120.16 121.76 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.85 -1.156 . . . . 1.0 110.763 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.34 -48.95 0.94 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -65.14 -147.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -1.109 . . . . 1.0 110.617 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CG ' ' A' ' 61' ' ' HIS . 4.6 p -128.81 161.06 30.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 110.996 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -105.68 170.13 8.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.69 . . . . 1.0 109.477 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 93.38 2.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.013 . . . . 1.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 81.9 m-85 -94.67 162.63 13.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.51 -0.744 . . . . 1.0 109.552 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 8' ' ' LEU . 4.2 mp0 -140.67 153.98 46.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.945 -1.097 . . . . 1.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' OG ' ' A' ' 80' ' ' SER . 3.6 tt -170.55 138.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.598 -0.689 . . . . 1.0 109.814 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' C ' HD12 ' A' ' 25' ' ' LEU . 30.1 tt0 -96.43 170.41 9.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 1.0 110.559 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.934 HD13 ' CD2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -159.17 175.03 13.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.522 -0.736 . . . . 1.0 109.889 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 2' ' ' ILE . 9.7 m -93.31 -44.16 8.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.083 -1.011 . . . . 1.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.82 150.79 53.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.95 . . . . 1.0 110.132 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.85 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.732 1.386 . . . . 1.0 110.652 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.65 76.65 9.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 1.0 110.218 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.456 HG11 HD22 ' A' ' 25' ' ' LEU . 7.4 p -95.17 143.73 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.29 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 31' ' ' HIS . 25.9 p80 -76.32 117.79 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.875 . . . . 1.0 110.231 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.92 -166.14 10.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.346 -1.502 . . . . 1.0 109.346 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.71 128.03 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -1.2 . . . . 1.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.758 ' CE3' HD22 ' A' ' 58' ' ' LEU . 28.2 m95 -94.7 154.66 17.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 1.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 4.4 ptmt -152.07 156.08 39.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 1.0 109.968 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.504 HD21 ' HE3' ' A' ' 67' ' ' MET . 5.4 mt -65.16 -133.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.903 . . . . 1.0 109.354 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -52.15 -23.31 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.474 -1.391 . . . . 1.0 110.126 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 159.52 39.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.385 -1.486 . . . . 1.0 109.385 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -119.33 109.15 39.04 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.235 -1.156 . . . . 1.0 109.607 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.21 111.56 3.34 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.586 1.308 . . . . 1.0 110.037 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 42' ' ' THR . 1.0 OUTLIER -114.84 -144.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 1.0 110.153 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 41' ' ' LEU . 4.2 m -143.96 150.9 39.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.986 -1.071 . . . . 1.0 110.319 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 49' ' ' ILE . . . -83.84 113.31 20.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 1.0 110.136 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -177.91 -59.71 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 1.0 110.372 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -69.73 -69.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.493 1.26 . . . . 1.0 111.305 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -132.68 64.24 1.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.935 -1.103 . . . . 1.0 110.494 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.43 ' HA ' HD23 ' A' ' 60' ' ' LEU . 8.9 t -169.05 139.93 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 1.0 110.348 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -135.5 85.52 2.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 1.0 110.21 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 43' ' ' ALA . 28.6 mt -80.3 130.2 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 1.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 59' ' ' ILE . 7.4 tt -142.97 102.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 1.0 109.848 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.57 159.27 19.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 1.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -113.44 20.84 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.395 -0.816 . . . . 1.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.84 -101.58 2.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.834 -1.307 . . . . 1.0 109.834 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -50.75 -21.76 1.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.417 -1.049 . . . . 1.0 110.673 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 1.5 mmtt -134.11 173.78 11.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 1.0 110.493 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.934 ' CD2' HD13 ' A' ' 25' ' ' LEU . 19.5 m-70 -126.34 135.95 52.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.0 109.736 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.3 mt -137.16 127.89 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.0 110.882 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.758 HD22 ' CE3' ' A' ' 34' ' ' TRP . 32.6 tp -103.25 149.12 25.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.0 109.963 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 HG21 ' A' ' 50' ' ' ILE . 55.1 mt -145.2 82.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.149 -0.969 . . . . 1.0 109.523 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HE1' ' A' ' 67' ' ' MET . 1.2 mt -76.83 -179.82 5.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 1.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' C ' ' A' ' 62' ' ' ASN . 65.8 m-70 -137.5 -162.4 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.57 -0.706 . . . . 1.0 109.103 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 61' ' ' HIS . 1.7 t-20 -14.25 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 113.415 0.895 . . . . 1.0 113.415 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.899 ' O ' HG13 ' A' ' 15' ' ' VAL . 73.5 m -71.03 163.49 27.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.682 -0.636 . . . . 1.0 110.142 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 39.3 tp60 -121.51 168.68 11.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.428 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 8.3 tp -76.52 17.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.849 -1.157 . . . . 1.0 112.124 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 -25.54 6.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.026 -1.63 . . . . 1.0 109.026 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.614 ' HE1' HD13 ' A' ' 60' ' ' LEU . 54.1 mtp -54.59 -18.58 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -1.116 . . . . 1.0 110.722 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -42.22 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.634 -0.666 . . . . 1.0 110.95 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -176.81 -116.74 0.48 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.336 -1.506 . . . . 1.0 109.336 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.72 130.39 10.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 27.6 t -79.1 100.4 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 1.0 109.168 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -99.34 116.55 31.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.0 110.947 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 31.5 t80 -87.54 146.4 25.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 1.0 108.959 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 105.3 8.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.959 -1.088 . . . . 1.0 111.055 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -139.45 121.48 15.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.595 -0.691 . . . . 1.0 109.369 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.32 -153.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 1.0 109.738 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -72.02 -10.51 59.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 110.719 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB2' ' HA ' ' A' ' 3' ' ' GLU . . . -80.13 155.5 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.042 . . . . 1.0 110.525 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -159.9 95.51 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 110.013 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 23' ' ' ILE . 36.8 m -85.51 167.54 15.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 1.0 110.293 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.415 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.89 106.22 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 1.0 110.894 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.841 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.42 -161.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.989 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -115.66 148.56 39.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.955 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.66 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 55.3 tp -140.82 132.44 27.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 1.0 110.518 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -132.6 131.2 41.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 1.0 109.825 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.607 ' CG1' HG22 ' A' ' 15' ' ' VAL . 61.1 t -108.44 151.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.309 -0.87 . . . . 1.0 110.124 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.3 mttt -148.34 144.8 27.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 1.0 110.382 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -73.51 146.16 45.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 1.0 110.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.233 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.239 0.543 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.97 118.17 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 1.0 110.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.68 179.0 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.936 . . . . 1.0 110.355 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 78' ' ' ALA . 61.9 t -88.58 106.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 1.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.87 -36.86 84.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.273 -0.892 . . . . 1.0 109.281 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 106.31 27.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.421 -0.799 . . . . 1.0 109.804 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.79 172.82 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.587 1.309 . . . . 1.0 110.864 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.6 mt -82.05 177.73 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.765 . . . . 1.0 109.56 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -136.25 6.65 3.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.941 -1.099 . . . . 1.0 111.483 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 62.41 144.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 1.0 109.997 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 5.8 m -141.36 -175.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -1.165 . . . . 1.0 110.14 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.43 158.16 45.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.194 -0.941 . . . . 1.0 110.322 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.473 HG23 ' CB ' ' A' ' 17' ' ' GLU . 2.9 p -153.87 134.37 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.348 -0.845 . . . . 1.0 109.837 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -92.09 55.19 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 1.0 110.546 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t 48.44 89.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.87 . . . . 1.0 110.808 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.44 -33.99 3.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.044 -1.622 . . . . 1.0 109.044 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.2 mt-10 -67.34 -162.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.351 -1.088 . . . . 1.0 109.552 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 m -135.64 119.59 17.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.135 -0.978 . . . . 1.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.97 165.25 23.67 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.348 -0.845 . . . . 1.0 109.077 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -147.13 115.57 6.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.923 -1.111 . . . . 1.0 110.883 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -113.82 130.8 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.0 109.758 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . 24.4 mp0 -115.06 151.61 33.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 1.0 110.649 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 56' ' ' HIS . 13.1 tt -170.87 154.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.447 -0.783 . . . . 1.0 109.73 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.488 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -151.3 160.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 1.0 110.311 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 25' ' ' LEU . 2.4 mm? -112.98 -168.76 1.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 1.0 109.898 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -99.55 -45.32 5.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 1.0 110.129 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.28 153.97 38.05 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 1.0 110.117 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.683 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.3 Cg_endo -78.35 -166.02 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.717 1.377 . . . . 1.0 110.485 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.82 54.68 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 1.0 110.398 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' PRO . 60.7 t -134.04 117.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 1.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -98.75 144.7 27.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 1.0 110.025 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -151.13 171.89 30.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.763 -1.335 . . . . 1.0 109.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -139.08 179.22 6.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.384 -1.068 . . . . 1.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 1.018 ' CE3' HD12 ' A' ' 58' ' ' LEU . 59.8 m95 -123.69 133.41 53.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 1.0 110.701 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -129.08 111.47 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.786 . . . . 1.0 110.711 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.806 HD12 HD22 ' A' ' 41' ' ' LEU . 6.6 mt -57.44 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 1.0 108.725 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -92.27 9.05 35.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 1.0 109.497 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 127.79 -1.23 6.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.09 -1.204 . . . . 1.0 110.09 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.6 mm-40 -96.7 137.61 21.42 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.251 . . . . 1.0 109.913 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.97 106.05 2.18 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.613 1.323 . . . . 1.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.806 HD22 HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -108.02 3.37 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 110.573 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 m -70.55 -35.48 73.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.07 . . . . 1.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.74 44.59 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 1.0 110.548 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -115.82 158.96 40.83 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.346 -0.847 . . . . 1.0 110.231 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.53 -12.87 27.34 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.759 1.4 . . . . 1.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.54 -17.81 15.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.0 110.518 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.4 131.84 35.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 1.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -133.15 77.41 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 1.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 58' ' ' LEU . 1.1 pp -96.83 105.32 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 1.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.8 111.54 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 1.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -132.83 161.46 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 1.0 110.094 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.27 33.23 5.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 1.0 110.183 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 56' ' ' HIS . . . 86.38 -91.11 1.7 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -48.24 -24.31 1.14 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.648 -0.913 . . . . 1.0 110.769 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -124.16 165.76 17.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 1.0 110.175 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 23' ' ' ILE . 94.1 m-70 -148.52 114.07 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 55' ' ' LYS . 55.3 mt -116.4 136.11 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 1.0 110.291 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.018 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -115.57 133.94 55.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.26 -0.9 . . . . 1.0 110.295 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.81 ' N ' HD23 ' A' ' 58' ' ' LEU . 5.6 mt -138.26 83.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 1.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 41' ' ' LEU . 4.6 mt -86.69 116.01 24.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 1.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 62' ' ' ASN . 86.9 m-70 -79.06 -169.65 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 1.0 110.452 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 61' ' ' HIS . 20.4 p-10 -14.95 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.0 m -71.11 178.53 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.69 . . . . 1.0 109.482 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.586 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.4 tp60 -111.28 158.82 18.55 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.092 -1.005 . . . . 1.0 109.102 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.1 mp -46.89 -25.29 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.0 111.074 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.72 -119.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.787 ' HB2' HG21 ' A' ' 86' ' ' VAL . 3.3 mtt 42.13 30.73 0.2 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.715 -0.874 . . . . 1.0 111.487 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.21 53.0 2.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 1.0 110.098 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.39 -126.46 2.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.57 154.07 36.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 1.0 110.374 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.907 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 74.5 t -89.28 86.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.328 -0.858 . . . . 1.0 110.031 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' SER . 97.2 p -94.25 109.62 21.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 1.0 110.231 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CZ ' ' HA3' ' A' ' 32' ' ' GLY . 42.5 t80 -78.54 157.44 28.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 1.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -146.1 146.0 30.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 1.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -169.45 -146.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 1.0 110.113 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.8 -69.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 1.0 110.634 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -142.98 33.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 1.0 110.249 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -121.81 120.43 34.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 1.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.18 88.45 2.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 1.0 110.237 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 23' ' ' ILE . 25.7 m -82.36 174.73 10.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.994 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.65 97.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 1.0 110.381 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.41 -163.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.0 109.995 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 129.04 53.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 1.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -127.57 126.52 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.0 110.299 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 137.82 46.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 1.0 109.902 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.787 HG21 ' HB2' ' A' ' 67' ' ' MET . 42.5 t -100.21 108.22 22.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 1.0 110.133 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -86.6 107.54 18.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 1.0 110.219 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.702 ' C ' HD13 ' A' ' 89' ' ' LEU . 1.2 pp20? -62.27 -152.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 1.0 110.281 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.821 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.97 -1.014 . . . . 1.0 110.653 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.169 0.509 . . . . 1.0 110.281 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 25' ' ' LEU . 69.5 mt -131.53 151.13 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 1.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -91.63 9.54 31.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 1.0 111.155 -179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.681 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t 62.06 145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.41 -0.806 . . . . 1.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.79 -41.2 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 1.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -116.79 107.88 45.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.609 -0.682 . . . . 1.0 109.899 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.07 176.65 6.72 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 1.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 12.4 mt -70.25 171.23 10.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.417 -0.802 . . . . 1.0 110.49 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.5 m-85 -129.72 169.23 15.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 1.0 110.074 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 155.52 31.9 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.202 -1.159 . . . . 1.0 110.202 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -159.55 155.23 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 1.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.1 157.11 30.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.983 . . . . 1.0 110.784 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 17' ' ' GLU . 6.8 p -157.87 142.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 1.0 110.078 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -97.41 46.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 1.0 110.472 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 63' ' ' CYS . 11.3 t 61.42 142.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 1.0 110.175 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 87.8 -56.21 4.39 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' CB ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -53.51 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -1.162 . . . . 1.0 109.926 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -115.17 150.33 36.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 1.0 110.367 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' CE2' ' A' ' 21' ' ' PHE . . . -95.1 168.94 10.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 1.0 109.654 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -147.58 97.04 2.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 1.0 110.78 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.97 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 90.8 m-85 -106.07 115.94 31.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 1.0 109.535 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -107.49 151.71 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.042 . . . . 1.0 110.985 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 23' ' ' ILE . 1.4 tt -159.29 123.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -0.767 . . . . 1.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.5 tt0 -87.3 142.05 28.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 1.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.761 ' O ' HD13 ' A' ' 2' ' ' ILE . 4.2 mm? -112.21 19.6 17.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 1.0 110.412 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.81 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.663 -0.648 . . . . 1.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.67 138.73 27.98 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.302 -0.874 . . . . 1.0 110.068 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.62 109.75 2.97 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.584 1.307 . . . . 1.0 110.452 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -174.71 -45.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 1.0 110.346 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG23 HD12 ' A' ' 2' ' ' ILE . 94.3 t -53.27 163.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 1.0 110.48 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.45 ' N ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -178.11 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 1.0 110.104 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -119.94 -132.42 4.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.433 ' CG ' ' HB2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.89 179.17 7.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -1.11 . . . . 1.0 110.378 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.713 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.5 m95 -127.25 148.44 50.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.103 -0.998 . . . . 1.0 111.622 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.74 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -154.35 -114.78 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.389 -0.82 . . . . 1.0 109.128 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.74 HD12 ' C ' ' A' ' 35' ' ' LYS . 2.7 mp -157.15 -158.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.925 -1.109 . . . . 1.0 108.775 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -22.44 8.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.777 -1.202 . . . . 1.0 109.425 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.09 -113.83 0.01 OUTLIER Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 1.3 mt-30 -134.72 178.43 1.77 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HB2' ' CG ' ' A' ' 33' ' ' GLN . 50.6 Cg_endo -89.29 113.07 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.443 1.233 . . . . 1.0 111.281 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -98.04 -168.27 1.64 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.672 -1.268 . . . . 1.0 110.211 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.6 t -113.24 161.91 16.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 1.0 110.086 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.02 123.32 20.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.263 -0.898 . . . . 1.0 109.491 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -175.8 -59.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 1.0 110.96 -179.543 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 40.2 Cg_endo -67.72 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.412 1.217 . . . . 1.0 111.296 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.11 69.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.14 . . . . 1.0 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 136.88 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 1.0 110.394 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.43 78.61 1.68 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 1.0 109.732 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.89 136.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 1.0 110.233 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 49' ' ' ILE . 1.1 pt -135.32 106.95 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.442 -0.786 . . . . 1.0 109.955 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.7 141.21 34.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 1.0 110.352 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.69 17.9 14.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 1.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 -26.61 16.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.79 -27.03 40.39 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.449 -1.03 . . . . 1.0 109.582 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.01 122.89 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.542 -0.724 . . . . 1.0 109.701 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -86.54 103.69 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 1.0 109.995 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.75 137.6 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 1.0 110.548 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.754 ' O ' HD13 ' A' ' 59' ' ' ILE . 29.3 tp -109.69 142.68 40.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 1.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.754 HD13 ' O ' ' A' ' 58' ' ' LEU . 38.0 mm -138.44 82.73 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 1.0 110.29 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.695 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.64 167.02 22.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 1.0 110.181 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 35.5 m-70 -129.75 -163.72 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 1.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -13.4 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.883 ' O ' HG13 ' A' ' 15' ' ' VAL . 69.6 m -87.61 -173.33 4.28 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.51 -0.744 . . . . 1.0 109.024 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.748 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -167.01 -160.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 1.0 110.098 -179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.48 81.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.865 0.84 . . . . 1.0 109.904 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.62 -40.67 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.604 -1.798 . . . . 1.0 108.604 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.481 ' HB3' HD23 ' A' ' 84' ' ' LEU . 31.0 mtt -87.06 39.95 0.89 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -1.121 . . . . 1.0 110.549 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -91.31 27.4 1.94 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 1.0 110.173 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.49 -109.74 2.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.229 -1.549 . . . . 1.0 109.229 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.1 pt-20 -146.56 139.58 25.49 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.538 -0.978 . . . . 1.0 110.522 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.97 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 26.2 t -78.99 128.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 p -123.97 127.58 48.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.0 111.285 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.524 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 51.1 t80 -104.63 137.11 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 1.0 109.439 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -130.72 144.17 51.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 1.0 109.939 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' CG1' ' A' ' 30' ' ' VAL . . . -159.12 -148.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.805 . . . . 1.0 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.26 51.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 1.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -154.46 30.28 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 1.0 109.931 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 25' ' ' LEU . . . -114.2 108.78 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.024 -1.047 . . . . 1.0 110.164 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.901 . . . . 1.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 6.5 p -102.39 175.57 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 1.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.76 103.12 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.123 -0.986 . . . . 1.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.63 -176.14 3.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 1.0 109.752 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -108.1 134.66 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 1.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.697 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 44.3 tp -133.08 141.61 48.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.409 -0.807 . . . . 1.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -139.22 125.93 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.0 110.062 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.748 HG11 ' O ' ' A' ' 64' ' ' GLN . 40.6 t -96.9 132.8 40.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.901 . . . . 1.0 109.921 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -124.23 119.51 29.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 1.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.19 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.935 . . . . 1.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 3.9 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.035 -0.983 . . . . 1.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.201 0.524 . . . . 1.0 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.674 HD13 ' N ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -171.11 126.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 1.0 109.85 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.674 ' N ' HD13 ' A' ' 2' ' ' ILE . 15.9 mt-10 -152.72 -77.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 1.0 110.784 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 23' ' ' ILE . 46.2 t -47.15 107.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 1.0 111.281 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 2.8 mm-40 -96.23 -26.1 15.55 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.431 -0.793 . . . . 1.0 109.039 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -135.49 119.39 13.03 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.4 168.12 18.78 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.537 1.283 . . . . 1.0 111.763 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.899 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.8 mt -82.4 161.33 22.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.631 -0.668 . . . . 1.0 109.923 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.809 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 2.5 m-85 -115.2 168.12 10.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 1.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.63 124.65 7.91 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.67 179.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 1.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -135.04 161.32 35.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 1.0 110.667 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 17' ' ' GLU . 5.0 p -160.7 129.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 1.0 109.957 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 57.3 4.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.951 . . . . 1.0 110.361 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 87' ' ' LYS . 42.1 t 48.66 91.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.174 -0.954 . . . . 1.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 132.36 -34.92 2.43 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.825 ' CB ' HG23 ' A' ' 13' ' ' VAL . 3.3 mt-10 -67.45 -163.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -1.07 . . . . 1.0 109.656 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.9 m -136.74 115.4 12.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 1.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.55 149.85 31.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.206 -0.934 . . . . 1.0 109.517 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -127.04 137.33 53.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 1.0 110.746 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.969 ' CE1' HG21 ' A' ' 71' ' ' VAL . 62.1 m-85 -133.38 115.45 14.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 1.0 109.797 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.3 154.76 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 1.0 110.731 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 4' ' ' VAL . 9.3 tt -170.32 122.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 1.0 109.911 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.533 ' C ' HD12 ' A' ' 25' ' ' LEU . 21.2 tt0 -88.01 171.62 10.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 1.0 110.217 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD13 ' ND1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -150.08 128.36 12.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.817 . . . . 1.0 110.097 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.6 t -67.19 -49.36 64.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 1.0 110.724 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.97 136.32 44.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 1.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.19 -159.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.605 1.318 . . . . 1.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.47 118.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.963 . . . . 1.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.814 HG21 ' OE2' ' A' ' 51' ' ' GLU . 17.8 m -103.22 119.35 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.383 -0.823 . . . . 1.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.09 19.92 2.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 1.0 110.312 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.38 -150.04 23.41 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.12 165.72 2.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -1.04 . . . . 1.0 109.907 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 1.06 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.8 m95 -104.55 150.6 24.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 1.0 110.374 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 2.3 ttpt -149.3 122.99 9.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 1.0 109.328 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' A' ' 67' ' ' MET . 11.2 mt -64.78 -132.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 1.0 108.824 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -52.46 -24.04 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.427 -1.421 . . . . 1.0 109.436 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.18 41.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -122.27 116.85 29.55 Favored Pre-proline 0 N--CA 1.484 1.273 0 O-C-N 121.271 -1.135 . . . . 1.0 109.213 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.82 99.86 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.562 1.296 . . . . 1.0 110.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 42' ' ' THR . 3.8 pp -70.95 -157.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 1.0 110.421 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.861 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -166.68 170.07 12.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 1.0 109.755 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.17 105.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 1.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.43 175.04 3.07 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 1.0 110.287 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.44 -24.62 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.676 1.356 . . . . 1.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -79.04 -11.56 60.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 1.0 110.631 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -124.53 167.45 14.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 1.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 84.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 1.0 110.009 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -102.1 131.99 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 1.0 110.268 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.797 ' N ' HD13 ' A' ' 49' ' ' ILE . 6.9 tt -147.95 135.54 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.0 110.214 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.814 ' OE2' HG21 ' A' ' 30' ' ' VAL . 5.1 pt-20 -133.78 176.74 8.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 1.0 110.512 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -136.01 23.11 3.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 1.0 109.977 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.35 -88.65 1.4 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -5.21 27.33 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.623 -0.928 . . . . 1.0 111.077 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -132.65 164.78 25.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.846 -1.159 . . . . 1.0 110.572 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.629 ' ND1' HD13 ' A' ' 25' ' ' LEU . 20.2 m80 -142.36 127.59 18.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 1.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.63 137.08 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.922 . . . . 1.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.06 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -126.15 144.29 50.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 1.0 110.591 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.3 mt -139.58 115.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 1.0 109.59 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mt -111.09 97.09 6.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.077 -1.014 . . . . 1.0 110.72 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 62' ' ' ASN . 62.7 m-70 -69.87 -166.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.007 . . . . 1.0 109.841 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 61' ' ' HIS . 45.0 p-10 -16.11 82.48 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.197 0.814 . . . . 1.0 113.197 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 70.1 m -77.4 -168.14 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.634 -0.666 . . . . 1.0 110.159 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.682 ' O ' HG11 ' A' ' 86' ' ' VAL . 14.6 tp60 -129.02 170.8 13.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 86' ' ' VAL . 9.1 tp -78.67 25.1 0.27 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 1.0 111.95 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.68 -23.14 5.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.527 ' HB2' HG21 ' A' ' 86' ' ' VAL . 33.1 mtt -61.3 -12.98 15.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -1.139 . . . . 1.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -43.3 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.416 -0.802 . . . . 1.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.59 -119.14 0.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.371 -1.492 . . . . 1.0 109.371 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.31 149.63 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -1.062 . . . . 1.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 21' ' ' PHE . 78.9 t -89.11 83.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.0 109.54 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -86.02 103.31 14.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 1.0 110.806 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 23' ' ' ILE . 85.9 t80 -98.15 151.64 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 1.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -156.43 129.69 8.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.967 -1.083 . . . . 1.0 111.393 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -139.08 22.72 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.707 0.765 . . . . 1.0 109.269 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 178.17 -160.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.544 -0.909 . . . . 1.0 108.544 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.46 -22.8 67.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.923 -1.11 . . . . 1.0 109.741 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.88 169.15 18.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.0 110.216 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.55 102.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.0 110.447 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.428 ' OG ' HG11 ' A' ' 4' ' ' VAL . 71.1 m -75.41 170.08 16.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 1.0 109.954 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -168.46 111.44 0.57 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.135 -0.978 . . . . 1.0 110.541 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.16 -173.71 2.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 1.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -119.07 106.89 12.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 1.0 110.144 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.624 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 65.2 tp -110.88 127.66 55.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.969 . . . . 1.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 3.1 pttp -130.88 113.62 14.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 1.0 110.291 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.709 ' O ' HD12 ' A' ' 65' ' ' LEU . 61.5 t -87.58 104.04 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.224 -0.923 . . . . 1.0 110.233 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.42 154.54 22.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.0 110.128 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.99 -153.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 1.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.311 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 1' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.641 0.734 . . . . 1.0 110.528 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 2.3 pt -117.08 178.88 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.054 -1.029 . . . . 1.0 110.194 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.77 -151.09 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.269 -0.894 . . . . 1.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 87.2 t -130.66 123.57 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.125 -0.984 . . . . 1.0 110.216 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -86.41 -57.18 3.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 1.0 109.326 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 102.96 48.6 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.657 -0.652 . . . . 1.0 109.896 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.93 174.51 10.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.627 1.33 . . . . 1.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 97.6 mt -75.42 174.78 9.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.0 110.355 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -142.94 150.3 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 1.0 109.883 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.98 140.3 28.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 12' ' ' GLU . 44.0 t -138.93 170.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 1.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 11' ' ' VAL . 10.0 pt-20 -138.29 158.35 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.963 -1.086 . . . . 1.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.931 HG23 ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -160.87 138.64 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 1.0 110.393 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.55 51.22 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 1.0 109.865 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 63' ' ' CYS . 23.1 t 51.83 72.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.815 0.817 . . . . 1.0 110.423 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 157.05 -28.57 0.52 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.564 -1.814 . . . . 1.0 108.564 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -73.96 -160.93 0.1 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.979 . . . . 1.0 109.579 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 58.2 m -135.28 116.46 14.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.927 . . . . 1.0 110.521 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.11 163.19 25.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 1.0 109.01 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -148.8 124.63 10.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.942 -1.098 . . . . 1.0 111.078 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 8' ' ' LEU . 64.6 m-85 -132.18 109.9 10.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.0 109.282 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -115.85 159.4 21.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0 110.515 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 23' ' ' ILE . 3.1 tt -170.83 123.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -0.764 . . . . 1.0 110.193 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -100.44 157.13 16.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 1.0 110.179 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.4 mt -114.8 -150.01 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.0 109.922 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -111.43 -70.23 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 1.0 110.119 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.61 143.49 33.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . 47.6 Cg_endo -74.08 -174.08 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 1.0 110.555 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' C ' HG13 ' A' ' 30' ' ' VAL . 9.3 t70 53.07 85.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 1.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 25' ' ' LEU . 30.7 m -148.47 174.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 1.0 110.256 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -128.81 130.04 46.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 1.0 109.878 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.68 175.12 23.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.963 -1.255 . . . . 1.0 109.963 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -156.17 151.64 26.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -1.053 . . . . 1.0 109.793 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 32.3 m95 -106.92 155.48 19.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 1.0 110.481 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 12.9 ttpt -143.26 112.73 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.335 -0.853 . . . . 1.0 109.61 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 41' ' ' LEU . 1.2 mp -66.37 -123.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 1.0 109.744 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -48.79 -25.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.477 -1.389 . . . . 1.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 148.97 39.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.45 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -136.88 136.91 21.94 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.047 -1.267 . . . . 1.0 109.95 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.22 91.01 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.65 1.342 . . . . 1.0 110.557 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 36' ' ' LEU . 1.4 pt? -69.46 -170.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 1.0 110.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 172.07 13.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.86 . . . . 1.0 109.965 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 104.14 5.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 1.0 110.17 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.407 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.13 176.11 2.26 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 1.0 110.161 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.74 -19.43 27.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.669 1.352 . . . . 1.0 110.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -102.3 -20.21 14.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 110.187 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 72.2 m -93.66 131.44 38.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 1.0 110.039 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 1.8 tt0 -104.98 46.16 0.93 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.262 -0.899 . . . . 1.0 109.801 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 49' ' ' ILE . 8.4 tt -79.59 80.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.935 -1.103 . . . . 1.0 109.901 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.16 145.63 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 1.0 110.224 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.94 120.1 18.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.212 -0.93 . . . . 1.0 110.341 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.76 19.59 12.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 1.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.32 -95.29 1.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -50.33 -21.23 1.32 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.671 -0.9 . . . . 1.0 111.101 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -134.07 136.31 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.916 -1.115 . . . . 1.0 111.046 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.7 m-70 -121.62 116.44 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 1.0 109.687 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.02 130.08 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 1.0 110.745 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' CE3' ' A' ' 34' ' ' TRP . 47.5 tp -117.13 131.61 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 1.0 109.982 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 96.5 mt -135.72 96.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 1.0 109.957 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 18' ' ' THR . 0.8 OUTLIER -100.2 144.99 28.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 1.0 110.507 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' C ' ' A' ' 62' ' ' ASN . 58.2 m-70 -111.24 -163.46 0.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 1.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 17.6 p-10 -14.49 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.866 ' O ' HG13 ' A' ' 15' ' ' VAL . 75.3 m -80.78 -159.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.694 -0.629 . . . . 1.0 109.645 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.664 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -158.02 -160.78 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.237 -0.914 . . . . 1.0 109.944 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.35 33.22 0.4 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.875 -1.141 . . . . 1.0 111.719 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.48 4.1 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 1.0 108.645 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.585 ' HG2' HD22 ' A' ' 36' ' ' LEU . 34.6 mtt -87.62 37.17 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.567 -0.961 . . . . 1.0 110.46 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 51.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 1.0 109.922 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.58 1.91 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -146.38 148.11 31.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 1.0 110.272 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 77.3 t -89.94 91.37 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 1.0 109.862 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.9 p -96.89 103.23 15.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 1.0 110.533 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -88.24 156.88 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 1.0 109.775 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG3' ' HG2' ' A' ' 79' ' ' LYS . 2.1 mt-30 -149.11 144.93 26.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.05 -1.031 . . . . 1.0 110.656 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.61 -147.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 1.0 109.887 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.83 -62.63 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.005 -1.06 . . . . 1.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.93 24.41 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.418 -0.801 . . . . 1.0 109.926 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.75 137.8 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 1.0 110.294 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HG2' ' HG3' ' A' ' 74' ' ' GLN . 5.1 mtmt -144.61 62.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 1.0 110.252 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -74.97 173.6 10.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 1.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.64 98.86 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -86.55 -173.55 4.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -126.45 104.73 8.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 1.0 109.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 56.8 tp -109.36 146.79 33.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 1.0 110.483 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -149.79 112.0 4.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 1.0 109.777 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' O ' ' A' ' 64' ' ' GLN . 42.3 t -79.41 111.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.064 -1.022 . . . . 1.0 110.079 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.53 108.5 20.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 1.0 110.246 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.567 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.7 mt-10 -75.22 149.06 39.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 1.0 110.092 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.6 tt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.199 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.289 0.566 . . . . 1.0 110.206 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.61 153.9 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 1.0 110.106 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.09 178.92 4.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.108 -0.995 . . . . 1.0 110.388 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.7 t -116.84 115.14 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 1.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -87.99 -51.29 5.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 1.0 109.608 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -114.0 105.27 54.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.702 -0.624 . . . . 1.0 110.428 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.4 178.03 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.619 1.326 . . . . 1.0 110.707 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.75 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.5 mt -78.34 -170.73 2.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.842 . . . . 1.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 9' ' ' TYR . 35.1 p90 -152.2 130.5 12.04 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 1.0 109.904 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.51 150.61 30.17 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLU . 48.1 t -149.13 167.97 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.484 -1.01 . . . . 1.0 109.826 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 45.6 mt-10 -125.87 154.99 41.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 1.0 110.368 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.6 p -154.01 147.95 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 1.0 109.948 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -98.14 47.09 1.0 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.0 111.012 -179.347 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.1 t 48.79 95.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.219 -0.926 . . . . 1.0 110.717 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' A' ' 62' ' ' ASN . . . 135.61 -38.15 1.82 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.644 -1.782 . . . . 1.0 108.644 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.595 ' HB2' HG23 ' A' ' 13' ' ' VAL . 3.2 mt-10 -69.7 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.484 -1.009 . . . . 1.0 109.179 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -134.27 122.16 22.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.94 -1.1 . . . . 1.0 110.954 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.58 157.7 27.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 1.0 108.859 178.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -139.84 131.16 26.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.838 -1.164 . . . . 1.0 111.051 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 47.2 m-85 -127.98 126.39 41.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 1.0 109.721 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.87 154.72 32.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.971 . . . . 1.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.8 tt -170.33 140.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 1.0 110.008 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -118.27 162.73 17.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.0 110.251 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.752 HD11 ' CD2' ' A' ' 56' ' ' HIS . 45.1 mt -124.97 -154.93 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 109.815 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.81 -30.12 5.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.132 -0.98 . . . . 1.0 110.04 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -127.77 121.95 22.28 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.0 109.847 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.27 116.86 4.87 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.47 1.247 . . . . 1.0 110.611 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.2 -1.87 7.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 1.0 110.64 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.1 t 55.7 64.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.048 -1.033 . . . . 1.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -168.8 135.4 1.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 1.0 110.223 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.94 168.16 24.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 11.4 tt0 -156.32 159.83 39.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.181 -1.188 . . . . 1.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.911 ' CE3' HD22 ' A' ' 58' ' ' LEU . 23.7 m95 -119.89 163.08 18.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 1.0 110.345 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -164.82 150.16 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 110.348 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.9 mt -68.32 -128.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.0 109.204 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -50.25 -24.64 3.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.604 -1.31 . . . . 1.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.71 41.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 1.1 mm100 -126.07 109.79 24.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.329 -1.1 . . . . 1.0 110.054 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 39' ' ' GLN . 42.3 Cg_endo -68.84 89.47 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.597 1.314 . . . . 1.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 pt? -69.75 -172.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 1.0 110.634 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.8 m -136.69 156.85 47.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 1.0 110.094 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -78.64 115.21 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 1.0 110.184 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -170.16 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 111.116 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 44.2 Cg_endo -70.83 -90.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.27 1.142 . . . . 1.0 110.837 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -125.23 40.33 3.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.774 -1.204 . . . . 1.0 110.43 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 27.8 t -107.92 146.92 31.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 1.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -141.63 74.38 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 1.0 110.077 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' ILE . 14.1 tt -91.09 128.94 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 1.0 110.481 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.0 118.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 1.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 170.2 16.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 1.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.88 19.94 2.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 1.0 110.216 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.56 -76.91 1.55 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -18.39 18.49 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.662 -0.905 . . . . 1.0 110.684 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.45 126.57 13.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 1.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.752 ' CD2' HD11 ' A' ' 25' ' ' LEU . 70.5 m-70 -103.19 115.12 29.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.797 . . . . 1.0 109.725 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 mt -118.26 144.32 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.004 . . . . 1.0 110.477 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.911 HD22 ' CE3' ' A' ' 34' ' ' TRP . 46.6 tp -132.92 132.56 42.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 1.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mt -132.38 118.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 1.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -119.87 106.71 12.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 1.0 110.529 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 83.9 m-70 -72.48 -170.86 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 1.0 109.965 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.0 p-10 -15.02 81.74 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 61' ' ' HIS . 72.8 m -70.92 -158.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.52 -0.738 . . . . 1.0 109.611 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.705 ' O ' HG21 ' A' ' 86' ' ' VAL . 1.1 tp60 -138.37 174.48 10.5 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.153 -0.967 . . . . 1.0 108.595 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 4.5 tp -78.37 30.07 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.98 -1.075 . . . . 1.0 112.037 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.79 -11.43 10.25 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.437 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 8.5 mtt -85.17 42.85 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 1.0 110.822 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -89.93 62.09 5.53 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.071 -1.018 . . . . 1.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.89 -119.59 1.37 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.796 -1.322 . . . . 1.0 109.796 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 2.2 pt-20 -145.85 156.59 43.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -1.007 . . . . 1.0 110.571 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.81 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 25.0 t -101.94 82.04 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.45 -0.781 . . . . 1.0 109.557 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.34 129.85 35.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 1.0 110.45 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.507 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 21.5 t80 -98.31 145.81 26.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.478 -0.764 . . . . 1.0 109.679 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -120.66 100.9 7.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 1.0 110.426 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -131.03 89.33 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.46 -153.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 1.0 110.341 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -53.35 -24.9 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.0 110.346 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.25 134.22 39.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 1.0 110.191 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.22 149.64 30.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 1.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.578 ' OG ' HD11 ' A' ' 8' ' ' LEU . 70.2 p -138.6 174.91 10.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.95 . . . . 1.0 110.18 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -163.64 104.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 1.0 110.302 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -95.48 -160.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 1.0 110.078 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.59 115.98 9.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.959 . . . . 1.0 110.014 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -124.68 128.95 49.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.516 ' N ' HD13 ' A' ' 84' ' ' LEU . 2.1 tttp -125.91 136.72 53.37 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.322 -0.861 . . . . 1.0 109.665 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 64' ' ' GLN . 32.1 t -92.64 140.5 16.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 1.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -124.59 128.34 48.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.09 140.67 37.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 1.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.219 0.533 . . . . 1.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 3' ' ' GLU . 2.8 tp -157.26 151.69 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -79.98 -147.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 1.0 110.188 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 HD11 ' A' ' 23' ' ' ILE . 58.8 t -134.65 136.68 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 1.0 110.113 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -86.98 -49.49 7.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.423 -0.798 . . . . 1.0 109.646 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 106.26 51.69 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 1.0 110.337 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -71.74 174.12 11.6 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.556 1.293 . . . . 1.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.818 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 15.5 mt -72.83 178.12 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 1.0 109.789 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.1 m-85 -142.24 132.91 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 1.0 110.073 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.24 141.85 48.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.1 t -141.09 156.84 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -1.086 . . . . 1.0 109.653 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -111.48 150.09 30.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 1.0 110.422 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.01 165.37 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 1.0 110.542 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.91 32.85 5.79 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.525 -0.735 . . . . 1.0 109.222 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 88' ' ' GLU . 10.9 t 64.92 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.69 0.757 . . . . 1.0 110.188 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 142.87 -25.44 2.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.139 -1.584 . . . . 1.0 109.139 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -1.093 . . . . 1.0 109.947 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 95.7 m -136.85 110.19 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 1.0 110.425 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.32 142.65 35.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 1.0 109.688 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -119.73 105.69 11.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 1.0 110.627 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CD2' HD23 ' A' ' 58' ' ' LEU . 62.6 m-85 -96.03 124.95 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 1.0 109.385 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -114.56 152.36 31.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.026 -1.046 . . . . 1.0 110.99 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.811 HD11 HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -167.6 117.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.681 . . . . 1.0 109.547 179.655 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -109.15 165.31 11.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 110.866 -179.331 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' CD2' ' A' ' 56' ' ' HIS . 40.5 mt -129.08 -144.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 1.0 109.494 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -130.91 -47.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -100.79 160.0 28.0 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.936 . . . . 1.0 110.696 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.99 124.23 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.728 1.383 . . . . 1.0 110.381 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.19 101.07 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 1.0 110.093 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 30' ' ' VAL . 9.9 p -97.21 60.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 28.1 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 1.0 109.992 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.23 176.17 28.94 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -158.74 139.96 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -1.101 . . . . 1.0 109.772 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.633 ' CE3' HD22 ' A' ' 58' ' ' LEU . 31.6 m95 -95.52 164.94 12.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 1.0 110.841 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -165.01 160.37 18.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 179.481 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.2 OUTLIER -65.08 -141.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.062 . . . . 1.0 108.838 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.8 -28.16 0.6 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.508 -1.37 . . . . 1.0 110.385 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 164.18 39.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.134 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.532 ' HG3' HD21 ' A' ' 41' ' ' LEU . 4.1 tt0 -123.32 95.91 44.83 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.37 -1.076 . . . . 1.0 108.515 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.72 77.23 3.76 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.693 1.365 . . . . 1.0 111.455 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 42' ' ' THR . 4.2 pp -171.76 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.198 -0.938 . . . . 1.0 110.625 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 65.9 m -69.86 -19.69 63.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.933 -1.104 . . . . 1.0 110.299 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.34 100.43 11.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.493 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -179.56 -59.02 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 1.0 110.375 179.78 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 43.9 Cg_endo -74.58 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.44 1.232 . . . . 1.0 110.445 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 30.12 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 1.0 110.16 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 44' ' ' SER . 52.8 t -129.13 155.62 45.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 1.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 80.98 1.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 1.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' ILE . 15.5 tt -82.31 117.28 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 1.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.59 94.54 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 1.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.22 163.05 15.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 1.0 110.359 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.67 26.33 5.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 1.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.21 -96.41 2.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -21.68 2.54 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.635 -0.921 . . . . 1.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -122.05 149.58 43.33 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.022 -1.049 . . . . 1.0 110.173 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.796 ' HB2' HG23 ' A' ' 23' ' ' ILE . 61.6 m-70 -128.29 113.57 15.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 1.0 109.83 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.5 mm -124.08 151.26 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 1.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 21' ' ' PHE . 6.5 tp -136.11 136.86 40.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.797 . . . . 1.0 109.989 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 58' ' ' LEU . 43.9 mm -126.41 93.53 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 1.0 110.276 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 18' ' ' THR . 7.0 mt -89.74 118.43 29.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.903 . . . . 1.0 110.242 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.7 m-70 -89.66 -167.83 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 1.0 110.289 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.465 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 43.0 t30 -15.35 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' HIS . 57.1 m -75.88 140.1 42.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.586 -0.696 . . . . 1.0 109.397 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.79 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -89.08 -177.39 5.43 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.218 -0.926 . . . . 1.0 110.455 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 86' ' ' VAL . 0.3 OUTLIER -71.8 -1.65 14.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 1.0 111.528 -179.73 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.35 -17.57 60.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.99 -1.244 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.617 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.5 mtt -84.73 42.07 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.281 . . . . 1.0 111.243 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -90.96 41.13 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 1.0 110.035 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.18 -139.5 5.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.99 157.95 34.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 1.0 110.509 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 41.9 t -101.11 98.54 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 1.0 109.71 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -96.76 141.1 30.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 1.0 110.76 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 35.9 t80 -121.77 143.44 49.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -0.829 . . . . 1.0 109.54 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -120.06 114.72 22.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 1.0 110.545 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -145.94 132.08 19.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 1.0 109.62 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.57 -150.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 1.0 109.765 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -90.35 45.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.973 . . . . 1.0 109.929 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.02 167.05 31.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 1.0 110.33 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.66 135.96 8.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 1.0 110.299 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.464 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 p -101.79 176.11 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.489 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.58 109.83 0.85 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.992 . . . . 1.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.08 179.88 4.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 1.0 109.816 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -114.12 107.94 16.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 1.0 110.089 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.506 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 50.4 tp -108.76 138.92 44.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 1.0 110.35 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -142.03 136.04 29.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 1.0 109.97 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 64' ' ' GLN . 45.2 t -101.28 135.07 39.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.268 -0.895 . . . . 1.0 110.245 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.33 120.33 18.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 15' ' ' VAL . 21.9 mt-10 -84.91 170.16 13.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 1.0 110.037 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.209 179.92 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 1' ' ' LEU . 5.0 tt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.312 0.577 . . . . 1.0 110.262 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.45 -175.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 1.0 110.007 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 2.4 pm0 -147.83 -159.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 1.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.92 107.47 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 1.0 110.306 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -74.96 -34.47 62.05 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 1.0 109.175 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -131.15 107.82 14.97 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.519 -0.738 . . . . 1.0 109.482 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.98 175.28 8.5 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.546 1.287 . . . . 1.0 110.99 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.924 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.7 mt -71.37 -177.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 1.0 109.771 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -122.57 -14.15 7.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.084 -1.01 . . . . 1.0 111.39 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 60.87 118.66 0.01 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.911 -1.275 . . . . 1.0 109.911 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.76 ' O ' HD12 ' A' ' 84' ' ' LEU . 34.4 m -136.5 -176.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.782 -1.423 . . . . 1.0 110.93 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 13' ' ' VAL . 9.2 pt-20 -127.5 173.01 10.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 1.0 109.592 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.646 HG12 ' OE2' ' A' ' 17' ' ' GLU . 25.7 m -149.86 -176.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.088 . . . . 1.0 111.11 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.39 25.22 6.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.147 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 13.4 t 61.91 85.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.575 -0.703 . . . . 1.0 110.759 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.55 -25.17 3.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.191 -1.163 . . . . 1.0 110.191 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.646 ' OE2' HG12 ' A' ' 13' ' ' VAL . 2.0 pt-20 -76.03 -144.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -1.203 . . . . 1.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.9 m -149.82 111.56 4.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 1.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.74 165.66 22.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 1.0 109.96 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -143.3 110.16 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 1.0 110.772 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 95.2 m-85 -112.45 125.02 53.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -0.807 . . . . 1.0 109.593 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.16 157.13 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 1.0 111.335 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.3 tt -166.32 129.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 1.0 109.556 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -108.63 138.2 45.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 1.0 110.681 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.574 HD11 ' NE2' ' A' ' 56' ' ' HIS . 66.4 mt -94.01 173.36 7.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 1.0 109.751 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -74.29 -61.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.0 . . . . 1.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -117.77 131.04 24.3 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.029 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.13 126.2 9.73 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.513 1.27 . . . . 1.0 110.236 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.63 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.3 t -97.34 148.19 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 1.0 110.065 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -86.53 -166.47 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.0 110.17 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.84 162.11 35.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 1.0 109.613 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.49 171.65 11.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -1.126 . . . . 1.0 109.98 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.893 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.8 m95 -111.87 176.37 5.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.106 -0.996 . . . . 1.0 110.589 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 5.6 ttmt -165.38 126.14 1.91 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.388 -0.82 . . . . 1.0 108.812 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.77 -131.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.0 109.112 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -51.65 -24.51 5.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.337 -1.477 . . . . 1.0 109.698 179.307 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.38 41.64 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.08 -1.608 . . . . 1.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -122.5 111.84 31.39 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 1.0 110.555 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.76 96.59 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.679 1.357 . . . . 1.0 109.651 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 42' ' ' THR . 3.1 pp -70.05 -153.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 1.0 110.526 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.887 ' N ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -152.72 -166.04 2.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 1.0 110.027 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.67 107.03 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 1.0 110.047 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 6.0 p -147.67 168.82 10.4 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 1.0 110.235 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 44.5 Cg_endo -72.05 -19.11 26.89 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.543 1.286 . . . . 1.0 110.475 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -23.54 59.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 1.0 110.344 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.5 t -141.36 125.64 17.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 1.0 110.413 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.17 135.1 54.02 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.251 -0.905 . . . . 1.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' HG2' ' A' ' 51' ' ' GLU . 3.5 mt -130.93 95.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.38 -0.825 . . . . 1.0 110.023 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.96 94.03 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 1.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' HG22 ' A' ' 49' ' ' ILE . 4.5 pt-20 -139.57 147.57 41.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 1.0 110.261 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -146.21 19.37 1.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 1.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.77 -23.55 30.27 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -90.07 -20.93 22.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.264 -1.139 . . . . 1.0 109.989 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.3 144.7 3.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.294 -0.879 . . . . 1.0 110.128 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.574 ' NE2' HD11 ' A' ' 25' ' ' LEU . 69.1 m-70 -110.94 118.85 37.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 1.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.53 128.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.34 -0.85 . . . . 1.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 34' ' ' TRP . 4.3 tt -116.23 133.21 56.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 1.0 110.56 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.751 ' N ' HD23 ' A' ' 58' ' ' LEU . 41.0 mm -133.55 86.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.59 103.37 15.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 1.0 110.758 -179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.2 m-70 -69.69 -156.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 1.0 109.304 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 59.7 t-20 -14.77 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 61' ' ' HIS . 76.7 m -71.78 171.02 12.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.714 -0.616 . . . . 1.0 110.419 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 2.9 tp-100 -110.07 163.57 13.46 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.361 -0.837 . . . . 1.0 108.905 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.549 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -75.39 5.08 6.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.868 -1.145 . . . . 1.0 111.739 -179.467 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.25 -20.24 28.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.559 ' HB2' HG21 ' A' ' 86' ' ' VAL . 12.0 mtt -55.3 -17.41 4.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 1.0 111.167 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -43.91 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 1.0 110.789 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.97 -121.35 0.63 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.92 135.5 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -1.066 . . . . 1.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.1 101.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 1.0 109.843 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -103.56 128.76 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 1.0 110.361 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -108.58 148.2 30.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.0 109.792 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 2.6 pt20 -136.33 137.09 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 1.0 110.55 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -165.58 99.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 56.93 -89.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 1.0 110.38 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 7.3 m-20 -119.18 32.38 6.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.968 -1.082 . . . . 1.0 110.281 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 74' ' ' GLN . . . -118.01 133.85 55.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 1.0 110.195 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 68.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 1.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.8 m -77.94 166.9 22.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.0 109.987 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.31 104.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 1.0 110.509 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.924 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.35 -170.67 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.08 123.44 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 1.0 109.848 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.779 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 57.5 tp -124.66 138.26 54.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 1.0 110.699 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -140.09 130.56 25.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.404 -0.81 . . . . 1.0 109.604 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 67' ' ' MET . 52.9 t -99.85 118.01 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 1.0 110.366 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 3.3 ttpt -97.99 140.57 32.14 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.32 -0.862 . . . . 1.0 109.665 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.94 -156.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 1.0 109.999 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.884 -1.055 . . . . 1.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.232 0.539 . . . . 1.0 110.308 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 26' ' ' SER . 43.9 pt -121.16 178.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 1.0 110.198 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -108.27 -166.97 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.937 . . . . 1.0 110.271 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG2' ' HA ' ' A' ' 78' ' ' ALA . 89.0 t -121.21 124.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 1.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.83 -31.83 31.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 1.0 110.289 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.2 113.82 6.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 1.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.77 -176.69 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.58 1.305 . . . . 1.0 110.25 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 19.1 mt -73.38 -154.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 1.0 110.396 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -155.98 116.32 3.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 1.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.25 133.46 45.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.16 152.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.302 -1.116 . . . . 1.0 110.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -94.03 175.35 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 1.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 14' ' ' PHE . 6.8 p -154.14 174.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 1.0 110.737 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -117.8 136.6 53.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 1.0 109.582 179.284 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.989 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -60.07 91.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 1.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 140.66 -37.8 1.64 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.017 -1.633 . . . . 1.0 109.017 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -71.99 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 1.0 109.684 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.9 m -160.65 150.32 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 1.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.22 176.99 5.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 1.0 109.197 179.349 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -160.5 112.29 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.0 111.664 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.863 ' CE2' HG21 ' A' ' 71' ' ' VAL . 47.1 m-85 -117.48 127.25 53.82 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 178.319 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -115.84 151.62 34.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 1.0 111.147 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 56' ' ' HIS . 1.2 tt -164.26 139.02 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.578 -0.701 . . . . 1.0 109.546 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 25' ' ' LEU . 1.3 mp0 -118.46 154.04 33.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 1.0 110.355 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 56' ' ' HIS . 24.7 mt -116.77 -152.88 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 1.0 110.048 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -121.09 -35.02 3.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 1.0 109.65 179.596 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.07 160.96 42.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.85 134.54 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.659 1.347 . . . . 1.0 110.446 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -171.58 113.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 110.241 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.82 54.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 1.0 110.088 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -131.53 45.87 2.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 1.0 110.052 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.02 164.18 12.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.044 -1.223 . . . . 1.0 110.044 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.01 169.94 16.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -1.055 . . . . 1.0 109.851 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.806 ' CE3' HD22 ' A' ' 58' ' ' LEU . 42.8 m95 -122.56 138.72 54.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 1.0 110.793 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 1.3 ttmt -121.62 143.27 49.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.527 -0.733 . . . . 1.0 110.287 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 41' ' ' LEU . 7.6 mt -93.96 -93.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 1.0 109.705 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -14.72 62.06 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.097 -1.002 . . . . 1.0 110.083 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 138.16 -10.14 3.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.978 -1.249 . . . . 1.0 109.978 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.99 159.81 28.6 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.065 -1.256 . . . . 1.0 109.605 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.25 79.17 3.02 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.751 1.395 . . . . 1.0 110.561 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 36' ' ' LEU . 1.5 pp -127.6 -15.79 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.349 -0.844 . . . . 1.0 110.891 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -69.45 -16.9 63.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 1.0 110.54 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.11 112.63 21.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 1.0 110.26 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.98 170.74 7.43 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.925 . . . . 1.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.38 5.1 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.621 1.327 . . . . 1.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.89 -11.78 11.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.844 -1.16 . . . . 1.0 110.904 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.1 -169.59 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 1.0 110.386 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -144.35 76.39 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.0 110.269 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -95.9 128.34 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 1.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.0 pt -133.21 133.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 1.0 109.916 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -142.37 137.62 30.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.986 -1.071 . . . . 1.0 110.508 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.62 21.9 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 1.0 110.202 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.05 -64.0 2.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.749 -1.34 . . . . 1.0 109.749 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.58 31.86 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.727 -0.867 . . . . 1.0 110.795 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -153.01 115.72 4.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 25' ' ' LEU . 91.8 m-70 -110.0 117.92 35.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 1.0 109.836 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 56' ' ' HIS . 41.9 mm -121.31 157.81 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 1.0 110.237 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.806 HD22 ' CE3' ' A' ' 34' ' ' TRP . 39.2 tp -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 1.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.02 111.57 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 1.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.742 HD13 ' CE ' ' A' ' 67' ' ' MET . 5.1 mt -110.46 103.26 11.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.049 . . . . 1.0 110.679 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 62' ' ' ASN . 80.6 m-70 -72.13 -162.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 1.0 110.374 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.512 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 39.7 t-20 -12.86 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.555 1.317 . . . . 1.0 114.555 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.989 ' O ' HG23 ' A' ' 15' ' ' VAL . 73.8 m -86.08 -158.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.711 ' O ' HG11 ' A' ' 86' ' ' VAL . 1.4 pm0 -158.67 -173.67 4.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.798 -1.189 . . . . 1.0 110.907 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.21 -18.53 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 1.0 111.465 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.74 -130.32 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.783 -1.727 . . . . 1.0 108.783 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.742 ' CE ' HD13 ' A' ' 60' ' ' LEU . 1.3 mtt 39.42 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.981 -0.717 . . . . 1.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 68' ' ' THR . 19.4 m -91.17 37.64 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.068 -1.02 . . . . 1.0 110.176 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.21 -122.46 3.57 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.491 -1.444 . . . . 1.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -150.09 162.94 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -1.113 . . . . 1.0 110.555 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.863 HG21 ' CE2' ' A' ' 21' ' ' PHE . 70.1 t -104.69 87.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 1.0 109.808 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 p -92.45 107.97 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.938 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 34.1 t80 -79.14 158.77 27.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.685 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.52 109.96 3.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 1.0 110.61 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.38 -146.09 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 1.0 109.625 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.12 43.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -0.991 . . . . 1.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 2' ' ' ILE . 49.3 t30 -163.11 30.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 1.0 110.004 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -113.03 74.27 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 1.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -86.59 86.1 7.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.864 . . . . 1.0 110.431 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.647 ' OG ' HD11 ' A' ' 8' ' ' LEU . 77.5 p -81.73 -179.22 7.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -0.945 . . . . 1.0 110.117 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.49 89.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 1.0 110.383 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -98.36 -177.52 3.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 1.0 110.123 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -110.49 138.76 46.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' SD ' ' A' ' 67' ' ' MET . 44.3 tp -134.69 130.35 36.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 1.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -143.75 147.26 33.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 1.0 109.687 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.711 HG11 ' O ' ' A' ' 64' ' ' GLN . 25.4 t -105.82 158.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.059 -1.026 . . . . 1.0 110.736 -179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -130.69 146.11 52.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 1.0 109.664 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -81.98 -160.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.0 110.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.961 -1.018 . . . . 1.0 110.269 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.14 153.95 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 1.0 109.721 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -128.9 -3.8 5.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 1.0 111.048 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 85.5 t 53.14 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 1.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -85.52 -26.58 26.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.316 -0.865 . . . . 1.0 109.995 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 105.33 40.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 1.0 110.079 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.84 178.55 5.7 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.604 1.318 . . . . 1.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.919 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 14.2 mt -73.77 -157.81 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 1.0 110.156 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -155.9 134.22 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 1.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.65 140.87 26.7 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.671 -1.372 . . . . 1.0 109.671 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.7 152.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 1.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -96.13 169.19 10.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 1.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' CD ' ' A' ' 17' ' ' GLU . 11.6 p -159.35 146.16 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 1.0 110.299 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -88.35 125.87 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 1.0 109.725 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -46.84 93.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.413 -0.805 . . . . 1.0 111.712 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 155.64 -36.4 0.63 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.055 -1.218 . . . . 1.0 110.055 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.594 ' CD ' HG23 ' A' ' 13' ' ' VAL . 3.6 pt-20 -85.73 -148.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.826 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.485 HG21 ' CE1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -136.75 137.24 39.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 1.0 110.472 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -85.36 -176.5 6.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 1.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.494 ' CD2' HG12 ' A' ' 59' ' ' ILE . 8.0 m80 -160.7 108.5 1.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.954 -1.091 . . . . 1.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CD1' HD23 ' A' ' 58' ' ' LEU . 91.6 m-85 -114.81 120.87 41.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.789 . . . . 1.0 109.369 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -109.8 155.18 21.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 1.0 110.925 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 23' ' ' ILE . 11.4 tt -161.37 119.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.767 . . . . 1.0 109.833 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -101.08 131.88 46.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 1.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 56' ' ' HIS . 22.0 mt -87.63 179.56 6.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.86 . . . . 1.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.7 p -85.26 -22.05 28.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.0 109.98 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -121.45 135.83 25.39 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 1.0 109.978 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.1 Cg_endo -75.52 -178.32 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.537 1.283 . . . . 1.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.68 67.48 0.98 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 1.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 28' ' ' PRO . 98.1 t -142.52 159.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 1.0 110.307 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.2 148.35 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 1.0 109.963 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.76 -134.02 2.34 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -167.54 140.44 3.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -1.117 . . . . 1.0 110.18 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.736 ' CE3' HD22 ' A' ' 58' ' ' LEU . 33.9 m95 -102.93 170.73 7.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 1.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -173.62 170.29 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.486 -0.759 . . . . 1.0 109.942 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.25 -131.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 1.0 109.469 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -49.6 -25.03 2.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.7 -1.25 . . . . 1.0 110.399 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.64 40.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -128.48 107.63 19.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.199 -1.177 . . . . 1.0 110.046 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.08 112.36 3.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.487 1.256 . . . . 1.0 110.637 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 42' ' ' THR . 1.3 pp -106.7 -146.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 1.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.705 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -132.66 128.12 36.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.05 -1.031 . . . . 1.0 110.39 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.28 111.32 1.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.873 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -177.3 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.386 -0.821 . . . . 1.0 110.244 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -72.19 -74.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.441 1.232 . . . . 1.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD2' ' CE ' ' A' ' 67' ' ' MET . 27.9 t70 -133.19 58.63 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 1.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 t -162.71 142.3 9.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.905 . . . . 1.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -144.5 87.98 1.9 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.284 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.0 mt -87.81 131.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.132 -0.98 . . . . 1.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 tt -134.95 146.36 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 1.0 110.318 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.0 146.7 19.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 110.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.68 9.01 11.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.739 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.49 -21.24 30.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.474 -1.051 . . . . 1.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 -23.22 20.6 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.172 -1.193 . . . . 1.0 109.718 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 56' ' ' HIS . 38.8 tttt -164.56 163.49 21.89 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.423 -0.798 . . . . 1.0 109.498 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.692 ' CD2' HD11 ' A' ' 25' ' ' LEU . 51.6 m-70 -113.19 121.63 45.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 1.0 110.04 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.19 141.62 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 1.0 110.345 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.736 HD22 ' CE3' ' A' ' 34' ' ' TRP . 21.6 tp -115.57 148.93 39.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.345 -0.847 . . . . 1.0 110.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 20' ' ' HIS . 58.4 mt -146.01 116.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 1.0 109.719 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -117.44 107.27 14.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 1.0 110.587 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.485 ' CE1' HG21 ' A' ' 18' ' ' THR . 67.5 m-70 -69.7 -172.14 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 1.0 110.328 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.8 p-10 -13.94 80.85 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.025 1.12 . . . . 1.0 114.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.837 ' O ' HG23 ' A' ' 15' ' ' VAL . 80.7 m -74.42 148.07 41.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.712 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -92.25 171.0 9.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 1.0 111.541 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -23.93 2.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.715 -0.615 . . . . 1.0 110.748 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.32 -123.87 0.06 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.98 -1.648 . . . . 1.0 108.98 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.655 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.7 mtt 43.53 28.02 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.895 . . . . 1.0 111.287 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.51 52.52 2.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.297 -0.877 . . . . 1.0 110.365 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.75 -141.84 5.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.416 -1.474 . . . . 1.0 109.416 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 37' ' ' LYS . 1.7 pt-20 -130.99 143.33 50.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -1.154 . . . . 1.0 110.258 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.597 HG23 ' HB2' ' A' ' 84' ' ' LEU . 45.7 t -79.71 99.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 1.0 109.856 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -103.11 128.02 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 1.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 64.4 t80 -104.63 154.82 19.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 109.707 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.61 146.85 51.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 1.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.21 -142.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 1.0 110.04 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.94 -70.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.274 -0.891 . . . . 1.0 110.702 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -146.42 21.21 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 1.0 110.106 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -111.8 167.1 10.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 1.0 110.157 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.61 115.79 2.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.939 . . . . 1.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 66.9 p -96.96 177.84 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.286 -0.884 . . . . 1.0 109.696 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.29 97.15 0.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.033 -1.042 . . . . 1.0 110.696 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.09 -175.98 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 1.0 109.691 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -100.14 138.33 37.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.047 . . . . 1.0 110.242 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' A' ' 71' ' ' VAL . 21.6 tp -131.6 120.74 23.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 1.0 110.249 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -134.35 136.63 43.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 1.0 110.101 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 64' ' ' GLN . 59.5 t -94.57 148.15 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.251 -0.906 . . . . 1.0 110.052 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.46 141.53 51.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 1.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -105.06 -157.84 0.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 tp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.261 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.321 0.581 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.666 HG21 ' HG3' ' A' ' 27' ' ' GLU . 5.1 tt -106.41 157.87 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 1.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.802 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.3 mt-10 -82.77 -148.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 1.0 110.041 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.03 HG23 ' HB1' ' A' ' 78' ' ' ALA . 61.2 t -129.11 129.89 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.64 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 -57.61 3.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.954 . . . . 1.0 109.652 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.09 100.68 15.79 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.661 -0.65 . . . . 1.0 110.345 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.92 -179.33 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.649 1.341 . . . . 1.0 110.441 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.928 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 22.6 mt -76.71 159.34 30.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.055 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -125.96 15.92 7.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.105 -0.997 . . . . 1.0 110.731 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 63.32 157.69 0.15 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.2 p -160.07 170.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.523 -0.986 . . . . 1.0 109.714 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -120.56 166.08 14.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 1.0 110.531 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 12' ' ' GLU . 18.7 m -151.18 147.7 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.422 -0.799 . . . . 1.0 110.496 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.415 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -97.04 27.73 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 1.0 109.4 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 63' ' ' CYS . 75.4 t 57.39 87.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.55 0.691 . . . . 1.0 110.721 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.48 -30.2 2.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.35 -138.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.304 -1.115 . . . . 1.0 109.386 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 ' CG2' ' ND1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -149.64 132.21 15.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 1.0 110.232 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -85.26 165.22 17.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.827 . . . . 1.0 110.037 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 34.4 m170 -144.14 80.52 1.65 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 1.0 110.764 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 67.3 m-85 -79.77 152.99 29.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 1.0 109.442 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' HD23 ' A' ' 8' ' ' LEU . 12.1 mt-10 -136.24 158.86 43.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 1.0 110.941 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.5 OUTLIER -168.06 127.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.503 -0.748 . . . . 1.0 109.765 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -103.37 150.12 24.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -0.925 . . . . 1.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' HD2' ' A' ' 56' ' ' HIS . 3.3 mp -134.18 1.1 3.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 1.0 111.569 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.464 ' OG ' HD11 ' A' ' 2' ' ' ILE . 6.3 p 41.16 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.6 -0.688 . . . . 1.0 111.721 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HG3' HG21 ' A' ' 2' ' ' ILE . 1.4 mm-40 -136.44 119.74 12.21 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.9 -1.125 . . . . 1.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 45.9 Cg_endo -72.75 161.11 44.71 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.501 1.264 . . . . 1.0 110.122 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.78 86.77 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.205 -0.935 . . . . 1.0 110.328 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -168.37 144.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 1.0 109.902 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.42 -175.95 3.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 1.0 110.608 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.0 -164.8 35.03 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -157.32 158.22 35.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -1.144 . . . . 1.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 22.5 m95 -115.49 166.55 11.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.0 110.451 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -162.19 142.8 10.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 1.0 109.758 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 mt -64.16 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 1.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -49.47 -25.46 2.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.635 -1.291 . . . . 1.0 110.056 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.499 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 160.79 40.2 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.484 -1.446 . . . . 1.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 7.4 mm-40 -118.8 121.58 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 1.0 110.174 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.73 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.449 1.236 . . . . 1.0 110.744 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -173.99 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 1.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 43' ' ' ALA . 1.6 m -150.93 -178.06 6.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 1.0 110.274 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' H ' HG22 ' A' ' 42' ' ' THR . . . -65.19 106.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 1.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 164.37 24.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 1.0 110.167 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.48 -17.52 30.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.656 1.345 . . . . 1.0 110.613 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -83.45 -26.16 30.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 1.0 110.125 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -118.76 119.79 35.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.0 110.074 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -107.13 88.84 2.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.966 . . . . 1.0 110.409 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.417 HG12 HD11 ' A' ' 58' ' ' LEU . 97.3 mt -86.97 106.96 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 1.0 109.867 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' ILE . 6.2 tp -131.28 118.33 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 1.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' HIS . 1.5 pt-20 -149.37 169.25 21.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 1.0 110.133 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -117.08 -134.51 0.34 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.281 -0.887 . . . . 1.0 109.126 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -117.68 -19.81 4.8 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.679 -1.248 . . . . 1.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -21.81 22.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 1.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -153.79 173.12 16.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.184 -0.947 . . . . 1.0 110.545 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.797 ' HD2' HD13 ' A' ' 25' ' ' LEU . 57.5 m-70 -133.25 127.62 34.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.352 -0.842 . . . . 1.0 109.787 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.87 135.79 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 1.0 110.715 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.527 HD22 ' CE3' ' A' ' 34' ' ' TRP . 23.8 tp -112.89 147.96 35.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.495 -0.753 . . . . 1.0 110.144 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 87.8 mt -138.73 82.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0 109.882 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -73.2 161.71 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 1.0 110.467 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.5 m-70 -126.89 -169.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.486 -0.759 . . . . 1.0 109.503 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.514 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 42.2 p30 -13.64 80.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.778 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.5 m -78.98 175.12 10.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 1.0 109.501 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG11 ' A' ' 86' ' ' VAL . 1.2 mt-30 -138.58 -163.89 1.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.047 -1.033 . . . . 1.0 110.567 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.32 8.56 4.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 1.0 111.476 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.93 -22.91 19.23 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.064 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.479 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 37.7 mtt -86.69 34.93 0.66 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.067 -1.255 . . . . 1.0 110.799 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 34.9 0.93 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 1.0 110.134 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.35 -124.83 4.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.57 147.17 46.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -1.121 . . . . 1.0 110.393 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 70.7 t -89.05 107.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.316 -0.865 . . . . 1.0 109.884 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 p -108.03 110.6 22.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 1.0 110.663 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 22.7 t80 -91.03 146.87 23.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 1.0 109.823 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -131.54 104.55 7.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.037 -1.04 . . . . 1.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -123.62 124.94 43.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 1.0 109.763 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.84 -90.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 1.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 6.2 p30 -129.66 -38.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.807 -1.183 . . . . 1.0 110.378 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 1.03 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -63.09 159.76 16.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 1.0 110.516 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -156.63 126.92 6.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 1.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.58 ' OG ' HD11 ' A' ' 8' ' ' LEU . 75.5 p -92.52 -179.14 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.32 88.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -91.67 -170.18 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 1.0 110.307 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -119.91 111.59 18.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 1.0 110.363 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.692 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 66.0 tp -102.15 145.43 29.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 1.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.64 107.92 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.299 -0.875 . . . . 1.0 110.207 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 64' ' ' GLN . 46.3 t -80.9 147.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.118 -0.989 . . . . 1.0 110.405 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -115.45 168.37 10.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 110.165 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -101.95 155.46 18.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.241 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.205 0.526 . . . . 1.0 110.176 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.14 140.94 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.34 156.63 17.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 1.0 109.971 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.78 167.28 2.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.116 -0.99 . . . . 1.0 110.018 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -123.69 -30.72 3.55 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.482 0.658 . . . . 1.0 110.033 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -146.96 122.39 5.37 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 1.0 110.029 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.55 -176.49 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.535 1.282 . . . . 1.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.616 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 18.3 mt -82.46 -164.62 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.21 -0.931 . . . . 1.0 110.777 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.13 139.78 26.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.404 -0.81 . . . . 1.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.6 150.29 34.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.429 -1.468 . . . . 1.0 109.429 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.4 p -158.56 169.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 1.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 11' ' ' VAL . 3.0 mt-10 -122.29 165.05 16.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 1.0 110.499 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.5 p -158.94 127.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.238 -0.914 . . . . 1.0 110.104 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.55 47.57 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.217 -0.927 . . . . 1.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 63' ' ' CYS . 21.8 t 48.77 71.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.683 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.65 -22.52 1.04 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 13' ' ' VAL . 53.4 mm-40 -78.99 -122.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -1.157 . . . . 1.0 109.232 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -161.17 157.85 26.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.705 -1.247 . . . . 1.0 110.492 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -108.64 172.52 6.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.393 -0.817 . . . . 1.0 108.883 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.72 122.87 4.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.112 . . . . 1.0 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 58' ' ' LEU . 73.6 m-85 -140.32 132.82 28.61 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.16 155.5 41.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.937 -1.102 . . . . 1.0 111.155 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -167.8 122.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.607 -0.683 . . . . 1.0 109.752 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.24 130.35 54.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 1.0 110.491 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 56' ' ' HIS . 55.6 mt -91.33 -174.2 3.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.822 . . . . 1.0 109.871 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -99.03 -57.37 2.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.0 109.963 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.99 144.01 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 1.0 109.852 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 -169.5 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.628 1.331 . . . . 1.0 110.567 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t0 55.26 80.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 1.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 32' ' ' GLY . 75.4 t -131.28 154.09 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 1.0 109.899 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -124.53 43.53 2.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.92 . . . . 1.0 110.452 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 30' ' ' VAL . . . -77.74 171.36 55.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 12.4 tm0? -145.07 165.26 28.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -1.112 . . . . 1.0 109.902 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.931 ' CE3' HD22 ' A' ' 58' ' ' LEU . 34.2 m95 -108.52 163.84 12.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 1.0 110.819 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.581 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -159.59 157.11 29.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.413 -0.804 . . . . 1.0 110.102 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.42 HD22 ' HG2' ' A' ' 67' ' ' MET . 51.6 mt -68.31 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 1.0 109.805 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -47.34 -25.92 1.13 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.856 -1.152 . . . . 1.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 150.64 39.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 11.2 tt0 -136.41 136.47 22.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 O-C-N 121.126 -1.22 . . . . 1.0 109.132 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.42 114.48 3.94 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.468 1.246 . . . . 1.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 42' ' ' THR . 0.7 OUTLIER -92.77 -139.58 0.2 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 1.0 109.926 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.452 ' H ' HD12 ' A' ' 41' ' ' LEU . 1.2 p -138.69 136.85 36.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.119 . . . . 1.0 110.013 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.79 98.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 1.0 110.088 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -88.69 169.12 14.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 1.0 110.184 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.06 -16.72 28.71 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.731 1.385 . . . . 1.0 110.513 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -98.37 -21.27 16.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 1.0 110.376 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.27 136.32 33.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 1.0 110.181 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.63 136.42 54.49 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 1.0 109.626 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 49' ' ' ILE . 95.7 mt -139.39 76.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 1.0 109.761 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' ILE . 41.9 pt -85.4 144.32 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 1.0 110.038 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.76 137.53 8.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 1.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 26.6 8.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 1.0 109.872 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 -92.39 1.77 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -15.79 30.55 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.631 -0.923 . . . . 1.0 110.547 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -121.63 130.72 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 1.0 110.588 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.778 ' HB2' HG23 ' A' ' 23' ' ' ILE . 29.3 m-70 -118.16 131.13 56.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.0 110.085 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.97 136.42 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 1.0 110.226 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.931 HD22 ' CE3' ' A' ' 34' ' ' TRP . 16.2 tp -125.17 139.96 53.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 1.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 58' ' ' LEU . 33.9 mm -140.61 115.43 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 1.0 109.331 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 9.0 mt -112.82 108.46 17.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 1.0 110.846 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 25.0 m-70 -75.44 -159.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 1.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 54.0 t30 -14.13 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.815 ' O ' HG13 ' A' ' 15' ' ' VAL . 91.7 m -86.29 -176.27 5.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.6 -0.688 . . . . 1.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.646 ' C ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -149.96 -164.22 1.97 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 1.0 110.202 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.58 13.43 0.62 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.071 . . . . 1.0 112.404 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.36 -30.97 10.04 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.46 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 36.9 mtt -86.72 39.23 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -1.121 . . . . 1.0 110.565 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -90.69 79.77 6.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.181 -0.949 . . . . 1.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.64 -120.76 0.59 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.63 140.1 31.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 1.0 110.415 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.527 ' O ' HD13 ' A' ' 8' ' ' LEU . 70.5 t -84.69 102.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 1.0 109.853 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 p -102.83 128.69 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 1.0 110.365 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 53.9 t80 -105.57 142.04 36.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.0 109.622 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 127.64 32.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.038 . . . . 1.0 110.647 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.49 -147.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 1.0 109.746 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.43 -73.53 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.932 -1.105 . . . . 1.0 110.081 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -130.12 -1.21 4.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 1.0 110.794 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.22 156.11 23.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.927 -1.108 . . . . 1.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.07 125.88 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.927 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 2.6 p -126.17 178.34 5.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 1.0 109.729 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.55 106.69 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.01 -170.44 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 1.0 109.716 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.14 109.18 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.025 . . . . 1.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 67' ' ' MET . 58.2 tp -108.01 147.01 31.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 1.0 110.036 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 105.09 3.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 110.136 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.646 HG11 ' C ' ' A' ' 64' ' ' GLN . 38.3 t -80.5 133.35 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.186 -0.946 . . . . 1.0 110.149 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -98.44 146.26 25.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.06 149.05 48.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 1.0 110.168 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.235 -179.819 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.444 HD23 ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.179 0.514 . . . . 1.0 110.157 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 1.2 pt -110.15 133.03 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 1.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.6 162.82 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 1.0 110.271 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.695 HG21 ' OG ' ' A' ' 80' ' ' SER . 1.3 p -74.59 124.98 33.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.236 -0.915 . . . . 1.0 110.002 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.21 -34.6 23.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.736 0.779 . . . . 1.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -126.17 109.36 24.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.76 -0.587 . . . . 1.0 110.137 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.0 174.81 10.7 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.578 1.304 . . . . 1.0 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.954 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -87.01 -174.08 4.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0 109.535 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.7 m-85 -145.34 131.4 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 1.0 110.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.35 152.55 14.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.78 142.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -1.074 . . . . 1.0 110.39 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.31 155.0 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 1.0 109.599 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.07 170.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.025 -1.047 . . . . 1.0 110.931 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' N ' HG22 ' A' ' 13' ' ' VAL . 1.7 m-85 -102.13 135.6 43.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.6 p -49.46 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.909 -1.119 . . . . 1.0 111.048 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 147.15 -41.97 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -161.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -1.068 . . . . 1.0 110.107 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 p -120.98 163.57 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 1.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 21' ' ' PHE . . . -120.65 172.56 7.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.529 -0.732 . . . . 1.0 109.268 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.502 ' CD2' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -155.41 124.43 6.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 1.0 111.178 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.707 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 60.4 m-85 -134.36 118.44 17.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.523 -0.736 . . . . 1.0 109.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.51 157.11 17.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.052 -1.03 . . . . 1.0 111.034 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 56' ' ' HIS . 5.6 tt -168.43 120.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 1.0 109.801 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.69 148.6 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 1.0 110.274 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.3 mt -103.84 -154.36 0.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 1.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 31.1 t -116.44 -76.05 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 1.0 109.931 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.66 137.42 20.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.0 109.789 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.31 136.76 27.17 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.578 1.304 . . . . 1.0 110.53 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -164.01 -61.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 110.091 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.82 148.38 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 1.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -75.61 -164.02 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.29 179.38 25.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -131.53 149.35 52.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -1.18 . . . . 1.0 109.944 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.783 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.8 m95 -104.91 154.21 20.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 1.0 110.776 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 6.9 pttt -147.66 162.28 39.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 1.0 109.514 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 67' ' ' MET . 2.1 mt -81.99 -84.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 1.0 110.115 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 21.16 5.78 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.513 -0.742 . . . . 1.0 110.053 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 107.85 -14.7 37.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 1.0 109.633 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.4 mt-30 -82.94 134.76 46.07 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.175 -1.191 . . . . 1.0 110.044 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.92 114.25 3.99 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.695 1.366 . . . . 1.0 110.615 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 42' ' ' THR . 1.1 pp -73.12 -141.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.836 . . . . 1.0 109.461 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.0 t -158.92 163.45 36.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.742 -1.224 . . . . 1.0 110.252 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.91 106.5 0.31 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 m -116.59 159.44 40.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 1.0 110.17 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -4.8 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.672 1.354 . . . . 1.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.19 -22.76 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.983 -1.073 . . . . 1.0 110.28 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.494 ' SG ' HD21 ' A' ' 60' ' ' LEU . 48.2 t -101.76 122.81 44.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 1.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.49 144.54 44.2 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.147 -0.971 . . . . 1.0 109.233 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.44 85.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 1.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -87.38 120.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 1.0 109.911 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 19.6 pt-20 -146.02 147.52 31.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 1.0 110.505 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.56 23.44 5.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.732 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -74.58 2.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -18.12 24.1 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.736 -0.861 . . . . 1.0 110.823 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.66 43.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.034 -1.041 . . . . 1.0 110.816 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.693 ' HB2' HG23 ' A' ' 23' ' ' ILE . 67.5 m-70 -143.06 103.35 4.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 1.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.87 136.83 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 1.0 110.502 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD22 ' CE3' ' A' ' 34' ' ' TRP . 34.3 tp -117.35 130.72 56.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.311 -0.868 . . . . 1.0 110.387 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.502 HG12 ' CD2' ' A' ' 20' ' ' HIS . 21.1 mt -132.18 100.81 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 1.0 109.636 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mt -103.72 116.16 31.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 1.0 110.922 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 62' ' ' ASN . 43.9 m-70 -77.59 -166.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 1.0 109.945 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 61' ' ' HIS . 54.0 t30 -15.45 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.66 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.4 m -73.71 143.92 45.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.503 -0.748 . . . . 1.0 109.496 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -79.13 173.51 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.0 110.825 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -9.52 46.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.774 . . . . 1.0 110.904 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.14 -10.61 82.35 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.944 -1.122 . . . . 1.0 110.342 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.666 ' HB2' HG21 ' A' ' 86' ' ' VAL . 6.2 mtt -84.37 38.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.888 -1.36 . . . . 1.0 111.458 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -91.43 40.0 1.02 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.019 -1.051 . . . . 1.0 109.918 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.33 -128.31 4.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 83' ' ' ASN . 1.9 mp0 -135.13 -170.66 2.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -1.083 . . . . 1.0 110.468 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 78.1 t -128.61 78.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 110.072 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' A' ' 35' ' ' LYS . 17.1 p -86.78 125.21 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 1.0 110.15 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 23' ' ' ILE . 57.2 t80 -103.23 143.83 32.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 1.0 110.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -133.72 127.12 32.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 1.0 110.125 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -159.78 118.58 2.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.0 110.5 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.62 -89.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 1.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.444 ' ND2' HD23 ' A' ' 1' ' ' LEU . 41.6 t30 -128.03 -35.77 2.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.893 -1.129 . . . . 1.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 150.32 11.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 1.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 125.96 6.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 1.0 110.24 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.695 ' OG ' HG21 ' A' ' 4' ' ' VAL . 23.1 m -125.5 174.51 8.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 1.0 110.38 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.4 94.21 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 1.0 110.193 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -90.84 -172.88 3.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 1.0 110.29 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 17.8 m-20 -123.26 139.23 54.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.707 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 60.7 tp -143.72 127.42 17.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 1.0 110.386 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -134.7 132.95 39.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 1.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 67' ' ' MET . 35.2 t -91.66 126.07 44.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.268 -0.895 . . . . 1.0 110.19 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 160.36 14.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 1.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.32 -176.74 3.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.0 110.177 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.993 -1.004 . . . . 1.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.436 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.338 0.59 . . . . 1.0 110.111 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 2' ' ' ILE . 6.9 tt -170.25 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 1.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.439 ' OE2' ' HB1' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -150.27 179.54 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 1.0 111.044 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' VAL . 54.2 t 48.56 85.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.439 0.638 . . . . 1.0 111.078 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 6.4 mm-40 -98.4 -29.26 13.23 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 23' ' ' ILE . 7.0 tmtt? -129.46 114.85 18.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.73 165.88 21.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.443 1.233 . . . . 1.0 111.586 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.985 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 3.9 mt -65.53 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.752 -0.592 . . . . 1.0 110.721 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 10' ' ' GLY . 86.0 t80 -144.74 159.92 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 1.0 109.994 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 9' ' ' TYR . . . -95.48 141.66 15.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.511 -1.435 . . . . 1.0 109.511 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 84' ' ' LEU . 10.4 p -149.88 166.46 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -1.222 . . . . 1.0 110.408 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' VAL . 80.1 mt-10 -122.02 166.13 14.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.0 110.299 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.504 HG23 ' HA ' ' A' ' 86' ' ' VAL . 15.8 m -152.65 157.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.171 -0.956 . . . . 1.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -117.42 33.73 5.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.497 -0.752 . . . . 1.0 109.011 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 18.5 t 61.75 73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.701 0.762 . . . . 1.0 109.895 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 152.54 -23.11 0.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.24 164.96 22.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -1.119 . . . . 1.0 110.096 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.5 m -112.26 105.95 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.289 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.54 171.46 15.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 1.0 109.839 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CD2' HG12 ' A' ' 59' ' ' ILE . 13.1 m80 -144.99 120.5 10.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.0 110.734 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.72 ' CD1' HD23 ' A' ' 58' ' ' LEU . 77.0 m-85 -114.11 111.43 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.843 . . . . 1.0 109.365 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.92 165.66 11.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.148 -0.97 . . . . 1.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -170.04 119.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 1.0 109.802 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.34 124.49 43.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 1.0 110.206 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' A' ' 56' ' ' HIS . 26.0 mt -86.94 -150.64 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.195 -0.941 . . . . 1.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.411 ' HB3' HG12 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -126.67 -47.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.972 . . . . 1.0 110.211 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.73 150.19 37.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 1.0 110.608 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.11 -165.66 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.597 1.314 . . . . 1.0 110.335 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 t70 49.92 81.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.276 -0.89 . . . . 1.0 110.544 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.7 t -138.87 148.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 1.0 110.154 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -140.63 40.74 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 1.0 110.331 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.45 -150.3 0.04 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -166.31 -179.8 5.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -1.095 . . . . 1.0 109.674 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.55 ' CE3' HD22 ' A' ' 58' ' ' LEU . 57.9 m95 -117.65 131.06 56.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.982 -1.074 . . . . 1.0 110.628 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 2.7 ttpt -124.03 133.82 53.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.505 -0.747 . . . . 1.0 109.978 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.46 -130.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 1.0 109.815 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -28.84 3.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.592 -1.317 . . . . 1.0 110.708 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 154.47 39.46 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.961 -1.255 . . . . 1.0 109.961 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 1.1 pt20 -150.39 150.42 28.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.106 -1.232 . . . . 1.0 110.014 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.45 113.35 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.601 1.316 . . . . 1.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -70.34 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.46 -0.775 . . . . 1.0 109.877 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.523 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -168.41 14.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 1.0 112.119 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -75.76 -162.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.709 -1.245 . . . . 1.0 109.817 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.73 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.22 -0.925 . . . . 1.0 110.384 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.19 -42.87 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.525 1.276 . . . . 1.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -23.83 51.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 1.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.84 121.77 42.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 110.308 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.1 144.13 39.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 1.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -134.04 119.26 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 1.0 109.825 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.64 HG23 ' HB ' ' A' ' 57' ' ' ILE . 7.0 tp -130.07 109.26 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.08 147.65 50.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 1.0 110.397 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.02 20.98 17.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 1.0 110.185 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 -90.5 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -59.39 -16.0 20.26 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.662 -0.905 . . . . 1.0 110.836 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -125.28 168.12 13.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 25' ' ' LEU . 94.8 m-70 -149.99 126.87 11.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.64 ' HB ' HG23 ' A' ' 50' ' ' ILE . 57.6 mt -124.08 142.2 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 1.0 109.981 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.72 HD23 ' CD1' ' A' ' 21' ' ' PHE . 24.6 tp -118.48 145.44 45.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.104 -0.997 . . . . 1.0 110.409 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 20' ' ' HIS . 56.6 mt -141.2 92.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 1.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' THR . 16.3 mt -98.47 115.21 28.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 62' ' ' ASN . 31.6 m-70 -83.04 -165.04 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 1.0 109.702 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 50.2 t30 -16.57 82.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.762 1.023 . . . . 1.0 113.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' HIS . 71.9 m -69.95 -175.54 0.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.809 ' O ' HG11 ' A' ' 86' ' ' VAL . 2.9 mt-30 -138.31 -168.23 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 1.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mp -84.81 69.1 10.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 1.0 110.264 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.84 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.6 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.19 -15.32 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -1.168 . . . . 1.0 111.622 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -43.57 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.417 -0.802 . . . . 1.0 110.929 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 174.11 -127.35 1.31 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -139.82 146.4 39.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 1.0 110.456 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' HD13 ' A' ' 8' ' ' LEU . 69.6 t -94.39 87.66 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.343 -0.848 . . . . 1.0 109.957 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -87.91 110.11 20.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 1.0 110.426 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 27.8 t80 -71.48 154.2 41.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 1.0 110.072 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 139.46 52.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 1.0 110.1 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB1' ' OE2' ' A' ' 3' ' ' GLU . . . -160.72 -148.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 1.0 109.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -77.5 126.95 31.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 1.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 18.1 p30 34.05 31.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 76' ' ' ALA . . . -152.26 158.32 42.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 1.0 110.791 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -160.54 115.07 2.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 1.0 110.003 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 7.3 m -72.62 -172.75 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 1.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.44 97.43 0.25 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 1.0 110.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.985 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.46 -164.53 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 1.0 110.406 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.42 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 61.0 t-20 -132.13 137.43 47.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 1.0 109.598 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.689 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 65.0 tp -154.35 143.29 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 1.0 110.531 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -145.17 127.65 16.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.431 -0.793 . . . . 1.0 110.082 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.809 HG11 ' O ' ' A' ' 64' ' ' GLN . 16.9 t -92.54 142.64 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.366 -0.834 . . . . 1.0 109.732 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -141.4 130.05 22.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.999 . . . . 1.0 110.492 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.34 174.08 8.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 1.0 109.99 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 pt -100.64 161.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 1.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.82 -162.17 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.819 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 93.8 t -126.39 120.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 1.0 110.345 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -93.59 -44.98 7.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.249 -0.907 . . . . 1.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.9 tttt -108.87 109.34 61.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 1.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.1 173.8 13.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.434 1.229 . . . . 1.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.925 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 42.3 mt -75.34 169.38 18.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 1.0 110.162 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -137.06 153.02 50.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 1.0 110.177 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.33 136.53 20.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.056 -1.217 . . . . 1.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.4 t -136.86 154.85 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -1.111 . . . . 1.0 110.03 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -107.73 155.2 20.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.184 -0.947 . . . . 1.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 86' ' ' VAL . 5.5 p -152.1 134.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 1.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.21 39.85 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.24 -0.912 . . . . 1.0 110.378 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 87' ' ' LYS . 89.2 t 52.09 88.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 1.0 110.306 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.31 -29.38 2.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.349 -1.5 . . . . 1.0 109.349 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.92 -124.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.182 . . . . 1.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -160.27 114.48 2.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.698 -1.251 . . . . 1.0 111.002 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.77 148.19 31.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.938 . . . . 1.0 108.808 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -128.33 128.92 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.169 . . . . 1.0 111.469 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.702 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 99.5 m-85 -134.1 112.12 10.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.549 -0.719 . . . . 1.0 109.404 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.51 165.8 11.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 1.0 111.066 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -170.45 137.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.4 164.55 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.978 . . . . 1.0 110.97 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.671 HD12 HG21 ' A' ' 30' ' ' VAL . 71.3 mt -124.3 -148.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 1.0 109.81 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.49 -67.74 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 1.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -97.26 155.55 37.26 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 1.0 110.171 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -75.25 -167.41 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.707 1.372 . . . . 1.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 53.55 67.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.848 . . . . 1.0 110.432 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 25' ' ' LEU . 29.5 m -142.79 170.51 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 1.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -143.43 165.95 26.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.1 -171.7 36.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.18 156.83 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -1.088 . . . . 1.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.894 ' CE3' HD12 ' A' ' 58' ' ' LEU . 45.4 m95 -108.8 139.12 44.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 1.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 39' ' ' GLN . 2.9 ttpt -132.99 125.19 29.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.532 -0.73 . . . . 1.0 109.215 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.409 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 mp -64.45 -132.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.135 -0.978 . . . . 1.0 109.596 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -26.08 3.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.644 -1.285 . . . . 1.0 109.572 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 156.81 38.71 0.02 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.781 -1.328 . . . . 1.0 109.781 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 1.3 mm-40 -131.25 104.01 15.09 Favored Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.141 -1.211 . . . . 1.0 109.997 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.73 101.74 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.673 1.354 . . . . 1.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 42' ' ' THR . 2.1 pp -84.71 -151.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 1.0 110.466 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 41' ' ' LEU . 14.9 p -135.0 133.91 39.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 1.0 110.087 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.31 113.7 24.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 1.0 110.274 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -176.69 -60.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 1.0 110.399 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.3 Cg_endo -72.05 -57.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.348 1.183 . . . . 1.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -133.8 69.28 1.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.0 110.565 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -157.2 134.78 10.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 1.0 110.029 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -127.32 86.65 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.0 110.338 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -105.11 98.21 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 1.0 110.158 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.23 112.2 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -130.61 157.81 41.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 1.0 110.531 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.65 27.16 9.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 1.0 109.762 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.42 -87.72 1.41 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -55.88 -19.83 13.37 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.677 -0.896 . . . . 1.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 155.38 33.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 1.0 110.749 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.0 m-70 -138.65 102.77 4.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 1.0 109.845 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -109.33 137.22 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 1.0 110.535 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.894 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.2 tt -114.35 133.05 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 1.0 110.224 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.747 ' N ' HD23 ' A' ' 58' ' ' LEU . 22.7 mt -136.22 80.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.377 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.94 125.4 35.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 1.0 110.524 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.3 m-70 -83.33 -160.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 1.0 109.716 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 61' ' ' HIS . 37.5 t30 -14.56 82.12 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' HIS . 68.0 m -75.46 -178.27 3.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.506 -0.746 . . . . 1.0 109.954 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG11 ' A' ' 86' ' ' VAL . 5.4 tp-100 -117.08 169.66 9.26 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.168 -0.958 . . . . 1.0 109.143 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 88' ' ' GLU . 2.2 mp -72.79 4.22 4.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.822 -1.174 . . . . 1.0 112.139 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.7 -27.11 15.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.776 ' HB2' HG21 ' A' ' 86' ' ' VAL . 4.3 mtt -50.55 -23.21 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -1.043 . . . . 1.0 111.016 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 p -48.52 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.163 -0.961 . . . . 1.0 110.503 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.31 -126.4 0.97 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.072 -1.611 . . . . 1.0 109.072 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -135.35 136.14 41.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.137 . . . . 1.0 110.175 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 8' ' ' LEU . 52.3 t -91.45 87.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 1.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -91.85 111.64 23.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 1.0 110.863 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.889 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 19.6 t80 -86.78 133.53 33.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 1.0 109.375 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -110.55 70.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.986 . . . . 1.0 110.755 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.889 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -94.38 112.32 24.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 1.0 109.784 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.4 -159.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 1.0 109.988 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 26.1 p30 -62.65 -16.89 59.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 1.0 110.455 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.819 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -69.84 158.58 35.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 1.0 110.217 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -159.69 116.77 2.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.137 -0.977 . . . . 1.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 4.6 p -105.34 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 1.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.55 101.73 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 1.0 110.556 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.23 -164.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 1.0 110.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.38 147.28 52.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 1.0 109.944 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.702 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 52.9 tp -145.11 145.5 31.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 1.0 110.515 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 9.2 ptpt -138.2 105.86 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 1.0 109.71 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 67' ' ' MET . 99.2 t -89.49 117.71 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.245 -0.91 . . . . 1.0 110.501 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.6 mtpt -116.78 146.63 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 1.0 110.203 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.488 ' HG3' HD11 ' A' ' 65' ' ' LEU . 19.4 mt-10 -64.69 -171.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 1.0 110.256 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.314 0.578 . . . . 1.0 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 tt -144.39 162.6 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.927 . . . . 1.0 110.109 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.59 166.95 21.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.0 110.006 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 23' ' ' ILE . 2.0 p -80.04 -165.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.087 -1.008 . . . . 1.0 109.691 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 4' ' ' VAL . 50.0 mm-40 -127.74 -54.26 1.32 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 1.0 110.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -126.57 112.36 22.93 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.593 -0.692 . . . . 1.0 110.095 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.92 178.11 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.645 1.34 . . . . 1.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -75.4 173.89 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 1.0 110.168 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.9 m-85 -134.67 12.53 3.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.142 -0.974 . . . . 1.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 74.09 150.32 1.84 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.879 -1.288 . . . . 1.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 19' ' ' ALA . 77.3 t -145.35 161.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -1.11 . . . . 1.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 11' ' ' VAL . 62.8 mt-10 -125.88 149.72 48.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.0 110.387 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.855 HG23 ' CB ' ' A' ' 17' ' ' GLU . 3.1 p -155.6 135.01 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 1.0 109.915 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.47 58.62 3.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.281 -0.887 . . . . 1.0 110.788 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.4 t 46.08 81.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 1.0 110.925 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 139.57 -31.63 2.3 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.746 -1.742 . . . . 1.0 108.746 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.855 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.7 mt-10 -66.17 -158.36 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.494 -1.004 . . . . 1.0 109.502 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -142.74 108.87 5.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 1.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' HG11 ' A' ' 11' ' ' VAL . . . -79.05 132.72 36.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 1.0 109.505 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.9 110.09 18.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 1.0 111.107 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 85.6 m-85 -101.25 134.71 43.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 1.0 109.324 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -130.08 162.79 27.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.934 -1.104 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.672 HD11 HG21 ' A' ' 4' ' ' VAL . 1.1 tt -170.77 125.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.0 109.806 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -90.73 145.2 25.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 1.0 110.225 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.579 HD22 ' C ' ' A' ' 24' ' ' GLU . 4.2 mm? -111.23 155.14 23.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 1.0 109.996 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.54 -58.0 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -88.29 141.38 30.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 1.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.03 104.56 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.653 1.344 . . . . 1.0 110.153 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -119.85 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.112 -0.992 . . . . 1.0 109.201 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 30' ' ' VAL . 8.7 p -176.61 43.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 1.0 110.027 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -152.57 143.63 23.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 1.0 110.27 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.0 146.36 5.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 1.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -129.71 146.72 51.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -1.183 . . . . 1.0 110.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 1.038 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -112.5 173.22 6.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.967 . . . . 1.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 3.3 ptpt -171.2 152.55 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.521 -0.737 . . . . 1.0 109.596 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 67' ' ' MET . 3.5 mt -66.35 -94.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 1.0 109.813 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.58 21.84 5.95 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.124 -0.985 . . . . 1.0 109.946 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 35' ' ' LYS . . . 117.2 -0.27 19.07 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -92.35 109.13 36.06 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.27 . . . . 1.0 110.27 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.01 104.77 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.572 1.301 . . . . 1.0 110.43 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -71.85 -168.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 1.0 110.606 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' THR . 5.6 t -109.12 175.01 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 1.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 109.65 11.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 1.0 110.372 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -122.22 170.56 7.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 1.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.41 -24.23 19.56 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.627 1.33 . . . . 1.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.31 -40.31 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 1.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.49 127.74 35.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 1.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -119.36 144.1 47.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.914 . . . . 1.0 109.573 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.25 90.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 1.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.0 tp -113.02 147.48 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 1.0 110.187 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -159.67 149.48 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.199 -0.938 . . . . 1.0 110.197 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.32 22.75 11.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 1.0 110.173 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.63 -85.02 1.07 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -6.82 31.85 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.656 -0.908 . . . . 1.0 111.031 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.24 107.62 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.865 -1.147 . . . . 1.0 110.623 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.458 ' HB2' HG23 ' A' ' 23' ' ' ILE . 54.1 m-70 -87.32 133.59 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.231 -0.918 . . . . 1.0 109.992 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.1 mt -132.71 134.84 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.058 -1.027 . . . . 1.0 110.534 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.038 HD22 ' CE3' ' A' ' 34' ' ' TRP . 27.2 tp -117.16 150.96 37.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 1.0 110.083 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 59' ' ' ILE . 24.9 mm -143.43 99.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 1.0 109.945 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -105.69 116.57 32.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.0 110.08 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 62' ' ' ASN . 42.2 m-70 -85.99 -164.03 0.97 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.877 . . . . 1.0 110.278 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 66.8 t30 -14.71 81.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.808 1.04 . . . . 1.0 113.808 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 64.3 m -73.92 142.58 45.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.506 -0.746 . . . . 1.0 109.562 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.881 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.31 -175.71 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 1.0 110.787 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 65' ' ' LEU . 17.8 tp -79.59 5.26 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 1.0 111.127 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.01 -29.3 6.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.884 ' HB2' HG21 ' A' ' 86' ' ' VAL . 2.8 mtt -49.99 -23.57 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -1.13 . . . . 1.0 110.648 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -47.06 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.51 -0.744 . . . . 1.0 110.406 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.98 -121.6 0.59 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.96 174.29 10.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -1.076 . . . . 1.0 110.585 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 76.9 t -127.61 89.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -0.795 . . . . 1.0 109.742 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -97.9 125.16 42.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 1.0 110.609 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 46.9 t80 -113.75 157.85 21.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.447 -0.783 . . . . 1.0 109.632 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -143.48 136.73 27.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 1.0 110.683 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -160.5 120.62 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 1.0 109.454 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.64 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -0.872 . . . . 1.0 109.799 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.3 m-20 -128.92 -15.31 4.32 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 1.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.48 157.91 8.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.0 110.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -158.1 93.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 1.0 109.776 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 49.5 p -101.73 172.06 7.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.912 . . . . 1.0 110.72 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.17 91.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -0.809 . . . . 1.0 109.816 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -94.02 -171.05 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 1.0 110.593 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.81 133.38 55.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 1.0 110.244 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 11' ' ' VAL . 64.7 tp -132.02 136.88 47.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 1.0 110.218 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -135.27 131.54 36.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 1.0 109.973 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' MET . 93.6 t -100.58 153.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 1.0 109.852 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.0 mtpp -144.32 130.2 19.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 1.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.471 ' HG3' HD13 ' A' ' 65' ' ' LEU . 6.2 mt-10 -71.96 173.3 8.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 1.0 110.302 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 89' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.066 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 77' ' ' ASN . 2.0 mp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.273 0.559 . . . . 1.0 110.184 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.929 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.3 mt -90.01 148.38 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 1.0 109.75 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.02 -5.61 6.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 1.0 111.211 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 46.1 t 60.16 136.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.344 -0.848 . . . . 1.0 110.959 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -116.85 -37.02 3.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 1.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -119.0 109.0 39.86 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.765 -0.584 . . . . 1.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.05 172.72 14.13 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.604 1.318 . . . . 1.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.808 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 51.4 mt -73.3 170.0 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 1.0 110.348 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.55 113.1 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 1.0 110.066 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.9 153.34 4.32 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.508 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 9.0 p -153.43 158.76 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.382 -1.069 . . . . 1.0 110.176 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -112.18 160.49 17.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 1.0 110.406 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 86' ' ' VAL . 9.6 m -147.83 172.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 1.0 110.592 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -129.53 30.35 4.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 63' ' ' CYS . 40.9 t 58.34 70.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.716 0.769 . . . . 1.0 109.95 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.45 -21.49 1.06 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 18' ' ' THR . 58.7 mm-40 -76.31 -121.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 1.0 109.705 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.2 p -160.27 171.12 19.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.845 -1.16 . . . . 1.0 110.452 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.683 ' HB1' ' HE1' ' A' ' 21' ' ' PHE . . . -136.3 158.37 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.417 -0.802 . . . . 1.0 109.548 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 56.3 m80 -146.63 92.35 2.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 1.0 110.946 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.683 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 87.4 m-85 -106.65 112.39 25.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.181 -0.949 . . . . 1.0 109.713 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -121.77 157.4 31.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.997 . . . . 1.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -163.84 122.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.0 109.792 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.62 138.23 33.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 1.0 110.262 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD11 ' CD2' ' A' ' 56' ' ' HIS . 33.9 mt -109.0 170.16 8.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 1.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -11.08 42.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 1.0 110.67 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -123.82 124.98 26.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.0 110.167 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.83 171.2 18.73 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.417 1.219 . . . . 1.0 110.645 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 50.72 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 1.0 110.584 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.26 179.96 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 1.0 110.062 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -127.39 41.26 3.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 1.0 110.382 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 75' ' ' ALA . . . -86.32 174.26 46.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.762 -1.335 . . . . 1.0 109.762 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.07 155.59 32.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -1.13 . . . . 1.0 110.148 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' CE3' HD12 ' A' ' 58' ' ' LEU . 77.0 m95 -86.75 135.56 33.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.047 -1.033 . . . . 1.0 110.475 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -138.69 126.39 22.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.382 -0.824 . . . . 1.0 109.424 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 67' ' ' MET . 1.3 mt -63.62 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.171 -0.956 . . . . 1.0 109.274 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -25.04 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.48 -1.388 . . . . 1.0 109.51 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.74 38.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -128.39 136.4 29.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.238 . . . . 1.0 110.294 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.98 121.03 6.33 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.534 1.281 . . . . 1.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 42' ' ' THR . 2.2 pp -83.29 -149.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 1.0 110.026 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.851 ' N ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -157.74 120.89 3.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.949 . . . . 1.0 109.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -88.2 97.67 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 1.0 110.518 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.464 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER 176.03 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.274 -0.891 . . . . 1.0 110.424 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.2 Cg_endo -72.02 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.579 1.305 . . . . 1.0 111.196 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -113.84 57.78 0.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.924 -1.11 . . . . 1.0 110.729 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 11.2 t -152.28 126.79 9.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 1.0 110.169 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 1.5 mt-10 -111.44 52.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 1.0 110.393 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.634 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.68 124.48 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 1.0 109.985 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.634 ' N ' HD13 ' A' ' 49' ' ' ILE . 3.8 tt -121.42 128.06 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.238 -0.914 . . . . 1.0 110.136 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.02 137.68 14.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.92 . . . . 1.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.89 17.51 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 1.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.48 -24.13 26.98 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -90.56 -20.32 22.75 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.391 -1.064 . . . . 1.0 110.108 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -164.38 127.89 2.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.33 -0.856 . . . . 1.0 110.287 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 23' ' ' ILE . 84.5 m-70 -96.61 120.6 37.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 1.0 110.03 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 55' ' ' LYS . 3.3 mp -130.15 140.07 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 110.217 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.705 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -127.76 130.77 49.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 58' ' ' LEU . 81.6 mt -135.41 87.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 1.0 109.394 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.721 HD13 ' CE ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -96.87 119.08 34.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 1.0 110.729 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.8 m-70 -80.08 -161.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 1.0 109.423 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.492 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.7 p30 -14.38 80.97 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.927 1.084 . . . . 1.0 113.927 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.445 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.7 m -70.22 -169.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.573 -0.704 . . . . 1.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.777 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.69 -163.68 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 1.0 110.435 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 88' ' ' GLU . 9.2 mp -82.38 34.21 0.42 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.105 -0.997 . . . . 1.0 111.472 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.82 -29.82 2.98 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.655 -1.778 . . . . 1.0 108.655 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 60' ' ' LEU . 53.6 mtp -88.02 36.22 0.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.991 . . . . 1.0 110.228 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -90.26 58.83 4.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 1.0 109.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -154.83 -125.81 0.99 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.54 151.19 52.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.438 -1.037 . . . . 1.0 110.483 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' LEU . 60.2 t -95.13 84.26 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 1.0 109.924 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.6 p -88.28 119.87 29.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -103.23 143.34 32.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' O ' ' CA ' ' A' ' 32' ' ' GLY . 24.3 mt-30 -130.41 137.18 49.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . . . -164.33 105.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 1.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.929 ' HB3' HD12 ' A' ' 2' ' ' ILE . . . 56.47 -89.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 1.0 110.31 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 1' ' ' LEU . 1.8 t30 -114.78 -27.18 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.956 -1.09 . . . . 1.0 110.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.04 141.91 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 1.0 110.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 75.62 1.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 1.0 109.967 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.438 ' OG ' HD11 ' A' ' 8' ' ' LEU . 61.4 p -90.98 176.96 6.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.953 . . . . 1.0 110.146 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.03 93.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.0 110.15 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.808 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -89.99 -171.29 3.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 1.0 110.069 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.12 105.61 8.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 1.0 109.932 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.608 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 42.5 tp -112.66 124.53 52.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 1.0 110.577 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -127.76 134.72 49.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 1.0 109.807 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.777 HG11 ' O ' ' A' ' 64' ' ' GLN . 84.3 t -100.19 135.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 109.934 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -122.95 134.17 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.0 110.306 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 65' ' ' LEU . 21.8 mt-10 -76.29 169.03 18.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 1.0 110.072 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.291 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.286 0.565 . . . . 1.0 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 16.9 pt -118.77 174.16 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.857 . . . . 1.0 110.136 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -122.52 -166.18 1.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 110.499 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.005 HG23 ' HB1' ' A' ' 78' ' ' ALA . 63.6 t -116.31 122.09 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 1.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.74 -41.72 26.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 1.0 108.733 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 2.3 mtmt -117.77 101.75 51.9 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.823 -0.548 . . . . 1.0 109.855 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.15 174.35 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.599 1.315 . . . . 1.0 110.74 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.874 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 17.7 mt -75.3 176.38 7.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 1.0 110.015 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 28.0 m-85 -135.18 125.0 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.0 110.234 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 142.69 40.78 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.558 ' O ' HD12 ' A' ' 84' ' ' LEU . 7.7 p -153.56 164.03 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -1.073 . . . . 1.0 109.851 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 11' ' ' VAL . 31.3 mt-10 -124.82 152.78 43.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 1.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 17' ' ' GLU . 11.3 p -142.12 149.02 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.82 . . . . 1.0 110.138 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -88.87 47.96 1.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 1.0 110.475 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.7 p 37.02 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.733 0.778 . . . . 1.0 111.72 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 159.01 -25.42 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.05 -1.62 . . . . 1.0 109.05 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.6 mm-40 -76.47 -112.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -1.098 . . . . 1.0 109.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -161.18 151.17 17.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.592 -1.317 . . . . 1.0 110.826 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -107.2 160.94 15.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 1.0 109.076 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -153.81 97.91 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.0 111.105 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.759 ' CD2' HD23 ' A' ' 58' ' ' LEU . 88.0 m-85 -111.73 108.14 17.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.544 -0.723 . . . . 1.0 109.324 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 155.17 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.324 -0.86 . . . . 1.0 110.509 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.738 HD11 ' OG ' ' A' ' 80' ' ' SER . 7.2 tt -164.81 139.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.444 -0.785 . . . . 1.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -120.45 143.38 48.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.975 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.2 mt -108.03 -156.71 0.59 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 1.0 110.179 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -108.1 -68.37 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 1.0 110.388 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.76 130.1 23.27 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 1.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -78.14 154.53 29.03 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.408 1.215 . . . . 1.0 110.166 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.22 -61.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 1.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.16 166.12 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 1.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 p-80 -70.81 -164.85 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.841 . . . . 1.0 110.411 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.4 -150.58 5.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.606 -1.398 . . . . 1.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.25 135.27 3.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.373 -1.075 . . . . 1.0 110.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.877 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -101.95 149.01 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 1.0 110.608 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 19.1 ttpt -141.54 123.14 15.09 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.35 -0.843 . . . . 1.0 109.592 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.44 -131.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 1.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.52 -25.16 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.411 -1.43 . . . . 1.0 109.619 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.42 38.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.698 -1.361 . . . . 1.0 109.698 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 7.9 mm-40 -126.68 109.03 22.79 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.162 -1.199 . . . . 1.0 110.147 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.08 83.83 1.58 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.62 1.326 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.09 -163.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 1.0 110.678 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.1 148.39 50.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 1.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.857 ' HB2' HG22 ' A' ' 49' ' ' ILE . . . -88.28 107.48 18.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 1.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -179.32 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.269 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.87 -50.82 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.59 1.31 . . . . 1.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.0 -54.72 1.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -0.985 . . . . 1.0 110.823 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HA ' HD23 ' A' ' 60' ' ' LEU . 36.8 t -69.5 150.04 47.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 1.0 110.443 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.15 65.0 1.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.875 . . . . 1.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.857 HG22 ' HB2' ' A' ' 43' ' ' ALA . 6.1 tp -84.56 140.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 1.0 110.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.7 mt -128.84 120.96 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.084 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -136.25 141.79 43.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 1.0 110.273 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.85 27.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.222 -0.924 . . . . 1.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.82 -23.92 30.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -90.38 71.8 7.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -1.018 . . . . 1.0 108.93 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 24' ' ' GLU . 5.4 mmtt 54.79 170.83 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.889 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 89.9 m-70 -114.69 144.92 42.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.982 -1.074 . . . . 1.0 110.763 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -140.47 115.06 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.842 . . . . 1.0 109.799 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.877 HD22 ' CE3' ' A' ' 34' ' ' TRP . 44.8 tp -99.19 132.03 44.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 1.0 110.862 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 20' ' ' HIS . 98.6 mt -133.33 93.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.474 -0.766 . . . . 1.0 109.456 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 2.6 mt -95.51 105.05 16.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 1.0 110.93 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 68.1 m-70 -69.85 -169.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 1.0 109.475 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 40.5 p-10 -14.87 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.867 1.062 . . . . 1.0 113.867 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.2 m -70.62 -156.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.639 -0.663 . . . . 1.0 109.429 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.783 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -151.43 -169.97 3.52 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.967 -1.083 . . . . 1.0 110.815 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 38.51 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -0.784 . . . . 1.0 111.517 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.55 -15.02 2.5 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.803 -1.189 . . . . 1.0 110.293 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -87.42 37.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.718 -1.46 . . . . 1.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.22 40.27 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 1.0 110.139 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 -125.11 2.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -136.93 152.33 50.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -1.042 . . . . 1.0 110.294 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 71.1 t -94.34 88.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.908 . . . . 1.0 109.84 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.5 p -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 1.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 41.0 t80 -96.39 146.27 24.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 1.0 109.95 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -152.58 126.6 9.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 1.0 110.379 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -132.66 16.06 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.11 -0.994 . . . . 1.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 169.15 -81.97 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.363 -0.835 . . . . 1.0 109.601 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -127.2 -39.03 1.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 1.0 109.535 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 1.005 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -69.29 119.38 13.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.831 . . . . 1.0 110.016 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 1.4 mtpt -123.29 95.81 4.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 1.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.738 ' OG ' HD11 ' A' ' 23' ' ' ILE . 14.3 m -73.35 -179.24 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 1.0 110.182 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.39 104.75 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 1.0 110.576 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.28 -176.64 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 1.0 110.108 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.37 121.15 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 1.0 109.838 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.668 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 56.4 tp -125.2 133.98 52.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 1.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -130.88 130.42 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 1.0 109.511 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 64' ' ' GLN . 92.0 t -91.64 145.48 7.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.181 -0.949 . . . . 1.0 110.447 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -135.47 141.37 45.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.418 -0.801 . . . . 1.0 109.921 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.98 -167.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 1.0 110.336 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.593 HD12 ' HE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.18 0.514 . . . . 1.0 110.217 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.6 mm -123.32 166.83 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 1.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.6 -154.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 1.0 110.344 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.991 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 27.7 t -125.17 127.49 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 1.0 109.958 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.39 -46.17 6.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 1.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.23 107.87 61.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.705 -0.622 . . . . 1.0 110.063 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.17 173.73 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.563 1.297 . . . . 1.0 110.799 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 49.6 mt -75.39 173.89 10.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 1.0 110.45 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -138.59 122.55 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 1.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.0 146.66 47.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.791 -1.323 . . . . 1.0 109.791 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 12' ' ' GLU . 74.3 t -144.23 162.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 1.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 11' ' ' VAL . 3.2 mt-10 -108.41 154.8 21.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 ' CG ' ' A' ' 17' ' ' GLU . 2.7 p -151.08 130.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.0 110.013 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.55 38.06 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 1.0 110.337 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.571 ' H ' HG22 ' A' ' 13' ' ' VAL . 47.3 t 55.82 99.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.374 -0.829 . . . . 1.0 110.684 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.435 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 131.83 -40.8 1.58 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.988 ' CG ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -69.69 -136.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 1.0 109.062 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.3 m -154.42 120.65 5.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.795 -1.191 . . . . 1.0 110.763 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 152.81 30.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 59' ' ' ILE . 10.0 m80 -138.07 133.34 33.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.907 -1.12 . . . . 1.0 111.561 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.837 ' CE1' HG21 ' A' ' 71' ' ' VAL . 75.0 m-85 -125.7 135.47 52.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -125.43 154.65 41.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.0 111.574 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -168.15 135.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.64 . . . . 1.0 109.438 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -125.98 142.97 51.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 1.0 110.618 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.03 -164.16 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.352 -0.842 . . . . 1.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.492 ' HB2' HG23 ' A' ' 2' ' ' ILE . 19.8 m -108.47 -42.85 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 1.0 109.981 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -132.13 132.56 23.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 1.0 110.045 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 143.41 35.49 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.362 1.19 . . . . 1.0 110.441 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -168.71 -54.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 1.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.52 157.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.06 174.4 10.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 1.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.33 -177.41 14.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.597 -1.401 . . . . 1.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.11 151.63 40.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.091 . . . . 1.0 110.107 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.683 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.7 m95 -110.46 147.06 34.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 1.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.451 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 ttpp -133.38 119.56 19.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.426 -0.796 . . . . 1.0 109.525 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -63.66 -135.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.395 -0.816 . . . . 1.0 108.816 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -49.8 -24.63 2.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.243 -1.535 . . . . 1.0 109.759 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 153.8 42.6 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -129.82 122.33 20.44 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.434 -1.039 . . . . 1.0 110.097 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.1 88.58 0.95 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.461 1.243 . . . . 1.0 110.386 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 42' ' ' THR . 4.4 pp -72.22 -160.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 1.0 110.691 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.834 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -170.32 -176.82 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.582 -0.699 . . . . 1.0 109.794 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 102.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.0 109.976 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -127.75 177.04 2.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 1.0 110.493 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 48.3 Cg_endo -73.87 -20.7 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.698 1.368 . . . . 1.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -98.18 -39.99 8.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 1.0 110.387 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.673 ' SG ' HD21 ' A' ' 60' ' ' LEU . 1.3 m -88.1 158.34 18.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.22 -0.925 . . . . 1.0 110.275 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -148.14 67.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 1.0 110.247 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.9 tt -85.09 128.67 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -0.793 . . . . 1.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.0 128.9 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 1.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.13 151.24 32.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 1.0 110.367 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -130.6 20.98 5.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 1.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.92 -61.97 3.34 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -12.79 61.88 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.614 -0.933 . . . . 1.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.89 148.5 29.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.978 -1.076 . . . . 1.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.731 ' HB2' HG23 ' A' ' 23' ' ' ILE . 62.4 m-70 -128.02 107.66 10.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 109.967 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.32 148.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 1.0 110.55 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.689 HD23 ' CD2' ' A' ' 21' ' ' PHE . 19.7 tp -133.48 121.79 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.353 -0.842 . . . . 1.0 110.188 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 20' ' ' HIS . 40.6 mt -122.9 126.17 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 1.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.941 HD22 ' CE ' ' A' ' 67' ' ' MET . 0.2 OUTLIER -129.35 103.0 6.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 1.0 110.372 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 79.6 m-70 -70.16 -163.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.25 -0.906 . . . . 1.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 29.2 t-20 -13.53 81.44 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 15' ' ' VAL . 78.5 m -83.15 -159.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.0 109.253 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.802 ' O ' HG11 ' A' ' 86' ' ' VAL . 3.1 mt-30 -142.82 -170.47 3.24 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.204 -0.935 . . . . 1.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.59 9.19 6.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.3 -29.26 10.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 1.0 109.39 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.941 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.29 -23.3 1.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.328 -1.101 . . . . 1.0 111.429 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -46.49 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.148 -0.97 . . . . 1.0 110.621 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.86 -121.29 0.63 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.253 -1.539 . . . . 1.0 109.253 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -155.3 145.74 22.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -1.12 . . . . 1.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.837 HG21 ' CE1' ' A' ' 21' ' ' PHE . 67.8 t -98.11 93.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 1.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' SER . 86.4 p -96.03 101.44 13.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.0 110.441 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 32.1 t80 -73.61 154.24 39.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 1.0 109.557 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 106.52 7.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.063 -1.023 . . . . 1.0 110.688 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -143.58 118.22 9.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 1.0 109.682 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.56 -153.99 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 1.0 109.865 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -74.29 -10.45 59.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 1.0 110.504 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.991 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -83.62 153.63 24.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.944 -1.098 . . . . 1.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -159.59 145.89 16.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 1.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 76.8 p -125.87 178.1 5.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.8 103.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 1.0 110.204 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.21 -174.59 2.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 1.0 110.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.88 129.6 36.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 1.0 110.004 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 1.1 tt -135.8 145.62 46.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 1.0 110.469 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 136.33 46.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 1.0 109.802 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.802 HG11 ' O ' ' A' ' 64' ' ' GLN . 61.3 t -103.7 151.16 6.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.249 -0.907 . . . . 1.0 110.446 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.66 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 1.0 110.201 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -93.42 145.59 24.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.358 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.105 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.252 0.549 . . . . 1.0 110.201 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.503 HG22 ' OG ' ' A' ' 26' ' ' SER . 25.8 pt -102.15 158.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 110.198 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.68 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 1.0 110.19 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.97 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -86.48 -34.45 20.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -131.01 112.47 15.93 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.13 171.4 11.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.647 1.34 . . . . 1.0 111.455 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.904 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 67.7 mt -59.95 -167.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.562 0.696 . . . . 1.0 110.913 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 10' ' ' GLY . 20.9 t80 -134.4 158.64 43.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 1.0 110.001 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -99.13 133.49 11.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.697 ' O ' HD12 ' A' ' 84' ' ' LEU . 8.6 p -152.81 164.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -1.144 . . . . 1.0 110.256 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' VAL . 4.6 pt-20 -118.69 172.31 7.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.92 . . . . 1.0 110.58 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG23 HG13 ' A' ' 86' ' ' VAL . 13.1 m -155.25 134.69 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 1.0 110.5 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.9 34.68 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 1.0 109.775 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 14.5 t 61.73 73.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.462 -0.773 . . . . 1.0 110.439 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.41 -25.34 1.09 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.866 -1.693 . . . . 1.0 108.866 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 -163.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.35 -1.088 . . . . 1.0 109.531 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 m -144.32 113.03 6.66 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.2 -0.938 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.29 161.8 26.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 1.0 109.638 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -139.29 88.31 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.002 . . . . 1.0 110.691 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.874 ' CD1' HD23 ' A' ' 58' ' ' LEU . 81.0 m-85 -84.03 162.12 20.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 1.0 109.594 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -153.65 162.49 41.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.046 . . . . 1.0 110.678 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 56' ' ' HIS . 4.7 tt -169.23 135.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.448 -0.782 . . . . 1.0 109.921 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.88 136.45 49.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.111 -0.993 . . . . 1.0 110.057 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.1 mt -101.7 -151.19 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.958 . . . . 1.0 109.879 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 2' ' ' ILE . 24.3 p -117.31 -46.72 2.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 1.0 109.989 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.1 140.8 21.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 1.0 110.064 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.17 178.91 6.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.558 1.294 . . . . 1.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 t70 54.59 92.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 1.0 110.732 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.4 p -156.84 154.51 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 1.0 109.874 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 49.1 p-80 -108.74 121.16 44.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 1.0 110.657 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.81 156.18 26.88 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.41 ' C ' ' CD1' ' A' ' 34' ' ' TRP . 14.2 mm-40 -124.41 177.81 5.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -1.232 . . . . 1.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.658 ' CB ' HD13 ' A' ' 58' ' ' LEU . 37.4 m95 -136.43 139.04 42.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.451 -0.78 . . . . 1.0 110.682 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 6.7 tttp -157.11 -109.99 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.211 -0.931 . . . . 1.0 109.614 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -157.89 -160.11 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.929 -1.107 . . . . 1.0 109.005 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.833 -1.167 . . . . 1.0 109.632 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.75 -114.19 0.01 OUTLIER Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 2.0 mm-40 -136.33 176.59 2.7 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 107.475 -1.306 . . . . 1.0 107.475 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HD2' ' OE1' ' A' ' 39' ' ' GLN . 50.5 Cg_endo -86.06 116.42 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.678 1.357 . . . . 1.0 110.878 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -95.29 -167.75 1.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.81 -1.181 . . . . 1.0 110.716 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.5 p -116.09 162.33 17.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.0 110.218 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.46 120.46 16.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.91 . . . . 1.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.487 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.4 t -173.29 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 1.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -67.87 -89.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.33 1.174 . . . . 1.0 111.146 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.29 70.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 1.0 110.322 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.83 129.6 11.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 1.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.18 94.76 4.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 1.0 109.878 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.2 89.31 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 1.0 110.664 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 50' ' ' ILE . 8.3 tt -89.17 119.65 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.868 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.68 145.5 47.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.99 . . . . 1.0 110.599 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.29 23.24 14.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 1.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.57 -89.25 1.23 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -49.15 -23.81 1.43 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.878 . . . . 1.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -137.5 157.35 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.983 -1.073 . . . . 1.0 110.237 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.741 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.1 m-70 -118.1 138.06 52.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.532 -0.73 . . . . 1.0 109.486 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -140.33 128.46 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.037 -1.039 . . . . 1.0 110.783 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.874 HD23 ' CD1' ' A' ' 21' ' ' PHE . 9.9 tp -103.99 149.9 24.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 1.0 110.421 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 64.9 mt -140.0 82.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.795 . . . . 1.0 109.372 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 60' ' ' LEU . 5.1 mt -84.19 115.37 22.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 1.0 110.729 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 62' ' ' ASN . 60.8 m-70 -87.74 -165.84 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 1.0 109.624 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 7.5 p-10 -14.27 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 85.2 m -74.86 -155.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.639 -0.663 . . . . 1.0 109.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.723 ' O ' HG11 ' A' ' 86' ' ' VAL . 15.6 mt-30 -159.47 -165.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 1.0 110.613 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.39 39.84 0.8 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 1.0 111.237 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.98 -37.83 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.981 -1.647 . . . . 1.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.463 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 50.3 mtt -63.15 -13.36 36.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.365 -1.079 . . . . 1.0 110.778 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.77 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.297 -0.877 . . . . 1.0 110.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 170.75 -113.57 0.5 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.933 -1.667 . . . . 1.0 108.933 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.81 136.4 24.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.48 -1.012 . . . . 1.0 110.468 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.1 t -79.28 144.07 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 1.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 p -136.42 126.56 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.48 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 59.1 t80 -105.66 147.11 28.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.695 . . . . 1.0 109.131 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -137.91 152.5 49.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 1.0 110.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.46 -149.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 1.0 109.939 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.03 -76.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 1.0 110.24 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -123.73 17.01 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 1.0 110.301 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.76 137.92 42.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 1.0 110.658 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 14.9 ptmt -154.16 101.53 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.515 -0.741 . . . . 1.0 109.637 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.41 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 13.4 m -105.15 -176.04 2.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 1.0 110.535 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -167.08 97.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 1.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.55 -168.07 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 1.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -122.14 143.97 49.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 1.0 110.178 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 11' ' ' VAL . 57.1 tp -150.69 119.75 6.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 1.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -117.33 125.98 51.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 1.0 109.852 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.723 HG11 ' O ' ' A' ' 64' ' ' GLN . 41.5 t -90.77 112.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.347 -0.845 . . . . 1.0 110.058 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.33 144.98 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 1.0 110.381 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.15 -177.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 1.0 110.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 89' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.226 0.536 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 77' ' ' ASN . 44.1 mm -95.37 146.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 1.0 109.756 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 1.1 tp10 -129.85 -5.16 4.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 1.0 111.194 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 47.5 t 56.72 108.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 1.0 110.308 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -78.18 -51.49 10.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.054 -1.029 . . . . 1.0 109.884 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -122.91 108.48 32.66 Favored Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 120.073 -0.651 . . . . 1.0 110.277 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.42 -175.8 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.572 1.301 . . . . 1.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 7.0 mt -71.0 -161.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 1.0 110.67 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 30.7 p90 -160.4 133.85 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.7 149.01 33.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 7.3 p -155.39 168.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -1.104 . . . . 1.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 44.8 mt-10 -114.69 158.92 21.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 1.0 110.28 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 14' ' ' PHE . 8.8 p -155.82 171.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 1.0 110.342 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.71 135.56 54.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 1.0 109.446 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 11.7 p -50.8 112.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 1.0 110.572 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 122.22 -48.67 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.825 -1.71 . . . . 1.0 108.825 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -165.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -1.018 . . . . 1.0 109.924 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 60' ' ' LEU . 1.1 p -121.42 148.29 44.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 1.0 110.449 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.2 174.97 6.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 1.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -158.97 110.94 2.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 1.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.816 ' CD1' HD23 ' A' ' 58' ' ' LEU . 96.2 m-85 -116.49 156.59 26.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.56 160.53 41.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.03 . . . . 1.0 110.45 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 23' ' ' ILE . 9.3 tt -170.56 124.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 1.0 109.848 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.535 ' O ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -79.73 132.71 36.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 1.0 110.107 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 24' ' ' GLU . 2.5 mm? -119.97 -177.35 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 1.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 t -132.1 20.53 4.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 1.0 110.122 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.22 156.37 66.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 1.0 110.197 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.72 -20.76 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.683 1.359 . . . . 1.0 110.38 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.62 -132.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 1.0 109.392 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.87 167.27 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.632 -1.293 . . . . 1.0 110.102 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -175.53 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 1.0 110.277 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -97.85 -177.46 33.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.42 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.25 167.77 25.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -1.078 . . . . 1.0 110.092 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.754 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.9 m95 -99.82 167.06 10.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 1.0 110.496 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -171.4 153.43 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 1.0 109.91 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 67' ' ' MET . 4.0 mt -67.22 -131.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.09 -1.006 . . . . 1.0 109.894 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -48.1 -25.36 1.42 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.666 -1.271 . . . . 1.0 110.638 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 154.06 39.3 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.645 -1.382 . . . . 1.0 109.645 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -131.87 117.21 16.08 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.164 -1.198 . . . . 1.0 109.442 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.88 94.07 1.01 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.649 1.342 . . . . 1.0 109.959 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -179.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 42' ' ' THR . 90.7 m -136.56 23.53 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.772 . . . . 1.0 110.094 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.56 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 1.0 110.397 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -174.4 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 1.0 110.91 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 45.0 Cg_endo -70.6 -14.11 33.14 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.304 1.16 . . . . 1.0 111.115 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 47' ' ' CYS . 2.6 p30 -113.05 -24.53 9.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.017 . . . . 1.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.41 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 53.4 t -122.7 128.8 51.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.114 -0.991 . . . . 1.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -118.45 140.04 50.48 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.189 -0.944 . . . . 1.0 109.664 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.562 HG22 ' OE2' ' A' ' 51' ' ' GLU . 97.1 mt -139.61 108.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.486 -0.759 . . . . 1.0 109.801 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 50' ' ' ILE . 8.9 tp -128.02 128.01 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 1.0 110.494 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -154.78 138.66 16.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 1.0 109.894 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -122.54 18.88 10.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 1.0 110.775 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -42.54 2.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.955 -1.258 . . . . 1.0 109.955 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -62.31 -29.69 70.62 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.571 -0.958 . . . . 1.0 110.044 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 146.5 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.33 -0.856 . . . . 1.0 110.283 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' ' HG ' ' A' ' 25' ' ' LEU . 86.0 m-70 -105.72 119.65 39.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 1.0 110.01 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.55 137.55 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.209 -0.932 . . . . 1.0 110.383 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 ' CD1' ' A' ' 21' ' ' PHE . 15.5 tp -120.63 136.98 54.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.393 -0.817 . . . . 1.0 110.186 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.2 mt -141.73 100.7 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 18' ' ' THR . 0.3 OUTLIER -98.25 170.93 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 1.0 110.499 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.4 m-70 -126.52 -168.31 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.421 -0.8 . . . . 1.0 109.665 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 61' ' ' HIS . 15.2 p-10 -14.78 81.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.815 1.042 . . . . 1.0 113.815 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 15' ' ' VAL . 62.7 m -78.63 165.47 23.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.694 -0.629 . . . . 1.0 109.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' VAL . 3.9 tp-100 -105.27 167.16 9.91 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.112 -0.992 . . . . 1.0 109.234 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.434 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -66.58 0.51 2.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.95 -1.094 . . . . 1.0 112.5 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.77 -21.42 33.88 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -50.99 -20.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -1.131 . . . . 1.0 111.523 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 m -44.42 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.305 -0.872 . . . . 1.0 110.736 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.78 -119.15 0.49 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.79 130.57 10.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.017 . . . . 1.0 110.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 8' ' ' LEU . 25.4 t -85.33 93.36 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 1.0 109.144 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -101.5 150.76 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.059 . . . . 1.0 110.934 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 64.2 t80 -118.12 138.04 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.517 -0.739 . . . . 1.0 109.692 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 10.3 pt20 -121.35 151.59 39.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 1.0 110.5 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . . . -167.8 -153.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 1.0 110.068 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -67.37 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.973 . . . . 1.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 57.2 t30 -130.25 18.76 5.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 1.0 110.152 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . . . -99.04 149.89 22.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -159.71 74.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 1.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.493 ' OG ' HD11 ' A' ' 8' ' ' LEU . 83.5 p -82.95 168.45 17.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.82 96.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.1 -174.22 3.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 1.0 110.08 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -125.49 107.54 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 1.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD22 ' HZ ' ' A' ' 21' ' ' PHE . 55.7 tp -108.42 138.89 43.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 1.0 110.567 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -131.11 140.45 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.815 . . . . 1.0 109.945 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 67' ' ' MET . 97.6 t -97.41 116.33 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.912 . . . . 1.0 110.195 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -93.85 130.67 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 110.491 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -68.23 179.03 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 1.0 110.039 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.232 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.43 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.267 0.556 . . . . 1.0 110.345 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 27' ' ' GLU . 6.1 pt -88.26 -170.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 1.0 110.272 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -135.95 -165.58 1.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.0 110.231 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.634 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 99.4 t -126.14 125.5 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 1.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -86.79 -48.0 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 1.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -117.79 107.27 44.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.65 -0.656 . . . . 1.0 109.886 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.76 176.83 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.679 1.357 . . . . 1.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.742 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 80.9 mt -60.16 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 1.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 88.4 t80 -152.36 163.31 39.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 1.0 109.549 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -87.45 145.92 19.86 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.842 -1.303 . . . . 1.0 109.842 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG22 ' N ' ' A' ' 12' ' ' GLU . 8.2 p -153.8 164.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.0 110.241 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 11' ' ' VAL . 36.9 mt-10 -121.26 163.48 18.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 1.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.2 p -155.65 132.61 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 1.0 109.931 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CA ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -87.32 76.08 9.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 1.0 110.959 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 32.8 t 59.36 97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.841 0.829 . . . . 1.0 112.049 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' ' N ' ' A' ' 63' ' ' CYS . . . 46.12 23.34 1.12 Allowed Glycine 0 N--CA 1.495 2.592 0 O-C-N 121.943 -0.473 . . . . 1.0 113.217 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HG3' ' CA ' ' A' ' 14' ' ' PHE . 1.8 mm-40 -62.49 -75.17 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.714 1.757 . . . . 1.0 107.653 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.701 HG23 ' CE1' ' A' ' 61' ' ' HIS . 63.3 m -162.02 151.38 15.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.783 -0.573 . . . . 1.0 109.672 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 60' ' ' LEU . . . -117.31 163.11 16.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 1.0 109.624 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -155.89 81.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.934 -1.104 . . . . 1.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -102.36 115.49 30.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -0.901 . . . . 1.0 109.591 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -112.16 157.34 20.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 1.0 111.111 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 23' ' ' ILE . 12.1 tt -167.09 120.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 1.0 109.488 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 2.7 tt0 -87.16 129.81 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 1.0 110.727 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -96.74 -171.99 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.814 . . . . 1.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -105.45 -83.82 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 1.0 110.398 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' HG21 ' A' ' 2' ' ' ILE . 55.6 mt-10 -90.78 121.89 67.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.0 110.216 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.26 111.87 3.39 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.41 1.216 . . . . 1.0 110.078 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.91 -64.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 1.0 110.444 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.44 157.6 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 1.0 110.335 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -107.58 -175.56 2.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 1.0 109.91 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.97 -159.33 9.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.471 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -156.8 171.05 21.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -1.081 . . . . 1.0 109.882 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.874 ' CD2' HD12 ' A' ' 58' ' ' LEU . 56.2 m95 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.038 -1.039 . . . . 1.0 110.648 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' CD ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -157.23 126.08 5.81 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.37 -133.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 1.0 108.873 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -24.76 6.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.328 -1.483 . . . . 1.0 109.355 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 162.64 40.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -115.72 101.74 54.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.265 -1.138 . . . . 1.0 110.299 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.73 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.889 1.468 . . . . 1.0 110.324 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 42' ' ' THR . 0.2 OUTLIER -78.82 -164.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 1.0 110.677 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -162.08 172.12 16.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 1.0 110.225 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.0 125.38 34.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 1.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -174.88 -59.93 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 1.0 110.343 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -71.13 -87.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.447 1.235 . . . . 1.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -142.15 52.88 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.877 -1.139 . . . . 1.0 110.487 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.04 138.07 31.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.202 -0.936 . . . . 1.0 110.167 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 4.2 tt0 -123.65 53.49 1.36 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.105 -0.997 . . . . 1.0 110.002 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.8 114.98 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.87 -1.144 . . . . 1.0 109.908 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.0 99.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 1.0 110.238 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 18.8 pt-20 -124.85 141.87 51.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.95 . . . . 1.0 110.277 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.85 14.48 2.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.12 -30.3 6.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.388 -1.085 . . . . 1.0 110.388 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -90.9 -16.24 28.49 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.309 -1.113 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.88 114.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.161 -0.962 . . . . 1.0 110.383 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.484 ' HB2' HG23 ' A' ' 23' ' ' ILE . 83.6 m-70 -95.1 111.63 23.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.843 . . . . 1.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 22' ' ' GLU . 28.7 mm -120.7 147.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 1.0 110.07 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.874 HD12 ' CD2' ' A' ' 34' ' ' TRP . 4.5 tt -123.9 130.51 52.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 1.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.786 ' N ' HD23 ' A' ' 58' ' ' LEU . 25.1 mt -133.46 103.1 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.659 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -125.43 127.34 46.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.006 -1.059 . . . . 1.0 111.722 -178.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.701 ' CE1' HG23 ' A' ' 18' ' ' THR . 12.8 m-70 -103.7 28.1 6.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.846 0.832 . . . . 1.0 108.82 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.624 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 m-20 -108.53 -4.58 17.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.596 -0.69 . . . . 1.0 111.319 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 76.8 m -43.04 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.274 -0.891 . . . . 1.0 111.395 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.66 ' C ' HG11 ' A' ' 86' ' ' VAL . 18.8 mt-30 -161.24 -166.78 1.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 1.0 110.213 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -3.44 18.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 1.0 111.152 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.85 -36.25 5.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.797 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -48.57 -23.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 1.0 111.548 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 p -46.34 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.933 . . . . 1.0 110.762 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -175.21 -125.67 0.88 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -139.76 142.94 36.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 1.0 110.513 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 55.2 t -94.51 105.2 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.634 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -107.77 108.09 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 1.0 110.625 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 24.4 t80 -81.07 145.01 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 1.0 109.586 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -121.2 111.01 16.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 1.0 110.593 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -147.26 109.57 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.528 -0.732 . . . . 1.0 109.502 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 57.93 -162.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 1.0 109.596 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 11.1 p30 -62.85 -19.49 64.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -72.7 145.36 47.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 1.0 110.398 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -153.57 133.37 13.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 1.0 110.094 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.562 ' OG ' HD11 ' A' ' 8' ' ' LEU . 69.8 p -112.16 178.35 4.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.947 . . . . 1.0 110.171 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.14 79.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 1.0 110.511 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -82.64 -178.74 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.985 . . . . 1.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -114.09 136.74 52.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 1.0 110.25 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 25.7 tp -136.55 134.25 37.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -131.92 125.88 32.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 1.0 109.744 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 67' ' ' MET . 51.4 t -90.92 112.29 24.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.304 -0.872 . . . . 1.0 109.949 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -75.75 172.38 12.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 1.0 110.519 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -86.73 176.47 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 1.0 110.226 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.108 179.8 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.611 HD13 HG11 ' A' ' 30' ' ' VAL . 20.7 pt -143.46 150.67 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.69 -172.66 2.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 1.0 110.301 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.0 111.53 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.27 -38.98 19.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.449 -0.945 . . . . 1.0 108.449 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -122.5 106.44 35.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.66 173.46 9.94 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.617 1.325 . . . . 1.0 111.032 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.825 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 12.8 mt -73.77 -160.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.515 -0.741 . . . . 1.0 109.981 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -148.66 114.05 5.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0 109.835 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 83' ' ' ASN . . . -64.4 132.3 38.55 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.6 p -154.14 161.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -1.179 . . . . 1.0 110.586 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' VAL . 2.4 pt-20 -107.49 169.63 8.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.0 109.96 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.35 172.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 1.0 110.49 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -111.68 137.46 49.54 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.461 -0.774 . . . . 1.0 108.948 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 63' ' ' CYS . 93.2 t -46.11 111.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.415 -0.803 . . . . 1.0 111.403 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 127.24 -47.33 1.03 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.37 -1.076 . . . . 1.0 109.965 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -130.17 139.93 50.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 110.569 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.16 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 1.0 109.744 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -130.64 100.68 5.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 1.0 110.755 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 51.8 m-85 -104.41 154.38 19.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 1.0 109.743 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 8' ' ' LEU . 44.3 mt-10 -140.92 157.61 45.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.002 -1.061 . . . . 1.0 110.611 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -169.48 139.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.446 -0.784 . . . . 1.0 110.154 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.13 132.27 54.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.334 -0.854 . . . . 1.0 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 2' ' ' ILE . 18.4 mt -94.37 -152.57 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 1.0 110.097 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -109.16 -37.77 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -0.834 . . . . 1.0 110.149 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.07 148.28 59.77 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 1.0 110.171 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.6 Cg_endo -74.62 -167.9 0.45 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.677 1.357 . . . . 1.0 110.797 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.53 46.49 22.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 1.0 110.364 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 28' ' ' PRO . 58.9 t -137.58 102.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 1.0 110.349 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -91.99 137.55 32.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.268 -0.895 . . . . 1.0 110.18 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.57 172.98 21.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -122.38 163.55 19.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 1.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.1 m95 -114.05 149.16 35.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 1.0 110.293 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 1.1 ttpt -139.47 131.33 27.63 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.318 -0.864 . . . . 1.0 109.939 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.7 mt -61.46 -112.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.142 -0.974 . . . . 1.0 109.304 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -85.97 12.62 8.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.448 -1.408 . . . . 1.0 110.264 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 131.19 -1.77 5.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -97.57 112.09 60.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.91 -1.347 . . . . 1.0 109.96 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.3 109.04 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.525 1.276 . . . . 1.0 110.543 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 169.42 17.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.288 -0.882 . . . . 1.0 110.534 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -143.52 24.13 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 1.0 109.742 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.02 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.832 . . . . 1.0 110.753 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.58 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 1.0 109.74 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.6 Cg_endo -70.54 -19.3 32.59 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.584 1.307 . . . . 1.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.89 -58.75 1.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.948 . . . . 1.0 109.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.26 152.13 44.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 1.0 109.95 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 3.1 mm-40 -133.57 86.51 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 1.0 110.409 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.68 128.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 1.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.05 122.47 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 1.0 110.591 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -142.55 162.25 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.0 109.72 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.55 16.76 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.02 -1.05 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.38 -29.86 7.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.984 -1.246 . . . . 1.0 109.984 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -74.12 -28.39 61.32 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.308 -1.113 . . . . 1.0 109.767 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.19 -173.66 1.32 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.376 -0.827 . . . . 1.0 110.063 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.659 ' HB2' HG23 ' A' ' 23' ' ' ILE . 81.1 m-70 -139.41 118.27 12.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.91 130.47 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 1.0 110.167 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.981 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.0 tt -105.88 136.34 45.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.833 . . . . 1.0 110.349 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.792 ' N ' HD23 ' A' ' 58' ' ' LEU . 69.8 mt -134.2 73.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 1.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 18' ' ' THR . 2.0 mt -72.06 151.12 43.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 1.0 110.533 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.537 ' HA ' HG22 ' A' ' 18' ' ' THR . 56.9 m-70 -113.99 -172.42 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.0 109.6 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 63.4 t-20 -14.52 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 61' ' ' HIS . 99.8 m -78.4 172.71 13.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.609 -0.682 . . . . 1.0 109.291 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' O ' HG21 ' A' ' 86' ' ' VAL . 49.4 tp60 -115.0 167.28 10.94 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.023 -1.048 . . . . 1.0 109.128 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 14.0 tp -63.86 -5.96 5.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.033 -1.042 . . . . 1.0 112.308 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.66 -12.53 82.76 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 120.674 -1.266 . . . . 1.0 110.445 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.521 ' HB2' HG21 ' A' ' 86' ' ' VAL . 23.1 mtt -86.06 41.95 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.374 . . . . 1.0 110.93 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -90.83 45.02 1.22 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 1.0 110.004 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.1 -125.32 3.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 8.6 pt-20 -144.59 151.89 39.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -1.057 . . . . 1.0 110.336 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.411 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 73.2 t -90.33 90.48 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 1.0 109.964 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 p -94.52 99.94 12.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.836 . . . . 1.0 110.287 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -73.28 167.86 20.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.968 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.99 107.31 1.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 1.0 110.258 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -139.74 122.92 16.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 1.0 109.99 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 2' ' ' ILE . . . 54.89 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 1.0 110.387 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' ALA . 24.3 t30 -128.54 -31.04 2.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.047 -1.033 . . . . 1.0 110.589 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.47 127.68 33.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 1.0 110.511 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 124.03 15.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 1.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.411 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.9 m -112.62 -174.22 2.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 1.0 110.486 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.05 102.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 1.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -99.98 -172.67 2.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.905 . . . . 1.0 109.903 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 19.6 t-20 -114.51 137.23 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.108 -0.995 . . . . 1.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -140.63 124.02 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 1.0 110.607 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -126.54 133.71 51.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 1.0 109.52 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 64' ' ' GLN . 43.4 t -91.79 149.83 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.14 -0.975 . . . . 1.0 110.377 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.66 104.78 4.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 1.0 110.029 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.45 -156.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 1.0 110.461 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.932 -1.032 . . . . 1.0 110.081 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.356 0.598 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.716 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.4 mm -112.87 137.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.312 -0.868 . . . . 1.0 110.485 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -171.36 2.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.348 -0.845 . . . . 1.0 110.063 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.5 t -119.13 119.38 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 1.0 110.1 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -82.64 -49.64 9.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.208 -0.932 . . . . 1.0 109.626 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 5.5 mmtt -119.14 107.91 41.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 1.0 109.913 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.41 -175.86 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.491 1.258 . . . . 1.0 110.482 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 6.6 mt -79.2 -172.65 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 1.0 110.494 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.35 136.48 33.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 1.0 110.125 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.89 149.91 36.84 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -160.11 154.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.161 . . . . 1.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.05 162.4 17.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 1.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.7 p -160.35 137.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 1.0 109.818 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.32 55.65 3.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.379 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 63' ' ' CYS . 5.9 p 36.55 76.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 CA-C-O 121.776 0.798 . . . . 1.0 111.95 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 158.13 -30.43 0.48 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.764 -1.735 . . . . 1.0 108.764 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.3 mt-10 -75.8 -161.94 0.19 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -1.027 . . . . 1.0 109.699 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 20.7 m -126.07 112.73 16.2 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.323 -0.951 . . . . 1.0 110.743 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.32 33.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 1.0 109.36 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -126.63 119.35 26.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.945 -1.097 . . . . 1.0 110.744 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.709 ' CD2' HD23 ' A' ' 58' ' ' LEU . 82.9 m-85 -117.21 123.48 46.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -0.883 . . . . 1.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.58 153.15 25.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.017 . . . . 1.0 110.167 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.587 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -166.83 120.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 1.0 109.495 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -107.38 148.34 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 1.0 110.403 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 56' ' ' HIS . 42.9 mt -106.56 -150.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 1.0 109.854 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.716 ' HB2' HG23 ' A' ' 2' ' ' ILE . 68.7 m -116.09 -40.96 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 1.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.13 135.95 12.97 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 1.0 110.179 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.57 153.96 49.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.481 1.253 . . . . 1.0 110.391 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.75 -64.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.0 110.301 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.38 -164.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 1.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -115.21 143.79 44.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 1.0 110.132 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.38 -166.22 22.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.45 -1.46 . . . . 1.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.64 154.35 36.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -1.182 . . . . 1.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.898 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.8 m95 -102.01 147.35 26.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -141.84 132.49 25.52 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.359 -0.838 . . . . 1.0 109.328 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.466 HD21 ' SD ' ' A' ' 67' ' ' MET . 5.5 mt -64.7 -136.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.062 -1.023 . . . . 1.0 109.004 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -25.11 7.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.443 -1.41 . . . . 1.0 109.315 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.35 42.73 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.82 33.03 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.372 -1.076 . . . . 1.0 109.765 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.79 85.24 1.35 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.721 1.38 . . . . 1.0 110.197 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -69.36 -172.97 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.243 -0.911 . . . . 1.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.4 p -136.39 -170.65 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.93 109.64 14.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 110.149 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 1.2 m -120.29 166.39 15.39 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 1.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 46.7 Cg_endo -72.6 -23.16 20.1 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.599 1.315 . . . . 1.0 110.486 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.39 -25.6 23.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 1.0 110.218 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.35 127.22 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.914 . . . . 1.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.18 147.46 44.18 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 1.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.9 mt -140.33 95.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 1.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -99.54 98.68 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 1.0 109.726 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.27 162.82 25.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 1.0 110.599 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.1 23.62 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 1.0 109.96 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 -86.24 1.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -50.08 -23.77 2.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.75 -0.853 . . . . 1.0 110.747 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -134.74 160.48 38.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 1.0 110.655 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.591 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.0 m-70 -143.34 105.42 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -104.83 144.49 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 1.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.898 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -128.87 136.18 50.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.0 110.272 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.58 93.9 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 1.0 109.8 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.56 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -103.09 103.89 14.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 1.0 110.531 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' C ' ' A' ' 62' ' ' ASN . 67.1 m-70 -69.44 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 1.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 61' ' ' HIS . 3.1 m120 -12.18 79.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 113.85 1.056 . . . . 1.0 113.85 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.813 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.7 m -71.63 145.44 48.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.781 . . . . 1.0 109.092 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.796 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -99.18 172.92 7.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 1.0 110.902 -179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -4.63 22.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.639 -0.663 . . . . 1.0 111.136 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.73 -11.91 76.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.793 -1.194 . . . . 1.0 110.336 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 86' ' ' VAL . 9.0 mtt -85.95 43.26 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.905 -1.35 . . . . 1.0 110.615 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 40.73 1.04 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 1.0 109.75 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.9 2.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.886 -1.285 . . . . 1.0 109.886 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.44 152.17 44.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.403 -1.057 . . . . 1.0 110.539 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 83.6 t -92.99 87.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 1.0 109.475 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.0 p -94.52 112.23 23.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 1.0 110.894 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 46.8 t80 -91.26 137.97 31.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 1.0 109.398 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -120.13 138.26 53.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 1.0 111.087 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -155.56 47.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.72 . . . . 1.0 109.356 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 62.22 132.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.782 . . . . 1.0 110.425 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.23 24.07 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 1.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.21 139.03 16.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.025 . . . . 1.0 109.972 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -155.96 68.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 1.0 110.8 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 8' ' ' LEU . 71.1 p -54.65 171.88 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.981 -1.074 . . . . 1.0 109.554 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.88 104.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.035 -1.04 . . . . 1.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -98.57 -167.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 1.0 109.828 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -128.19 137.45 52.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 1.0 109.787 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 84' ' ' LEU . 1.9 tm? -139.27 116.31 10.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.043 -1.036 . . . . 1.0 111.146 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.486 ' N ' HD13 ' A' ' 84' ' ' LEU . 11.7 mttt -111.12 132.82 53.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.416 -0.803 . . . . 1.0 109.39 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 64' ' ' GLN . 28.0 t -103.9 111.09 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.228 -0.92 . . . . 1.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -99.58 129.9 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.72 -176.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 1.0 110.374 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.321 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.279 0.561 . . . . 1.0 110.12 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 26' ' ' SER . 37.6 mm -101.93 140.31 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.128 -0.983 . . . . 1.0 110.073 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.3 mt-10 -123.84 -178.6 4.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 1.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.917 HG23 ' HB1' ' A' ' 78' ' ' ALA . 74.2 t -105.4 115.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.804 . . . . 1.0 109.93 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -75.95 -39.76 55.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 5.6 mptt -124.95 106.92 28.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.65 176.57 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.565 1.297 . . . . 1.0 110.705 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 4.1 mt -72.05 172.22 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 1.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 20.6 m-85 -129.25 3.71 5.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.137 -0.977 . . . . 1.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.702 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 70.43 153.52 1.04 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 11' ' ' VAL . 7.1 p -156.95 134.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.114 . . . . 1.0 110.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -109.07 150.64 27.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.0 110.068 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 14' ' ' PHE . 1.1 p -160.55 -158.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.454 -0.779 . . . . 1.0 109.782 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.635 ' N ' HG13 ' A' ' 13' ' ' VAL . 5.8 m-85 -107.33 -154.51 0.53 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 63' ' ' CYS . 81.6 t -120.16 121.76 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.85 -1.156 . . . . 1.0 110.763 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.34 -48.95 0.94 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -65.14 -147.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -1.109 . . . . 1.0 110.617 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CG ' ' A' ' 61' ' ' HIS . 4.6 p -128.81 161.06 30.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 110.996 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -105.68 170.13 8.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.69 . . . . 1.0 109.477 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 93.38 2.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.013 . . . . 1.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 81.9 m-85 -94.67 162.63 13.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.51 -0.744 . . . . 1.0 109.552 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 8' ' ' LEU . 4.2 mp0 -140.67 153.98 46.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.945 -1.097 . . . . 1.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' OG ' ' A' ' 80' ' ' SER . 3.6 tt -170.55 138.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.598 -0.689 . . . . 1.0 109.814 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.538 ' C ' HD12 ' A' ' 25' ' ' LEU . 30.1 tt0 -96.43 170.41 9.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 1.0 110.559 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.934 HD13 ' CD2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -159.17 175.03 13.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.522 -0.736 . . . . 1.0 109.889 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 2' ' ' ILE . 9.7 m -93.31 -44.16 8.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.083 -1.011 . . . . 1.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.82 150.79 53.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.95 . . . . 1.0 110.132 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.85 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.732 1.386 . . . . 1.0 110.652 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.65 76.65 9.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 1.0 110.218 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.456 HG11 HD22 ' A' ' 25' ' ' LEU . 7.4 p -95.17 143.73 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.29 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 31' ' ' HIS . 25.9 p80 -76.32 117.79 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.875 . . . . 1.0 110.231 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.92 -166.14 10.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.346 -1.502 . . . . 1.0 109.346 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.71 128.03 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -1.2 . . . . 1.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.758 ' CE3' HD22 ' A' ' 58' ' ' LEU . 28.2 m95 -94.7 154.66 17.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 1.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 4.4 ptmt -152.07 156.08 39.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 1.0 109.968 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.504 HD21 ' HE3' ' A' ' 67' ' ' MET . 5.4 mt -65.16 -133.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.903 . . . . 1.0 109.354 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -52.15 -23.31 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.474 -1.391 . . . . 1.0 110.126 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 159.52 39.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.385 -1.486 . . . . 1.0 109.385 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -119.33 109.15 39.04 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.235 -1.156 . . . . 1.0 109.607 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.21 111.56 3.34 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.586 1.308 . . . . 1.0 110.037 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 42' ' ' THR . 1.0 OUTLIER -114.84 -144.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 1.0 110.153 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 41' ' ' LEU . 4.2 m -143.96 150.9 39.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.986 -1.071 . . . . 1.0 110.319 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 49' ' ' ILE . . . -83.84 113.31 20.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 1.0 110.136 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -177.91 -59.71 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 1.0 110.372 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -69.73 -69.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.493 1.26 . . . . 1.0 111.305 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -132.68 64.24 1.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.935 -1.103 . . . . 1.0 110.494 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.43 ' HA ' HD23 ' A' ' 60' ' ' LEU . 8.9 t -169.05 139.93 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 1.0 110.348 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -135.5 85.52 2.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 1.0 110.21 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 43' ' ' ALA . 28.6 mt -80.3 130.2 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 1.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 59' ' ' ILE . 7.4 tt -142.97 102.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 1.0 109.848 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.57 159.27 19.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 1.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -113.44 20.84 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.395 -0.816 . . . . 1.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.84 -101.58 2.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.834 -1.307 . . . . 1.0 109.834 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -50.75 -21.76 1.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.417 -1.049 . . . . 1.0 110.673 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 1.5 mmtt -134.11 173.78 11.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 1.0 110.493 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.934 ' CD2' HD13 ' A' ' 25' ' ' LEU . 19.5 m-70 -126.34 135.95 52.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.0 109.736 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.3 mt -137.16 127.89 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.0 110.882 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.758 HD22 ' CE3' ' A' ' 34' ' ' TRP . 32.6 tp -103.25 149.12 25.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.0 109.963 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 HG21 ' A' ' 50' ' ' ILE . 55.1 mt -145.2 82.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.149 -0.969 . . . . 1.0 109.523 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HE1' ' A' ' 67' ' ' MET . 1.2 mt -76.83 -179.82 5.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 1.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' C ' ' A' ' 62' ' ' ASN . 65.8 m-70 -137.5 -162.4 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.57 -0.706 . . . . 1.0 109.103 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 61' ' ' HIS . 1.7 t-20 -14.25 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 113.415 0.895 . . . . 1.0 113.415 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.899 ' O ' HG13 ' A' ' 15' ' ' VAL . 73.5 m -71.03 163.49 27.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.682 -0.636 . . . . 1.0 110.142 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 4.5 tp-100 -121.51 168.68 11.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.428 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 8.3 tp -76.52 17.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.849 -1.157 . . . . 1.0 112.124 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 -25.54 6.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.026 -1.63 . . . . 1.0 109.026 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.614 ' HE1' HD13 ' A' ' 60' ' ' LEU . 54.1 mtp -54.59 -18.58 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -1.116 . . . . 1.0 110.722 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -42.22 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.634 -0.666 . . . . 1.0 110.95 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -176.81 -116.74 0.48 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.336 -1.506 . . . . 1.0 109.336 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.72 130.39 10.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 27.6 t -79.1 100.4 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 1.0 109.168 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -99.34 116.55 31.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.0 110.947 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 31.5 t80 -87.54 146.4 25.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 1.0 108.959 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 105.3 8.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.959 -1.088 . . . . 1.0 111.055 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -139.45 121.48 15.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.595 -0.691 . . . . 1.0 109.369 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.32 -153.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 1.0 109.738 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -72.02 -10.51 59.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 110.719 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB2' ' HA ' ' A' ' 3' ' ' GLU . . . -80.13 155.5 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.042 . . . . 1.0 110.525 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -159.9 95.51 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 110.013 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 23' ' ' ILE . 36.8 m -85.51 167.54 15.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 1.0 110.293 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.415 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.89 106.22 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 1.0 110.894 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.841 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.42 -161.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.989 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -115.66 148.56 39.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.955 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.66 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 55.3 tp -140.82 132.44 27.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 1.0 110.518 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -132.6 131.2 41.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 1.0 109.825 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.607 ' CG1' HG22 ' A' ' 15' ' ' VAL . 61.1 t -108.44 151.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.309 -0.87 . . . . 1.0 110.124 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.3 mttt -148.34 144.8 27.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 1.0 110.382 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -73.51 146.16 45.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 1.0 110.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.233 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.239 0.543 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.97 118.17 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 1.0 110.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.68 179.0 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.936 . . . . 1.0 110.355 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 78' ' ' ALA . 61.9 t -88.58 106.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 1.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.87 -36.86 84.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.273 -0.892 . . . . 1.0 109.281 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 106.31 27.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.421 -0.799 . . . . 1.0 109.804 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.79 172.82 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.587 1.309 . . . . 1.0 110.864 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.6 mt -82.05 177.73 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.765 . . . . 1.0 109.56 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -136.25 6.65 3.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.941 -1.099 . . . . 1.0 111.483 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 62.41 144.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 1.0 109.997 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 5.8 m -141.36 -175.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -1.165 . . . . 1.0 110.14 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.43 158.16 45.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.194 -0.941 . . . . 1.0 110.322 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.473 HG23 ' CB ' ' A' ' 17' ' ' GLU . 2.9 p -153.87 134.37 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.348 -0.845 . . . . 1.0 109.837 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -92.09 55.19 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 1.0 110.546 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t 48.44 89.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.87 . . . . 1.0 110.808 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.44 -33.99 3.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.044 -1.622 . . . . 1.0 109.044 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.2 mt-10 -67.34 -162.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.351 -1.088 . . . . 1.0 109.552 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 m -135.64 119.59 17.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.135 -0.978 . . . . 1.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.97 165.25 23.67 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.348 -0.845 . . . . 1.0 109.077 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -147.13 115.57 6.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.923 -1.111 . . . . 1.0 110.883 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -113.82 130.8 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.0 109.758 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . 24.4 mp0 -115.06 151.61 33.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 1.0 110.649 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 56' ' ' HIS . 13.1 tt -170.87 154.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.447 -0.783 . . . . 1.0 109.73 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.488 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -151.3 160.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 1.0 110.311 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.721 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.4 mm? -112.98 -168.76 1.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 1.0 109.898 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -99.55 -45.32 5.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 1.0 110.129 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.28 153.97 38.05 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 1.0 110.117 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.683 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.3 Cg_endo -78.35 -166.02 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.717 1.377 . . . . 1.0 110.485 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.82 54.68 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 1.0 110.398 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' PRO . 60.7 t -134.04 117.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 1.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -98.75 144.7 27.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 1.0 110.025 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -151.13 171.89 30.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.763 -1.335 . . . . 1.0 109.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -139.08 179.22 6.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.384 -1.068 . . . . 1.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 1.018 ' CE3' HD12 ' A' ' 58' ' ' LEU . 59.8 m95 -123.69 133.41 53.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 1.0 110.701 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -129.08 111.47 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.786 . . . . 1.0 110.711 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.806 HD12 HD22 ' A' ' 41' ' ' LEU . 6.6 mt -57.44 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 1.0 108.725 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -92.27 9.05 35.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 1.0 109.497 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 127.79 -1.23 6.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.09 -1.204 . . . . 1.0 110.09 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.6 mm-40 -96.7 137.61 21.42 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.251 . . . . 1.0 109.913 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.97 106.05 2.18 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.613 1.323 . . . . 1.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.806 HD22 HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -108.02 3.37 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 110.573 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 m -70.55 -35.48 73.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.07 . . . . 1.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.74 44.59 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 1.0 110.548 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -115.82 158.96 40.83 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.346 -0.847 . . . . 1.0 110.231 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.53 -12.87 27.34 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.759 1.4 . . . . 1.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.54 -17.81 15.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.0 110.518 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.4 131.84 35.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 1.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -133.15 77.41 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 1.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 58' ' ' LEU . 1.1 pp -96.83 105.32 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 1.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.8 111.54 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 1.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -132.83 161.46 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 1.0 110.094 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.27 33.23 5.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 1.0 110.183 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 56' ' ' HIS . . . 86.38 -91.11 1.7 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -48.24 -24.31 1.14 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.648 -0.913 . . . . 1.0 110.769 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -124.16 165.76 17.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 1.0 110.175 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 23' ' ' ILE . 94.1 m-70 -148.52 114.07 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 55' ' ' LYS . 55.3 mt -116.4 136.11 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 1.0 110.291 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.018 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -115.57 133.94 55.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.26 -0.9 . . . . 1.0 110.295 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.81 ' N ' HD23 ' A' ' 58' ' ' LEU . 5.6 mt -138.26 83.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 1.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 41' ' ' LEU . 4.6 mt -86.69 116.01 24.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 1.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 62' ' ' ASN . 86.9 m-70 -79.06 -169.65 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 1.0 110.452 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 61' ' ' HIS . 20.4 p-10 -14.95 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.0 m -71.11 178.53 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.69 . . . . 1.0 109.482 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.586 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.4 tp60 -111.28 158.82 18.55 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.092 -1.005 . . . . 1.0 109.102 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.1 mp -46.89 -25.29 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.0 111.074 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.72 -119.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.787 ' HB2' HG21 ' A' ' 86' ' ' VAL . 3.3 mtt 42.13 30.73 0.2 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.715 -0.874 . . . . 1.0 111.487 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.21 53.0 2.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 1.0 110.098 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.39 -126.46 2.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.57 154.07 36.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 1.0 110.374 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.907 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 74.5 t -89.28 86.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.328 -0.858 . . . . 1.0 110.031 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' SER . 97.2 p -94.25 109.62 21.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 1.0 110.231 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CZ ' ' HA3' ' A' ' 32' ' ' GLY . 42.5 t80 -78.54 157.44 28.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 1.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -146.1 146.0 30.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 1.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -169.45 -146.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 1.0 110.113 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.8 -69.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 1.0 110.634 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -142.98 33.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 1.0 110.249 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -121.81 120.43 34.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 1.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.18 88.45 2.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 1.0 110.237 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 23' ' ' ILE . 25.7 m -82.36 174.73 10.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.994 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.65 97.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 1.0 110.381 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.41 -163.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.0 109.995 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 129.04 53.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 1.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -127.57 126.52 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.0 110.299 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 137.82 46.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 1.0 109.902 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.787 HG21 ' HB2' ' A' ' 67' ' ' MET . 42.5 t -100.21 108.22 22.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 1.0 110.133 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -86.6 107.54 18.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 1.0 110.219 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.702 ' C ' HD13 ' A' ' 89' ' ' LEU . 1.2 pp20? -62.27 -152.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 1.0 110.281 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.821 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.97 -1.014 . . . . 1.0 110.653 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.169 0.509 . . . . 1.0 110.281 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 25' ' ' LEU . 69.5 mt -131.53 151.13 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 1.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -91.63 9.54 31.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 1.0 111.155 -179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.681 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t 62.06 145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.41 -0.806 . . . . 1.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.79 -41.2 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 1.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -116.79 107.88 45.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.609 -0.682 . . . . 1.0 109.899 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.07 176.65 6.72 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 1.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 12.4 mt -70.25 171.23 10.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.417 -0.802 . . . . 1.0 110.49 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.5 m-85 -129.72 169.23 15.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 1.0 110.074 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 155.52 31.9 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.202 -1.159 . . . . 1.0 110.202 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -159.55 155.23 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 1.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.1 157.11 30.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.983 . . . . 1.0 110.784 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 17' ' ' GLU . 6.8 p -157.87 142.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 1.0 110.078 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -97.41 46.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 1.0 110.472 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 63' ' ' CYS . 11.3 t 61.42 142.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 1.0 110.175 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 87.8 -56.21 4.39 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' CB ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -53.51 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -1.162 . . . . 1.0 109.926 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -115.17 150.33 36.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 1.0 110.367 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' CE2' ' A' ' 21' ' ' PHE . . . -95.1 168.94 10.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 1.0 109.654 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -147.58 97.04 2.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 1.0 110.78 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.97 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 90.8 m-85 -106.07 115.94 31.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 1.0 109.535 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -107.49 151.71 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.042 . . . . 1.0 110.985 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 23' ' ' ILE . 1.4 tt -159.29 123.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -0.767 . . . . 1.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.5 tt0 -87.3 142.05 28.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 1.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.761 ' O ' HD13 ' A' ' 2' ' ' ILE . 4.2 mm? -112.21 19.6 17.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 1.0 110.412 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.81 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.663 -0.648 . . . . 1.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.67 138.73 27.98 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.302 -0.874 . . . . 1.0 110.068 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.62 109.75 2.97 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.584 1.307 . . . . 1.0 110.452 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -174.71 -45.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 1.0 110.346 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG23 HD12 ' A' ' 2' ' ' ILE . 94.3 t -53.27 163.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 1.0 110.48 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -178.11 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 1.0 110.104 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -119.94 -132.42 4.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.433 ' CG ' ' HB2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.89 179.17 7.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -1.11 . . . . 1.0 110.378 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.713 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.5 m95 -127.25 148.44 50.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.103 -0.998 . . . . 1.0 111.622 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.74 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -154.35 -114.78 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.389 -0.82 . . . . 1.0 109.128 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.74 HD12 ' C ' ' A' ' 35' ' ' LYS . 2.7 mp -157.15 -158.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.925 -1.109 . . . . 1.0 108.775 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -22.44 8.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.777 -1.202 . . . . 1.0 109.425 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.09 -113.83 0.01 OUTLIER Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 1.3 mt-30 -134.72 178.43 1.77 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HB2' ' CG ' ' A' ' 33' ' ' GLN . 50.6 Cg_endo -89.29 113.07 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.443 1.233 . . . . 1.0 111.281 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -98.04 -168.27 1.64 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.672 -1.268 . . . . 1.0 110.211 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.6 t -113.24 161.91 16.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 1.0 110.086 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.02 123.32 20.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.263 -0.898 . . . . 1.0 109.491 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -175.8 -59.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 1.0 110.96 -179.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 40.2 Cg_endo -67.72 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.412 1.217 . . . . 1.0 111.296 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.11 69.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.14 . . . . 1.0 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 136.88 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 1.0 110.394 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.43 78.61 1.68 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 1.0 109.732 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.89 136.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 1.0 110.233 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 49' ' ' ILE . 1.1 pt -135.32 106.95 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.442 -0.786 . . . . 1.0 109.955 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.7 141.21 34.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 1.0 110.352 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.69 17.9 14.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 1.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 -26.61 16.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.79 -27.03 40.39 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.449 -1.03 . . . . 1.0 109.582 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.01 122.89 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.542 -0.724 . . . . 1.0 109.701 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.54 103.69 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 1.0 109.995 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.75 137.6 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 1.0 110.548 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.754 ' O ' HD13 ' A' ' 59' ' ' ILE . 29.3 tp -109.69 142.68 40.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 1.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.754 HD13 ' O ' ' A' ' 58' ' ' LEU . 38.0 mm -138.44 82.73 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 1.0 110.29 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.695 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.64 167.02 22.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 1.0 110.181 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 35.5 m-70 -129.75 -163.72 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 1.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -13.4 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.883 ' O ' HG13 ' A' ' 15' ' ' VAL . 69.6 m -87.61 -173.33 4.28 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.51 -0.744 . . . . 1.0 109.024 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.748 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -167.01 -160.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 1.0 110.098 -179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.48 81.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.865 0.84 . . . . 1.0 109.904 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.62 -40.67 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.604 -1.798 . . . . 1.0 108.604 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.481 ' HB3' HD23 ' A' ' 84' ' ' LEU . 31.0 mtt -87.06 39.95 0.89 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -1.121 . . . . 1.0 110.549 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -91.31 27.4 1.94 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 1.0 110.173 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.49 -109.74 2.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.229 -1.549 . . . . 1.0 109.229 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.1 pt-20 -146.56 139.58 25.49 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.538 -0.978 . . . . 1.0 110.522 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.97 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 26.2 t -78.99 128.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 p -123.97 127.58 48.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.0 111.285 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.524 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 51.1 t80 -104.63 137.11 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 1.0 109.439 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -130.72 144.17 51.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 1.0 109.939 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' CG1' ' A' ' 30' ' ' VAL . . . -159.12 -148.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.805 . . . . 1.0 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.26 51.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 1.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -154.46 30.28 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 1.0 109.931 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 25' ' ' LEU . . . -114.2 108.78 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.024 -1.047 . . . . 1.0 110.164 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.901 . . . . 1.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 6.5 p -102.39 175.57 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 1.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.76 103.12 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.123 -0.986 . . . . 1.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.63 -176.14 3.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 1.0 109.752 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -108.1 134.66 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 1.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.697 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 44.3 tp -133.08 141.61 48.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.409 -0.807 . . . . 1.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -139.22 125.93 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.0 110.062 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.748 HG11 ' O ' ' A' ' 64' ' ' GLN . 40.6 t -96.9 132.8 40.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.901 . . . . 1.0 109.921 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -124.23 119.51 29.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 1.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.19 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.935 . . . . 1.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 3.9 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.035 -0.983 . . . . 1.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.484 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 2.7 mp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.201 0.524 . . . . 1.0 110.278 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.674 HD13 ' N ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -171.11 126.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 1.0 109.85 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.674 ' N ' HD13 ' A' ' 2' ' ' ILE . 15.9 mt-10 -152.72 -77.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 1.0 110.784 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 23' ' ' ILE . 46.2 t -47.15 107.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 1.0 111.281 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 2.8 mm-40 -96.23 -26.1 15.55 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.431 -0.793 . . . . 1.0 109.039 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -135.49 119.39 13.03 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.4 168.12 18.78 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.537 1.283 . . . . 1.0 111.763 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.899 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.8 mt -82.4 161.33 22.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.631 -0.668 . . . . 1.0 109.923 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.809 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 2.5 m-85 -115.2 168.12 10.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 1.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.63 124.65 7.91 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.67 179.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 1.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -135.04 161.32 35.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 1.0 110.667 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 17' ' ' GLU . 5.0 p -160.7 129.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 1.0 109.957 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 57.3 4.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.951 . . . . 1.0 110.361 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 87' ' ' LYS . 42.1 t 48.66 91.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.174 -0.954 . . . . 1.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 132.36 -34.92 2.43 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.825 ' CB ' HG23 ' A' ' 13' ' ' VAL . 3.3 mt-10 -67.45 -163.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -1.07 . . . . 1.0 109.656 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.9 m -136.74 115.4 12.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 1.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.55 149.85 31.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.206 -0.934 . . . . 1.0 109.517 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -127.04 137.33 53.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 1.0 110.746 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.969 ' CE1' HG21 ' A' ' 71' ' ' VAL . 62.1 m-85 -133.38 115.45 14.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 1.0 109.797 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.3 154.76 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 1.0 110.731 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 4' ' ' VAL . 9.3 tt -170.32 122.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 1.0 109.911 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.533 ' C ' HD12 ' A' ' 25' ' ' LEU . 21.2 tt0 -88.01 171.62 10.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 1.0 110.217 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.842 HD13 ' CD2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -150.08 128.36 12.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.817 . . . . 1.0 110.097 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.6 t -67.19 -49.36 64.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 1.0 110.724 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.97 136.32 44.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 1.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.19 -159.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.605 1.318 . . . . 1.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.47 118.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.963 . . . . 1.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.814 HG21 ' OE2' ' A' ' 51' ' ' GLU . 17.8 m -103.22 119.35 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.383 -0.823 . . . . 1.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.09 19.92 2.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 1.0 110.312 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.38 -150.04 23.41 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.12 165.72 2.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -1.04 . . . . 1.0 109.907 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 1.06 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.8 m95 -104.55 150.6 24.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 1.0 110.374 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 2.3 ttpt -149.3 122.99 9.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 1.0 109.328 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' A' ' 67' ' ' MET . 11.2 mt -64.78 -132.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 1.0 108.824 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -52.46 -24.04 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.427 -1.421 . . . . 1.0 109.436 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.18 41.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -122.27 116.85 29.55 Favored Pre-proline 0 N--CA 1.484 1.273 0 O-C-N 121.271 -1.135 . . . . 1.0 109.213 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.82 99.86 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.562 1.296 . . . . 1.0 110.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 42' ' ' THR . 3.8 pp -70.95 -157.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 1.0 110.421 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.861 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -166.68 170.07 12.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 1.0 109.755 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.17 105.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 1.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.43 175.04 3.07 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 1.0 110.287 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.44 -24.62 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.676 1.356 . . . . 1.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -79.04 -11.56 60.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 1.0 110.631 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -124.53 167.45 14.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 1.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 84.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 1.0 110.009 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -102.1 131.99 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 1.0 110.268 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.797 ' N ' HD13 ' A' ' 49' ' ' ILE . 6.9 tt -147.95 135.54 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.0 110.214 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.814 ' OE2' HG21 ' A' ' 30' ' ' VAL . 5.1 pt-20 -133.78 176.74 8.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 1.0 110.512 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -136.01 23.11 3.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 1.0 109.977 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.35 -88.65 1.4 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -5.21 27.33 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.623 -0.928 . . . . 1.0 111.077 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -132.65 164.78 25.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.846 -1.159 . . . . 1.0 110.572 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.842 ' CD2' HD13 ' A' ' 25' ' ' LEU . 27.7 m-70 -142.36 127.59 18.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 1.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.63 137.08 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.922 . . . . 1.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.06 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -126.15 144.29 50.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 1.0 110.591 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.3 mt -139.58 115.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 1.0 109.59 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mt -111.09 97.09 6.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.077 -1.014 . . . . 1.0 110.72 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 62' ' ' ASN . 62.7 m-70 -69.87 -166.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.007 . . . . 1.0 109.841 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 61' ' ' HIS . 45.0 p-10 -16.11 82.48 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.197 0.814 . . . . 1.0 113.197 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 70.1 m -77.4 -168.14 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.634 -0.666 . . . . 1.0 110.159 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.682 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -129.02 170.8 13.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 86' ' ' VAL . 9.1 tp -78.67 25.1 0.27 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 1.0 111.95 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.68 -23.14 5.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.527 ' HB2' HG21 ' A' ' 86' ' ' VAL . 33.1 mtt -61.3 -12.98 15.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -1.139 . . . . 1.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -43.3 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.416 -0.802 . . . . 1.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.59 -119.14 0.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.371 -1.492 . . . . 1.0 109.371 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.31 149.63 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -1.062 . . . . 1.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 21' ' ' PHE . 78.9 t -89.11 83.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.0 109.54 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -86.02 103.31 14.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 1.0 110.806 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 23' ' ' ILE . 85.9 t80 -98.15 151.64 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 1.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -156.43 129.69 8.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.967 -1.083 . . . . 1.0 111.393 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -139.08 22.72 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.707 0.765 . . . . 1.0 109.269 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 178.17 -160.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.544 -0.909 . . . . 1.0 108.544 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 12.2 p30 -64.46 -22.8 67.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.923 -1.11 . . . . 1.0 109.741 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.88 169.15 18.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.0 110.216 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.55 102.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.0 110.447 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.428 ' OG ' HG11 ' A' ' 4' ' ' VAL . 71.1 m -75.41 170.08 16.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 1.0 109.954 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -168.46 111.44 0.57 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.135 -0.978 . . . . 1.0 110.541 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.16 -173.71 2.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 1.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -119.07 106.89 12.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 1.0 110.144 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.624 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 65.2 tp -110.88 127.66 55.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.969 . . . . 1.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 3.1 pttp -130.88 113.62 14.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 1.0 110.291 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.709 ' O ' HD12 ' A' ' 65' ' ' LEU . 61.5 t -87.58 104.04 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.224 -0.923 . . . . 1.0 110.233 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.42 154.54 22.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.0 110.128 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.99 -153.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 1.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.311 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 1' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.641 0.734 . . . . 1.0 110.528 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 2.3 pt -117.08 178.88 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.054 -1.029 . . . . 1.0 110.194 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.77 -151.09 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.269 -0.894 . . . . 1.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 87.2 t -130.66 123.57 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.125 -0.984 . . . . 1.0 110.216 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -86.41 -57.18 3.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 1.0 109.326 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 102.96 48.6 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.657 -0.652 . . . . 1.0 109.896 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.93 174.51 10.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.627 1.33 . . . . 1.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 97.6 mt -75.42 174.78 9.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.0 110.355 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -142.94 150.3 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 1.0 109.883 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.98 140.3 28.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 12' ' ' GLU . 44.0 t -138.93 170.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 1.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 11' ' ' VAL . 10.0 pt-20 -138.29 158.35 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.963 -1.086 . . . . 1.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.931 HG23 ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -160.87 138.64 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 1.0 110.393 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.55 51.22 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 1.0 109.865 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 63' ' ' CYS . 23.1 t 51.83 72.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.815 0.817 . . . . 1.0 110.423 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 157.05 -28.57 0.52 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.564 -1.814 . . . . 1.0 108.564 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -73.96 -160.93 0.1 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.979 . . . . 1.0 109.579 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 58.2 m -135.28 116.46 14.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.927 . . . . 1.0 110.521 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.11 163.19 25.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 1.0 109.01 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -148.8 124.63 10.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.942 -1.098 . . . . 1.0 111.078 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 8' ' ' LEU . 64.6 m-85 -132.18 109.9 10.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.0 109.282 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -115.85 159.4 21.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0 110.515 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 23' ' ' ILE . 3.1 tt -170.83 123.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -0.764 . . . . 1.0 110.193 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -100.44 157.13 16.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 1.0 110.179 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.4 mt -114.8 -150.01 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.0 109.922 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -111.43 -70.23 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 1.0 110.119 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.61 143.49 33.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . 47.6 Cg_endo -74.08 -174.08 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 1.0 110.555 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' C ' HG13 ' A' ' 30' ' ' VAL . 9.3 t70 53.07 85.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 1.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 25' ' ' LEU . 30.7 m -148.47 174.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 1.0 110.256 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -128.81 130.04 46.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 1.0 109.878 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.68 175.12 23.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.963 -1.255 . . . . 1.0 109.963 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -156.17 151.64 26.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -1.053 . . . . 1.0 109.793 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 32.3 m95 -106.92 155.48 19.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 1.0 110.481 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 12.9 ttpt -143.26 112.73 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.335 -0.853 . . . . 1.0 109.61 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 41' ' ' LEU . 1.2 mp -66.37 -123.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 1.0 109.744 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -48.79 -25.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.477 -1.389 . . . . 1.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 148.97 39.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.45 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -136.88 136.91 21.94 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.047 -1.267 . . . . 1.0 109.95 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.22 91.01 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.65 1.342 . . . . 1.0 110.557 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 36' ' ' LEU . 1.4 pt? -69.46 -170.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 1.0 110.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 172.07 13.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.86 . . . . 1.0 109.965 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 104.14 5.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 1.0 110.17 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.407 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.13 176.11 2.26 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 1.0 110.161 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.74 -19.43 27.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.669 1.352 . . . . 1.0 110.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -102.3 -20.21 14.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 110.187 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 72.2 m -93.66 131.44 38.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 1.0 110.039 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 1.8 tt0 -104.98 46.16 0.93 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.262 -0.899 . . . . 1.0 109.801 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 49' ' ' ILE . 8.4 tt -79.59 80.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.935 -1.103 . . . . 1.0 109.901 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.16 145.63 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 1.0 110.224 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.94 120.1 18.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.212 -0.93 . . . . 1.0 110.341 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.76 19.59 12.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 1.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.32 -95.29 1.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -50.33 -21.23 1.32 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.671 -0.9 . . . . 1.0 111.101 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -134.07 136.31 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.916 -1.115 . . . . 1.0 111.046 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.7 m-70 -121.62 116.44 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 1.0 109.687 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.02 130.08 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 1.0 110.745 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' CE3' ' A' ' 34' ' ' TRP . 47.5 tp -117.13 131.61 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 1.0 109.982 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 96.5 mt -135.72 96.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 1.0 109.957 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 18' ' ' THR . 0.8 OUTLIER -100.2 144.99 28.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 1.0 110.507 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' C ' ' A' ' 62' ' ' ASN . 58.2 m-70 -111.24 -163.46 0.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 1.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 17.6 p-10 -14.49 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.866 ' O ' HG13 ' A' ' 15' ' ' VAL . 75.3 m -80.78 -159.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.694 -0.629 . . . . 1.0 109.645 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.664 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -158.02 -160.78 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.237 -0.914 . . . . 1.0 109.944 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.35 33.22 0.4 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.875 -1.141 . . . . 1.0 111.719 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.48 4.1 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 1.0 108.645 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.585 ' HG2' HD22 ' A' ' 36' ' ' LEU . 34.6 mtt -87.62 37.17 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.567 -0.961 . . . . 1.0 110.46 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 51.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 1.0 109.922 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.58 1.91 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -146.38 148.11 31.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 1.0 110.272 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 77.3 t -89.94 91.37 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 1.0 109.862 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.9 p -96.89 103.23 15.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 1.0 110.533 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -88.24 156.88 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 1.0 109.775 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG3' ' HG2' ' A' ' 79' ' ' LYS . 2.1 mt-30 -149.11 144.93 26.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.05 -1.031 . . . . 1.0 110.656 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.61 -147.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 1.0 109.887 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.83 -62.63 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.005 -1.06 . . . . 1.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.93 24.41 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.418 -0.801 . . . . 1.0 109.926 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.75 137.8 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 1.0 110.294 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HG2' ' HG3' ' A' ' 74' ' ' GLN . 5.1 mtmt -144.61 62.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 1.0 110.252 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -74.97 173.6 10.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 1.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.64 98.86 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -86.55 -173.55 4.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -126.45 104.73 8.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 1.0 109.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 56.8 tp -109.36 146.79 33.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 1.0 110.483 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -149.79 112.0 4.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 1.0 109.777 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' O ' ' A' ' 64' ' ' GLN . 42.3 t -79.41 111.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.064 -1.022 . . . . 1.0 110.079 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.53 108.5 20.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 1.0 110.246 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.567 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.7 mt-10 -75.22 149.06 39.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 1.0 110.092 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 89' ' ' LEU . 5.6 tt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.199 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.289 0.566 . . . . 1.0 110.206 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.61 153.9 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 1.0 110.106 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.09 178.92 4.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.108 -0.995 . . . . 1.0 110.388 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.7 t -116.84 115.14 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 1.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -87.99 -51.29 5.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 1.0 109.608 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -114.0 105.27 54.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.702 -0.624 . . . . 1.0 110.428 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.4 178.03 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.619 1.326 . . . . 1.0 110.707 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.75 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.5 mt -78.34 -170.73 2.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.842 . . . . 1.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 35.1 p90 -152.2 130.5 12.04 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 1.0 109.904 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.51 150.61 30.17 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLU . 48.1 t -149.13 167.97 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.484 -1.01 . . . . 1.0 109.826 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 45.6 mt-10 -125.87 154.99 41.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 1.0 110.368 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.6 p -154.01 147.95 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 1.0 109.948 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -98.14 47.09 1.0 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.0 111.012 -179.347 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.1 t 48.79 95.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.219 -0.926 . . . . 1.0 110.717 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' A' ' 62' ' ' ASN . . . 135.61 -38.15 1.82 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.644 -1.782 . . . . 1.0 108.644 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.595 ' HB2' HG23 ' A' ' 13' ' ' VAL . 3.2 mt-10 -69.7 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.484 -1.009 . . . . 1.0 109.179 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -134.27 122.16 22.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.94 -1.1 . . . . 1.0 110.954 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.58 157.7 27.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 1.0 108.859 178.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -139.84 131.16 26.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.838 -1.164 . . . . 1.0 111.051 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 47.2 m-85 -127.98 126.39 41.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 1.0 109.721 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.87 154.72 32.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.971 . . . . 1.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.8 tt -170.33 140.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 1.0 110.008 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -118.27 162.73 17.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.0 110.251 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.752 HD11 ' CD2' ' A' ' 56' ' ' HIS . 45.1 mt -124.97 -154.93 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 109.815 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.81 -30.12 5.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.132 -0.98 . . . . 1.0 110.04 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -127.77 121.95 22.28 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.0 109.847 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.27 116.86 4.87 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.47 1.247 . . . . 1.0 110.611 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.2 -1.87 7.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 1.0 110.64 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.1 t 55.7 64.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.048 -1.033 . . . . 1.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -168.8 135.4 1.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 1.0 110.223 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.94 168.16 24.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 11.4 tt0 -156.32 159.83 39.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.181 -1.188 . . . . 1.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.911 ' CE3' HD22 ' A' ' 58' ' ' LEU . 23.7 m95 -119.89 163.08 18.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 1.0 110.345 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -164.82 150.16 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 110.348 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.9 mt -68.32 -128.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.0 109.204 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -50.25 -24.64 3.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.604 -1.31 . . . . 1.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.71 41.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 1.1 mm100 -126.07 109.79 24.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.329 -1.1 . . . . 1.0 110.054 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 39' ' ' GLN . 42.3 Cg_endo -68.84 89.47 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.597 1.314 . . . . 1.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 pt? -69.75 -172.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 1.0 110.634 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.8 m -136.69 156.85 47.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 1.0 110.094 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -78.64 115.21 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 1.0 110.184 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -170.16 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 111.116 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 44.2 Cg_endo -70.83 -90.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.27 1.142 . . . . 1.0 110.837 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -125.23 40.33 3.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.774 -1.204 . . . . 1.0 110.43 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 27.8 t -107.92 146.92 31.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 1.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -141.63 74.38 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 1.0 110.077 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' ILE . 14.1 tt -91.09 128.94 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 1.0 110.481 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.0 118.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 1.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 170.2 16.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 1.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.88 19.94 2.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 1.0 110.216 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.56 -76.91 1.55 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -18.39 18.49 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.662 -0.905 . . . . 1.0 110.684 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.45 126.57 13.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 1.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.752 ' CD2' HD11 ' A' ' 25' ' ' LEU . 70.5 m-70 -103.19 115.12 29.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.797 . . . . 1.0 109.725 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 mt -118.26 144.32 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.004 . . . . 1.0 110.477 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.911 HD22 ' CE3' ' A' ' 34' ' ' TRP . 46.6 tp -132.92 132.56 42.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 1.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mt -132.38 118.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 1.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -119.87 106.71 12.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 1.0 110.529 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 83.9 m-70 -72.48 -170.86 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 1.0 109.965 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.0 p-10 -15.02 81.74 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 61' ' ' HIS . 72.8 m -70.92 -158.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.52 -0.738 . . . . 1.0 109.611 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.705 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -138.37 174.48 10.5 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.153 -0.967 . . . . 1.0 108.595 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 4.5 tp -78.37 30.07 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.98 -1.075 . . . . 1.0 112.037 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.79 -11.43 10.25 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.437 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 8.5 mtt -85.17 42.85 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 1.0 110.822 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -89.93 62.09 5.53 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.071 -1.018 . . . . 1.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.89 -119.59 1.37 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.796 -1.322 . . . . 1.0 109.796 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 2.2 pt-20 -145.85 156.59 43.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -1.007 . . . . 1.0 110.571 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.81 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 25.0 t -101.94 82.04 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.45 -0.781 . . . . 1.0 109.557 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.34 129.85 35.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 1.0 110.45 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.507 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 21.5 t80 -98.31 145.81 26.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.478 -0.764 . . . . 1.0 109.679 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -120.66 100.9 7.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 1.0 110.426 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -131.03 89.33 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.46 -153.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 1.0 110.341 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -53.35 -24.9 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.0 110.346 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.25 134.22 39.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 1.0 110.191 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.22 149.64 30.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 1.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.578 ' OG ' HD11 ' A' ' 8' ' ' LEU . 70.2 p -138.6 174.91 10.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.95 . . . . 1.0 110.18 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -163.64 104.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 1.0 110.302 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -95.48 -160.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 1.0 110.078 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.59 115.98 9.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.959 . . . . 1.0 110.014 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -124.68 128.95 49.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.516 ' N ' HD13 ' A' ' 84' ' ' LEU . 2.1 tttp -125.91 136.72 53.37 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.322 -0.861 . . . . 1.0 109.665 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 64' ' ' GLN . 32.1 t -92.64 140.5 16.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 1.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -124.59 128.34 48.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.09 140.67 37.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 1.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.219 0.533 . . . . 1.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 3' ' ' GLU . 2.8 tp -157.26 151.69 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -79.98 -147.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 1.0 110.188 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 HD11 ' A' ' 23' ' ' ILE . 58.8 t -134.65 136.68 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 1.0 110.113 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -86.98 -49.49 7.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.423 -0.798 . . . . 1.0 109.646 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 106.26 51.69 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 1.0 110.337 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -71.74 174.12 11.6 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.556 1.293 . . . . 1.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.818 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 15.5 mt -72.83 178.12 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 1.0 109.789 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.1 m-85 -142.24 132.91 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 1.0 110.073 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.24 141.85 48.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.1 t -141.09 156.84 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -1.086 . . . . 1.0 109.653 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -111.48 150.09 30.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 1.0 110.422 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.01 165.37 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 1.0 110.542 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.91 32.85 5.79 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.525 -0.735 . . . . 1.0 109.222 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 88' ' ' GLU . 10.9 t 64.92 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.69 0.757 . . . . 1.0 110.188 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 142.87 -25.44 2.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.139 -1.584 . . . . 1.0 109.139 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -1.093 . . . . 1.0 109.947 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 95.7 m -136.85 110.19 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 1.0 110.425 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.32 142.65 35.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 1.0 109.688 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -119.73 105.69 11.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 1.0 110.627 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CD2' HD23 ' A' ' 58' ' ' LEU . 62.6 m-85 -96.03 124.95 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 1.0 109.385 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -114.56 152.36 31.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.026 -1.046 . . . . 1.0 110.99 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.811 HD11 HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -167.6 117.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.681 . . . . 1.0 109.547 179.655 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -109.15 165.31 11.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 110.866 -179.331 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' CD2' ' A' ' 56' ' ' HIS . 40.5 mt -129.08 -144.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 1.0 109.494 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -130.91 -47.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -100.79 160.0 28.0 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.936 . . . . 1.0 110.696 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.99 124.23 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.728 1.383 . . . . 1.0 110.381 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.19 101.07 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 1.0 110.093 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 30' ' ' VAL . 9.9 p -97.21 60.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 28.1 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 1.0 109.992 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.23 176.17 28.94 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -158.74 139.96 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -1.101 . . . . 1.0 109.772 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.633 ' CE3' HD22 ' A' ' 58' ' ' LEU . 31.6 m95 -95.52 164.94 12.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 1.0 110.841 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -165.01 160.37 18.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 179.481 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.2 OUTLIER -65.08 -141.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.062 . . . . 1.0 108.838 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.8 -28.16 0.6 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.508 -1.37 . . . . 1.0 110.385 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 164.18 39.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.741 HE21 HD11 ' A' ' 41' ' ' LEU . 26.4 tt0 -123.32 95.91 44.83 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.37 -1.076 . . . . 1.0 108.515 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.72 77.23 3.76 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.693 1.365 . . . . 1.0 111.455 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.741 HD11 HE21 ' A' ' 39' ' ' GLN . 4.2 pp -171.76 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.198 -0.938 . . . . 1.0 110.625 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 65.9 m -69.86 -19.69 63.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.933 -1.104 . . . . 1.0 110.299 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.34 100.43 11.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.493 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -179.56 -59.02 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 1.0 110.375 179.78 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 43.9 Cg_endo -74.58 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.44 1.232 . . . . 1.0 110.445 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 30.12 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 1.0 110.16 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 44' ' ' SER . 52.8 t -129.13 155.62 45.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 1.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 80.98 1.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 1.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' ILE . 15.5 tt -82.31 117.28 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 1.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.59 94.54 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 1.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.22 163.05 15.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 1.0 110.359 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.67 26.33 5.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 1.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.21 -96.41 2.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -21.68 2.54 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.635 -0.921 . . . . 1.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -122.05 149.58 43.33 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.022 -1.049 . . . . 1.0 110.173 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.796 ' HB2' HG23 ' A' ' 23' ' ' ILE . 61.6 m-70 -128.29 113.57 15.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 1.0 109.83 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.5 mm -124.08 151.26 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 1.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 21' ' ' PHE . 6.5 tp -136.11 136.86 40.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.797 . . . . 1.0 109.989 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 58' ' ' LEU . 43.9 mm -126.41 93.53 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 1.0 110.276 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 18' ' ' THR . 7.0 mt -89.74 118.43 29.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.903 . . . . 1.0 110.242 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.7 m-70 -89.66 -167.83 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 1.0 110.289 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.465 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 43.0 t30 -15.35 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' HIS . 57.1 m -75.88 140.1 42.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.586 -0.696 . . . . 1.0 109.397 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.79 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -89.08 -177.39 5.43 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.218 -0.926 . . . . 1.0 110.455 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 86' ' ' VAL . 0.3 OUTLIER -71.8 -1.65 14.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 1.0 111.528 -179.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.35 -17.57 60.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.99 -1.244 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.617 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.5 mtt -84.73 42.07 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.281 . . . . 1.0 111.243 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -90.96 41.13 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 1.0 110.035 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.18 -139.5 5.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.99 157.95 34.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 1.0 110.509 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 41.9 t -101.11 98.54 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 1.0 109.71 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -96.76 141.1 30.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 1.0 110.76 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 35.9 t80 -121.77 143.44 49.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -0.829 . . . . 1.0 109.54 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -120.06 114.72 22.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 1.0 110.545 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -145.94 132.08 19.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 1.0 109.62 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.57 -150.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 1.0 109.765 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -90.35 45.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.973 . . . . 1.0 109.929 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.02 167.05 31.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 1.0 110.33 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.66 135.96 8.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 1.0 110.299 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.464 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 p -101.79 176.11 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.489 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.58 109.83 0.85 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.992 . . . . 1.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.08 179.88 4.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 1.0 109.816 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -114.12 107.94 16.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 1.0 110.089 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.506 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 50.4 tp -108.76 138.92 44.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 1.0 110.35 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -142.03 136.04 29.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 1.0 109.97 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 64' ' ' GLN . 45.2 t -101.28 135.07 39.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.268 -0.895 . . . . 1.0 110.245 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.33 120.33 18.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 15' ' ' VAL . 21.9 mt-10 -84.91 170.16 13.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 1.0 110.037 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.209 179.92 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 1' ' ' LEU . 5.0 tt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.312 0.577 . . . . 1.0 110.262 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.45 -175.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 1.0 110.007 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 2.4 pm0 -147.83 -159.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 1.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.92 107.47 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 1.0 110.306 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -74.96 -34.47 62.05 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 1.0 109.175 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -131.15 107.82 14.97 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.519 -0.738 . . . . 1.0 109.482 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.98 175.28 8.5 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.546 1.287 . . . . 1.0 110.99 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.924 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.7 mt -71.37 -177.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 1.0 109.771 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -122.57 -14.15 7.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.084 -1.01 . . . . 1.0 111.39 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 60.87 118.66 0.01 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.911 -1.275 . . . . 1.0 109.911 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.76 ' O ' HD12 ' A' ' 84' ' ' LEU . 34.4 m -136.5 -176.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.782 -1.423 . . . . 1.0 110.93 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 13' ' ' VAL . 9.2 pt-20 -127.5 173.01 10.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 1.0 109.592 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.646 HG12 ' OE2' ' A' ' 17' ' ' GLU . 25.7 m -149.86 -176.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.088 . . . . 1.0 111.11 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.39 25.22 6.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 13.4 t 61.91 85.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.575 -0.703 . . . . 1.0 110.759 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.55 -25.17 3.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.191 -1.163 . . . . 1.0 110.191 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.646 ' OE2' HG12 ' A' ' 13' ' ' VAL . 2.0 pt-20 -76.03 -144.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -1.203 . . . . 1.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.9 m -149.82 111.56 4.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 1.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.74 165.66 22.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 1.0 109.96 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -143.3 110.16 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 1.0 110.772 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 95.2 m-85 -112.45 125.02 53.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -0.807 . . . . 1.0 109.593 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.16 157.13 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 1.0 111.335 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.3 tt -166.32 129.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 1.0 109.556 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -108.63 138.2 45.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 1.0 110.681 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.574 HD11 ' NE2' ' A' ' 56' ' ' HIS . 66.4 mt -94.01 173.36 7.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 1.0 109.751 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -74.29 -61.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.0 . . . . 1.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -117.77 131.04 24.3 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.029 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.13 126.2 9.73 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.513 1.27 . . . . 1.0 110.236 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.63 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.3 t -97.34 148.19 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 1.0 110.065 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -86.53 -166.47 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.0 110.17 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.84 162.11 35.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 1.0 109.613 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.49 171.65 11.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -1.126 . . . . 1.0 109.98 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.893 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.8 m95 -111.87 176.37 5.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.106 -0.996 . . . . 1.0 110.589 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 5.6 ttmt -165.38 126.14 1.91 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.388 -0.82 . . . . 1.0 108.812 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.77 -131.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.0 109.112 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -51.65 -24.51 5.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.337 -1.477 . . . . 1.0 109.698 179.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.38 41.64 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.08 -1.608 . . . . 1.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -122.5 111.84 31.39 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 1.0 110.555 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.76 96.59 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.679 1.357 . . . . 1.0 109.651 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 42' ' ' THR . 3.1 pp -70.05 -153.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 1.0 110.526 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.887 ' N ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -152.72 -166.04 2.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 1.0 110.027 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.67 107.03 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 1.0 110.047 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 6.0 p -147.67 168.82 10.4 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 1.0 110.235 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 44.5 Cg_endo -72.05 -19.11 26.89 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.543 1.286 . . . . 1.0 110.475 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -23.54 59.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 1.0 110.344 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.5 t -141.36 125.64 17.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 1.0 110.413 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.17 135.1 54.02 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.251 -0.905 . . . . 1.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' HG2' ' A' ' 51' ' ' GLU . 3.5 mt -130.93 95.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.38 -0.825 . . . . 1.0 110.023 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.96 94.03 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 1.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' HG22 ' A' ' 49' ' ' ILE . 4.5 pt-20 -139.57 147.57 41.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 1.0 110.261 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -146.21 19.37 1.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 1.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.77 -23.55 30.27 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -90.07 -20.93 22.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.264 -1.139 . . . . 1.0 109.989 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.3 144.7 3.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.294 -0.879 . . . . 1.0 110.128 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.574 ' NE2' HD11 ' A' ' 25' ' ' LEU . 69.1 m-70 -110.94 118.85 37.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 1.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.53 128.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.34 -0.85 . . . . 1.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 34' ' ' TRP . 4.3 tt -116.23 133.21 56.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 1.0 110.56 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.751 ' N ' HD23 ' A' ' 58' ' ' LEU . 41.0 mm -133.55 86.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.59 103.37 15.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 1.0 110.758 -179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.2 m-70 -69.69 -156.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 1.0 109.304 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 59.7 t-20 -14.77 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 61' ' ' HIS . 76.7 m -71.78 171.02 12.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.714 -0.616 . . . . 1.0 110.419 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 1.2 tp60 -110.07 163.57 13.46 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.361 -0.837 . . . . 1.0 108.905 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.549 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -75.39 5.08 6.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.868 -1.145 . . . . 1.0 111.739 -179.467 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.25 -20.24 28.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.559 ' HB2' HG21 ' A' ' 86' ' ' VAL . 12.0 mtt -55.3 -17.41 4.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 1.0 111.167 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -43.91 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 1.0 110.789 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.97 -121.35 0.63 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.92 135.5 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -1.066 . . . . 1.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.1 101.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 1.0 109.843 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -103.56 128.76 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 1.0 110.361 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -108.58 148.2 30.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.0 109.792 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -136.33 137.09 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 1.0 110.55 -179.64 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -165.58 99.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 56.93 -89.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 1.0 110.38 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 7.3 m-20 -119.18 32.38 6.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.968 -1.082 . . . . 1.0 110.281 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 74' ' ' GLN . . . -118.01 133.85 55.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 1.0 110.195 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 68.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 1.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.8 m -77.94 166.9 22.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.0 109.987 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.31 104.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 1.0 110.509 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.924 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.35 -170.67 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.08 123.44 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 1.0 109.848 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.779 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 57.5 tp -124.66 138.26 54.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 1.0 110.699 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -140.09 130.56 25.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.404 -0.81 . . . . 1.0 109.604 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 67' ' ' MET . 52.9 t -99.85 118.01 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 1.0 110.366 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 3.3 ttpt -97.99 140.57 32.14 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.32 -0.862 . . . . 1.0 109.665 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.94 -156.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 1.0 109.999 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.884 -1.055 . . . . 1.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.232 0.539 . . . . 1.0 110.308 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 26' ' ' SER . 43.9 pt -121.16 178.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 1.0 110.198 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -108.27 -166.97 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.937 . . . . 1.0 110.271 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG2' ' HA ' ' A' ' 78' ' ' ALA . 89.0 t -121.21 124.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 1.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.83 -31.83 31.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 1.0 110.289 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.2 113.82 6.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 1.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.77 -176.69 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.58 1.305 . . . . 1.0 110.25 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 19.1 mt -73.38 -154.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 1.0 110.396 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -155.98 116.32 3.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 1.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.25 133.46 45.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.16 152.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.302 -1.116 . . . . 1.0 110.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -94.03 175.35 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 1.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 14' ' ' PHE . 6.8 p -154.14 174.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 1.0 110.737 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -117.8 136.6 53.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 1.0 109.582 179.284 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.989 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -60.07 91.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 1.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 140.66 -37.8 1.64 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.017 -1.633 . . . . 1.0 109.017 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -71.99 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 1.0 109.684 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.9 m -160.65 150.32 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 1.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.22 176.99 5.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 1.0 109.197 179.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -160.5 112.29 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.0 111.664 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.863 ' CE2' HG21 ' A' ' 71' ' ' VAL . 47.1 m-85 -117.48 127.25 53.82 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 178.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -115.84 151.62 34.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 1.0 111.147 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 56' ' ' HIS . 1.2 tt -164.26 139.02 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.578 -0.701 . . . . 1.0 109.546 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 25' ' ' LEU . 1.3 mp0 -118.46 154.04 33.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 1.0 110.355 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 56' ' ' HIS . 24.7 mt -116.77 -152.88 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 1.0 110.048 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -121.09 -35.02 3.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 1.0 109.65 179.596 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.07 160.96 42.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.85 134.54 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.659 1.347 . . . . 1.0 110.446 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -171.58 113.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 110.241 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.82 54.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 1.0 110.088 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -131.53 45.87 2.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 1.0 110.052 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.02 164.18 12.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.044 -1.223 . . . . 1.0 110.044 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.01 169.94 16.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -1.055 . . . . 1.0 109.851 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.806 ' CE3' HD22 ' A' ' 58' ' ' LEU . 42.8 m95 -122.56 138.72 54.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 1.0 110.793 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 1.3 ttmt -121.62 143.27 49.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.527 -0.733 . . . . 1.0 110.287 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 41' ' ' LEU . 7.6 mt -93.96 -93.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 1.0 109.705 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -14.72 62.06 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.097 -1.002 . . . . 1.0 110.083 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 138.16 -10.14 3.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.978 -1.249 . . . . 1.0 109.978 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.99 159.81 28.6 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.065 -1.256 . . . . 1.0 109.605 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.25 79.17 3.02 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.751 1.395 . . . . 1.0 110.561 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 36' ' ' LEU . 1.5 pp -127.6 -15.79 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.349 -0.844 . . . . 1.0 110.891 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -69.45 -16.9 63.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 1.0 110.54 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.11 112.63 21.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 1.0 110.26 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.98 170.74 7.43 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.925 . . . . 1.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.38 5.1 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.621 1.327 . . . . 1.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.89 -11.78 11.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.844 -1.16 . . . . 1.0 110.904 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.1 -169.59 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 1.0 110.386 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -144.35 76.39 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.0 110.269 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -95.9 128.34 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 1.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 50' ' ' ILE . 23.0 pt -133.21 133.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 1.0 109.916 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -142.37 137.62 30.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.986 -1.071 . . . . 1.0 110.508 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.62 21.9 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 1.0 110.202 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.05 -64.0 2.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.749 -1.34 . . . . 1.0 109.749 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.58 31.86 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.727 -0.867 . . . . 1.0 110.795 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -153.01 115.72 4.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 25' ' ' LEU . 91.8 m-70 -110.0 117.92 35.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 1.0 109.836 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 56' ' ' HIS . 41.9 mm -121.31 157.81 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 1.0 110.237 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.806 HD22 ' CE3' ' A' ' 34' ' ' TRP . 39.2 tp -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 1.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.02 111.57 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 1.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.742 HD13 ' CE ' ' A' ' 67' ' ' MET . 5.1 mt -110.46 103.26 11.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.049 . . . . 1.0 110.679 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 62' ' ' ASN . 80.6 m-70 -72.13 -162.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 1.0 110.374 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.512 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 39.7 t-20 -12.86 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.555 1.317 . . . . 1.0 114.555 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.989 ' O ' HG23 ' A' ' 15' ' ' VAL . 73.8 m -86.08 -158.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.711 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -158.67 -173.67 4.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.798 -1.189 . . . . 1.0 110.907 179.654 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.21 -18.53 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 1.0 111.465 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.74 -130.32 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.783 -1.727 . . . . 1.0 108.783 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.742 ' CE ' HD13 ' A' ' 60' ' ' LEU . 1.3 mtt 39.42 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.981 -0.717 . . . . 1.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 68' ' ' THR . 19.4 m -91.17 37.64 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.068 -1.02 . . . . 1.0 110.176 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.21 -122.46 3.57 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.491 -1.444 . . . . 1.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -150.09 162.94 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -1.113 . . . . 1.0 110.555 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.863 HG21 ' CE2' ' A' ' 21' ' ' PHE . 70.1 t -104.69 87.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 1.0 109.808 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 p -92.45 107.97 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.938 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 34.1 t80 -79.14 158.77 27.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.685 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.52 109.96 3.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 1.0 110.61 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.38 -146.09 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 1.0 109.625 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.12 43.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -0.991 . . . . 1.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 2' ' ' ILE . 49.3 t30 -163.11 30.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 1.0 110.004 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -113.03 74.27 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 1.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -86.59 86.1 7.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.864 . . . . 1.0 110.431 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.647 ' OG ' HD11 ' A' ' 8' ' ' LEU . 77.5 p -81.73 -179.22 7.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -0.945 . . . . 1.0 110.117 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.49 89.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 1.0 110.383 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -98.36 -177.52 3.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 1.0 110.123 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -110.49 138.76 46.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' SD ' ' A' ' 67' ' ' MET . 44.3 tp -134.69 130.35 36.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 1.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -143.75 147.26 33.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 1.0 109.687 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.711 HG11 ' O ' ' A' ' 64' ' ' GLN . 25.4 t -105.82 158.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.059 -1.026 . . . . 1.0 110.736 -179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -130.69 146.11 52.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 1.0 109.664 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -81.98 -160.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.0 110.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.961 -1.018 . . . . 1.0 110.269 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.14 153.95 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 1.0 109.721 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -128.9 -3.8 5.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 1.0 111.048 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 85.5 t 53.14 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 1.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -85.52 -26.58 26.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.316 -0.865 . . . . 1.0 109.995 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 105.33 40.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 1.0 110.079 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.84 178.55 5.7 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.604 1.318 . . . . 1.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.919 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 14.2 mt -73.77 -157.81 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 1.0 110.156 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -155.9 134.22 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 1.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.65 140.87 26.7 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.671 -1.372 . . . . 1.0 109.671 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.7 152.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 1.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -96.13 169.19 10.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 1.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' CD ' ' A' ' 17' ' ' GLU . 11.6 p -159.35 146.16 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 1.0 110.299 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -88.35 125.87 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 1.0 109.725 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -46.84 93.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.413 -0.805 . . . . 1.0 111.712 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 155.64 -36.4 0.63 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.055 -1.218 . . . . 1.0 110.055 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' CD ' HG23 ' A' ' 13' ' ' VAL . 3.6 pt-20 -85.73 -148.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 1.0 109.826 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.485 HG21 ' CE1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -136.75 137.24 39.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 1.0 110.472 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -85.36 -176.5 6.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 1.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.494 ' CD2' HG12 ' A' ' 59' ' ' ILE . 8.0 m80 -160.7 108.5 1.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.954 -1.091 . . . . 1.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CD1' HD23 ' A' ' 58' ' ' LEU . 91.6 m-85 -114.81 120.87 41.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.789 . . . . 1.0 109.369 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -109.8 155.18 21.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 1.0 110.925 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 23' ' ' ILE . 11.4 tt -161.37 119.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.767 . . . . 1.0 109.833 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -101.08 131.88 46.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 1.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 56' ' ' HIS . 22.0 mt -87.63 179.56 6.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.86 . . . . 1.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.7 p -85.26 -22.05 28.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.0 109.98 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -121.45 135.83 25.39 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 1.0 109.978 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.1 Cg_endo -75.52 -178.32 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.537 1.283 . . . . 1.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.68 67.48 0.98 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 1.0 110.22 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 28' ' ' PRO . 98.1 t -142.52 159.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 1.0 110.307 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.2 148.35 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 1.0 109.963 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.76 -134.02 2.34 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -167.54 140.44 3.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -1.117 . . . . 1.0 110.18 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.736 ' CE3' HD22 ' A' ' 58' ' ' LEU . 33.9 m95 -102.93 170.73 7.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 1.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -173.62 170.29 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.486 -0.759 . . . . 1.0 109.942 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.25 -131.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 1.0 109.469 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -49.6 -25.03 2.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.7 -1.25 . . . . 1.0 110.399 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.64 40.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -128.48 107.63 19.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.199 -1.177 . . . . 1.0 110.046 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.08 112.36 3.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.487 1.256 . . . . 1.0 110.637 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 42' ' ' THR . 1.3 pp -106.7 -146.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 1.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.705 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -132.66 128.12 36.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.05 -1.031 . . . . 1.0 110.39 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.28 111.32 1.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.873 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -177.3 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.386 -0.821 . . . . 1.0 110.244 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -72.19 -74.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.441 1.232 . . . . 1.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD2' ' CE ' ' A' ' 67' ' ' MET . 27.9 t70 -133.19 58.63 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 1.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 t -162.71 142.3 9.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.905 . . . . 1.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -144.5 87.98 1.9 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.284 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.0 mt -87.81 131.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.132 -0.98 . . . . 1.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 tt -134.95 146.36 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 1.0 110.318 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.0 146.7 19.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 110.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.68 9.01 11.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.739 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.49 -21.24 30.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.474 -1.051 . . . . 1.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 -23.22 20.6 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.172 -1.193 . . . . 1.0 109.718 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 56' ' ' HIS . 38.8 tttt -164.56 163.49 21.89 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.423 -0.798 . . . . 1.0 109.498 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.692 ' CD2' HD11 ' A' ' 25' ' ' LEU . 51.6 m-70 -113.19 121.63 45.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 1.0 110.04 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.19 141.62 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 1.0 110.345 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.736 HD22 ' CE3' ' A' ' 34' ' ' TRP . 21.6 tp -115.57 148.93 39.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.345 -0.847 . . . . 1.0 110.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 20' ' ' HIS . 58.4 mt -146.01 116.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 1.0 109.719 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -117.44 107.27 14.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 1.0 110.587 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' CE1' HG21 ' A' ' 18' ' ' THR . 67.5 m-70 -69.7 -172.14 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 1.0 110.328 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.8 p-10 -13.94 80.85 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.025 1.12 . . . . 1.0 114.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.837 ' O ' HG23 ' A' ' 15' ' ' VAL . 80.7 m -74.42 148.07 41.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -92.25 171.0 9.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 1.0 111.541 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -23.93 2.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.715 -0.615 . . . . 1.0 110.748 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.32 -123.87 0.06 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.98 -1.648 . . . . 1.0 108.98 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.655 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.7 mtt 43.53 28.02 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.895 . . . . 1.0 111.287 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.51 52.52 2.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.297 -0.877 . . . . 1.0 110.365 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.75 -141.84 5.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.416 -1.474 . . . . 1.0 109.416 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 37' ' ' LYS . 1.7 pt-20 -130.99 143.33 50.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -1.154 . . . . 1.0 110.258 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.597 HG23 ' HB2' ' A' ' 84' ' ' LEU . 45.7 t -79.71 99.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 1.0 109.856 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -103.11 128.02 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 1.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 34' ' ' TRP . 64.4 t80 -104.63 154.82 19.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 109.707 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.61 146.85 51.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 1.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.21 -142.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 1.0 110.04 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.94 -70.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.274 -0.891 . . . . 1.0 110.702 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -146.42 21.21 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 1.0 110.106 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -111.8 167.1 10.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 1.0 110.157 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.61 115.79 2.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.939 . . . . 1.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 66.9 p -96.96 177.84 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.286 -0.884 . . . . 1.0 109.696 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.29 97.15 0.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.033 -1.042 . . . . 1.0 110.696 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.09 -175.98 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 1.0 109.691 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -100.14 138.33 37.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.047 . . . . 1.0 110.242 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' A' ' 71' ' ' VAL . 21.6 tp -131.6 120.74 23.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 1.0 110.249 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -134.35 136.63 43.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 1.0 110.101 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 64' ' ' GLN . 59.5 t -94.57 148.15 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.251 -0.906 . . . . 1.0 110.052 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.46 141.53 51.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 1.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -105.06 -157.84 0.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 tp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.261 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.321 0.581 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.666 HG21 ' HG3' ' A' ' 27' ' ' GLU . 5.1 tt -106.41 157.87 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 1.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.802 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.3 mt-10 -82.77 -148.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 1.0 110.041 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.03 HG23 ' HB1' ' A' ' 78' ' ' ALA . 61.2 t -129.11 129.89 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 1.0 109.64 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 -57.61 3.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.954 . . . . 1.0 109.652 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.09 100.68 15.79 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.661 -0.65 . . . . 1.0 110.345 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.92 -179.33 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.649 1.341 . . . . 1.0 110.441 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.928 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 22.6 mt -76.71 159.34 30.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.055 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -125.96 15.92 7.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.105 -0.997 . . . . 1.0 110.731 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 63.32 157.69 0.15 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.2 p -160.07 170.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.523 -0.986 . . . . 1.0 109.714 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -120.56 166.08 14.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 1.0 110.531 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 12' ' ' GLU . 18.7 m -151.18 147.7 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.422 -0.799 . . . . 1.0 110.496 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.415 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -97.04 27.73 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 1.0 109.4 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 63' ' ' CYS . 75.4 t 57.39 87.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.55 0.691 . . . . 1.0 110.721 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.48 -30.2 2.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.35 -138.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.304 -1.115 . . . . 1.0 109.386 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 ' CG2' ' ND1' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -149.64 132.21 15.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 1.0 110.232 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -85.26 165.22 17.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.827 . . . . 1.0 110.037 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 34.4 m170 -144.14 80.52 1.65 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 1.0 110.764 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 67.3 m-85 -79.77 152.99 29.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 1.0 109.442 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' HD23 ' A' ' 8' ' ' LEU . 12.1 mt-10 -136.24 158.86 43.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 1.0 110.941 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.5 OUTLIER -168.06 127.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.503 -0.748 . . . . 1.0 109.765 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -103.37 150.12 24.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -0.925 . . . . 1.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' HD2' ' A' ' 56' ' ' HIS . 3.3 mp -134.18 1.1 3.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 1.0 111.569 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.464 ' OG ' HD11 ' A' ' 2' ' ' ILE . 6.3 p 41.16 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.6 -0.688 . . . . 1.0 111.721 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HG3' HG21 ' A' ' 2' ' ' ILE . 1.4 mm-40 -136.44 119.74 12.21 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.9 -1.125 . . . . 1.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 45.9 Cg_endo -72.75 161.11 44.71 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.501 1.264 . . . . 1.0 110.122 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.78 86.77 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.205 -0.935 . . . . 1.0 110.328 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -168.37 144.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 1.0 109.902 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.42 -175.95 3.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 1.0 110.608 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.0 -164.8 35.03 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -157.32 158.22 35.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -1.144 . . . . 1.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.535 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 22.5 m95 -115.49 166.55 11.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.0 110.451 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -162.19 142.8 10.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 1.0 109.758 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 mt -64.16 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 1.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -49.47 -25.46 2.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.635 -1.291 . . . . 1.0 110.056 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.499 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 160.79 40.2 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.484 -1.446 . . . . 1.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 7.4 mm-40 -118.8 121.58 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 1.0 110.174 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.73 103.75 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.449 1.236 . . . . 1.0 110.744 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -173.99 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 1.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 43' ' ' ALA . 1.6 m -150.93 -178.06 6.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 1.0 110.274 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' H ' HG22 ' A' ' 42' ' ' THR . . . -65.19 106.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 1.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 164.37 24.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 1.0 110.167 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.48 -17.52 30.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.656 1.345 . . . . 1.0 110.613 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -83.45 -26.16 30.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 1.0 110.125 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -118.76 119.79 35.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.0 110.074 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -107.13 88.84 2.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.966 . . . . 1.0 110.409 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.417 HG12 HD11 ' A' ' 58' ' ' LEU . 97.3 mt -86.97 106.96 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 1.0 109.867 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' ILE . 6.2 tp -131.28 118.33 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 1.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 56' ' ' HIS . 1.5 pt-20 -149.37 169.25 21.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 1.0 110.133 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -117.08 -134.51 0.34 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.281 -0.887 . . . . 1.0 109.126 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -117.68 -19.81 4.8 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.679 -1.248 . . . . 1.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -21.81 22.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 1.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -153.79 173.12 16.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.184 -0.947 . . . . 1.0 110.545 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.797 ' HD2' HD13 ' A' ' 25' ' ' LEU . 57.5 m-70 -133.25 127.62 34.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.352 -0.842 . . . . 1.0 109.787 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.87 135.79 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 1.0 110.715 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.527 HD22 ' CE3' ' A' ' 34' ' ' TRP . 23.8 tp -112.89 147.96 35.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.495 -0.753 . . . . 1.0 110.144 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 87.8 mt -138.73 82.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0 109.882 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -73.2 161.71 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 1.0 110.467 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.5 m-70 -126.89 -169.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.486 -0.759 . . . . 1.0 109.503 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.514 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 42.2 p30 -13.64 80.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.778 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.5 m -78.98 175.12 10.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 1.0 109.501 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG11 ' A' ' 86' ' ' VAL . 1.2 mt-30 -138.58 -163.89 1.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.047 -1.033 . . . . 1.0 110.567 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.32 8.56 4.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 1.0 111.476 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.93 -22.91 19.23 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.064 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.479 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 37.7 mtt -86.69 34.93 0.66 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.067 -1.255 . . . . 1.0 110.799 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 34.9 0.93 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 1.0 110.134 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.35 -124.83 4.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.57 147.17 46.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -1.121 . . . . 1.0 110.393 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 70.7 t -89.05 107.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.316 -0.865 . . . . 1.0 109.884 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 p -108.03 110.6 22.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 1.0 110.663 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 22.7 t80 -91.03 146.87 23.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 1.0 109.823 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -131.54 104.55 7.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.037 -1.04 . . . . 1.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -123.62 124.94 43.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 1.0 109.763 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.84 -90.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 1.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 6.2 p30 -129.66 -38.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.807 -1.183 . . . . 1.0 110.378 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 1.03 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -63.09 159.76 16.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 1.0 110.516 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -156.63 126.92 6.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 1.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.58 ' OG ' HD11 ' A' ' 8' ' ' LEU . 75.5 p -92.52 -179.14 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.32 88.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -91.67 -170.18 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 1.0 110.307 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -119.91 111.59 18.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 1.0 110.363 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.692 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 66.0 tp -102.15 145.43 29.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 1.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.64 107.92 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.299 -0.875 . . . . 1.0 110.207 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 64' ' ' GLN . 46.3 t -80.9 147.43 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.118 -0.989 . . . . 1.0 110.405 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -115.45 168.37 10.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 110.165 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -101.95 155.46 18.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.241 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.205 0.526 . . . . 1.0 110.176 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.14 140.94 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.34 156.63 17.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 1.0 109.971 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.78 167.28 2.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.116 -0.99 . . . . 1.0 110.018 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -123.69 -30.72 3.55 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.482 0.658 . . . . 1.0 110.033 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -146.96 122.39 5.37 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 1.0 110.029 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.55 -176.49 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.535 1.282 . . . . 1.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 18.3 mt -82.46 -164.62 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.21 -0.931 . . . . 1.0 110.777 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.13 139.78 26.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.404 -0.81 . . . . 1.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.6 150.29 34.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.429 -1.468 . . . . 1.0 109.429 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 12' ' ' GLU . 10.4 p -158.56 169.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 1.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 11' ' ' VAL . 3.0 mt-10 -122.29 165.05 16.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 1.0 110.499 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.5 p -158.94 127.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.238 -0.914 . . . . 1.0 110.104 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.55 47.57 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.217 -0.927 . . . . 1.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 63' ' ' CYS . 21.8 t 48.77 71.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.683 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.65 -22.52 1.04 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 13' ' ' VAL . 53.4 mm-40 -78.99 -122.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -1.157 . . . . 1.0 109.232 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -161.17 157.85 26.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.705 -1.247 . . . . 1.0 110.492 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -108.64 172.52 6.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.393 -0.817 . . . . 1.0 108.883 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.72 122.87 4.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.922 -1.112 . . . . 1.0 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 58' ' ' LEU . 73.6 m-85 -140.32 132.82 28.61 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.16 155.5 41.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.937 -1.102 . . . . 1.0 111.155 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -167.8 122.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.607 -0.683 . . . . 1.0 109.752 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.24 130.35 54.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 1.0 110.491 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 56' ' ' HIS . 55.6 mt -91.33 -174.2 3.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.822 . . . . 1.0 109.871 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -99.03 -57.37 2.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.0 109.963 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.99 144.01 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 1.0 109.852 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 -169.5 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.628 1.331 . . . . 1.0 110.567 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t0 55.26 80.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 1.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 32' ' ' GLY . 75.4 t -131.28 154.09 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 1.0 109.899 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -124.53 43.53 2.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.92 . . . . 1.0 110.452 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 30' ' ' VAL . . . -77.74 171.36 55.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 12.4 tm0? -145.07 165.26 28.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -1.112 . . . . 1.0 109.902 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.931 ' CE3' HD22 ' A' ' 58' ' ' LEU . 34.2 m95 -108.52 163.84 12.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 1.0 110.819 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.581 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -159.59 157.11 29.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.413 -0.804 . . . . 1.0 110.102 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.42 HD22 ' HG2' ' A' ' 67' ' ' MET . 51.6 mt -68.31 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 1.0 109.805 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -47.34 -25.92 1.13 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.856 -1.152 . . . . 1.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 150.64 39.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 11.2 tt0 -136.41 136.47 22.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 O-C-N 121.126 -1.22 . . . . 1.0 109.132 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.42 114.48 3.94 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.468 1.246 . . . . 1.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 42' ' ' THR . 0.7 OUTLIER -92.77 -139.58 0.2 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 1.0 109.926 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.452 ' H ' HD12 ' A' ' 41' ' ' LEU . 1.2 p -138.69 136.85 36.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.119 . . . . 1.0 110.013 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.79 98.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 1.0 110.088 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -88.69 169.12 14.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 1.0 110.184 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.06 -16.72 28.71 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.731 1.385 . . . . 1.0 110.513 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -98.37 -21.27 16.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 1.0 110.376 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.27 136.32 33.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 1.0 110.181 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.63 136.42 54.49 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 1.0 109.626 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 49' ' ' ILE . 95.7 mt -139.39 76.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 1.0 109.761 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' ILE . 41.9 pt -85.4 144.32 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 1.0 110.038 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.76 137.53 8.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 1.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.09 26.6 8.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 1.0 109.872 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 -92.39 1.77 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.5 -15.79 30.55 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.631 -0.923 . . . . 1.0 110.547 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -121.63 130.72 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 1.0 110.588 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.778 ' HB2' HG23 ' A' ' 23' ' ' ILE . 29.3 m-70 -118.16 131.13 56.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.0 110.085 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.97 136.42 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 1.0 110.226 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.931 HD22 ' CE3' ' A' ' 34' ' ' TRP . 16.2 tp -125.17 139.96 53.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 1.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 58' ' ' LEU . 33.9 mm -140.61 115.43 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 1.0 109.331 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 9.0 mt -112.82 108.46 17.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 1.0 110.846 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 25.0 m-70 -75.44 -159.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 1.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 54.0 t30 -14.13 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.815 ' O ' HG13 ' A' ' 15' ' ' VAL . 91.7 m -86.29 -176.27 5.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.6 -0.688 . . . . 1.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.646 ' C ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -149.96 -164.22 1.97 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 1.0 110.202 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.58 13.43 0.62 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.071 . . . . 1.0 112.404 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.36 -30.97 10.04 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.46 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 36.9 mtt -86.72 39.23 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -1.121 . . . . 1.0 110.565 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -90.69 79.77 6.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.181 -0.949 . . . . 1.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.64 -120.76 0.59 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.63 140.1 31.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 1.0 110.415 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.527 ' O ' HD13 ' A' ' 8' ' ' LEU . 70.5 t -84.69 102.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 1.0 109.853 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 p -102.83 128.69 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 1.0 110.365 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 53.9 t80 -105.57 142.04 36.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.0 109.622 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 127.64 32.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.038 . . . . 1.0 110.647 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.49 -147.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 1.0 109.746 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.43 -73.53 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.932 -1.105 . . . . 1.0 110.081 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -130.12 -1.21 4.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 1.0 110.794 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.22 156.11 23.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.927 -1.108 . . . . 1.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.07 125.88 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.927 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 2.6 p -126.17 178.34 5.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 1.0 109.729 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.55 106.69 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.01 -170.44 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 1.0 109.716 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.14 109.18 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.025 . . . . 1.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 67' ' ' MET . 58.2 tp -108.01 147.01 31.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 1.0 110.036 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 105.09 3.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 1.0 110.136 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.646 HG11 ' C ' ' A' ' 64' ' ' GLN . 38.3 t -80.5 133.35 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.186 -0.946 . . . . 1.0 110.149 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -98.44 146.26 25.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.06 149.05 48.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 1.0 110.168 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.235 -179.819 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.444 HD23 ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.179 0.514 . . . . 1.0 110.157 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 1.2 pt -110.15 133.03 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 1.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.6 162.82 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 1.0 110.271 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.695 HG21 ' OG ' ' A' ' 80' ' ' SER . 1.3 p -74.59 124.98 33.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.236 -0.915 . . . . 1.0 110.002 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.21 -34.6 23.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.736 0.779 . . . . 1.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -126.17 109.36 24.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.76 -0.587 . . . . 1.0 110.137 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.0 174.81 10.7 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.578 1.304 . . . . 1.0 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.954 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -87.01 -174.08 4.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0 109.535 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.7 m-85 -145.34 131.4 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 1.0 110.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.35 152.55 14.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.78 142.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.374 -1.074 . . . . 1.0 110.39 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.31 155.0 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 1.0 109.599 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.07 170.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.025 -1.047 . . . . 1.0 110.931 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' N ' HG22 ' A' ' 13' ' ' VAL . 1.7 m-85 -102.13 135.6 43.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.6 p -49.46 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.909 -1.119 . . . . 1.0 111.048 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 147.15 -41.97 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -161.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -1.068 . . . . 1.0 110.107 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 p -120.98 163.57 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 1.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 21' ' ' PHE . . . -120.65 172.56 7.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.529 -0.732 . . . . 1.0 109.268 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.502 ' CD2' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -155.41 124.43 6.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 1.0 111.178 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.707 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 60.4 m-85 -134.36 118.44 17.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.523 -0.736 . . . . 1.0 109.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.51 157.11 17.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.052 -1.03 . . . . 1.0 111.034 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 56' ' ' HIS . 5.6 tt -168.43 120.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 1.0 109.801 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.69 148.6 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 1.0 110.274 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.3 mt -103.84 -154.36 0.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 1.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 31.1 t -116.44 -76.05 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 1.0 109.931 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.66 137.42 20.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.0 109.789 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.31 136.76 27.17 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.578 1.304 . . . . 1.0 110.53 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -164.01 -61.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 1.0 110.091 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.82 148.38 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 1.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -75.61 -164.02 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.29 179.38 25.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -131.53 149.35 52.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -1.18 . . . . 1.0 109.944 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.783 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.8 m95 -104.91 154.21 20.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 1.0 110.776 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 6.9 pttt -147.66 162.28 39.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 1.0 109.514 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 67' ' ' MET . 2.1 mt -81.99 -84.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 1.0 110.115 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 21.16 5.78 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.513 -0.742 . . . . 1.0 110.053 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 107.85 -14.7 37.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 1.0 109.633 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.4 mt-30 -82.94 134.76 46.07 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.175 -1.191 . . . . 1.0 110.044 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.92 114.25 3.99 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.695 1.366 . . . . 1.0 110.615 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 42' ' ' THR . 1.1 pp -73.12 -141.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.836 . . . . 1.0 109.461 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.0 t -158.92 163.45 36.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.742 -1.224 . . . . 1.0 110.252 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.91 106.5 0.31 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 m -116.59 159.44 40.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 1.0 110.17 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -4.8 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.672 1.354 . . . . 1.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.19 -22.76 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.983 -1.073 . . . . 1.0 110.28 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.494 ' SG ' HD21 ' A' ' 60' ' ' LEU . 48.2 t -101.76 122.81 44.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 1.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.49 144.54 44.2 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.147 -0.971 . . . . 1.0 109.233 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.44 85.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 1.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -87.38 120.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 1.0 109.911 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 19.6 pt-20 -146.02 147.52 31.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 1.0 110.505 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.56 23.44 5.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.0 109.732 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -74.58 2.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -18.12 24.1 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.736 -0.861 . . . . 1.0 110.823 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.66 43.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.034 -1.041 . . . . 1.0 110.816 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.693 ' HB2' HG23 ' A' ' 23' ' ' ILE . 67.5 m-70 -143.06 103.35 4.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 1.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.87 136.83 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 1.0 110.502 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD22 ' CE3' ' A' ' 34' ' ' TRP . 34.3 tp -117.35 130.72 56.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.311 -0.868 . . . . 1.0 110.387 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.502 HG12 ' CD2' ' A' ' 20' ' ' HIS . 21.1 mt -132.18 100.81 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 1.0 109.636 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mt -103.72 116.16 31.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 1.0 110.922 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 62' ' ' ASN . 43.9 m-70 -77.59 -166.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 1.0 109.945 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 61' ' ' HIS . 54.0 t30 -15.45 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.66 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.4 m -73.71 143.92 45.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.503 -0.748 . . . . 1.0 109.496 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -79.13 173.51 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.0 110.825 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -9.52 46.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.774 . . . . 1.0 110.904 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.14 -10.61 82.35 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.944 -1.122 . . . . 1.0 110.342 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.666 ' HB2' HG21 ' A' ' 86' ' ' VAL . 6.2 mtt -84.37 38.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.888 -1.36 . . . . 1.0 111.458 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -91.43 40.0 1.02 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.019 -1.051 . . . . 1.0 109.918 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.33 -128.31 4.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 83' ' ' ASN . 1.9 mp0 -135.13 -170.66 2.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -1.083 . . . . 1.0 110.468 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 78.1 t -128.61 78.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 110.072 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' A' ' 35' ' ' LYS . 17.1 p -86.78 125.21 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 1.0 110.15 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 23' ' ' ILE . 57.2 t80 -103.23 143.83 32.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 1.0 110.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -133.72 127.12 32.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 1.0 110.125 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -159.78 118.58 2.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.0 110.5 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.62 -89.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 1.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.444 ' ND2' HD23 ' A' ' 1' ' ' LEU . 41.6 t30 -128.03 -35.77 2.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.893 -1.129 . . . . 1.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 150.32 11.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 1.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 125.96 6.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 1.0 110.24 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.695 ' OG ' HG21 ' A' ' 4' ' ' VAL . 23.1 m -125.5 174.51 8.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 1.0 110.38 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.4 94.21 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 1.0 110.193 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.954 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -90.84 -172.88 3.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 1.0 110.29 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 17.8 m-20 -123.26 139.23 54.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.707 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 60.7 tp -143.72 127.42 17.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 1.0 110.386 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -134.7 132.95 39.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 1.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 67' ' ' MET . 35.2 t -91.66 126.07 44.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.268 -0.895 . . . . 1.0 110.19 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 160.36 14.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 1.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.32 -176.74 3.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.0 110.177 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.993 -1.004 . . . . 1.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.436 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.338 0.59 . . . . 1.0 110.111 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 2' ' ' ILE . 6.9 tt -170.25 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 1.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' OE2' ' HB1' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -150.27 179.54 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 1.0 111.044 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' VAL . 54.2 t 48.56 85.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.439 0.638 . . . . 1.0 111.078 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 6.4 mm-40 -98.4 -29.26 13.23 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 23' ' ' ILE . 7.0 tmtt? -129.46 114.85 18.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.73 165.88 21.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.443 1.233 . . . . 1.0 111.586 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.985 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 3.9 mt -65.53 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.752 -0.592 . . . . 1.0 110.721 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 10' ' ' GLY . 86.0 t80 -144.74 159.92 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 1.0 109.994 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 9' ' ' TYR . . . -95.48 141.66 15.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.511 -1.435 . . . . 1.0 109.511 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 84' ' ' LEU . 10.4 p -149.88 166.46 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -1.222 . . . . 1.0 110.408 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' VAL . 80.1 mt-10 -122.02 166.13 14.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.0 110.299 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.504 HG23 ' HA ' ' A' ' 86' ' ' VAL . 15.8 m -152.65 157.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.171 -0.956 . . . . 1.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -117.42 33.73 5.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.497 -0.752 . . . . 1.0 109.011 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 18.5 t 61.75 73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.701 0.762 . . . . 1.0 109.895 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 152.54 -23.11 0.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.24 164.96 22.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -1.119 . . . . 1.0 110.096 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.5 m -112.26 105.95 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.289 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.54 171.46 15.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 1.0 109.839 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CD2' HG12 ' A' ' 59' ' ' ILE . 13.1 m80 -144.99 120.5 10.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.0 110.734 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.72 ' CD1' HD23 ' A' ' 58' ' ' LEU . 77.0 m-85 -114.11 111.43 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.843 . . . . 1.0 109.365 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.92 165.66 11.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.148 -0.97 . . . . 1.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -170.04 119.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 1.0 109.802 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.34 124.49 43.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 1.0 110.206 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' A' ' 56' ' ' HIS . 26.0 mt -86.94 -150.64 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.195 -0.941 . . . . 1.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.411 ' HB3' HG12 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -126.67 -47.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.972 . . . . 1.0 110.211 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.73 150.19 37.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 1.0 110.608 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.11 -165.66 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.597 1.314 . . . . 1.0 110.335 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 t70 49.92 81.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.276 -0.89 . . . . 1.0 110.544 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.7 t -138.87 148.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 1.0 110.154 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -140.63 40.74 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 1.0 110.331 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.45 -150.3 0.04 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -166.31 -179.8 5.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -1.095 . . . . 1.0 109.674 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.55 ' CE3' HD22 ' A' ' 58' ' ' LEU . 57.9 m95 -117.65 131.06 56.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.982 -1.074 . . . . 1.0 110.628 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 2.7 ttpt -124.03 133.82 53.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.505 -0.747 . . . . 1.0 109.978 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.46 -130.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 1.0 109.815 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -28.84 3.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.592 -1.317 . . . . 1.0 110.708 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 154.47 39.46 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.961 -1.255 . . . . 1.0 109.961 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 1.1 pt20 -150.39 150.42 28.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.106 -1.232 . . . . 1.0 110.014 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.45 113.35 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.601 1.316 . . . . 1.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -70.34 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.46 -0.775 . . . . 1.0 109.877 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.523 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -168.41 14.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 1.0 112.119 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -75.76 -162.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.709 -1.245 . . . . 1.0 109.817 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.73 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.22 -0.925 . . . . 1.0 110.384 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.19 -42.87 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.525 1.276 . . . . 1.0 110.582 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -23.83 51.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 1.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.84 121.77 42.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 110.308 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.1 144.13 39.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 1.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -134.04 119.26 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 1.0 109.825 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.64 HG23 ' HB ' ' A' ' 57' ' ' ILE . 7.0 tp -130.07 109.26 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.08 147.65 50.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 1.0 110.397 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.02 20.98 17.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 1.0 110.185 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 -90.5 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -59.39 -16.0 20.26 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.662 -0.905 . . . . 1.0 110.836 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -125.28 168.12 13.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 25' ' ' LEU . 94.8 m-70 -149.99 126.87 11.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.64 ' HB ' HG23 ' A' ' 50' ' ' ILE . 57.6 mt -124.08 142.2 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 1.0 109.981 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.72 HD23 ' CD1' ' A' ' 21' ' ' PHE . 24.6 tp -118.48 145.44 45.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.104 -0.997 . . . . 1.0 110.409 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 20' ' ' HIS . 56.6 mt -141.2 92.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 1.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' THR . 16.3 mt -98.47 115.21 28.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 62' ' ' ASN . 31.6 m-70 -83.04 -165.04 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 1.0 109.702 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 50.2 t30 -16.57 82.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.762 1.023 . . . . 1.0 113.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.446 ' N ' ' O ' ' A' ' 61' ' ' HIS . 71.9 m -69.95 -175.54 0.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.809 ' O ' HG11 ' A' ' 86' ' ' VAL . 2.9 mt-30 -138.31 -168.23 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 1.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mp -84.81 69.1 10.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 1.0 110.264 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.84 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.6 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.19 -15.32 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -1.168 . . . . 1.0 111.622 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -43.57 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.417 -0.802 . . . . 1.0 110.929 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 174.11 -127.35 1.31 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -139.82 146.4 39.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 1.0 110.456 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' HD13 ' A' ' 8' ' ' LEU . 69.6 t -94.39 87.66 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.343 -0.848 . . . . 1.0 109.957 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -87.91 110.11 20.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 1.0 110.426 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 27.8 t80 -71.48 154.2 41.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 1.0 110.072 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 139.46 52.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 1.0 110.1 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB1' ' OE2' ' A' ' 3' ' ' GLU . . . -160.72 -148.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 1.0 109.744 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -77.5 126.95 31.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 1.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 18.1 p30 34.05 31.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 76' ' ' ALA . . . -152.26 158.32 42.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 1.0 110.791 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -160.54 115.07 2.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 1.0 110.003 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 7.3 m -72.62 -172.75 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 1.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.44 97.43 0.25 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 1.0 110.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.985 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.46 -164.53 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 1.0 110.406 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.42 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 61.0 t-20 -132.13 137.43 47.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 1.0 109.598 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.689 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 65.0 tp -154.35 143.29 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 1.0 110.531 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -145.17 127.65 16.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.431 -0.793 . . . . 1.0 110.082 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.809 HG11 ' O ' ' A' ' 64' ' ' GLN . 16.9 t -92.54 142.64 12.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.366 -0.834 . . . . 1.0 109.732 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -141.4 130.05 22.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.999 . . . . 1.0 110.492 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.34 174.08 8.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 1.0 109.99 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 pt -100.64 161.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 1.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.82 -162.17 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 1.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.819 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 93.8 t -126.39 120.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 1.0 110.345 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -93.59 -44.98 7.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.249 -0.907 . . . . 1.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.9 tttt -108.87 109.34 61.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 1.0 110.003 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.1 173.8 13.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.434 1.229 . . . . 1.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.925 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 42.3 mt -75.34 169.38 18.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 1.0 110.162 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -137.06 153.02 50.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 1.0 110.177 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.33 136.53 20.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.056 -1.217 . . . . 1.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.4 t -136.86 154.85 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -1.111 . . . . 1.0 110.03 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -107.73 155.2 20.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.184 -0.947 . . . . 1.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 86' ' ' VAL . 5.5 p -152.1 134.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 1.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.21 39.85 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.24 -0.912 . . . . 1.0 110.378 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 87' ' ' LYS . 89.2 t 52.09 88.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 1.0 110.306 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 135.31 -29.38 2.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.349 -1.5 . . . . 1.0 109.349 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.92 -124.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.182 . . . . 1.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -160.27 114.48 2.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.698 -1.251 . . . . 1.0 111.002 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.77 148.19 31.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.938 . . . . 1.0 108.808 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -128.33 128.92 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.169 . . . . 1.0 111.469 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.702 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 99.5 m-85 -134.1 112.12 10.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.549 -0.719 . . . . 1.0 109.404 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.51 165.8 11.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 1.0 111.066 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -170.45 137.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.4 164.55 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.978 . . . . 1.0 110.97 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.671 HD12 HG21 ' A' ' 30' ' ' VAL . 71.3 mt -124.3 -148.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 1.0 109.81 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.49 -67.74 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 1.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -97.26 155.55 37.26 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 1.0 110.171 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -75.25 -167.41 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.707 1.372 . . . . 1.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 53.55 67.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.848 . . . . 1.0 110.432 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 25' ' ' LEU . 29.5 m -142.79 170.51 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 1.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -143.43 165.95 26.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.1 -171.7 36.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.18 156.83 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -1.088 . . . . 1.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.894 ' CE3' HD12 ' A' ' 58' ' ' LEU . 45.4 m95 -108.8 139.12 44.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 1.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 39' ' ' GLN . 2.9 ttpt -132.99 125.19 29.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.532 -0.73 . . . . 1.0 109.215 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.409 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 mp -64.45 -132.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.135 -0.978 . . . . 1.0 109.596 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -26.08 3.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.644 -1.285 . . . . 1.0 109.572 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 156.81 38.71 0.02 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.781 -1.328 . . . . 1.0 109.781 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 1.3 mm-40 -131.25 104.01 15.09 Favored Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.141 -1.211 . . . . 1.0 109.997 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.73 101.74 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.673 1.354 . . . . 1.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 42' ' ' THR . 2.1 pp -84.71 -151.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 1.0 110.466 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 41' ' ' LEU . 14.9 p -135.0 133.91 39.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 1.0 110.087 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.31 113.7 24.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 1.0 110.274 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -176.69 -60.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 1.0 110.399 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.3 Cg_endo -72.05 -57.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.348 1.183 . . . . 1.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -133.8 69.28 1.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.0 110.565 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -157.2 134.78 10.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 1.0 110.029 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -127.32 86.65 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.0 110.338 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -105.11 98.21 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 1.0 110.158 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.23 112.2 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.0 110.088 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -130.61 157.81 41.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 1.0 110.531 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.65 27.16 9.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 1.0 109.762 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.42 -87.72 1.41 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -55.88 -19.83 13.37 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.677 -0.896 . . . . 1.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 155.38 33.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 1.0 110.749 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.0 m-70 -138.65 102.77 4.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 1.0 109.845 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -109.33 137.22 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 1.0 110.535 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.894 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.2 tt -114.35 133.05 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 1.0 110.224 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.747 ' N ' HD23 ' A' ' 58' ' ' LEU . 22.7 mt -136.22 80.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.377 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.94 125.4 35.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 1.0 110.524 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.3 m-70 -83.33 -160.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 1.0 109.716 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 61' ' ' HIS . 37.5 t30 -14.56 82.12 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' HIS . 68.0 m -75.46 -178.27 3.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.506 -0.746 . . . . 1.0 109.954 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG11 ' A' ' 86' ' ' VAL . 5.4 tp-100 -117.08 169.66 9.26 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.168 -0.958 . . . . 1.0 109.143 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 88' ' ' GLU . 2.2 mp -72.79 4.22 4.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.822 -1.174 . . . . 1.0 112.139 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.7 -27.11 15.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.776 ' HB2' HG21 ' A' ' 86' ' ' VAL . 4.3 mtt -50.55 -23.21 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -1.043 . . . . 1.0 111.016 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 p -48.52 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.163 -0.961 . . . . 1.0 110.503 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.31 -126.4 0.97 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.072 -1.611 . . . . 1.0 109.072 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -135.35 136.14 41.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.137 . . . . 1.0 110.175 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 8' ' ' LEU . 52.3 t -91.45 87.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 1.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -91.85 111.64 23.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 1.0 110.863 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.889 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 19.6 t80 -86.78 133.53 33.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 1.0 109.375 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -110.55 70.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.986 . . . . 1.0 110.755 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.889 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -94.38 112.32 24.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 1.0 109.784 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.4 -159.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 1.0 109.988 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 26.1 p30 -62.65 -16.89 59.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 1.0 110.455 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.819 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -69.84 158.58 35.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 1.0 110.217 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -159.69 116.77 2.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.137 -0.977 . . . . 1.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 73' ' ' PHE . 4.6 p -105.34 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 1.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.55 101.73 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 1.0 110.556 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.925 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.23 -164.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 1.0 110.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -130.38 147.28 52.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 1.0 109.944 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 52.9 tp -145.11 145.5 31.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 1.0 110.515 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 9.2 ptpt -138.2 105.86 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 1.0 109.71 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 67' ' ' MET . 99.2 t -89.49 117.71 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.245 -0.91 . . . . 1.0 110.501 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.6 mtpt -116.78 146.63 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 1.0 110.203 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.488 ' HG3' HD11 ' A' ' 65' ' ' LEU . 19.4 mt-10 -64.69 -171.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 1.0 110.256 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.314 0.578 . . . . 1.0 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 tt -144.39 162.6 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.927 . . . . 1.0 110.109 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.59 166.95 21.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.0 110.006 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 23' ' ' ILE . 2.0 p -80.04 -165.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.087 -1.008 . . . . 1.0 109.691 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 4' ' ' VAL . 50.0 mm-40 -127.74 -54.26 1.32 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 1.0 110.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -126.57 112.36 22.93 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.593 -0.692 . . . . 1.0 110.095 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.92 178.11 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.645 1.34 . . . . 1.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.1 mt -75.4 173.89 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 1.0 110.168 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.9 m-85 -134.67 12.53 3.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.142 -0.974 . . . . 1.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 74.09 150.32 1.84 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.879 -1.288 . . . . 1.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 19' ' ' ALA . 77.3 t -145.35 161.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -1.11 . . . . 1.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 11' ' ' VAL . 62.8 mt-10 -125.88 149.72 48.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.0 110.387 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.855 HG23 ' CB ' ' A' ' 17' ' ' GLU . 3.1 p -155.6 135.01 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 1.0 109.915 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.47 58.62 3.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.281 -0.887 . . . . 1.0 110.788 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.4 t 46.08 81.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 1.0 110.925 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 139.57 -31.63 2.3 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.746 -1.742 . . . . 1.0 108.746 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.855 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.7 mt-10 -66.17 -158.36 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.494 -1.004 . . . . 1.0 109.502 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -142.74 108.87 5.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.984 . . . . 1.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' HG11 ' A' ' 11' ' ' VAL . . . -79.05 132.72 36.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 1.0 109.505 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.9 110.09 18.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 1.0 111.107 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 85.6 m-85 -101.25 134.71 43.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 1.0 109.324 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -130.08 162.79 27.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.934 -1.104 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.672 HD11 HG21 ' A' ' 4' ' ' VAL . 1.1 tt -170.77 125.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.0 109.806 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -90.73 145.2 25.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 1.0 110.225 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD22 ' C ' ' A' ' 24' ' ' GLU . 4.2 mm? -111.23 155.14 23.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 1.0 109.996 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.54 -58.0 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.0 110.402 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -88.29 141.38 30.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 1.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.03 104.56 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.653 1.344 . . . . 1.0 110.153 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -119.85 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.112 -0.992 . . . . 1.0 109.201 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 30' ' ' VAL . 8.7 p -176.61 43.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 1.0 110.027 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -152.57 143.63 23.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 1.0 110.27 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.0 146.36 5.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 1.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -129.71 146.72 51.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -1.183 . . . . 1.0 110.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 1.038 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -112.5 173.22 6.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.967 . . . . 1.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 3.3 ptpt -171.2 152.55 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.521 -0.737 . . . . 1.0 109.596 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 67' ' ' MET . 3.5 mt -66.35 -94.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 1.0 109.813 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.58 21.84 5.95 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.124 -0.985 . . . . 1.0 109.946 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 35' ' ' LYS . . . 117.2 -0.27 19.07 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -92.35 109.13 36.06 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.27 . . . . 1.0 110.27 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.01 104.77 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.572 1.301 . . . . 1.0 110.43 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -71.85 -168.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 1.0 110.606 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' THR . 5.6 t -109.12 175.01 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 1.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 109.65 11.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 1.0 110.372 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -122.22 170.56 7.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 1.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.41 -24.23 19.56 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.627 1.33 . . . . 1.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.31 -40.31 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 1.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.49 127.74 35.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 1.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -119.36 144.1 47.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.914 . . . . 1.0 109.573 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.25 90.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 1.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.0 tp -113.02 147.48 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 1.0 110.187 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -159.67 149.48 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.199 -0.938 . . . . 1.0 110.197 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.32 22.75 11.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 1.0 110.173 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.63 -85.02 1.07 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -6.82 31.85 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.656 -0.908 . . . . 1.0 111.031 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.24 107.62 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.865 -1.147 . . . . 1.0 110.623 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.458 ' HB2' HG23 ' A' ' 23' ' ' ILE . 54.1 m-70 -87.32 133.59 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.231 -0.918 . . . . 1.0 109.992 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.1 mt -132.71 134.84 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.058 -1.027 . . . . 1.0 110.534 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.038 HD22 ' CE3' ' A' ' 34' ' ' TRP . 27.2 tp -117.16 150.96 37.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 1.0 110.083 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 59' ' ' ILE . 24.9 mm -143.43 99.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 1.0 109.945 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -105.69 116.57 32.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.0 110.08 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 62' ' ' ASN . 42.2 m-70 -85.99 -164.03 0.97 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.877 . . . . 1.0 110.278 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 66.8 t30 -14.71 81.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.808 1.04 . . . . 1.0 113.808 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 64.3 m -73.92 142.58 45.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.506 -0.746 . . . . 1.0 109.562 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.881 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.31 -175.71 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 1.0 110.787 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 65' ' ' LEU . 17.8 tp -79.59 5.26 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 1.0 111.127 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.01 -29.3 6.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.884 ' HB2' HG21 ' A' ' 86' ' ' VAL . 2.8 mtt -49.99 -23.57 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -1.13 . . . . 1.0 110.648 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -47.06 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.51 -0.744 . . . . 1.0 110.406 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.98 -121.6 0.59 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.96 174.29 10.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -1.076 . . . . 1.0 110.585 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 76.9 t -127.61 89.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -0.795 . . . . 1.0 109.742 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -97.9 125.16 42.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 1.0 110.609 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 46.9 t80 -113.75 157.85 21.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.447 -0.783 . . . . 1.0 109.632 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -143.48 136.73 27.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 1.0 110.683 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -160.5 120.62 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 1.0 109.454 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.64 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -0.872 . . . . 1.0 109.799 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.3 m-20 -128.92 -15.31 4.32 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 1.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.48 157.91 8.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.0 110.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -158.1 93.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 1.0 109.776 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 49.5 p -101.73 172.06 7.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.912 . . . . 1.0 110.72 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.17 91.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -0.809 . . . . 1.0 109.816 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -94.02 -171.05 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 1.0 110.593 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.81 133.38 55.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 1.0 110.244 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 11' ' ' VAL . 64.7 tp -132.02 136.88 47.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 1.0 110.218 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -135.27 131.54 36.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 1.0 109.973 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' MET . 93.6 t -100.58 153.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 1.0 109.852 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.0 mtpp -144.32 130.2 19.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 1.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.471 ' HG3' HD13 ' A' ' 65' ' ' LEU . 6.2 mt-10 -71.96 173.3 8.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 1.0 110.302 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 89' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.066 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 77' ' ' ASN . 2.0 mp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.273 0.559 . . . . 1.0 110.184 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.929 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.3 mt -90.01 148.38 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 1.0 109.75 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.02 -5.61 6.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 1.0 111.211 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 46.1 t 60.16 136.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.344 -0.848 . . . . 1.0 110.959 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -116.85 -37.02 3.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 1.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -119.0 109.0 39.86 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.765 -0.584 . . . . 1.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.05 172.72 14.13 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.604 1.318 . . . . 1.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.808 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 51.4 mt -73.3 170.0 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 1.0 110.348 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.55 113.1 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 1.0 110.066 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.9 153.34 4.32 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.508 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 9.0 p -153.43 158.76 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.382 -1.069 . . . . 1.0 110.176 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -112.18 160.49 17.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 1.0 110.406 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 86' ' ' VAL . 9.6 m -147.83 172.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 1.0 110.592 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -129.53 30.35 4.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 63' ' ' CYS . 40.9 t 58.34 70.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.716 0.769 . . . . 1.0 109.95 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.45 -21.49 1.06 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.3 -1.52 . . . . 1.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 18' ' ' THR . 58.7 mm-40 -76.31 -121.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 1.0 109.705 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.2 p -160.27 171.12 19.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.845 -1.16 . . . . 1.0 110.452 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.683 ' HB1' ' HE1' ' A' ' 21' ' ' PHE . . . -136.3 158.37 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.417 -0.802 . . . . 1.0 109.548 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 56.3 m80 -146.63 92.35 2.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 1.0 110.946 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.683 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 87.4 m-85 -106.65 112.39 25.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.181 -0.949 . . . . 1.0 109.713 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -121.77 157.4 31.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.997 . . . . 1.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -163.84 122.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.0 109.792 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.62 138.23 33.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 1.0 110.262 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD11 ' CD2' ' A' ' 56' ' ' HIS . 33.9 mt -109.0 170.16 8.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 1.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -11.08 42.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 1.0 110.67 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -123.82 124.98 26.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.0 110.167 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.83 171.2 18.73 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.417 1.219 . . . . 1.0 110.645 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 50.72 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 1.0 110.584 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.26 179.96 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 1.0 110.062 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -127.39 41.26 3.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 1.0 110.382 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 75' ' ' ALA . . . -86.32 174.26 46.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.762 -1.335 . . . . 1.0 109.762 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.07 155.59 32.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -1.13 . . . . 1.0 110.148 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' CE3' HD12 ' A' ' 58' ' ' LEU . 77.0 m95 -86.75 135.56 33.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.047 -1.033 . . . . 1.0 110.475 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -138.69 126.39 22.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.382 -0.824 . . . . 1.0 109.424 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 67' ' ' MET . 1.3 mt -63.62 -133.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.171 -0.956 . . . . 1.0 109.274 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -25.04 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.48 -1.388 . . . . 1.0 109.51 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.74 38.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -128.39 136.4 29.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.238 . . . . 1.0 110.294 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.98 121.03 6.33 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.534 1.281 . . . . 1.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 42' ' ' THR . 2.2 pp -83.29 -149.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 1.0 110.026 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.851 ' N ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -157.74 120.89 3.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.949 . . . . 1.0 109.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -88.2 97.67 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 1.0 110.518 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.464 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER 176.03 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.274 -0.891 . . . . 1.0 110.424 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 42.2 Cg_endo -72.02 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.579 1.305 . . . . 1.0 111.196 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -113.84 57.78 0.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.924 -1.11 . . . . 1.0 110.729 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 11.2 t -152.28 126.79 9.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 1.0 110.169 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 1.5 mt-10 -111.44 52.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 1.0 110.393 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.634 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.68 124.48 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 1.0 109.985 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.634 ' N ' HD13 ' A' ' 49' ' ' ILE . 3.8 tt -121.42 128.06 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.238 -0.914 . . . . 1.0 110.136 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.02 137.68 14.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.92 . . . . 1.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.89 17.51 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 1.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.48 -24.13 26.98 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -90.56 -20.32 22.75 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.391 -1.064 . . . . 1.0 110.108 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -164.38 127.89 2.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.33 -0.856 . . . . 1.0 110.287 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 23' ' ' ILE . 84.5 m-70 -96.61 120.6 37.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 1.0 110.03 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 55' ' ' LYS . 3.3 mp -130.15 140.07 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 110.217 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.705 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -127.76 130.77 49.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 58' ' ' LEU . 81.6 mt -135.41 87.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 1.0 109.394 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.721 HD13 ' CE ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -96.87 119.08 34.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 1.0 110.729 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.8 m-70 -80.08 -161.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 1.0 109.423 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.492 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 11.7 p30 -14.38 80.97 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.927 1.084 . . . . 1.0 113.927 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' O ' HG13 ' A' ' 15' ' ' VAL . 80.7 m -70.22 -169.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.573 -0.704 . . . . 1.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.777 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.69 -163.68 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 1.0 110.435 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 88' ' ' GLU . 9.2 mp -82.38 34.21 0.42 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.105 -0.997 . . . . 1.0 111.472 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.82 -29.82 2.98 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.655 -1.778 . . . . 1.0 108.655 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 60' ' ' LEU . 53.6 mtp -88.02 36.22 0.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.991 . . . . 1.0 110.228 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -90.26 58.83 4.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 1.0 109.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -154.83 -125.81 0.99 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.54 151.19 52.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.438 -1.037 . . . . 1.0 110.483 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' LEU . 60.2 t -95.13 84.26 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 1.0 109.924 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.6 p -88.28 119.87 29.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -103.23 143.34 32.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' O ' ' CA ' ' A' ' 32' ' ' GLY . 24.3 mt-30 -130.41 137.18 49.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . . . -164.33 105.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 1.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.929 ' HB3' HD12 ' A' ' 2' ' ' ILE . . . 56.47 -89.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 1.0 110.31 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 1' ' ' LEU . 1.8 t30 -114.78 -27.18 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.956 -1.09 . . . . 1.0 110.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.04 141.91 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 1.0 110.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 75.62 1.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 1.0 109.967 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.438 ' OG ' HD11 ' A' ' 8' ' ' LEU . 61.4 p -90.98 176.96 6.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.953 . . . . 1.0 110.146 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.03 93.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.0 110.15 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.808 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -89.99 -171.29 3.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 1.0 110.069 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.12 105.61 8.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 1.0 109.932 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.608 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 42.5 tp -112.66 124.53 52.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 1.0 110.577 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -127.76 134.72 49.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 1.0 109.807 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.777 HG11 ' O ' ' A' ' 64' ' ' GLN . 84.3 t -100.19 135.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 109.934 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -122.95 134.17 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.0 110.306 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 65' ' ' LEU . 21.8 mt-10 -76.29 169.03 18.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 1.0 110.072 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.291 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.286 0.565 . . . . 1.0 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 16.9 pt -118.77 174.16 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.857 . . . . 1.0 110.136 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -122.52 -166.18 1.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 110.499 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.005 HG23 ' HB1' ' A' ' 78' ' ' ALA . 63.6 t -116.31 122.09 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 1.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.74 -41.72 26.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 1.0 108.733 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 2.3 mtmt -117.77 101.75 51.9 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.823 -0.548 . . . . 1.0 109.855 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.15 174.35 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.599 1.315 . . . . 1.0 110.74 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.874 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 17.7 mt -75.3 176.38 7.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 1.0 110.015 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 28.0 m-85 -135.18 125.0 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.0 110.234 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 142.69 40.78 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.872 -1.291 . . . . 1.0 109.872 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.558 ' O ' HD12 ' A' ' 84' ' ' LEU . 7.7 p -153.56 164.03 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -1.073 . . . . 1.0 109.851 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 11' ' ' VAL . 31.3 mt-10 -124.82 152.78 43.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 1.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 17' ' ' GLU . 11.3 p -142.12 149.02 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.82 . . . . 1.0 110.138 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -88.87 47.96 1.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 1.0 110.475 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 63' ' ' CYS . 7.7 p 37.02 68.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.733 0.778 . . . . 1.0 111.72 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 159.01 -25.42 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.05 -1.62 . . . . 1.0 109.05 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.6 mm-40 -76.47 -112.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -1.098 . . . . 1.0 109.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -161.18 151.17 17.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.592 -1.317 . . . . 1.0 110.826 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -107.2 160.94 15.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 1.0 109.076 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -153.81 97.91 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.0 111.105 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.759 ' CD2' HD23 ' A' ' 58' ' ' LEU . 88.0 m-85 -111.73 108.14 17.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.544 -0.723 . . . . 1.0 109.324 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 155.17 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.324 -0.86 . . . . 1.0 110.509 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.738 HD11 ' OG ' ' A' ' 80' ' ' SER . 7.2 tt -164.81 139.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.444 -0.785 . . . . 1.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -120.45 143.38 48.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 1.0 109.975 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.2 mt -108.03 -156.71 0.59 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 1.0 110.179 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -108.1 -68.37 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 1.0 110.388 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.76 130.1 23.27 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 1.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -78.14 154.53 29.03 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.408 1.215 . . . . 1.0 110.166 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.22 -61.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 1.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.16 166.12 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 1.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 p-80 -70.81 -164.85 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.841 . . . . 1.0 110.411 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.4 -150.58 5.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.606 -1.398 . . . . 1.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.25 135.27 3.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.373 -1.075 . . . . 1.0 110.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.877 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.9 m95 -101.95 149.01 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 1.0 110.608 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 19.1 ttpt -141.54 123.14 15.09 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.35 -0.843 . . . . 1.0 109.592 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.44 -131.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 1.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.52 -25.16 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.411 -1.43 . . . . 1.0 109.619 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.42 38.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.698 -1.361 . . . . 1.0 109.698 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 7.9 mm-40 -126.68 109.03 22.79 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.162 -1.199 . . . . 1.0 110.147 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.08 83.83 1.58 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.62 1.326 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.09 -163.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 1.0 110.678 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.1 148.39 50.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 1.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.857 ' HB2' HG22 ' A' ' 49' ' ' ILE . . . -88.28 107.48 18.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 1.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -179.32 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.269 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.87 -50.82 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.59 1.31 . . . . 1.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.0 -54.72 1.39 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -0.985 . . . . 1.0 110.823 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HA ' HD23 ' A' ' 60' ' ' LEU . 36.8 t -69.5 150.04 47.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 1.0 110.443 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.15 65.0 1.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.875 . . . . 1.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.857 HG22 ' HB2' ' A' ' 43' ' ' ALA . 6.1 tp -84.56 140.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 1.0 110.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.7 mt -128.84 120.96 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.084 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -136.25 141.79 43.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 1.0 110.273 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.85 27.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.222 -0.924 . . . . 1.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.82 -23.92 30.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -90.38 71.8 7.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -1.018 . . . . 1.0 108.93 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 24' ' ' GLU . 5.4 mmtt 54.79 170.83 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.889 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 89.9 m-70 -114.69 144.92 42.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.982 -1.074 . . . . 1.0 110.763 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -140.47 115.06 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.842 . . . . 1.0 109.799 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.877 HD22 ' CE3' ' A' ' 34' ' ' TRP . 44.8 tp -99.19 132.03 44.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 1.0 110.862 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 20' ' ' HIS . 98.6 mt -133.33 93.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.474 -0.766 . . . . 1.0 109.456 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 2.6 mt -95.51 105.05 16.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 1.0 110.93 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 68.1 m-70 -69.85 -169.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 1.0 109.475 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 40.5 p-10 -14.87 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.867 1.062 . . . . 1.0 113.867 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 15' ' ' VAL . 61.2 m -70.62 -156.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.639 -0.663 . . . . 1.0 109.429 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.783 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -151.43 -169.97 3.52 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.967 -1.083 . . . . 1.0 110.815 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 38.51 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -0.784 . . . . 1.0 111.517 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.55 -15.02 2.5 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.803 -1.189 . . . . 1.0 110.293 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 9.0 mtt -87.42 37.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.718 -1.46 . . . . 1.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.22 40.27 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 1.0 110.139 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 -125.11 2.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -136.93 152.33 50.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -1.042 . . . . 1.0 110.294 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 82' ' ' ALA . 71.1 t -94.34 88.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.908 . . . . 1.0 109.84 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.5 p -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 1.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 41.0 t80 -96.39 146.27 24.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 1.0 109.95 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -152.58 126.6 9.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 1.0 110.379 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -132.66 16.06 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.11 -0.994 . . . . 1.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 169.15 -81.97 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.363 -0.835 . . . . 1.0 109.601 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -127.2 -39.03 1.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 1.0 109.535 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 1.005 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -69.29 119.38 13.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.831 . . . . 1.0 110.016 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 1.4 mtpt -123.29 95.81 4.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 1.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.738 ' OG ' HD11 ' A' ' 23' ' ' ILE . 14.3 m -73.35 -179.24 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 1.0 110.182 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.39 104.75 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 1.0 110.576 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.28 -176.64 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 1.0 110.108 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.37 121.15 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 1.0 109.838 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.668 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 56.4 tp -125.2 133.98 52.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 1.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -130.88 130.42 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 1.0 109.511 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 64' ' ' GLN . 92.0 t -91.64 145.48 7.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.181 -0.949 . . . . 1.0 110.447 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -135.47 141.37 45.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.418 -0.801 . . . . 1.0 109.921 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -96.98 -167.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 1.0 110.336 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.593 HD12 ' HE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.18 0.514 . . . . 1.0 110.217 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.6 mm -123.32 166.83 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 1.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.6 -154.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 1.0 110.344 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.991 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 27.7 t -125.17 127.49 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 1.0 109.958 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.39 -46.17 6.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 1.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.23 107.87 61.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.705 -0.622 . . . . 1.0 110.063 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.17 173.73 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.563 1.297 . . . . 1.0 110.799 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 49.6 mt -75.39 173.89 10.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 1.0 110.45 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -138.59 122.55 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 1.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.0 146.66 47.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.791 -1.323 . . . . 1.0 109.791 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 12' ' ' GLU . 74.3 t -144.23 162.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 1.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 11' ' ' VAL . 3.2 mt-10 -108.41 154.8 21.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 1.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 ' CG ' ' A' ' 17' ' ' GLU . 2.7 p -151.08 130.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.0 110.013 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.55 38.06 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 1.0 110.337 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.571 ' H ' HG22 ' A' ' 13' ' ' VAL . 47.3 t 55.82 99.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.374 -0.829 . . . . 1.0 110.684 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.435 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 131.83 -40.8 1.58 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.988 ' CG ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -69.69 -136.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 1.0 109.062 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.3 m -154.42 120.65 5.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.795 -1.191 . . . . 1.0 110.763 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 152.81 30.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 59' ' ' ILE . 10.0 m80 -138.07 133.34 33.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.907 -1.12 . . . . 1.0 111.561 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.837 ' CE1' HG21 ' A' ' 71' ' ' VAL . 75.0 m-85 -125.7 135.47 52.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -125.43 154.65 41.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.0 111.574 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -168.15 135.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.64 . . . . 1.0 109.438 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -125.98 142.97 51.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 1.0 110.618 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.03 -164.16 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.352 -0.842 . . . . 1.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.492 ' HB2' HG23 ' A' ' 2' ' ' ILE . 19.8 m -108.47 -42.85 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 1.0 109.981 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -132.13 132.56 23.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 1.0 110.045 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 143.41 35.49 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.362 1.19 . . . . 1.0 110.441 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -168.71 -54.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 1.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.52 157.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.06 174.4 10.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 1.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.33 -177.41 14.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.597 -1.401 . . . . 1.0 109.597 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.11 151.63 40.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.091 . . . . 1.0 110.107 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.683 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.7 m95 -110.46 147.06 34.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 1.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 ttpp -133.38 119.56 19.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.426 -0.796 . . . . 1.0 109.525 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -63.66 -135.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.395 -0.816 . . . . 1.0 108.816 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -49.8 -24.63 2.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.243 -1.535 . . . . 1.0 109.759 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 153.8 42.6 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -129.82 122.33 20.44 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.434 -1.039 . . . . 1.0 110.097 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.1 88.58 0.95 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.461 1.243 . . . . 1.0 110.386 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 42' ' ' THR . 4.4 pp -72.22 -160.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 1.0 110.691 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.834 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -170.32 -176.82 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.582 -0.699 . . . . 1.0 109.794 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 102.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.0 109.976 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -127.75 177.04 2.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 1.0 110.493 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 48.3 Cg_endo -73.87 -20.7 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.698 1.368 . . . . 1.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -98.18 -39.99 8.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 1.0 110.387 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.673 ' SG ' HD21 ' A' ' 60' ' ' LEU . 1.3 m -88.1 158.34 18.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.22 -0.925 . . . . 1.0 110.275 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -148.14 67.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 1.0 110.247 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.9 tt -85.09 128.67 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -0.793 . . . . 1.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.0 128.9 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 1.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.13 151.24 32.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 1.0 110.367 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -130.6 20.98 5.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 1.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.92 -61.97 3.34 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -12.79 61.88 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.614 -0.933 . . . . 1.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.89 148.5 29.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.978 -1.076 . . . . 1.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.731 ' HB2' HG23 ' A' ' 23' ' ' ILE . 62.4 m-70 -128.02 107.66 10.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 109.967 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.32 148.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 1.0 110.55 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.689 HD23 ' CD2' ' A' ' 21' ' ' PHE . 19.7 tp -133.48 121.79 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.353 -0.842 . . . . 1.0 110.188 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 20' ' ' HIS . 40.6 mt -122.9 126.17 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 1.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.941 HD22 ' CE ' ' A' ' 67' ' ' MET . 0.2 OUTLIER -129.35 103.0 6.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 1.0 110.372 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 79.6 m-70 -70.16 -163.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.25 -0.906 . . . . 1.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 29.2 t-20 -13.53 81.44 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 15' ' ' VAL . 78.5 m -83.15 -159.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.0 109.253 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.802 ' O ' HG11 ' A' ' 86' ' ' VAL . 3.1 mt-30 -142.82 -170.47 3.24 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.204 -0.935 . . . . 1.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.59 9.19 6.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.0 111.259 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.3 -29.26 10.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 1.0 109.39 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.941 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.29 -23.3 1.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.328 -1.101 . . . . 1.0 111.429 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -46.49 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.148 -0.97 . . . . 1.0 110.621 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.86 -121.29 0.63 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.253 -1.539 . . . . 1.0 109.253 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -155.3 145.74 22.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -1.12 . . . . 1.0 110.397 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.837 HG21 ' CE1' ' A' ' 21' ' ' PHE . 67.8 t -98.11 93.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 1.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' SER . 86.4 p -96.03 101.44 13.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.0 110.441 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 32.1 t80 -73.61 154.24 39.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 1.0 109.557 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 106.52 7.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.063 -1.023 . . . . 1.0 110.688 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -143.58 118.22 9.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 1.0 109.682 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.56 -153.99 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 1.0 109.865 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -74.29 -10.45 59.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 1.0 110.504 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.991 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -83.62 153.63 24.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.944 -1.098 . . . . 1.0 110.245 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -159.59 145.89 16.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 1.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' HD11 ' A' ' 8' ' ' LEU . 76.8 p -125.87 178.1 5.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.8 103.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 1.0 110.204 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.21 -174.59 2.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 1.0 110.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.88 129.6 36.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.313 -0.867 . . . . 1.0 110.004 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 1.1 tt -135.8 145.62 46.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 1.0 110.469 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.75 136.33 46.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 1.0 109.802 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.802 HG11 ' O ' ' A' ' 64' ' ' GLN . 61.3 t -103.7 151.16 6.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.249 -0.907 . . . . 1.0 110.446 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.66 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 1.0 110.201 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -93.42 145.59 24.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.358 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.105 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.252 0.549 . . . . 1.0 110.201 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.503 HG22 ' OG ' ' A' ' 26' ' ' SER . 25.8 pt -102.15 158.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.0 110.198 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.68 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 1.0 110.19 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.97 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 1.0 110.403 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -86.48 -34.45 20.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.504 -0.924 . . . . 1.0 108.504 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -131.01 112.47 15.93 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.13 171.4 11.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.647 1.34 . . . . 1.0 111.455 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.904 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 67.7 mt -59.95 -167.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.562 0.696 . . . . 1.0 110.913 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 10' ' ' GLY . 20.9 t80 -134.4 158.64 43.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 1.0 110.001 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -99.13 133.49 11.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.697 ' O ' HD12 ' A' ' 84' ' ' LEU . 8.6 p -152.81 164.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -1.144 . . . . 1.0 110.256 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' VAL . 4.6 pt-20 -118.69 172.31 7.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.92 . . . . 1.0 110.58 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG23 HG13 ' A' ' 86' ' ' VAL . 13.1 m -155.25 134.69 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 1.0 110.5 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.9 34.68 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 1.0 109.775 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 14.5 t 61.73 73.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.462 -0.773 . . . . 1.0 110.439 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 150.41 -25.34 1.09 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.866 -1.693 . . . . 1.0 108.866 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 -163.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.35 -1.088 . . . . 1.0 109.531 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 m -144.32 113.03 6.66 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.2 -0.938 . . . . 1.0 110.196 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 11' ' ' VAL . . . -79.29 161.8 26.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 1.0 109.638 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -139.29 88.31 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.002 . . . . 1.0 110.691 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.874 ' CD1' HD23 ' A' ' 58' ' ' LEU . 81.0 m-85 -84.03 162.12 20.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 1.0 109.594 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -153.65 162.49 41.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.046 . . . . 1.0 110.678 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 56' ' ' HIS . 4.7 tt -169.23 135.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.448 -0.782 . . . . 1.0 109.921 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.88 136.45 49.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.111 -0.993 . . . . 1.0 110.057 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.1 mt -101.7 -151.19 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.958 . . . . 1.0 109.879 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 2' ' ' ILE . 24.3 p -117.31 -46.72 2.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 1.0 109.989 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.1 140.8 21.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 1.0 110.064 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.17 178.91 6.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.558 1.294 . . . . 1.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 t70 54.59 92.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 1.0 110.732 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.4 p -156.84 154.51 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 1.0 109.874 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 49.1 p-80 -108.74 121.16 44.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 1.0 110.657 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.81 156.18 26.88 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.236 -1.546 . . . . 1.0 109.236 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' C ' ' CD1' ' A' ' 34' ' ' TRP . 14.2 mm-40 -124.41 177.81 5.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -1.232 . . . . 1.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.658 ' CB ' HD13 ' A' ' 58' ' ' LEU . 37.4 m95 -136.43 139.04 42.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.451 -0.78 . . . . 1.0 110.682 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLN . 6.7 tttp -157.11 -109.99 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.211 -0.931 . . . . 1.0 109.614 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -157.89 -160.11 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.929 -1.107 . . . . 1.0 109.005 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.833 -1.167 . . . . 1.0 109.632 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.75 -114.19 0.01 OUTLIER Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 2.0 mm-40 -136.33 176.59 2.7 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 107.475 -1.306 . . . . 1.0 107.475 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HD2' ' OE1' ' A' ' 39' ' ' GLN . 50.5 Cg_endo -86.06 116.42 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.678 1.357 . . . . 1.0 110.878 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -95.29 -167.75 1.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.81 -1.181 . . . . 1.0 110.716 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.5 p -116.09 162.33 17.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.0 110.218 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.46 120.46 16.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.91 . . . . 1.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.487 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.4 t -173.29 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 1.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -67.87 -89.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.33 1.174 . . . . 1.0 111.146 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.29 70.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 1.0 110.322 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.83 129.6 11.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 1.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.18 94.76 4.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 1.0 109.878 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.2 89.31 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 1.0 110.664 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 50' ' ' ILE . 8.3 tt -89.17 119.65 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.868 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.68 145.5 47.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.99 . . . . 1.0 110.599 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.29 23.24 14.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 1.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.57 -89.25 1.23 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -49.15 -23.81 1.43 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.878 . . . . 1.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -137.5 157.35 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.983 -1.073 . . . . 1.0 110.237 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.741 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.1 m-70 -118.1 138.06 52.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.532 -0.73 . . . . 1.0 109.486 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -140.33 128.46 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.037 -1.039 . . . . 1.0 110.783 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.874 HD23 ' CD1' ' A' ' 21' ' ' PHE . 9.9 tp -103.99 149.9 24.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 1.0 110.421 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 64.9 mt -140.0 82.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.795 . . . . 1.0 109.372 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 60' ' ' LEU . 5.1 mt -84.19 115.37 22.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 1.0 110.729 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 62' ' ' ASN . 60.8 m-70 -87.74 -165.84 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 1.0 109.624 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 7.5 p-10 -14.27 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' HIS . 85.2 m -74.86 -155.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.639 -0.663 . . . . 1.0 109.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.723 ' O ' HG11 ' A' ' 86' ' ' VAL . 15.6 mt-30 -159.47 -165.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 1.0 110.613 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.39 39.84 0.8 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 1.0 111.237 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.98 -37.83 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.981 -1.647 . . . . 1.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.463 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 50.3 mtt -63.15 -13.36 36.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.365 -1.079 . . . . 1.0 110.778 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.77 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.297 -0.877 . . . . 1.0 110.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 67' ' ' MET . . . 170.75 -113.57 0.5 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.933 -1.667 . . . . 1.0 108.933 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.81 136.4 24.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.48 -1.012 . . . . 1.0 110.468 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.1 t -79.28 144.07 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 1.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 p -136.42 126.56 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.48 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 59.1 t80 -105.66 147.11 28.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.695 . . . . 1.0 109.131 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -137.91 152.5 49.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 1.0 110.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.46 -149.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 1.0 109.939 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.03 -76.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 1.0 110.24 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -123.73 17.01 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 1.0 110.301 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.76 137.92 42.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 1.0 110.658 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 14.9 ptmt -154.16 101.53 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.515 -0.741 . . . . 1.0 109.637 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.41 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 13.4 m -105.15 -176.04 2.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 1.0 110.535 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -167.08 97.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 1.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.55 -168.07 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 1.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -122.14 143.97 49.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 1.0 110.178 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 11' ' ' VAL . 57.1 tp -150.69 119.75 6.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 1.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -117.33 125.98 51.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 1.0 109.852 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.723 HG11 ' O ' ' A' ' 64' ' ' GLN . 41.5 t -90.77 112.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.347 -0.845 . . . . 1.0 110.058 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.33 144.98 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 1.0 110.381 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.15 -177.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 1.0 110.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 89' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.226 0.536 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 77' ' ' ASN . 44.1 mm -95.37 146.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 1.0 109.756 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 1.1 tp10 -129.85 -5.16 4.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 1.0 111.194 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 47.5 t 56.72 108.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 1.0 110.308 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -78.18 -51.49 10.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.054 -1.029 . . . . 1.0 109.884 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -122.91 108.48 32.66 Favored Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 120.073 -0.651 . . . . 1.0 110.277 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.42 -175.8 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.572 1.301 . . . . 1.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 7.0 mt -71.0 -161.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 1.0 110.67 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 30.7 p90 -160.4 133.85 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.7 149.01 33.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 12' ' ' GLU . 7.3 p -155.39 168.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -1.104 . . . . 1.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 11' ' ' VAL . 44.8 mt-10 -114.69 158.92 21.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 1.0 110.28 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 14' ' ' PHE . 8.8 p -155.82 171.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 1.0 110.342 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.71 135.56 54.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 1.0 109.446 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 11.7 p -50.8 112.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 1.0 110.572 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 122.22 -48.67 0.93 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.825 -1.71 . . . . 1.0 108.825 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -165.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -1.018 . . . . 1.0 109.924 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 60' ' ' LEU . 1.1 p -121.42 148.29 44.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 1.0 110.449 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.2 174.97 6.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 1.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -158.97 110.94 2.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 1.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.816 ' CD1' HD23 ' A' ' 58' ' ' LEU . 96.2 m-85 -116.49 156.59 26.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.56 160.53 41.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.03 . . . . 1.0 110.45 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 23' ' ' ILE . 9.3 tt -170.56 124.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 1.0 109.848 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.535 ' O ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -79.73 132.71 36.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 1.0 110.107 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 24' ' ' GLU . 2.5 mm? -119.97 -177.35 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 1.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 t -132.1 20.53 4.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 1.0 110.122 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.22 156.37 66.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 1.0 110.197 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.72 -20.76 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.683 1.359 . . . . 1.0 110.38 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.62 -132.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 1.0 109.392 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.87 167.27 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.632 -1.293 . . . . 1.0 110.102 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -175.53 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 1.0 110.277 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -97.85 -177.46 33.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.42 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.25 167.77 25.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -1.078 . . . . 1.0 110.092 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.754 ' CE3' HD22 ' A' ' 58' ' ' LEU . 26.9 m95 -99.82 167.06 10.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 1.0 110.496 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -171.4 153.43 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 1.0 109.91 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 67' ' ' MET . 4.0 mt -67.22 -131.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.09 -1.006 . . . . 1.0 109.894 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -48.1 -25.36 1.42 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.666 -1.271 . . . . 1.0 110.638 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 154.06 39.3 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.645 -1.382 . . . . 1.0 109.645 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -131.87 117.21 16.08 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.164 -1.198 . . . . 1.0 109.442 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.88 94.07 1.01 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.649 1.342 . . . . 1.0 109.959 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -179.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 42' ' ' THR . 90.7 m -136.56 23.53 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.772 . . . . 1.0 110.094 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.56 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 1.0 110.397 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -174.4 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 1.0 110.91 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 45.0 Cg_endo -70.6 -14.11 33.14 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.304 1.16 . . . . 1.0 111.115 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 47' ' ' CYS . 2.6 p30 -113.05 -24.53 9.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.017 . . . . 1.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.41 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 53.4 t -122.7 128.8 51.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.114 -0.991 . . . . 1.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -118.45 140.04 50.48 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.189 -0.944 . . . . 1.0 109.664 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.562 HG22 ' OE2' ' A' ' 51' ' ' GLU . 97.1 mt -139.61 108.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.486 -0.759 . . . . 1.0 109.801 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 50' ' ' ILE . 8.9 tp -128.02 128.01 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 1.0 110.494 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -154.78 138.66 16.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 1.0 109.894 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -122.54 18.88 10.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 1.0 110.775 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -42.54 2.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.955 -1.258 . . . . 1.0 109.955 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -62.31 -29.69 70.62 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.571 -0.958 . . . . 1.0 110.044 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 146.5 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.33 -0.856 . . . . 1.0 110.283 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' ' HG ' ' A' ' 25' ' ' LEU . 86.0 m-70 -105.72 119.65 39.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 1.0 110.01 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.55 137.55 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.209 -0.932 . . . . 1.0 110.383 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 ' CD1' ' A' ' 21' ' ' PHE . 15.5 tp -120.63 136.98 54.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.393 -0.817 . . . . 1.0 110.186 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.2 mt -141.73 100.7 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.0 109.859 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 18' ' ' THR . 0.3 OUTLIER -98.25 170.93 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 1.0 110.499 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' ASN . 40.4 m-70 -126.52 -168.31 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.421 -0.8 . . . . 1.0 109.665 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 61' ' ' HIS . 15.2 p-10 -14.78 81.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.815 1.042 . . . . 1.0 113.815 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 15' ' ' VAL . 62.7 m -78.63 165.47 23.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.694 -0.629 . . . . 1.0 109.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' VAL . 3.9 tp-100 -105.27 167.16 9.91 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.112 -0.992 . . . . 1.0 109.234 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.434 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -66.58 0.51 2.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.95 -1.094 . . . . 1.0 112.5 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.77 -21.42 33.88 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -50.99 -20.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -1.131 . . . . 1.0 111.523 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 m -44.42 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.305 -0.872 . . . . 1.0 110.736 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -170.78 -119.15 0.49 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.79 130.57 10.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.017 . . . . 1.0 110.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 8' ' ' LEU . 25.4 t -85.33 93.36 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 1.0 109.144 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -101.5 150.76 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.059 . . . . 1.0 110.934 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 64.2 t80 -118.12 138.04 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.517 -0.739 . . . . 1.0 109.692 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 10.3 pt20 -121.35 151.59 39.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 1.0 110.5 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . . . -167.8 -153.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 1.0 110.068 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -67.37 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.973 . . . . 1.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 57.2 t30 -130.25 18.76 5.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 1.0 110.152 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . . . -99.04 149.89 22.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -159.71 74.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 1.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.493 ' OG ' HD11 ' A' ' 8' ' ' LEU . 83.5 p -82.95 168.45 17.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.82 96.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -95.1 -174.22 3.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 1.0 110.08 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -125.49 107.54 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 1.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD22 ' HZ ' ' A' ' 21' ' ' PHE . 55.7 tp -108.42 138.89 43.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 1.0 110.567 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -131.11 140.45 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.815 . . . . 1.0 109.945 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 67' ' ' MET . 97.6 t -97.41 116.33 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.912 . . . . 1.0 110.195 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -93.85 130.67 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 110.491 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -68.23 179.03 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 1.0 110.039 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.232 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.43 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.267 0.556 . . . . 1.0 110.345 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 27' ' ' GLU . 6.1 pt -88.26 -170.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 1.0 110.272 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -135.95 -165.58 1.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.0 110.231 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.634 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 99.4 t -126.14 125.5 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 1.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -86.79 -48.0 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 1.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -117.79 107.27 44.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.65 -0.656 . . . . 1.0 109.886 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.76 176.83 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.679 1.357 . . . . 1.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.742 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 80.9 mt -60.16 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 1.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 88.4 t80 -152.36 163.31 39.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 1.0 109.549 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -87.45 145.92 19.86 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.842 -1.303 . . . . 1.0 109.842 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG22 ' N ' ' A' ' 12' ' ' GLU . 8.2 p -153.8 164.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.0 110.241 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 11' ' ' VAL . 36.9 mt-10 -121.26 163.48 18.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 1.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 17' ' ' GLU . 4.2 p -155.65 132.61 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 1.0 109.931 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CA ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -87.32 76.08 9.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 1.0 110.959 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 14' ' ' PHE . 32.8 t 59.36 97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.841 0.829 . . . . 1.0 112.049 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' ' N ' ' A' ' 63' ' ' CYS . . . 46.12 23.34 1.12 Allowed Glycine 0 N--CA 1.495 2.592 0 O-C-N 121.943 -0.473 . . . . 1.0 113.217 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HG3' ' CA ' ' A' ' 14' ' ' PHE . 1.8 mm-40 -62.49 -75.17 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 119.714 1.757 . . . . 1.0 107.653 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.701 HG23 ' CE1' ' A' ' 61' ' ' HIS . 63.3 m -162.02 151.38 15.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.783 -0.573 . . . . 1.0 109.672 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB3' ' H ' ' A' ' 60' ' ' LEU . . . -117.31 163.11 16.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 1.0 109.624 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -155.89 81.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.934 -1.104 . . . . 1.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -102.36 115.49 30.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -0.901 . . . . 1.0 109.591 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG2' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -112.16 157.34 20.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 1.0 111.111 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 23' ' ' ILE . 12.1 tt -167.09 120.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 1.0 109.488 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 2.7 tt0 -87.16 129.81 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 1.0 110.727 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -96.74 -171.99 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.814 . . . . 1.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -105.45 -83.82 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 1.0 110.398 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' HG21 ' A' ' 2' ' ' ILE . 55.6 mt-10 -90.78 121.89 67.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.0 110.216 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.26 111.87 3.39 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.41 1.216 . . . . 1.0 110.078 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.91 -64.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 1.0 110.444 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.44 157.6 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 1.0 110.335 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -107.58 -175.56 2.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 1.0 109.91 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.97 -159.33 9.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.471 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -156.8 171.05 21.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -1.081 . . . . 1.0 109.882 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.874 ' CD2' HD12 ' A' ' 58' ' ' LEU . 56.2 m95 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.038 -1.039 . . . . 1.0 110.648 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' CD ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -157.23 126.08 5.81 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mt -64.37 -133.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 1.0 108.873 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -24.76 6.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.328 -1.483 . . . . 1.0 109.355 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA2' ' CD ' ' A' ' 35' ' ' LYS . . . 162.64 40.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -115.72 101.74 54.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.265 -1.138 . . . . 1.0 110.299 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.73 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.889 1.468 . . . . 1.0 110.324 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 42' ' ' THR . 0.2 OUTLIER -78.82 -164.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 1.0 110.677 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -162.08 172.12 16.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 1.0 110.225 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.0 125.38 34.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 1.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -174.88 -59.93 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 1.0 110.343 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 41.6 Cg_endo -71.13 -87.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.447 1.235 . . . . 1.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -142.15 52.88 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.877 -1.139 . . . . 1.0 110.487 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.04 138.07 31.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.202 -0.936 . . . . 1.0 110.167 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 4.2 tt0 -123.65 53.49 1.36 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.105 -0.997 . . . . 1.0 110.002 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.8 114.98 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.87 -1.144 . . . . 1.0 109.908 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.0 99.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 1.0 110.238 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HB2' ' ND1' ' A' ' 56' ' ' HIS . 18.8 pt-20 -124.85 141.87 51.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.95 . . . . 1.0 110.277 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.85 14.48 2.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.12 -30.3 6.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.388 -1.085 . . . . 1.0 110.388 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -90.9 -16.24 28.49 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.309 -1.113 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.88 114.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.161 -0.962 . . . . 1.0 110.383 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.484 ' HB2' HG23 ' A' ' 23' ' ' ILE . 83.6 m-70 -95.1 111.63 23.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.843 . . . . 1.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 22' ' ' GLU . 28.7 mm -120.7 147.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 1.0 110.07 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.874 HD12 ' CD2' ' A' ' 34' ' ' TRP . 4.5 tt -123.9 130.51 52.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 1.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.786 ' N ' HD23 ' A' ' 58' ' ' LEU . 25.1 mt -133.46 103.1 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.659 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -125.43 127.34 46.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.006 -1.059 . . . . 1.0 111.722 -178.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.701 ' CE1' HG23 ' A' ' 18' ' ' THR . 12.8 m-70 -103.7 28.1 6.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.846 0.832 . . . . 1.0 108.82 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.624 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 m-20 -108.53 -4.58 17.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.596 -0.69 . . . . 1.0 111.319 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 76.8 m -43.04 161.14 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.274 -0.891 . . . . 1.0 111.395 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.66 ' C ' HG11 ' A' ' 86' ' ' VAL . 18.8 mt-30 -161.24 -166.78 1.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 1.0 110.213 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -3.44 18.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 1.0 111.152 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.85 -36.25 5.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.797 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -48.57 -23.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 1.0 111.548 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 p -46.34 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.933 . . . . 1.0 110.762 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -175.21 -125.67 0.88 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -139.76 142.94 36.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -1.149 . . . . 1.0 110.513 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 55.2 t -94.51 105.2 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.634 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -107.77 108.09 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 1.0 110.625 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 24.4 t80 -81.07 145.01 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 1.0 109.586 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -121.2 111.01 16.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 1.0 110.593 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -147.26 109.57 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.528 -0.732 . . . . 1.0 109.502 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 57.93 -162.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 1.0 109.596 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 11.1 p30 -62.85 -19.49 64.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB1' ' CG2' ' A' ' 4' ' ' VAL . . . -72.7 145.36 47.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 1.0 110.398 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -153.57 133.37 13.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 1.0 110.094 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.562 ' OG ' HD11 ' A' ' 8' ' ' LEU . 69.8 p -112.16 178.35 4.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.947 . . . . 1.0 110.171 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.14 79.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 1.0 110.511 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -82.64 -178.74 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.985 . . . . 1.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -114.09 136.74 52.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 1.0 110.25 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 25.7 tp -136.55 134.25 37.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -131.92 125.88 32.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 1.0 109.744 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 67' ' ' MET . 51.4 t -90.92 112.29 24.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.304 -0.872 . . . . 1.0 109.949 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -75.75 172.38 12.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 1.0 110.519 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -86.73 176.47 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 1.0 110.226 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.108 179.8 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.611 HD13 HG11 ' A' ' 30' ' ' VAL . 20.7 pt -143.46 150.67 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.94 . . . . 1.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.69 -172.66 2.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 1.0 110.301 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.0 111.53 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.27 -38.98 19.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.449 -0.945 . . . . 1.0 108.449 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -122.5 106.44 35.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.66 173.46 9.94 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.617 1.325 . . . . 1.0 111.032 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.825 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 12.8 mt -73.77 -160.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.515 -0.741 . . . . 1.0 109.981 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -148.66 114.05 5.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0 109.835 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 83' ' ' ASN . . . -64.4 132.3 38.55 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.6 p -154.14 161.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -1.179 . . . . 1.0 110.586 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' VAL . 2.4 pt-20 -107.49 169.63 8.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.0 109.96 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 14' ' ' PHE . 9.9 p -160.35 172.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 1.0 110.49 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -111.68 137.46 49.54 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.461 -0.774 . . . . 1.0 108.948 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 63' ' ' CYS . 93.2 t -46.11 111.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.415 -0.803 . . . . 1.0 111.403 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 127.24 -47.33 1.03 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.37 -1.076 . . . . 1.0 109.965 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -130.17 139.93 50.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 110.569 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.16 20.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 1.0 109.744 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -130.64 100.68 5.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 1.0 110.755 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 51.8 m-85 -104.41 154.38 19.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 1.0 109.743 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 8' ' ' LEU . 44.3 mt-10 -140.92 157.61 45.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.002 -1.061 . . . . 1.0 110.611 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -169.48 139.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.446 -0.784 . . . . 1.0 110.154 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.13 132.27 54.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.334 -0.854 . . . . 1.0 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 2' ' ' ILE . 18.4 mt -94.37 -152.57 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 1.0 110.097 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -109.16 -37.77 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -0.834 . . . . 1.0 110.149 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.07 148.28 59.77 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 1.0 110.171 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.6 Cg_endo -74.62 -167.9 0.45 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.677 1.357 . . . . 1.0 110.797 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.53 46.49 22.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 1.0 110.364 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 28' ' ' PRO . 58.9 t -137.58 102.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 1.0 110.349 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -91.99 137.55 32.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.268 -0.895 . . . . 1.0 110.18 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.57 172.98 21.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -122.38 163.55 19.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 1.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.1 m95 -114.05 149.16 35.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 1.0 110.293 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 1.1 ttpt -139.47 131.33 27.63 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.318 -0.864 . . . . 1.0 109.939 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.7 mt -61.46 -112.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.142 -0.974 . . . . 1.0 109.304 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -85.97 12.62 8.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.448 -1.408 . . . . 1.0 110.264 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 35' ' ' LYS . . . 131.19 -1.77 5.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -97.57 112.09 60.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.91 -1.347 . . . . 1.0 109.96 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.3 109.04 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.525 1.276 . . . . 1.0 110.543 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 169.42 17.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.288 -0.882 . . . . 1.0 110.534 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -143.52 24.13 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 1.0 109.742 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.02 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.832 . . . . 1.0 110.753 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -178.58 -59.39 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 1.0 109.74 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 43.6 Cg_endo -70.54 -19.3 32.59 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.584 1.307 . . . . 1.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.89 -58.75 1.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.948 . . . . 1.0 109.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.26 152.13 44.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 1.0 109.95 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 3.1 mm-40 -133.57 86.51 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 1.0 110.409 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.68 128.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 1.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.05 122.47 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 1.0 110.591 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -142.55 162.25 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.0 109.72 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.55 16.76 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.02 -1.05 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.38 -29.86 7.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.984 -1.246 . . . . 1.0 109.984 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -74.12 -28.39 61.32 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.308 -1.113 . . . . 1.0 109.767 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.19 -173.66 1.32 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.376 -0.827 . . . . 1.0 110.063 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.659 ' HB2' HG23 ' A' ' 23' ' ' ILE . 81.1 m-70 -139.41 118.27 12.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 1.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.91 130.47 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 1.0 110.167 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.981 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.0 tt -105.88 136.34 45.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.833 . . . . 1.0 110.349 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.792 ' N ' HD23 ' A' ' 58' ' ' LEU . 69.8 mt -134.2 73.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 1.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 18' ' ' THR . 2.0 mt -72.06 151.12 43.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 1.0 110.533 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.537 ' HA ' HG22 ' A' ' 18' ' ' THR . 56.9 m-70 -113.99 -172.42 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.0 109.6 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 61' ' ' HIS . 63.4 t-20 -14.52 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 61' ' ' HIS . 99.8 m -78.4 172.71 13.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.609 -0.682 . . . . 1.0 109.291 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' O ' HG21 ' A' ' 86' ' ' VAL . 49.4 tp60 -115.0 167.28 10.94 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.023 -1.048 . . . . 1.0 109.128 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 14.0 tp -63.86 -5.96 5.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.033 -1.042 . . . . 1.0 112.308 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.66 -12.53 82.76 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 120.674 -1.266 . . . . 1.0 110.445 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.521 ' HB2' HG21 ' A' ' 86' ' ' VAL . 23.1 mtt -86.06 41.95 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.865 -1.374 . . . . 1.0 110.93 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -90.83 45.02 1.22 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 1.0 110.004 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.1 -125.32 3.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 8.6 pt-20 -144.59 151.89 39.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -1.057 . . . . 1.0 110.336 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 73.2 t -90.33 90.48 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 1.0 109.964 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 p -94.52 99.94 12.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.836 . . . . 1.0 110.287 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -73.28 167.86 20.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.968 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.99 107.31 1.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 1.0 110.258 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' ASN . . . -139.74 122.92 16.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 1.0 109.99 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 2' ' ' ILE . . . 54.89 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 1.0 110.387 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' ALA . 24.3 t30 -128.54 -31.04 2.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.047 -1.033 . . . . 1.0 110.589 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.47 127.68 33.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 1.0 110.511 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 124.03 15.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 1.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.411 ' OG ' ' CD1' ' A' ' 23' ' ' ILE . 14.9 m -112.62 -174.22 2.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 1.0 110.486 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.05 102.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 1.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -99.98 -172.67 2.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.905 . . . . 1.0 109.903 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 19.6 t-20 -114.51 137.23 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.108 -0.995 . . . . 1.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -140.63 124.02 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 1.0 110.607 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -126.54 133.71 51.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 1.0 109.52 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 64' ' ' GLN . 43.4 t -91.79 149.83 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.14 -0.975 . . . . 1.0 110.377 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.66 104.78 4.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 1.0 110.029 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.45 -156.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 1.0 110.461 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.932 -1.032 . . . . 1.0 110.081 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.356 0.598 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.716 HG23 ' HB2' ' A' ' 26' ' ' SER . 47.4 mm -112.87 137.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.312 -0.868 . . . . 1.0 110.485 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -171.36 2.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.348 -0.845 . . . . 1.0 110.063 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.5 t -119.13 119.38 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 1.0 110.1 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -82.64 -49.64 9.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.208 -0.932 . . . . 1.0 109.626 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 5.5 mmtt -119.14 107.91 41.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 1.0 109.913 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.41 -175.86 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.491 1.258 . . . . 1.0 110.482 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 6.6 mt -79.2 -172.65 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 1.0 110.494 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.35 136.48 33.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 1.0 110.125 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.89 149.91 36.84 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -160.11 154.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.161 . . . . 1.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.05 162.4 17.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 1.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.7 p -160.35 137.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 1.0 109.818 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -88.32 55.65 3.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.379 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 63' ' ' CYS . 5.9 p 36.55 76.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 CA-C-O 121.776 0.798 . . . . 1.0 111.95 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 158.13 -30.43 0.48 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.764 -1.735 . . . . 1.0 108.764 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' HG23 ' A' ' 13' ' ' VAL . 1.3 mt-10 -75.8 -161.94 0.19 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -1.027 . . . . 1.0 109.699 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 20.7 m -126.07 112.73 16.2 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.323 -0.951 . . . . 1.0 110.743 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.32 33.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 1.0 109.36 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -126.63 119.35 26.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.945 -1.097 . . . . 1.0 110.744 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.709 ' CD2' HD23 ' A' ' 58' ' ' LEU . 82.9 m-85 -117.21 123.48 46.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -0.883 . . . . 1.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.58 153.15 25.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.017 . . . . 1.0 110.167 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.587 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -166.83 120.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 1.0 109.495 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -107.38 148.34 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 1.0 110.403 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 56' ' ' HIS . 42.9 mt -106.56 -150.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 1.0 109.854 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.716 ' HB2' HG23 ' A' ' 2' ' ' ILE . 68.7 m -116.09 -40.96 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 1.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.13 135.95 12.97 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 1.0 110.179 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.57 153.96 49.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.481 1.253 . . . . 1.0 110.391 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.75 -64.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 1.0 110.301 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.38 -164.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 1.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -115.21 143.79 44.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 1.0 110.132 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.38 -166.22 22.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.45 -1.46 . . . . 1.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.64 154.35 36.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -1.182 . . . . 1.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.898 ' CE3' HD22 ' A' ' 58' ' ' LEU . 30.8 m95 -102.01 147.35 26.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -141.84 132.49 25.52 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.359 -0.838 . . . . 1.0 109.328 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.466 HD21 ' SD ' ' A' ' 67' ' ' MET . 5.5 mt -64.7 -136.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.062 -1.023 . . . . 1.0 109.004 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -25.11 7.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.443 -1.41 . . . . 1.0 109.315 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.35 42.73 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.82 33.03 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.372 -1.076 . . . . 1.0 109.765 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.79 85.24 1.35 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.721 1.38 . . . . 1.0 110.197 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.5 pt? -69.36 -172.97 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.243 -0.911 . . . . 1.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.4 p -136.39 -170.65 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.93 109.64 14.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 1.0 110.149 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 1.2 m -120.29 166.39 15.39 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 1.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 46.7 Cg_endo -72.6 -23.16 20.1 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.599 1.315 . . . . 1.0 110.486 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.39 -25.6 23.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 1.0 110.218 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.35 127.22 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.914 . . . . 1.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.18 147.46 44.18 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 1.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.9 mt -140.33 95.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 1.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -99.54 98.68 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 1.0 109.726 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.27 162.82 25.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 1.0 110.599 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.1 23.62 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 1.0 109.96 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 -86.24 1.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -50.08 -23.77 2.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.75 -0.853 . . . . 1.0 110.747 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -134.74 160.48 38.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 1.0 110.655 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.591 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.0 m-70 -143.34 105.42 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -104.83 144.49 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 1.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.898 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -128.87 136.18 50.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.0 110.272 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.58 93.9 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 1.0 109.8 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.56 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -103.09 103.89 14.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 1.0 110.531 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' C ' ' A' ' 62' ' ' ASN . 67.1 m-70 -69.44 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 1.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 61' ' ' HIS . 3.1 m120 -12.18 79.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 113.85 1.056 . . . . 1.0 113.85 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.813 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.7 m -71.63 145.44 48.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.781 . . . . 1.0 109.092 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.796 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -99.18 172.92 7.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 1.0 110.902 -179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -4.63 22.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.639 -0.663 . . . . 1.0 111.136 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.73 -11.91 76.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.793 -1.194 . . . . 1.0 110.336 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 86' ' ' VAL . 9.0 mtt -85.95 43.26 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.905 -1.35 . . . . 1.0 110.615 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.5 40.73 1.04 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 1.0 109.75 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.9 2.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.886 -1.285 . . . . 1.0 109.886 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.44 152.17 44.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.403 -1.057 . . . . 1.0 110.539 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 83.6 t -92.99 87.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 1.0 109.475 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.0 p -94.52 112.23 23.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 1.0 110.894 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' LYS . 46.8 t80 -91.26 137.97 31.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 1.0 109.398 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -120.13 138.26 53.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.979 . . . . 1.0 111.087 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -155.56 47.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.72 . . . . 1.0 109.356 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 62.22 132.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.782 . . . . 1.0 110.425 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.23 24.07 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 1.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.21 139.03 16.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.025 . . . . 1.0 109.972 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -155.96 68.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 1.0 110.8 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 8' ' ' LEU . 71.1 p -54.65 171.88 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.981 -1.074 . . . . 1.0 109.554 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.88 104.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.035 -1.04 . . . . 1.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -98.57 -167.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 1.0 109.828 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -128.19 137.45 52.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 1.0 109.787 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 84' ' ' LEU . 1.9 tm? -139.27 116.31 10.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.043 -1.036 . . . . 1.0 111.146 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.486 ' N ' HD13 ' A' ' 84' ' ' LEU . 11.7 mttt -111.12 132.82 53.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.416 -0.803 . . . . 1.0 109.39 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 64' ' ' GLN . 28.0 t -103.9 111.09 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.228 -0.92 . . . . 1.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -99.58 129.9 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.72 -176.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 1.0 110.374 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.321 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.279 0.561 . . . . 1.0 110.12 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 26' ' ' SER . 37.6 mm -101.93 140.31 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.128 -0.983 . . . . 1.0 110.073 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.3 mt-10 -123.84 -178.6 4.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 1.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.917 HG23 ' HB1' ' A' ' 78' ' ' ALA . 74.2 t -105.4 115.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.804 . . . . 1.0 109.93 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -75.95 -39.76 55.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 5.6 mptt -124.95 106.92 28.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.65 176.57 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.565 1.297 . . . . 1.0 110.705 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 4.1 mt -72.05 172.22 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 1.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 20.6 m-85 -129.25 3.71 5.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.137 -0.977 . . . . 1.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.702 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 70.43 153.52 1.04 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 11' ' ' VAL . 7.1 p -156.95 134.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.114 . . . . 1.0 110.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -109.07 150.64 27.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.0 110.068 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 14' ' ' PHE . 1.1 p -160.55 -158.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.454 -0.779 . . . . 1.0 109.782 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.635 ' N ' HG13 ' A' ' 13' ' ' VAL . 5.8 m-85 -107.33 -154.51 0.53 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 63' ' ' CYS . 81.6 t -120.16 121.76 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.85 -1.156 . . . . 1.0 110.763 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.34 -48.95 0.94 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -65.14 -147.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -1.109 . . . . 1.0 110.617 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CG ' ' A' ' 61' ' ' HIS . 4.6 p -128.81 161.06 30.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 110.996 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -105.68 170.13 8.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.69 . . . . 1.0 109.477 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 93.38 2.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.013 . . . . 1.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 81.9 m-85 -94.67 162.63 13.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.51 -0.744 . . . . 1.0 109.552 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 8' ' ' LEU . 4.2 mp0 -140.67 153.98 46.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.945 -1.097 . . . . 1.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' OG ' ' A' ' 80' ' ' SER . 3.6 tt -170.55 138.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.598 -0.689 . . . . 1.0 109.814 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' C ' HD12 ' A' ' 25' ' ' LEU . 30.1 tt0 -96.43 170.41 9.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 1.0 110.559 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.934 HD13 ' CD2' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -159.17 175.03 13.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.522 -0.736 . . . . 1.0 109.889 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 2' ' ' ILE . 9.7 m -93.31 -44.16 8.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.083 -1.011 . . . . 1.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.82 150.79 53.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.95 . . . . 1.0 110.132 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.85 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.732 1.386 . . . . 1.0 110.652 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.65 76.65 9.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 1.0 110.218 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.456 HG11 HD22 ' A' ' 25' ' ' LEU . 7.4 p -95.17 143.73 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.29 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 31' ' ' HIS . 25.9 p80 -76.32 117.79 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.875 . . . . 1.0 110.231 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.92 -166.14 10.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.346 -1.502 . . . . 1.0 109.346 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.71 128.03 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -1.2 . . . . 1.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.758 ' CE3' HD22 ' A' ' 58' ' ' LEU . 28.2 m95 -94.7 154.66 17.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 1.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 4.4 ptmt -152.07 156.08 39.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 1.0 109.968 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.504 HD21 ' HE3' ' A' ' 67' ' ' MET . 5.4 mt -65.16 -133.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.903 . . . . 1.0 109.354 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -52.15 -23.31 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.474 -1.391 . . . . 1.0 110.126 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 159.52 39.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.385 -1.486 . . . . 1.0 109.385 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -119.33 109.15 39.04 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.235 -1.156 . . . . 1.0 109.607 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.21 111.56 3.34 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.586 1.308 . . . . 1.0 110.037 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 42' ' ' THR . 1.0 OUTLIER -114.84 -144.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 1.0 110.153 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 41' ' ' LEU . 4.2 m -143.96 150.9 39.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.986 -1.071 . . . . 1.0 110.319 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 49' ' ' ILE . . . -83.84 113.31 20.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 1.0 110.136 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -177.91 -59.71 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 1.0 110.372 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 38.4 Cg_endo -69.73 -69.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.493 1.26 . . . . 1.0 111.305 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -132.68 64.24 1.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.935 -1.103 . . . . 1.0 110.494 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.43 ' HA ' HD23 ' A' ' 60' ' ' LEU . 8.9 t -169.05 139.93 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 1.0 110.348 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -135.5 85.52 2.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 1.0 110.21 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 43' ' ' ALA . 28.6 mt -80.3 130.2 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 1.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 59' ' ' ILE . 7.4 tt -142.97 102.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 1.0 109.848 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.57 159.27 19.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 1.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -113.44 20.84 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.395 -0.816 . . . . 1.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.84 -101.58 2.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.834 -1.307 . . . . 1.0 109.834 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -50.75 -21.76 1.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.417 -1.049 . . . . 1.0 110.673 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 1.5 mmtt -134.11 173.78 11.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 1.0 110.493 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.934 ' CD2' HD13 ' A' ' 25' ' ' LEU . 19.5 m-70 -126.34 135.95 52.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.0 109.736 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.3 mt -137.16 127.89 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.0 110.882 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.758 HD22 ' CE3' ' A' ' 34' ' ' TRP . 32.6 tp -103.25 149.12 25.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.0 109.963 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 HG21 ' A' ' 50' ' ' ILE . 55.1 mt -145.2 82.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.149 -0.969 . . . . 1.0 109.523 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HE1' ' A' ' 67' ' ' MET . 1.2 mt -76.83 -179.82 5.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 1.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' C ' ' A' ' 62' ' ' ASN . 65.8 m-70 -137.5 -162.4 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.57 -0.706 . . . . 1.0 109.103 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 61' ' ' HIS . 1.7 t-20 -14.25 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 113.415 0.895 . . . . 1.0 113.415 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.899 ' O ' HG13 ' A' ' 15' ' ' VAL . 73.5 m -71.03 163.49 27.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.682 -0.636 . . . . 1.0 110.142 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 4.5 tp-100 -121.51 168.68 11.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.428 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 8.3 tp -76.52 17.04 0.42 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.849 -1.157 . . . . 1.0 112.124 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 -25.54 6.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.026 -1.63 . . . . 1.0 109.026 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.614 ' HE1' HD13 ' A' ' 60' ' ' LEU . 54.1 mtp -54.59 -18.58 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -1.116 . . . . 1.0 110.722 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -42.22 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.634 -0.666 . . . . 1.0 110.95 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -176.81 -116.74 0.48 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.336 -1.506 . . . . 1.0 109.336 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.72 130.39 10.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 27.6 t -79.1 100.4 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 1.0 109.168 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -99.34 116.55 31.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.0 110.947 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 31.5 t80 -87.54 146.4 25.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 1.0 108.959 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 105.3 8.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.959 -1.088 . . . . 1.0 111.055 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -139.45 121.48 15.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.595 -0.691 . . . . 1.0 109.369 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.32 -153.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 1.0 109.738 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -72.02 -10.51 59.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 110.719 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB2' ' HA ' ' A' ' 3' ' ' GLU . . . -80.13 155.5 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.042 . . . . 1.0 110.525 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -159.9 95.51 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 110.013 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.679 ' OG ' HD11 ' A' ' 23' ' ' ILE . 36.8 m -85.51 167.54 15.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 1.0 110.293 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.415 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.89 106.22 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 1.0 110.894 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.841 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.42 -161.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.989 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -115.66 148.56 39.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.955 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.66 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 55.3 tp -140.82 132.44 27.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 1.0 110.518 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -132.6 131.2 41.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 1.0 109.825 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.607 ' CG1' HG22 ' A' ' 15' ' ' VAL . 61.1 t -108.44 151.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.309 -0.87 . . . . 1.0 110.124 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.3 mttt -148.34 144.8 27.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 1.0 110.382 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -73.51 146.16 45.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 1.0 110.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.233 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.239 0.543 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.97 118.17 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 1.0 110.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.68 179.0 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.936 . . . . 1.0 110.355 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 78' ' ' ALA . 61.9 t -88.58 106.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 1.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.87 -36.86 84.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.273 -0.892 . . . . 1.0 109.281 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 106.31 27.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.421 -0.799 . . . . 1.0 109.804 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.79 172.82 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.587 1.309 . . . . 1.0 110.864 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 10.6 mt -82.05 177.73 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.765 . . . . 1.0 109.56 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -136.25 6.65 3.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.941 -1.099 . . . . 1.0 111.483 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 62.41 144.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 1.0 109.997 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 5.8 m -141.36 -175.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -1.165 . . . . 1.0 110.14 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.43 158.16 45.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.194 -0.941 . . . . 1.0 110.322 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.473 HG23 ' CB ' ' A' ' 17' ' ' GLU . 2.9 p -153.87 134.37 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.348 -0.845 . . . . 1.0 109.837 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -92.09 55.19 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 1.0 110.546 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t 48.44 89.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.87 . . . . 1.0 110.808 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 128.44 -33.99 3.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.044 -1.622 . . . . 1.0 109.044 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' CB ' HG23 ' A' ' 13' ' ' VAL . 2.2 mt-10 -67.34 -162.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.351 -1.088 . . . . 1.0 109.552 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 m -135.64 119.59 17.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.135 -0.978 . . . . 1.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.97 165.25 23.67 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.348 -0.845 . . . . 1.0 109.077 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -147.13 115.57 6.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.923 -1.111 . . . . 1.0 110.883 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 71.9 m-85 -113.82 130.8 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.0 109.758 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . 24.4 mp0 -115.06 151.61 33.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 1.0 110.649 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 56' ' ' HIS . 13.1 tt -170.87 154.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.447 -0.783 . . . . 1.0 109.73 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.488 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -151.3 160.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 1.0 110.311 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.721 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.4 mm? -112.98 -168.76 1.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 1.0 109.898 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -99.55 -45.32 5.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 1.0 110.129 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.28 153.97 38.05 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 1.0 110.117 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.683 ' O ' HG23 ' A' ' 30' ' ' VAL . 49.3 Cg_endo -78.35 -166.02 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.717 1.377 . . . . 1.0 110.485 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.82 54.68 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 1.0 110.398 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' PRO . 60.7 t -134.04 117.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 1.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -98.75 144.7 27.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 1.0 110.025 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -151.13 171.89 30.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.763 -1.335 . . . . 1.0 109.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -139.08 179.22 6.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.384 -1.068 . . . . 1.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 1.018 ' CE3' HD12 ' A' ' 58' ' ' LEU . 59.8 m95 -123.69 133.41 53.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 1.0 110.701 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -129.08 111.47 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.786 . . . . 1.0 110.711 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.806 HD12 HD22 ' A' ' 41' ' ' LEU . 6.6 mt -57.44 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 1.0 108.725 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -92.27 9.05 35.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 1.0 109.497 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 127.79 -1.23 6.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.09 -1.204 . . . . 1.0 110.09 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.6 mm-40 -96.7 137.61 21.42 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.251 . . . . 1.0 109.913 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.97 106.05 2.18 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.613 1.323 . . . . 1.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.806 HD22 HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -108.02 3.37 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 110.573 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 m -70.55 -35.48 73.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.07 . . . . 1.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.74 44.59 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 1.0 110.548 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -115.82 158.96 40.83 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.346 -0.847 . . . . 1.0 110.231 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.53 -12.87 27.34 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.759 1.4 . . . . 1.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.54 -17.81 15.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.0 110.518 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.4 131.84 35.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 1.0 110.218 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -133.15 77.41 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 1.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 58' ' ' LEU . 1.1 pp -96.83 105.32 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 1.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.8 111.54 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 1.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -132.83 161.46 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 1.0 110.094 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.27 33.23 5.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 1.0 110.183 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 56' ' ' HIS . . . 86.38 -91.11 1.7 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -48.24 -24.31 1.14 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.648 -0.913 . . . . 1.0 110.769 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -124.16 165.76 17.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 1.0 110.175 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 23' ' ' ILE . 94.1 m-70 -148.52 114.07 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 1.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 55' ' ' LYS . 55.3 mt -116.4 136.11 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 1.0 110.291 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.018 HD12 ' CE3' ' A' ' 34' ' ' TRP . 3.4 tt -115.57 133.94 55.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.26 -0.9 . . . . 1.0 110.295 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.81 ' N ' HD23 ' A' ' 58' ' ' LEU . 5.6 mt -138.26 83.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 1.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 41' ' ' LEU . 4.6 mt -86.69 116.01 24.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 1.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 62' ' ' ASN . 86.9 m-70 -79.06 -169.65 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 1.0 110.452 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 61' ' ' HIS . 20.4 p-10 -14.95 81.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' HIS . 63.0 m -71.11 178.53 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.69 . . . . 1.0 109.482 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.586 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.4 tp60 -111.28 158.82 18.55 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.092 -1.005 . . . . 1.0 109.102 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 2.1 mp -46.89 -25.29 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.0 111.074 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.72 -119.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.787 ' HB2' HG21 ' A' ' 86' ' ' VAL . 3.3 mtt 42.13 30.73 0.2 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.715 -0.874 . . . . 1.0 111.487 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.21 53.0 2.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 1.0 110.098 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.39 -126.46 2.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.57 154.07 36.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 1.0 110.374 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.907 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 74.5 t -89.28 86.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.328 -0.858 . . . . 1.0 110.031 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' SER . 97.2 p -94.25 109.62 21.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 1.0 110.231 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CZ ' ' HA3' ' A' ' 32' ' ' GLY . 42.5 t80 -78.54 157.44 28.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 1.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -146.1 146.0 30.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 1.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -169.45 -146.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 1.0 110.113 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.8 -69.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 1.0 110.634 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -142.98 33.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 1.0 110.249 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -121.81 120.43 34.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 1.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.18 88.45 2.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 1.0 110.237 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 23' ' ' ILE . 25.7 m -82.36 174.73 10.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.994 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.65 97.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 1.0 110.381 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.921 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -97.41 -163.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.0 109.995 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 129.04 53.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 1.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -127.57 126.52 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.0 110.299 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 137.82 46.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 1.0 109.902 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.787 HG21 ' HB2' ' A' ' 67' ' ' MET . 42.5 t -100.21 108.22 22.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 1.0 110.133 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -86.6 107.54 18.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 1.0 110.219 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.702 ' C ' HD13 ' A' ' 89' ' ' LEU . 1.2 pp20? -62.27 -152.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 1.0 110.281 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.821 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.97 -1.014 . . . . 1.0 110.653 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.169 0.509 . . . . 1.0 110.281 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 25' ' ' LEU . 69.5 mt -131.53 151.13 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 1.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -91.63 9.54 31.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 1.0 111.155 -179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.681 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t 62.06 145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.41 -0.806 . . . . 1.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.79 -41.2 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 1.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -116.79 107.88 45.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.609 -0.682 . . . . 1.0 109.899 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.07 176.65 6.72 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 1.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.809 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 12.4 mt -70.25 171.23 10.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.417 -0.802 . . . . 1.0 110.49 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 21.5 m-85 -129.72 169.23 15.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 1.0 110.074 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 155.52 31.9 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.202 -1.159 . . . . 1.0 110.202 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -159.55 155.23 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 1.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.1 157.11 30.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.983 . . . . 1.0 110.784 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 17' ' ' GLU . 6.8 p -157.87 142.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 1.0 110.078 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -97.41 46.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 1.0 110.472 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 63' ' ' CYS . 11.3 t 61.42 142.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 1.0 110.175 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 87.8 -56.21 4.39 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' CB ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -53.51 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -1.162 . . . . 1.0 109.926 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -115.17 150.33 36.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 1.0 110.367 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' CE2' ' A' ' 21' ' ' PHE . . . -95.1 168.94 10.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 1.0 109.654 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -147.58 97.04 2.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 1.0 110.78 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.97 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 90.8 m-85 -106.07 115.94 31.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 1.0 109.535 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -107.49 151.71 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.042 . . . . 1.0 110.985 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 23' ' ' ILE . 1.4 tt -159.29 123.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -0.767 . . . . 1.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.5 tt0 -87.3 142.05 28.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 1.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.761 ' O ' HD13 ' A' ' 2' ' ' ILE . 4.2 mm? -112.21 19.6 17.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 1.0 110.412 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.81 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.663 -0.648 . . . . 1.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.67 138.73 27.98 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.302 -0.874 . . . . 1.0 110.068 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.62 109.75 2.97 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.584 1.307 . . . . 1.0 110.452 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -174.71 -45.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 1.0 110.346 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG23 HD12 ' A' ' 2' ' ' ILE . 94.3 t -53.27 163.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 1.0 110.48 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 0.3 OUTLIER -178.11 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 1.0 110.104 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 74' ' ' GLN . . . -119.94 -132.42 4.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.433 ' CG ' ' HB2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.89 179.17 7.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -1.11 . . . . 1.0 110.378 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.713 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.5 m95 -127.25 148.44 50.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.103 -0.998 . . . . 1.0 111.622 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.74 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -154.35 -114.78 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.389 -0.82 . . . . 1.0 109.128 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.74 HD12 ' C ' ' A' ' 35' ' ' LYS . 2.7 mp -157.15 -158.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.925 -1.109 . . . . 1.0 108.775 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -22.44 8.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.777 -1.202 . . . . 1.0 109.425 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.09 -113.83 0.01 OUTLIER Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 1.3 mt-30 -134.72 178.43 1.77 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HB2' ' CG ' ' A' ' 33' ' ' GLN . 50.6 Cg_endo -89.29 113.07 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.443 1.233 . . . . 1.0 111.281 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -98.04 -168.27 1.64 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.672 -1.268 . . . . 1.0 110.211 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 4.6 t -113.24 161.91 16.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 1.0 110.086 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.02 123.32 20.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.263 -0.898 . . . . 1.0 109.491 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -175.8 -59.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 1.0 110.96 -179.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 40.2 Cg_endo -67.72 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.412 1.217 . . . . 1.0 111.296 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.11 69.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.14 . . . . 1.0 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 136.88 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 1.0 110.394 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.43 78.61 1.68 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 1.0 109.732 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.89 136.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 1.0 110.233 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 49' ' ' ILE . 1.1 pt -135.32 106.95 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.442 -0.786 . . . . 1.0 109.955 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.7 141.21 34.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 1.0 110.352 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.69 17.9 14.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 1.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 -26.61 16.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.79 -27.03 40.39 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.449 -1.03 . . . . 1.0 109.582 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.01 122.89 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.542 -0.724 . . . . 1.0 109.701 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.54 103.69 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 1.0 109.995 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.75 137.6 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 1.0 110.548 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.754 ' O ' HD13 ' A' ' 59' ' ' ILE . 29.3 tp -109.69 142.68 40.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 1.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.754 HD13 ' O ' ' A' ' 58' ' ' LEU . 38.0 mm -138.44 82.73 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 1.0 110.29 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.695 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.64 167.02 22.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 1.0 110.181 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 35.5 m-70 -129.75 -163.72 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 1.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 16' ' ' GLY . 15.2 p-10 -13.4 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.883 ' O ' HG13 ' A' ' 15' ' ' VAL . 69.6 m -87.61 -173.33 4.28 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.51 -0.744 . . . . 1.0 109.024 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.748 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -167.01 -160.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 1.0 110.098 -179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.48 81.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.865 0.84 . . . . 1.0 109.904 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.62 -40.67 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.604 -1.798 . . . . 1.0 108.604 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.481 ' HB3' HD23 ' A' ' 84' ' ' LEU . 31.0 mtt -87.06 39.95 0.89 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -1.121 . . . . 1.0 110.549 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -91.31 27.4 1.94 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 1.0 110.173 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.49 -109.74 2.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.229 -1.549 . . . . 1.0 109.229 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.1 pt-20 -146.56 139.58 25.49 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.538 -0.978 . . . . 1.0 110.522 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.97 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 26.2 t -78.99 128.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 p -123.97 127.58 48.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.0 111.285 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.524 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 51.1 t80 -104.63 137.11 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 1.0 109.439 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -130.72 144.17 51.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 1.0 109.939 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' CG1' ' A' ' 30' ' ' VAL . . . -159.12 -148.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.805 . . . . 1.0 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.26 51.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 1.0 110.243 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -154.46 30.28 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 1.0 109.931 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 25' ' ' LEU . . . -114.2 108.78 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.024 -1.047 . . . . 1.0 110.164 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.901 . . . . 1.0 110.425 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 6.5 p -102.39 175.57 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 1.0 110.094 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -169.76 103.12 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.123 -0.986 . . . . 1.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.63 -176.14 3.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 1.0 109.752 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -108.1 134.66 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 1.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.697 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 44.3 tp -133.08 141.61 48.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.409 -0.807 . . . . 1.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -139.22 125.93 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.0 110.062 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.748 HG11 ' O ' ' A' ' 64' ' ' GLN . 40.6 t -96.9 132.8 40.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.901 . . . . 1.0 109.921 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -124.23 119.51 29.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 1.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.19 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.935 . . . . 1.0 110.193 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 3.9 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.035 -0.983 . . . . 1.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.484 ' HA ' ' ND2' ' A' ' 77' ' ' ASN . 2.7 mp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.201 0.524 . . . . 1.0 110.278 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.674 HD13 ' N ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -171.11 126.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 1.0 109.85 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.674 ' N ' HD13 ' A' ' 2' ' ' ILE . 15.9 mt-10 -152.72 -77.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 1.0 110.784 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.569 HG22 HD11 ' A' ' 23' ' ' ILE . 46.2 t -47.15 107.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 1.0 111.281 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 2.8 mm-40 -96.23 -26.1 15.55 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.431 -0.793 . . . . 1.0 109.039 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -135.49 119.39 13.03 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.4 168.12 18.78 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.537 1.283 . . . . 1.0 111.763 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.899 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.8 mt -82.4 161.33 22.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.631 -0.668 . . . . 1.0 109.923 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.809 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 2.5 m-85 -115.2 168.12 10.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 1.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.63 124.65 7.91 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.67 179.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 1.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -135.04 161.32 35.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 1.0 110.667 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 17' ' ' GLU . 5.0 p -160.7 129.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 1.0 109.957 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 57.3 4.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.951 . . . . 1.0 110.361 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 87' ' ' LYS . 42.1 t 48.66 91.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.174 -0.954 . . . . 1.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 132.36 -34.92 2.43 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.825 ' CB ' HG23 ' A' ' 13' ' ' VAL . 3.3 mt-10 -67.45 -163.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -1.07 . . . . 1.0 109.656 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.9 m -136.74 115.4 12.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 1.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.55 149.85 31.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.206 -0.934 . . . . 1.0 109.517 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -127.04 137.33 53.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 1.0 110.746 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.969 ' CE1' HG21 ' A' ' 71' ' ' VAL . 62.1 m-85 -133.38 115.45 14.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 1.0 109.797 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.3 154.76 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 1.0 110.731 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 4' ' ' VAL . 9.3 tt -170.32 122.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 1.0 109.911 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.533 ' C ' HD12 ' A' ' 25' ' ' LEU . 21.2 tt0 -88.01 171.62 10.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 1.0 110.217 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.842 HD13 ' CD2' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -150.08 128.36 12.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.817 . . . . 1.0 110.097 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.6 t -67.19 -49.36 64.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 1.0 110.724 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.97 136.32 44.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 1.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.19 -159.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.605 1.318 . . . . 1.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.47 118.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.963 . . . . 1.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.814 HG21 ' OE2' ' A' ' 51' ' ' GLU . 17.8 m -103.22 119.35 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.383 -0.823 . . . . 1.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.09 19.92 2.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 1.0 110.312 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.38 -150.04 23.41 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.12 165.72 2.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -1.04 . . . . 1.0 109.907 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 1.06 ' CE3' HD22 ' A' ' 58' ' ' LEU . 27.8 m95 -104.55 150.6 24.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 1.0 110.374 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 2.3 ttpt -149.3 122.99 9.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 1.0 109.328 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' A' ' 67' ' ' MET . 11.2 mt -64.78 -132.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 1.0 108.824 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -52.46 -24.04 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.427 -1.421 . . . . 1.0 109.436 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 156.18 41.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.527 -1.429 . . . . 1.0 109.527 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -122.27 116.85 29.55 Favored Pre-proline 0 N--CA 1.484 1.273 0 O-C-N 121.271 -1.135 . . . . 1.0 109.213 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.82 99.86 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.562 1.296 . . . . 1.0 110.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 42' ' ' THR . 3.8 pp -70.95 -157.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 1.0 110.421 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.861 ' N ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -166.68 170.07 12.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 1.0 109.755 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.17 105.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 1.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.43 175.04 3.07 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 1.0 110.287 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.44 -24.62 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.676 1.356 . . . . 1.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -79.04 -11.56 60.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 1.0 110.631 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -124.53 167.45 14.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 1.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 84.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 1.0 110.009 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -102.1 131.99 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 1.0 110.268 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.797 ' N ' HD13 ' A' ' 49' ' ' ILE . 6.9 tt -147.95 135.54 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.0 110.214 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.814 ' OE2' HG21 ' A' ' 30' ' ' VAL . 5.1 pt-20 -133.78 176.74 8.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 1.0 110.512 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -136.01 23.11 3.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 1.0 109.977 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.35 -88.65 1.4 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -5.21 27.33 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.623 -0.928 . . . . 1.0 111.077 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -132.65 164.78 25.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.846 -1.159 . . . . 1.0 110.572 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.842 ' CD2' HD13 ' A' ' 25' ' ' LEU . 27.7 m-70 -142.36 127.59 18.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 1.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.63 137.08 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.922 . . . . 1.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.06 HD22 ' CE3' ' A' ' 34' ' ' TRP . 15.7 tp -126.15 144.29 50.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 1.0 110.591 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.3 mt -139.58 115.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 1.0 109.59 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mt -111.09 97.09 6.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.077 -1.014 . . . . 1.0 110.72 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 62' ' ' ASN . 62.7 m-70 -69.87 -166.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.007 . . . . 1.0 109.841 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 61' ' ' HIS . 45.0 p-10 -16.11 82.48 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.197 0.814 . . . . 1.0 113.197 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' HIS . 70.1 m -77.4 -168.14 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.634 -0.666 . . . . 1.0 110.159 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.682 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -129.02 170.8 13.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 86' ' ' VAL . 9.1 tp -78.67 25.1 0.27 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 1.0 111.95 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.68 -23.14 5.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.527 ' HB2' HG21 ' A' ' 86' ' ' VAL . 33.1 mtt -61.3 -12.98 15.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -1.139 . . . . 1.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -43.3 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.416 -0.802 . . . . 1.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.59 -119.14 0.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.371 -1.492 . . . . 1.0 109.371 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.31 149.63 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -1.062 . . . . 1.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 21' ' ' PHE . 78.9 t -89.11 83.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.0 109.54 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -86.02 103.31 14.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 1.0 110.806 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 23' ' ' ILE . 85.9 t80 -98.15 151.64 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 1.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -156.43 129.69 8.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.967 -1.083 . . . . 1.0 111.393 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -139.08 22.72 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.707 0.765 . . . . 1.0 109.269 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . 178.17 -160.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.544 -0.909 . . . . 1.0 108.544 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 12.2 p30 -64.46 -22.8 67.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.923 -1.11 . . . . 1.0 109.741 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.88 169.15 18.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.0 110.216 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.55 102.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.0 110.447 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.428 ' OG ' HG11 ' A' ' 4' ' ' VAL . 71.1 m -75.41 170.08 16.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 1.0 109.954 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' VAL . . . -168.46 111.44 0.57 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.135 -0.978 . . . . 1.0 110.541 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -100.16 -173.71 2.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 1.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -119.07 106.89 12.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 1.0 110.144 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.624 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 65.2 tp -110.88 127.66 55.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.969 . . . . 1.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 3.1 pttp -130.88 113.62 14.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 1.0 110.291 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.709 ' O ' HD12 ' A' ' 65' ' ' LEU . 61.5 t -87.58 104.04 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.224 -0.923 . . . . 1.0 110.233 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.42 154.54 22.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.0 110.128 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.99 -153.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 1.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.311 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 1' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.641 0.734 . . . . 1.0 110.528 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 2.3 pt -117.08 178.88 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.054 -1.029 . . . . 1.0 110.194 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.77 -151.09 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.269 -0.894 . . . . 1.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 87.2 t -130.66 123.57 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.125 -0.984 . . . . 1.0 110.216 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -86.41 -57.18 3.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 1.0 109.326 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 102.96 48.6 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.657 -0.652 . . . . 1.0 109.896 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.93 174.51 10.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.627 1.33 . . . . 1.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 97.6 mt -75.42 174.78 9.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.0 110.355 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -142.94 150.3 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 1.0 109.883 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.98 140.3 28.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 12' ' ' GLU . 44.0 t -138.93 170.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 1.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 11' ' ' VAL . 10.0 pt-20 -138.29 158.35 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.963 -1.086 . . . . 1.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.931 HG23 ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -160.87 138.64 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 1.0 110.393 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.55 51.22 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 1.0 109.865 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 63' ' ' CYS . 23.1 t 51.83 72.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.815 0.817 . . . . 1.0 110.423 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 157.05 -28.57 0.52 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.564 -1.814 . . . . 1.0 108.564 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -73.96 -160.93 0.1 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.979 . . . . 1.0 109.579 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 58.2 m -135.28 116.46 14.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.216 -0.927 . . . . 1.0 110.521 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.11 163.19 25.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 1.0 109.01 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -148.8 124.63 10.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.942 -1.098 . . . . 1.0 111.078 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 8' ' ' LEU . 64.6 m-85 -132.18 109.9 10.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.0 109.282 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -115.85 159.4 21.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0 110.515 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 23' ' ' ILE . 3.1 tt -170.83 123.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -0.764 . . . . 1.0 110.193 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -100.44 157.13 16.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 1.0 110.179 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 56' ' ' HIS . 35.4 mt -114.8 -150.01 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.0 109.922 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -111.43 -70.23 0.82 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 1.0 110.119 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.61 143.49 33.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 1.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . 47.6 Cg_endo -74.08 -174.08 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 1.0 110.555 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' C ' HG13 ' A' ' 30' ' ' VAL . 9.3 t70 53.07 85.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 1.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 25' ' ' LEU . 30.7 m -148.47 174.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 1.0 110.256 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -128.81 130.04 46.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 1.0 109.878 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.68 175.12 23.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.963 -1.255 . . . . 1.0 109.963 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -156.17 151.64 26.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -1.053 . . . . 1.0 109.793 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 34' ' ' TRP . 32.3 m95 -106.92 155.48 19.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 1.0 110.481 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 12.9 ttpt -143.26 112.73 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.335 -0.853 . . . . 1.0 109.61 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 41' ' ' LEU . 1.2 mp -66.37 -123.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 1.0 109.744 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -48.79 -25.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.477 -1.389 . . . . 1.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 148.97 39.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.45 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -136.88 136.91 21.94 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.047 -1.267 . . . . 1.0 109.95 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.22 91.01 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.65 1.342 . . . . 1.0 110.557 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 36' ' ' LEU . 1.4 pt? -69.46 -170.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 1.0 110.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 172.07 13.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.86 . . . . 1.0 109.965 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 104.14 5.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 1.0 110.17 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.407 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.13 176.11 2.26 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 1.0 110.161 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 44' ' ' SER . 46.0 Cg_endo -71.74 -19.43 27.61 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.669 1.352 . . . . 1.0 110.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -102.3 -20.21 14.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 1.0 110.187 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 72.2 m -93.66 131.44 38.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 1.0 110.039 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 1.8 tt0 -104.98 46.16 0.93 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.262 -0.899 . . . . 1.0 109.801 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 49' ' ' ILE . 8.4 tt -79.59 80.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.935 -1.103 . . . . 1.0 109.901 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.16 145.63 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 1.0 110.224 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.94 120.1 18.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.212 -0.93 . . . . 1.0 110.341 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.76 19.59 12.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 1.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.32 -95.29 1.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -50.33 -21.23 1.32 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.671 -0.9 . . . . 1.0 111.101 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -134.07 136.31 43.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.916 -1.115 . . . . 1.0 111.046 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' HD11 ' A' ' 25' ' ' LEU . 76.7 m-70 -121.62 116.44 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 1.0 109.687 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.02 130.08 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 1.0 110.745 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' CE3' ' A' ' 34' ' ' TRP . 47.5 tp -117.13 131.61 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 1.0 109.982 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 96.5 mt -135.72 96.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 1.0 109.957 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 18' ' ' THR . 0.8 OUTLIER -100.2 144.99 28.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 1.0 110.507 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' C ' ' A' ' 62' ' ' ASN . 58.2 m-70 -111.24 -163.46 0.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 1.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 17.6 p-10 -14.49 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.866 ' O ' HG13 ' A' ' 15' ' ' VAL . 75.3 m -80.78 -159.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.694 -0.629 . . . . 1.0 109.645 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.664 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -158.02 -160.78 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.237 -0.914 . . . . 1.0 109.944 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.35 33.22 0.4 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.875 -1.141 . . . . 1.0 111.719 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.48 4.1 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 1.0 108.645 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.585 ' HG2' HD22 ' A' ' 36' ' ' LEU . 34.6 mtt -87.62 37.17 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.567 -0.961 . . . . 1.0 110.46 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 51.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 1.0 109.922 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.58 1.91 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -146.38 148.11 31.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 1.0 110.272 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 77.3 t -89.94 91.37 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 1.0 109.862 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.9 p -96.89 103.23 15.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 1.0 110.533 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -88.24 156.88 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 1.0 109.775 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG3' ' HG2' ' A' ' 79' ' ' LYS . 2.1 mt-30 -149.11 144.93 26.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.05 -1.031 . . . . 1.0 110.656 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.61 -147.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 1.0 109.887 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.83 -62.63 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.005 -1.06 . . . . 1.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -136.93 24.41 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.418 -0.801 . . . . 1.0 109.926 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.75 137.8 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 1.0 110.294 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HG2' ' HG3' ' A' ' 74' ' ' GLN . 5.1 mtmt -144.61 62.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 1.0 110.252 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -74.97 173.6 10.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 1.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.64 98.86 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -86.55 -173.55 4.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -126.45 104.73 8.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 1.0 109.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 56.8 tp -109.36 146.79 33.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 1.0 110.483 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -149.79 112.0 4.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 1.0 109.777 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' O ' ' A' ' 64' ' ' GLN . 42.3 t -79.41 111.74 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.064 -1.022 . . . . 1.0 110.079 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.53 108.5 20.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 1.0 110.246 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.567 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.7 mt-10 -75.22 149.06 39.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 1.0 110.092 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 89' ' ' LEU . 5.6 tt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.199 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.289 0.566 . . . . 1.0 110.206 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.61 153.9 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 1.0 110.106 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.09 178.92 4.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.108 -0.995 . . . . 1.0 110.388 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.7 t -116.84 115.14 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 1.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -87.99 -51.29 5.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 1.0 109.608 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -114.0 105.27 54.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.702 -0.624 . . . . 1.0 110.428 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.4 178.03 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.619 1.326 . . . . 1.0 110.707 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.75 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 7.5 mt -78.34 -170.73 2.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.842 . . . . 1.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 35.1 p90 -152.2 130.5 12.04 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 1.0 109.904 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.51 150.61 30.17 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLU . 48.1 t -149.13 167.97 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.484 -1.01 . . . . 1.0 109.826 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 45.6 mt-10 -125.87 154.99 41.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 1.0 110.368 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 17' ' ' GLU . 3.6 p -154.01 147.95 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 1.0 109.948 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -98.14 47.09 1.0 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.0 111.012 -179.347 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 86' ' ' VAL . 61.1 t 48.79 95.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.219 -0.926 . . . . 1.0 110.717 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' A' ' 62' ' ' ASN . . . 135.61 -38.15 1.82 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.644 -1.782 . . . . 1.0 108.644 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.595 ' HB2' HG23 ' A' ' 13' ' ' VAL . 3.2 mt-10 -69.7 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.484 -1.009 . . . . 1.0 109.179 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -134.27 122.16 22.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.94 -1.1 . . . . 1.0 110.954 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.58 157.7 27.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 1.0 108.859 178.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -139.84 131.16 26.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.838 -1.164 . . . . 1.0 111.051 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 47.2 m-85 -127.98 126.39 41.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 1.0 109.721 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.87 154.72 32.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.971 . . . . 1.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.8 tt -170.33 140.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 1.0 110.008 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -118.27 162.73 17.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.0 110.251 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.752 HD11 ' CD2' ' A' ' 56' ' ' HIS . 45.1 mt -124.97 -154.93 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 109.815 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.81 -30.12 5.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.132 -0.98 . . . . 1.0 110.04 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -127.77 121.95 22.28 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.0 109.847 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.27 116.86 4.87 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.47 1.247 . . . . 1.0 110.611 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.2 -1.87 7.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 1.0 110.64 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.1 t 55.7 64.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.048 -1.033 . . . . 1.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -168.8 135.4 1.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 1.0 110.223 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.94 168.16 24.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 11.4 tt0 -156.32 159.83 39.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.181 -1.188 . . . . 1.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.911 ' CE3' HD22 ' A' ' 58' ' ' LEU . 23.7 m95 -119.89 163.08 18.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 1.0 110.345 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -164.82 150.16 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 110.348 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.9 mt -68.32 -128.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.0 109.204 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -50.25 -24.64 3.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.604 -1.31 . . . . 1.0 110.166 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 156.71 41.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 1.1 mm100 -126.07 109.79 24.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.329 -1.1 . . . . 1.0 110.054 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 39' ' ' GLN . 42.3 Cg_endo -68.84 89.47 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.597 1.314 . . . . 1.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 pt? -69.75 -172.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 1.0 110.634 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.8 m -136.69 156.85 47.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 1.0 110.094 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -78.64 115.21 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 1.0 110.184 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -170.16 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 111.116 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 44.2 Cg_endo -70.83 -90.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.27 1.142 . . . . 1.0 110.837 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -125.23 40.33 3.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.774 -1.204 . . . . 1.0 110.43 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 27.8 t -107.92 146.92 31.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 1.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -141.63 74.38 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 1.0 110.077 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' ILE . 14.1 tt -91.09 128.94 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 1.0 110.481 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.0 118.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 1.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 170.2 16.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 1.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.88 19.94 2.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 1.0 110.216 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.56 -76.91 1.55 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -18.39 18.49 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.662 -0.905 . . . . 1.0 110.684 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.45 126.57 13.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 1.0 110.738 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.752 ' CD2' HD11 ' A' ' 25' ' ' LEU . 70.5 m-70 -103.19 115.12 29.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.797 . . . . 1.0 109.725 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 mt -118.26 144.32 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.004 . . . . 1.0 110.477 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.911 HD22 ' CE3' ' A' ' 34' ' ' TRP . 46.6 tp -132.92 132.56 42.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 1.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mt -132.38 118.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 1.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 mt -119.87 106.71 12.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 1.0 110.529 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' A' ' 62' ' ' ASN . 83.9 m-70 -72.48 -170.86 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 1.0 109.965 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' HIS . 7.0 p-10 -15.02 81.74 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 61' ' ' HIS . 72.8 m -70.92 -158.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.52 -0.738 . . . . 1.0 109.611 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.705 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -138.37 174.48 10.5 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.153 -0.967 . . . . 1.0 108.595 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 4.5 tp -78.37 30.07 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.98 -1.075 . . . . 1.0 112.037 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.79 -11.43 10.25 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.163 -1.575 . . . . 1.0 109.163 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.437 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . 8.5 mtt -85.17 42.85 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 1.0 110.822 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -89.93 62.09 5.53 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.071 -1.018 . . . . 1.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.89 -119.59 1.37 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.796 -1.322 . . . . 1.0 109.796 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 2.2 pt-20 -145.85 156.59 43.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -1.007 . . . . 1.0 110.571 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.81 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 25.0 t -101.94 82.04 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.45 -0.781 . . . . 1.0 109.557 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.34 129.85 35.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 1.0 110.45 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.507 ' CE1' ' NE1' ' A' ' 34' ' ' TRP . 21.5 t80 -98.31 145.81 26.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.478 -0.764 . . . . 1.0 109.679 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -120.66 100.9 7.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 1.0 110.426 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -131.03 89.33 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 55.46 -153.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 1.0 110.341 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -53.35 -24.9 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.0 110.346 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.25 134.22 39.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 1.0 110.191 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.22 149.64 30.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 1.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.578 ' OG ' HD11 ' A' ' 8' ' ' LEU . 70.2 p -138.6 174.91 10.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.95 . . . . 1.0 110.18 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -163.64 104.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 1.0 110.302 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -95.48 -160.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 1.0 110.078 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.59 115.98 9.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.959 . . . . 1.0 110.014 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -124.68 128.95 49.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 1.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.516 ' N ' HD13 ' A' ' 84' ' ' LEU . 2.1 tttp -125.91 136.72 53.37 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.322 -0.861 . . . . 1.0 109.665 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 64' ' ' GLN . 32.1 t -92.64 140.5 16.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 1.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -124.59 128.34 48.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 1.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.09 140.67 37.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 1.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HA ' ' CE2' ' A' ' 14' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.219 0.533 . . . . 1.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 3' ' ' GLU . 2.8 tp -157.26 151.69 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -79.98 -147.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 1.0 110.188 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 HD11 ' A' ' 23' ' ' ILE . 58.8 t -134.65 136.68 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 1.0 110.113 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -86.98 -49.49 7.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.423 -0.798 . . . . 1.0 109.646 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 106.26 51.69 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 1.0 110.337 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -71.74 174.12 11.6 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.556 1.293 . . . . 1.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.818 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 15.5 mt -72.83 178.12 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 1.0 109.789 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.1 m-85 -142.24 132.91 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 1.0 110.073 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.24 141.85 48.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.1 t -141.09 156.84 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -1.086 . . . . 1.0 109.653 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -111.48 150.09 30.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 1.0 110.422 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.01 165.37 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 1.0 110.542 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.91 32.85 5.79 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.525 -0.735 . . . . 1.0 109.222 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 88' ' ' GLU . 10.9 t 64.92 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.69 0.757 . . . . 1.0 110.188 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 142.87 -25.44 2.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.139 -1.584 . . . . 1.0 109.139 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -1.093 . . . . 1.0 109.947 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 95.7 m -136.85 110.19 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 1.0 110.425 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.32 142.65 35.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 1.0 109.688 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -119.73 105.69 11.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 1.0 110.627 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CD2' HD23 ' A' ' 58' ' ' LEU . 62.6 m-85 -96.03 124.95 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 1.0 109.385 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -114.56 152.36 31.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.026 -1.046 . . . . 1.0 110.99 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.811 HD11 HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -167.6 117.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.681 . . . . 1.0 109.547 179.655 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -109.15 165.31 11.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 1.0 110.866 -179.331 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' CD2' ' A' ' 56' ' ' HIS . 40.5 mt -129.08 -144.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 1.0 109.494 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -130.91 -47.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -100.79 160.0 28.0 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.936 . . . . 1.0 110.696 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.99 124.23 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.728 1.383 . . . . 1.0 110.381 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.19 101.07 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 1.0 110.093 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 30' ' ' VAL . 9.9 p -97.21 60.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 28.1 5.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 1.0 109.992 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.23 176.17 28.94 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -158.74 139.96 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -1.101 . . . . 1.0 109.772 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.633 ' CE3' HD22 ' A' ' 58' ' ' LEU . 31.6 m95 -95.52 164.94 12.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 1.0 110.841 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -165.01 160.37 18.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 179.481 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 67' ' ' MET . 0.2 OUTLIER -65.08 -141.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.062 . . . . 1.0 108.838 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.8 -28.16 0.6 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.508 -1.37 . . . . 1.0 110.385 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' HG3' ' A' ' 35' ' ' LYS . . . 164.18 39.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.741 HE21 HD11 ' A' ' 41' ' ' LEU . 26.4 tt0 -123.32 95.91 44.83 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.37 -1.076 . . . . 1.0 108.515 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.72 77.23 3.76 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.693 1.365 . . . . 1.0 111.455 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.741 HD11 HE21 ' A' ' 39' ' ' GLN . 4.2 pp -171.76 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.198 -0.938 . . . . 1.0 110.625 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 41' ' ' LEU . 65.9 m -69.86 -19.69 63.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.933 -1.104 . . . . 1.0 110.299 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.34 100.43 11.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.493 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -179.56 -59.02 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 1.0 110.375 179.78 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 43.9 Cg_endo -74.58 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.44 1.232 . . . . 1.0 110.445 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 30.12 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 1.0 110.16 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 44' ' ' SER . 52.8 t -129.13 155.62 45.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 1.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 80.98 1.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 1.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' ILE . 15.5 tt -82.31 117.28 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 1.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.59 94.54 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 1.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.22 163.05 15.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 1.0 110.359 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.67 26.33 5.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 1.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.21 -96.41 2.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -21.68 2.54 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.635 -0.921 . . . . 1.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -122.05 149.58 43.33 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.022 -1.049 . . . . 1.0 110.173 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.796 ' HB2' HG23 ' A' ' 23' ' ' ILE . 61.6 m-70 -128.29 113.57 15.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 1.0 109.83 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.5 mm -124.08 151.26 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 1.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 21' ' ' PHE . 6.5 tp -136.11 136.86 40.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.797 . . . . 1.0 109.989 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 58' ' ' LEU . 43.9 mm -126.41 93.53 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 1.0 110.276 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 18' ' ' THR . 7.0 mt -89.74 118.43 29.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.903 . . . . 1.0 110.242 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' ASN . 71.7 m-70 -89.66 -167.83 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 1.0 110.289 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.465 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 43.0 t30 -15.35 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' HIS . 57.1 m -75.88 140.1 42.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.586 -0.696 . . . . 1.0 109.397 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.79 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -89.08 -177.39 5.43 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.218 -0.926 . . . . 1.0 110.455 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 86' ' ' VAL . 0.3 OUTLIER -71.8 -1.65 14.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 1.0 111.528 -179.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.35 -17.57 60.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.99 -1.244 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.617 ' HB2' HG21 ' A' ' 86' ' ' VAL . 1.5 mtt -84.73 42.07 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.281 . . . . 1.0 111.243 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -90.96 41.13 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 1.0 110.035 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.18 -139.5 5.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.99 157.95 34.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 1.0 110.509 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 41.9 t -101.11 98.54 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 1.0 109.71 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -96.76 141.1 30.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 1.0 110.76 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 35.9 t80 -121.77 143.44 49.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -0.829 . . . . 1.0 109.54 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -120.06 114.72 22.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 1.0 110.545 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -145.94 132.08 19.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 1.0 109.62 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 54.57 -150.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 1.0 109.765 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -90.35 45.31 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.973 . . . . 1.0 109.929 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.02 167.05 31.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 1.0 110.33 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.66 135.96 8.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 1.0 110.299 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.464 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 p -101.79 176.11 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.489 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -165.58 109.83 0.85 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.992 . . . . 1.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . . . -99.08 179.88 4.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 1.0 109.816 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -114.12 107.94 16.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 1.0 110.089 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.506 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 50.4 tp -108.76 138.92 44.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 1.0 110.35 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -142.03 136.04 29.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 1.0 109.97 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 64' ' ' GLN . 45.2 t -101.28 135.07 39.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.268 -0.895 . . . . 1.0 110.245 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.33 120.33 18.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 15' ' ' VAL . 21.9 mt-10 -84.91 170.16 13.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 1.0 110.037 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.209 179.92 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 1' ' ' LEU . 5.0 tt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.312 0.577 . . . . 1.0 110.262 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.45 -175.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 1.0 110.007 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 2.4 pm0 -147.83 -159.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 1.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.92 107.47 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 1.0 110.306 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -74.96 -34.47 62.05 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 1.0 109.175 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -131.15 107.82 14.97 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.519 -0.738 . . . . 1.0 109.482 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.98 175.28 8.5 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.546 1.287 . . . . 1.0 110.99 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.924 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.7 mt -71.37 -177.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 1.0 109.771 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -122.57 -14.15 7.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.084 -1.01 . . . . 1.0 111.39 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' HB1' ' A' ' 82' ' ' ALA . . . 60.87 118.66 0.01 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.911 -1.275 . . . . 1.0 109.911 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.76 ' O ' HD12 ' A' ' 84' ' ' LEU . 34.4 m -136.5 -176.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.782 -1.423 . . . . 1.0 110.93 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 13' ' ' VAL . 9.2 pt-20 -127.5 173.01 10.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 1.0 109.592 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.646 HG12 ' OE2' ' A' ' 17' ' ' GLU . 25.7 m -149.86 -176.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.088 . . . . 1.0 111.11 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.39 25.22 6.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 13.4 t 61.91 85.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.575 -0.703 . . . . 1.0 110.759 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 137.55 -25.17 3.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.191 -1.163 . . . . 1.0 110.191 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.646 ' OE2' HG12 ' A' ' 13' ' ' VAL . 2.0 pt-20 -76.03 -144.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -1.203 . . . . 1.0 110.269 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.9 m -149.82 111.56 4.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 1.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.74 165.66 22.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 1.0 109.96 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -143.3 110.16 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 1.0 110.772 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HZ ' HD13 ' A' ' 84' ' ' LEU . 95.2 m-85 -112.45 125.02 53.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -0.807 . . . . 1.0 109.593 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.16 157.13 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 1.0 111.335 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 56' ' ' HIS . 9.3 tt -166.32 129.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 1.0 109.556 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -108.63 138.2 45.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 1.0 110.681 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.574 HD11 ' NE2' ' A' ' 56' ' ' HIS . 66.4 mt -94.01 173.36 7.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 1.0 109.751 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -74.29 -61.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.0 . . . . 1.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -117.77 131.04 24.3 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.029 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.13 126.2 9.73 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.513 1.27 . . . . 1.0 110.236 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.63 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 1.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.3 t -97.34 148.19 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 1.0 110.065 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -86.53 -166.47 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.0 110.17 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.84 162.11 35.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 1.0 109.613 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.49 171.65 11.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -1.126 . . . . 1.0 109.98 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.893 ' CE3' HD12 ' A' ' 58' ' ' LEU . 28.8 m95 -111.87 176.37 5.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.106 -0.996 . . . . 1.0 110.589 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 5.6 ttmt -165.38 126.14 1.91 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.388 -0.82 . . . . 1.0 108.812 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.77 -131.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.0 109.112 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -51.65 -24.51 5.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.337 -1.477 . . . . 1.0 109.698 179.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CG ' ' A' ' 35' ' ' LYS . . . 157.38 41.64 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.08 -1.608 . . . . 1.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -122.5 111.84 31.39 Favored Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 1.0 110.555 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.76 96.59 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.679 1.357 . . . . 1.0 109.651 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 42' ' ' THR . 3.1 pp -70.05 -153.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 1.0 110.526 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.887 ' N ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -152.72 -166.04 2.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 1.0 110.027 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.67 107.03 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 1.0 110.047 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 6.0 p -147.67 168.82 10.4 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 1.0 110.235 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 44.5 Cg_endo -72.05 -19.11 26.89 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.543 1.286 . . . . 1.0 110.475 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -23.54 59.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 1.0 110.344 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.5 t -141.36 125.64 17.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 1.0 110.413 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.17 135.1 54.02 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.251 -0.905 . . . . 1.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' HG2' ' A' ' 51' ' ' GLU . 3.5 mt -130.93 95.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.38 -0.825 . . . . 1.0 110.023 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.96 94.03 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 1.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' HG22 ' A' ' 49' ' ' ILE . 4.5 pt-20 -139.57 147.57 41.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 1.0 110.261 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -146.21 19.37 1.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 1.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.77 -23.55 30.27 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -90.07 -20.93 22.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.264 -1.139 . . . . 1.0 109.989 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.3 144.7 3.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.294 -0.879 . . . . 1.0 110.128 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.574 ' NE2' HD11 ' A' ' 25' ' ' LEU . 69.1 m-70 -110.94 118.85 37.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 1.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.53 128.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.34 -0.85 . . . . 1.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 34' ' ' TRP . 4.3 tt -116.23 133.21 56.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 1.0 110.56 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.751 ' N ' HD23 ' A' ' 58' ' ' LEU . 41.0 mm -133.55 86.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.59 103.37 15.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 1.0 110.758 -179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 62' ' ' ASN . 77.2 m-70 -69.69 -156.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 1.0 109.304 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 59.7 t-20 -14.77 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 61' ' ' HIS . 76.7 m -71.78 171.02 12.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.714 -0.616 . . . . 1.0 110.419 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 65' ' ' LEU . 1.2 tp60 -110.07 163.57 13.46 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.361 -0.837 . . . . 1.0 108.905 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.549 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -75.39 5.08 6.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.868 -1.145 . . . . 1.0 111.739 -179.467 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.25 -20.24 28.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.559 ' HB2' HG21 ' A' ' 86' ' ' VAL . 12.0 mtt -55.3 -17.41 4.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 1.0 111.167 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -43.91 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 1.0 110.789 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 67' ' ' MET . . . -174.97 -121.35 0.63 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.92 135.5 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -1.066 . . . . 1.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.1 101.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 1.0 109.843 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -103.56 128.76 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 1.0 110.361 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -108.58 148.2 30.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.0 109.792 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -136.33 137.09 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 1.0 110.55 -179.64 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -165.58 99.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 1.0 110.061 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . 56.93 -89.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 1.0 110.38 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 1' ' ' LEU . 7.3 m-20 -119.18 32.38 6.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.968 -1.082 . . . . 1.0 110.281 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 74' ' ' GLN . . . -118.01 133.85 55.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 1.0 110.195 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 68.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 1.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.8 m -77.94 166.9 22.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.0 109.987 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.31 104.4 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 1.0 110.509 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.924 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.35 -170.67 1.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.08 123.44 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 1.0 109.848 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.779 HD13 ' HZ ' ' A' ' 21' ' ' PHE . 57.5 tp -124.66 138.26 54.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 1.0 110.699 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -140.09 130.56 25.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.404 -0.81 . . . . 1.0 109.604 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 67' ' ' MET . 52.9 t -99.85 118.01 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 1.0 110.366 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 3.3 ttpt -97.99 140.57 32.14 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.32 -0.862 . . . . 1.0 109.665 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.94 -156.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 1.0 109.999 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.884 -1.055 . . . . 1.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.232 0.539 . . . . 1.0 110.308 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 26' ' ' SER . 43.9 pt -121.16 178.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 1.0 110.198 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -108.27 -166.97 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.937 . . . . 1.0 110.271 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG2' ' HA ' ' A' ' 78' ' ' ALA . 89.0 t -121.21 124.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 1.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.83 -31.83 31.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 1.0 110.289 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.2 113.82 6.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 1.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.77 -176.69 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.58 1.305 . . . . 1.0 110.25 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 19.1 mt -73.38 -154.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 1.0 110.396 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -155.98 116.32 3.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 1.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.25 133.46 45.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.16 152.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.302 -1.116 . . . . 1.0 110.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -94.03 175.35 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 1.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 14' ' ' PHE . 6.8 p -154.14 174.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 1.0 110.737 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -117.8 136.6 53.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 1.0 109.582 179.284 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.989 HG23 ' O ' ' A' ' 63' ' ' CYS . 6.4 p -60.07 91.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 1.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' N ' ' HA ' ' A' ' 62' ' ' ASN . . . 140.66 -37.8 1.64 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.017 -1.633 . . . . 1.0 109.017 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -71.99 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 1.0 109.684 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.9 m -160.65 150.32 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 1.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.22 176.99 5.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 1.0 109.197 179.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -160.5 112.29 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.0 111.664 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.863 ' CE2' HG21 ' A' ' 71' ' ' VAL . 47.1 m-85 -117.48 127.25 53.82 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 178.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -115.84 151.62 34.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 1.0 111.147 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 56' ' ' HIS . 1.2 tt -164.26 139.02 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.578 -0.701 . . . . 1.0 109.546 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 25' ' ' LEU . 1.3 mp0 -118.46 154.04 33.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 1.0 110.355 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 56' ' ' HIS . 24.7 mt -116.77 -152.88 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 1.0 110.048 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -121.09 -35.02 3.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 1.0 109.65 179.596 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.07 160.96 42.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.85 134.54 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.659 1.347 . . . . 1.0 110.446 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -171.58 113.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 1.0 110.241 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.82 54.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 1.0 110.088 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -131.53 45.87 2.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 1.0 110.052 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.02 164.18 12.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.044 -1.223 . . . . 1.0 110.044 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.01 169.94 16.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -1.055 . . . . 1.0 109.851 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.806 ' CE3' HD22 ' A' ' 58' ' ' LEU . 42.8 m95 -122.56 138.72 54.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.057 -1.027 . . . . 1.0 110.793 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 1.3 ttmt -121.62 143.27 49.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.527 -0.733 . . . . 1.0 110.287 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 41' ' ' LEU . 7.6 mt -93.96 -93.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 1.0 109.705 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -14.72 62.06 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.097 -1.002 . . . . 1.0 110.083 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' CA ' ' HG2' ' A' ' 35' ' ' LYS . . . 138.16 -10.14 3.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.978 -1.249 . . . . 1.0 109.978 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.99 159.81 28.6 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.065 -1.256 . . . . 1.0 109.605 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.25 79.17 3.02 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.751 1.395 . . . . 1.0 110.561 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 36' ' ' LEU . 1.5 pp -127.6 -15.79 4.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.349 -0.844 . . . . 1.0 110.891 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -69.45 -16.9 63.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 1.0 110.54 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.11 112.63 21.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 1.0 110.26 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.98 170.74 7.43 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.925 . . . . 1.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.38 5.1 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.621 1.327 . . . . 1.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.89 -11.78 11.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.844 -1.16 . . . . 1.0 110.904 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.1 -169.59 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 1.0 110.386 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -144.35 76.39 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.0 110.269 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -95.9 128.34 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 1.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 50' ' ' ILE . 23.0 pt -133.21 133.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 1.0 109.916 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -142.37 137.62 30.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.986 -1.071 . . . . 1.0 110.508 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.62 21.9 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 1.0 110.202 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.05 -64.0 2.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.749 -1.34 . . . . 1.0 109.749 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.58 31.86 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.727 -0.867 . . . . 1.0 110.795 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -153.01 115.72 4.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 25' ' ' LEU . 91.8 m-70 -110.0 117.92 35.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 1.0 109.836 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 56' ' ' HIS . 41.9 mm -121.31 157.81 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 1.0 110.237 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.806 HD22 ' CE3' ' A' ' 34' ' ' TRP . 39.2 tp -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 1.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.02 111.57 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 1.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.742 HD13 ' CE ' ' A' ' 67' ' ' MET . 5.1 mt -110.46 103.26 11.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.049 . . . . 1.0 110.679 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 62' ' ' ASN . 80.6 m-70 -72.13 -162.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 1.0 110.374 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.512 ' HA ' ' N ' ' A' ' 16' ' ' GLY . 39.7 t-20 -12.86 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.555 1.317 . . . . 1.0 114.555 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.989 ' O ' HG23 ' A' ' 15' ' ' VAL . 73.8 m -86.08 -158.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.711 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -158.67 -173.67 4.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.798 -1.189 . . . . 1.0 110.907 179.654 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.21 -18.53 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 1.0 111.465 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.74 -130.32 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.783 -1.727 . . . . 1.0 108.783 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.742 ' CE ' HD13 ' A' ' 60' ' ' LEU . 1.3 mtt 39.42 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.981 -0.717 . . . . 1.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 68' ' ' THR . 19.4 m -91.17 37.64 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.068 -1.02 . . . . 1.0 110.176 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.21 -122.46 3.57 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.491 -1.444 . . . . 1.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -150.09 162.94 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -1.113 . . . . 1.0 110.555 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.863 HG21 ' CE2' ' A' ' 21' ' ' PHE . 70.1 t -104.69 87.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 1.0 109.808 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 p -92.45 107.97 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.938 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 34.1 t80 -79.14 158.77 27.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.685 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.52 109.96 3.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 1.0 110.61 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.38 -146.09 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 1.0 109.625 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.12 43.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -0.991 . . . . 1.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 2' ' ' ILE . 49.3 t30 -163.11 30.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -0.846 . . . . 1.0 110.004 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . . . -113.03 74.27 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 1.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -86.59 86.1 7.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.864 . . . . 1.0 110.431 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.647 ' OG ' HD11 ' A' ' 8' ' ' LEU . 77.5 p -81.73 -179.22 7.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -0.945 . . . . 1.0 110.117 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.49 89.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 1.0 110.383 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -98.36 -177.52 3.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 1.0 110.123 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -110.49 138.76 46.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 1.0 110.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' SD ' ' A' ' 67' ' ' MET . 44.3 tp -134.69 130.35 36.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 1.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -143.75 147.26 33.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 1.0 109.687 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.711 HG11 ' O ' ' A' ' 64' ' ' GLN . 25.4 t -105.82 158.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.059 -1.026 . . . . 1.0 110.736 -179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -130.69 146.11 52.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 1.0 109.664 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -81.98 -160.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.0 110.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.961 -1.018 . . . . 1.0 110.269 179.892 . . . . . . . . 1 1 . 1 stop_ save_